drug_internal_id,drug_id,drug_name,protein_internal_id,protein_id,protein_name,pchembl_max,pchembl_avg,best_value,num_measurements,confidence
111185,CHEMBL1000,CETIRIZINE,127,CHEMBL231,Histamine H1 receptor,8.23,7.5,5.89,12,9
111185,CHEMBL1000,CETIRIZINE,102,CHEMBL1941,Histamine H2 receptor,5.73,5.73,1851.4,1,8
111185,CHEMBL1000,CETIRIZINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.67,5.67,2117.8,1,8
165474,CHEMBL100116,PENTAZOCINE,137,CHEMBL237,Kappa-type opioid receptor,8.66,8.06,2.2,3,9
165474,CHEMBL100116,PENTAZOCINE,129,CHEMBL233,Mu-type opioid receptor,8.57,7.65,2.7,12,9
165474,CHEMBL100116,PENTAZOCINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,8.33,8.13,4.7,2,9
165474,CHEMBL100116,PENTAZOCINE,136,CHEMBL236,Delta-type opioid receptor,7.21,7.21,62.0,1,9
165474,CHEMBL100116,PENTAZOCINE,117512,CHEMBL4105907,Sigma intracellular receptor 2,5.83,5.8,1465.0,3,9
111482,CHEMBL1002,LEVOSALBUTAMOL,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,8.49,7.53,3.2,6,9
111482,CHEMBL1002,LEVOSALBUTAMOL,78,CHEMBL1963,Thyrotropin receptor,6.9,6.19,125.9,7,9
111482,CHEMBL1002,LEVOSALBUTAMOL,43,CHEMBL210,Beta-2 adrenergic receptor,6.84,6.58,144.54,6,9
111482,CHEMBL1002,LEVOSALBUTAMOL,11365,CHEMBL289,Cytochrome P450 2D6,5.9,5.9,1258.9,1,9
112480,CHEMBL1006,AMIFOSTINE,130,CHEMBL234,D(3) dopamine receptor,6.18,5.95,655.0,2,8
112560,CHEMBL1007,GONADORELIN,118,CHEMBL1855,Gonadotropin-releasing hormone receptor,8.0,8.0,10.0,1,8
112651,CHEMBL1008,BEPRIDIL,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,7.64,6.51,22.91,14,9
112651,CHEMBL1008,BEPRIDIL,169,CHEMBL1940,Voltage-dependent L-type calcium channel subunit alpha-1C,5.85,5.85,1400.0,1,9
112651,CHEMBL1008,BEPRIDIL,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,5.68,5.68,2100.0,1,8
112651,CHEMBL1008,BEPRIDIL,137,CHEMBL237,Kappa-type opioid receptor,5.64,5.64,2300.0,1,8
112651,CHEMBL1008,BEPRIDIL,130,CHEMBL234,D(3) dopamine receptor,5.58,5.58,2600.0,1,8
112655,CHEMBL1009,LEVODOPA,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,6.5,6.5,316.2,1,9
112655,CHEMBL1009,LEVODOPA,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.3,6.3,501.2,1,9
112655,CHEMBL1009,LEVODOPA,96,CHEMBL221,Prostaglandin G/H synthase 1,6.17,6.17,670.0,1,8
112655,CHEMBL1009,LEVODOPA,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,5.67,5.67,2146.0,1,8
112655,CHEMBL1009,LEVODOPA,9,CHEMBL203,Epidermal growth factor receptor,5.54,5.54,2880.0,1,8
12417,CHEMBL101,PHENYLBUTAZONE,119104,CHEMBL4523354,Nicotinate phosphoribosyltransferase,10.0,10.0,0.1,1,9
12417,CHEMBL101,PHENYLBUTAZONE,103668,CHEMBL1293235,Prelamin-A/C,8.0,8.0,10.0,1,9
12417,CHEMBL101,PHENYLBUTAZONE,101097,CHEMBL5162,Neuropeptide S receptor,6.5,6.5,316.2,1,9
12417,CHEMBL101,PHENYLBUTAZONE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.05,6.05,891.3,1,9
12417,CHEMBL101,PHENYLBUTAZONE,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,5.95,5.95,1122.0,1,9
12417,CHEMBL101,PHENYLBUTAZONE,103665,CHEMBL1293232,Survival motor neuron protein,5.8,5.8,1584.9,1,9
12417,CHEMBL101,PHENYLBUTAZONE,96,CHEMBL221,Prostaglandin G/H synthase 1,5.52,5.52,3000.0,1,8
12417,CHEMBL101,PHENYLBUTAZONE,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,5.5,5.5,3162.3,1,9
112665,CHEMBL1010,CEFOTAXIME SODIUM,101476,CHEMBL5619,DNA repair nuclease/redox regulator APEX1,5.65,5.65,2238.7,1,9
112665,CHEMBL1010,CEFOTAXIME SODIUM,103657,CHEMBL1293224,Microtubule-associated protein tau,5.6,5.6,2511.9,1,9
116349,CHEMBL1014,CANDESARTAN CILEXETIL,87,CHEMBL218,Cannabinoid receptor 1,8.92,8.92,1.2,1,8
116349,CHEMBL1014,CANDESARTAN CILEXETIL,115,CHEMBL227,Type-1 angiotensin II receptor,7.88,7.81,13.2,2,8
116349,CHEMBL1014,CANDESARTAN CILEXETIL,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,6.4,6.27,400.0,2,8
116349,CHEMBL1014,CANDESARTAN CILEXETIL,133,CHEMBL235,Peroxisome proliferator-activated receptor gamma,6.17,6.17,680.0,1,8
116349,CHEMBL1014,CANDESARTAN CILEXETIL,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,6.16,6.16,700.0,1,8
116349,CHEMBL1014,CANDESARTAN CILEXETIL,103660,CHEMBL1293227,Ubiquitin carboxyl-terminal hydrolase 2,6.1,6.1,794.3,1,9
116349,CHEMBL1014,CANDESARTAN CILEXETIL,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",5.86,5.86,1393.1,1,8
116349,CHEMBL1014,CANDESARTAN CILEXETIL,246,CHEMBL2069,Thromboxane A2 receptor,5.77,5.77,1691.1,1,8
116349,CHEMBL1014,CANDESARTAN CILEXETIL,280,CHEMBL256,Adenosine receptor A3,5.72,5.72,1903.2,1,8
116349,CHEMBL1014,CANDESARTAN CILEXETIL,104062,CHEMBL1743121,Solute carrier organic anion transporter family member 1B3,5.72,5.67,1900.0,2,8
116659,CHEMBL1015,EVANS BLUE FREE ACID,11307,CHEMBL1865,Histone deacetylase 6,5.71,5.71,1955.0,1,9
116949,CHEMBL1017,TELMISARTAN,10692,CHEMBL4607,Type-2 angiotensin II receptor,9.48,9.48,0.33,1,8
116949,CHEMBL1017,TELMISARTAN,115,CHEMBL227,Type-1 angiotensin II receptor,9.31,8.69,0.49,11,9
116949,CHEMBL1017,TELMISARTAN,100611,CHEMBL3491,Cytochrome P450 2J2,7.0,6.53,100.0,5,9
116949,CHEMBL1017,TELMISARTAN,133,CHEMBL235,Peroxisome proliferator-activated receptor gamma,6.16,5.84,700.0,7,9
116949,CHEMBL1017,TELMISARTAN,104062,CHEMBL1743121,Solute carrier organic anion transporter family member 1B3,6.02,5.96,960.0,2,8
116949,CHEMBL1017,TELMISARTAN,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,5.99,5.86,1030.0,2,8
116949,CHEMBL1017,TELMISARTAN,101097,CHEMBL5162,Neuropeptide S receptor,5.9,5.9,1258.9,1,9
116949,CHEMBL1017,TELMISARTAN,10472,CHEMBL1901,Cholecystokinin receptor type A,5.62,5.62,2427.4,1,8
116949,CHEMBL1017,TELMISARTAN,129,CHEMBL233,Mu-type opioid receptor,5.59,5.59,2564.1,1,8
116949,CHEMBL1017,TELMISARTAN,125,CHEMBL229,Alpha-1A adrenergic receptor,5.52,5.52,3000.0,1,8
116949,CHEMBL1017,TELMISARTAN,102688,CHEMBL5845,Glycine receptor subunit alpha-1,5.5,5.5,3200.0,1,9
117108,CHEMBL1018,DIENESTROL,19,CHEMBL206,Estrogen receptor,8.46,8.46,3.5,1,8
117108,CHEMBL1018,DIENESTROL,103668,CHEMBL1293235,Prelamin-A/C,8.0,6.85,10.0,2,9
117108,CHEMBL1018,DIENESTROL,25,CHEMBL2034,Glucocorticoid receptor,6.13,6.13,736.3,1,8
117108,CHEMBL1018,DIENESTROL,12911,CHEMBL3397,Cytochrome P450 2C9,6.1,6.1,794.3,2,9
117108,CHEMBL1018,DIENESTROL,12912,CHEMBL3622,Cytochrome P450 2C19,5.5,5.5,3162.28,2,9
118617,CHEMBL1020,TOLMETIN,96,CHEMBL221,Prostaglandin G/H synthase 1,7.39,7.08,41.0,4,9
118617,CHEMBL1020,TOLMETIN,10040,CHEMBL2157,Interleukin-8,7.05,7.05,90.0,1,9
118617,CHEMBL1020,TOLMETIN,126,CHEMBL230,Prostaglandin G/H synthase 2,6.09,6.09,820.0,1,9
118617,CHEMBL1020,TOLMETIN,242,CHEMBL1900,Aldo-keto reductase family 1 member B1,5.62,5.62,2390.0,1,9
119498,CHEMBL1023,BEXAROTENE,275,CHEMBL2061,Retinoic acid receptor RXR-alpha,8.57,7.32,2.7,43,9
119498,CHEMBL1023,BEXAROTENE,277,CHEMBL1870,Retinoic acid receptor RXR-beta,8.23,7.62,5.9,12,9
119498,CHEMBL1023,BEXAROTENE,57,CHEMBL2055,Retinoic acid receptor alpha,8.22,7.49,6.0,2,9
119498,CHEMBL1023,BEXAROTENE,266,CHEMBL2004,Retinoic acid receptor RXR-gamma,8.08,7.55,8.3,13,9
119498,CHEMBL1023,BEXAROTENE,270,CHEMBL2008,Retinoic acid receptor beta,7.3,6.92,50.0,2,9
119498,CHEMBL1023,BEXAROTENE,240,CHEMBL2003,Retinoic acid receptor gamma,6.89,6.54,130.0,2,9
119498,CHEMBL1023,BEXAROTENE,11269,CHEMBL2808,Oxysterols receptor LXR-alpha,6.71,6.71,196.0,1,9
119498,CHEMBL1023,BEXAROTENE,20113,CHEMBL4093,Oxysterols receptor LXR-beta,6.36,6.36,434.0,1,9
119498,CHEMBL1023,BEXAROTENE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.12,6.12,749.7,1,8
119640,CHEMBL1024,IFOSFAMIDE,103668,CHEMBL1293235,Prelamin-A/C,7.25,7.25,56.2,1,9
119717,CHEMBL1025,ISOFLUROPHATE,93,CHEMBL220,Acetylcholinesterase,6.92,6.92,120.0,1,9
121124,CHEMBL1026,FENOLDOPAM MESYLATE,103985,CHEMBL1741189,FAD-linked sulfhydryl oxidase ALR,5.86,5.86,1373.0,1,8
121124,CHEMBL1026,FENOLDOPAM MESYLATE,101361,CHEMBL5857,Trace amine-associated receptor 1,5.57,5.57,2703.0,1,8
122170,CHEMBL1027,TIAGABINE,113,CHEMBL1903,Sodium- and chloride-dependent GABA transporter 1,7.77,7.03,16.98,8,9
122901,CHEMBL1029,MIGLUSTAT,11815,CHEMBL3761,Beta-glucosidase,7.85,6.8,14.0,7,9
122901,CHEMBL1029,MIGLUSTAT,10977,CHEMBL2608,Lysosomal alpha-glucosidase,7.0,6.9,100.0,3,9
122901,CHEMBL1029,MIGLUSTAT,11997,CHEMBL2748,"Sucrase-isomaltase, intestinal",6.3,6.3,500.0,1,8
122901,CHEMBL1029,MIGLUSTAT,1,CHEMBL2074,Maltase-glucoamylase,5.68,5.68,2100.0,1,8
12825,CHEMBL103,PROGESTERONE,36,CHEMBL208,Progesterone receptor,10.0,8.6,0.1,43,9
12825,CHEMBL103,PROGESTERONE,48,CHEMBL1994,Mineralocorticoid receptor,9.41,8.05,0.39,6,9
12825,CHEMBL103,PROGESTERONE,56,CHEMBL1871,Androgen receptor,8.07,7.77,8.5,14,9
12825,CHEMBL103,PROGESTERONE,25,CHEMBL2034,Glucocorticoid receptor,7.52,7.21,30.5,10,9
12825,CHEMBL103,PROGESTERONE,10503,CHEMBL2421,Corticosteroid-binding globulin,7.38,7.38,41.69,1,8
12825,CHEMBL103,PROGESTERONE,12643,CHEMBL3305,Sex hormone-binding globulin,6.94,6.94,114.82,1,9
12825,CHEMBL103,PROGESTERONE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.58,5.99,260.0,3,8
12825,CHEMBL103,PROGESTERONE,11904,CHEMBL2998,P2X purinoceptor 3,5.8,5.8,1600.0,1,9
12825,CHEMBL103,PROGESTERONE,103665,CHEMBL1293232,Survival motor neuron protein,5.7,5.7,1995.3,1,9
12825,CHEMBL103,PROGESTERONE,100857,CHEMBL5409,G-protein coupled bile acid receptor 1,5.56,5.56,2770.0,1,9
12825,CHEMBL103,PROGESTERONE,101283,CHEMBL5685,Solute carrier family 22 member 1,5.52,5.52,3050.0,1,8
123693,CHEMBL1034,DICLOFENAC SODIUM,126,CHEMBL230,Prostaglandin G/H synthase 2,8.89,6.44,1.3,8,9
123693,CHEMBL1034,DICLOFENAC SODIUM,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.6,8.6,2.5,2,9
123693,CHEMBL1034,DICLOFENAC SODIUM,96,CHEMBL221,Prostaglandin G/H synthase 1,8.52,8.46,3.0,2,9
123693,CHEMBL1034,DICLOFENAC SODIUM,12911,CHEMBL3397,Cytochrome P450 2C9,5.8,5.8,1584.89,2,9
123693,CHEMBL1034,DICLOFENAC SODIUM,100481,CHEMBL4681,Aldo-keto reductase family 1 member C3,5.58,5.58,2600.0,1,9
13494,CHEMBL104,CLOTRIMAZOLE,65,CHEMBL1978,Aromatase,8.74,8.74,1.8,1,9
13494,CHEMBL104,CLOTRIMAZOLE,103668,CHEMBL1293235,Prelamin-A/C,8.35,8.35,4.5,1,9
13494,CHEMBL104,CLOTRIMAZOLE,248,CHEMBL1835,Thromboxane-A synthase,7.85,7.85,14.0,1,9
13494,CHEMBL104,CLOTRIMAZOLE,12911,CHEMBL3397,Cytochrome P450 2C9,7.8,6.61,16.0,6,9
13494,CHEMBL104,CLOTRIMAZOLE,12912,CHEMBL3622,Cytochrome P450 2C19,7.8,7.8,16.0,1,8
13494,CHEMBL104,CLOTRIMAZOLE,17045,CHEMBL340,Cytochrome P450 3A4,7.8,7.24,16.0,14,9
13494,CHEMBL104,CLOTRIMAZOLE,10992,CHEMBL4305,Intermediate conductance calcium-activated potassium channel protein 4,7.16,6.92,70.0,3,9
13494,CHEMBL104,CLOTRIMAZOLE,100997,CHEMBL5503,Nuclear receptor subfamily 1 group I member 3,7.1,6.79,80.0,5,9
13494,CHEMBL104,CLOTRIMAZOLE,12949,CHEMBL3522,"Steroid 17-alpha-hydroxylase/17,20 lyase",7.09,7.09,81.5,1,9
13494,CHEMBL104,CLOTRIMAZOLE,11188,CHEMBL3849,Lanosterol 14-alpha demethylase,6.89,6.89,130.0,1,9
13494,CHEMBL104,CLOTRIMAZOLE,169,CHEMBL1940,Voltage-dependent L-type calcium channel subunit alpha-1C,6.23,6.23,590.0,1,9
13494,CHEMBL104,CLOTRIMAZOLE,129,CHEMBL233,Mu-type opioid receptor,6.14,5.94,731.0,2,8
13494,CHEMBL104,CLOTRIMAZOLE,137,CHEMBL237,Kappa-type opioid receptor,6.13,5.87,745.7,2,8
13494,CHEMBL104,CLOTRIMAZOLE,119244,CHEMBL4523494,7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase,6.1,6.1,800.0,1,9
13494,CHEMBL104,CLOTRIMAZOLE,10163,CHEMBL3721,Cytochrome P450 2C8,6.09,6.09,803.0,1,9
13494,CHEMBL104,CLOTRIMAZOLE,130,CHEMBL234,D(3) dopamine receptor,6.05,5.81,899.0,2,8
13494,CHEMBL104,CLOTRIMAZOLE,11365,CHEMBL289,Cytochrome P450 2D6,6.05,6.05,883.0,1,9
13494,CHEMBL104,CLOTRIMAZOLE,12594,CHEMBL3356,Cytochrome P450 1A2,5.9,5.9,1250.0,1,9
13494,CHEMBL104,CLOTRIMAZOLE,11398,CHEMBL4302,ATP-dependent translocase ABCB1,5.89,5.89,1300.0,1,8
13494,CHEMBL104,CLOTRIMAZOLE,103079,CHEMBL1075145,Transitional endoplasmic reticulum ATPase,5.85,5.85,1400.0,1,9
13494,CHEMBL104,CLOTRIMAZOLE,25,CHEMBL2034,Glucocorticoid receptor,5.83,5.83,1481.0,1,8
13494,CHEMBL104,CLOTRIMAZOLE,10579,CHEMBL2414,C-C chemokine receptor type 4,5.8,5.8,1600.0,1,9
13494,CHEMBL104,CLOTRIMAZOLE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,5.79,5.79,1640.0,1,8
13494,CHEMBL104,CLOTRIMAZOLE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.78,5.78,1654.0,1,8
13494,CHEMBL104,CLOTRIMAZOLE,136,CHEMBL236,Delta-type opioid receptor,5.76,5.76,1755.0,1,8
13494,CHEMBL104,CLOTRIMAZOLE,11574,CHEMBL4029,C-X-C chemokine receptor type 1,5.7,5.7,1995.26,2,9
13494,CHEMBL104,CLOTRIMAZOLE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,5.68,5.68,2104.0,1,8
13494,CHEMBL104,CLOTRIMAZOLE,112,CHEMBL1790,Vasopressin V2 receptor,5.6,5.58,2511.89,2,9
13494,CHEMBL104,CLOTRIMAZOLE,280,CHEMBL256,Adenosine receptor A3,5.57,5.54,2686.0,2,8
13494,CHEMBL104,CLOTRIMAZOLE,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.57,5.57,2700.0,1,9
13494,CHEMBL104,CLOTRIMAZOLE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.52,5.52,3019.95,1,9
13494,CHEMBL104,CLOTRIMAZOLE,103516,CHEMBL1250402,Transient receptor potential cation channel subfamily M member 2,5.52,5.52,3000.0,1,9
13494,CHEMBL104,CLOTRIMAZOLE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.51,5.51,3060.0,1,8
13494,CHEMBL104,CLOTRIMAZOLE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.5,5.5,3183.0,1,8
125261,CHEMBL1040,CALCIFEDIOL ANHYDROUS,119911,CHEMBL4630818,Sterol regulatory element-binding protein 1,5.93,5.93,1176.0,1,9
125294,CHEMBL1042,CHOLECALCIFEROL,64,CHEMBL1977,Vitamin D3 receptor,9.68,8.37,0.21,2,9
125294,CHEMBL1042,CHOLECALCIFEROL,102688,CHEMBL5845,Glycine receptor subunit alpha-1,6.4,6.4,400.0,1,9
126356,CHEMBL1043,DAPSONE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.74,6.74,183.0,1,9
126356,CHEMBL1043,DAPSONE,10567,CHEMBL2439,Myeloperoxidase,6.38,6.38,420.0,1,9
126356,CHEMBL1043,DAPSONE,12911,CHEMBL3397,Cytochrome P450 2C9,6.1,6.1,794.3,1,9
126356,CHEMBL1043,DAPSONE,103668,CHEMBL1293235,Prelamin-A/C,5.85,5.85,1412.5,1,9
127755,CHEMBL1046,AMINOCAPROIC ACID,12054,CHEMBL2903,Polyunsaturated fatty acid lipoxygenase ALOX15,8.3,8.3,5.0,1,9
127755,CHEMBL1046,AMINOCAPROIC ACID,271,CHEMBL1947,Thyroid hormone receptor beta,6.4,6.4,398.1,1,9
127755,CHEMBL1046,AMINOCAPROIC ACID,103668,CHEMBL1293235,Prelamin-A/C,5.9,5.9,1258.9,1,9
134100,CHEMBL1054,TRICHLORMETHIAZIDE,11060,CHEMBL2326,Carbonic anhydrase 7,8.1,8.1,7.9,1,9
134100,CHEMBL1054,TRICHLORMETHIAZIDE,12952,CHEMBL3594,Carbonic anhydrase 9,7.06,7.06,87.0,1,9
134100,CHEMBL1054,TRICHLORMETHIAZIDE,15,CHEMBL205,Carbonic anhydrase 2,7.04,6.13,91.0,3,9
134100,CHEMBL1054,TRICHLORMETHIAZIDE,11016,CHEMBL3969,"Carbonic anhydrase 5B, mitochondrial",6.87,6.87,134.0,1,9
134100,CHEMBL1054,TRICHLORMETHIAZIDE,12209,CHEMBL3242,Carbonic anhydrase 12,6.51,6.51,312.0,1,9
134100,CHEMBL1054,TRICHLORMETHIAZIDE,10193,CHEMBL261,Carbonic anhydrase 1,6.46,6.46,345.0,1,9
134100,CHEMBL1054,TRICHLORMETHIAZIDE,12896,CHEMBL3729,Carbonic anhydrase 4,6.35,6.35,449.0,1,9
134100,CHEMBL1054,TRICHLORMETHIAZIDE,11042,CHEMBL4789,"Carbonic anhydrase 5A, mitochondrial",6.12,6.12,763.0,1,9
134100,CHEMBL1054,TRICHLORMETHIAZIDE,10186,CHEMBL3025,Carbonic anhydrase 6,5.61,5.61,2459.0,1,9
134333,CHEMBL1055,CHLORTHALIDONE,11060,CHEMBL2326,Carbonic anhydrase 7,8.55,8.55,2.8,1,9
134333,CHEMBL1055,CHLORTHALIDONE,12209,CHEMBL3242,Carbonic anhydrase 12,8.35,8.35,4.5,1,9
134333,CHEMBL1055,CHLORTHALIDONE,11016,CHEMBL3969,"Carbonic anhydrase 5B, mitochondrial",8.05,8.05,9.0,1,9
134333,CHEMBL1055,CHLORTHALIDONE,12952,CHEMBL3594,Carbonic anhydrase 9,7.64,7.64,23.0,1,9
134333,CHEMBL1055,CHLORTHALIDONE,15,CHEMBL205,Carbonic anhydrase 2,6.86,6.52,138.0,2,9
134333,CHEMBL1055,CHLORTHALIDONE,12896,CHEMBL3729,Carbonic anhydrase 4,6.71,6.71,196.0,1,9
134333,CHEMBL1055,CHLORTHALIDONE,10193,CHEMBL261,Carbonic anhydrase 1,6.58,6.52,260.0,2,9
134333,CHEMBL1055,CHLORTHALIDONE,11042,CHEMBL4789,"Carbonic anhydrase 5A, mitochondrial",6.04,6.04,917.0,1,9
134333,CHEMBL1055,CHLORTHALIDONE,10186,CHEMBL3025,Carbonic anhydrase 6,5.87,5.87,1347.0,1,9
134966,CHEMBL1057,FLUORESCEIN,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,8.05,7.95,8.9,4,9
134966,CHEMBL1057,FLUORESCEIN,101216,CHEMBL5514,Huntingtin,7.5,7.5,31.6,1,9
134966,CHEMBL1057,FLUORESCEIN,103657,CHEMBL1293224,Microtubule-associated protein tau,6.45,6.33,354.8,2,9
134966,CHEMBL1057,FLUORESCEIN,12912,CHEMBL3622,Cytochrome P450 2C19,6.04,6.04,907.4,1,8
136161,CHEMBL1059,PREGABALIN,150,CHEMBL1919,Voltage-dependent calcium channel subunit alpha-2/delta-1,7.72,7.72,19.0,2,9
136161,CHEMBL1059,PREGABALIN,11959,CHEMBL3896,Voltage-dependent calcium channel subunit alpha-2/delta-2,7.0,7.0,99.0,1,9
13758,CHEMBL106,FLUCONAZOLE,103668,CHEMBL1293235,Prelamin-A/C,6.3,6.3,501.2,1,9
138562,CHEMBL1064,SIMVASTATIN,24,CHEMBL402,3-hydroxy-3-methylglutaryl-coenzyme A reductase,9.05,8.01,0.9,8,9
138562,CHEMBL1064,SIMVASTATIN,11180,CHEMBL2047,Bile acid receptor,6.24,6.24,570.0,1,8
138562,CHEMBL1064,SIMVASTATIN,100997,CHEMBL5503,Nuclear receptor subfamily 1 group I member 3,6.24,6.24,570.0,1,8
138562,CHEMBL1064,SIMVASTATIN,88,CHEMBL2056,D(1A) dopamine receptor,5.75,5.75,1800.0,1,8
138562,CHEMBL1064,SIMVASTATIN,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.66,5.66,2196.0,1,8
138562,CHEMBL1064,SIMVASTATIN,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.64,5.64,2300.0,1,8
138605,CHEMBL1065,METHYSERGIDE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,9.45,8.6,0.358,7,9
138605,CHEMBL1065,METHYSERGIDE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,8.96,8.58,1.093,4,9
138605,CHEMBL1065,METHYSERGIDE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.8,8.01,1.585,6,9
138605,CHEMBL1065,METHYSERGIDE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,7.9,7.5,12.59,2,9
138605,CHEMBL1065,METHYSERGIDE,130,CHEMBL234,D(3) dopamine receptor,7.23,6.79,59.0,3,8
138605,CHEMBL1065,METHYSERGIDE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,7.12,6.96,75.0,2,8
138605,CHEMBL1065,METHYSERGIDE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.77,6.73,170.0,3,8
138605,CHEMBL1065,METHYSERGIDE,72,CHEMBL217,D(2) dopamine receptor,6.57,6.39,269.0,3,8
138605,CHEMBL1065,METHYSERGIDE,88,CHEMBL2056,D(1A) dopamine receptor,6.33,6.05,472.0,3,8
138605,CHEMBL1065,METHYSERGIDE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.21,5.87,611.0,3,8
138605,CHEMBL1065,METHYSERGIDE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.06,6.06,880.0,1,8
138605,CHEMBL1065,METHYSERGIDE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.04,6.04,912.01,1,8
138605,CHEMBL1065,METHYSERGIDE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.66,5.66,2175.0,1,8
138605,CHEMBL1065,METHYSERGIDE,102,CHEMBL1941,Histamine H2 receptor,5.61,5.58,2437.2,2,8
138605,CHEMBL1065,METHYSERGIDE,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,5.5,5.5,3162.3,1,9
139045,CHEMBL1069,VALSARTAN,115,CHEMBL227,Type-1 angiotensin II receptor,8.57,8.41,2.7,3,9
14440,CHEMBL107,COLCHICINE,103668,CHEMBL1293235,Prelamin-A/C,8.05,7.37,8.9,3,9
14440,CHEMBL107,COLCHICINE,103711,CHEMBL1293278,Geminin,7.4,7.4,39.8,1,9
14440,CHEMBL107,COLCHICINE,104614,CHEMBL2073673,Solute carrier family 22 member 3,6.92,6.92,120.0,1,8
14440,CHEMBL107,COLCHICINE,103689,CHEMBL1293256,Thrombopoietin,6.3,6.3,501.2,2,9
14440,CHEMBL107,COLCHICINE,11365,CHEMBL289,Cytochrome P450 2D6,6.1,6.1,794.3,2,9
14440,CHEMBL107,COLCHICINE,20053,CHEMBL4096,Cellular tumor antigen p53,5.8,5.8,1584.9,1,9
14440,CHEMBL107,COLCHICINE,78,CHEMBL1963,Thyrotropin receptor,5.7,5.7,1995.3,2,9
14440,CHEMBL107,COLCHICINE,103727,CHEMBL1293294,Ras-related protein Rab-9A,5.7,5.7,1995.3,1,9
14440,CHEMBL107,COLCHICINE,17045,CHEMBL340,Cytochrome P450 3A4,5.6,5.6,2511.89,3,9
14440,CHEMBL107,COLCHICINE,101097,CHEMBL5162,Neuropeptide S receptor,5.6,5.6,2511.9,1,9
14440,CHEMBL107,COLCHICINE,12911,CHEMBL3397,Cytochrome P450 2C9,5.5,5.5,3162.28,2,9
139210,CHEMBL1070,NABUMETONE,12594,CHEMBL3356,Cytochrome P450 1A2,6.4,6.4,398.11,1,8
139210,CHEMBL1070,NABUMETONE,103668,CHEMBL1293235,Prelamin-A/C,6.25,6.25,562.3,1,9
139210,CHEMBL1070,NABUMETONE,86,CHEMBL1951,Amine oxidase [flavin-containing] A,6.0,6.0,998.0,1,8
139210,CHEMBL1070,NABUMETONE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.73,5.73,1853.0,2,8
139210,CHEMBL1070,NABUMETONE,103710,CHEMBL1293277,NPC intracellular cholesterol transporter 1,5.55,5.55,2818.4,1,9
139210,CHEMBL1070,NABUMETONE,103727,CHEMBL1293294,Ras-related protein Rab-9A,5.55,5.55,2818.4,1,9
139225,CHEMBL1071,OXAPROZIN,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.08,7.08,83.7,1,8
139225,CHEMBL1071,OXAPROZIN,125,CHEMBL229,Alpha-1A adrenergic receptor,7.03,7.03,92.6,1,8
139225,CHEMBL1071,OXAPROZIN,126,CHEMBL230,Prostaglandin G/H synthase 2,6.96,6.96,110.0,1,9
139225,CHEMBL1071,OXAPROZIN,127,CHEMBL231,Histamine H1 receptor,6.51,6.51,310.0,1,8
139225,CHEMBL1071,OXAPROZIN,103668,CHEMBL1293235,Prelamin-A/C,6.45,6.45,354.8,1,9
139225,CHEMBL1071,OXAPROZIN,106142,CHEMBL2364163,Complement C5,6.19,6.19,640.0,1,9
139225,CHEMBL1071,OXAPROZIN,96,CHEMBL221,Prostaglandin G/H synthase 1,6.13,5.95,740.0,3,9
139225,CHEMBL1071,OXAPROZIN,130,CHEMBL234,D(3) dopamine receptor,6.09,6.09,810.0,1,8
139225,CHEMBL1071,OXAPROZIN,72,CHEMBL217,D(2) dopamine receptor,5.93,5.93,1180.0,1,8
139225,CHEMBL1071,OXAPROZIN,117992,CHEMBL4295747,"Serine hydroxymethyltransferase, mitochondrial",5.71,5.71,1949.84,1,9
139225,CHEMBL1071,OXAPROZIN,12912,CHEMBL3622,Cytochrome P450 2C19,5.6,5.6,2511.9,1,9
139281,CHEMBL1072,BUMETANIDE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,6.1,5.95,794.3,4,9
139281,CHEMBL1072,BUMETANIDE,103769,CHEMBL1615383,Solute carrier family 12 member 2,5.81,5.81,1540.0,1,9
139281,CHEMBL1072,BUMETANIDE,101097,CHEMBL5162,Neuropeptide S receptor,5.5,5.5,3162.3,1,9
139286,CHEMBL1073,GLIPIZIDE,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,7.95,7.95,11.2,2,9
139286,CHEMBL1073,GLIPIZIDE,87,CHEMBL218,Cannabinoid receptor 1,7.73,7.73,18.7,1,8
139286,CHEMBL1073,GLIPIZIDE,103668,CHEMBL1293235,Prelamin-A/C,7.05,7.05,89.1,1,9
139286,CHEMBL1073,GLIPIZIDE,12912,CHEMBL3622,Cytochrome P450 2C19,6.3,6.3,501.2,1,9
139286,CHEMBL1073,GLIPIZIDE,103665,CHEMBL1293232,Survival motor neuron protein,5.9,5.9,1258.9,1,9
139866,CHEMBL1075,MORICIZINE,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",6.11,6.11,770.0,1,8
139866,CHEMBL1075,MORICIZINE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,5.8,5.8,1584.9,2,9
614499,CHEMBL1076903,VARENICLINE,10670,CHEMBL1882,Neuronal acetylcholine receptor subunit alpha-4,7.04,7.04,91.0,1,8
614499,CHEMBL1076903,VARENICLINE,10635,CHEMBL2492,Neuronal acetylcholine receptor subunit alpha-7,6.9,6.9,125.0,1,8
140107,CHEMBL1077,BROMFENAC,126,CHEMBL230,Prostaglandin G/H synthase 2,8.32,8.32,4.803,1,8
140107,CHEMBL1077,BROMFENAC,96,CHEMBL221,Prostaglandin G/H synthase 1,8.17,7.9,6.7,3,9
618203,CHEMBL1077896,ROPIVACAINE,103668,CHEMBL1293235,Prelamin-A/C,5.6,5.6,2511.9,1,9
617563,CHEMBL1078178,MOMELOTINIB,10919,CHEMBL2835,Tyrosine-protein kinase JAK1,8.8,7.82,1.6,15,9
617563,CHEMBL1078178,MOMELOTINIB,117538,CHEMBL4105933,Uncharacterized protein FLJ45252,8.52,8.52,3.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,30000,CHEMBL3830,AP2-associated protein kinase 1,8.4,8.4,4.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,8.35,7.77,4.5,17,9
617563,CHEMBL1078178,MOMELOTINIB,101598,CHEMBL5903,Activin receptor type-1,8.1,7.85,8.0,2,8
617563,CHEMBL1078178,MOMELOTINIB,12694,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,8.04,7.27,9.2,6,9
617563,CHEMBL1078178,MOMELOTINIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,7.72,6.84,19.0,9,9
617563,CHEMBL1078178,MOMELOTINIB,101204,CHEMBL5476,Bone morphogenetic protein receptor type-1B,7.72,7.34,19.0,4,8
617563,CHEMBL1078178,MOMELOTINIB,30030,CHEMBL5257,Serine/threonine-protein kinase Nek9,7.0,6.66,100.0,2,9
617563,CHEMBL1078178,MOMELOTINIB,12915,CHEMBL3529,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,6.7,6.7,200.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,13004,CHEMBL4439,TGF-beta receptor type-1,6.69,6.43,205.0,4,8
617563,CHEMBL1078178,MOMELOTINIB,11149,CHEMBL2973,Rho-associated protein kinase 2,6.66,6.66,219.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,117490,CHEMBL4105885,AarF domain-containing protein kinase 1,6.66,6.66,217.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,101048,CHEMBL5047,Serine/threonine-protein kinase ULK3,6.54,6.54,291.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,102421,CHEMBL5679,Serine/threonine-protein kinase Nek3,6.54,6.54,286.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,12780,CHEMBL4070,Casein kinase II subunit alpha',6.52,6.52,302.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,101239,CHEMBL5579,Citron Rho-interacting kinase,6.5,6.5,313.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,101178,CHEMBL5403,Signal transducer and activator of transcription 5A,6.4,6.4,400.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,100907,CHEMBL5275,Bone morphogenetic protein receptor type-1A,6.39,6.2,405.0,2,8
617563,CHEMBL1078178,MOMELOTINIB,30042,CHEMBL4522,BMP-2-inducible protein kinase,6.38,6.38,422.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,100140,CHEMBL5600,MAP/microtubule affinity-regulating kinase 3,6.38,6.38,417.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,100415,CHEMBL4900,Serine/threonine-protein kinase D2,6.28,6.28,531.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,100856,CHEMBL5408,Serine/threonine-protein kinase TBK1,6.25,6.25,562.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,12261,CHEMBL2276,Mitogen-activated protein kinase 8,6.22,6.22,599.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,30002,CHEMBL3829,Calcium/calmodulin-dependent protein kinase type II subunit gamma,6.22,6.22,597.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,30001,CHEMBL3831,Serine/threonine-protein kinase MARK2,6.21,6.21,614.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,30003,CHEMBL3788,Serine/threonine-protein kinase PLK4,6.21,6.21,619.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,10885,CHEMBL2595,Serine/threonine-protein kinase D3,6.19,6.19,650.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,11622,CHEMBL2801,Calcium/calmodulin-dependent protein kinase type II subunit delta,6.18,6.18,666.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,117310,CHEMBL4105705,"Dynamin-like GTPase OPA1, mitochondrial",6.15,6.15,705.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,103455,CHEMBL1163126,Serine/threonine-protein kinase ICK,6.14,6.14,720.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,11626,CHEMBL3116,Cyclin-dependent kinase 9,6.13,6.13,741.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,101504,CHEMBL5699,Serine/threonine-protein kinase SIK2,6.1,6.1,790.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,20020,CHEMBL4355,Cyclin-G-associated kinase,6.08,6.08,822.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,102770,CHEMBL6149,Serine/threonine-protein kinase SIK3,6.07,6.07,859.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,30013,CHEMBL4224,Dual specificity protein kinase CLK1,6.04,6.04,918.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,11407,CHEMBL4179,Mitogen-activated protein kinase 9,5.94,5.94,1137.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,30022,CHEMBL4597,Cyclin-dependent kinase 16,5.93,5.93,1162.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,11408,CHEMBL2637,Mitogen-activated protein kinase 10,5.92,5.92,1191.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,30004,CHEMBL3938,Serine/threonine-protein kinase 16,5.89,5.89,1281.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,10811,CHEMBL3231,Rho-associated protein kinase 1,5.87,5.87,1362.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,101553,CHEMBL5790,Cyclin-dependent kinase 17,5.86,5.86,1382.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,11678,CHEMBL301,Cyclin-dependent kinase 2,5.67,5.67,2113.0,1,9
617563,CHEMBL1078178,MOMELOTINIB,11472,CHEMBL4026,Signal transducer and activator of transcription 3,5.6,5.6,2500.0,1,9
140117,CHEMBL1079,TIZANIDINE,125,CHEMBL229,Alpha-1A adrenergic receptor,8.01,6.87,9.8,2,8
140117,CHEMBL1079,TIZANIDINE,11684,CHEMBL3923,Nischarin,7.55,7.55,28.3,2,9
140117,CHEMBL1079,TIZANIDINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.07,6.69,86.0,4,9
140117,CHEMBL1079,TIZANIDINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.53,6.53,292.2,1,8
140117,CHEMBL1079,TIZANIDINE,102,CHEMBL1941,Histamine H2 receptor,6.03,6.03,930.0,1,8
140117,CHEMBL1079,TIZANIDINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.91,5.89,1231.0,2,9
611647,CHEMBL1079742,ERLOTINIB HYDROCHLORIDE,9,CHEMBL203,Epidermal growth factor receptor,8.7,7.51,2.0,4,9
611647,CHEMBL1079742,ERLOTINIB HYDROCHLORIDE,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,5.82,5.77,1520.0,2,9
15086,CHEMBL108,CARBAMAZEPINE,103668,CHEMBL1293235,Prelamin-A/C,8.4,8.4,4.0,1,9
15086,CHEMBL108,CARBAMAZEPINE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,7.0,7.0,100.0,1,9
630886,CHEMBL1082407,ENZALUTAMIDE,56,CHEMBL1871,Androgen receptor,7.85,6.72,14.0,50,9
630886,CHEMBL1082407,ENZALUTAMIDE,10373,CHEMBL2099,Prostate-specific antigen,6.89,6.89,130.0,1,9
631502,CHEMBL1082607,SALMETEROL XINAFOATE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.55,8.55,2.8,2,9
631502,CHEMBL1082607,SALMETEROL XINAFOATE,43,CHEMBL210,Beta-2 adrenergic receptor,8.35,8.35,4.49,1,8
630322,CHEMBL1083659,SUVOREXANT,12968,CHEMBL4792,Orexin receptor type 2,9.46,8.2,0.35,11,9
630322,CHEMBL1083659,SUVOREXANT,10009,CHEMBL5113,Orexin/Hypocretin receptor type 1,9.4,8.28,0.3981,12,9
630439,CHEMBL1083993,AMIODARONE HYDROCHLORIDE,103665,CHEMBL1293232,Survival motor neuron protein,5.8,5.8,1584.9,1,9
630439,CHEMBL1083993,AMIODARONE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,5.55,5.55,2818.4,1,9
147927,CHEMBL1085,ACETOPHENAZINE,130,CHEMBL234,D(3) dopamine receptor,8.36,8.36,4.4,1,8
147927,CHEMBL1085,ACETOPHENAZINE,125,CHEMBL229,Alpha-1A adrenergic receptor,8.35,8.35,4.5,1,8
147927,CHEMBL1085,ACETOPHENAZINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,8.15,8.15,7.0,1,8
147927,CHEMBL1085,ACETOPHENAZINE,72,CHEMBL217,D(2) dopamine receptor,7.93,7.93,11.8,1,8
147927,CHEMBL1085,ACETOPHENAZINE,127,CHEMBL231,Histamine H1 receptor,7.31,7.31,49.0,1,8
147927,CHEMBL1085,ACETOPHENAZINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.25,7.25,56.0,1,8
147927,CHEMBL1085,ACETOPHENAZINE,88,CHEMBL2056,D(1A) dopamine receptor,7.0,6.47,100.0,2,8
147927,CHEMBL1085,ACETOPHENAZINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.14,6.14,720.0,1,8
147927,CHEMBL1085,ACETOPHENAZINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.06,6.06,869.5,1,8
147927,CHEMBL1085,ACETOPHENAZINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.92,5.92,1200.0,1,8
147927,CHEMBL1085,ACETOPHENAZINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.64,5.64,2300.0,1,8
178495,CHEMBL108545,METHYL SALICYLATE,103668,CHEMBL1293235,Prelamin-A/C,6.1,6.1,794.3,1,9
147956,CHEMBL1086,DIBUCAINE,103668,CHEMBL1293235,Prelamin-A/C,8.15,8.15,7.1,1,9
147956,CHEMBL1086,DIBUCAINE,103665,CHEMBL1293232,Survival motor neuron protein,6.05,6.05,891.3,1,9
147956,CHEMBL1086,DIBUCAINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.85,5.85,1419.0,1,8
147956,CHEMBL1086,DIBUCAINE,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,5.75,5.75,1800.0,1,8
8209,CHEMBL10878,AGOMELATINE,11085,CHEMBL1946,Melatonin receptor type 1B,10.38,9.79,0.042,19,9
8209,CHEMBL10878,AGOMELATINE,11084,CHEMBL1945,Melatonin receptor type 1A,10.22,9.58,0.06,19,9
8209,CHEMBL10878,AGOMELATINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.2,6.16,630.0,4,9
8209,CHEMBL10878,AGOMELATINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.06,5.87,879.5,2,8
148004,CHEMBL1088,MESORIDAZINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.77,7.77,17.1,1,8
148004,CHEMBL1088,MESORIDAZINE,130,CHEMBL234,D(3) dopamine receptor,7.71,7.71,19.7,1,8
148004,CHEMBL1088,MESORIDAZINE,88,CHEMBL2056,D(1A) dopamine receptor,7.15,7.15,71.2,1,8
148004,CHEMBL1088,MESORIDAZINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.82,6.82,153.0,1,8
148004,CHEMBL1088,MESORIDAZINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.67,6.67,214.4,1,8
148004,CHEMBL1088,MESORIDAZINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.5,6.46,316.23,6,9
148004,CHEMBL1088,MESORIDAZINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.59,5.59,2587.4,1,8
148004,CHEMBL1088,MESORIDAZINE,129,CHEMBL233,Mu-type opioid receptor,5.52,5.52,2991.4,1,8
148018,CHEMBL1089,PHENELZINE,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,8.0,8.0,10.0,2,9
148018,CHEMBL1089,PHENELZINE,20143,CHEMBL3437,Amine oxidase [copper-containing] 3,7.7,7.7,19.95,1,9
148018,CHEMBL1089,PHENELZINE,104,CHEMBL2039,Amine oxidase [flavin-containing] B,7.03,6.93,94.0,3,9
148018,CHEMBL1089,PHENELZINE,78,CHEMBL1963,Thyrotropin receptor,6.9,6.9,125.9,1,9
148018,CHEMBL1089,PHENELZINE,86,CHEMBL1951,Amine oxidase [flavin-containing] A,6.84,6.56,146.0,5,9
148018,CHEMBL1089,PHENELZINE,12911,CHEMBL3397,Cytochrome P450 2C9,6.8,6.8,158.49,2,9
148018,CHEMBL1089,PHENELZINE,12912,CHEMBL3622,Cytochrome P450 2C19,6.5,6.26,316.2,5,9
148018,CHEMBL1089,PHENELZINE,96,CHEMBL221,Prostaglandin G/H synthase 1,6.3,6.17,500.1,2,8
148018,CHEMBL1089,PHENELZINE,103668,CHEMBL1293235,Prelamin-A/C,6.3,6.3,501.2,1,9
148018,CHEMBL1089,PHENELZINE,11365,CHEMBL289,Cytochrome P450 2D6,6.0,5.73,1000.0,3,9
148018,CHEMBL1089,PHENELZINE,12594,CHEMBL3356,Cytochrome P450 1A2,6.0,5.75,1000.0,2,8
148018,CHEMBL1089,PHENELZINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.95,5.95,1132.8,1,8
148018,CHEMBL1089,PHENELZINE,10163,CHEMBL3721,Cytochrome P450 2C8,5.92,5.92,1200.0,1,9
148018,CHEMBL1089,PHENELZINE,17045,CHEMBL340,Cytochrome P450 3A4,5.7,5.55,2000.0,4,9
622408,CHEMBL1089318,OPICAPONE,91,CHEMBL2023,Catechol O-methyltransferase,9.0,8.5,1.0,2,9
622436,CHEMBL1089641,TRYPAN BLUE FREE ACID,101216,CHEMBL5514,Huntingtin,7.7,7.7,20.0,1,9
15217,CHEMBL109,VALPROIC ACID,127,CHEMBL231,Histamine H1 receptor,7.0,7.0,100.0,1,8
15217,CHEMBL109,VALPROIC ACID,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.78,6.78,165.8,1,8
15217,CHEMBL109,VALPROIC ACID,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.07,6.07,850.0,1,8
15217,CHEMBL109,VALPROIC ACID,125,CHEMBL229,Alpha-1A adrenergic receptor,5.96,5.96,1093.8,1,8
15217,CHEMBL109,VALPROIC ACID,219,CHEMBL245,Muscarinic acetylcholine receptor M3,5.89,5.89,1300.0,1,8
15217,CHEMBL109,VALPROIC ACID,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,5.6,5.6,2511.9,1,9
149095,CHEMBL1090,VIDARABINE,11140,CHEMBL284,Dipeptidyl peptidase 4,7.21,7.21,62.0,1,9
150313,CHEMBL1091,HYDROCORTISONE ACETATE,10503,CHEMBL2421,Corticosteroid-binding globulin,7.55,7.55,28.18,1,8
150313,CHEMBL1091,HYDROCORTISONE ACETATE,103668,CHEMBL1293235,Prelamin-A/C,7.5,7.5,31.6,1,9
150313,CHEMBL1091,HYDROCORTISONE ACETATE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,6.9,6.9,125.9,2,9
624012,CHEMBL1091250,INDIGOTINDISULFONATE,105140,CHEMBL2146312,Bifunctional 3'-5' exonuclease/ATP-dependent helicase WRN,6.7,6.7,200.0,1,9
624012,CHEMBL1091250,INDIGOTINDISULFONATE,280,CHEMBL256,Adenosine receptor A3,6.0,6.0,995.5,1,8
624012,CHEMBL1091250,INDIGOTINDISULFONATE,11,CHEMBL204,Prothrombin,5.55,5.55,2830.0,1,8
624012,CHEMBL1091250,INDIGOTINDISULFONATE,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,5.52,5.52,3051.1,1,8
150389,CHEMBL1092,TRIHEXYPHENIDYL HYDROCHLORIDE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,8.89,8.89,1.3,1,8
150389,CHEMBL1092,TRIHEXYPHENIDYL HYDROCHLORIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.49,8.49,3.2,2,9
150389,CHEMBL1092,TRIHEXYPHENIDYL HYDROCHLORIDE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,8.17,8.17,6.7,1,8
150389,CHEMBL1092,TRIHEXYPHENIDYL HYDROCHLORIDE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,7.99,7.99,10.3,1,8
150389,CHEMBL1092,TRIHEXYPHENIDYL HYDROCHLORIDE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.73,7.73,18.6,1,8
150389,CHEMBL1092,TRIHEXYPHENIDYL HYDROCHLORIDE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,7.58,7.58,26.3,1,8
150389,CHEMBL1092,TRIHEXYPHENIDYL HYDROCHLORIDE,103657,CHEMBL1293224,Microtubule-associated protein tau,5.75,5.75,1778.3,1,9
150423,CHEMBL1093,ARTICAINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.72,5.72,1903.7,1,8
150451,CHEMBL1094,FELBAMATE,103134,CHEMBL1075189,Pyruvate kinase PKM,8.0,8.0,10.0,2,9
150451,CHEMBL1094,FELBAMATE,103665,CHEMBL1293232,Survival motor neuron protein,7.4,7.4,39.8,1,9
150451,CHEMBL1094,FELBAMATE,11365,CHEMBL289,Cytochrome P450 2D6,6.1,6.1,794.3,2,9
150451,CHEMBL1094,FELBAMATE,101097,CHEMBL5162,Neuropeptide S receptor,6.1,6.1,794.3,1,9
624225,CHEMBL1094636,NIRAPARIB,11663,CHEMBL3105,Poly [ADP-ribose] polymerase 1,9.0,7.94,1.0,22,9
624225,CHEMBL1094636,NIRAPARIB,100933,CHEMBL5366,Poly [ADP-ribose] polymerase 2,8.68,7.94,2.1,10,9
624225,CHEMBL1094636,NIRAPARIB,107665,CHEMBL2429709,Protein mono-ADP-ribosyltransferase PARP12,7.1,6.6,79.0,2,9
624225,CHEMBL1094636,NIRAPARIB,155,CHEMBL238,Sodium-dependent dopamine transporter,6.95,6.95,113.1,1,8
624225,CHEMBL1094636,NIRAPARIB,101014,CHEMBL5543,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,6.59,6.15,254.0,2,9
624225,CHEMBL1094636,NIRAPARIB,102445,CHEMBL6142,Protein mono-ADP-ribosyltransferase PARP4,6.57,6.44,272.0,4,9
624225,CHEMBL1094636,NIRAPARIB,12090,CHEMBL2292,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,6.53,6.19,297.0,2,9
624225,CHEMBL1094636,NIRAPARIB,101057,CHEMBL5083,Protein mono-ADP-ribosyltransferase PARP3,6.53,6.32,295.12,3,9
624225,CHEMBL1094636,NIRAPARIB,101462,CHEMBL6164,Poly [ADP-ribose] polymerase tankyrase-1,6.24,5.83,570.0,3,9
624225,CHEMBL1094636,NIRAPARIB,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.0,6.0,1004.0,1,8
624225,CHEMBL1094636,NIRAPARIB,121,CHEMBL228,Sodium-dependent serotonin transporter,5.93,5.93,1173.2,1,8
624225,CHEMBL1094636,NIRAPARIB,105352,CHEMBL2176777,Protein mono-ADP-ribosyltransferase PARP14,5.76,5.76,1737.8,1,9
624225,CHEMBL1094636,NIRAPARIB,107664,CHEMBL2429708,Protein mono-ADP-ribosyltransferase PARP10,5.72,5.71,1900.0,2,9
626453,CHEMBL1095097,EPLERENONE,48,CHEMBL1994,Mineralocorticoid receptor,7.2,6.52,63.1,18,9
626453,CHEMBL1095097,EPLERENONE,25,CHEMBL2034,Glucocorticoid receptor,5.5,5.5,3162.28,1,9
624251,CHEMBL1095292,BRETYLIUM TOSYLATE,103668,CHEMBL1293235,Prelamin-A/C,7.15,7.15,70.8,1,9
624251,CHEMBL1095292,BRETYLIUM TOSYLATE,17045,CHEMBL340,Cytochrome P450 3A4,5.8,5.8,1584.9,2,9
625589,CHEMBL1095777,INDACATEROL,43,CHEMBL210,Beta-2 adrenergic receptor,9.1,7.8,0.79,9,9
625589,CHEMBL1095777,INDACATEROL,155,CHEMBL238,Sodium-dependent dopamine transporter,7.12,7.12,75.02,1,9
625589,CHEMBL1095777,INDACATEROL,50,CHEMBL213,Beta-1 adrenergic receptor,7.04,6.86,91.0,3,9
625589,CHEMBL1095777,INDACATEROL,117512,CHEMBL4105907,Sigma intracellular receptor 2,6.97,6.97,106.86,1,9
625589,CHEMBL1095777,INDACATEROL,125,CHEMBL229,Alpha-1A adrenergic receptor,6.45,6.45,355.59,1,9
625589,CHEMBL1095777,INDACATEROL,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.25,6.25,568.66,1,9
625589,CHEMBL1095777,INDACATEROL,103,CHEMBL223,Alpha-1D adrenergic receptor,6.14,6.14,731.31,1,9
625589,CHEMBL1095777,INDACATEROL,121,CHEMBL228,Sodium-dependent serotonin transporter,6.11,6.11,770.02,1,9
625589,CHEMBL1095777,INDACATEROL,130,CHEMBL234,D(3) dopamine receptor,5.98,5.93,1048.0,2,9
625589,CHEMBL1095777,INDACATEROL,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.75,5.75,1800.32,1,9
625589,CHEMBL1095777,INDACATEROL,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.7,5.7,2019.53,1,9
624296,CHEMBL1095930,CEFUROXIME AXETIL,276,CHEMBL254,"3',5'-cyclic-AMP phosphodiesterase 4A",5.79,5.79,1610.0,1,8
150549,CHEMBL1096,AMLEXANOX,103710,CHEMBL1293277,NPC intracellular cholesterol transporter 1,6.5,6.5,316.2,1,9
150549,CHEMBL1096,AMLEXANOX,103727,CHEMBL1293294,Ras-related protein Rab-9A,6.3,6.3,501.2,1,9
150549,CHEMBL1096,AMLEXANOX,100856,CHEMBL5408,Serine/threonine-protein kinase TBK1,6.07,6.05,850.0,3,9
150549,CHEMBL1096,AMLEXANOX,104069,CHEMBL1743128,ATP-binding cassette sub-family C member 4,5.66,5.66,2200.0,1,9
628156,CHEMBL1096146,PONESIMOD,11631,CHEMBL4333,Sphingosine 1-phosphate receptor 1,8.01,7.97,9.7,3,9
628156,CHEMBL1096146,PONESIMOD,10950,CHEMBL3892,Sphingosine 1-phosphate receptor 3,6.96,6.96,109.0,1,9
624161,CHEMBL1096882,FLUDARABINE PHOSPHATE,11042,CHEMBL4789,"Carbonic anhydrase 5A, mitochondrial",6.88,6.88,130.9,1,9
626138,CHEMBL1097279,CANGRELOR TETRASODIUM,176,CHEMBL2001,P2Y purinoceptor 12,9.15,9.15,0.7,1,8
626138,CHEMBL1097279,CANGRELOR TETRASODIUM,103101,CHEMBL1075162,Uracil nucleotide/cysteinyl leukotriene receptor,9.15,9.15,0.7,1,9
624467,CHEMBL1098319,2-MERCAPTOETHANESULFONIC ACID,96,CHEMBL221,Prostaglandin G/H synthase 1,6.31,6.21,485.8,2,8
605,CHEMBL11,IMIPRAMINE,121,CHEMBL228,Sodium-dependent serotonin transporter,9.28,8.31,0.52,32,9
605,CHEMBL11,IMIPRAMINE,127,CHEMBL231,Histamine H1 receptor,8.0,7.78,10.0,3,9
605,CHEMBL11,IMIPRAMINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,7.8,7.34,16.0,3,9
605,CHEMBL11,IMIPRAMINE,102,CHEMBL1941,Histamine H2 receptor,7.16,7.16,69.7,1,8
605,CHEMBL11,IMIPRAMINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.09,6.7,80.4,3,8
605,CHEMBL11,IMIPRAMINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.03,6.81,94.0,4,9
605,CHEMBL11,IMIPRAMINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.89,6.84,130.0,2,8
605,CHEMBL11,IMIPRAMINE,87,CHEMBL218,Cannabinoid receptor 1,6.76,6.76,173.9,1,8
605,CHEMBL11,IMIPRAMINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.5,6.5,320.0,1,8
605,CHEMBL11,IMIPRAMINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.5,6.5,319.0,1,8
605,CHEMBL11,IMIPRAMINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.5,6.5,312.8,1,8
605,CHEMBL11,IMIPRAMINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.48,6.48,330.4,1,8
605,CHEMBL11,IMIPRAMINE,72,CHEMBL217,D(2) dopamine receptor,6.39,6.14,410.0,3,9
605,CHEMBL11,IMIPRAMINE,130,CHEMBL234,D(3) dopamine receptor,6.39,6.39,410.0,1,8
605,CHEMBL11,IMIPRAMINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.34,6.34,453.6,1,8
605,CHEMBL11,IMIPRAMINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.31,6.31,490.0,1,8
605,CHEMBL11,IMIPRAMINE,103657,CHEMBL1293224,Microtubule-associated protein tau,6.25,6.25,562.3,1,9
605,CHEMBL11,IMIPRAMINE,104063,CHEMBL1743122,Solute carrier family 22 member 2,6.22,6.22,600.0,1,9
605,CHEMBL11,IMIPRAMINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.11,6.11,780.0,1,8
605,CHEMBL11,IMIPRAMINE,103668,CHEMBL1293235,Prelamin-A/C,6.1,6.1,794.3,1,9
605,CHEMBL11,IMIPRAMINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,5.97,5.97,1067.5,1,8
605,CHEMBL11,IMIPRAMINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.68,5.68,2100.0,1,8
605,CHEMBL11,IMIPRAMINE,10624,CHEMBL3426,5-hydroxytryptamine receptor 5A,5.64,5.64,2262.6,1,8
605,CHEMBL11,IMIPRAMINE,137,CHEMBL237,Kappa-type opioid receptor,5.58,5.58,2609.9,1,8
605,CHEMBL11,IMIPRAMINE,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,5.54,5.54,2900.0,1,8
605,CHEMBL11,IMIPRAMINE,88,CHEMBL2056,D(1A) dopamine receptor,5.5,5.5,3202.0,1,8
151063,CHEMBL1101,BIPERIDEN,61,CHEMBL216,Muscarinic acetylcholine receptor M1,8.63,8.11,2.36,4,9
151063,CHEMBL1101,BIPERIDEN,219,CHEMBL245,Muscarinic acetylcholine receptor M3,8.22,7.14,5.95,2,9
151063,CHEMBL1101,BIPERIDEN,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.86,7.19,13.7,2,9
151063,CHEMBL1101,BIPERIDEN,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,7.49,7.49,32.1,1,9
151408,CHEMBL1104,EDROPHONIUM,93,CHEMBL220,Acetylcholinesterase,5.52,5.52,3010.0,1,8
178290,CHEMBL110458,MIGALASTAT,10693,CHEMBL2524,Alpha-galactosidase A,7.89,7.4,13.0,4,9
178290,CHEMBL110458,MIGALASTAT,10977,CHEMBL2608,Lysosomal alpha-glucosidase,7.08,7.08,82.3,1,9
178290,CHEMBL110458,MIGALASTAT,11997,CHEMBL2748,"Sucrase-isomaltase, intestinal",6.58,6.58,260.0,1,8
178290,CHEMBL110458,MIGALASTAT,10733,CHEMBL2179,Lysosomal acid glucosylceramidase,5.85,5.85,1422.0,2,9
178290,CHEMBL110458,MIGALASTAT,1,CHEMBL2074,Maltase-glucoamylase,5.82,5.82,1500.0,1,8
152610,CHEMBL1106,EPINASTINE,88,CHEMBL2056,D(1A) dopamine receptor,6.9,6.9,124.6,1,8
152610,CHEMBL1106,EPINASTINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.6,6.6,252.7,1,8
152610,CHEMBL1106,EPINASTINE,104067,CHEMBL1743126,Multidrug and toxin extrusion protein 1,5.96,5.96,1100.0,1,9
152610,CHEMBL1106,EPINASTINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.89,5.89,1284.1,1,8
152610,CHEMBL1106,EPINASTINE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.6,5.6,2531.9,1,8
182928,CHEMBL110691,CHLORMADINONE ACETATE,36,CHEMBL208,Progesterone receptor,8.52,8.52,3.0,1,8
182928,CHEMBL110691,CHLORMADINONE ACETATE,56,CHEMBL1871,Androgen receptor,8.13,8.13,7.4,1,8
182928,CHEMBL110691,CHLORMADINONE ACETATE,271,CHEMBL1947,Thyroid hormone receptor beta,8.1,8.1,7.9,1,9
182928,CHEMBL110691,CHLORMADINONE ACETATE,25,CHEMBL2034,Glucocorticoid receptor,7.76,7.59,17.2,2,8
182928,CHEMBL110691,CHLORMADINONE ACETATE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,7.0,7.0,100.0,2,9
182928,CHEMBL110691,CHLORMADINONE ACETATE,12912,CHEMBL3622,Cytochrome P450 2C19,5.52,5.52,3000.0,1,8
152728,CHEMBL1107,HALOFANTRINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,7.4,6.8,40.0,12,9
152751,CHEMBL1108,DROPERIDOL,107,CHEMBL224,5-hydroxytryptamine receptor 2A,9.13,8.86,0.738,2,8
152751,CHEMBL1108,DROPERIDOL,72,CHEMBL217,D(2) dopamine receptor,9.1,8.86,0.802,2,8
152751,CHEMBL1108,DROPERIDOL,130,CHEMBL234,D(3) dopamine receptor,9.03,8.79,0.939,2,8
152751,CHEMBL1108,DROPERIDOL,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,7.49,7.15,32.2,11,9
152751,CHEMBL1108,DROPERIDOL,103,CHEMBL223,Alpha-1D adrenergic receptor,7.39,7.23,41.0,2,8
152751,CHEMBL1108,DROPERIDOL,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.0,6.83,101.0,2,8
152751,CHEMBL1108,DROPERIDOL,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.62,6.48,238.0,2,8
152751,CHEMBL1108,DROPERIDOL,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.59,6.17,256.0,2,8
152751,CHEMBL1108,DROPERIDOL,127,CHEMBL231,Histamine H1 receptor,6.28,6.28,525.0,1,8
152751,CHEMBL1108,DROPERIDOL,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.27,6.27,537.0,1,8
152751,CHEMBL1108,DROPERIDOL,88,CHEMBL2056,D(1A) dopamine receptor,6.26,6.11,546.0,2,8
152751,CHEMBL1108,DROPERIDOL,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.07,5.97,854.0,2,8
152751,CHEMBL1108,DROPERIDOL,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.95,5.74,1112.0,2,8
152751,CHEMBL1108,DROPERIDOL,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,5.78,5.71,1651.0,2,8
152751,CHEMBL1108,DROPERIDOL,11365,CHEMBL289,Cytochrome P450 2D6,5.5,5.5,3162.28,2,9
153330,CHEMBL1109,SULFAPHENAZOLE,12911,CHEMBL3397,Cytochrome P450 2C9,7.3,6.42,50.1,58,9
153330,CHEMBL1109,SULFAPHENAZOLE,17045,CHEMBL340,Cytochrome P450 3A4,6.9,6.06,125.9,5,9
153330,CHEMBL1109,SULFAPHENAZOLE,10206,CHEMBL2392,DNA polymerase beta,6.05,6.05,891.3,1,9
153330,CHEMBL1109,SULFAPHENAZOLE,101097,CHEMBL5162,Neuropeptide S receptor,5.5,5.5,3162.3,1,9
16088,CHEMBL111,RIMONABANT,87,CHEMBL218,Cannabinoid receptor 1,9.96,8.18,0.11,135,9
16088,CHEMBL111,RIMONABANT,259,CHEMBL253,Cannabinoid receptor 2,8.96,6.15,1.1,55,9
16088,CHEMBL111,RIMONABANT,12911,CHEMBL3397,Cytochrome P450 2C9,8.28,8.28,5.3,1,9
16088,CHEMBL111,RIMONABANT,12030,CHEMBL3004,Multidrug resistance-associated protein 1,5.85,5.85,1400.0,1,9
16088,CHEMBL111,RIMONABANT,137,CHEMBL237,Kappa-type opioid receptor,5.77,5.77,1682.0,1,8
16088,CHEMBL111,RIMONABANT,103170,CHEMBL1075322,G-protein coupled receptor 55,5.7,5.7,2010.0,2,9
16088,CHEMBL111,RIMONABANT,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.55,5.55,2790.0,1,9
153342,CHEMBL1110,ALOSETRON,144,CHEMBL1899,5-hydroxytryptamine receptor 3A,9.3,9.19,0.5,5,9
153342,CHEMBL1110,ALOSETRON,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.5,7.1,31.4,4,8
153342,CHEMBL1110,ALOSETRON,12594,CHEMBL3356,Cytochrome P450 1A2,6.22,6.22,604.7,1,8
153342,CHEMBL1110,ALOSETRON,17045,CHEMBL340,Cytochrome P450 3A4,6.22,6.22,600.0,3,9
153342,CHEMBL1110,ALOSETRON,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.64,5.55,2300.0,3,9
154051,CHEMBL1111,AMBRISENTAN,249,CHEMBL252,Endothelin-1 receptor,9.0,8.33,1.0,2,9
154051,CHEMBL1111,AMBRISENTAN,247,CHEMBL1785,Endothelin receptor type B,6.71,6.31,195.0,2,9
155006,CHEMBL1112,ARIPIPRAZOLE,72,CHEMBL217,D(2) dopamine receptor,9.7,8.27,0.2,76,9
155006,CHEMBL1112,ARIPIPRAZOLE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,9.44,8.22,0.36,8,9
155006,CHEMBL1112,ARIPIPRAZOLE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,9.1,7.65,0.8,36,9
155006,CHEMBL1112,ARIPIPRAZOLE,130,CHEMBL234,D(3) dopamine receptor,9.1,8.19,0.8,30,9
155006,CHEMBL1112,ARIPIPRAZOLE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,8.77,7.77,1.7,26,9
155006,CHEMBL1112,ARIPIPRAZOLE,125,CHEMBL229,Alpha-1A adrenergic receptor,8.05,6.81,8.9,10,9
155006,CHEMBL1112,ARIPIPRAZOLE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,8.0,7.66,10.0,9,9
155006,CHEMBL1112,ARIPIPRAZOLE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.74,6.73,18.2,15,9
155006,CHEMBL1112,ARIPIPRAZOLE,127,CHEMBL231,Histamine H1 receptor,7.6,6.95,25.1,11,9
155006,CHEMBL1112,ARIPIPRAZOLE,121,CHEMBL228,Sodium-dependent serotonin transporter,7.5,6.52,31.62,8,9
155006,CHEMBL1112,ARIPIPRAZOLE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.42,7.13,37.9,3,9
155006,CHEMBL1112,ARIPIPRAZOLE,90,CHEMBL219,D(4) dopamine receptor,7.36,6.8,44.0,17,9
155006,CHEMBL1112,ARIPIPRAZOLE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,7.05,6.67,89.0,6,9
155006,CHEMBL1112,ARIPIPRAZOLE,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.0,6.68,100.0,5,9
155006,CHEMBL1112,ARIPIPRAZOLE,105,CHEMBL1983,5-hydroxytryptamine receptor 1D,7.0,7.0,100.0,1,9
155006,CHEMBL1112,ARIPIPRAZOLE,128,CHEMBL232,Alpha-1B adrenergic receptor,7.0,7.0,100.0,1,9
155006,CHEMBL1112,ARIPIPRAZOLE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.54,6.54,289.3,1,8
155006,CHEMBL1112,ARIPIPRAZOLE,88,CHEMBL2056,D(1A) dopamine receptor,6.51,6.18,310.0,10,9
155006,CHEMBL1112,ARIPIPRAZOLE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.47,6.23,339.1,2,9
155006,CHEMBL1112,ARIPIPRAZOLE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.22,6.09,598.0,7,9
155006,CHEMBL1112,ARIPIPRAZOLE,50,CHEMBL213,Beta-1 adrenergic receptor,6.14,6.14,722.7,1,8
155006,CHEMBL1112,ARIPIPRAZOLE,11398,CHEMBL4302,ATP-dependent translocase ABCB1,6.11,6.11,780.0,1,9
155006,CHEMBL1112,ARIPIPRAZOLE,43,CHEMBL210,Beta-2 adrenergic receptor,6.02,6.02,964.2,1,8
155006,CHEMBL1112,ARIPIPRAZOLE,106,CHEMBL1898,5-hydroxytryptamine receptor 1B,6.0,6.0,1000.0,1,9
155006,CHEMBL1112,ARIPIPRAZOLE,115,CHEMBL227,Type-1 angiotensin II receptor,6.0,6.0,1000.0,1,8
155006,CHEMBL1112,ARIPIPRAZOLE,144,CHEMBL1899,5-hydroxytryptamine receptor 3A,6.0,6.0,1000.0,1,9
155006,CHEMBL1112,ARIPIPRAZOLE,10624,CHEMBL3426,5-hydroxytryptamine receptor 5A,6.0,6.0,1000.0,1,9
155006,CHEMBL1112,ARIPIPRAZOLE,220,CHEMBL1850,D(1B) dopamine receptor,5.98,5.86,1051.0,3,9
155006,CHEMBL1112,ARIPIPRAZOLE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.81,5.81,1564.2,1,8
155006,CHEMBL1112,ARIPIPRAZOLE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.75,5.75,1800.0,1,8
155006,CHEMBL1112,ARIPIPRAZOLE,10977,CHEMBL2608,Lysosomal alpha-glucosidase,5.75,5.75,1778.3,2,9
155006,CHEMBL1112,ARIPIPRAZOLE,246,CHEMBL2069,Thromboxane A2 receptor,5.72,5.72,1900.0,1,8
155006,CHEMBL1112,ARIPIPRAZOLE,102,CHEMBL1941,Histamine H2 receptor,5.66,5.66,2196.5,1,8
155006,CHEMBL1112,ARIPIPRAZOLE,10280,CHEMBL264,Histamine H3 receptor,5.63,5.63,2361.0,1,9
155006,CHEMBL1112,ARIPIPRAZOLE,134,CHEMBL1889,Vasopressin V1a receptor,5.6,5.6,2500.0,1,8
155006,CHEMBL1112,ARIPIPRAZOLE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.51,5.51,3093.5,1,8
155045,CHEMBL1113,AMOXAPINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,9.35,8.55,0.444,5,9
155045,CHEMBL1113,AMOXAPINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,8.7,8.36,1.984,3,8
155045,CHEMBL1113,AMOXAPINE,103668,CHEMBL1293235,Prelamin-A/C,8.3,8.3,5.0,1,9
155045,CHEMBL1113,AMOXAPINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,8.18,7.8,6.569,4,8
155045,CHEMBL1113,AMOXAPINE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,8.0,8.0,10.0,1,9
155045,CHEMBL1113,AMOXAPINE,127,CHEMBL231,Histamine H1 receptor,7.96,7.15,11.0,4,8
155045,CHEMBL1113,AMOXAPINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,7.89,7.62,13.0,3,8
155045,CHEMBL1113,AMOXAPINE,121,CHEMBL228,Sodium-dependent serotonin transporter,7.75,7.08,18.0,3,8
155045,CHEMBL1113,AMOXAPINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,7.63,7.4,23.4,3,8
155045,CHEMBL1113,AMOXAPINE,90,CHEMBL219,D(4) dopamine receptor,7.47,7.38,34.0,2,9
155045,CHEMBL1113,AMOXAPINE,130,CHEMBL234,D(3) dopamine receptor,7.34,7.15,46.0,3,8
155045,CHEMBL1113,AMOXAPINE,72,CHEMBL217,D(2) dopamine receptor,7.17,6.93,67.0,3,8
155045,CHEMBL1113,AMOXAPINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.08,6.94,82.3,2,8
155045,CHEMBL1113,AMOXAPINE,103,CHEMBL223,Alpha-1D adrenergic receptor,6.82,6.67,150.0,2,8
155045,CHEMBL1113,AMOXAPINE,88,CHEMBL2056,D(1A) dopamine receptor,6.73,6.62,186.0,3,8
155045,CHEMBL1113,AMOXAPINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.66,6.66,221.0,1,9
155045,CHEMBL1113,AMOXAPINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.62,6.19,242.0,2,8
155045,CHEMBL1113,AMOXAPINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.59,6.27,255.0,3,8
155045,CHEMBL1113,AMOXAPINE,102,CHEMBL1941,Histamine H2 receptor,6.55,6.55,282.7,1,8
155045,CHEMBL1113,AMOXAPINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.54,6.08,287.0,3,8
155045,CHEMBL1113,AMOXAPINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.42,5.89,378.0,3,8
155045,CHEMBL1113,AMOXAPINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.34,5.78,461.0,3,8
155045,CHEMBL1113,AMOXAPINE,220,CHEMBL1850,D(1B) dopamine receptor,6.32,6.32,479.8,1,8
155045,CHEMBL1113,AMOXAPINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.31,6.09,493.0,2,8
155045,CHEMBL1113,AMOXAPINE,144,CHEMBL1899,5-hydroxytryptamine receptor 3A,6.31,6.31,490.0,1,8
155045,CHEMBL1113,AMOXAPINE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,6.3,6.27,500.0,2,9
155045,CHEMBL1113,AMOXAPINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.21,6.02,615.0,3,8
155045,CHEMBL1113,AMOXAPINE,10624,CHEMBL3426,5-hydroxytryptamine receptor 5A,6.21,6.21,618.2,1,8
155045,CHEMBL1113,AMOXAPINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.03,5.8,933.0,2,8
155045,CHEMBL1113,AMOXAPINE,43,CHEMBL210,Beta-2 adrenergic receptor,5.57,5.57,2700.0,1,8
155045,CHEMBL1113,AMOXAPINE,250,CHEMBL249,Substance-P receptor,5.57,5.57,2667.7,1,8
155045,CHEMBL1113,AMOXAPINE,103665,CHEMBL1293232,Survival motor neuron protein,5.55,5.55,2818.4,1,9
155045,CHEMBL1113,AMOXAPINE,136,CHEMBL236,Delta-type opioid receptor,5.54,5.54,2900.0,1,8
157330,CHEMBL1115,PYRIDOSTIGMINE,93,CHEMBL220,Acetylcholinesterase,6.43,6.17,372.6,2,8
158276,CHEMBL1116,RALOXIFENE HYDROCHLORIDE,19,CHEMBL206,Estrogen receptor,10.15,8.98,0.07,6,9
158276,CHEMBL1116,RALOXIFENE HYDROCHLORIDE,174,CHEMBL242,Estrogen receptor beta,7.37,6.81,43.0,3,9
158276,CHEMBL1116,RALOXIFENE HYDROCHLORIDE,103657,CHEMBL1293224,Microtubule-associated protein tau,5.8,5.7,1584.9,2,9
158276,CHEMBL1116,RALOXIFENE HYDROCHLORIDE,17045,CHEMBL340,Cytochrome P450 3A4,5.6,5.6,2511.9,2,9
158276,CHEMBL1116,RALOXIFENE HYDROCHLORIDE,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,5.55,5.55,2818.4,1,9
158277,CHEMBL1117,IDARUBICIN,63,CHEMBL1806,DNA topoisomerase 2-alpha,8.59,8.59,2.6,1,9
158277,CHEMBL1117,IDARUBICIN,25,CHEMBL2034,Glucocorticoid receptor,6.96,6.96,110.0,1,8
158277,CHEMBL1117,IDARUBICIN,103668,CHEMBL1293235,Prelamin-A/C,6.6,6.55,251.2,2,9
158277,CHEMBL1117,IDARUBICIN,11400,CHEMBL2842,Serine/threonine-protein kinase mTOR,6.38,6.0,414.0,2,9
158277,CHEMBL1117,IDARUBICIN,103731,CHEMBL1293298,Peripheral myelin protein 22,6.37,6.37,425.6,1,9
158277,CHEMBL1117,IDARUBICIN,101216,CHEMBL5514,Huntingtin,6.2,6.2,631.0,1,9
158277,CHEMBL1117,IDARUBICIN,103665,CHEMBL1293232,Survival motor neuron protein,6.2,6.2,631.0,1,9
158277,CHEMBL1117,IDARUBICIN,103711,CHEMBL1293278,Geminin,5.7,5.7,1995.3,1,9
161281,CHEMBL1118,DESVENLAFAXINE,121,CHEMBL228,Sodium-dependent serotonin transporter,8.39,7.72,4.1,5,9
161281,CHEMBL1118,DESVENLAFAXINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.27,6.09,538.0,3,9
16450,CHEMBL112,ACETAMINOPHEN,78,CHEMBL1963,Thyrotropin receptor,6.8,6.8,158.5,1,9
16450,CHEMBL112,ACETAMINOPHEN,107627,CHEMBL2406892,Myoglobin,5.64,5.64,2300.0,1,9
161649,CHEMBL1120,BISMUTH SUBSALICYLATE,103668,CHEMBL1293235,Prelamin-A/C,7.3,7.3,50.1,1,9
164064,CHEMBL1121,SINCALIDE,10472,CHEMBL1901,Cholecystokinin receptor type A,10.36,9.23,0.04365,17,9
164064,CHEMBL1121,SINCALIDE,11522,CHEMBL298,Gastrin/cholecystokinin type B receptor,10.3,9.32,0.05012,27,9
165774,CHEMBL1123,DICYCLOMINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,9.39,8.96,0.411,2,8
165774,CHEMBL1123,DICYCLOMINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,9.08,8.11,0.834,5,8
165774,CHEMBL1123,DICYCLOMINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,9.03,8.1,0.927,3,8
165774,CHEMBL1123,DICYCLOMINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,8.77,8.7,1.711,2,8
165774,CHEMBL1123,DICYCLOMINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,8.69,8.5,2.055,2,8
165774,CHEMBL1123,DICYCLOMINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.8,7.57,16.0,2,8
165774,CHEMBL1123,DICYCLOMINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.16,6.89,69.0,2,8
165774,CHEMBL1123,DICYCLOMINE,103668,CHEMBL1293235,Prelamin-A/C,7.15,7.15,70.8,1,9
165774,CHEMBL1123,DICYCLOMINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.61,6.47,245.0,2,8
165774,CHEMBL1123,DICYCLOMINE,130,CHEMBL234,D(3) dopamine receptor,6.39,6.15,411.0,2,8
165774,CHEMBL1123,DICYCLOMINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.08,5.98,828.0,2,8
165774,CHEMBL1123,DICYCLOMINE,88,CHEMBL2056,D(1A) dopamine receptor,5.96,5.96,1100.0,1,8
165774,CHEMBL1123,DICYCLOMINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,5.85,5.68,1423.0,2,8
165774,CHEMBL1123,DICYCLOMINE,102,CHEMBL1941,Histamine H2 receptor,5.8,5.79,1598.0,2,8
165774,CHEMBL1123,DICYCLOMINE,17045,CHEMBL340,Cytochrome P450 3A4,5.6,5.6,2511.89,3,9
167875,CHEMBL1128,EDROPHONIUM CHLORIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.6,8.6,2.5,2,9
167875,CHEMBL1128,EDROPHONIUM CHLORIDE,93,CHEMBL220,Acetylcholinesterase,6.7,6.38,200.0,6,9
169321,CHEMBL1129,TRIFLURIDINE,103668,CHEMBL1293235,Prelamin-A/C,5.7,5.7,1995.3,1,9
16485,CHEMBL113,CAFFEINE,87,CHEMBL218,Cannabinoid receptor 1,9.22,9.22,0.6,1,8
16485,CHEMBL113,CAFFEINE,100446,CHEMBL4461,"NAD-dependent protein deacetylase sirtuin-3, mitochondrial",6.16,6.16,690.0,1,9
16485,CHEMBL113,CAFFEINE,252,CHEMBL251,Adenosine receptor A2a,5.61,5.61,2480.0,1,9
169652,CHEMBL1131,ACITRETIN,103665,CHEMBL1293232,Survival motor neuron protein,5.5,5.5,3162.3,1,9
171062,CHEMBL1134,DECAMETHONIUM BROMIDE,93,CHEMBL220,Acetylcholinesterase,6.0,6.0,1000.0,1,9
171062,CHEMBL1134,DECAMETHONIUM BROMIDE,103665,CHEMBL1293232,Survival motor neuron protein,5.8,5.8,1584.9,1,9
8633,CHEMBL11359,CISPLATIN,12054,CHEMBL2903,Polyunsaturated fatty acid lipoxygenase ALOX15,7.0,7.0,100.0,1,9
8633,CHEMBL11359,CISPLATIN,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,6.9,6.9,125.9,1,9
8633,CHEMBL11359,CISPLATIN,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,5.95,5.95,1122.0,1,9
8633,CHEMBL11359,CISPLATIN,103688,CHEMBL1293255,15-hydroxyprostaglandin dehydrogenase [NAD(+)],5.65,5.65,2238.7,1,9
8633,CHEMBL11359,CISPLATIN,280,CHEMBL256,Adenosine receptor A3,5.62,5.62,2398.0,1,8
8633,CHEMBL11359,CISPLATIN,103657,CHEMBL1293224,Microtubule-associated protein tau,5.6,5.57,2511.9,2,9
8633,CHEMBL11359,CISPLATIN,9,CHEMBL203,Epidermal growth factor receptor,5.58,5.58,2621.0,1,8
175106,CHEMBL1138,EZETIMIBE,329,CHEMBL2027,NPC1-like intracellular cholesterol transporter 1,6.43,6.43,370.0,1,9
17169,CHEMBL114,SAQUINAVIR,17045,CHEMBL340,Cytochrome P450 3A4,6.77,6.26,170.0,3,9
17169,CHEMBL114,SAQUINAVIR,11398,CHEMBL4302,ATP-dependent translocase ABCB1,5.8,5.8,1600.0,1,8
17169,CHEMBL114,SAQUINAVIR,10184,CHEMBL2327,Substance-K receptor,5.68,5.68,2071.0,1,8
17169,CHEMBL114,SAQUINAVIR,248,CHEMBL1835,Thromboxane-A synthase,5.66,5.66,2182.0,1,9
17169,CHEMBL114,SAQUINAVIR,137,CHEMBL237,Kappa-type opioid receptor,5.61,5.58,2451.3,2,8
17169,CHEMBL114,SAQUINAVIR,102394,CHEMBL6020,Bile salt export pump,5.54,5.54,2900.0,2,9
175447,CHEMBL1140,NIACINAMIDE,100447,CHEMBL4462,NAD-dependent protein deacetylase sirtuin-2,5.92,5.92,1200.0,2,9
178796,CHEMBL1144,PRAVASTATIN,24,CHEMBL402,3-hydroxy-3-methylglutaryl-coenzyme A reductase,8.25,7.39,5.591,3,9
180329,CHEMBL1148,TORSEMIDE,17045,CHEMBL340,Cytochrome P450 3A4,6.0,6.0,1000.0,3,9
182546,CHEMBL1152,PREDNISOLONE ACETATE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,7.6,7.6,25.1,2,9
187515,CHEMBL1159,PINACIDIL ANHYDROUS,103668,CHEMBL1293235,Prelamin-A/C,5.9,5.9,1258.9,1,9
187515,CHEMBL1159,PINACIDIL ANHYDROUS,10693,CHEMBL2524,Alpha-galactosidase A,5.5,5.5,3162.3,1,9
187515,CHEMBL1159,PINACIDIL ANHYDROUS,17045,CHEMBL340,Cytochrome P450 3A4,5.5,5.5,3162.3,2,9
641189,CHEMBL1159650,CLOBETASOL PROPIONATE,25,CHEMBL2034,Glucocorticoid receptor,9.18,8.71,0.662,3,8
641189,CHEMBL1159650,CLOBETASOL PROPIONATE,12739,CHEMBL3019,Cytochrome P450 3A5,7.68,7.23,21.0,5,9
641189,CHEMBL1159650,CLOBETASOL PROPIONATE,36,CHEMBL208,Progesterone receptor,7.28,7.28,53.0,1,8
641189,CHEMBL1159650,CLOBETASOL PROPIONATE,17045,CHEMBL340,Cytochrome P450 3A4,6.69,6.69,206.0,1,9
641189,CHEMBL1159650,CLOBETASOL PROPIONATE,101097,CHEMBL5162,Neuropeptide S receptor,6.0,5.9,1000.0,3,9
641189,CHEMBL1159650,CLOBETASOL PROPIONATE,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.82,5.82,1500.0,1,8
641189,CHEMBL1159650,CLOBETASOL PROPIONATE,103665,CHEMBL1293232,Survival motor neuron protein,5.8,5.8,1584.9,1,9
17347,CHEMBL116,AMPRENAVIR,12739,CHEMBL3019,Cytochrome P450 3A5,6.7,6.7,200.0,1,9
17347,CHEMBL116,AMPRENAVIR,17045,CHEMBL340,Cytochrome P450 3A4,6.58,6.34,260.0,3,9
17347,CHEMBL116,AMPRENAVIR,103668,CHEMBL1293235,Prelamin-A/C,6.2,6.2,631.0,1,9
187696,CHEMBL1161,MOMETASONE FUROATE,36,CHEMBL208,Progesterone receptor,10.1,9.31,0.08,2,8
187696,CHEMBL1161,MOMETASONE FUROATE,25,CHEMBL2034,Glucocorticoid receptor,9.3,9.0,0.5,3,9
187696,CHEMBL1161,MOMETASONE FUROATE,56,CHEMBL1871,Androgen receptor,7.47,7.47,33.7,1,8
187696,CHEMBL1161,MOMETASONE FUROATE,104062,CHEMBL1743121,Solute carrier organic anion transporter family member 1B3,6.06,6.0,870.0,2,8
187696,CHEMBL1161,MOMETASONE FUROATE,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,5.79,5.66,1620.0,2,8
187696,CHEMBL1161,MOMETASONE FUROATE,280,CHEMBL256,Adenosine receptor A3,5.78,5.78,1644.2,1,8
187696,CHEMBL1161,MOMETASONE FUROATE,102394,CHEMBL6020,Bile salt export pump,5.62,5.62,2400.0,1,8
187962,CHEMBL1162,NORETHINDRONE,36,CHEMBL208,Progesterone receptor,9.4,8.72,0.4,5,9
187962,CHEMBL1162,NORETHINDRONE,12643,CHEMBL3305,Sex hormone-binding globulin,7.97,7.97,10.72,1,9
187962,CHEMBL1162,NORETHINDRONE,25,CHEMBL2034,Glucocorticoid receptor,7.09,6.72,82.0,3,8
187962,CHEMBL1162,NORETHINDRONE,19,CHEMBL206,Estrogen receptor,6.64,6.37,231.0,2,8
187962,CHEMBL1162,NORETHINDRONE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.62,5.62,2411.0,1,8
188196,CHEMBL1163,ATAZANAVIR,103619,CHEMBL1287617,UDP-glucuronosyltransferase 1A1,6.52,6.37,300.0,4,9
188196,CHEMBL1163,ATAZANAVIR,104062,CHEMBL1743121,Solute carrier organic anion transporter family member 1B3,6.43,6.42,370.0,2,9
188196,CHEMBL1163,ATAZANAVIR,137,CHEMBL237,Kappa-type opioid receptor,5.97,5.97,1059.3,1,8
188196,CHEMBL1163,ATAZANAVIR,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,5.89,5.87,1300.0,2,9
188196,CHEMBL1163,ATAZANAVIR,102394,CHEMBL6020,Bile salt export pump,5.7,5.7,2000.0,1,8
647206,CHEMBL1164729,FEBUXOSTAT,149,CHEMBL1929,Xanthine dehydrogenase/oxidase,10.0,8.35,0.1,14,9
647206,CHEMBL1164729,FEBUXOSTAT,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,7.57,7.57,27.0,1,9
647206,CHEMBL1164729,FEBUXOSTAT,11307,CHEMBL1865,Histone deacetylase 6,7.26,7.26,55.42,1,9
647206,CHEMBL1164729,FEBUXOSTAT,100283,CHEMBL5019,Flavin reductase (NADPH),5.79,5.79,1621.81,2,9
647206,CHEMBL1164729,FEBUXOSTAT,104069,CHEMBL1743128,ATP-binding cassette sub-family C member 4,5.72,5.72,1900.0,1,9
188707,CHEMBL1165,MOEXIPRIL,69,CHEMBL1808,Angiotensin-converting enzyme,8.59,7.92,2.6,2,8
646449,CHEMBL1165268,IODIPAMIDE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,5.9,5.9,1258.9,1,9
644928,CHEMBL1165342,VINCAMINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.34,6.34,460.0,1,8
188815,CHEMBL1166,ARGATROBAN,11,CHEMBL204,Prothrombin,8.62,7.57,2.42,25,9
9623,CHEMBL11662,OZAGREL,248,CHEMBL1835,Thromboxane-A synthase,7.62,6.93,24.0,7,9
189203,CHEMBL1168,RAMIPRIL,69,CHEMBL1808,Angiotensin-converting enzyme,8.4,8.39,4.0,2,9
190629,CHEMBL1170,TESTOSTERONE PROPIONATE,56,CHEMBL1871,Androgen receptor,9.6,8.68,0.25,2,9
190629,CHEMBL1170,TESTOSTERONE PROPIONATE,103668,CHEMBL1293235,Prelamin-A/C,8.1,8.1,7.9,1,9
190629,CHEMBL1170,TESTOSTERONE PROPIONATE,12949,CHEMBL3522,"Steroid 17-alpha-hydroxylase/17,20 lyase",7.25,7.25,56.0,1,8
190629,CHEMBL1170,TESTOSTERONE PROPIONATE,25,CHEMBL2034,Glucocorticoid receptor,6.96,6.96,109.0,1,8
190629,CHEMBL1170,TESTOSTERONE PROPIONATE,36,CHEMBL208,Progesterone receptor,6.48,6.48,328.0,1,8
190629,CHEMBL1170,TESTOSTERONE PROPIONATE,17045,CHEMBL340,Cytochrome P450 3A4,5.9,5.9,1258.9,2,9
649637,CHEMBL1171837,PONATINIB,11785,CHEMBL3234,Tyrosine-protein kinase HCK,9.96,8.53,0.11,2,9
649637,CHEMBL1171837,PONATINIB,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,9.8,8.93,0.16,4,9
649637,CHEMBL1171837,PONATINIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,9.55,8.59,0.28,2,9
649637,CHEMBL1171837,PONATINIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,9.52,8.93,0.3,38,9
649637,CHEMBL1171837,PONATINIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,9.52,8.15,0.3,7,9
649637,CHEMBL1171837,PONATINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,9.52,7.99,0.3,10,9
649637,CHEMBL1171837,PONATINIB,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,9.44,8.44,0.36,2,9
649637,CHEMBL1171837,PONATINIB,10266,CHEMBL3650,Fibroblast growth factor receptor 1,9.15,8.88,0.7,8,9
649637,CHEMBL1171837,PONATINIB,18033,CHEMBL2073,Tyrosine-protein kinase Yes,9.05,7.86,0.89,2,9
649637,CHEMBL1171837,PONATINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,9.0,8.61,1.0,10,9
649637,CHEMBL1171837,PONATINIB,20025,CHEMBL5014,Receptor-interacting serine/threonine-protein kinase 2,9.0,8.1,1.0,4,9
649637,CHEMBL1171837,PONATINIB,12627,CHEMBL2007,Platelet-derived growth factor receptor alpha,8.96,8.84,1.1,3,9
649637,CHEMBL1171837,PONATINIB,197,CHEMBL1913,Platelet-derived growth factor receptor beta,8.92,8.92,1.2,1,9
649637,CHEMBL1171837,PONATINIB,10264,CHEMBL4142,Fibroblast growth factor receptor 2,8.89,8.79,1.3,2,9
649637,CHEMBL1171837,PONATINIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,8.89,7.96,1.3,2,9
649637,CHEMBL1171837,PONATINIB,104279,CHEMBL1795199,Receptor-interacting serine/threonine-protein kinase 3,8.8,8.05,1.6,5,9
649637,CHEMBL1171837,PONATINIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,8.77,8.04,1.7,7,9
649637,CHEMBL1171837,PONATINIB,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,8.6,8.08,2.5,8,9
649637,CHEMBL1171837,PONATINIB,10979,CHEMBL1868,Vascular endothelial growth factor receptor 1,8.43,8.05,3.7,2,9
649637,CHEMBL1171837,PONATINIB,11925,CHEMBL3973,Fibroblast growth factor receptor 4,8.15,7.87,7.1,3,9
649637,CHEMBL1171837,PONATINIB,30019,CHEMBL3987,Ephrin type-A receptor 5,8.1,8.1,8.0,1,9
649637,CHEMBL1171837,PONATINIB,12840,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,8.07,8.07,8.6,1,9
649637,CHEMBL1171837,PONATINIB,11926,CHEMBL2742,Fibroblast growth factor receptor 3,8.03,7.89,9.4,2,9
649637,CHEMBL1171837,PONATINIB,100917,CHEMBL5319,Epithelial discoidin domain-containing receptor 1,8.03,7.89,9.4,2,9
649637,CHEMBL1171837,PONATINIB,11902,CHEMBL2815,High affinity nerve growth factor receptor,7.94,7.55,11.4,2,9
649637,CHEMBL1171837,PONATINIB,100990,CHEMBL5464,Receptor-interacting serine/threonine-protein kinase 1,7.92,7.76,12.0,3,9
649637,CHEMBL1171837,PONATINIB,10844,CHEMBL2634,Tyrosine-protein kinase CSK,7.9,7.2,12.7,2,9
649637,CHEMBL1171837,PONATINIB,101300,CHEMBL5719,Cyclin-dependent kinase 8,7.85,7.85,14.0,1,9
649637,CHEMBL1171837,PONATINIB,11209,CHEMBL4014,Tyrosine-protein kinase ABL2,7.7,7.7,20.0,1,9
649637,CHEMBL1171837,PONATINIB,9,CHEMBL203,Epidermal growth factor receptor,7.66,7.66,22.0,1,8
649637,CHEMBL1171837,PONATINIB,30008,CHEMBL2068,Ephrin type-A receptor 2,7.57,7.57,27.0,1,9
649637,CHEMBL1171837,PONATINIB,103154,CHEMBL1075104,Leucine-rich repeat serine/threonine-protein kinase 2,7.51,6.81,31.0,3,9
649637,CHEMBL1171837,PONATINIB,10919,CHEMBL2835,Tyrosine-protein kinase JAK1,7.49,7.49,32.2,1,9
649637,CHEMBL1171837,PONATINIB,100127,CHEMBL4454,Tyrosine-protein kinase Fgr,7.42,7.42,38.0,1,9
649637,CHEMBL1171837,PONATINIB,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,7.4,7.4,40.0,1,9
649637,CHEMBL1171837,PONATINIB,20007,CHEMBL3886,Mitogen-activated protein kinase kinase kinase 20,7.39,7.39,41.0,1,9
649637,CHEMBL1171837,PONATINIB,100947,CHEMBL5330,Mitogen-activated protein kinase kinase kinase kinase 2,7.39,7.39,41.0,1,9
649637,CHEMBL1171837,PONATINIB,100128,CHEMBL5146,Breakpoint cluster region protein,7.3,7.3,50.0,1,9
649637,CHEMBL1171837,PONATINIB,19639,CHEMBL3778,Interleukin-1 receptor-associated kinase 4,7.17,6.42,66.9,2,9
649637,CHEMBL1171837,PONATINIB,100951,CHEMBL5334,Non-receptor tyrosine-protein kinase TNK1,7.08,7.08,84.0,1,9
649637,CHEMBL1171837,PONATINIB,104502,CHEMBL2010634,ATP-dependent RNA helicase DDX1,7.07,7.07,86.0,1,9
649637,CHEMBL1171837,PONATINIB,101079,CHEMBL5122,Discoidin domain-containing receptor 2,7.06,7.06,87.0,1,9
649637,CHEMBL1171837,PONATINIB,10250,CHEMBL2428,"Myosin light chain kinase, smooth muscle",7.0,7.0,99.0,1,9
649637,CHEMBL1171837,PONATINIB,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,6.92,6.92,120.0,1,8
649637,CHEMBL1171837,PONATINIB,101340,CHEMBL5810,Ephrin type-A receptor 1,6.84,6.39,143.0,2,9
649637,CHEMBL1171837,PONATINIB,10188,CHEMBL260,Mitogen-activated protein kinase 14,6.81,6.81,154.0,1,9
649637,CHEMBL1171837,PONATINIB,121,CHEMBL228,Sodium-dependent serotonin transporter,6.78,6.78,164.9,1,8
649637,CHEMBL1171837,PONATINIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,6.77,6.77,169.0,1,9
649637,CHEMBL1171837,PONATINIB,100995,CHEMBL5469,Protein-tyrosine kinase 2-beta,6.53,6.53,295.0,1,9
649637,CHEMBL1171837,PONATINIB,101464,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,6.51,6.51,307.0,1,9
649637,CHEMBL1171837,PONATINIB,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.5,6.5,317.5,1,8
649637,CHEMBL1171837,PONATINIB,101553,CHEMBL5790,Cyclin-dependent kinase 17,6.47,6.47,335.0,1,9
649637,CHEMBL1171837,PONATINIB,30047,CHEMBL4527,TRAF2 and NCK-interacting protein kinase,6.42,6.42,385.0,1,9
649637,CHEMBL1171837,PONATINIB,11082,CHEMBL2208,MAP kinase-activated protein kinase 2,6.33,6.33,468.0,1,9
649637,CHEMBL1171837,PONATINIB,12276,CHEMBL3956,Mitogen-activated protein kinase kinase kinase 1,6.31,6.31,493.0,1,9
649637,CHEMBL1171837,PONATINIB,100416,CHEMBL4901,Ephrin type-B receptor 3,6.26,6.26,547.0,1,9
649637,CHEMBL1171837,PONATINIB,11969,CHEMBL4101,cAMP-dependent protein kinase catalytic subunit alpha,6.21,6.21,613.0,1,9
649637,CHEMBL1171837,PONATINIB,19623,CHEMBL3357,Interleukin-1 receptor-associated kinase 1,6.16,6.16,691.0,1,9
649637,CHEMBL1171837,PONATINIB,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.11,6.11,770.0,1,9
649637,CHEMBL1171837,PONATINIB,101312,CHEMBL5749,Mitogen-activated protein kinase kinase kinase kinase 1,6.11,6.11,769.0,1,9
649637,CHEMBL1171837,PONATINIB,10120,CHEMBL3961,Mitogen-activated protein kinase 11,6.0,6.0,1012.0,1,9
649637,CHEMBL1171837,PONATINIB,100126,CHEMBL5145,Serine/threonine-protein kinase B-raf,5.92,5.92,1194.0,1,9
649637,CHEMBL1171837,PONATINIB,86,CHEMBL1951,Amine oxidase [flavin-containing] A,5.91,5.91,1228.9,1,8
649637,CHEMBL1171837,PONATINIB,100129,CHEMBL5147,Ephrin type-B receptor 4,5.83,5.83,1493.0,1,9
649637,CHEMBL1171837,PONATINIB,30022,CHEMBL4597,Cyclin-dependent kinase 16,5.76,5.76,1729.0,1,9
649637,CHEMBL1171837,PONATINIB,101048,CHEMBL5047,Serine/threonine-protein kinase ULK3,5.76,5.76,1720.0,1,9
649637,CHEMBL1171837,PONATINIB,30032,CHEMBL5284,Calcium/calmodulin-dependent protein kinase kinase 2,5.75,5.75,1766.0,1,9
649637,CHEMBL1171837,PONATINIB,100075,CHEMBL4267,TGF-beta receptor type-2,5.75,5.75,1779.0,1,9
649637,CHEMBL1171837,PONATINIB,100097,CHEMBL5251,Tyrosine-protein kinase BTK,5.74,5.74,1841.0,1,9
649637,CHEMBL1171837,PONATINIB,11569,CHEMBL3290,Ephrin type-B receptor 2,5.73,5.73,1857.0,1,9
649637,CHEMBL1171837,PONATINIB,20020,CHEMBL4355,Cyclin-G-associated kinase,5.73,5.73,1862.0,1,9
649637,CHEMBL1171837,PONATINIB,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,5.7,5.7,2000.0,1,8
649637,CHEMBL1171837,PONATINIB,101506,CHEMBL5701,Serine/threonine-protein kinase TAO3,5.67,5.67,2136.0,1,9
649637,CHEMBL1171837,PONATINIB,10371,CHEMBL4948,Dual specificity mitogen-activated protein kinase kinase 5,5.53,5.53,2952.0,1,9
649637,CHEMBL1171837,PONATINIB,100854,CHEMBL4578,Maternal embryonic leucine zipper kinase,5.53,5.53,2987.0,1,9
649637,CHEMBL1171837,PONATINIB,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.5,5.5,3200.0,1,8
191342,CHEMBL1172,DESLORATADINE,127,CHEMBL231,Histamine H1 receptor,9.19,8.58,0.644,9,9
191342,CHEMBL1172,DESLORATADINE,102,CHEMBL1941,Histamine H2 receptor,8.48,6.8,3.3,3,8
191342,CHEMBL1172,DESLORATADINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.03,7.18,9.45,4,8
191342,CHEMBL1172,DESLORATADINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.8,7.29,16.0,3,8
191342,CHEMBL1172,DESLORATADINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.55,7.31,28.0,4,8
191342,CHEMBL1172,DESLORATADINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.43,7.05,37.5,5,8
191342,CHEMBL1172,DESLORATADINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,7.33,6.9,47.0,2,8
191342,CHEMBL1172,DESLORATADINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.19,6.51,64.0,4,8
191342,CHEMBL1172,DESLORATADINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,7.02,6.52,95.0,4,9
191342,CHEMBL1172,DESLORATADINE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.91,6.45,122.0,4,8
191342,CHEMBL1172,DESLORATADINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.68,6.61,210.0,2,8
191342,CHEMBL1172,DESLORATADINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.3,6.0,499.0,2,9
191342,CHEMBL1172,DESLORATADINE,130,CHEMBL234,D(3) dopamine receptor,6.19,6.04,647.0,4,8
191342,CHEMBL1172,DESLORATADINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.01,5.84,980.0,2,8
191342,CHEMBL1172,DESLORATADINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.0,5.83,1008.0,2,8
191342,CHEMBL1172,DESLORATADINE,90,CHEMBL219,D(4) dopamine receptor,5.97,5.97,1062.9,1,8
191342,CHEMBL1172,DESLORATADINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.96,5.83,1107.0,3,8
191342,CHEMBL1172,DESLORATADINE,72,CHEMBL217,D(2) dopamine receptor,5.8,5.8,1600.0,1,8
191342,CHEMBL1172,DESLORATADINE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.53,5.52,2960.0,2,8
191342,CHEMBL1172,DESLORATADINE,103668,CHEMBL1293235,Prelamin-A/C,5.5,5.5,3162.3,1,9
191172,CHEMBL117287,PRUCALOPRIDE,168,CHEMBL1875,5-hydroxytryptamine receptor 4,8.6,7.88,2.512,7,9
651088,CHEMBL1173055,RUCAPARIB,54,CHEMBL1828,DNA polymerase alpha catalytic subunit,9.4,9.4,0.4,1,9
651088,CHEMBL1173055,RUCAPARIB,100933,CHEMBL5366,Poly [ADP-ribose] polymerase 2,9.4,8.4,0.4,17,9
651088,CHEMBL1173055,RUCAPARIB,11663,CHEMBL3105,Poly [ADP-ribose] polymerase 1,9.15,8.46,0.7,35,9
651088,CHEMBL1173055,RUCAPARIB,102783,CHEMBL6154,Poly [ADP-ribose] polymerase tankyrase-2,7.85,6.95,14.0,4,9
651088,CHEMBL1173055,RUCAPARIB,101462,CHEMBL6164,Poly [ADP-ribose] polymerase tankyrase-1,7.6,7.22,25.0,4,9
651088,CHEMBL1173055,RUCAPARIB,101057,CHEMBL5083,Protein mono-ADP-ribosyltransferase PARP3,7.55,6.87,28.0,5,9
651088,CHEMBL1173055,RUCAPARIB,30022,CHEMBL4597,Cyclin-dependent kinase 16,6.42,6.42,381.0,1,9
651088,CHEMBL1173055,RUCAPARIB,100855,CHEMBL5407,Serine/threonine-protein kinase pim-3,6.36,6.36,436.0,1,9
651088,CHEMBL1173055,RUCAPARIB,12090,CHEMBL2292,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,6.3,5.96,501.19,2,9
651088,CHEMBL1173055,RUCAPARIB,102445,CHEMBL6142,Protein mono-ADP-ribosyltransferase PARP4,6.3,6.15,503.0,3,9
651088,CHEMBL1173055,RUCAPARIB,107664,CHEMBL2429708,Protein mono-ADP-ribosyltransferase PARP10,6.25,5.86,562.34,5,9
651088,CHEMBL1173055,RUCAPARIB,101014,CHEMBL5543,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,6.13,5.92,747.0,2,9
651088,CHEMBL1173055,RUCAPARIB,10839,CHEMBL2147,Serine/threonine-protein kinase pim-1,5.9,5.9,1258.93,1,8
651088,CHEMBL1173055,RUCAPARIB,12071,CHEMBL308,Cyclin-dependent kinase 1,5.6,5.6,2511.89,1,8
651088,CHEMBL1173055,RUCAPARIB,117586,CHEMBL4105981,Protein mono-ADP-ribosyltransferase PARP16,5.54,5.54,2900.0,1,9
651088,CHEMBL1173055,RUCAPARIB,118140,CHEMBL4295895,Protein mono-ADP-ribosyltransferase PARP9,5.51,5.51,3100.0,1,9
650126,CHEMBL1173655,AFATINIB,9,CHEMBL203,Epidermal growth factor receptor,10.1,8.69,0.08,125,9
650126,CHEMBL1173655,AFATINIB,12699,CHEMBL3009,Receptor tyrosine-protein kinase erbB-4,9.0,8.59,1.0,4,9
650126,CHEMBL1173655,AFATINIB,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,8.7,7.85,1.98,22,9
650126,CHEMBL1173655,AFATINIB,20020,CHEMBL4355,Cyclin-G-associated kinase,7.1,6.65,79.0,3,9
650126,CHEMBL1173655,AFATINIB,11451,CHEMBL3717,Hepatocyte growth factor receptor,6.8,5.95,157.0,4,9
650126,CHEMBL1173655,AFATINIB,11691,CHEMBL2250,Tyrosine-protein kinase Blk,6.66,6.66,220.0,1,8
650126,CHEMBL1173655,AFATINIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,6.64,6.08,230.0,17,9
650126,CHEMBL1173655,AFATINIB,19623,CHEMBL3357,Interleukin-1 receptor-associated kinase 1,6.62,6.62,240.0,1,8
650126,CHEMBL1173655,AFATINIB,30046,CHEMBL4526,Ephrin type-A receptor 6,6.47,6.47,340.0,1,8
650126,CHEMBL1173655,AFATINIB,103106,CHEMBL1075167,Homeodomain-interacting protein kinase 4,6.44,6.44,360.0,1,8
650126,CHEMBL1173655,AFATINIB,12735,CHEMBL2349,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",6.33,6.33,470.0,1,8
650126,CHEMBL1173655,AFATINIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,6.24,6.24,570.0,1,8
650126,CHEMBL1173655,AFATINIB,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,6.13,6.13,736.0,1,9
650126,CHEMBL1173655,AFATINIB,11082,CHEMBL2208,MAP kinase-activated protein kinase 2,6.09,6.09,817.0,1,9
650126,CHEMBL1173655,AFATINIB,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.06,6.06,870.0,1,8
650126,CHEMBL1173655,AFATINIB,12090,CHEMBL2292,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,6.01,6.01,970.0,1,8
650126,CHEMBL1173655,AFATINIB,10188,CHEMBL260,Mitogen-activated protein kinase 14,5.98,5.94,1047.0,2,9
650126,CHEMBL1173655,AFATINIB,10371,CHEMBL4948,Dual specificity mitogen-activated protein kinase kinase 5,5.89,5.89,1300.0,1,8
650126,CHEMBL1173655,AFATINIB,10967,CHEMBL4937,Casein kinase I isoform epsilon,5.89,5.89,1300.0,1,8
650126,CHEMBL1173655,AFATINIB,11361,CHEMBL4004,"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",5.89,5.89,1300.0,1,8
650126,CHEMBL1173655,AFATINIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,5.85,5.8,1400.0,2,8
650126,CHEMBL1173655,AFATINIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,5.85,5.85,1400.0,1,8
650126,CHEMBL1173655,AFATINIB,30037,CHEMBL4204,MAP kinase-interacting serine/threonine-protein kinase 2,5.8,5.8,1600.0,1,8
650126,CHEMBL1173655,AFATINIB,100790,CHEMBL4376,Dual specificity tyrosine-phosphorylation-regulated kinase 2,5.75,5.75,1800.0,1,8
650126,CHEMBL1173655,AFATINIB,100835,CHEMBL4718,MAP kinase-interacting serine/threonine-protein kinase 1,5.75,5.75,1800.0,1,8
650126,CHEMBL1173655,AFATINIB,11408,CHEMBL2637,Mitogen-activated protein kinase 10,5.7,5.7,2000.0,1,8
650126,CHEMBL1173655,AFATINIB,11407,CHEMBL4179,Mitogen-activated protein kinase 9,5.68,5.63,2100.0,2,9
650126,CHEMBL1173655,AFATINIB,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.66,5.66,2206.0,1,9
650126,CHEMBL1173655,AFATINIB,11785,CHEMBL3234,Tyrosine-protein kinase HCK,5.66,5.66,2200.0,1,8
650126,CHEMBL1173655,AFATINIB,30045,CHEMBL4525,Serine/threonine-protein kinase 17A,5.64,5.64,2300.0,1,8
650126,CHEMBL1173655,AFATINIB,20025,CHEMBL5014,Receptor-interacting serine/threonine-protein kinase 2,5.57,5.57,2700.0,1,8
650126,CHEMBL1173655,AFATINIB,10120,CHEMBL3961,Mitogen-activated protein kinase 11,5.55,5.55,2811.0,1,9
650126,CHEMBL1173655,AFATINIB,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,5.55,5.55,2800.0,1,8
650126,CHEMBL1173655,AFATINIB,101014,CHEMBL5543,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,5.55,5.55,2800.0,1,8
650126,CHEMBL1173655,AFATINIB,101239,CHEMBL5579,Citron Rho-interacting kinase,5.54,5.54,2900.0,1,8
650126,CHEMBL1173655,AFATINIB,10939,CHEMBL4924,Ribosomal protein S6 kinase alpha-6,5.51,5.51,3100.0,1,8
650126,CHEMBL1173655,AFATINIB,100424,CHEMBL4367,Tyrosine-protein kinase TXK,5.51,5.51,3100.0,1,8
650126,CHEMBL1173655,AFATINIB,102676,CHEMBL5836,Ephrin type-B receptor 6,5.51,5.51,3100.0,1,8
192908,CHEMBL1175,DULOXETINE,121,CHEMBL228,Sodium-dependent serotonin transporter,9.62,8.54,0.24,22,9
192908,CHEMBL1175,DULOXETINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,8.8,7.83,1.585,24,9
192908,CHEMBL1175,DULOXETINE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.62,6.27,240.0,18,9
192908,CHEMBL1175,DULOXETINE,17045,CHEMBL340,Cytochrome P450 3A4,6.36,6.36,440.0,2,9
192908,CHEMBL1175,DULOXETINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.2,6.2,630.3,1,8
192908,CHEMBL1175,DULOXETINE,11365,CHEMBL289,Cytochrome P450 2D6,6.0,5.83,1000.0,4,9
192908,CHEMBL1175,DULOXETINE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.98,5.98,1051.9,1,8
192908,CHEMBL1175,DULOXETINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.85,5.85,1400.0,1,8
192908,CHEMBL1175,DULOXETINE,137,CHEMBL237,Kappa-type opioid receptor,5.71,5.71,1961.3,1,8
192908,CHEMBL1175,DULOXETINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.62,5.62,2377.0,1,8
193096,CHEMBL1177,PEMOLINE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.38,6.33,414.2,2,8
193096,CHEMBL1177,PEMOLINE,103727,CHEMBL1293294,Ras-related protein Rab-9A,5.9,5.9,1258.9,1,9
193281,CHEMBL117785,TETRABENAZINE,162,CHEMBL1893,Synaptic vesicular amine transporter,7.7,7.7,19.8,1,9
18694,CHEMBL118,CELECOXIB,126,CHEMBL230,Prostaglandin G/H synthase 2,9.33,6.97,0.47,221,9
18694,CHEMBL118,CELECOXIB,96,CHEMBL221,Prostaglandin G/H synthase 1,7.89,6.45,13.0,17,9
18694,CHEMBL118,CELECOXIB,12952,CHEMBL3594,Carbonic anhydrase 9,7.83,7.78,14.8,4,9
18694,CHEMBL118,CELECOXIB,15,CHEMBL205,Carbonic anhydrase 2,7.8,7.3,15.8,7,9
18694,CHEMBL118,CELECOXIB,12209,CHEMBL3242,Carbonic anhydrase 12,7.75,7.75,18.0,7,9
18694,CHEMBL118,CELECOXIB,12054,CHEMBL2903,Polyunsaturated fatty acid lipoxygenase ALOX15,7.31,7.31,49.0,1,9
18694,CHEMBL118,CELECOXIB,10186,CHEMBL3025,Carbonic anhydrase 6,7.03,7.03,94.0,3,9
18694,CHEMBL118,CELECOXIB,11016,CHEMBL3969,"Carbonic anhydrase 5B, mitochondrial",7.03,7.03,93.0,2,9
18694,CHEMBL118,CELECOXIB,12923,CHEMBL3912,Carbonic anhydrase 13,7.01,7.01,98.0,2,9
18694,CHEMBL118,CELECOXIB,101472,CHEMBL6174,Cytochrome c oxidase subunit 2,6.55,6.45,280.0,3,9
18694,CHEMBL118,CELECOXIB,12896,CHEMBL3729,Carbonic anhydrase 4,6.54,6.25,290.0,5,9
18694,CHEMBL118,CELECOXIB,101277,CHEMBL5658,Prostaglandin E synthase,6.37,6.3,425.0,3,9
18694,CHEMBL118,CELECOXIB,11307,CHEMBL1865,Histone deacetylase 6,6.19,6.19,643.0,1,9
18694,CHEMBL118,CELECOXIB,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.16,5.9,692.0,3,8
18694,CHEMBL118,CELECOXIB,11063,CHEMBL3510,Carbonic anhydrase 14,6.16,6.16,689.0,2,9
18694,CHEMBL118,CELECOXIB,78,CHEMBL1963,Thyrotropin receptor,6.1,6.1,794.3,2,9
18694,CHEMBL118,CELECOXIB,11042,CHEMBL4789,"Carbonic anhydrase 5A, mitochondrial",6.1,6.1,794.0,2,9
18694,CHEMBL118,CELECOXIB,10188,CHEMBL260,Mitogen-activated protein kinase 14,6.09,6.09,810.0,1,9
18694,CHEMBL118,CELECOXIB,11365,CHEMBL289,Cytochrome P450 2D6,6.0,6.0,1000.0,1,8
18694,CHEMBL118,CELECOXIB,12697,CHEMBL325,Histone deacetylase 1,5.93,5.93,1185.0,1,9
18694,CHEMBL118,CELECOXIB,55,CHEMBL215,Polyunsaturated fatty acid 5-lipoxygenase,5.76,5.76,1720.0,1,9
18694,CHEMBL118,CELECOXIB,155,CHEMBL238,Sodium-dependent dopamine transporter,5.71,5.66,1931.0,2,8
18694,CHEMBL118,CELECOXIB,11060,CHEMBL2326,Carbonic anhydrase 7,5.66,5.66,2170.0,6,9
18694,CHEMBL118,CELECOXIB,121,CHEMBL228,Sodium-dependent serotonin transporter,5.64,5.64,2300.0,1,8
654675,CHEMBL1180725,PROPANTHELINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,8.52,8.52,3.0,1,8
654675,CHEMBL1180725,PROPANTHELINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,8.52,8.52,3.0,1,8
654675,CHEMBL1180725,PROPANTHELINE,11365,CHEMBL289,Cytochrome P450 2D6,5.9,5.9,1258.9,2,9
654675,CHEMBL1180725,PROPANTHELINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.7,5.7,2000.0,1,8
195974,CHEMBL1184,ACETYLCHOLINE CHLORIDE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.66,6.66,220.0,1,8
195974,CHEMBL1184,ACETYLCHOLINE CHLORIDE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.11,6.11,770.0,1,8
195974,CHEMBL1184,ACETYLCHOLINE CHLORIDE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.1,6.1,790.0,1,8
658310,CHEMBL1184360,DIAMTHAZOLE,103668,CHEMBL1293235,Prelamin-A/C,5.85,5.85,1412.5,1,9
196215,CHEMBL1185,ZOLMITRIPTAN,105,CHEMBL1983,5-hydroxytryptamine receptor 1D,9.4,8.89,0.4,6,9
196215,CHEMBL1185,ZOLMITRIPTAN,106,CHEMBL1898,5-hydroxytryptamine receptor 1B,9.4,8.52,0.4,5,9
196215,CHEMBL1185,ZOLMITRIPTAN,51,CHEMBL214,5-hydroxytryptamine receptor 1A,8.74,7.59,1.8,3,9
660529,CHEMBL1186579,METHYLNALTREXONE,129,CHEMBL233,Mu-type opioid receptor,8.26,8.12,5.5,3,9
660529,CHEMBL1186579,METHYLNALTREXONE,137,CHEMBL237,Kappa-type opioid receptor,8.17,7.83,6.7,2,9
660529,CHEMBL1186579,METHYLNALTREXONE,136,CHEMBL236,Delta-type opioid receptor,6.3,6.3,501.19,1,9
660560,CHEMBL1186610,ANISOTROPINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,7.44,7.44,36.0,1,8
660560,CHEMBL1186610,ANISOTROPINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.77,6.77,170.0,1,8
660560,CHEMBL1186610,ANISOTROPINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.2,6.2,630.0,1,8
660560,CHEMBL1186610,ANISOTROPINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.68,5.68,2100.0,1,8
661783,CHEMBL1187833,UMECLIDINIUM,47,CHEMBL211,Muscarinic acetylcholine receptor M2,8.36,8.36,4.4,1,8
661783,CHEMBL1187833,UMECLIDINIUM,61,CHEMBL216,Muscarinic acetylcholine receptor M1,8.28,8.28,5.3,1,8
661783,CHEMBL1187833,UMECLIDINIUM,121,CHEMBL228,Sodium-dependent serotonin transporter,6.52,6.52,301.7,1,8
661783,CHEMBL1187833,UMECLIDINIUM,155,CHEMBL238,Sodium-dependent dopamine transporter,6.05,6.05,897.7,1,8
661783,CHEMBL1187833,UMECLIDINIUM,129,CHEMBL233,Mu-type opioid receptor,5.97,5.97,1073.0,1,8
661783,CHEMBL1187833,UMECLIDINIUM,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.56,5.56,2726.8,1,8
663629,CHEMBL1189679,PALONOSETRON,144,CHEMBL1899,5-hydroxytryptamine receptor 3A,10.5,9.12,0.03162,21,9
663629,CHEMBL1189679,PALONOSETRON,11305,CHEMBL3895,5-hydroxytryptamine receptor 3B,9.85,9.6,0.14,5,9
663629,CHEMBL1189679,PALONOSETRON,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.05,5.88,890.0,2,8
663629,CHEMBL1189679,PALONOSETRON,127,CHEMBL231,Histamine H1 receptor,5.96,5.96,1100.0,1,8
663629,CHEMBL1189679,PALONOSETRON,121,CHEMBL228,Sodium-dependent serotonin transporter,5.62,5.62,2400.0,1,8
19101,CHEMBL119,TRIMETREXATE,6,CHEMBL202,Dihydrofolate reductase,10.4,8.32,0.04,15,9
19101,CHEMBL119,TRIMETREXATE,129,CHEMBL233,Mu-type opioid receptor,5.92,5.92,1200.0,1,8
19101,CHEMBL119,TRIMETREXATE,93,CHEMBL220,Acetylcholinesterase,5.79,5.79,1620.0,1,8
19101,CHEMBL119,TRIMETREXATE,88,CHEMBL2056,D(1A) dopamine receptor,5.71,5.71,1940.0,1,8
19101,CHEMBL119,TRIMETREXATE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.67,5.67,2160.0,1,8
19101,CHEMBL119,TRIMETREXATE,96,CHEMBL221,Prostaglandin G/H synthase 1,5.62,5.62,2400.0,1,8
19101,CHEMBL119,TRIMETREXATE,130,CHEMBL234,D(3) dopamine receptor,5.57,5.57,2670.0,1,8
203048,CHEMBL1190,DECAMETHONIUM,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,6.2,6.2,631.0,2,9
203048,CHEMBL1190,DECAMETHONIUM,10280,CHEMBL264,Histamine H3 receptor,6.09,6.09,820.0,1,8
668275,CHEMBL1194325,ACLIDINIUM,219,CHEMBL245,Muscarinic acetylcholine receptor M3,8.36,8.36,4.4,2,9
668616,CHEMBL1194666,DIETHYLPROPION,36,CHEMBL208,Progesterone receptor,6.66,6.66,220.0,1,8
208978,CHEMBL1195,PROPOXYCAINE,11365,CHEMBL289,Cytochrome P450 2D6,5.7,5.7,1995.26,2,9
209007,CHEMBL1196,PROPARACAINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,7.0,6.81,100.0,2,8
209007,CHEMBL1196,PROPARACAINE,17045,CHEMBL340,Cytochrome P450 3A4,5.9,5.9,1258.9,3,9
209007,CHEMBL1196,PROPARACAINE,10280,CHEMBL264,Histamine H3 receptor,5.89,5.89,1300.0,1,8
209007,CHEMBL1196,PROPARACAINE,86,CHEMBL1951,Amine oxidase [flavin-containing] A,5.75,5.75,1777.0,1,8
209224,CHEMBL1198,PRAMOXINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,7.29,7.11,51.0,2,8
209224,CHEMBL1198,PRAMOXINE,10280,CHEMBL264,Histamine H3 receptor,5.61,5.61,2452.4,1,8
672807,CHEMBL1198857,VILANTEROL,43,CHEMBL210,Beta-2 adrenergic receptor,8.24,8.24,5.8,1,8
672807,CHEMBL1198857,VILANTEROL,125,CHEMBL229,Alpha-1A adrenergic receptor,5.96,5.96,1100.0,1,8
672807,CHEMBL1198857,VILANTEROL,88,CHEMBL2056,D(1A) dopamine receptor,5.66,5.66,2200.0,1,8
672807,CHEMBL1198857,VILANTEROL,121,CHEMBL228,Sodium-dependent serotonin transporter,5.55,5.55,2800.0,1,8
721,CHEMBL12,DIAZEPAM,11440,CHEMBL5112,Gamma-aminobutyric acid receptor subunit alpha-5,7.82,7.73,15.0,2,9
721,CHEMBL12,DIAZEPAM,74,CHEMBL1962,Gamma-aminobutyric acid receptor subunit alpha-1,7.8,7.62,16.0,2,9
721,CHEMBL12,DIAZEPAM,12757,CHEMBL3026,Gamma-aminobutyric acid receptor subunit alpha-3,7.77,7.77,17.0,1,9
721,CHEMBL12,DIAZEPAM,12770,CHEMBL4956,Gamma-aminobutyric acid receptor subunit alpha-2,7.77,7.77,17.0,1,9
721,CHEMBL12,DIAZEPAM,137,CHEMBL237,Kappa-type opioid receptor,5.65,5.65,2242.9,1,8
721,CHEMBL12,DIAZEPAM,101351,CHEMBL5847,Aldo-keto reductase family 1 member C2,5.62,5.62,2400.0,1,8
209594,CHEMBL1200,BENOXINATE,12594,CHEMBL3356,Cytochrome P450 1A2,6.4,6.4,398.11,1,8
674273,CHEMBL1200322,ESCITALOPRAM OXALATE,121,CHEMBL228,Sodium-dependent serotonin transporter,9.0,9.0,1.0,1,9
674273,CHEMBL1200322,ESCITALOPRAM OXALATE,103668,CHEMBL1293235,Prelamin-A/C,6.1,6.1,794.3,1,9
674274,CHEMBL1200323,LABETALOL HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,6.4,6.4,398.1,1,9
674274,CHEMBL1200323,LABETALOL HYDROCHLORIDE,10977,CHEMBL2608,Lysosomal alpha-glucosidase,5.75,5.75,1778.3,2,9
674277,CHEMBL1200326,NICARDIPINE HYDROCHLORIDE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,7.9,7.9,12.6,1,9
674277,CHEMBL1200326,NICARDIPINE HYDROCHLORIDE,12911,CHEMBL3397,Cytochrome P450 2C9,6.7,6.7,199.5,2,9
674277,CHEMBL1200326,NICARDIPINE HYDROCHLORIDE,17045,CHEMBL340,Cytochrome P450 3A4,6.1,6.06,794.3,5,9
674280,CHEMBL1200329,TIZANIDINE HYDROCHLORIDE,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.48,7.48,32.91,1,9
674281,CHEMBL1200330,PILOCARPINE HYDROCHLORIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.55,8.55,2.8,2,9
674281,CHEMBL1200330,PILOCARPINE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,8.3,8.3,5.0,1,9
674283,CHEMBL1200332,PROTRIPTYLINE HYDROCHLORIDE,103665,CHEMBL1293232,Survival motor neuron protein,5.85,5.85,1412.5,1,9
674290,CHEMBL1200339,PHENYLEPHRINE HYDROCHLORIDE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,7.0,7.0,100.0,2,9
674290,CHEMBL1200339,PHENYLEPHRINE HYDROCHLORIDE,10977,CHEMBL2608,Lysosomal alpha-glucosidase,6.55,6.55,281.8,2,9
674290,CHEMBL1200339,PHENYLEPHRINE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,5.8,5.8,1584.9,1,9
674299,CHEMBL1200348,SULCONAZOLE NITRATE,17045,CHEMBL340,Cytochrome P450 3A4,6.7,6.7,199.5,2,9
674299,CHEMBL1200348,SULCONAZOLE NITRATE,11213,CHEMBL3880,Heat shock protein HSP 90-alpha,6.53,6.53,294.0,1,8
674299,CHEMBL1200348,SULCONAZOLE NITRATE,103665,CHEMBL1293232,Survival motor neuron protein,5.8,5.8,1584.9,1,9
674299,CHEMBL1200348,SULCONAZOLE NITRATE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,5.6,5.6,2511.9,1,9
674299,CHEMBL1200348,SULCONAZOLE NITRATE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,5.5,5.5,3162.3,1,9
674307,CHEMBL1200356,CYCLACILLIN,103668,CHEMBL1293235,Prelamin-A/C,5.9,5.9,1258.9,1,9
674321,CHEMBL1200370,BENZOYL PEROXIDE,103668,CHEMBL1293235,Prelamin-A/C,8.2,8.2,6.3,1,9
674325,CHEMBL1200374,EXEMESTANE,65,CHEMBL1978,Aromatase,9.02,7.47,0.95,13,9
674325,CHEMBL1200374,EXEMESTANE,137,CHEMBL237,Kappa-type opioid receptor,5.62,5.62,2406.5,1,8
674335,CHEMBL1200384,BETAMETHASONE DIPROPIONATE,25,CHEMBL2034,Glucocorticoid receptor,8.0,8.0,10.0,1,8
674335,CHEMBL1200384,BETAMETHASONE DIPROPIONATE,36,CHEMBL208,Progesterone receptor,6.52,6.52,300.0,1,8
674335,CHEMBL1200384,BETAMETHASONE DIPROPIONATE,72,CHEMBL217,D(2) dopamine receptor,6.11,6.11,770.0,1,8
674335,CHEMBL1200384,BETAMETHASONE DIPROPIONATE,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.62,5.62,2400.0,1,8
674337,CHEMBL1200386,PREDNICARBATE,25,CHEMBL2034,Glucocorticoid receptor,7.77,7.77,17.0,1,8
674337,CHEMBL1200386,PREDNICARBATE,36,CHEMBL208,Progesterone receptor,5.89,5.89,1300.0,1,8
674342,CHEMBL1200391,TROMETHAMINE,103668,CHEMBL1293235,Prelamin-A/C,6.45,6.45,354.8,1,9
674343,CHEMBL1200392,DOXYLAMINE SUCCINATE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,7.15,7.15,70.8,2,9
674346,CHEMBL1200395,ORPHENADRINE CITRATE,103668,CHEMBL1293235,Prelamin-A/C,7.35,7.35,44.7,1,9
674347,CHEMBL1200396,BUPIVACAINE HYDROCHLORIDE,11365,CHEMBL289,Cytochrome P450 2D6,6.4,6.4,400.0,1,8
674357,CHEMBL1200406,DIMENHYDRINATE,103668,CHEMBL1293235,Prelamin-A/C,9.0,9.0,1.0,1,9
674357,CHEMBL1200406,DIMENHYDRINATE,127,CHEMBL231,Histamine H1 receptor,7.43,6.96,37.0,2,8
674357,CHEMBL1200406,DIMENHYDRINATE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,7.1,6.67,80.0,2,8
674357,CHEMBL1200406,DIMENHYDRINATE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,7.02,6.68,95.0,2,8
674357,CHEMBL1200406,DIMENHYDRINATE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.96,6.65,109.0,2,8
674357,CHEMBL1200406,DIMENHYDRINATE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.79,6.56,164.0,2,8
674357,CHEMBL1200406,DIMENHYDRINATE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.7,6.43,198.0,2,8
674357,CHEMBL1200406,DIMENHYDRINATE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.64,6.57,227.0,2,8
674357,CHEMBL1200406,DIMENHYDRINATE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.48,6.34,332.0,2,8
674357,CHEMBL1200406,DIMENHYDRINATE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.31,6.13,487.0,2,8
674357,CHEMBL1200406,DIMENHYDRINATE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.96,5.86,1097.0,2,8
674357,CHEMBL1200406,DIMENHYDRINATE,103,CHEMBL223,Alpha-1D adrenergic receptor,5.85,5.7,1423.0,2,8
674357,CHEMBL1200406,DIMENHYDRINATE,11365,CHEMBL289,Cytochrome P450 2D6,5.82,5.82,1509.0,1,8
674357,CHEMBL1200406,DIMENHYDRINATE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.79,5.79,1617.0,1,8
674357,CHEMBL1200406,DIMENHYDRINATE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.75,5.7,1784.0,2,8
674357,CHEMBL1200406,DIMENHYDRINATE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.7,5.7,2020.0,2,8
674357,CHEMBL1200406,DIMENHYDRINATE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.6,5.6,2491.0,1,8
674364,CHEMBL1200413,TETRAHYDROZOLINE HYDROCHLORIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.49,8.49,3.2,2,9
674364,CHEMBL1200413,TETRAHYDROZOLINE HYDROCHLORIDE,101361,CHEMBL5857,Trace amine-associated receptor 1,6.81,6.8,154.41,2,8
674370,CHEMBL1200419,MOLINDONE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,5.9,5.9,1258.9,1,9
674376,CHEMBL1200425,PARGYLINE HYDROCHLORIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.55,8.55,2.8,2,9
674376,CHEMBL1200425,PARGYLINE HYDROCHLORIDE,103665,CHEMBL1293232,Survival motor neuron protein,6.05,6.05,891.3,1,9
674376,CHEMBL1200425,PARGYLINE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,5.55,5.55,2818.4,1,9
674381,CHEMBL1200430,ESTRADIOL ACETATE,19,CHEMBL206,Estrogen receptor,7.65,7.65,22.4,1,8
674381,CHEMBL1200430,ESTRADIOL ACETATE,56,CHEMBL1871,Androgen receptor,7.53,7.53,29.6,1,8
674381,CHEMBL1200430,ESTRADIOL ACETATE,36,CHEMBL208,Progesterone receptor,6.68,6.68,208.6,1,8
674381,CHEMBL1200430,ESTRADIOL ACETATE,103665,CHEMBL1293232,Survival motor neuron protein,5.9,5.9,1258.9,1,9
674387,CHEMBL1200436,OXANDROLONE,56,CHEMBL1871,Androgen receptor,9.09,8.15,0.808,2,9
674389,CHEMBL1200438,TIOCONAZOLE,12949,CHEMBL3522,"Steroid 17-alpha-hydroxylase/17,20 lyase",6.3,6.3,505.0,1,9
674389,CHEMBL1200438,TIOCONAZOLE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.01,6.01,968.0,1,8
674389,CHEMBL1200438,TIOCONAZOLE,104017,CHEMBL1741221,Cysteine protease ATG4B,5.89,5.8,1300.0,3,9
674389,CHEMBL1200438,TIOCONAZOLE,120720,CHEMBL5169181,Cysteine protease ATG4A,5.89,5.89,1300.0,1,9
674389,CHEMBL1200438,TIOCONAZOLE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.82,5.82,1500.0,1,8
674389,CHEMBL1200438,TIOCONAZOLE,137,CHEMBL237,Kappa-type opioid receptor,5.75,5.75,1800.0,1,8
674389,CHEMBL1200438,TIOCONAZOLE,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.6,5.6,2499.4,1,8
674389,CHEMBL1200438,TIOCONAZOLE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.5,5.5,3200.0,1,8
674389,CHEMBL1200438,TIOCONAZOLE,136,CHEMBL236,Delta-type opioid receptor,5.5,5.5,3200.0,1,8
674397,CHEMBL1200446,TRIPELENNAMINE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,7.65,7.6,22.4,2,9
674397,CHEMBL1200446,TRIPELENNAMINE HYDROCHLORIDE,103665,CHEMBL1293232,Survival motor neuron protein,6.2,6.2,631.0,1,9
674418,CHEMBL1200467,HYDROXYZINE PAMOATE,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,6.35,6.22,450.0,2,8
674418,CHEMBL1200467,HYDROXYZINE PAMOATE,104062,CHEMBL1743121,Solute carrier organic anion transporter family member 1B3,6.03,5.97,940.0,2,8
674419,CHEMBL1200468,MALATHION,17045,CHEMBL340,Cytochrome P450 3A4,6.0,6.0,1000.0,2,9
674420,CHEMBL1200469,PROMAZINE HYDROCHLORIDE,103665,CHEMBL1293232,Survival motor neuron protein,5.9,5.9,1258.9,1,9
674420,CHEMBL1200469,PROMAZINE HYDROCHLORIDE,103985,CHEMBL1741189,FAD-linked sulfhydryl oxidase ALR,5.89,5.89,1284.0,1,8
674420,CHEMBL1200469,PROMAZINE HYDROCHLORIDE,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,5.55,5.55,2818.4,1,9
674422,CHEMBL1200471,PYRITHIONE ZINC,103668,CHEMBL1293235,Prelamin-A/C,7.0,7.0,100.0,1,9
674422,CHEMBL1200471,PYRITHIONE ZINC,12054,CHEMBL2903,Polyunsaturated fatty acid lipoxygenase ALOX15,6.7,6.15,199.5,2,9
674422,CHEMBL1200471,PYRITHIONE ZINC,20053,CHEMBL4096,Cellular tumor antigen p53,6.1,5.85,794.3,2,9
674422,CHEMBL1200471,PYRITHIONE ZINC,101216,CHEMBL5514,Huntingtin,6.05,6.05,891.3,1,9
674422,CHEMBL1200471,PYRITHIONE ZINC,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,5.9,5.72,1258.9,2,9
674422,CHEMBL1200471,PYRITHIONE ZINC,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,5.9,5.9,1258.9,1,9
674422,CHEMBL1200471,PYRITHIONE ZINC,10139,CHEMBL2885,Carbonic anhydrase 3,5.79,5.79,1620.0,2,9
674422,CHEMBL1200471,PYRITHIONE ZINC,12952,CHEMBL3594,Carbonic anhydrase 9,5.76,5.76,1720.0,2,9
674422,CHEMBL1200471,PYRITHIONE ZINC,103660,CHEMBL1293227,Ubiquitin carboxyl-terminal hydrolase 2,5.7,5.7,1995.3,1,9
674422,CHEMBL1200471,PYRITHIONE ZINC,10186,CHEMBL3025,Carbonic anhydrase 6,5.62,5.62,2410.0,2,9
674422,CHEMBL1200471,PYRITHIONE ZINC,103659,CHEMBL1293226,Lysine-specific demethylase 4E,5.6,5.6,2511.9,1,9
674422,CHEMBL1200471,PYRITHIONE ZINC,103665,CHEMBL1293232,Survival motor neuron protein,5.6,5.6,2511.9,1,9
674422,CHEMBL1200471,PYRITHIONE ZINC,11063,CHEMBL3510,Carbonic anhydrase 14,5.54,5.54,2910.0,2,9
674422,CHEMBL1200471,PYRITHIONE ZINC,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,5.5,5.5,3162.3,1,9
674424,CHEMBL1200473,CYCLOPENTOLATE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,5.65,5.65,2238.7,1,9
674424,CHEMBL1200473,CYCLOPENTOLATE HYDROCHLORIDE,103665,CHEMBL1293232,Survival motor neuron protein,5.6,5.6,2511.9,1,9
674425,CHEMBL1200474,DEMECLOCYCLINE HYDROCHLORIDE,174,CHEMBL242,Estrogen receptor beta,7.21,7.21,61.42,1,9
674429,CHEMBL1200478,DYCLONINE HYDROCHLORIDE,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,7.35,6.72,44.7,2,9
674429,CHEMBL1200478,DYCLONINE HYDROCHLORIDE,103665,CHEMBL1293232,Survival motor neuron protein,5.65,5.65,2238.7,1,9
674429,CHEMBL1200478,DYCLONINE HYDROCHLORIDE,271,CHEMBL1947,Thyroid hormone receptor beta,5.6,5.6,2511.9,1,9
674430,CHEMBL1200479,DICYCLOMINE HYDROCHLORIDE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,7.7,7.7,20.0,1,9
674436,CHEMBL1200485,SORAFENIB TOSYLATE,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,8.07,7.88,8.5,3,9
674436,CHEMBL1200485,SORAFENIB TOSYLATE,10781,CHEMBL2185,Aurora kinase B,5.75,5.75,1800.0,1,8
674441,CHEMBL1200490,CETRORELIX,118,CHEMBL1855,Gonadotropin-releasing hormone receptor,9.87,9.05,0.135,3,9
674441,CHEMBL1200490,CETRORELIX,101353,CHEMBL5849,Mas-related G-protein coupled receptor member X2,6.21,6.15,616.6,2,9
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.81,7.81,15.62,1,9
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,7.15,7.15,70.25,1,9
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,6.95,6.95,112.2,1,9
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,105,CHEMBL1983,5-hydroxytryptamine receptor 1D,6.92,6.92,121.68,1,9
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,127,CHEMBL231,Histamine H1 receptor,6.9,6.9,124.91,1,9
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.86,6.86,137.29,1,9
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.76,6.76,175.27,1,9
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.72,6.72,192.4,1,9
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.67,6.67,215.65,1,9
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,117512,CHEMBL4105907,Sigma intracellular receptor 2,6.65,6.65,221.95,1,9
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.6,6.6,253.05,1,9
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,106,CHEMBL1898,5-hydroxytryptamine receptor 1B,6.58,6.58,262.12,1,9
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,90,CHEMBL219,D(4) dopamine receptor,6.49,6.49,326.32,1,9
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.45,6.45,358.92,1,9
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,130,CHEMBL234,D(3) dopamine receptor,6.42,6.42,380.19,1,9
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,103,CHEMBL223,Alpha-1D adrenergic receptor,6.35,6.35,445.25,1,9
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,128,CHEMBL232,Alpha-1B adrenergic receptor,6.24,6.24,572.4,1,9
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,88,CHEMBL2056,D(1A) dopamine receptor,6.15,6.15,711.62,1,9
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.14,6.14,730.55,1,9
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,72,CHEMBL217,D(2) dopamine receptor,6.13,6.13,735.53,1,9
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,10624,CHEMBL3426,5-hydroxytryptamine receptor 5A,5.96,5.96,1092.07,1,9
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,5.95,5.95,1114.68,1,9
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.86,5.86,1370.88,1,9
674443,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,101532,CHEMBL5742,Translocator protein,5.7,5.7,1986.32,1,9
674445,CHEMBL1200494,GUANFACINE HYDROCHLORIDE,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.93,7.93,11.77,1,9
674445,CHEMBL1200494,GUANFACINE HYDROCHLORIDE,103657,CHEMBL1293224,Microtubule-associated protein tau,7.0,7.0,100.0,1,9
674446,CHEMBL1200495,HYDROCORTISONE SODIUM SUCCINATE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,6.2,6.2,631.0,2,9
674451,CHEMBL1200500,BECLOMETHASONE DIPROPIONATE,25,CHEMBL2034,Glucocorticoid receptor,8.22,8.22,6.0,1,8
674451,CHEMBL1200500,BECLOMETHASONE DIPROPIONATE,36,CHEMBL208,Progesterone receptor,8.17,7.75,6.7,2,8
674451,CHEMBL1200500,BECLOMETHASONE DIPROPIONATE,56,CHEMBL1871,Androgen receptor,6.65,6.65,224.6,1,8
674451,CHEMBL1200500,BECLOMETHASONE DIPROPIONATE,87,CHEMBL218,Cannabinoid receptor 1,5.55,5.55,2831.7,1,8
674466,CHEMBL1200515,DESERPIDINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.61,5.61,2449.0,1,8
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.87,7.87,13.57,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.83,7.83,14.62,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.7,7.7,19.76,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.68,7.68,21.05,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,10624,CHEMBL3426,5-hydroxytryptamine receptor 5A,7.5,7.5,31.3,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,90,CHEMBL219,D(4) dopamine receptor,7.48,7.48,32.82,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.48,7.48,32.9,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,130,CHEMBL234,D(3) dopamine receptor,7.47,7.47,33.96,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.41,7.41,39.06,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,7.22,7.22,60.17,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,72,CHEMBL217,D(2) dopamine receptor,7.21,7.21,60.92,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,106,CHEMBL1898,5-hydroxytryptamine receptor 1B,6.97,6.97,107.89,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,128,CHEMBL232,Alpha-1B adrenergic receptor,6.92,6.92,118.74,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,103668,CHEMBL1293235,Prelamin-A/C,6.85,6.85,141.3,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,129,CHEMBL233,Mu-type opioid receptor,6.81,6.81,154.01,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.67,6.67,214.19,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.65,6.65,224.56,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.22,6.22,603.74,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,10618,CHEMBL2182,5-hydroxytryptamine receptor 1E,6.17,6.17,682.18,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,103665,CHEMBL1293232,Survival motor neuron protein,6.05,6.05,891.3,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,101271,CHEMBL5652,Glucose-dependent insulinotropic receptor,5.72,5.72,1914.23,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,103800,CHEMBL1628481,Apelin receptor,5.66,5.66,2188.88,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,11758,CHEMBL1784,Glucagon-like peptide 1 receptor,5.62,5.62,2404.63,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,100956,CHEMBL5339,Free fatty acid receptor 4,5.59,5.59,2571.77,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,43,CHEMBL210,Beta-2 adrenergic receptor,5.55,5.55,2830.0,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,117512,CHEMBL4105907,Sigma intracellular receptor 2,5.55,5.55,2843.48,1,9
674468,CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE,220,CHEMBL1850,D(1B) dopamine receptor,5.53,5.53,2948.83,1,9
674473,CHEMBL1200522,AVOBENZONE,103668,CHEMBL1293235,Prelamin-A/C,7.15,7.15,70.8,1,9
674474,CHEMBL1200523,CEFAZOLIN SODIUM,103668,CHEMBL1293235,Prelamin-A/C,6.9,6.9,125.9,1,9
674479,CHEMBL1200528,CHROMIC CHLORIDE,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,5.76,5.76,1750.0,1,8
674479,CHEMBL1200528,CHROMIC CHLORIDE,9,CHEMBL203,Epidermal growth factor receptor,5.53,5.53,2955.0,1,8
674482,CHEMBL1200531,ALFENTANIL HYDROCHLORIDE,129,CHEMBL233,Mu-type opioid receptor,6.11,6.11,781.41,1,8
674493,CHEMBL1200542,DESOXYCORTICOSTERONE ACETATE,103657,CHEMBL1293224,Microtubule-associated protein tau,6.75,6.75,177.8,1,9
674493,CHEMBL1200542,DESOXYCORTICOSTERONE ACETATE,103665,CHEMBL1293232,Survival motor neuron protein,5.8,5.8,1584.9,1,9
674496,CHEMBL1200545,DIFLORASONE DIACETATE,25,CHEMBL2034,Glucocorticoid receptor,8.54,8.36,2.907,2,8
674496,CHEMBL1200545,DIFLORASONE DIACETATE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,8.0,8.0,10.0,2,9
674496,CHEMBL1200545,DIFLORASONE DIACETATE,36,CHEMBL208,Progesterone receptor,7.71,7.71,19.3,1,8
674496,CHEMBL1200545,DIFLORASONE DIACETATE,56,CHEMBL1871,Androgen receptor,6.6,6.6,253.7,1,8
674496,CHEMBL1200545,DIFLORASONE DIACETATE,103665,CHEMBL1293232,Survival motor neuron protein,5.5,5.5,3162.3,1,9
674509,CHEMBL1200558,BACITRACIN,10140,CHEMBL258,Tyrosine-protein kinase Lck,5.72,5.72,1923.0,1,8
674510,CHEMBL1200559,LACTIC ACID,20053,CHEMBL4096,Cellular tumor antigen p53,7.6,7.6,25.1,1,9
674511,CHEMBL1200560,GUANABENZ ACETATE,103668,CHEMBL1293235,Prelamin-A/C,8.55,7.5,2.8,2,9
674511,CHEMBL1200560,GUANABENZ ACETATE,12594,CHEMBL3356,Cytochrome P450 1A2,5.7,5.7,1995.26,1,8
674511,CHEMBL1200560,GUANABENZ ACETATE,101097,CHEMBL5162,Neuropeptide S receptor,5.5,5.5,3162.3,1,9
674513,CHEMBL1200562,HYDROCORTISONE VALERATE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,8.3,8.3,5.0,2,9
674532,CHEMBL1200581,DIATRIZOATE SODIUM,103668,CHEMBL1293235,Prelamin-A/C,8.35,8.35,4.5,1,9
674536,CHEMBL1200585,OXYMETHOLONE,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,7.15,7.15,70.8,1,9
674543,CHEMBL1200592,DESOXYCORTICOSTERONE PIVALATE,36,CHEMBL208,Progesterone receptor,6.67,6.67,213.0,1,8
674543,CHEMBL1200592,DESOXYCORTICOSTERONE PIVALATE,25,CHEMBL2034,Glucocorticoid receptor,6.39,6.39,408.0,1,8
674547,CHEMBL1200596,CHLOROXINE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.35,6.35,446.7,1,9
674547,CHEMBL1200596,CHLOROXINE,11134,CHEMBL3687,Polyunsaturated fatty acid lipoxygenase ALOX12,6.0,5.86,1000.0,2,9
674547,CHEMBL1200596,CHLOROXINE,11213,CHEMBL3880,Heat shock protein HSP 90-alpha,5.98,5.98,1045.0,1,8
674547,CHEMBL1200596,CHLOROXINE,11154,CHEMBL3869,Matrix metalloproteinase-14,5.62,5.62,2400.0,1,9
674547,CHEMBL1200596,CHLOROXINE,12054,CHEMBL2903,Polyunsaturated fatty acid lipoxygenase ALOX15,5.62,5.62,2400.0,1,9
674547,CHEMBL1200596,CHLOROXINE,101216,CHEMBL5514,Huntingtin,5.55,5.55,2818.4,1,9
674547,CHEMBL1200596,CHLOROXINE,20053,CHEMBL4096,Cellular tumor antigen p53,5.5,5.5,3162.3,1,9
674551,CHEMBL1200600,FLUOROMETHOLONE,25,CHEMBL2034,Glucocorticoid receptor,8.8,8.55,1.578,3,8
674551,CHEMBL1200600,FLUOROMETHOLONE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,8.0,8.0,10.0,2,9
674551,CHEMBL1200600,FLUOROMETHOLONE,36,CHEMBL208,Progesterone receptor,7.28,7.28,53.0,1,8
674551,CHEMBL1200600,FLUOROMETHOLONE,10977,CHEMBL2608,Lysosomal alpha-glucosidase,6.75,6.75,177.8,2,9
674551,CHEMBL1200600,FLUOROMETHOLONE,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.89,5.7,1300.0,2,9
674555,CHEMBL1200604,TROPICAMIDE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,8.46,8.03,3.483,2,8
674555,CHEMBL1200604,TROPICAMIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.46,8.46,3.5,2,9
674555,CHEMBL1200604,TROPICAMIDE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,7.52,6.93,30.0,3,8
674555,CHEMBL1200604,TROPICAMIDE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.43,6.53,37.0,5,8
674555,CHEMBL1200604,TROPICAMIDE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,7.19,7.12,64.0,2,8
674555,CHEMBL1200604,TROPICAMIDE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.17,6.52,68.0,3,8
674555,CHEMBL1200604,TROPICAMIDE,12911,CHEMBL3397,Cytochrome P450 2C9,6.0,6.0,1000.0,1,8
674555,CHEMBL1200604,TROPICAMIDE,12912,CHEMBL3622,Cytochrome P450 2C19,6.0,6.0,1000.0,1,8
674557,CHEMBL1200606,MEXILETINE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,7.95,7.95,11.2,1,9
674568,CHEMBL1200617,RIMEXOLONE,36,CHEMBL208,Progesterone receptor,8.49,8.49,3.2,1,8
674568,CHEMBL1200617,RIMEXOLONE,25,CHEMBL2034,Glucocorticoid receptor,8.0,8.0,10.0,1,8
674568,CHEMBL1200617,RIMEXOLONE,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,6.4,5.93,400.0,3,9
674569,CHEMBL1200618,FEXOFENADINE HYDROCHLORIDE,127,CHEMBL231,Histamine H1 receptor,7.03,7.03,93.11,1,9
674569,CHEMBL1200618,FEXOFENADINE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,6.6,6.6,251.2,1,9
674569,CHEMBL1200618,FEXOFENADINE HYDROCHLORIDE,130,CHEMBL234,D(3) dopamine receptor,5.63,5.63,2350.17,1,9
674569,CHEMBL1200618,FEXOFENADINE HYDROCHLORIDE,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,5.5,5.5,3162.3,1,9
674572,CHEMBL1200621,GEMIFLOXACIN MESYLATE,103668,CHEMBL1293235,Prelamin-A/C,6.2,6.2,631.0,1,9
674574,CHEMBL1200623,ETHYLESTRENOL,121,CHEMBL228,Sodium-dependent serotonin transporter,7.37,7.23,43.0,2,8
674574,CHEMBL1200623,ETHYLESTRENOL,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.98,6.76,104.0,2,8
674574,CHEMBL1200623,ETHYLESTRENOL,19,CHEMBL206,Estrogen receptor,6.5,6.22,320.0,2,8
674574,CHEMBL1200623,ETHYLESTRENOL,12912,CHEMBL3622,Cytochrome P450 2C19,5.89,5.89,1290.7,1,8
674574,CHEMBL1200623,ETHYLESTRENOL,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.68,5.68,2080.0,2,8
674575,CHEMBL1200624,ETHYNODIOL DIACETATE,36,CHEMBL208,Progesterone receptor,7.89,7.89,12.9,1,8
674575,CHEMBL1200624,ETHYNODIOL DIACETATE,56,CHEMBL1871,Androgen receptor,6.23,6.23,583.7,1,8
674575,CHEMBL1200624,ETHYNODIOL DIACETATE,280,CHEMBL256,Adenosine receptor A3,5.54,5.54,2848.7,1,8
674575,CHEMBL1200624,ETHYNODIOL DIACETATE,276,CHEMBL254,"3',5'-cyclic-AMP phosphodiesterase 4A",5.51,5.51,3093.6,1,8
674578,CHEMBL1200627,PROPIOLACTONE,20053,CHEMBL4096,Cellular tumor antigen p53,6.6,6.6,251.2,1,9
674579,CHEMBL1200628,VANCOMYCIN HYDROCHLORIDE,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,8.35,8.35,4.5,1,9
674580,CHEMBL1200629,VECURONIUM BROMIDE,104067,CHEMBL1743126,Multidrug and toxin extrusion protein 1,5.72,5.72,1900.0,1,9
674592,CHEMBL1200641,CISATRACURIUM BESYLATE,103668,CHEMBL1293235,Prelamin-A/C,6.9,6.9,125.9,1,9
674595,CHEMBL1200644,FONDAPARINUX SODIUM,194,CHEMBL244,Coagulation factor X,7.0,7.0,99.6,1,9
674610,CHEMBL1200659,ENALAPRIL MALEATE,103665,CHEMBL1293232,Survival motor neuron protein,5.65,5.65,2238.7,1,9
674611,CHEMBL1200660,ISOSORBIDE,271,CHEMBL1947,Thyroid hormone receptor beta,7.4,7.4,39.8,1,9
674612,CHEMBL1200661,UNOPROSTONE ISOPROPYL,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.05,6.05,890.0,1,8
674617,CHEMBL1200666,CALCIPOTRIENE,64,CHEMBL1977,Vitamin D3 receptor,9.51,9.51,0.31,1,8
674630,CHEMBL1200679,ZINC CHLORIDE,107977,CHEMBL3091266,G-protein coupled receptor 39,8.44,8.44,3.6,1,9
674630,CHEMBL1200679,ZINC CHLORIDE,12579,CHEMBL4445,Protein phosphatase 3 catalytic subunit alpha,5.96,5.96,1100.3,1,8
674630,CHEMBL1200679,ZINC CHLORIDE,15,CHEMBL205,Carbonic anhydrase 2,5.94,5.94,1159.0,1,9
674630,CHEMBL1200679,ZINC CHLORIDE,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,5.73,5.73,1877.9,1,8
674630,CHEMBL1200679,ZINC CHLORIDE,9,CHEMBL203,Epidermal growth factor receptor,5.66,5.66,2188.4,1,8
674632,CHEMBL1200681,MONTELUKAST SODIUM,179,CHEMBL1798,Cysteinyl leukotriene receptor 1,8.64,7.58,2.3,2,9
674639,CHEMBL1200688,ERYTHROMYCIN ETHYLSUCCINATE,104062,CHEMBL1743121,Solute carrier organic anion transporter family member 1B3,5.79,5.73,1610.0,2,8
674639,CHEMBL1200688,ERYTHROMYCIN ETHYLSUCCINATE,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,5.78,5.65,1670.0,2,8
674643,CHEMBL1200692,OLMESARTAN MEDOXOMIL,115,CHEMBL227,Type-1 angiotensin II receptor,9.05,8.91,0.9,2,8
674643,CHEMBL1200692,OLMESARTAN MEDOXOMIL,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,7.65,7.65,22.4,1,9
674643,CHEMBL1200692,OLMESARTAN MEDOXOMIL,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,6.27,6.14,540.0,2,8
674643,CHEMBL1200692,OLMESARTAN MEDOXOMIL,104062,CHEMBL1743121,Solute carrier organic anion transporter family member 1B3,6.12,6.06,750.0,2,8
674643,CHEMBL1200692,OLMESARTAN MEDOXOMIL,102723,CHEMBL5918,ATP-binding cassette sub-family C member 3,5.7,5.7,2000.0,1,9
674652,CHEMBL1200701,DICLOXACILLIN SODIUM,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,6.43,6.3,370.0,2,8
674652,CHEMBL1200701,DICLOXACILLIN SODIUM,104062,CHEMBL1743121,Solute carrier organic anion transporter family member 1B3,5.81,5.75,1550.0,2,8
674656,CHEMBL1200705,HYDROXYAMPHETAMINE HYDROBROMIDE,101361,CHEMBL5857,Trace amine-associated receptor 1,5.93,5.85,1178.0,2,8
674661,CHEMBL1200710,CLOMIPRAMINE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,5.55,5.55,2818.4,1,9
674663,CHEMBL1200712,EVANS BLUE,100594,CHEMBL3691,Autotaxin,6.08,6.06,824.0,2,9
674663,CHEMBL1200712,EVANS BLUE,13061,CHEMBL335,Tyrosine-protein phosphatase non-receptor type 1,5.89,5.89,1300.0,1,9
674663,CHEMBL1200712,EVANS BLUE,10697,CHEMBL3253,Albumin,5.6,5.6,2500.0,1,9
674676,CHEMBL1200725,SERTACONAZOLE NITRATE,11213,CHEMBL3880,Heat shock protein HSP 90-alpha,6.63,6.63,233.0,1,8
674683,CHEMBL1200732,AMCINONIDE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,8.89,8.89,1.3,2,9
674683,CHEMBL1200732,AMCINONIDE,25,CHEMBL2034,Glucocorticoid receptor,7.8,7.8,16.0,1,8
674683,CHEMBL1200732,AMCINONIDE,36,CHEMBL208,Progesterone receptor,6.67,6.67,212.0,1,8
674688,CHEMBL1200737,COLFOSCERIL PALMITATE,103665,CHEMBL1293232,Survival motor neuron protein,5.75,5.75,1778.3,1,9
674699,CHEMBL1200748,CARBIDOPA,103659,CHEMBL1293226,Lysine-specific demethylase 4E,5.7,5.7,1980.0,1,8
674701,CHEMBL1200750,PROMETHAZINE HYDROCHLORIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.2,8.2,6.3,2,9
674701,CHEMBL1200750,PROMETHAZINE HYDROCHLORIDE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,7.5,7.5,31.6,1,9
674701,CHEMBL1200750,PROMETHAZINE HYDROCHLORIDE,103985,CHEMBL1741189,FAD-linked sulfhydryl oxidase ALR,6.43,6.43,367.0,1,8
674701,CHEMBL1200750,PROMETHAZINE HYDROCHLORIDE,103665,CHEMBL1293232,Survival motor neuron protein,5.85,5.85,1412.5,1,9
674708,CHEMBL1200757,PANCURONIUM BROMIDE,103668,CHEMBL1293235,Prelamin-A/C,6.85,6.85,141.3,1,9
674712,CHEMBL1200761,CHLOROTRIANISENE,12912,CHEMBL3622,Cytochrome P450 2C19,7.0,7.0,100.0,2,9
674712,CHEMBL1200761,CHLOROTRIANISENE,103668,CHEMBL1293235,Prelamin-A/C,6.55,6.55,281.8,1,9
674712,CHEMBL1200761,CHLOROTRIANISENE,19,CHEMBL206,Estrogen receptor,6.09,6.09,817.1,1,8
674715,CHEMBL1200764,METHACHOLINE CHLORIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.6,8.6,2.5,2,9
674727,CHEMBL1200776,CINACALCET HYDROCHLORIDE,282,CHEMBL1878,Extracellular calcium-sensing receptor,7.7,7.22,19.95,2,9
674727,CHEMBL1200776,CINACALCET HYDROCHLORIDE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.4,7.4,39.66,1,9
674727,CHEMBL1200776,CINACALCET HYDROCHLORIDE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,7.04,7.04,90.62,1,9
674727,CHEMBL1200776,CINACALCET HYDROCHLORIDE,130,CHEMBL234,D(3) dopamine receptor,6.41,6.41,390.88,1,9
674727,CHEMBL1200776,CINACALCET HYDROCHLORIDE,117512,CHEMBL4105907,Sigma intracellular receptor 2,6.41,6.41,388.24,1,9
674727,CHEMBL1200776,CINACALCET HYDROCHLORIDE,137,CHEMBL237,Kappa-type opioid receptor,6.35,6.35,444.22,1,9
674727,CHEMBL1200776,CINACALCET HYDROCHLORIDE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,6.24,6.24,571.15,1,9
674727,CHEMBL1200776,CINACALCET HYDROCHLORIDE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.18,6.18,658.04,1,9
674727,CHEMBL1200776,CINACALCET HYDROCHLORIDE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.11,6.11,785.15,1,9
674727,CHEMBL1200776,CINACALCET HYDROCHLORIDE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.08,6.08,841.68,1,9
674727,CHEMBL1200776,CINACALCET HYDROCHLORIDE,10624,CHEMBL3426,5-hydroxytryptamine receptor 5A,6.01,6.01,971.52,1,9
674727,CHEMBL1200776,CINACALCET HYDROCHLORIDE,129,CHEMBL233,Mu-type opioid receptor,5.89,5.89,1295.69,1,9
674727,CHEMBL1200776,CINACALCET HYDROCHLORIDE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.84,5.84,1451.11,1,9
674727,CHEMBL1200776,CINACALCET HYDROCHLORIDE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.8,5.8,1565.67,1,9
674727,CHEMBL1200776,CINACALCET HYDROCHLORIDE,105,CHEMBL1983,5-hydroxytryptamine receptor 1D,5.77,5.77,1695.7,1,9
674727,CHEMBL1200776,CINACALCET HYDROCHLORIDE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,5.74,5.74,1822.85,1,9
674727,CHEMBL1200776,CINACALCET HYDROCHLORIDE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.71,5.71,1962.68,1,9
674727,CHEMBL1200776,CINACALCET HYDROCHLORIDE,102,CHEMBL1941,Histamine H2 receptor,5.58,5.58,2624.52,1,9
674727,CHEMBL1200776,CINACALCET HYDROCHLORIDE,128,CHEMBL232,Alpha-1B adrenergic receptor,5.54,5.54,2889.68,1,9
674727,CHEMBL1200776,CINACALCET HYDROCHLORIDE,116042,CHEMBL3714081,Psychosine receptor,5.52,5.52,3013.59,1,9
674732,CHEMBL1200781,CITALOPRAM HYDROBROMIDE,121,CHEMBL228,Sodium-dependent serotonin transporter,9.11,9.11,0.78,1,9
674732,CHEMBL1200781,CITALOPRAM HYDROBROMIDE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,5.5,5.5,3162.3,1,9
674738,CHEMBL1200787,PHENOXYBENZAMINE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,8.3,8.3,5.0,1,9
674738,CHEMBL1200787,PHENOXYBENZAMINE HYDROCHLORIDE,17045,CHEMBL340,Cytochrome P450 3A4,7.3,7.3,50.1,2,9
674738,CHEMBL1200787,PHENOXYBENZAMINE HYDROCHLORIDE,78,CHEMBL1963,Thyrotropin receptor,7.2,7.2,63.1,2,9
674738,CHEMBL1200787,PHENOXYBENZAMINE HYDROCHLORIDE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,5.5,5.5,3162.3,2,9
674739,CHEMBL1200788,CISAPRIDE MONOHYDRATE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,7.4,7.4,40.0,1,9
674742,CHEMBL1200791,OXYMETAZOLINE HYDROCHLORIDE,52,CHEMBL1867,Alpha-2A adrenergic receptor,8.48,8.48,3.29,1,9
674742,CHEMBL1200791,OXYMETAZOLINE HYDROCHLORIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.46,8.46,3.5,2,9
674742,CHEMBL1200791,OXYMETAZOLINE HYDROCHLORIDE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.16,7.16,70.0,1,9
674747,CHEMBL1200796,CYCLOPHOSPHAMIDE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,6.8,6.8,158.5,1,9
674749,CHEMBL1200798,TRAZODONE HYDROCHLORIDE,10804,CHEMBL2632,"HLA class I histocompatibility antigen, A alpha chain",5.6,5.6,2500.0,1,9
674754,CHEMBL1200803,SOLIFENACIN SUCCINATE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.2,7.2,63.5,1,9
674754,CHEMBL1200803,SOLIFENACIN SUCCINATE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.88,6.88,130.8,1,9
674754,CHEMBL1200803,SOLIFENACIN SUCCINATE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.24,6.24,573.7,1,9
674757,CHEMBL1200806,NAPROXEN SODIUM,103668,CHEMBL1293235,Prelamin-A/C,8.55,8.55,2.8,1,9
674760,CHEMBL1200809,AZELASTINE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,9.0,9.0,1.0,1,9
674760,CHEMBL1200809,AZELASTINE HYDROCHLORIDE,127,CHEMBL231,Histamine H1 receptor,8.96,8.96,1.09,1,9
674760,CHEMBL1200809,AZELASTINE HYDROCHLORIDE,117512,CHEMBL4105907,Sigma intracellular receptor 2,7.5,7.5,31.96,1,9
674760,CHEMBL1200809,AZELASTINE HYDROCHLORIDE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.82,6.82,149.83,1,9
674760,CHEMBL1200809,AZELASTINE HYDROCHLORIDE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.64,6.64,229.61,1,9
674760,CHEMBL1200809,AZELASTINE HYDROCHLORIDE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.64,6.64,230.35,1,9
674760,CHEMBL1200809,AZELASTINE HYDROCHLORIDE,103,CHEMBL223,Alpha-1D adrenergic receptor,6.48,6.48,333.27,1,9
674760,CHEMBL1200809,AZELASTINE HYDROCHLORIDE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,6.41,6.41,385.48,1,9
674760,CHEMBL1200809,AZELASTINE HYDROCHLORIDE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.3,6.3,495.79,1,9
674760,CHEMBL1200809,AZELASTINE HYDROCHLORIDE,88,CHEMBL2056,D(1A) dopamine receptor,6.24,6.24,577.17,1,9
674760,CHEMBL1200809,AZELASTINE HYDROCHLORIDE,130,CHEMBL234,D(3) dopamine receptor,6.2,6.2,636.36,1,9
674760,CHEMBL1200809,AZELASTINE HYDROCHLORIDE,105,CHEMBL1983,5-hydroxytryptamine receptor 1D,6.05,6.05,885.42,1,9
674760,CHEMBL1200809,AZELASTINE HYDROCHLORIDE,72,CHEMBL217,D(2) dopamine receptor,5.93,5.93,1176.52,1,9
674760,CHEMBL1200809,AZELASTINE HYDROCHLORIDE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.84,5.84,1451.11,1,9
674760,CHEMBL1200809,AZELASTINE HYDROCHLORIDE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,5.68,5.68,2092.42,1,9
674761,CHEMBL1200810,DOXERCALCIFEROL,64,CHEMBL1977,Vitamin D3 receptor,6.02,6.02,960.0,1,9
674773,CHEMBL1200822,FLECAINIDE ACETATE,101097,CHEMBL5162,Neuropeptide S receptor,6.2,6.2,631.0,1,9
674773,CHEMBL1200822,FLECAINIDE ACETATE,103665,CHEMBL1293232,Survival motor neuron protein,6.05,6.05,891.3,1,9
674780,CHEMBL1200829,GLUCONOLACTONE,103668,CHEMBL1293235,Prelamin-A/C,6.1,6.1,794.3,1,9
674787,CHEMBL1200836,OXICONAZOLE NITRATE,17045,CHEMBL340,Cytochrome P450 3A4,6.7,6.7,199.5,2,9
674790,CHEMBL1200839,DIATRIZOATE MEGLUMINE,103665,CHEMBL1293232,Survival motor neuron protein,6.6,6.6,251.2,1,9
674792,CHEMBL1200841,PROCAINE HYDROCHLORIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,7.05,7.05,89.1,2,9
674796,CHEMBL1200845,HALCINONIDE,25,CHEMBL2034,Glucocorticoid receptor,9.13,8.96,0.732,2,8
674796,CHEMBL1200845,HALCINONIDE,36,CHEMBL208,Progesterone receptor,8.52,8.52,3.0,1,8
674796,CHEMBL1200845,HALCINONIDE,56,CHEMBL1871,Androgen receptor,6.77,6.77,168.5,1,8
674799,CHEMBL1200848,HYDROXYPROGESTERONE CAPROATE,36,CHEMBL208,Progesterone receptor,8.52,8.52,3.0,1,8
674799,CHEMBL1200848,HYDROXYPROGESTERONE CAPROATE,25,CHEMBL2034,Glucocorticoid receptor,8.15,8.15,7.0,1,8
674799,CHEMBL1200848,HYDROXYPROGESTERONE CAPROATE,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.77,5.77,1702.9,1,8
674804,CHEMBL1200853,DYDROGESTERONE,36,CHEMBL208,Progesterone receptor,8.02,8.02,9.6,1,8
674804,CHEMBL1200853,DYDROGESTERONE,56,CHEMBL1871,Androgen receptor,6.92,6.92,120.0,1,8
674806,CHEMBL1200855,TICARCILLIN DISODIUM,103665,CHEMBL1293232,Survival motor neuron protein,6.2,6.2,631.0,1,9
674816,CHEMBL1200865,LOTEPREDNOL ETABONATE,25,CHEMBL2034,Glucocorticoid receptor,8.25,8.25,5.6,1,8
674816,CHEMBL1200865,LOTEPREDNOL ETABONATE,36,CHEMBL208,Progesterone receptor,7.62,7.62,24.0,1,8
674816,CHEMBL1200865,LOTEPREDNOL ETABONATE,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.61,5.59,2440.0,2,8
674817,CHEMBL1200866,PERFLUBRON,103668,CHEMBL1293235,Prelamin-A/C,6.15,6.15,707.9,1,9
674819,CHEMBL1200868,PHENYL AMINOSALICYLATE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.63,6.63,235.2,1,8
674819,CHEMBL1200868,PHENYL AMINOSALICYLATE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.11,6.11,776.7,1,8
674819,CHEMBL1200868,PHENYL AMINOSALICYLATE,103668,CHEMBL1293235,Prelamin-A/C,6.05,6.05,891.3,1,9
674819,CHEMBL1200868,PHENYL AMINOSALICYLATE,11307,CHEMBL1865,Histone deacetylase 6,5.73,5.73,1857.0,1,9
674819,CHEMBL1200868,PHENYL AMINOSALICYLATE,103657,CHEMBL1293224,Microtubule-associated protein tau,5.5,5.5,3162.3,1,9
674821,CHEMBL1200870,TIMOLOL MALEATE,103665,CHEMBL1293232,Survival motor neuron protein,5.5,5.5,3162.3,1,9
674824,CHEMBL1200873,PHENTOLAMINE MESYLATE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,5.95,5.95,1122.0,2,9
674824,CHEMBL1200873,PHENTOLAMINE MESYLATE,17045,CHEMBL340,Cytochrome P450 3A4,5.6,5.6,2511.9,2,9
674824,CHEMBL1200873,PHENTOLAMINE MESYLATE,11365,CHEMBL289,Cytochrome P450 2D6,5.5,5.5,3162.28,2,9
674828,CHEMBL1200877,FLUMETHASONE PIVALATE,56,CHEMBL1871,Androgen receptor,5.86,5.86,1396.3,1,8
674834,CHEMBL1200883,THONZONIUM BROMIDE,101440,CHEMBL6089,Ubiquitin-conjugating enzyme E2 N,5.54,5.54,2863.0,2,9
674838,CHEMBL1200887,TRIMETHOBENZAMIDE HYDROCHLORIDE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,8.0,8.0,10.0,1,9
674846,CHEMBL1200895,PHENELZINE SULFATE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,7.7,7.7,20.0,2,9
674847,CHEMBL1200896,DINOPROST TROMETHAMINE,103668,CHEMBL1293235,Prelamin-A/C,8.0,8.0,10.0,1,9
674855,CHEMBL1200904,SELEGILINE HYDROCHLORIDE,104,CHEMBL2039,Amine oxidase [flavin-containing] B,8.18,8.18,6.59,2,9
674855,CHEMBL1200904,SELEGILINE HYDROCHLORIDE,86,CHEMBL1951,Amine oxidase [flavin-containing] A,5.77,5.77,1700.0,1,9
674859,CHEMBL1200908,HALOBETASOL PROPIONATE,36,CHEMBL208,Progesterone receptor,8.52,8.52,3.0,1,8
674859,CHEMBL1200908,HALOBETASOL PROPIONATE,56,CHEMBL1871,Androgen receptor,7.41,7.41,38.6,1,8
674867,CHEMBL1200916,THIORIDAZINE HYDROCHLORIDE,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,7.9,7.9,12.6,1,9
674867,CHEMBL1200916,THIORIDAZINE HYDROCHLORIDE,103665,CHEMBL1293232,Survival motor neuron protein,5.9,5.9,1258.9,1,9
674881,CHEMBL1200930,RABEPRAZOLE SODIUM,103727,CHEMBL1293294,Ras-related protein Rab-9A,5.55,5.55,2818.4,1,9
674881,CHEMBL1200930,RABEPRAZOLE SODIUM,103710,CHEMBL1293277,NPC intracellular cholesterol transporter 1,5.5,5.5,3162.3,1,9
674883,CHEMBL1200932,IOPAMIDOL,103668,CHEMBL1293235,Prelamin-A/C,5.85,5.85,1412.5,1,9
674885,CHEMBL1200934,NORGESTIMATE,36,CHEMBL208,Progesterone receptor,7.7,7.7,20.0,1,8
674885,CHEMBL1200934,NORGESTIMATE,25,CHEMBL2034,Glucocorticoid receptor,7.39,7.39,41.0,1,8
674889,CHEMBL1200938,METHYSERGIDE MALEATE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,9.1,9.1,0.7943,1,9
674889,CHEMBL1200938,METHYSERGIDE MALEATE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,8.72,8.72,1.9,1,9
674889,CHEMBL1200938,METHYSERGIDE MALEATE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.77,6.87,17.0,2,9
674889,CHEMBL1200938,METHYSERGIDE MALEATE,103657,CHEMBL1293224,Microtubule-associated protein tau,6.95,6.95,112.2,1,9
674889,CHEMBL1200938,METHYSERGIDE MALEATE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,6.0,6.0,1000.0,2,9
674899,CHEMBL1200948,TRIMIPRAMINE MALEATE,103669,CHEMBL1293236,ATP-dependent DNA helicase Q1,5.5,5.5,3162.3,1,9
674915,CHEMBL1200964,AMITRIPTYLINE HYDROCHLORIDE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.7,6.7,200.0,1,9
674915,CHEMBL1200964,AMITRIPTYLINE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,5.85,5.85,1412.5,1,9
674920,CHEMBL1200969,DUTASTERIDE,79,CHEMBL1787,3-oxo-5-alpha-steroid 4-dehydrogenase 1,8.4,8.4,4.0,1,9
674920,CHEMBL1200969,DUTASTERIDE,102688,CHEMBL5845,Glycine receptor subunit alpha-1,6.48,6.48,330.0,1,9
674921,CHEMBL1200970,ETHOPROPAZINE HYDROCHLORIDE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,7.4,7.4,39.8,1,9
674921,CHEMBL1200970,ETHOPROPAZINE HYDROCHLORIDE,10532,CHEMBL1914,Cholinesterase,5.8,5.8,1600.0,3,9
674924,CHEMBL1200973,ESTRADIOL CYPIONATE,19,CHEMBL206,Estrogen receptor,6.42,6.42,378.9,1,8
674924,CHEMBL1200973,ESTRADIOL CYPIONATE,56,CHEMBL1871,Androgen receptor,6.13,6.13,741.7,1,8
674924,CHEMBL1200973,ESTRADIOL CYPIONATE,36,CHEMBL208,Progesterone receptor,5.78,5.78,1649.1,1,8
674926,CHEMBL1200975,CLOCORTOLONE PIVALATE,36,CHEMBL208,Progesterone receptor,7.93,7.93,11.8,1,8
674926,CHEMBL1200975,CLOCORTOLONE PIVALATE,56,CHEMBL1871,Androgen receptor,7.08,7.08,83.3,1,8
674937,CHEMBL1200986,HALOPERIDOL DECANOATE,72,CHEMBL217,D(2) dopamine receptor,9.34,9.04,0.46,2,9
674937,CHEMBL1200986,HALOPERIDOL DECANOATE,130,CHEMBL234,D(3) dopamine receptor,8.46,8.46,3.5,1,9
674937,CHEMBL1200986,HALOPERIDOL DECANOATE,90,CHEMBL219,D(4) dopamine receptor,8.24,8.24,5.8,1,9
674940,CHEMBL1200989,ALCLOMETASONE DIPROPIONATE,25,CHEMBL2034,Glucocorticoid receptor,7.85,7.85,14.0,1,8
674940,CHEMBL1200989,ALCLOMETASONE DIPROPIONATE,87,CHEMBL218,Cannabinoid receptor 1,6.67,6.46,213.4,2,8
674940,CHEMBL1200989,ALCLOMETASONE DIPROPIONATE,36,CHEMBL208,Progesterone receptor,6.4,6.4,400.0,1,8
674944,CHEMBL1200993,GALLAMINE TRIETHIODIDE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.33,6.07,467.74,4,9
209829,CHEMBL1201,THIOTHIXENE,72,CHEMBL217,D(2) dopamine receptor,8.57,8.57,2.7,1,8
209829,CHEMBL1201,THIOTHIXENE,130,CHEMBL234,D(3) dopamine receptor,7.86,7.86,13.9,1,8
209829,CHEMBL1201,THIOTHIXENE,88,CHEMBL2056,D(1A) dopamine receptor,7.72,6.95,19.0,3,8
209829,CHEMBL1201,THIOTHIXENE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.61,7.11,24.4,3,8
209829,CHEMBL1201,THIOTHIXENE,127,CHEMBL231,Histamine H1 receptor,7.44,7.44,36.0,1,8
209829,CHEMBL1201,THIOTHIXENE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.11,7.11,78.0,1,8
209829,CHEMBL1201,THIOTHIXENE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.96,6.42,110.6,2,8
209829,CHEMBL1201,THIOTHIXENE,102,CHEMBL1941,Histamine H2 receptor,6.84,6.84,144.9,1,8
209829,CHEMBL1201,THIOTHIXENE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,6.59,6.59,254.4,1,8
209829,CHEMBL1201,THIOTHIXENE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.34,6.34,455.4,1,8
209829,CHEMBL1201,THIOTHIXENE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.31,6.08,494.5,2,8
209829,CHEMBL1201,THIOTHIXENE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.12,6.12,754.8,1,8
209829,CHEMBL1201,THIOTHIXENE,90,CHEMBL219,D(4) dopamine receptor,6.11,6.11,779.6,1,8
209829,CHEMBL1201,THIOTHIXENE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.07,6.07,857.3,1,8
209829,CHEMBL1201,THIOTHIXENE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.85,5.85,1400.0,1,8
209829,CHEMBL1201,THIOTHIXENE,144,CHEMBL1899,5-hydroxytryptamine receptor 3A,5.8,5.8,1600.0,1,8
209829,CHEMBL1201,THIOTHIXENE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.79,5.79,1630.0,1,8
209829,CHEMBL1201,THIOTHIXENE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.55,5.55,2800.0,1,8
674952,CHEMBL1201001,MECHLORETHAMINE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,5.5,5.5,3162.3,1,9
674957,CHEMBL1201006,PYRILAMINE MALEATE,103665,CHEMBL1293232,Survival motor neuron protein,5.75,5.75,1778.3,1,9
674961,CHEMBL1201010,FLUDROCORTISONE ACETATE,25,CHEMBL2034,Glucocorticoid receptor,8.03,7.44,9.253,3,8
674963,CHEMBL1201012,FLURANDRENOLIDE,25,CHEMBL2034,Glucocorticoid receptor,8.69,8.52,2.021,2,8
674963,CHEMBL1201012,FLURANDRENOLIDE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,8.2,8.2,6.3,2,9
674963,CHEMBL1201012,FLURANDRENOLIDE,36,CHEMBL208,Progesterone receptor,7.18,7.18,66.6,1,8
674963,CHEMBL1201012,FLURANDRENOLIDE,101097,CHEMBL5162,Neuropeptide S receptor,6.5,6.5,316.2,1,9
674963,CHEMBL1201012,FLURANDRENOLIDE,103665,CHEMBL1293232,Survival motor neuron protein,6.05,6.05,891.3,1,9
674973,CHEMBL1201022,PHENAZOPYRIDINE HYDROCHLORIDE,103657,CHEMBL1293224,Microtubule-associated protein tau,7.15,7.15,70.8,1,9
674974,CHEMBL1201023,ORPHENADRINE HYDROCHLORIDE,101097,CHEMBL5162,Neuropeptide S receptor,7.7,7.7,20.0,1,9
674978,CHEMBL1201027,GLYCOPYRRONIUM BROMIDE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,9.9,8.59,0.1259,5,9
674978,CHEMBL1201027,GLYCOPYRRONIUM BROMIDE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,9.8,9.4,0.1585,2,9
674978,CHEMBL1201027,GLYCOPYRRONIUM BROMIDE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,9.7,9.22,0.1995,2,9
674978,CHEMBL1201027,GLYCOPYRRONIUM BROMIDE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,9.6,9.14,0.2512,3,9
674978,CHEMBL1201027,GLYCOPYRRONIUM BROMIDE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,9.3,8.73,0.5012,6,9
674989,CHEMBL1201038,ACRISORCIN,103660,CHEMBL1293227,Ubiquitin carboxyl-terminal hydrolase 2,6.3,6.3,501.2,1,9
674990,CHEMBL1201039,BENZTHIAZIDE,103665,CHEMBL1293232,Survival motor neuron protein,6.0,6.0,1000.0,1,9
674990,CHEMBL1201039,BENZTHIAZIDE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.82,5.82,1500.0,1,8
674990,CHEMBL1201039,BENZTHIAZIDE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.77,5.69,1700.0,2,8
674994,CHEMBL1201043,CEPHAPIRIN SODIUM,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,5.6,5.6,2511.9,1,9
675000,CHEMBL1201049,ECONAZOLE NITRATE,17045,CHEMBL340,Cytochrome P450 3A4,7.2,6.8,63.1,4,9
675000,CHEMBL1201049,ECONAZOLE NITRATE,11213,CHEMBL3880,Heat shock protein HSP 90-alpha,6.57,6.57,267.0,1,8
675017,CHEMBL1201066,VENLAFAXINE HYDROCHLORIDE,121,CHEMBL228,Sodium-dependent serotonin transporter,7.44,6.79,36.1,8,9
675017,CHEMBL1201066,VENLAFAXINE HYDROCHLORIDE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.59,5.59,2550.0,7,9
675017,CHEMBL1201066,VENLAFAXINE HYDROCHLORIDE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.59,5.59,2550.0,1,9
675024,CHEMBL1201073,SUCCIMER,11,CHEMBL204,Prothrombin,5.58,5.58,2640.0,1,8
675033,CHEMBL1201082,FLUOXETINE HYDROCHLORIDE,121,CHEMBL228,Sodium-dependent serotonin transporter,8.96,7.89,1.1,2,9
675033,CHEMBL1201082,FLUOXETINE HYDROCHLORIDE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.14,7.14,72.0,1,9
675033,CHEMBL1201082,FLUOXETINE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,6.8,6.8,158.5,1,9
675033,CHEMBL1201082,FLUOXETINE HYDROCHLORIDE,116042,CHEMBL3714081,Psychosine receptor,5.58,5.58,2607.59,1,9
675033,CHEMBL1201082,FLUOXETINE HYDROCHLORIDE,100138,CHEMBL4843,CX3C chemokine receptor 1,5.52,5.52,3001.59,1,9
675038,CHEMBL1201087,CABERGOLINE,72,CHEMBL217,D(2) dopamine receptor,9.44,8.92,0.36,3,9
675038,CHEMBL1201087,CABERGOLINE,88,CHEMBL2056,D(1A) dopamine receptor,8.85,7.49,1.4,3,9
675038,CHEMBL1201087,CABERGOLINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,8.85,7.98,1.4,6,9
675038,CHEMBL1201087,CABERGOLINE,130,CHEMBL234,D(3) dopamine receptor,8.52,8.32,3.0,2,8
675038,CHEMBL1201087,CABERGOLINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.11,7.65,7.7,2,8
675038,CHEMBL1201087,CABERGOLINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,8.08,7.34,8.3,3,8
675038,CHEMBL1201087,CABERGOLINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.99,6.41,102.7,4,9
675038,CHEMBL1201087,CABERGOLINE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.85,6.54,141.9,2,8
675038,CHEMBL1201087,CABERGOLINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.52,6.52,300.0,1,8
675038,CHEMBL1201087,CABERGOLINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.6,5.6,2500.0,1,8
675043,CHEMBL1201092,RIVASTIGMINE TARTRATE,10532,CHEMBL1914,Cholinesterase,5.84,5.84,1439.0,1,9
675044,CHEMBL1201093,METHYL AMINOLEVULINATE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,7.5,7.5,31.6,1,9
675054,CHEMBL1201103,METHOXAMINE HYDROCHLORIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,6.7,6.7,199.5,2,9
675054,CHEMBL1201103,METHOXAMINE HYDROCHLORIDE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,5.8,5.8,1584.9,1,9
675060,CHEMBL1201109,DESONIDE,25,CHEMBL2034,Glucocorticoid receptor,7.8,7.8,16.0,1,8
675060,CHEMBL1201109,DESONIDE,36,CHEMBL208,Progesterone receptor,7.19,7.19,65.0,1,8
675068,CHEMBL1201117,METHOCARBAMOL,103665,CHEMBL1293232,Survival motor neuron protein,6.1,6.1,794.3,1,9
675069,CHEMBL1201118,CEFMETAZOLE SODIUM,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,7.65,7.65,22.4,2,9
675069,CHEMBL1201118,CEFMETAZOLE SODIUM,103665,CHEMBL1293232,Survival motor neuron protein,6.15,6.15,707.9,1,9
675070,CHEMBL1201119,LIOTHYRONINE SODIUM,103657,CHEMBL1293224,Microtubule-associated protein tau,5.8,5.8,1584.9,1,9
675075,CHEMBL1201124,KETOROLAC TROMETHAMINE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,9.0,9.0,1.0,2,9
675075,CHEMBL1201124,KETOROLAC TROMETHAMINE,126,CHEMBL230,Prostaglandin G/H synthase 2,6.92,6.92,120.0,1,9
675075,CHEMBL1201124,KETOROLAC TROMETHAMINE,104069,CHEMBL1743128,ATP-binding cassette sub-family C member 4,5.57,5.57,2700.0,1,9
675080,CHEMBL1201129,DECITABINE,321,CHEMBL1993,DNA (cytosine-5)-methyltransferase 1,7.52,7.52,30.0,1,9
675082,CHEMBL1201131,PIPERONYL BUTOXIDE,17045,CHEMBL340,Cytochrome P450 3A4,6.3,5.91,501.2,4,9
675090,CHEMBL1201139,MEGESTROL ACETATE,36,CHEMBL208,Progesterone receptor,8.52,8.52,3.0,1,8
675090,CHEMBL1201139,MEGESTROL ACETATE,25,CHEMBL2034,Glucocorticoid receptor,8.06,7.89,8.769,2,8
675090,CHEMBL1201139,MEGESTROL ACETATE,56,CHEMBL1871,Androgen receptor,7.74,7.74,18.1,1,8
675090,CHEMBL1201139,MEGESTROL ACETATE,103665,CHEMBL1293232,Survival motor neuron protein,5.9,5.9,1258.9,1,9
675090,CHEMBL1201139,MEGESTROL ACETATE,101097,CHEMBL5162,Neuropeptide S receptor,5.5,5.5,3162.3,1,9
675093,CHEMBL1201142,RASAGILINE MESYLATE,104,CHEMBL2039,Amine oxidase [flavin-containing] B,7.85,7.59,14.0,3,9
675093,CHEMBL1201142,RASAGILINE MESYLATE,86,CHEMBL1951,Amine oxidase [flavin-containing] A,6.15,6.15,710.0,1,9
675097,CHEMBL1201146,NORETHINDRONE ACETATE,36,CHEMBL208,Progesterone receptor,7.48,7.48,33.0,1,8
675097,CHEMBL1201146,NORETHINDRONE ACETATE,56,CHEMBL1871,Androgen receptor,6.9,6.9,124.6,1,8
675097,CHEMBL1201146,NORETHINDRONE ACETATE,25,CHEMBL2034,Glucocorticoid receptor,6.53,6.36,293.0,2,8
675097,CHEMBL1201146,NORETHINDRONE ACETATE,12912,CHEMBL3622,Cytochrome P450 2C19,6.1,6.1,800.0,1,8
675097,CHEMBL1201146,NORETHINDRONE ACETATE,280,CHEMBL256,Adenosine receptor A3,6.08,6.08,837.9,1,8
675097,CHEMBL1201146,NORETHINDRONE ACETATE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.51,5.51,3101.1,1,8
675100,CHEMBL1201149,NALTREXONE HYDROCHLORIDE,137,CHEMBL237,Kappa-type opioid receptor,6.76,6.76,174.0,1,9
675100,CHEMBL1201149,NALTREXONE HYDROCHLORIDE,103665,CHEMBL1293232,Survival motor neuron protein,5.85,5.85,1412.5,1,9
675102,CHEMBL1201151,MESTRANOL,19,CHEMBL206,Estrogen receptor,8.28,7.63,5.223,3,8
675102,CHEMBL1201151,MESTRANOL,121,CHEMBL228,Sodium-dependent serotonin transporter,7.66,7.02,22.0,3,8
675102,CHEMBL1201151,MESTRANOL,36,CHEMBL208,Progesterone receptor,7.02,7.02,96.0,1,8
675102,CHEMBL1201151,MESTRANOL,25,CHEMBL2034,Glucocorticoid receptor,6.29,6.29,516.0,1,8
675102,CHEMBL1201151,MESTRANOL,103668,CHEMBL1293235,Prelamin-A/C,5.9,5.9,1258.9,1,9
675102,CHEMBL1201151,MESTRANOL,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.86,5.86,1371.0,2,8
675104,CHEMBL1201153,ISOETHARINE MESYLATE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,5.7,5.7,1995.3,2,9
675104,CHEMBL1201153,ISOETHARINE MESYLATE,103749,CHEMBL1293316,Relaxin receptor 1,5.5,5.5,3162.3,1,9
675106,CHEMBL1201155,LOXAPINE SUCCINATE,103668,CHEMBL1293235,Prelamin-A/C,8.35,8.35,4.5,1,9
675106,CHEMBL1201155,LOXAPINE SUCCINATE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,7.55,7.55,28.2,2,9
675106,CHEMBL1201155,LOXAPINE SUCCINATE,103665,CHEMBL1293232,Survival motor neuron protein,6.05,6.05,891.3,1,9
675106,CHEMBL1201155,LOXAPINE SUCCINATE,12594,CHEMBL3356,Cytochrome P450 1A2,5.5,5.5,3162.28,1,8
675107,CHEMBL1201156,NORTRIPTYLINE HYDROCHLORIDE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,7.4,7.4,40.0,1,9
675107,CHEMBL1201156,NORTRIPTYLINE HYDROCHLORIDE,101097,CHEMBL5162,Neuropeptide S receptor,7.1,7.1,79.4,1,9
675116,CHEMBL1201165,QUINESTROL,25,CHEMBL2034,Glucocorticoid receptor,7.01,7.01,97.0,1,8
675116,CHEMBL1201165,QUINESTROL,103668,CHEMBL1293235,Prelamin-A/C,6.95,6.63,112.2,2,9
675116,CHEMBL1201165,QUINESTROL,36,CHEMBL208,Progesterone receptor,6.66,6.66,221.0,1,8
675116,CHEMBL1201165,QUINESTROL,19,CHEMBL206,Estrogen receptor,6.21,6.21,611.0,1,8
675119,CHEMBL1201168,ISOCARBOXAZID,103668,CHEMBL1293235,Prelamin-A/C,5.5,5.5,3162.3,1,9
675122,CHEMBL1201171,PRAMOXINE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,6.45,6.45,354.8,1,9
675122,CHEMBL1201171,PRAMOXINE HYDROCHLORIDE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,6.0,6.0,1000.0,1,9
675124,CHEMBL1201173,MEDRYSONE,36,CHEMBL208,Progesterone receptor,8.57,8.57,2.7,1,8
675124,CHEMBL1201173,MEDRYSONE,25,CHEMBL2034,Glucocorticoid receptor,8.3,8.3,5.0,1,8
675124,CHEMBL1201173,MEDRYSONE,103665,CHEMBL1293232,Survival motor neuron protein,5.85,5.85,1412.5,1,9
675125,CHEMBL1201174,SITAGLIPTIN PHOSPHATE,11140,CHEMBL284,Dipeptidyl peptidase 4,8.05,8.05,9.0,1,9
675130,CHEMBL1201179,LAPATINIB DITOSYLATE,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,8.52,7.98,3.0,7,9
675130,CHEMBL1201179,LAPATINIB DITOSYLATE,9,CHEMBL203,Epidermal growth factor receptor,8.3,7.8,5.0,7,9
675133,CHEMBL1201182,TEMSIROLIMUS,11400,CHEMBL2842,Serine/threonine-protein kinase mTOR,5.75,5.72,1760.0,4,9
675133,CHEMBL1201182,TEMSIROLIMUS,102394,CHEMBL6020,Bile salt export pump,5.57,5.55,2690.0,2,9
675136,CHEMBL1201185,LANREOTIDE,117,CHEMBL1804,Somatostatin receptor type 2,9.3,9.3,0.5012,1,8
675136,CHEMBL1201185,LANREOTIDE,11265,CHEMBL1792,Somatostatin receptor type 5,8.4,8.4,3.981,1,8
675136,CHEMBL1201185,LANREOTIDE,11261,CHEMBL2028,Somatostatin receptor type 3,7.2,7.2,63.1,1,8
675136,CHEMBL1201185,LANREOTIDE,12786,CHEMBL1917,Somatostatin receptor type 1,6.3,6.3,501.19,1,8
675141,CHEMBL1201190,LEVOCETIRIZINE DIHYDROCHLORIDE,127,CHEMBL231,Histamine H1 receptor,7.3,7.3,50.0,1,8
675143,CHEMBL1201192,ARMODAFINIL,72,CHEMBL217,D(2) dopamine receptor,8.68,8.68,2.1,1,9
675143,CHEMBL1201192,ARMODAFINIL,155,CHEMBL238,Sodium-dependent dopamine transporter,6.19,6.19,647.0,1,9
675144,CHEMBL1201193,LEVOBUPIVACAINE,11365,CHEMBL289,Cytochrome P450 2D6,6.71,6.44,196.4,3,9
675147,CHEMBL1201196,SERTACONAZOLE,56,CHEMBL1871,Androgen receptor,7.7,7.7,20.1,1,8
675147,CHEMBL1201196,SERTACONAZOLE,93,CHEMBL220,Acetylcholinesterase,7.0,7.0,100.0,1,9
675147,CHEMBL1201196,SERTACONAZOLE,36,CHEMBL208,Progesterone receptor,6.08,6.08,831.1,1,8
675147,CHEMBL1201196,SERTACONAZOLE,280,CHEMBL256,Adenosine receptor A3,5.79,5.79,1627.0,1,8
675147,CHEMBL1201196,SERTACONAZOLE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.77,5.77,1700.0,1,8
675147,CHEMBL1201196,SERTACONAZOLE,130,CHEMBL234,D(3) dopamine receptor,5.75,5.75,1780.2,1,8
675147,CHEMBL1201196,SERTACONAZOLE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.72,5.72,1882.4,1,8
675147,CHEMBL1201196,SERTACONAZOLE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.54,5.54,2886.9,1,8
675150,CHEMBL1201199,LEUPROLIDE,118,CHEMBL1855,Gonadotropin-releasing hormone receptor,9.54,9.42,0.2884,4,9
675152,CHEMBL1201201,METHAMPHETAMINE,101361,CHEMBL5857,Trace amine-associated receptor 1,5.89,5.86,1300.0,2,9
675153,CHEMBL1201202,FONDAPARINUX,194,CHEMBL244,Coagulation factor X,7.96,7.96,11.0,1,9
675154,CHEMBL1201203,BENZTROPINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,9.88,8.88,0.131,4,8
675154,CHEMBL1201203,BENZTROPINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,9.56,8.43,0.272,4,9
675154,CHEMBL1201203,BENZTROPINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,9.48,8.8,0.333,3,9
675154,CHEMBL1201203,BENZTROPINE,127,CHEMBL231,Histamine H1 receptor,9.43,8.6,0.37,3,8
675154,CHEMBL1201203,BENZTROPINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,8.84,8.77,1.451,2,8
675154,CHEMBL1201203,BENZTROPINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,8.44,7.5,3.668,5,9
675154,CHEMBL1201203,BENZTROPINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.16,7.2,6.968,3,8
675154,CHEMBL1201203,BENZTROPINE,103,CHEMBL223,Alpha-1D adrenergic receptor,7.58,7.43,26.0,2,8
675154,CHEMBL1201203,BENZTROPINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.52,6.84,30.0,3,8
675154,CHEMBL1201203,BENZTROPINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.5,7.36,32.0,2,8
675154,CHEMBL1201203,BENZTROPINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.24,6.46,57.0,3,8
675154,CHEMBL1201203,BENZTROPINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,7.23,7.04,59.0,2,8
675154,CHEMBL1201203,BENZTROPINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.11,6.56,78.0,2,8
675154,CHEMBL1201203,BENZTROPINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.9,6.51,127.0,4,8
675154,CHEMBL1201203,BENZTROPINE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.71,6.58,193.0,5,8
675154,CHEMBL1201203,BENZTROPINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.69,6.47,204.0,2,8
675154,CHEMBL1201203,BENZTROPINE,130,CHEMBL234,D(3) dopamine receptor,6.65,6.13,222.0,3,8
675154,CHEMBL1201203,BENZTROPINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.05,6.05,900.0,1,8
675154,CHEMBL1201203,BENZTROPINE,137,CHEMBL237,Kappa-type opioid receptor,6.0,6.0,992.8,1,8
675154,CHEMBL1201203,BENZTROPINE,102,CHEMBL1941,Histamine H2 receptor,5.93,5.92,1185.0,2,8
675154,CHEMBL1201203,BENZTROPINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,5.89,5.72,1294.0,2,8
675154,CHEMBL1201203,BENZTROPINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.86,5.86,1379.0,2,8
675158,CHEMBL1201207,BETAMETHASONE PHOSPHORIC ACID,25,CHEMBL2034,Glucocorticoid receptor,8.43,8.26,3.734,2,8
675158,CHEMBL1201207,BETAMETHASONE PHOSPHORIC ACID,127,CHEMBL231,Histamine H1 receptor,5.93,5.93,1169.0,1,8
675158,CHEMBL1201207,BETAMETHASONE PHOSPHORIC ACID,219,CHEMBL245,Muscarinic acetylcholine receptor M3,5.87,5.87,1363.0,1,8
675158,CHEMBL1201207,BETAMETHASONE PHOSPHORIC ACID,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.78,5.78,1676.0,1,8
675158,CHEMBL1201207,BETAMETHASONE PHOSPHORIC ACID,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,5.78,5.78,1663.0,1,8
675158,CHEMBL1201207,BETAMETHASONE PHOSPHORIC ACID,12883,CHEMBL2288,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1,5.66,5.66,2200.0,1,9
675161,CHEMBL1201210,PROPIOMAZINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.63,6.81,23.3,2,8
675161,CHEMBL1201210,PROPIOMAZINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.53,7.53,29.4,1,8
675161,CHEMBL1201210,PROPIOMAZINE,127,CHEMBL231,Histamine H1 receptor,7.47,7.47,34.0,1,8
675161,CHEMBL1201210,PROPIOMAZINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.92,6.92,120.0,1,8
675161,CHEMBL1201210,PROPIOMAZINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.75,6.75,180.0,1,8
675161,CHEMBL1201210,PROPIOMAZINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.75,6.75,180.0,1,8
675161,CHEMBL1201210,PROPIOMAZINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.64,6.64,230.0,1,8
675161,CHEMBL1201210,PROPIOMAZINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.58,6.27,265.5,2,8
675161,CHEMBL1201210,PROPIOMAZINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.5,6.5,320.0,1,8
675161,CHEMBL1201210,PROPIOMAZINE,130,CHEMBL234,D(3) dopamine receptor,6.28,6.28,530.0,1,8
675161,CHEMBL1201210,PROPIOMAZINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.16,6.16,685.0,1,8
675161,CHEMBL1201210,PROPIOMAZINE,137,CHEMBL237,Kappa-type opioid receptor,5.77,5.77,1699.9,1,8
675161,CHEMBL1201210,PROPIOMAZINE,72,CHEMBL217,D(2) dopamine receptor,5.58,5.58,2600.0,1,8
675161,CHEMBL1201210,PROPIOMAZINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.57,5.57,2700.0,1,8
675164,CHEMBL1201213,ISOETHARINE,43,CHEMBL210,Beta-2 adrenergic receptor,6.0,6.0,1000.0,1,9
675164,CHEMBL1201213,ISOETHARINE,126,CHEMBL230,Prostaglandin G/H synthase 2,5.51,5.51,3100.0,1,8
675167,CHEMBL1201216,DAPIPRAZOLE,103,CHEMBL223,Alpha-1D adrenergic receptor,8.39,8.23,4.086,2,8
675167,CHEMBL1201216,DAPIPRAZOLE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.76,6.49,173.0,2,8
675167,CHEMBL1201216,DAPIPRAZOLE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.49,6.35,327.0,2,8
675167,CHEMBL1201216,DAPIPRAZOLE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.28,6.28,523.4,1,8
675167,CHEMBL1201216,DAPIPRAZOLE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.28,6.11,526.0,2,8
675167,CHEMBL1201216,DAPIPRAZOLE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.2,6.2,627.5,1,8
675167,CHEMBL1201216,DAPIPRAZOLE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.17,6.08,672.0,2,8
675168,CHEMBL1201217,DYCLONINE,93,CHEMBL220,Acetylcholinesterase,6.74,6.74,181.0,1,9
675168,CHEMBL1201217,DYCLONINE,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,6.65,6.65,223.9,1,9
675168,CHEMBL1201217,DYCLONINE,103668,CHEMBL1293235,Prelamin-A/C,6.2,6.2,631.0,1,9
675168,CHEMBL1201217,DYCLONINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.64,5.64,2300.0,1,8
675168,CHEMBL1201217,DYCLONINE,12911,CHEMBL3397,Cytochrome P450 2C9,5.6,5.6,2511.89,2,9
675168,CHEMBL1201217,DYCLONINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.55,5.55,2813.4,1,8
675168,CHEMBL1201217,DYCLONINE,102,CHEMBL1941,Histamine H2 receptor,5.5,5.5,3126.9,1,8
675168,CHEMBL1201217,DYCLONINE,12594,CHEMBL3356,Cytochrome P450 1A2,5.5,5.5,3162.28,1,8
675175,CHEMBL1201224,CEFMENOXIME,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,6.15,6.15,710.0,1,8
675175,CHEMBL1201224,CEFMENOXIME,36,CHEMBL208,Progesterone receptor,5.75,5.75,1800.0,1,8
675183,CHEMBL1201232,ISOPROPAMIDE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,8.25,8.25,5.6,1,8
675183,CHEMBL1201232,ISOPROPAMIDE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,8.0,7.96,10.0,2,8
675183,CHEMBL1201232,ISOPROPAMIDE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.89,7.89,13.0,1,8
675185,CHEMBL1201234,MEPHENTERMINE,103668,CHEMBL1293235,Prelamin-A/C,8.49,8.49,3.2,1,9
675186,CHEMBL1201235,METHYLHOMATROPINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.86,6.86,138.7,1,8
675186,CHEMBL1201235,METHYLHOMATROPINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.66,6.66,220.0,1,8
675187,CHEMBL1201236,CARBIDOPA ANHYDROUS,11638,CHEMBL4040,Mitogen-activated protein kinase 1,7.4,7.4,39.8,1,9
675187,CHEMBL1201236,CARBIDOPA ANHYDROUS,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,6.8,6.8,158.5,1,9
675187,CHEMBL1201236,CARBIDOPA ANHYDROUS,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,5.95,5.95,1122.0,1,9
675187,CHEMBL1201236,CARBIDOPA ANHYDROUS,103665,CHEMBL1293232,Survival motor neuron protein,5.95,5.95,1122.0,1,9
675187,CHEMBL1201236,CARBIDOPA ANHYDROUS,103659,CHEMBL1293226,Lysine-specific demethylase 4E,5.65,5.65,2238.7,1,9
675188,CHEMBL1201237,LEVOBUNOLOL,43,CHEMBL210,Beta-2 adrenergic receptor,9.26,9.18,0.546,2,8
675188,CHEMBL1201237,LEVOBUNOLOL,50,CHEMBL213,Beta-1 adrenergic receptor,8.4,8.28,3.985,2,8
675188,CHEMBL1201237,LEVOBUNOLOL,226,CHEMBL246,Beta-3 adrenergic receptor,6.59,6.53,255.0,2,8
675188,CHEMBL1201237,LEVOBUNOLOL,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.49,6.3,325.0,2,8
675188,CHEMBL1201237,LEVOBUNOLOL,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.05,6.05,886.0,1,8
675188,CHEMBL1201237,LEVOBUNOLOL,121,CHEMBL228,Sodium-dependent serotonin transporter,5.58,5.58,2602.0,1,8
675190,CHEMBL1201239,IODAMIDE,103668,CHEMBL1293235,Prelamin-A/C,7.5,7.5,31.6,1,9
675195,CHEMBL1201244,ROCURONIUM,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.97,5.97,1060.0,1,8
675195,CHEMBL1201244,ROCURONIUM,115,CHEMBL227,Type-1 angiotensin II receptor,5.92,5.92,1200.0,1,8
675196,CHEMBL1201245,BROMODIPHENHYDRAMINE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.68,6.68,207.4,1,8
675196,CHEMBL1201245,BROMODIPHENHYDRAMINE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.12,6.12,756.7,1,8
675196,CHEMBL1201245,BROMODIPHENHYDRAMINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.85,5.85,1420.8,1,8
675196,CHEMBL1201245,BROMODIPHENHYDRAMINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.83,5.83,1489.6,1,8
675196,CHEMBL1201245,BROMODIPHENHYDRAMINE,130,CHEMBL234,D(3) dopamine receptor,5.57,5.57,2676.0,1,8
675196,CHEMBL1201245,BROMODIPHENHYDRAMINE,88,CHEMBL2056,D(1A) dopamine receptor,5.53,5.53,2952.6,1,8
675201,CHEMBL1201250,BENZQUINAMIDE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.5,6.5,320.0,1,8
675201,CHEMBL1201250,BENZQUINAMIDE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.23,6.02,587.6,2,8
675201,CHEMBL1201250,BENZQUINAMIDE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.13,5.82,734.8,2,8
675201,CHEMBL1201250,BENZQUINAMIDE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.99,5.99,1033.4,1,8
675201,CHEMBL1201250,BENZQUINAMIDE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.77,5.77,1700.0,1,8
675201,CHEMBL1201250,BENZQUINAMIDE,72,CHEMBL217,D(2) dopamine receptor,5.6,5.6,2500.0,1,8
675207,CHEMBL1201256,TRIMETHOBENZAMIDE,103668,CHEMBL1293235,Prelamin-A/C,7.25,7.25,56.2,1,9
675207,CHEMBL1201256,TRIMETHOBENZAMIDE,130,CHEMBL234,D(3) dopamine receptor,6.15,5.91,710.0,2,8
675215,CHEMBL1201264,METHANTHELINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.9,7.9,12.6,1,8
675215,CHEMBL1201264,METHANTHELINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.54,7.54,28.7,1,8
675216,CHEMBL1201265,METHYLPREDNISOLONE HEMISUCCINATE,25,CHEMBL2034,Glucocorticoid receptor,6.17,6.17,670.0,1,8
675217,CHEMBL1201266,LODOXAMIDE,103700,CHEMBL1293267,G-protein coupled receptor 35,7.39,7.39,41.1,1,9
675220,CHEMBL1201269,CHLORPHENTERMINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.52,5.52,2996.6,1,8
675222,CHEMBL1201271,BUCLIZINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.92,5.92,1200.0,1,8
675222,CHEMBL1201271,BUCLIZINE,87,CHEMBL218,Cannabinoid receptor 1,5.75,5.75,1800.0,1,8
675222,CHEMBL1201271,BUCLIZINE,127,CHEMBL231,Histamine H1 receptor,5.68,5.68,2100.0,1,8
675235,CHEMBL1201284,CINACALCET,282,CHEMBL1878,Extracellular calcium-sensing receptor,8.4,7.75,4.0,2,9
675235,CHEMBL1201284,CINACALCET,11365,CHEMBL289,Cytochrome P450 2D6,7.3,7.3,50.0,2,9
675235,CHEMBL1201284,CINACALCET,102688,CHEMBL5845,Glycine receptor subunit alpha-1,6.5,6.5,320.0,1,9
675235,CHEMBL1201284,CINACALCET,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.14,6.14,730.0,1,8
675235,CHEMBL1201284,CINACALCET,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.08,6.08,830.0,1,8
675235,CHEMBL1201284,CINACALCET,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.89,5.89,1300.0,1,8
675235,CHEMBL1201284,CINACALCET,130,CHEMBL234,D(3) dopamine receptor,5.82,5.82,1500.0,1,8
675235,CHEMBL1201284,CINACALCET,121,CHEMBL228,Sodium-dependent serotonin transporter,5.75,5.75,1800.0,1,8
675235,CHEMBL1201284,CINACALCET,129,CHEMBL233,Mu-type opioid receptor,5.72,5.66,1900.0,2,8
675237,CHEMBL1201286,OXYPHENONIUM,47,CHEMBL211,Muscarinic acetylcholine receptor M2,8.52,8.52,3.0,1,8
675237,CHEMBL1201286,OXYPHENONIUM,61,CHEMBL216,Muscarinic acetylcholine receptor M1,8.52,8.52,3.0,1,8
675238,CHEMBL1201287,DEXBROMPHENIRAMINE,127,CHEMBL231,Histamine H1 receptor,8.2,8.2,6.3,1,8
675238,CHEMBL1201287,DEXBROMPHENIRAMINE,121,CHEMBL228,Sodium-dependent serotonin transporter,7.62,7.62,23.8,1,8
675238,CHEMBL1201287,DEXBROMPHENIRAMINE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.87,5.87,1339.5,1,8
675239,CHEMBL1201288,DANTROLENE,104248,CHEMBL1795168,CDGSH iron-sulfur domain-containing protein 1,5.68,5.68,2065.0,1,9
675245,CHEMBL1201294,DIPHENOXYLATE,129,CHEMBL233,Mu-type opioid receptor,7.91,7.91,12.37,1,9
675254,CHEMBL1201303,PYRVINIUM,11720,CHEMBL2793,Casein kinase I isoform alpha,9.0,9.0,1.0,1,9
675254,CHEMBL1201303,PYRVINIUM,100,CHEMBL222,Sodium-dependent noradrenaline transporter,7.7,7.7,20.0,1,8
675254,CHEMBL1201303,PYRVINIUM,10280,CHEMBL264,Histamine H3 receptor,7.44,7.44,36.0,1,8
675254,CHEMBL1201303,PYRVINIUM,155,CHEMBL238,Sodium-dependent dopamine transporter,7.34,7.34,46.0,1,8
675254,CHEMBL1201303,PYRVINIUM,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.75,6.75,180.0,1,8
675254,CHEMBL1201303,PYRVINIUM,56,CHEMBL1871,Androgen receptor,6.72,6.72,190.0,1,9
675254,CHEMBL1201303,PYRVINIUM,118886,CHEMBL4523136,Synaptojanin-1,6.0,6.0,1000.0,2,9
675254,CHEMBL1201303,PYRVINIUM,118879,CHEMBL4523129,Synaptojanin-2,5.9,5.9,1250.0,3,9
675254,CHEMBL1201303,PYRVINIUM,121,CHEMBL228,Sodium-dependent serotonin transporter,5.75,5.75,1800.0,1,8
675254,CHEMBL1201303,PYRVINIUM,117992,CHEMBL4295747,"Serine hydroxymethyltransferase, mitochondrial",5.59,5.59,2570.4,1,9
675254,CHEMBL1201303,PYRVINIUM,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.52,5.52,3000.0,1,8
675254,CHEMBL1201303,PYRVINIUM,219,CHEMBL245,Muscarinic acetylcholine receptor M3,5.51,5.51,3100.0,1,8
675255,CHEMBL1201304,INDOCYANINE GREEN ACID FORM,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,6.0,6.0,1000.0,1,8
675255,CHEMBL1201304,INDOCYANINE GREEN ACID FORM,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",5.64,5.64,2300.0,1,8
675255,CHEMBL1201304,INDOCYANINE GREEN ACID FORM,280,CHEMBL256,Adenosine receptor A3,5.52,5.52,3000.0,1,8
675260,CHEMBL1201309,NAFARELIN,10142,CHEMBL259,Melanocortin receptor 4,5.76,5.76,1750.0,1,8
675260,CHEMBL1201309,NAFARELIN,11003,CHEMBL4644,Melanocortin receptor 3,5.56,5.56,2730.0,1,8
675274,CHEMBL1201323,BETAZOLE,102,CHEMBL1941,Histamine H2 receptor,6.04,6.04,910.0,1,8
675274,CHEMBL1201323,BETAZOLE,103668,CHEMBL1293235,Prelamin-A/C,5.95,5.95,1122.0,1,9
675276,CHEMBL1201325,HEXOCYCLIUM,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.78,7.78,16.7,1,8
675276,CHEMBL1201325,HEXOCYCLIUM,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.14,7.14,71.8,1,8
675286,CHEMBL1201335,GLYCOPYRRONIUM,219,CHEMBL245,Muscarinic acetylcholine receptor M3,9.9,9.75,0.1259,2,9
675286,CHEMBL1201335,GLYCOPYRRONIUM,47,CHEMBL211,Muscarinic acetylcholine receptor M2,9.8,9.8,0.1585,1,9
675289,CHEMBL1201338,CYCLOPENTOLATE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,7.4,7.4,40.0,1,8
675289,CHEMBL1201338,CYCLOPENTOLATE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.16,7.16,69.0,1,8
675289,CHEMBL1201338,CYCLOPENTOLATE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.54,6.38,290.0,2,8
675291,CHEMBL1201340,DIPHEMANIL,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.92,6.65,120.0,2,8
675291,CHEMBL1201340,DIPHEMANIL,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.8,6.79,160.0,2,8
675291,CHEMBL1201340,DIPHEMANIL,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.73,6.73,187.0,1,8
675291,CHEMBL1201340,DIPHEMANIL,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.72,6.72,190.0,1,8
675291,CHEMBL1201340,DIPHEMANIL,127,CHEMBL231,Histamine H1 receptor,5.54,5.54,2900.0,1,8
675293,CHEMBL1201342,METHIXENE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,8.28,8.27,5.3,2,8
675293,CHEMBL1201342,METHIXENE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.96,7.96,10.9,1,8
675293,CHEMBL1201342,METHIXENE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.23,6.23,586.1,1,8
675293,CHEMBL1201342,METHIXENE,130,CHEMBL234,D(3) dopamine receptor,6.13,6.13,741.6,1,8
675293,CHEMBL1201342,METHIXENE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.72,5.72,1900.9,1,8
675293,CHEMBL1201342,METHIXENE,88,CHEMBL2056,D(1A) dopamine receptor,5.69,5.69,2031.6,1,8
675293,CHEMBL1201342,METHIXENE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.51,5.51,3100.0,1,8
675300,CHEMBL1201349,HEXAFLUORENIUM,130,CHEMBL234,D(3) dopamine receptor,7.17,7.17,67.1,1,8
675300,CHEMBL1201349,HEXAFLUORENIUM,93,CHEMBL220,Acetylcholinesterase,6.77,6.77,171.4,1,8
675300,CHEMBL1201349,HEXAFLUORENIUM,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.29,6.29,513.8,1,8
675300,CHEMBL1201349,HEXAFLUORENIUM,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.06,6.06,867.6,1,8
675300,CHEMBL1201349,HEXAFLUORENIUM,129,CHEMBL233,Mu-type opioid receptor,5.99,5.99,1030.4,1,8
675300,CHEMBL1201349,HEXAFLUORENIUM,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.84,5.84,1437.0,1,8
675300,CHEMBL1201349,HEXAFLUORENIUM,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.66,5.66,2186.9,1,8
675300,CHEMBL1201349,HEXAFLUORENIUM,10280,CHEMBL264,Histamine H3 receptor,5.57,5.57,2720.6,1,8
675300,CHEMBL1201349,HEXAFLUORENIUM,121,CHEMBL228,Sodium-dependent serotonin transporter,5.52,5.52,3020.9,1,8
675300,CHEMBL1201349,HEXAFLUORENIUM,125,CHEMBL229,Alpha-1A adrenergic receptor,5.51,5.51,3085.1,1,8
675304,CHEMBL1201353,DEXCHLORPHENIRAMINE,127,CHEMBL231,Histamine H1 receptor,9.14,8.35,0.73,3,8
675304,CHEMBL1201353,DEXCHLORPHENIRAMINE,121,CHEMBL228,Sodium-dependent serotonin transporter,7.89,7.53,13.0,3,8
675304,CHEMBL1201353,DEXCHLORPHENIRAMINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.56,6.13,276.0,2,8
675304,CHEMBL1201353,DEXCHLORPHENIRAMINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.48,6.17,333.0,2,8
675304,CHEMBL1201353,DEXCHLORPHENIRAMINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.26,5.92,547.0,2,8
675304,CHEMBL1201353,DEXCHLORPHENIRAMINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.16,5.97,697.0,2,8
675304,CHEMBL1201353,DEXCHLORPHENIRAMINE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.13,5.9,739.0,3,8
675304,CHEMBL1201353,DEXCHLORPHENIRAMINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.13,6.05,749.0,2,8
675304,CHEMBL1201353,DEXCHLORPHENIRAMINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.05,6.05,890.0,1,8
675304,CHEMBL1201353,DEXCHLORPHENIRAMINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.98,5.98,1055.0,1,8
675304,CHEMBL1201353,DEXCHLORPHENIRAMINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.92,5.78,1217.0,2,8
675304,CHEMBL1201353,DEXCHLORPHENIRAMINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.68,5.68,2103.0,1,8
675304,CHEMBL1201353,DEXCHLORPHENIRAMINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.6,5.6,2487.0,1,8
675305,CHEMBL1201354,TRIDIHEXETHYL,61,CHEMBL216,Muscarinic acetylcholine receptor M1,8.08,8.08,8.3,1,8
675305,CHEMBL1201354,TRIDIHEXETHYL,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.82,7.82,15.3,1,8
675305,CHEMBL1201354,TRIDIHEXETHYL,11365,CHEMBL289,Cytochrome P450 2D6,7.7,7.7,19.95,2,9
675307,CHEMBL1201356,METHYLERGONOVINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,9.14,8.62,0.728,3,8
675307,CHEMBL1201356,METHYLERGONOVINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,9.1,8.41,0.8,7,9
675307,CHEMBL1201356,METHYLERGONOVINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,8.93,8.77,1.178,2,8
675307,CHEMBL1201356,METHYLERGONOVINE,88,CHEMBL2056,D(1A) dopamine receptor,8.51,6.92,3.1,3,8
675307,CHEMBL1201356,METHYLERGONOVINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,8.18,7.66,6.558,3,8
675307,CHEMBL1201356,METHYLERGONOVINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.84,7.84,14.4,1,8
675307,CHEMBL1201356,METHYLERGONOVINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.7,7.7,20.0,1,8
675307,CHEMBL1201356,METHYLERGONOVINE,102,CHEMBL1941,Histamine H2 receptor,7.24,7.24,58.0,1,8
675307,CHEMBL1201356,METHYLERGONOVINE,130,CHEMBL234,D(3) dopamine receptor,7.24,6.85,57.0,3,8
675307,CHEMBL1201356,METHYLERGONOVINE,11365,CHEMBL289,Cytochrome P450 2D6,6.7,6.7,200.0,1,8
675307,CHEMBL1201356,METHYLERGONOVINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.68,6.49,210.0,3,8
675307,CHEMBL1201356,METHYLERGONOVINE,72,CHEMBL217,D(2) dopamine receptor,6.56,6.32,276.0,2,8
675307,CHEMBL1201356,METHYLERGONOVINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.22,6.01,596.0,2,8
675307,CHEMBL1201356,METHYLERGONOVINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.77,5.77,1700.0,1,8
675307,CHEMBL1201356,METHYLERGONOVINE,127,CHEMBL231,Histamine H1 receptor,5.58,5.58,2600.0,1,8
675500,CHEMBL1201469,GRAMICIDIN,248,CHEMBL1835,Thromboxane-A synthase,6.11,6.11,774.0,1,9
675500,CHEMBL1201469,GRAMICIDIN,10140,CHEMBL258,Tyrosine-protein kinase Lck,5.96,5.96,1094.0,1,8
675500,CHEMBL1201469,GRAMICIDIN,10184,CHEMBL2327,Substance-K receptor,5.82,5.82,1521.0,1,8
675500,CHEMBL1201469,GRAMICIDIN,249,CHEMBL252,Endothelin-1 receptor,5.74,5.63,1835.0,2,8
675500,CHEMBL1201469,GRAMICIDIN,11006,CHEMBL4608,Melanocortin receptor 5,5.72,5.71,1888.0,2,8
675500,CHEMBL1201469,GRAMICIDIN,10142,CHEMBL259,Melanocortin receptor 4,5.5,5.5,3186.0,1,8
675680,CHEMBL1201729,DRONEDARONE HYDROCHLORIDE,10198,CHEMBL4306,Potassium voltage-gated channel subfamily A member 5,5.62,5.62,2370.0,1,9
675697,CHEMBL1201746,PRALATREXATE,6,CHEMBL202,Dihydrofolate reductase,10.87,10.87,0.0134,1,9
675697,CHEMBL1201746,PRALATREXATE,10123,CHEMBL4833,Reduced folate transporter,9.16,9.16,0.69,1,9
675697,CHEMBL1201746,PRALATREXATE,104268,CHEMBL1795188,Proton-coupled folate transporter,7.24,7.24,57.0,1,9
675697,CHEMBL1201746,PRALATREXATE,10103,CHEMBL2121,Folate receptor alpha,6.78,6.78,168.0,1,9
675700,CHEMBL1201749,DIFLUPREDNATE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,8.4,8.4,4.0,2,9
675700,CHEMBL1201749,DIFLUPREDNATE,103668,CHEMBL1293235,Prelamin-A/C,6.25,6.25,562.3,1,9
675700,CHEMBL1201749,DIFLUPREDNATE,101097,CHEMBL5162,Neuropeptide S receptor,5.6,5.6,2511.9,1,9
675703,CHEMBL1201752,IXABEPILONE,100304,CHEMBL4860,Apoptosis regulator Bcl-2,6.47,6.47,337.0,1,9
675704,CHEMBL1201753,PITAVASTATIN,101254,CHEMBL5002,Nuclear receptor subfamily 4 group A member 2,6.92,6.92,120.0,2,9
675704,CHEMBL1201753,PITAVASTATIN,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",6.17,6.1,670.0,2,8
675705,CHEMBL1201754,RUFINAMIDE,11042,CHEMBL4789,"Carbonic anhydrase 5A, mitochondrial",6.46,6.46,343.8,1,9
675715,CHEMBL1201764,FESOTERODINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.45,6.45,354.2,1,8
675715,CHEMBL1201764,FESOTERODINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.38,6.38,414.1,1,8
675721,CHEMBL1201770,METHYLNALTREXONE BROMIDE,129,CHEMBL233,Mu-type opioid receptor,8.26,8.18,5.48,2,9
675721,CHEMBL1201770,METHYLNALTREXONE BROMIDE,136,CHEMBL236,Delta-type opioid receptor,6.3,6.3,501.19,1,9
675723,CHEMBL1201772,PRASUGREL,176,CHEMBL2001,P2Y purinoceptor 12,5.75,5.75,1800.0,1,9
675725,CHEMBL1201774,SAPROPTERIN,11037,CHEMBL3568,Nitric oxide synthase 1,5.95,5.95,1120.0,1,8
675727,CHEMBL1201776,TAPENTADOL,129,CHEMBL233,Mu-type opioid receptor,6.8,6.48,160.0,2,9
675745,CHEMBL1201794,RIBOFLAVIN 5'-PHOSPHATE,43,CHEMBL210,Beta-2 adrenergic receptor,5.54,5.54,2900.0,1,8
675842,CHEMBL1201891,DEFLAZACORT,25,CHEMBL2034,Glucocorticoid receptor,6.18,6.18,660.0,1,8
213505,CHEMBL1205,NELFINAVIR MESYLATE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,8.89,8.89,1.3,1,9
213505,CHEMBL1205,NELFINAVIR MESYLATE,17045,CHEMBL340,Cytochrome P450 3A4,5.8,5.8,1584.9,2,9
213639,CHEMBL1206,ETHOPROPAZINE,10532,CHEMBL1914,Cholinesterase,7.7,7.15,20.0,4,9
213639,CHEMBL1206,ETHOPROPAZINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.44,7.44,36.6,1,8
213639,CHEMBL1206,ETHOPROPAZINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.34,7.34,46.1,1,8
213639,CHEMBL1206,ETHOPROPAZINE,11365,CHEMBL289,Cytochrome P450 2D6,6.8,6.8,158.49,2,9
213639,CHEMBL1206,ETHOPROPAZINE,93,CHEMBL220,Acetylcholinesterase,6.58,6.55,260.0,4,9
213639,CHEMBL1206,ETHOPROPAZINE,12594,CHEMBL3356,Cytochrome P450 1A2,6.3,6.3,501.19,1,8
213639,CHEMBL1206,ETHOPROPAZINE,130,CHEMBL234,D(3) dopamine receptor,5.63,5.63,2315.0,1,8
213639,CHEMBL1206,ETHOPROPAZINE,129,CHEMBL233,Mu-type opioid receptor,5.54,5.54,2900.8,1,8
680641,CHEMBL1206690,PARECOXIB,126,CHEMBL230,Prostaglandin G/H synthase 2,8.3,8.3,5.0,1,9
214701,CHEMBL1208,CINOXACIN,103668,CHEMBL1293235,Prelamin-A/C,8.3,8.3,5.0,1,9
214701,CHEMBL1208,CINOXACIN,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,6.55,6.55,281.8,2,9
682373,CHEMBL1208422,ROSE BENGAL FREE ACID,103668,CHEMBL1293235,Prelamin-A/C,6.4,6.4,398.1,1,9
682373,CHEMBL1208422,ROSE BENGAL FREE ACID,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.1,6.0,794.3,2,9
682373,CHEMBL1208422,ROSE BENGAL FREE ACID,103657,CHEMBL1293224,Microtubule-associated protein tau,5.8,5.65,1584.9,2,9
682373,CHEMBL1208422,ROSE BENGAL FREE ACID,271,CHEMBL1947,Thyroid hormone receptor beta,5.55,5.55,2818.4,1,9
20027,CHEMBL121,ROSIGLITAZONE,133,CHEMBL235,Peroxisome proliferator-activated receptor gamma,9.0,7.15,1.0,226,9
20027,CHEMBL121,ROSIGLITAZONE,103668,CHEMBL1293235,Prelamin-A/C,8.66,8.66,2.2,1,9
20027,CHEMBL121,ROSIGLITAZONE,163,CHEMBL239,Peroxisome proliferator-activated receptor alpha,8.4,6.92,4.0,6,9
20027,CHEMBL121,ROSIGLITAZONE,104248,CHEMBL1795168,CDGSH iron-sulfur domain-containing protein 1,7.51,6.82,31.0,2,9
20027,CHEMBL121,ROSIGLITAZONE,104,CHEMBL2039,Amine oxidase [flavin-containing] B,6.08,6.08,832.0,2,9
20027,CHEMBL121,ROSIGLITAZONE,102394,CHEMBL6020,Bile salt export pump,6.0,5.78,1000.0,2,9
20027,CHEMBL121,ROSIGLITAZONE,119149,CHEMBL4523399,CDGSH iron-sulfur domain-containing protein 2,5.64,5.64,2290.0,1,9
685092,CHEMBL1213251,CLOBENZOREX,103668,CHEMBL1293235,Prelamin-A/C,6.75,6.75,177.8,1,9
685193,CHEMBL1213351,PROPOXYPHENE,129,CHEMBL233,Mu-type opioid receptor,6.77,6.46,170.0,2,8
685193,CHEMBL1213351,PROPOXYPHENE,137,CHEMBL237,Kappa-type opioid receptor,6.09,6.09,803.6,1,8
685193,CHEMBL1213351,PROPOXYPHENE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.76,5.76,1739.0,1,8
685336,CHEMBL1213492,GIVINOSTAT,12697,CHEMBL325,Histone deacetylase 1,8.7,7.78,2.0,5,9
685336,CHEMBL1213492,GIVINOSTAT,11206,CHEMBL1937,Histone deacetylase 2,8.52,7.86,3.0,3,9
685336,CHEMBL1213492,GIVINOSTAT,11208,CHEMBL1829,Histone deacetylase 3,8.52,8.52,3.0,2,9
685336,CHEMBL1213492,GIVINOSTAT,11307,CHEMBL1865,Histone deacetylase 6,8.38,7.65,4.2,7,9
685336,CHEMBL1213492,GIVINOSTAT,10869,CHEMBL3192,Histone deacetylase 8,7.41,6.97,39.0,3,9
685336,CHEMBL1213492,GIVINOSTAT,12443,CHEMBL2716,Histone deacetylase 7,6.62,6.51,240.0,3,9
685336,CHEMBL1213492,GIVINOSTAT,12021,CHEMBL3310,Histone deacetylase 11,6.54,6.54,287.0,1,9
685336,CHEMBL1213492,GIVINOSTAT,10945,CHEMBL5103,Polyamine deacetylase HDAC10,6.48,6.48,331.0,1,9
685336,CHEMBL1213492,GIVINOSTAT,11797,CHEMBL4145,Histone deacetylase 9,6.41,6.37,390.0,3,9
685336,CHEMBL1213492,GIVINOSTAT,12283,CHEMBL2563,Histone deacetylase 5,6.27,6.24,532.0,3,9
685336,CHEMBL1213492,GIVINOSTAT,11232,CHEMBL3524,Histone deacetylase 4,5.98,5.98,1050.0,2,9
685974,CHEMBL1214124,PERAMPANEL,11114,CHEMBL2009,Glutamate receptor 1,6.61,6.26,243.0,4,9
685974,CHEMBL1214124,PERAMPANEL,10429,CHEMBL3595,Glutamate receptor 3,5.68,5.68,2100.0,1,9
219334,CHEMBL1215,PHENYLEPHRINE,128,CHEMBL232,Alpha-1B adrenergic receptor,9.07,8.65,0.86,2,9
219334,CHEMBL1215,PHENYLEPHRINE,125,CHEMBL229,Alpha-1A adrenergic receptor,8.55,7.39,2.8,5,9
219334,CHEMBL1215,PHENYLEPHRINE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,6.6,6.6,251.2,2,9
219334,CHEMBL1215,PHENYLEPHRINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.51,6.01,306.0,7,9
219334,CHEMBL1215,PHENYLEPHRINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.47,6.47,340.0,1,9
219334,CHEMBL1215,PHENYLEPHRINE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,5.96,5.96,1110.07,1,9
219334,CHEMBL1215,PHENYLEPHRINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.88,5.88,1310.3,1,8
219334,CHEMBL1215,PHENYLEPHRINE,88,CHEMBL2056,D(1A) dopamine receptor,5.5,5.5,3130.5,1,8
201284,CHEMBL121663,DEQUALINIUM CHLORIDE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.15,6.15,707.9,1,9
201284,CHEMBL121663,DEQUALINIUM CHLORIDE,12500,CHEMBL3381,Small conductance calcium-activated potassium channel protein 3,5.89,5.79,1300.0,2,8
201284,CHEMBL121663,DEQUALINIUM CHLORIDE,103669,CHEMBL1293236,ATP-dependent DNA helicase Q1,5.8,5.8,1584.9,1,9
201284,CHEMBL121663,DEQUALINIUM CHLORIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,5.55,5.55,2818.4,1,9
221962,CHEMBL1218,RAMELTEON,11084,CHEMBL1945,Melatonin receptor type 1A,10.86,10.86,0.0138,2,9
221962,CHEMBL1218,RAMELTEON,11085,CHEMBL1946,Melatonin receptor type 1B,10.35,10.15,0.045,2,9
222203,CHEMBL1219,RABEPRAZOLE,103668,CHEMBL1293235,Prelamin-A/C,7.55,7.55,28.2,1,9
222203,CHEMBL1219,RABEPRAZOLE,96,CHEMBL221,Prostaglandin G/H synthase 1,6.15,6.15,710.0,1,8
222203,CHEMBL1219,RABEPRAZOLE,130,CHEMBL234,D(3) dopamine receptor,6.1,5.87,790.0,2,8
222203,CHEMBL1219,RABEPRAZOLE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.1,5.93,793.0,2,8
222203,CHEMBL1219,RABEPRAZOLE,280,CHEMBL256,Adenosine receptor A3,5.74,5.7,1820.0,2,8
222203,CHEMBL1219,RABEPRAZOLE,119100,CHEMBL4523350,NAD(+) hydrolase SARM1,5.5,5.5,3200.0,1,9
21697,CHEMBL122,ROFECOXIB,126,CHEMBL230,Prostaglandin G/H synthase 2,9.0,6.72,1.0,60,9
21697,CHEMBL122,ROFECOXIB,101472,CHEMBL6174,Cytochrome c oxidase subunit 2,7.7,6.61,20.0,2,9
21697,CHEMBL122,ROFECOXIB,96,CHEMBL221,Prostaglandin G/H synthase 1,6.3,5.83,500.6,6,9
21697,CHEMBL122,ROFECOXIB,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,5.55,5.55,2818.4,1,9
222633,CHEMBL1220,TINIDAZOLE,103665,CHEMBL1293232,Survival motor neuron protein,5.75,5.75,1778.3,1,9
222633,CHEMBL1220,TINIDAZOLE,103668,CHEMBL1293235,Prelamin-A/C,5.7,5.7,1995.3,1,9
223819,CHEMBL1221,SULCONAZOLE,12912,CHEMBL3622,Cytochrome P450 2C19,7.8,7.8,16.0,1,8
223819,CHEMBL1221,SULCONAZOLE,17045,CHEMBL340,Cytochrome P450 3A4,7.16,7.16,70.0,1,8
223819,CHEMBL1221,SULCONAZOLE,121,CHEMBL228,Sodium-dependent serotonin transporter,7.12,6.75,75.0,3,8
223819,CHEMBL1221,SULCONAZOLE,248,CHEMBL1835,Thromboxane-A synthase,6.74,6.74,183.0,1,9
223819,CHEMBL1221,SULCONAZOLE,12911,CHEMBL3397,Cytochrome P450 2C9,6.7,6.7,200.0,1,8
223819,CHEMBL1221,SULCONAZOLE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.26,6.26,552.0,1,8
223819,CHEMBL1221,SULCONAZOLE,12594,CHEMBL3356,Cytochrome P450 1A2,6.22,6.22,600.0,1,8
223819,CHEMBL1221,SULCONAZOLE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.14,6.14,717.0,1,8
223819,CHEMBL1221,SULCONAZOLE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.14,6.14,721.0,1,8
223819,CHEMBL1221,SULCONAZOLE,11365,CHEMBL289,Cytochrome P450 2D6,6.1,6.1,800.0,1,8
223819,CHEMBL1221,SULCONAZOLE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.05,6.05,885.0,1,8
223819,CHEMBL1221,SULCONAZOLE,130,CHEMBL234,D(3) dopamine receptor,5.98,5.75,1054.0,2,8
223819,CHEMBL1221,SULCONAZOLE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.95,5.95,1122.0,1,8
223819,CHEMBL1221,SULCONAZOLE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.86,5.81,1371.0,2,8
223819,CHEMBL1221,SULCONAZOLE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.84,5.7,1459.0,2,8
223819,CHEMBL1221,SULCONAZOLE,280,CHEMBL256,Adenosine receptor A3,5.83,5.71,1485.0,2,8
223819,CHEMBL1221,SULCONAZOLE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.82,5.82,1516.0,1,8
223819,CHEMBL1221,SULCONAZOLE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.79,5.79,1636.0,1,8
223819,CHEMBL1221,SULCONAZOLE,10184,CHEMBL2327,Substance-K receptor,5.78,5.78,1653.0,1,8
223819,CHEMBL1221,SULCONAZOLE,137,CHEMBL237,Kappa-type opioid receptor,5.77,5.77,1700.0,1,8
223819,CHEMBL1221,SULCONAZOLE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,5.73,5.66,1873.0,2,8
223819,CHEMBL1221,SULCONAZOLE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.72,5.62,1922.0,2,8
223819,CHEMBL1221,SULCONAZOLE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.7,5.7,2010.0,2,8
223819,CHEMBL1221,SULCONAZOLE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.62,5.62,2400.0,1,8
223819,CHEMBL1221,SULCONAZOLE,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.57,5.57,2700.0,1,8
226400,CHEMBL1223,PENICILLIN G POTASSIUM,103665,CHEMBL1293232,Survival motor neuron protein,5.85,5.85,1412.5,1,9
226880,CHEMBL1224,ACRIVASTINE,127,CHEMBL231,Histamine H1 receptor,6.77,6.77,170.0,1,8
226880,CHEMBL1224,ACRIVASTINE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.15,6.15,710.0,1,8
226880,CHEMBL1224,ACRIVASTINE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.64,5.64,2300.0,1,8
227917,CHEMBL1228,OXYPHENBUTAZONE ANHYDROUS,119104,CHEMBL4523354,Nicotinate phosphoribosyltransferase,9.52,9.52,0.3,1,9
691562,CHEMBL1229211,DOLUTEGRAVIR,117512,CHEMBL4105907,Sigma intracellular receptor 2,7.75,7.75,18.0,1,9
691562,CHEMBL1229211,DOLUTEGRAVIR,104063,CHEMBL1743122,Solute carrier family 22 member 2,5.72,5.72,1900.0,1,9
691867,CHEMBL1229517,VEMURAFENIB,103465,CHEMBL1169596,Serine/threonine-protein kinase A-Raf,8.68,7.0,2.1,5,9
691867,CHEMBL1229517,VEMURAFENIB,100126,CHEMBL5145,Serine/threonine-protein kinase B-raf,8.49,7.31,3.2,68,9
691867,CHEMBL1229517,VEMURAFENIB,20007,CHEMBL3886,Mitogen-activated protein kinase kinase kinase 20,8.4,7.51,4.0,4,9
691867,CHEMBL1229517,VEMURAFENIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,8.32,8.32,4.8,1,9
691867,CHEMBL1229517,VEMURAFENIB,30023,CHEMBL4599,Activated CDC42 kinase 1,7.72,7.72,19.0,2,9
691867,CHEMBL1229517,VEMURAFENIB,9,CHEMBL203,Epidermal growth factor receptor,7.32,7.32,48.0,1,9
691867,CHEMBL1229517,VEMURAFENIB,10904,CHEMBL1906,RAF proto-oncogene serine/threonine-protein kinase,7.32,6.93,48.0,8,9
691867,CHEMBL1229517,VEMURAFENIB,102473,CHEMBL5638,Serine/threonine-protein kinase Nek11,6.72,6.72,190.0,1,9
691867,CHEMBL1229517,VEMURAFENIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,6.44,6.44,360.0,1,9
691867,CHEMBL1229517,VEMURAFENIB,20025,CHEMBL5014,Receptor-interacting serine/threonine-protein kinase 2,6.37,6.37,427.0,1,9
691867,CHEMBL1229517,VEMURAFENIB,10371,CHEMBL4948,Dual specificity mitogen-activated protein kinase kinase 5,6.13,6.13,734.0,1,9
691867,CHEMBL1229517,VEMURAFENIB,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.1,5.95,790.0,2,9
691867,CHEMBL1229517,VEMURAFENIB,30026,CHEMBL4601,Protein-tyrosine kinase 6,5.85,5.85,1411.0,1,9
691867,CHEMBL1229517,VEMURAFENIB,116956,CHEMBL3879831,"Ferrochelatase, mitochondrial",5.85,5.85,1419.0,1,9
691867,CHEMBL1229517,VEMURAFENIB,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.8,5.8,1600.0,1,9
691867,CHEMBL1229517,VEMURAFENIB,30049,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,5.75,5.75,1800.0,1,9
691867,CHEMBL1229517,VEMURAFENIB,104279,CHEMBL1795199,Receptor-interacting serine/threonine-protein kinase 3,5.68,5.68,2079.0,1,9
692664,CHEMBL1230314,ESTETROL ANHYDROUS,19,CHEMBL206,Estrogen receptor,8.31,8.31,4.9,5,9
692664,CHEMBL1230314,ESTETROL ANHYDROUS,174,CHEMBL242,Estrogen receptor beta,7.72,7.72,19.0,5,9
229058,CHEMBL1231,OXYBUTYNIN,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,9.56,8.9,0.278,3,9
229058,CHEMBL1231,OXYBUTYNIN,219,CHEMBL245,Muscarinic acetylcholine receptor M3,9.24,8.93,0.574,5,9
229058,CHEMBL1231,OXYBUTYNIN,61,CHEMBL216,Muscarinic acetylcholine receptor M1,9.07,8.68,0.847,5,9
229058,CHEMBL1231,OXYBUTYNIN,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,8.63,8.32,2.315,3,9
229058,CHEMBL1231,OXYBUTYNIN,47,CHEMBL211,Muscarinic acetylcholine receptor M2,8.09,7.84,8.1,7,9
229058,CHEMBL1231,OXYBUTYNIN,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,7.99,7.8,10.2,2,8
229058,CHEMBL1231,OXYBUTYNIN,155,CHEMBL238,Sodium-dependent dopamine transporter,7.17,7.1,67.9,3,8
229058,CHEMBL1231,OXYBUTYNIN,130,CHEMBL234,D(3) dopamine receptor,7.0,6.74,99.6,3,8
229058,CHEMBL1231,OXYBUTYNIN,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.3,6.2,504.0,2,8
229058,CHEMBL1231,OXYBUTYNIN,12912,CHEMBL3622,Cytochrome P450 2C19,6.22,6.22,600.0,1,8
229058,CHEMBL1231,OXYBUTYNIN,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.59,5.56,2573.7,3,8
230249,CHEMBL1233,CARISOPRODOL,103668,CHEMBL1293235,Prelamin-A/C,8.25,8.25,5.6,1,9
230249,CHEMBL1233,CARISOPRODOL,78,CHEMBL1963,Thyrotropin receptor,6.2,6.2,631.0,2,9
230249,CHEMBL1233,CARISOPRODOL,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.1,6.1,794.3,1,9
230444,CHEMBL1234,DEFEROXAMINE MESYLATE,103659,CHEMBL1293226,Lysine-specific demethylase 4E,5.6,5.6,2511.9,1,9
697802,CHEMBL1235452,SULFUR,10193,CHEMBL261,Carbonic anhydrase 1,6.22,6.22,600.0,1,9
230659,CHEMBL1237,LISINOPRIL ANHYDROUS,69,CHEMBL1808,Angiotensin-converting enzyme,10.0,8.6,0.1,14,9
699372,CHEMBL1237021,LURASIDONE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,9.3,8.8,0.5,3,9
699372,CHEMBL1237021,LURASIDONE,72,CHEMBL217,D(2) dopamine receptor,8.77,8.26,1.7,2,9
699372,CHEMBL1237021,LURASIDONE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.7,8.17,2.0,2,9
699372,CHEMBL1237021,LURASIDONE,130,CHEMBL234,D(3) dopamine receptor,8.38,7.38,4.2,2,8
699372,CHEMBL1237021,LURASIDONE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,8.17,7.62,6.7,4,9
699372,CHEMBL1237021,LURASIDONE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.15,7.15,71.0,1,8
699372,CHEMBL1237021,LURASIDONE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.12,7.0,75.4,2,8
699372,CHEMBL1237021,LURASIDONE,88,CHEMBL2056,D(1A) dopamine receptor,6.88,6.2,131.0,2,8
699372,CHEMBL1237021,LURASIDONE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.67,6.25,215.5,3,8
699372,CHEMBL1237021,LURASIDONE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.64,6.64,230.0,1,8
699372,CHEMBL1237021,LURASIDONE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.28,6.28,530.0,1,8
699372,CHEMBL1237021,LURASIDONE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.96,5.96,1100.0,1,8
699372,CHEMBL1237021,LURASIDONE,93,CHEMBL220,Acetylcholinesterase,5.89,5.89,1300.0,1,8
699372,CHEMBL1237021,LURASIDONE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.68,5.68,2100.0,1,8
699395,CHEMBL1237044,TRAMADOL,136,CHEMBL236,Delta-type opioid receptor,8.03,8.03,9.4,1,9
699395,CHEMBL1237044,TRAMADOL,137,CHEMBL237,Kappa-type opioid receptor,7.85,7.85,14.0,1,9
699395,CHEMBL1237044,TRAMADOL,121,CHEMBL228,Sodium-dependent serotonin transporter,6.7,6.17,198.0,4,8
699395,CHEMBL1237044,TRAMADOL,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.1,6.1,790.0,1,9
699395,CHEMBL1237044,TRAMADOL,129,CHEMBL233,Mu-type opioid receptor,5.89,5.8,1300.0,3,9
699395,CHEMBL1237044,TRAMADOL,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.83,5.83,1471.1,1,8
699470,CHEMBL1237119,TREPROSTINIL,12659,CHEMBL4427,Prostaglandin D2 receptor,9.22,9.22,0.6,1,9
699470,CHEMBL1237119,TREPROSTINIL,143,CHEMBL1995,Prostacyclin receptor,8.72,8.72,1.9,1,9
699470,CHEMBL1237119,TREPROSTINIL,142,CHEMBL1881,Prostaglandin E2 receptor EP2 subtype,8.21,8.21,6.2,1,9
699470,CHEMBL1237119,TREPROSTINIL,261,CHEMBL1811,Prostaglandin E2 receptor EP1 subtype,6.54,6.54,285.0,1,9
699486,CHEMBL1237135,MAPROTILINE HYDROCHLORIDE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,7.3,7.3,50.0,1,9
699486,CHEMBL1237135,MAPROTILINE HYDROCHLORIDE,17045,CHEMBL340,Cytochrome P450 3A4,5.9,5.9,1258.93,1,8
699486,CHEMBL1237135,MAPROTILINE HYDROCHLORIDE,10977,CHEMBL2608,Lysosomal alpha-glucosidase,5.6,5.6,2511.9,2,9
230691,CHEMBL1238,AZELAIC ACID,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,8.55,8.55,2.8,2,9
230691,CHEMBL1238,AZELAIC ACID,103668,CHEMBL1293235,Prelamin-A/C,8.3,7.65,5.0,2,9
230999,CHEMBL1240,PROPANTHELINE BROMIDE,103669,CHEMBL1293236,ATP-dependent DNA helicase Q1,6.6,6.6,251.2,1,9
230999,CHEMBL1240,PROPANTHELINE BROMIDE,103668,CHEMBL1293235,Prelamin-A/C,6.2,6.2,631.0,1,9
230999,CHEMBL1240,PROPANTHELINE BROMIDE,103665,CHEMBL1293232,Survival motor neuron protein,6.05,6.05,891.3,1,9
231013,CHEMBL1241,TRIPELENNAMINE,127,CHEMBL231,Histamine H1 receptor,7.4,7.25,39.81,2,8
231013,CHEMBL1241,TRIPELENNAMINE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.68,6.54,209.0,2,8
231013,CHEMBL1241,TRIPELENNAMINE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.21,6.05,618.6,2,8
231013,CHEMBL1241,TRIPELENNAMINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.58,5.58,2615.3,1,8
231013,CHEMBL1241,TRIPELENNAMINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.55,5.55,2800.0,1,8
231013,CHEMBL1241,TRIPELENNAMINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.51,5.51,3083.3,1,8
701175,CHEMBL1241951,LETERMOVIR,125,CHEMBL229,Alpha-1A adrenergic receptor,5.72,5.72,1900.0,1,8
701175,CHEMBL1241951,LETERMOVIR,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.62,5.62,2400.0,1,8
231062,CHEMBL1242,PHENAZOPYRIDINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.72,5.72,1907.9,1,8
231062,CHEMBL1242,PHENAZOPYRIDINE,136,CHEMBL236,Delta-type opioid receptor,5.54,5.54,2900.0,1,8
231062,CHEMBL1242,PHENAZOPYRIDINE,130,CHEMBL234,D(3) dopamine receptor,5.51,5.51,3100.0,1,8
231062,CHEMBL1242,PHENAZOPYRIDINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.5,5.5,3200.0,1,8
237298,CHEMBL1252,ABARELIX,118,CHEMBL1855,Gonadotropin-releasing hormone receptor,9.1,8.78,0.7943,2,8
704148,CHEMBL1254682,LEVALLORPHAN,129,CHEMBL233,Mu-type opioid receptor,9.32,8.88,0.48,4,8
704633,CHEMBL1255654,TETRACAINE HYDROCHLORIDE,103731,CHEMBL1293298,Peripheral myelin protein 22,5.52,5.52,3013.1,1,9
705121,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.8,8.8,1.6,2,9
705121,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.2,6.0,631.0,3,9
705121,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,103657,CHEMBL1293224,Microtubule-associated protein tau,5.55,5.55,2818.4,1,9
705377,CHEMBL1256391,PIRFENIDONE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,7.15,7.15,70.8,2,9
705687,CHEMBL1256696,CARBETAPENTANE CITRATE,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,6.85,6.85,141.3,2,9
705687,CHEMBL1256696,CARBETAPENTANE CITRATE,78,CHEMBL1963,Thyrotropin receptor,6.5,6.5,316.2,1,9
705778,CHEMBL1256786,FORMOTEROL,43,CHEMBL210,Beta-2 adrenergic receptor,9.72,8.7,0.19,24,9
705778,CHEMBL1256786,FORMOTEROL,78,CHEMBL1963,Thyrotropin receptor,8.89,8.89,1.3,2,9
705778,CHEMBL1256786,FORMOTEROL,11638,CHEMBL4040,Mitogen-activated protein kinase 1,8.7,8.7,2.0,1,9
705778,CHEMBL1256786,FORMOTEROL,50,CHEMBL213,Beta-1 adrenergic receptor,7.9,7.05,12.59,9,9
705778,CHEMBL1256786,FORMOTEROL,226,CHEMBL246,Beta-3 adrenergic receptor,7.6,7.6,25.12,4,9
705778,CHEMBL1256786,FORMOTEROL,130,CHEMBL234,D(3) dopamine receptor,5.79,5.79,1626.0,1,9
705778,CHEMBL1256786,FORMOTEROL,11365,CHEMBL289,Cytochrome P450 2D6,5.7,5.7,1995.26,2,9
705811,CHEMBL1256818,DEXTROMETHORPHAN HYDROBROMIDE,103668,CHEMBL1293235,Prelamin-A/C,7.15,7.15,70.8,1,9
705834,CHEMBL1256841,NIALAMIDE,96,CHEMBL221,Prostaglandin G/H synthase 1,5.78,5.78,1654.8,1,8
705835,CHEMBL1256842,NOMIFENSINE MALEATE,103668,CHEMBL1293235,Prelamin-A/C,8.49,8.49,3.2,1,9
705835,CHEMBL1256842,NOMIFENSINE MALEATE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,5.95,5.95,1122.0,1,9
705952,CHEMBL1256958,EPINEPHRINE BITARTRATE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,6.0,6.0,1000.0,2,9
705952,CHEMBL1256958,EPINEPHRINE BITARTRATE,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,5.9,5.9,1258.9,1,9
705952,CHEMBL1256958,EPINEPHRINE BITARTRATE,43,CHEMBL210,Beta-2 adrenergic receptor,5.86,5.86,1380.0,1,8
705952,CHEMBL1256958,EPINEPHRINE BITARTRATE,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,5.75,5.75,1778.3,2,9
705952,CHEMBL1256958,EPINEPHRINE BITARTRATE,103665,CHEMBL1293232,Survival motor neuron protein,5.65,5.65,2238.7,1,9
26280,CHEMBL126,LINEZOLID,104,CHEMBL2039,Amine oxidase [flavin-containing] B,6.21,6.03,619.0,3,9
242303,CHEMBL1262,OXICONAZOLE,12912,CHEMBL3622,Cytochrome P450 2C19,7.4,7.4,40.0,1,8
242303,CHEMBL1262,OXICONAZOLE,17045,CHEMBL340,Cytochrome P450 3A4,7.05,7.05,90.0,1,8
242303,CHEMBL1262,OXICONAZOLE,56,CHEMBL1871,Androgen receptor,6.77,6.77,168.8,1,8
242303,CHEMBL1262,OXICONAZOLE,280,CHEMBL256,Adenosine receptor A3,6.45,6.23,358.6,3,8
242303,CHEMBL1262,OXICONAZOLE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.37,6.01,425.1,3,8
242303,CHEMBL1262,OXICONAZOLE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.22,6.22,605.1,1,8
242303,CHEMBL1262,OXICONAZOLE,248,CHEMBL1835,Thromboxane-A synthase,6.21,6.21,617.4,1,9
242303,CHEMBL1262,OXICONAZOLE,130,CHEMBL234,D(3) dopamine receptor,6.17,5.94,677.1,2,8
242303,CHEMBL1262,OXICONAZOLE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.02,6.02,960.4,1,8
242303,CHEMBL1262,OXICONAZOLE,11365,CHEMBL289,Cytochrome P450 2D6,6.0,6.0,1000.0,1,8
242303,CHEMBL1262,OXICONAZOLE,10184,CHEMBL2327,Substance-K receptor,5.97,5.97,1073.9,1,8
242303,CHEMBL1262,OXICONAZOLE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.94,5.94,1140.7,1,8
242303,CHEMBL1262,OXICONAZOLE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.92,5.92,1189.4,1,8
242303,CHEMBL1262,OXICONAZOLE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.82,5.82,1531.0,1,8
242303,CHEMBL1262,OXICONAZOLE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.78,5.78,1666.3,1,8
242303,CHEMBL1262,OXICONAZOLE,136,CHEMBL236,Delta-type opioid receptor,5.73,5.73,1871.2,1,8
242303,CHEMBL1262,OXICONAZOLE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.72,5.69,1894.5,3,8
242303,CHEMBL1262,OXICONAZOLE,88,CHEMBL2056,D(1A) dopamine receptor,5.68,5.68,2068.0,1,8
242303,CHEMBL1262,OXICONAZOLE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.68,5.61,2109.8,3,8
242303,CHEMBL1262,OXICONAZOLE,36,CHEMBL208,Progesterone receptor,5.53,5.53,2933.6,1,8
242303,CHEMBL1262,OXICONAZOLE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.53,5.53,2931.4,1,8
242303,CHEMBL1262,OXICONAZOLE,12911,CHEMBL3397,Cytochrome P450 2C9,5.52,5.52,3000.0,1,8
242303,CHEMBL1262,OXICONAZOLE,129,CHEMBL233,Mu-type opioid receptor,5.51,5.51,3093.6,1,8
242716,CHEMBL1263,SALMETEROL,43,CHEMBL210,Beta-2 adrenergic receptor,10.35,9.14,0.04467,45,9
242716,CHEMBL1263,SALMETEROL,50,CHEMBL213,Beta-1 adrenergic receptor,7.53,6.28,29.51,23,9
242716,CHEMBL1263,SALMETEROL,117512,CHEMBL4105907,Sigma intracellular receptor 2,7.49,7.49,32.43,1,9
242716,CHEMBL1263,SALMETEROL,155,CHEMBL238,Sodium-dependent dopamine transporter,6.83,6.45,149.42,2,9
242716,CHEMBL1263,SALMETEROL,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,6.59,6.59,256.92,1,9
242716,CHEMBL1263,SALMETEROL,121,CHEMBL228,Sodium-dependent serotonin transporter,6.53,6.42,294.2,2,9
242716,CHEMBL1263,SALMETEROL,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.42,6.42,381.86,1,9
242716,CHEMBL1263,SALMETEROL,125,CHEMBL229,Alpha-1A adrenergic receptor,6.26,5.98,548.66,3,9
242716,CHEMBL1263,SALMETEROL,103,CHEMBL223,Alpha-1D adrenergic receptor,6.02,6.02,963.16,1,9
242716,CHEMBL1263,SALMETEROL,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.01,6.01,971.3,1,9
242716,CHEMBL1263,SALMETEROL,226,CHEMBL246,Beta-3 adrenergic receptor,6.0,5.93,1000.0,7,9
242716,CHEMBL1263,SALMETEROL,105,CHEMBL1983,5-hydroxytryptamine receptor 1D,5.99,5.99,1036.33,1,9
242716,CHEMBL1263,SALMETEROL,130,CHEMBL234,D(3) dopamine receptor,5.98,5.94,1049.0,2,9
242716,CHEMBL1263,SALMETEROL,90,CHEMBL219,D(4) dopamine receptor,5.97,5.97,1076.34,1,9
242716,CHEMBL1263,SALMETEROL,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.89,5.87,1274.77,2,9
242716,CHEMBL1263,SALMETEROL,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.71,5.71,1942.9,1,9
242716,CHEMBL1263,SALMETEROL,106,CHEMBL1898,5-hydroxytryptamine receptor 1B,5.7,5.7,1985.41,1,9
242716,CHEMBL1263,SALMETEROL,116042,CHEMBL3714081,Psychosine receptor,5.61,5.61,2463.2,1,9
242716,CHEMBL1263,SALMETEROL,100138,CHEMBL4843,CX3C chemokine receptor 1,5.5,5.5,3138.6,1,9
244450,CHEMBL1265,ADAPALENE,270,CHEMBL2008,Retinoic acid receptor beta,8.7,8.08,2.0,4,9
244450,CHEMBL1265,ADAPALENE,240,CHEMBL2003,Retinoic acid receptor gamma,8.52,7.7,3.0,4,9
244450,CHEMBL1265,ADAPALENE,57,CHEMBL2055,Retinoic acid receptor alpha,7.66,6.81,22.0,4,9
244450,CHEMBL1265,ADAPALENE,102688,CHEMBL5845,Glycine receptor subunit alpha-1,5.89,5.89,1300.0,1,9
244450,CHEMBL1265,ADAPALENE,103668,CHEMBL1293235,Prelamin-A/C,5.5,5.5,3162.3,1,9
245084,CHEMBL1266,TETRAHYDROZOLINE,125,CHEMBL229,Alpha-1A adrenergic receptor,8.21,8.21,6.1,1,8
245084,CHEMBL1266,TETRAHYDROZOLINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.18,7.18,66.7,1,8
245084,CHEMBL1266,TETRAHYDROZOLINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.72,5.72,1905.0,1,8
709600,CHEMBL1269025,EDOXABAN,194,CHEMBL244,Coagulation factor X,9.25,8.99,0.56,6,9
10813,CHEMBL12713,SERTINDOLE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,9.7,8.66,0.2,4,9
10813,CHEMBL12713,SERTINDOLE,72,CHEMBL217,D(2) dopamine receptor,9.42,8.62,0.38,5,9
10813,CHEMBL12713,SERTINDOLE,127,CHEMBL231,Histamine H1 receptor,9.29,7.76,0.51,2,9
10813,CHEMBL12713,SERTINDOLE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,9.22,8.08,0.6,4,8
10813,CHEMBL12713,SERTINDOLE,130,CHEMBL234,D(3) dopamine receptor,8.59,7.88,2.6,3,8
10813,CHEMBL12713,SERTINDOLE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,8.57,7.92,2.7,15,9
10813,CHEMBL12713,SERTINDOLE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,8.3,8.3,5.0,1,9
10813,CHEMBL12713,SERTINDOLE,90,CHEMBL219,D(4) dopamine receptor,7.96,7.82,11.0,2,8
10813,CHEMBL12713,SERTINDOLE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.92,7.07,12.0,2,8
10813,CHEMBL12713,SERTINDOLE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.77,6.98,17.0,2,8
10813,CHEMBL12713,SERTINDOLE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.48,7.48,33.0,1,8
10813,CHEMBL12713,SERTINDOLE,106,CHEMBL1898,5-hydroxytryptamine receptor 1B,7.25,7.25,56.0,1,8
10813,CHEMBL12713,SERTINDOLE,88,CHEMBL2056,D(1A) dopamine receptor,6.68,6.68,210.0,1,8
10813,CHEMBL12713,SERTINDOLE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.77,5.77,1700.0,1,8
10813,CHEMBL12713,SERTINDOLE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.7,5.7,2000.0,1,8
10813,CHEMBL12713,SERTINDOLE,10198,CHEMBL4306,Potassium voltage-gated channel subfamily A member 5,5.7,5.7,2000.0,1,8
10813,CHEMBL12713,SERTINDOLE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.57,5.57,2700.0,1,8
248669,CHEMBL1272,REPAGLINIDE,164,CHEMBL2071,ATP-binding cassette sub-family C member 8,7.3,7.13,50.0,2,9
248669,CHEMBL1272,REPAGLINIDE,103668,CHEMBL1293235,Prelamin-A/C,6.4,6.4,398.1,1,9
249414,CHEMBL1274,NILUTAMIDE,56,CHEMBL1871,Androgen receptor,8.05,7.36,9.0,4,9
249414,CHEMBL1274,NILUTAMIDE,78,CHEMBL1963,Thyrotropin receptor,6.9,6.9,125.9,1,9
249414,CHEMBL1274,NILUTAMIDE,12912,CHEMBL3622,Cytochrome P450 2C19,6.9,6.75,125.89,4,9
249414,CHEMBL1274,NILUTAMIDE,103668,CHEMBL1293235,Prelamin-A/C,5.75,5.75,1778.3,1,9
249414,CHEMBL1274,NILUTAMIDE,12594,CHEMBL3356,Cytochrome P450 1A2,5.6,5.55,2511.89,2,8
249814,CHEMBL1275,PERGOLIDE MESYLATE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,7.5,7.5,31.6,2,9
209964,CHEMBL127516,BUTAMBEN,12594,CHEMBL3356,Cytochrome P450 1A2,6.5,6.5,316.23,1,8
712273,CHEMBL1276308,MIFEPRISTONE,36,CHEMBL208,Progesterone receptor,10.68,9.2,0.021,59,9
712273,CHEMBL1276308,MIFEPRISTONE,25,CHEMBL2034,Glucocorticoid receptor,10.05,8.61,0.09,76,9
712273,CHEMBL1276308,MIFEPRISTONE,56,CHEMBL1871,Androgen receptor,9.19,8.08,0.65,29,9
712273,CHEMBL1276308,MIFEPRISTONE,48,CHEMBL1994,Mineralocorticoid receptor,6.23,6.15,590.0,6,9
712273,CHEMBL1276308,MIFEPRISTONE,174,CHEMBL242,Estrogen receptor beta,6.09,5.81,812.0,2,9
712273,CHEMBL1276308,MIFEPRISTONE,129,CHEMBL233,Mu-type opioid receptor,6.0,5.8,997.0,2,8
712273,CHEMBL1276308,MIFEPRISTONE,10163,CHEMBL3721,Cytochrome P450 2C8,5.82,5.82,1500.0,2,9
712273,CHEMBL1276308,MIFEPRISTONE,102394,CHEMBL6020,Bile salt export pump,5.7,5.7,2020.0,1,9
712273,CHEMBL1276308,MIFEPRISTONE,280,CHEMBL256,Adenosine receptor A3,5.58,5.58,2649.8,1,8
250297,CHEMBL1278,NARATRIPTAN,105,CHEMBL1983,5-hydroxytryptamine receptor 1D,8.82,8.75,1.5,3,9
250297,CHEMBL1278,NARATRIPTAN,106,CHEMBL1898,5-hydroxytryptamine receptor 1B,8.82,8.65,1.5,2,9
250297,CHEMBL1278,NARATRIPTAN,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.35,7.35,45.0,1,8
250328,CHEMBL1279,FROVATRIPTAN,105,CHEMBL1983,5-hydroxytryptamine receptor 1D,8.36,8.36,4.4,2,9
250328,CHEMBL1279,FROVATRIPTAN,106,CHEMBL1898,5-hydroxytryptamine receptor 1B,8.36,8.18,4.4,2,9
250328,CHEMBL1279,FROVATRIPTAN,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.21,7.21,62.0,1,8
27111,CHEMBL128,SUMATRIPTAN,105,CHEMBL1983,5-hydroxytryptamine receptor 1D,9.3,7.95,0.5,34,9
27111,CHEMBL128,SUMATRIPTAN,106,CHEMBL1898,5-hydroxytryptamine receptor 1B,9.3,7.9,0.5,23,9
27111,CHEMBL128,SUMATRIPTAN,108,CHEMBL225,5-hydroxytryptamine receptor 2C,8.14,8.14,7.3,1,8
27111,CHEMBL128,SUMATRIPTAN,144,CHEMBL1899,5-hydroxytryptamine receptor 3A,8.03,8.03,9.3,1,8
27111,CHEMBL128,SUMATRIPTAN,279,CHEMBL1805,5-hydroxytryptamine receptor 1F,7.59,7.53,25.7,2,8
27111,CHEMBL128,SUMATRIPTAN,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.64,6.38,230.0,14,9
27111,CHEMBL128,SUMATRIPTAN,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.42,6.42,376.0,1,8
27111,CHEMBL128,SUMATRIPTAN,10624,CHEMBL3426,5-hydroxytryptamine receptor 5A,6.3,6.3,501.19,1,8
27111,CHEMBL128,SUMATRIPTAN,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,6.0,6.0,1000.0,1,9
250508,CHEMBL1280,VERAPAMIL HYDROCHLORIDE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.7,6.47,200.0,2,9
250508,CHEMBL1280,VERAPAMIL HYDROCHLORIDE,17045,CHEMBL340,Cytochrome P450 3A4,6.2,5.8,631.0,6,9
250508,CHEMBL1280,VERAPAMIL HYDROCHLORIDE,103665,CHEMBL1293232,Survival motor neuron protein,5.95,5.95,1122.0,1,9
250508,CHEMBL1280,VERAPAMIL HYDROCHLORIDE,103669,CHEMBL1293236,ATP-dependent DNA helicase Q1,5.8,5.8,1584.9,1,9
250908,CHEMBL1282,IMIQUIMOD,101608,CHEMBL5936,Toll-like receptor 7,6.7,5.92,202.0,4,9
250908,CHEMBL1282,IMIQUIMOD,110226,CHEMBL3708265,Oxidized purine nucleoside triphosphate hydrolase,6.19,6.19,646.0,1,9
250908,CHEMBL1282,IMIQUIMOD,103,CHEMBL223,Alpha-1D adrenergic receptor,5.89,5.73,1288.0,2,8
250908,CHEMBL1282,IMIQUIMOD,102,CHEMBL1941,Histamine H2 receptor,5.83,5.83,1481.0,2,8
250908,CHEMBL1282,IMIQUIMOD,252,CHEMBL251,Adenosine receptor A2a,5.53,5.53,2987.0,1,8
11066,CHEMBL12856,INAMRINONE,103668,CHEMBL1293235,Prelamin-A/C,6.5,6.5,316.2,1,9
11066,CHEMBL12856,INAMRINONE,101216,CHEMBL5514,Huntingtin,6.3,6.3,501.2,1,9
11066,CHEMBL12856,INAMRINONE,103659,CHEMBL1293226,Lysine-specific demethylase 4E,5.95,5.95,1122.0,1,9
11066,CHEMBL12856,INAMRINONE,10693,CHEMBL2524,Alpha-galactosidase A,5.9,5.9,1258.9,1,9
11066,CHEMBL12856,INAMRINONE,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,5.9,5.9,1258.9,1,9
11066,CHEMBL12856,INAMRINONE,103657,CHEMBL1293224,Microtubule-associated protein tau,5.85,5.78,1412.5,2,9
11066,CHEMBL12856,INAMRINONE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.64,5.64,2300.0,1,8
11066,CHEMBL12856,INAMRINONE,17045,CHEMBL340,Cytochrome P450 3A4,5.5,5.5,3162.28,3,9
714243,CHEMBL1287853,FEDRATINIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,9.12,7.8,0.75,42,9
714243,CHEMBL1287853,FEDRATINIB,20020,CHEMBL4355,Cyclin-G-associated kinase,9.0,8.43,1.0,3,9
714243,CHEMBL1287853,FEDRATINIB,10051,CHEMBL2468,Death-associated protein kinase 3,8.92,8.92,1.2,1,8
714243,CHEMBL1287853,FEDRATINIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,8.31,7.22,4.9,18,9
714243,CHEMBL1287853,FEDRATINIB,30004,CHEMBL3938,Serine/threonine-protein kinase 16,8.18,7.21,6.6,2,9
714243,CHEMBL1287853,FEDRATINIB,10919,CHEMBL2835,Tyrosine-protein kinase JAK1,7.91,7.27,12.3,11,9
714243,CHEMBL1287853,FEDRATINIB,101448,CHEMBL6123,Serine/threonine-protein kinase DCLK3,7.89,7.89,13.0,1,8
714243,CHEMBL1287853,FEDRATINIB,11150,CHEMBL2558,Death-associated protein kinase 1,7.8,7.8,16.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,7.77,6.69,17.0,14,9
714243,CHEMBL1287853,FEDRATINIB,102799,CHEMBL6191,Mitogen-activated protein kinase kinase kinase 19,7.72,7.72,19.0,1,8
714243,CHEMBL1287853,FEDRATINIB,12694,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,7.68,6.71,21.0,10,9
714243,CHEMBL1287853,FEDRATINIB,10778,CHEMBL3123,Death-associated protein kinase 2,7.54,7.54,29.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30000,CHEMBL3830,AP2-associated protein kinase 1,7.5,7.14,32.0,3,9
714243,CHEMBL1287853,FEDRATINIB,30042,CHEMBL4522,BMP-2-inducible protein kinase,7.5,6.89,32.0,2,9
714243,CHEMBL1287853,FEDRATINIB,101332,CHEMBL5784,NUAK family SNF1-like kinase 1,7.47,7.47,34.0,1,8
714243,CHEMBL1287853,FEDRATINIB,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,7.42,7.42,38.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101433,CHEMBL6082,Serine/threonine-protein kinase SIK1,7.41,7.41,39.0,1,8
714243,CHEMBL1287853,FEDRATINIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,7.4,6.91,40.0,15,8
714243,CHEMBL1287853,FEDRATINIB,11242,CHEMBL2695,Focal adhesion kinase 1,7.38,7.07,42.0,2,9
714243,CHEMBL1287853,FEDRATINIB,197,CHEMBL1913,Platelet-derived growth factor receptor beta,7.35,7.35,45.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30005,CHEMBL3980,Serine/threonine-protein kinase 17B,7.35,7.35,45.0,1,8
714243,CHEMBL1287853,FEDRATINIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,7.34,6.83,46.0,7,8
714243,CHEMBL1287853,FEDRATINIB,101503,CHEMBL5698,NUAK family SNF1-like kinase 2,7.31,7.31,49.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30023,CHEMBL4599,Activated CDC42 kinase 1,7.19,6.52,64.0,2,9
714243,CHEMBL1287853,FEDRATINIB,100949,CHEMBL5332,Mitogen-activated protein kinase 7,7.18,6.53,66.0,2,9
714243,CHEMBL1287853,FEDRATINIB,101398,CHEMBL5969,Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha,7.18,7.18,66.0,1,8
714243,CHEMBL1287853,FEDRATINIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,7.14,7.14,72.0,1,8
714243,CHEMBL1287853,FEDRATINIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,7.13,6.3,74.0,11,9
714243,CHEMBL1287853,FEDRATINIB,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,7.12,7.12,75.0,1,8
714243,CHEMBL1287853,FEDRATINIB,155,CHEMBL238,Sodium-dependent dopamine transporter,7.1,7.1,80.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101191,CHEMBL5435,Serine/threonine-protein kinase ULK2,7.1,7.1,79.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100127,CHEMBL4454,Tyrosine-protein kinase Fgr,7.09,7.09,82.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100856,CHEMBL5408,Serine/threonine-protein kinase TBK1,7.04,6.35,92.0,2,9
714243,CHEMBL1287853,FEDRATINIB,101278,CHEMBL5659,Serine/threonine-protein kinase RIO3,7.04,7.03,91.0,3,9
714243,CHEMBL1287853,FEDRATINIB,30003,CHEMBL3788,Serine/threonine-protein kinase PLK4,7.02,6.37,96.0,2,9
714243,CHEMBL1287853,FEDRATINIB,101504,CHEMBL5699,Serine/threonine-protein kinase SIK2,7.01,6.5,98.0,2,9
714243,CHEMBL1287853,FEDRATINIB,100925,CHEMBL5358,eIF-2-alpha kinase GCN2,7.0,7.0,100.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101404,CHEMBL5975,Serine/threonine-protein kinase RIO1,7.0,7.0,100.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101496,CHEMBL5668,SRSF protein kinase 2,7.0,7.0,100.0,1,8
714243,CHEMBL1287853,FEDRATINIB,12780,CHEMBL4070,Casein kinase II subunit alpha',6.92,6.25,120.0,2,9
714243,CHEMBL1287853,FEDRATINIB,12829,CHEMBL3055,Cyclin-dependent kinase 7,6.92,6.92,120.0,1,8
714243,CHEMBL1287853,FEDRATINIB,18033,CHEMBL2073,Tyrosine-protein kinase Yes,6.92,6.92,120.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30038,CHEMBL4309,Serine/threonine-protein kinase Nek6,6.92,6.92,120.0,2,9
714243,CHEMBL1287853,FEDRATINIB,101055,CHEMBL5081,Interleukin-1 receptor-associated kinase 3,6.92,6.38,120.0,2,9
714243,CHEMBL1287853,FEDRATINIB,101182,CHEMBL5426,Myosin light chain kinase family member 4,6.89,6.89,130.0,1,8
714243,CHEMBL1287853,FEDRATINIB,103454,CHEMBL1163125,Bromodomain-containing protein 4,6.89,6.47,130.0,5,9
714243,CHEMBL1287853,FEDRATINIB,10782,CHEMBL3125,Ribosomal protein S6 kinase alpha-4,6.85,6.85,140.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101239,CHEMBL5579,Citron Rho-interacting kinase,6.85,6.85,140.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30030,CHEMBL5257,Serine/threonine-protein kinase Nek9,6.82,6.48,150.0,3,9
714243,CHEMBL1287853,FEDRATINIB,101598,CHEMBL5903,Activin receptor type-1,6.82,6.35,150.0,2,9
714243,CHEMBL1287853,FEDRATINIB,100410,CHEMBL4895,Tyrosine-protein kinase receptor UFO,6.8,6.8,160.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100789,CHEMBL4375,SRSF protein kinase 1,6.8,6.8,160.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100836,CHEMBL4849,Serine/threonine-protein kinase Nek7,6.8,6.8,160.0,2,9
714243,CHEMBL1287853,FEDRATINIB,101495,CHEMBL5667,Phosphatidylinositol 5-phosphate 4-kinase type-2 beta,6.8,6.8,160.0,1,8
714243,CHEMBL1287853,FEDRATINIB,104265,CHEMBL1795185,Bromodomain testis-specific protein,6.79,6.6,164.0,3,9
714243,CHEMBL1287853,FEDRATINIB,100975,CHEMBL5415,SRSF protein kinase 3,6.77,6.77,170.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101584,CHEMBL5861,G protein-coupled receptor kinase 4,6.77,6.77,170.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101281,CHEMBL5683,Serine/threonine-protein kinase DCLK1,6.72,6.72,190.0,1,8
714243,CHEMBL1287853,FEDRATINIB,11408,CHEMBL2637,Mitogen-activated protein kinase 10,6.7,6.7,200.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,6.7,6.7,200.0,1,8
714243,CHEMBL1287853,FEDRATINIB,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",6.66,6.66,220.0,1,8
714243,CHEMBL1287853,FEDRATINIB,19623,CHEMBL3357,Interleukin-1 receptor-associated kinase 1,6.66,6.66,220.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100995,CHEMBL5469,Protein-tyrosine kinase 2-beta,6.66,6.66,220.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101410,CHEMBL6005,Serine/threonine-protein kinase 33,6.66,6.66,220.0,1,8
714243,CHEMBL1287853,FEDRATINIB,103106,CHEMBL1075167,Homeodomain-interacting protein kinase 4,6.66,6.66,220.0,1,8
714243,CHEMBL1287853,FEDRATINIB,104315,CHEMBL1908384,SNF-related serine/threonine-protein kinase,6.64,6.64,230.0,1,8
714243,CHEMBL1287853,FEDRATINIB,117490,CHEMBL4105885,AarF domain-containing protein kinase 1,6.64,6.64,231.0,1,9
714243,CHEMBL1287853,FEDRATINIB,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.62,6.62,240.0,1,8
714243,CHEMBL1287853,FEDRATINIB,11407,CHEMBL4179,Mitogen-activated protein kinase 9,6.62,6.21,240.0,2,9
714243,CHEMBL1287853,FEDRATINIB,12261,CHEMBL2276,Mitogen-activated protein kinase 8,6.58,6.12,260.0,2,9
714243,CHEMBL1287853,FEDRATINIB,101411,CHEMBL6006,Serine/threonine-protein kinase ULK1,6.57,6.57,270.0,1,8
714243,CHEMBL1287853,FEDRATINIB,117538,CHEMBL4105933,Uncharacterized protein FLJ45252,6.56,6.56,277.0,1,9
714243,CHEMBL1287853,FEDRATINIB,10266,CHEMBL3650,Fibroblast growth factor receptor 1,6.55,6.55,280.0,1,8
714243,CHEMBL1287853,FEDRATINIB,10907,CHEMBL3024,Serine/threonine-protein kinase PLK1,6.55,6.55,280.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101048,CHEMBL5047,Serine/threonine-protein kinase ULK3,6.54,6.54,290.0,1,8
714243,CHEMBL1287853,FEDRATINIB,12415,CHEMBL4147,Calcium/calmodulin-dependent protein kinase type II subunit alpha,6.52,6.52,300.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100140,CHEMBL5600,MAP/microtubule affinity-regulating kinase 3,6.52,6.52,300.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101316,CHEMBL5753,"Atypical kinase COQ8B, mitochondrial",6.52,6.52,300.0,1,8
714243,CHEMBL1287853,FEDRATINIB,102676,CHEMBL5836,Ephrin type-B receptor 6,6.52,6.52,300.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101032,CHEMBL5606,Serine/threonine-protein kinase STK11,6.51,6.51,310.0,1,8
714243,CHEMBL1287853,FEDRATINIB,11361,CHEMBL4004,"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",6.48,6.48,330.0,1,8
714243,CHEMBL1287853,FEDRATINIB,20171,CHEMBL3935,Aurora kinase C,6.46,6.46,350.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101553,CHEMBL5790,Cyclin-dependent kinase 17,6.46,6.46,350.0,1,8
714243,CHEMBL1287853,FEDRATINIB,10371,CHEMBL4948,Dual specificity mitogen-activated protein kinase kinase 5,6.44,6.44,360.0,1,8
714243,CHEMBL1287853,FEDRATINIB,10752,CHEMBL1991,Inhibitor of nuclear factor kappa-B kinase subunit beta,6.44,6.44,360.0,1,8
714243,CHEMBL1287853,FEDRATINIB,10939,CHEMBL4924,Ribosomal protein S6 kinase alpha-6,6.44,6.44,360.0,1,8
714243,CHEMBL1287853,FEDRATINIB,11926,CHEMBL2742,Fibroblast growth factor receptor 3,6.44,6.28,360.0,2,8
714243,CHEMBL1287853,FEDRATINIB,12915,CHEMBL3529,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,6.44,6.04,360.0,2,9
714243,CHEMBL1287853,FEDRATINIB,100951,CHEMBL5334,Non-receptor tyrosine-protein kinase TNK1,6.44,6.44,360.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30037,CHEMBL4204,MAP kinase-interacting serine/threonine-protein kinase 2,6.42,6.42,380.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100098,CHEMBL5491,Wee1-like protein kinase,6.41,6.06,390.0,2,9
714243,CHEMBL1287853,FEDRATINIB,104313,CHEMBL1908382,Serine/threonine-protein kinase PRP4 homolog,6.41,6.41,390.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101204,CHEMBL5476,Bone morphogenetic protein receptor type-1B,6.39,6.39,410.0,1,8
714243,CHEMBL1287853,FEDRATINIB,10929,CHEMBL2553,Ribosomal protein S6 kinase alpha-1,6.38,6.15,420.0,2,8
714243,CHEMBL1287853,FEDRATINIB,30011,CHEMBL3983,Dual specificity protein kinase TTK,6.35,6.35,450.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30028,CHEMBL5073,Calcium/calmodulin-dependent protein kinase type 1D,6.34,6.34,460.0,1,8
714243,CHEMBL1287853,FEDRATINIB,10264,CHEMBL4142,Fibroblast growth factor receptor 2,6.33,6.33,470.0,1,8
714243,CHEMBL1287853,FEDRATINIB,10781,CHEMBL2185,Aurora kinase B,6.31,5.97,490.0,2,9
714243,CHEMBL1287853,FEDRATINIB,10918,CHEMBL2959,Tyrosine-protein kinase ITK/TSK,6.31,6.31,490.0,1,8
714243,CHEMBL1287853,FEDRATINIB,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,6.3,6.3,500.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100833,CHEMBL5198,Mitogen-activated protein kinase 15,6.29,6.29,510.0,1,8
714243,CHEMBL1287853,FEDRATINIB,10250,CHEMBL2428,"Myosin light chain kinase, smooth muscle",6.28,6.28,520.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100069,CHEMBL5455,Tyrosine-protein kinase Fes/Fps,6.28,6.28,530.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30002,CHEMBL3829,Calcium/calmodulin-dependent protein kinase type II subunit gamma,6.27,6.27,540.0,1,8
714243,CHEMBL1287853,FEDRATINIB,9,CHEMBL203,Epidermal growth factor receptor,6.24,6.1,570.0,3,8
714243,CHEMBL1287853,FEDRATINIB,11209,CHEMBL4014,Tyrosine-protein kinase ABL2,6.24,6.24,570.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101045,CHEMBL5044,Serine/threonine-protein kinase Nek5,6.24,6.24,570.0,2,9
714243,CHEMBL1287853,FEDRATINIB,102711,CHEMBL5914,Mitogen-activated protein kinase kinase kinase 2,6.24,6.24,580.0,1,8
714243,CHEMBL1287853,FEDRATINIB,11622,CHEMBL2801,Calcium/calmodulin-dependent protein kinase type II subunit delta,6.23,6.23,590.0,1,8
714243,CHEMBL1287853,FEDRATINIB,103453,CHEMBL1163124,Mitogen-activated protein kinase kinase kinase 13,6.23,6.23,590.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101019,CHEMBL5568,Proto-oncogene tyrosine-protein kinase ROS,6.22,6.22,600.0,1,8
714243,CHEMBL1287853,FEDRATINIB,12840,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,6.21,6.21,620.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30045,CHEMBL4525,Serine/threonine-protein kinase 17A,6.21,6.21,610.0,1,8
714243,CHEMBL1287853,FEDRATINIB,11691,CHEMBL2250,Tyrosine-protein kinase Blk,6.19,6.19,650.0,1,8
714243,CHEMBL1287853,FEDRATINIB,20007,CHEMBL3886,Mitogen-activated protein kinase kinase kinase 20,6.19,6.19,650.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100417,CHEMBL4247,ALK tyrosine kinase receptor,6.19,6.19,650.0,1,8
714243,CHEMBL1287853,FEDRATINIB,102421,CHEMBL5679,Serine/threonine-protein kinase Nek3,6.19,6.19,640.0,2,9
714243,CHEMBL1287853,FEDRATINIB,30035,CHEMBL4202,STE20-like serine/threonine-protein kinase,6.17,6.17,680.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100906,CHEMBL5274,Tyrosine-protein kinase receptor Tie-1,6.16,6.16,700.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101612,CHEMBL5940,Serine/threonine-protein kinase MARK1,6.16,6.16,700.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101340,CHEMBL5810,Ephrin type-A receptor 1,6.14,6.14,730.0,1,8
714243,CHEMBL1287853,FEDRATINIB,121,CHEMBL228,Sodium-dependent serotonin transporter,6.13,6.13,732.0,1,8
714243,CHEMBL1287853,FEDRATINIB,103140,CHEMBL1075195,Serine/threonine-protein kinase TAO2,6.12,6.12,760.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101282,CHEMBL5684,"Muscle, skeletal receptor tyrosine-protein kinase",6.1,6.1,800.0,1,8
714243,CHEMBL1287853,FEDRATINIB,103458,CHEMBL1163129,Serine/threonine-protein kinase SBK1,6.1,6.1,790.0,1,8
714243,CHEMBL1287853,FEDRATINIB,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.09,6.09,820.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100948,CHEMBL5331,Tyrosine-protein kinase Mer,6.09,6.09,820.0,1,8
714243,CHEMBL1287853,FEDRATINIB,10751,CHEMBL3476,Inhibitor of nuclear factor kappa-B kinase subunit alpha,6.08,6.08,830.0,1,8
714243,CHEMBL1287853,FEDRATINIB,11902,CHEMBL2815,High affinity nerve growth factor receptor,6.08,6.08,840.0,1,8
714243,CHEMBL1287853,FEDRATINIB,35,CHEMBL1981,Insulin receptor,6.07,6.07,850.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100097,CHEMBL5251,Tyrosine-protein kinase BTK,6.07,6.07,850.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101183,CHEMBL5427,Homeodomain-interacting protein kinase 1,6.07,6.07,860.0,1,8
714243,CHEMBL1287853,FEDRATINIB,12946,CHEMBL331,Cyclin-dependent kinase 4,6.06,6.06,870.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30041,CHEMBL4312,Serine/threonine-protein kinase 36,6.06,6.06,870.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101221,CHEMBL5519,Serine/threonine-protein kinase DCLK2,6.06,6.06,870.0,1,8
714243,CHEMBL1287853,FEDRATINIB,103154,CHEMBL1075104,Leucine-rich repeat serine/threonine-protein kinase 2,6.06,6.03,870.0,2,8
714243,CHEMBL1287853,FEDRATINIB,10044,CHEMBL3629,Casein kinase II subunit alpha,6.04,6.04,920.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30018,CHEMBL3836,LIM domain kinase 1,6.03,6.03,940.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101079,CHEMBL5122,Discoidin domain-containing receptor 2,6.02,6.02,950.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101317,CHEMBL5754,MAP/microtubule affinity-regulating kinase 4,6.01,6.01,970.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100852,CHEMBL4576,Homeodomain-interacting protein kinase 2,6.0,6.0,1000.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100918,CHEMBL5320,Myotonin-protein kinase,6.0,6.0,1000.0,1,8
714243,CHEMBL1287853,FEDRATINIB,102667,CHEMBL6029,Eukaryotic translation initiation factor 2-alpha kinase 1,6.0,6.0,1000.0,1,8
714243,CHEMBL1287853,FEDRATINIB,11637,CHEMBL3384,Serine/threonine-protein kinase N1,5.96,5.96,1100.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30007,CHEMBL3982,Tyrosine-protein kinase Fer,5.96,5.96,1100.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100075,CHEMBL4267,TGF-beta receptor type-2,5.96,5.96,1100.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101333,CHEMBL5785,"Interferon-induced, double-stranded RNA-activated protein kinase",5.96,5.96,1100.0,1,8
714243,CHEMBL1287853,FEDRATINIB,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.92,5.92,1200.0,1,8
714243,CHEMBL1287853,FEDRATINIB,19639,CHEMBL3778,Interleukin-1 receptor-associated kinase 4,5.92,5.92,1200.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30016,CHEMBL3834,Cytoplasmic tyrosine-protein kinase BMX,5.92,5.92,1200.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30026,CHEMBL4601,Protein-tyrosine kinase 6,5.92,5.92,1200.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30044,CHEMBL4524,Serine/threonine-protein kinase PAK 5,5.92,5.92,1200.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101078,CHEMBL5121,Mitogen-activated protein kinase 6,5.92,5.92,1200.0,1,8
714243,CHEMBL1287853,FEDRATINIB,102473,CHEMBL5638,Serine/threonine-protein kinase Nek11,5.92,5.92,1200.0,2,9
714243,CHEMBL1287853,FEDRATINIB,103430,CHEMBL1163101,Serine/threonine-protein kinase/endoribonuclease IRE1,5.92,5.92,1200.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100853,CHEMBL4577,Homeodomain-interacting protein kinase 3,5.89,5.89,1300.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100969,CHEMBL5388,Serine/threonine-protein kinase tousled-like 1,5.89,5.89,1300.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101131,CHEMBL5261,Serine/threonine-protein kinase TAO1,5.89,5.89,1300.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101309,CHEMBL5728,Cyclin-dependent kinase-like 2,5.89,5.89,1300.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101312,CHEMBL5749,Mitogen-activated protein kinase kinase kinase kinase 1,5.89,5.89,1300.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101399,CHEMBL5970,Mitogen-activated protein kinase kinase kinase 3,5.89,5.89,1300.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101408,CHEMBL6003,Testis-specific serine/threonine-protein kinase 1,5.89,5.89,1300.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100424,CHEMBL4367,Tyrosine-protein kinase TXK,5.82,5.82,1500.0,1,8
714243,CHEMBL1287853,FEDRATINIB,10970,CHEMBL2493,Calcium/calmodulin-dependent protein kinase type 1,5.8,5.8,1600.0,1,8
714243,CHEMBL1287853,FEDRATINIB,11018,CHEMBL2896,cGMP-dependent protein kinase 2,5.8,5.8,1600.0,1,8
714243,CHEMBL1287853,FEDRATINIB,12735,CHEMBL2349,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",5.8,5.8,1600.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100412,CHEMBL4897,Serine/threonine-protein kinase PLK3,5.8,5.8,1600.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101211,CHEMBL5483,Insulin receptor-related protein,5.8,5.8,1600.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101349,CHEMBL5819,Serine/threonine-protein kinase Nek4,5.8,5.8,1600.0,2,9
714243,CHEMBL1287853,FEDRATINIB,103437,CHEMBL1163108,STE20/SPS1-related proline-alanine-rich protein kinase,5.8,5.8,1600.0,1,8
714243,CHEMBL1287853,FEDRATINIB,11868,CHEMBL4175,Megakaryocyte-associated tyrosine-protein kinase,5.77,5.77,1700.0,1,8
714243,CHEMBL1287853,FEDRATINIB,11941,CHEMBL3268,Phosphatidylinositol 4-kinase beta,5.77,5.77,1700.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30017,CHEMBL3835,Serine/threonine-protein kinase Nek2,5.77,5.77,1700.0,2,9
714243,CHEMBL1287853,FEDRATINIB,30020,CHEMBL5072,Ephrin type-B receptor 1,5.77,5.77,1700.0,1,8
714243,CHEMBL1287853,FEDRATINIB,104317,CHEMBL1908386,Dual serine/threonine and tyrosine protein kinase,5.77,5.77,1700.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100128,CHEMBL5146,Breakpoint cluster region protein,5.76,5.76,1727.0,1,9
714243,CHEMBL1287853,FEDRATINIB,30029,CHEMBL5256,Calcium/calmodulin-dependent protein kinase kinase 1,5.75,5.75,1800.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101130,CHEMBL5260,Serine/threonine-protein kinase TNNI3K,5.75,5.75,1800.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101188,CHEMBL5432,Mitogen-activated protein kinase kinase kinase kinase 3,5.75,5.75,1800.0,1,8
714243,CHEMBL1287853,FEDRATINIB,12913,CHEMBL4128,Angiopoietin-1 receptor,5.72,5.72,1900.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100917,CHEMBL5319,Epithelial discoidin domain-containing receptor 1,5.72,5.72,1900.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101506,CHEMBL5701,Serine/threonine-protein kinase TAO3,5.72,5.72,1900.0,1,8
714243,CHEMBL1287853,FEDRATINIB,102770,CHEMBL6149,Serine/threonine-protein kinase SIK3,5.72,5.72,1900.0,1,8
714243,CHEMBL1287853,FEDRATINIB,103455,CHEMBL1163126,Serine/threonine-protein kinase ICK,5.72,5.72,1900.0,1,8
714243,CHEMBL1287853,FEDRATINIB,11752,CHEMBL1955,Vascular endothelial growth factor receptor 3,5.7,5.7,2000.0,1,8
714243,CHEMBL1287853,FEDRATINIB,11925,CHEMBL3973,Fibroblast growth factor receptor 4,5.7,5.7,2000.0,1,8
714243,CHEMBL1287853,FEDRATINIB,12699,CHEMBL3009,Receptor tyrosine-protein kinase erbB-4,5.7,5.7,2000.0,1,8
714243,CHEMBL1287853,FEDRATINIB,12944,CHEMBL4501,Ribosomal protein S6 kinase beta-1,5.7,5.7,2000.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30036,CHEMBL4203,Dual specificity protein kinase CLK4,5.7,5.7,2000.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101179,CHEMBL5404,Serine/threonine-protein kinase tousled-like 2,5.7,5.7,2000.0,1,8
714243,CHEMBL1287853,FEDRATINIB,10811,CHEMBL3231,Rho-associated protein kinase 1,5.68,5.68,2100.0,1,8
714243,CHEMBL1287853,FEDRATINIB,11785,CHEMBL3234,Tyrosine-protein kinase HCK,5.68,5.68,2100.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100129,CHEMBL5147,Ephrin type-B receptor 4,5.68,5.68,2100.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100947,CHEMBL5330,Mitogen-activated protein kinase kinase kinase kinase 2,5.68,5.68,2100.0,1,8
714243,CHEMBL1287853,FEDRATINIB,234,CHEMBL1957,Insulin-like growth factor 1 receptor,5.66,5.66,2200.0,1,8
714243,CHEMBL1287853,FEDRATINIB,10850,CHEMBL4237,Ribosomal protein S6 kinase alpha-5,5.66,5.66,2200.0,1,8
714243,CHEMBL1287853,FEDRATINIB,11149,CHEMBL2973,Rho-associated protein kinase 2,5.66,5.66,2200.0,1,8
714243,CHEMBL1287853,FEDRATINIB,11843,CHEMBL3906,Ribosomal protein S6 kinase alpha-2,5.64,5.64,2300.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30014,CHEMBL4225,Dual specificity protein kinase CLK2,5.64,5.64,2300.0,1,8
714243,CHEMBL1287853,FEDRATINIB,11364,CHEMBL4045,5'-AMP-activated protein kinase catalytic subunit alpha-1,5.62,5.62,2400.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100909,CHEMBL5311,Activin receptor type-1-like,5.62,5.62,2400.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101610,CHEMBL5938,Serine/threonine-protein kinase PLK2,5.62,5.62,2400.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30013,CHEMBL4224,Dual specificity protein kinase CLK1,5.6,5.6,2500.0,1,8
714243,CHEMBL1287853,FEDRATINIB,102465,CHEMBL6186,Serine/threonine-protein kinase Sgk3,5.6,5.6,2500.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100854,CHEMBL4578,Maternal embryonic leucine zipper kinase,5.58,5.58,2600.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101405,CHEMBL6000,Serine/threonine-protein kinase RIO2,5.58,5.58,2600.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101460,CHEMBL6162,Cyclin-dependent kinase 14,5.58,5.58,2600.0,1,8
714243,CHEMBL1287853,FEDRATINIB,103062,CHEMBL1075133,Rhodopsin kinase GRK7,5.58,5.58,2600.0,1,8
714243,CHEMBL1287853,FEDRATINIB,10906,CHEMBL2599,Tyrosine-protein kinase SYK,5.57,5.57,2700.0,1,8
714243,CHEMBL1287853,FEDRATINIB,12627,CHEMBL2007,Platelet-derived growth factor receptor alpha,5.57,5.57,2700.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100914,CHEMBL5316,Cyclin-dependent kinase 18,5.57,5.57,2700.0,1,8
714243,CHEMBL1287853,FEDRATINIB,104312,CHEMBL1908381,Peripheral plasma membrane protein CASK,5.55,5.55,2800.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30006,CHEMBL3981,Serine/threonine-protein kinase 10,5.54,5.54,2900.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100993,CHEMBL5467,Bone morphogenetic protein receptor type-2,5.54,5.54,2900.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101073,CHEMBL5116,Uncharacterized serine/threonine-protein kinase SBK3,5.54,5.54,2900.0,1,8
714243,CHEMBL1287853,FEDRATINIB,12037,CHEMBL2777,"Myosin light chain kinase 2, skeletal/cardiac muscle",5.52,5.52,3000.0,1,8
714243,CHEMBL1287853,FEDRATINIB,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.51,5.51,3118.5,1,8
714243,CHEMBL1287853,FEDRATINIB,11046,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,5.51,5.51,3100.0,1,8
714243,CHEMBL1287853,FEDRATINIB,11870,CHEMBL2708,Mitogen-activated protein kinase kinase kinase 11,5.51,5.51,3100.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30001,CHEMBL3831,Serine/threonine-protein kinase MARK2,5.51,5.51,3100.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30022,CHEMBL4597,Cyclin-dependent kinase 16,5.51,5.51,3100.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30025,CHEMBL4600,Serine/threonine-protein kinase PAK 1,5.51,5.51,3100.0,1,8
714243,CHEMBL1287853,FEDRATINIB,100413,CHEMBL4898,BDNF/NT-3 growth factors receptor,5.51,5.51,3100.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101324,CHEMBL5776,Mitogen-activated protein kinase kinase kinase 7,5.51,5.51,3100.0,1,8
714243,CHEMBL1287853,FEDRATINIB,12038,CHEMBL2872,Mitogen-activated protein kinase kinase kinase 9,5.5,5.5,3200.0,1,8
714243,CHEMBL1287853,FEDRATINIB,30031,CHEMBL5258,Calcium/calmodulin-dependent protein kinase type 1G,5.5,5.5,3200.0,1,8
714243,CHEMBL1287853,FEDRATINIB,101030,CHEMBL5604,Dual specificity testis-specific protein kinase 1,5.5,5.5,3200.0,1,8
253862,CHEMBL1289,HALOPROGIN,280,CHEMBL256,Adenosine receptor A3,6.9,6.52,126.0,3,8
253862,CHEMBL1289,HALOPROGIN,130,CHEMBL234,D(3) dopamine receptor,6.78,6.34,166.0,3,8
253862,CHEMBL1289,HALOPROGIN,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.6,6.43,251.0,2,8
253862,CHEMBL1289,HALOPROGIN,88,CHEMBL2056,D(1A) dopamine receptor,6.55,6.13,282.0,3,8
253862,CHEMBL1289,HALOPROGIN,121,CHEMBL228,Sodium-dependent serotonin transporter,6.37,6.23,431.0,2,8
253862,CHEMBL1289,HALOPROGIN,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.34,6.13,458.0,2,8
253862,CHEMBL1289,HALOPROGIN,137,CHEMBL237,Kappa-type opioid receptor,6.34,6.14,459.0,2,8
253862,CHEMBL1289,HALOPROGIN,10184,CHEMBL2327,Substance-K receptor,6.31,6.07,491.0,2,8
253862,CHEMBL1289,HALOPROGIN,102684,CHEMBL5843,UDP-glucose 4-epimerase,6.3,6.3,500.0,1,9
253862,CHEMBL1289,HALOPROGIN,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.23,6.23,588.0,1,8
253862,CHEMBL1289,HALOPROGIN,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.16,5.89,692.0,2,8
253862,CHEMBL1289,HALOPROGIN,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.87,5.72,1363.0,2,8
253862,CHEMBL1289,HALOPROGIN,155,CHEMBL238,Sodium-dependent dopamine transporter,5.8,5.75,1565.0,2,8
253862,CHEMBL1289,HALOPROGIN,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,5.73,5.73,1862.0,1,8
253862,CHEMBL1289,HALOPROGIN,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.56,5.56,2747.0,2,8
715901,CHEMBL1289494,TIVOZANIB,11639,CHEMBL3385,Mitogen-activated protein kinase 3,9.89,9.89,0.13,1,9
715901,CHEMBL1289494,TIVOZANIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,9.8,8.67,0.16,8,9
715901,CHEMBL1289494,TIVOZANIB,11638,CHEMBL4040,Mitogen-activated protein kinase 1,9.74,9.74,0.18,1,9
715901,CHEMBL1289494,TIVOZANIB,10979,CHEMBL1868,Vascular endothelial growth factor receptor 1,9.68,8.47,0.21,3,9
715901,CHEMBL1289494,TIVOZANIB,11752,CHEMBL1955,Vascular endothelial growth factor receptor 3,9.62,8.89,0.24,4,9
715901,CHEMBL1289494,TIVOZANIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,8.79,7.95,1.63,2,9
715901,CHEMBL1289494,TIVOZANIB,197,CHEMBL1913,Platelet-derived growth factor receptor beta,8.76,7.23,1.72,3,9
715901,CHEMBL1289494,TIVOZANIB,12627,CHEMBL2007,Platelet-derived growth factor receptor alpha,8.65,8.03,2.26,2,9
715901,CHEMBL1289494,TIVOZANIB,117461,CHEMBL4105856,Phosphatidylethanolamine-binding protein 1,8.52,8.52,3.0,1,9
715901,CHEMBL1289494,TIVOZANIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,7.92,7.92,12.0,1,9
715901,CHEMBL1289494,TIVOZANIB,11569,CHEMBL3290,Ephrin type-B receptor 2,7.76,7.24,17.5,3,9
715901,CHEMBL1289494,TIVOZANIB,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,7.16,7.16,70.0,1,9
715901,CHEMBL1289494,TIVOZANIB,12913,CHEMBL4128,Angiopoietin-1 receptor,7.11,7.11,78.0,1,9
715901,CHEMBL1289494,TIVOZANIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,6.84,6.84,145.0,1,9
715901,CHEMBL1289494,TIVOZANIB,30008,CHEMBL2068,Ephrin type-A receptor 2,6.83,6.83,147.0,1,9
715901,CHEMBL1289494,TIVOZANIB,100128,CHEMBL5146,Breakpoint cluster region protein,6.8,6.8,160.0,1,9
715901,CHEMBL1289494,TIVOZANIB,100917,CHEMBL5319,Epithelial discoidin domain-containing receptor 1,6.72,6.72,190.0,1,9
715901,CHEMBL1289494,TIVOZANIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,6.71,6.46,195.0,2,9
715901,CHEMBL1289494,TIVOZANIB,10266,CHEMBL3650,Fibroblast growth factor receptor 1,6.52,6.4,299.0,2,9
715901,CHEMBL1289494,TIVOZANIB,11209,CHEMBL4014,Tyrosine-protein kinase ABL2,6.52,6.52,302.0,1,9
715901,CHEMBL1289494,TIVOZANIB,100129,CHEMBL5147,Ephrin type-B receptor 4,6.51,6.42,310.0,2,9
715901,CHEMBL1289494,TIVOZANIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,6.38,6.38,422.0,1,9
715901,CHEMBL1289494,TIVOZANIB,11451,CHEMBL3717,Hepatocyte growth factor receptor,6.26,6.06,550.0,2,9
715901,CHEMBL1289494,TIVOZANIB,101079,CHEMBL5122,Discoidin domain-containing receptor 2,6.23,6.23,592.0,1,9
715901,CHEMBL1289494,TIVOZANIB,30019,CHEMBL3987,Ephrin type-A receptor 5,6.22,6.22,601.0,1,9
715901,CHEMBL1289494,TIVOZANIB,20025,CHEMBL5014,Receptor-interacting serine/threonine-protein kinase 2,6.1,6.1,801.0,1,9
715901,CHEMBL1289494,TIVOZANIB,30026,CHEMBL4601,Protein-tyrosine kinase 6,6.1,6.1,787.0,1,9
715901,CHEMBL1289494,TIVOZANIB,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,6.02,6.02,960.0,1,9
715901,CHEMBL1289494,TIVOZANIB,104279,CHEMBL1795199,Receptor-interacting serine/threonine-protein kinase 3,5.87,5.87,1346.0,1,9
715901,CHEMBL1289494,TIVOZANIB,10781,CHEMBL2185,Aurora kinase B,5.81,5.81,1562.0,1,9
715901,CHEMBL1289494,TIVOZANIB,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,5.7,5.7,2019.0,1,9
715901,CHEMBL1289494,TIVOZANIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,5.66,5.66,2183.0,1,9
715901,CHEMBL1289494,TIVOZANIB,100947,CHEMBL5330,Mitogen-activated protein kinase kinase kinase kinase 2,5.62,5.62,2375.0,1,9
715901,CHEMBL1289494,TIVOZANIB,155,CHEMBL238,Sodium-dependent dopamine transporter,5.58,5.58,2600.0,1,8
716009,CHEMBL1289601,LENVATINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,9.15,8.52,0.7,10,9
716009,CHEMBL1289601,LENVATINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,8.82,8.29,1.5,4,9
716009,CHEMBL1289601,LENVATINIB,11925,CHEMBL3973,Fibroblast growth factor receptor 4,8.72,7.62,1.9,2,9
716009,CHEMBL1289601,LENVATINIB,11752,CHEMBL1955,Vascular endothelial growth factor receptor 3,8.28,8.28,5.2,4,9
716009,CHEMBL1289601,LENVATINIB,10264,CHEMBL4142,Fibroblast growth factor receptor 2,7.96,7.96,11.0,1,9
716009,CHEMBL1289601,LENVATINIB,20025,CHEMBL5014,Receptor-interacting serine/threonine-protein kinase 2,7.96,7.96,11.0,1,9
716009,CHEMBL1289601,LENVATINIB,10979,CHEMBL1868,Vascular endothelial growth factor receptor 1,7.66,7.66,22.0,3,9
716009,CHEMBL1289601,LENVATINIB,197,CHEMBL1913,Platelet-derived growth factor receptor beta,7.41,6.96,39.0,2,9
716009,CHEMBL1289601,LENVATINIB,100917,CHEMBL5319,Epithelial discoidin domain-containing receptor 1,7.34,7.34,46.0,1,9
716009,CHEMBL1289601,LENVATINIB,12627,CHEMBL2007,Platelet-derived growth factor receptor alpha,7.29,7.29,51.0,1,9
716009,CHEMBL1289601,LENVATINIB,11082,CHEMBL2208,MAP kinase-activated protein kinase 2,7.2,7.2,63.0,1,9
716009,CHEMBL1289601,LENVATINIB,10266,CHEMBL3650,Fibroblast growth factor receptor 1,7.18,7.18,66.0,1,9
716009,CHEMBL1289601,LENVATINIB,11042,CHEMBL4789,"Carbonic anhydrase 5A, mitochondrial",6.88,6.88,132.7,1,9
716009,CHEMBL1289601,LENVATINIB,30026,CHEMBL4601,Protein-tyrosine kinase 6,6.76,6.76,173.0,1,9
716009,CHEMBL1289601,LENVATINIB,10188,CHEMBL260,Mitogen-activated protein kinase 14,6.66,6.66,217.0,1,9
716009,CHEMBL1289601,LENVATINIB,101079,CHEMBL5122,Discoidin domain-containing receptor 2,6.66,6.66,218.0,1,9
716009,CHEMBL1289601,LENVATINIB,104279,CHEMBL1795199,Receptor-interacting serine/threonine-protein kinase 3,6.5,6.5,316.0,1,9
716009,CHEMBL1289601,LENVATINIB,30047,CHEMBL4527,TRAF2 and NCK-interacting protein kinase,6.25,6.25,565.0,1,9
716009,CHEMBL1289601,LENVATINIB,100947,CHEMBL5330,Mitogen-activated protein kinase kinase kinase kinase 2,6.24,6.24,578.0,1,9
716009,CHEMBL1289601,LENVATINIB,30006,CHEMBL3981,Serine/threonine-protein kinase 10,6.1,6.1,793.0,1,9
716009,CHEMBL1289601,LENVATINIB,155,CHEMBL238,Sodium-dependent dopamine transporter,5.85,5.85,1400.0,1,8
716009,CHEMBL1289601,LENVATINIB,10170,CHEMBL3959,Ribosyldihydronicotinamide dehydrogenase [quinone],5.82,5.82,1523.0,1,9
716009,CHEMBL1289601,LENVATINIB,103452,CHEMBL1163123,Mitogen-activated protein kinase kinase kinase 6,5.8,5.8,1575.0,1,9
716009,CHEMBL1289601,LENVATINIB,10781,CHEMBL2185,Aurora kinase B,5.75,5.75,1781.0,1,9
716009,CHEMBL1289601,LENVATINIB,103430,CHEMBL1163101,Serine/threonine-protein kinase/endoribonuclease IRE1,5.65,5.65,2242.0,1,9
716009,CHEMBL1289601,LENVATINIB,116956,CHEMBL3879831,"Ferrochelatase, mitochondrial",5.55,5.55,2806.0,1,9
716009,CHEMBL1289601,LENVATINIB,10371,CHEMBL4948,Dual specificity mitogen-activated protein kinase kinase 5,5.54,5.54,2910.0,1,9
716009,CHEMBL1289601,LENVATINIB,30049,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,5.51,5.51,3117.0,1,9
716337,CHEMBL1289926,AXITINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,10.7,9.24,0.02,11,9
716337,CHEMBL1289926,AXITINIB,10979,CHEMBL1868,Vascular endothelial growth factor receptor 1,10.0,9.41,0.1,3,9
716337,CHEMBL1289926,AXITINIB,11752,CHEMBL1955,Vascular endothelial growth factor receptor 3,10.0,8.92,0.1,3,9
716337,CHEMBL1289926,AXITINIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,9.7,7.49,0.2,24,9
716337,CHEMBL1289926,AXITINIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,9.31,8.06,0.49,10,9
716337,CHEMBL1289926,AXITINIB,12627,CHEMBL2007,Platelet-derived growth factor receptor alpha,9.29,9.29,0.51,1,8
716337,CHEMBL1289926,AXITINIB,197,CHEMBL1913,Platelet-derived growth factor receptor beta,9.24,8.14,0.57,3,9
716337,CHEMBL1289926,AXITINIB,20171,CHEMBL3935,Aurora kinase C,8.89,8.89,1.3,1,8
716337,CHEMBL1289926,AXITINIB,30003,CHEMBL3788,Serine/threonine-protein kinase PLK4,8.38,7.72,4.2,9,9
716337,CHEMBL1289926,AXITINIB,10781,CHEMBL2185,Aurora kinase B,7.96,7.29,11.0,2,9
716337,CHEMBL1289926,AXITINIB,12840,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,7.68,7.39,21.0,2,9
716337,CHEMBL1289926,AXITINIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,7.51,6.69,31.0,7,8
716337,CHEMBL1289926,AXITINIB,10266,CHEMBL3650,Fibroblast growth factor receptor 1,7.25,6.75,56.0,3,9
716337,CHEMBL1289926,AXITINIB,155,CHEMBL238,Sodium-dependent dopamine transporter,7.16,7.16,70.0,1,8
716337,CHEMBL1289926,AXITINIB,11209,CHEMBL4014,Tyrosine-protein kinase ABL2,7.16,6.57,70.0,2,9
716337,CHEMBL1289926,AXITINIB,20014,CHEMBL4722,Aurora kinase A,7.14,6.79,72.0,2,9
716337,CHEMBL1289926,AXITINIB,100906,CHEMBL5274,Tyrosine-protein kinase receptor Tie-1,7.01,7.01,97.0,1,8
716337,CHEMBL1289926,AXITINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,7.0,6.52,100.0,5,9
716337,CHEMBL1289926,AXITINIB,10264,CHEMBL4142,Fibroblast growth factor receptor 2,6.96,6.96,110.0,1,8
716337,CHEMBL1289926,AXITINIB,10371,CHEMBL4948,Dual specificity mitogen-activated protein kinase kinase 5,6.85,6.85,140.0,1,8
716337,CHEMBL1289926,AXITINIB,100951,CHEMBL5334,Non-receptor tyrosine-protein kinase TNK1,6.8,6.27,160.0,2,9
716337,CHEMBL1289926,AXITINIB,30047,CHEMBL4527,TRAF2 and NCK-interacting protein kinase,6.75,6.25,180.0,2,9
716337,CHEMBL1289926,AXITINIB,100128,CHEMBL5146,Breakpoint cluster region protein,6.73,6.73,188.0,1,9
716337,CHEMBL1289926,AXITINIB,11926,CHEMBL2742,Fibroblast growth factor receptor 3,6.68,6.68,210.0,2,8
716337,CHEMBL1289926,AXITINIB,102799,CHEMBL6191,Mitogen-activated protein kinase kinase kinase 19,6.57,6.57,270.0,1,8
716337,CHEMBL1289926,AXITINIB,12913,CHEMBL4128,Angiopoietin-1 receptor,6.51,6.51,310.0,1,8
716337,CHEMBL1289926,AXITINIB,101312,CHEMBL5749,Mitogen-activated protein kinase kinase kinase kinase 1,6.48,6.48,330.0,1,8
716337,CHEMBL1289926,AXITINIB,100917,CHEMBL5319,Epithelial discoidin domain-containing receptor 1,6.47,6.47,340.0,1,8
716337,CHEMBL1289926,AXITINIB,101464,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,6.46,6.1,350.0,2,9
716337,CHEMBL1289926,AXITINIB,102676,CHEMBL5836,Ephrin type-B receptor 6,6.44,6.44,360.0,1,8
716337,CHEMBL1289926,AXITINIB,30004,CHEMBL3938,Serine/threonine-protein kinase 16,6.43,6.43,370.0,1,8
716337,CHEMBL1289926,AXITINIB,11307,CHEMBL1865,Histone deacetylase 6,6.39,6.39,403.5,1,9
716337,CHEMBL1289926,AXITINIB,100410,CHEMBL4895,Tyrosine-protein kinase receptor UFO,6.38,6.38,420.0,1,8
716337,CHEMBL1289926,AXITINIB,101309,CHEMBL5728,Cyclin-dependent kinase-like 2,6.28,6.28,530.0,1,8
716337,CHEMBL1289926,AXITINIB,30049,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,6.26,5.91,550.0,2,9
716337,CHEMBL1289926,AXITINIB,101220,CHEMBL5518,Misshapen-like kinase 1,6.25,6.25,560.0,1,8
716337,CHEMBL1289926,AXITINIB,100127,CHEMBL4454,Tyrosine-protein kinase Fgr,6.19,5.97,642.0,2,9
716337,CHEMBL1289926,AXITINIB,101048,CHEMBL5047,Serine/threonine-protein kinase ULK3,6.17,6.17,670.0,1,8
716337,CHEMBL1289926,AXITINIB,11451,CHEMBL3717,Hepatocyte growth factor receptor,6.09,6.02,820.0,3,8
716337,CHEMBL1289926,AXITINIB,103154,CHEMBL1075104,Leucine-rich repeat serine/threonine-protein kinase 2,6.04,6.02,920.0,2,8
716337,CHEMBL1289926,AXITINIB,30035,CHEMBL4202,STE20-like serine/threonine-protein kinase,6.0,6.0,1000.0,1,8
716337,CHEMBL1289926,AXITINIB,30042,CHEMBL4522,BMP-2-inducible protein kinase,6.0,5.83,1000.0,2,9
716337,CHEMBL1289926,AXITINIB,101278,CHEMBL5659,Serine/threonine-protein kinase RIO3,6.0,6.0,1000.0,3,9
716337,CHEMBL1289926,AXITINIB,10844,CHEMBL2634,Tyrosine-protein kinase CSK,5.96,5.96,1100.0,1,8
716337,CHEMBL1289926,AXITINIB,11408,CHEMBL2637,Mitogen-activated protein kinase 10,5.96,5.96,1100.0,1,8
716337,CHEMBL1289926,AXITINIB,10918,CHEMBL2959,Tyrosine-protein kinase ITK/TSK,5.92,5.92,1200.0,1,8
716337,CHEMBL1289926,AXITINIB,30000,CHEMBL3830,AP2-associated protein kinase 1,5.92,5.79,1200.0,2,9
716337,CHEMBL1289926,AXITINIB,30006,CHEMBL3981,Serine/threonine-protein kinase 10,5.92,5.75,1200.0,2,9
716337,CHEMBL1289926,AXITINIB,101188,CHEMBL5432,Mitogen-activated protein kinase kinase kinase kinase 3,5.92,5.92,1200.0,1,8
716337,CHEMBL1289926,AXITINIB,101404,CHEMBL5975,Serine/threonine-protein kinase RIO1,5.92,5.92,1200.0,1,8
716337,CHEMBL1289926,AXITINIB,12037,CHEMBL2777,"Myosin light chain kinase 2, skeletal/cardiac muscle",5.89,5.89,1300.0,1,8
716337,CHEMBL1289926,AXITINIB,100947,CHEMBL5330,Mitogen-activated protein kinase kinase kinase kinase 2,5.89,5.89,1300.0,1,8
716337,CHEMBL1289926,AXITINIB,101503,CHEMBL5698,NUAK family SNF1-like kinase 2,5.89,5.89,1300.0,1,8
716337,CHEMBL1289926,AXITINIB,30024,CHEMBL4598,Serine/threonine-protein kinase 4,5.85,5.85,1400.0,1,8
716337,CHEMBL1289926,AXITINIB,30029,CHEMBL5256,Calcium/calmodulin-dependent protein kinase kinase 1,5.85,5.85,1400.0,1,8
716337,CHEMBL1289926,AXITINIB,101434,CHEMBL6083,Receptor-interacting serine/threonine-protein kinase 4,5.85,5.85,1400.0,1,8
716337,CHEMBL1289926,AXITINIB,30032,CHEMBL5284,Calcium/calmodulin-dependent protein kinase kinase 2,5.82,5.82,1500.0,1,8
716337,CHEMBL1289926,AXITINIB,104245,CHEMBL1795165,Hormonally up-regulated neu tumor-associated kinase,5.82,5.82,1500.0,1,8
716337,CHEMBL1289926,AXITINIB,12959,CHEMBL4627,Myosin light chain kinase,5.77,5.77,1700.0,1,8
716337,CHEMBL1289926,AXITINIB,101499,CHEMBL5671,Protein delta homolog 1,5.77,5.77,1700.0,1,9
716337,CHEMBL1289926,AXITINIB,104320,CHEMBL1908389,Mitogen-activated protein kinase kinase kinase 12,5.77,5.77,1700.0,1,8
716337,CHEMBL1289926,AXITINIB,11902,CHEMBL2815,High affinity nerve growth factor receptor,5.75,5.75,1800.0,1,8
716337,CHEMBL1289926,AXITINIB,100789,CHEMBL4375,SRSF protein kinase 1,5.75,5.75,1800.0,1,8
716337,CHEMBL1289926,AXITINIB,101225,CHEMBL5546,Myosin-IIIa,5.72,5.72,1900.0,1,8
716337,CHEMBL1289926,AXITINIB,101433,CHEMBL6082,Serine/threonine-protein kinase SIK1,5.68,5.68,2100.0,1,8
716337,CHEMBL1289926,AXITINIB,10277,CHEMBL4708,Serine/threonine-protein kinase 3,5.66,5.66,2200.0,1,8
716337,CHEMBL1289926,AXITINIB,9,CHEMBL203,Epidermal growth factor receptor,5.64,5.64,2300.0,1,8
716337,CHEMBL1289926,AXITINIB,100975,CHEMBL5415,SRSF protein kinase 3,5.64,5.64,2300.0,1,8
716337,CHEMBL1289926,AXITINIB,101584,CHEMBL5861,G protein-coupled receptor kinase 4,5.64,5.64,2300.0,1,8
716337,CHEMBL1289926,AXITINIB,117538,CHEMBL4105933,Uncharacterized protein FLJ45252,5.64,5.64,2299.0,1,9
716337,CHEMBL1289926,AXITINIB,100424,CHEMBL4367,Tyrosine-protein kinase TXK,5.62,5.62,2400.0,1,8
716337,CHEMBL1289926,AXITINIB,100990,CHEMBL5464,Receptor-interacting serine/threonine-protein kinase 1,5.6,5.6,2500.0,1,8
716337,CHEMBL1289926,AXITINIB,11046,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,5.58,5.58,2600.0,1,8
716337,CHEMBL1289926,AXITINIB,20007,CHEMBL3886,Mitogen-activated protein kinase kinase kinase 20,5.58,5.58,2600.0,1,8
716337,CHEMBL1289926,AXITINIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,5.57,5.57,2700.0,1,8
716337,CHEMBL1289926,AXITINIB,10842,CHEMBL3032,Serine/threonine-protein kinase N2,5.57,5.57,2700.0,1,8
716337,CHEMBL1289926,AXITINIB,11409,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,5.57,5.57,2700.0,1,8
716337,CHEMBL1289926,AXITINIB,18033,CHEMBL2073,Tyrosine-protein kinase Yes,5.57,5.57,2700.0,1,8
716337,CHEMBL1289926,AXITINIB,20020,CHEMBL4355,Cyclin-G-associated kinase,5.57,5.57,2700.0,1,8
716337,CHEMBL1289926,AXITINIB,12780,CHEMBL4070,Casein kinase II subunit alpha',5.55,5.55,2800.0,1,8
716337,CHEMBL1289926,AXITINIB,101399,CHEMBL5970,Mitogen-activated protein kinase kinase kinase 3,5.55,5.55,2800.0,1,8
716337,CHEMBL1289926,AXITINIB,101204,CHEMBL5476,Bone morphogenetic protein receptor type-1B,5.54,5.54,2900.0,1,8
716337,CHEMBL1289926,AXITINIB,12038,CHEMBL2872,Mitogen-activated protein kinase kinase kinase 9,5.52,5.52,3000.0,1,8
716337,CHEMBL1289926,AXITINIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,5.51,5.51,3100.0,1,8
716337,CHEMBL1289926,AXITINIB,11691,CHEMBL2250,Tyrosine-protein kinase Blk,5.51,5.51,3100.0,1,8
716337,CHEMBL1289926,AXITINIB,19623,CHEMBL3357,Interleukin-1 receptor-associated kinase 1,5.51,5.51,3100.0,1,8
716337,CHEMBL1289926,AXITINIB,100948,CHEMBL5331,Tyrosine-protein kinase Mer,5.5,5.5,3200.0,1,8
716337,CHEMBL1289926,AXITINIB,101019,CHEMBL5568,Proto-oncogene tyrosine-protein kinase ROS,5.5,5.5,3200.0,1,8
27307,CHEMBL129,ZIDOVUDINE,10125,CHEMBL2883,"Thymidine kinase, cytosolic",5.54,5.53,2900.0,2,9
254975,CHEMBL1290,PENBUTOLOL,51,CHEMBL214,5-hydroxytryptamine receptor 1A,8.44,8.44,3.6,1,8
254975,CHEMBL1290,PENBUTOLOL,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.01,6.01,966.4,1,8
254975,CHEMBL1290,PENBUTOLOL,125,CHEMBL229,Alpha-1A adrenergic receptor,5.59,5.59,2540.4,1,8
255347,CHEMBL1292,CLOFAZIMINE,25,CHEMBL2034,Glucocorticoid receptor,7.47,7.47,34.0,1,8
255347,CHEMBL1292,CLOFAZIMINE,19,CHEMBL206,Estrogen receptor,6.89,6.89,130.0,1,8
255347,CHEMBL1292,CLOFAZIMINE,11398,CHEMBL4302,ATP-dependent translocase ABCB1,6.22,6.06,600.0,3,8
255347,CHEMBL1292,CLOFAZIMINE,11536,CHEMBL4616,Growth hormone secretagogue receptor type 1,6.04,6.04,920.0,1,8
255347,CHEMBL1292,CLOFAZIMINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.02,6.02,958.1,1,8
255347,CHEMBL1292,CLOFAZIMINE,11365,CHEMBL289,Cytochrome P450 2D6,5.6,5.6,2511.89,2,9
255347,CHEMBL1292,CLOFAZIMINE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,5.6,5.6,2511.9,2,9
255347,CHEMBL1292,CLOFAZIMINE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,5.5,5.5,3162.3,1,9
255347,CHEMBL1292,CLOFAZIMINE,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,5.5,5.5,3200.0,1,9
255373,CHEMBL1293,BETA CAROTENE,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,6.47,6.34,340.0,2,8
255373,CHEMBL1293,BETA CAROTENE,104062,CHEMBL1743121,Solute carrier organic anion transporter family member 1B3,5.65,5.59,2260.0,2,8
255477,CHEMBL1294,QUINIDINE,11365,CHEMBL289,Cytochrome P450 2D6,8.7,7.44,2.0,74,9
255477,CHEMBL1294,QUINIDINE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,7.5,7.5,31.6,1,9
255477,CHEMBL1294,QUINIDINE,78,CHEMBL1963,Thyrotropin receptor,7.0,7.0,100.0,1,9
255477,CHEMBL1294,QUINIDINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.52,6.15,300.0,8,9
255477,CHEMBL1294,QUINIDINE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.37,6.37,424.0,1,8
255477,CHEMBL1294,QUINIDINE,11398,CHEMBL4302,ATP-dependent translocase ABCB1,6.37,5.85,430.0,6,8
255477,CHEMBL1294,QUINIDINE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.04,6.04,922.6,1,8
255477,CHEMBL1294,QUINIDINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.01,5.88,976.5,3,8
255477,CHEMBL1294,QUINIDINE,10532,CHEMBL1914,Cholinesterase,5.91,5.91,1230.0,1,9
255477,CHEMBL1294,QUINIDINE,130,CHEMBL234,D(3) dopamine receptor,5.55,5.55,2800.0,1,8
255508,CHEMBL1295,BUTOCONAZOLE,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,6.07,6.07,860.0,1,8
255508,CHEMBL1295,BUTOCONAZOLE,137,CHEMBL237,Kappa-type opioid receptor,5.75,5.75,1800.0,1,8
255534,CHEMBL1297,FENOPROFEN,96,CHEMBL221,Prostaglandin G/H synthase 1,6.84,6.33,145.0,2,9
789,CHEMBL13,METOPROLOL,50,CHEMBL213,Beta-1 adrenergic receptor,7.8,6.92,15.85,5,9
789,CHEMBL13,METOPROLOL,43,CHEMBL210,Beta-2 adrenergic receptor,6.89,6.22,130.0,4,9
258371,CHEMBL1303,ROTIGOTINE,72,CHEMBL217,D(2) dopamine receptor,10.22,8.68,0.06,8,9
258371,CHEMBL1303,ROTIGOTINE,88,CHEMBL2056,D(1A) dopamine receptor,9.0,7.6,1.0,3,9
258371,CHEMBL1303,ROTIGOTINE,125,CHEMBL229,Alpha-1A adrenergic receptor,8.48,8.48,3.3,1,8
258371,CHEMBL1303,ROTIGOTINE,130,CHEMBL234,D(3) dopamine receptor,8.4,8.26,3.99,3,8
258371,CHEMBL1303,ROTIGOTINE,90,CHEMBL219,D(4) dopamine receptor,7.26,7.26,55.0,1,8
258371,CHEMBL1303,ROTIGOTINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.89,6.89,130.0,1,8
258371,CHEMBL1303,ROTIGOTINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.4,6.4,400.0,1,8
258371,CHEMBL1303,ROTIGOTINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.37,6.37,430.0,1,8
258371,CHEMBL1303,ROTIGOTINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.34,6.34,460.0,1,8
258371,CHEMBL1303,ROTIGOTINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.17,6.17,670.0,1,8
258371,CHEMBL1303,ROTIGOTINE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.89,5.89,1300.0,1,8
258709,CHEMBL1305,ANTAZOLINE,103668,CHEMBL1293235,Prelamin-A/C,8.6,8.6,2.5,1,9
258709,CHEMBL1305,ANTAZOLINE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.47,6.14,340.0,2,8
258709,CHEMBL1305,ANTAZOLINE,170,CHEMBL241,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",5.92,5.92,1200.0,1,8
258709,CHEMBL1305,ANTAZOLINE,127,CHEMBL231,Histamine H1 receptor,5.66,5.66,2200.0,1,8
258709,CHEMBL1305,ANTAZOLINE,11365,CHEMBL289,Cytochrome P450 2D6,5.6,5.6,2511.89,2,9
258709,CHEMBL1305,ANTAZOLINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.59,5.56,2540.0,2,8
27370,CHEMBL131,PREDNISOLONE,48,CHEMBL1994,Mineralocorticoid receptor,9.54,7.93,0.29,8,9
27370,CHEMBL131,PREDNISOLONE,25,CHEMBL2034,Glucocorticoid receptor,9.28,8.01,0.526,96,9
27370,CHEMBL131,PREDNISOLONE,104209,CHEMBL1795129,Interleukin-6,8.38,8.38,4.2,1,8
27370,CHEMBL131,PREDNISOLONE,11473,CHEMBL3706,Disintegrin and metalloproteinase domain-containing protein 17,7.83,7.83,14.9,1,8
27370,CHEMBL131,PREDNISOLONE,10503,CHEMBL2421,Corticosteroid-binding globulin,7.51,7.51,30.9,1,8
27370,CHEMBL131,PREDNISOLONE,11590,CHEMBL4612,Glutamine synthetase,7.5,7.5,32.0,1,8
27370,CHEMBL131,PREDNISOLONE,185,CHEMBL1825,Tumor necrosis factor,6.6,6.6,251.0,1,9
27370,CHEMBL131,PREDNISOLONE,100857,CHEMBL5409,G-protein coupled bile acid receptor 1,6.6,6.6,251.0,1,9
27370,CHEMBL131,PREDNISOLONE,36,CHEMBL208,Progesterone receptor,5.82,5.75,1500.0,2,9
27370,CHEMBL131,PREDNISOLONE,56,CHEMBL1871,Androgen receptor,5.6,5.57,2520.0,3,9
264400,CHEMBL1314,TIOPRONIN,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.0,6.0,1000.0,1,9
264400,CHEMBL1314,TIOPRONIN,126,CHEMBL230,Prostaglandin G/H synthase 2,5.8,5.8,1600.0,1,8
739751,CHEMBL1315867,TERBUTALINE SULFATE,103668,CHEMBL1293235,Prelamin-A/C,6.8,6.8,158.5,1,9
739751,CHEMBL1315867,TERBUTALINE SULFATE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,6.5,6.5,316.2,2,9
264453,CHEMBL1316,CARPROFEN,96,CHEMBL221,Prostaglandin G/H synthase 1,8.28,8.28,5.3,1,9
264453,CHEMBL1316,CARPROFEN,126,CHEMBL230,Prostaglandin G/H synthase 2,8.28,7.31,5.3,4,9
264453,CHEMBL1316,CARPROFEN,106142,CHEMBL2364163,Complement C5,6.24,6.24,580.0,1,9
264453,CHEMBL1316,CARPROFEN,104069,CHEMBL1743128,ATP-binding cassette sub-family C member 4,5.52,5.52,3000.0,1,9
266225,CHEMBL1321,PROCARBAZINE,126,CHEMBL230,Prostaglandin G/H synthase 2,5.82,5.82,1500.0,1,8
266225,CHEMBL1321,PROCARBAZINE,12594,CHEMBL3356,Cytochrome P450 1A2,5.8,5.8,1584.89,1,8
266225,CHEMBL1321,PROCARBAZINE,103668,CHEMBL1293235,Prelamin-A/C,5.5,5.5,3162.3,1,9
267825,CHEMBL1324,TOLCAPONE,12704,CHEMBL3194,Transthyretin,7.69,6.94,20.6,10,9
267825,CHEMBL1324,TOLCAPONE,91,CHEMBL2023,Catechol O-methyltransferase,6.9,6.9,127.0,1,9
267825,CHEMBL1324,TOLCAPONE,36,CHEMBL208,Progesterone receptor,5.96,5.96,1091.5,1,8
267825,CHEMBL1324,TOLCAPONE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.96,5.96,1100.0,1,8
267825,CHEMBL1324,TOLCAPONE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.71,5.71,1949.0,1,8
267825,CHEMBL1324,TOLCAPONE,126,CHEMBL230,Prostaglandin G/H synthase 2,5.55,5.55,2800.0,1,8
271725,CHEMBL1328,PENTAGASTRIN,11522,CHEMBL298,Gastrin/cholecystokinin type B receptor,9.0,8.07,1.0,5,9
11715,CHEMBL13280,FLUNITRAZEPAM,11440,CHEMBL5112,Gamma-aminobutyric acid receptor subunit alpha-5,8.52,8.52,3.0,1,8
11715,CHEMBL13280,FLUNITRAZEPAM,74,CHEMBL1962,Gamma-aminobutyric acid receptor subunit alpha-1,8.35,8.35,4.5,1,8
754676,CHEMBL1330792,ACETARSONE,103665,CHEMBL1293232,Survival motor neuron protein,6.3,6.3,501.2,1,9
757917,CHEMBL1334033,PERHEXILINE MALEATE,103657,CHEMBL1293224,Microtubule-associated protein tau,6.9,6.9,125.9,1,9
757917,CHEMBL1334033,PERHEXILINE MALEATE,103665,CHEMBL1293232,Survival motor neuron protein,6.2,6.2,631.0,1,9
757917,CHEMBL1334033,PERHEXILINE MALEATE,103170,CHEMBL1075322,G-protein coupled receptor 55,5.5,5.5,3188.77,1,9
276734,CHEMBL1336,SORAFENIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,10.68,7.56,0.021,112,9
276734,CHEMBL1336,SORAFENIB,100129,CHEMBL5147,Ephrin type-B receptor 4,9.7,7.27,0.2,11,9
276734,CHEMBL1336,SORAFENIB,197,CHEMBL1913,Platelet-derived growth factor receptor beta,9.59,7.47,0.26,19,9
276734,CHEMBL1336,SORAFENIB,12913,CHEMBL4128,Angiopoietin-1 receptor,9.41,7.42,0.39,9,9
276734,CHEMBL1336,SORAFENIB,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,9.25,7.48,0.56,4,9
276734,CHEMBL1336,SORAFENIB,10904,CHEMBL1906,RAF proto-oncogene serine/threonine-protein kinase,9.0,7.82,1.0,37,9
276734,CHEMBL1336,SORAFENIB,100126,CHEMBL5145,Serine/threonine-protein kinase B-raf,9.0,7.41,1.0,69,9
276734,CHEMBL1336,SORAFENIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,8.89,7.57,1.3,58,9
276734,CHEMBL1336,SORAFENIB,100917,CHEMBL5319,Epithelial discoidin domain-containing receptor 1,8.82,8.21,1.5,5,9
276734,CHEMBL1336,SORAFENIB,103106,CHEMBL1075167,Homeodomain-interacting protein kinase 4,8.57,8.11,2.7,5,9
276734,CHEMBL1336,SORAFENIB,9,CHEMBL203,Epidermal growth factor receptor,8.53,6.94,2.96,13,9
276734,CHEMBL1336,SORAFENIB,11752,CHEMBL1955,Vascular endothelial growth factor receptor 3,8.52,7.33,3.0,14,9
276734,CHEMBL1336,SORAFENIB,10266,CHEMBL3650,Fibroblast growth factor receptor 1,8.33,6.16,4.63,9,9
276734,CHEMBL1336,SORAFENIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,8.23,7.69,5.9,37,9
276734,CHEMBL1336,SORAFENIB,20007,CHEMBL3886,Mitogen-activated protein kinase kinase kinase 20,8.2,7.71,6.3,5,9
276734,CHEMBL1336,SORAFENIB,101079,CHEMBL5122,Discoidin domain-containing receptor 2,8.18,7.63,6.6,9,9
276734,CHEMBL1336,SORAFENIB,103465,CHEMBL1169596,Serine/threonine-protein kinase A-Raf,8.15,8.07,7.1,3,9
276734,CHEMBL1336,SORAFENIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,8.0,7.15,10.0,31,9
276734,CHEMBL1336,SORAFENIB,11727,CHEMBL2409,Bifunctional epoxide hydrolase 2,7.92,7.92,12.0,2,9
276734,CHEMBL1336,SORAFENIB,10188,CHEMBL260,Mitogen-activated protein kinase 14,7.8,6.8,15.85,15,9
276734,CHEMBL1336,SORAFENIB,10979,CHEMBL1868,Vascular endothelial growth factor receptor 1,7.75,7.26,18.0,10,9
276734,CHEMBL1336,SORAFENIB,11639,CHEMBL3385,Mitogen-activated protein kinase 3,7.74,7.74,18.1,1,9
276734,CHEMBL1336,SORAFENIB,12840,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,7.72,7.2,19.0,9,9
276734,CHEMBL1336,SORAFENIB,101300,CHEMBL5719,Cyclin-dependent kinase 8,7.52,6.86,30.0,11,9
276734,CHEMBL1336,SORAFENIB,101034,CHEMBL5608,NT-3 growth factor receptor,7.43,6.5,37.2,5,9
276734,CHEMBL1336,SORAFENIB,100833,CHEMBL5198,Mitogen-activated protein kinase 15,7.34,7.34,46.0,3,9
276734,CHEMBL1336,SORAFENIB,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.25,7.25,56.0,1,8
276734,CHEMBL1336,SORAFENIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,7.22,5.98,60.0,4,9
276734,CHEMBL1336,SORAFENIB,12627,CHEMBL2007,Platelet-derived growth factor receptor alpha,7.21,6.89,62.0,7,9
276734,CHEMBL1336,SORAFENIB,100906,CHEMBL5274,Tyrosine-protein kinase receptor Tie-1,7.17,7.17,68.0,3,9
276734,CHEMBL1336,SORAFENIB,20025,CHEMBL5014,Receptor-interacting serine/threonine-protein kinase 2,7.12,6.07,75.0,5,9
276734,CHEMBL1336,SORAFENIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,7.1,6.38,80.0,36,9
276734,CHEMBL1336,SORAFENIB,11902,CHEMBL2815,High affinity nerve growth factor receptor,7.08,6.44,82.9,2,9
276734,CHEMBL1336,SORAFENIB,100852,CHEMBL4576,Homeodomain-interacting protein kinase 2,7.0,6.21,100.0,4,9
276734,CHEMBL1336,SORAFENIB,100853,CHEMBL4577,Homeodomain-interacting protein kinase 3,7.0,6.59,100.0,3,9
276734,CHEMBL1336,SORAFENIB,101130,CHEMBL5260,Serine/threonine-protein kinase TNNI3K,7.0,6.63,100.0,6,9
276734,CHEMBL1336,SORAFENIB,101183,CHEMBL5427,Homeodomain-interacting protein kinase 1,7.0,6.48,100.0,2,9
276734,CHEMBL1336,SORAFENIB,102799,CHEMBL6191,Mitogen-activated protein kinase kinase kinase 19,7.0,7.0,99.0,2,8
276734,CHEMBL1336,SORAFENIB,11638,CHEMBL4040,Mitogen-activated protein kinase 1,6.96,6.96,109.5,1,9
276734,CHEMBL1336,SORAFENIB,10480,CHEMBL2508,Cyclin-dependent kinase 6,6.89,6.89,130.0,1,9
276734,CHEMBL1336,SORAFENIB,30037,CHEMBL4204,MAP kinase-interacting serine/threonine-protein kinase 2,6.89,6.73,130.0,6,9
276734,CHEMBL1336,SORAFENIB,101282,CHEMBL5684,"Muscle, skeletal receptor tyrosine-protein kinase",6.89,6.89,130.0,3,9
276734,CHEMBL1336,SORAFENIB,101309,CHEMBL5728,Cyclin-dependent kinase-like 2,6.89,6.89,130.0,2,8
276734,CHEMBL1336,SORAFENIB,12829,CHEMBL3055,Cyclin-dependent kinase 7,6.85,6.85,140.0,3,9
276734,CHEMBL1336,SORAFENIB,30006,CHEMBL3981,Serine/threonine-protein kinase 10,6.85,6.83,140.0,5,9
276734,CHEMBL1336,SORAFENIB,100410,CHEMBL4895,Tyrosine-protein kinase receptor UFO,6.8,6.8,158.49,1,8
276734,CHEMBL1336,SORAFENIB,10371,CHEMBL4948,Dual specificity mitogen-activated protein kinase kinase 5,6.72,6.72,190.0,1,8
276734,CHEMBL1336,SORAFENIB,10120,CHEMBL3961,Mitogen-activated protein kinase 11,6.7,6.66,200.0,5,9
276734,CHEMBL1336,SORAFENIB,10781,CHEMBL2185,Aurora kinase B,6.7,6.45,199.53,4,9
276734,CHEMBL1336,SORAFENIB,101407,CHEMBL6002,Cyclin-dependent kinase 19,6.69,6.62,206.0,4,9
276734,CHEMBL1336,SORAFENIB,20171,CHEMBL3935,Aurora kinase C,6.68,6.68,210.0,3,9
276734,CHEMBL1336,SORAFENIB,100835,CHEMBL4718,MAP kinase-interacting serine/threonine-protein kinase 1,6.64,6.64,230.0,3,9
276734,CHEMBL1336,SORAFENIB,30046,CHEMBL4526,Ephrin type-A receptor 6,6.62,6.51,240.0,5,9
276734,CHEMBL1336,SORAFENIB,102676,CHEMBL5836,Ephrin type-B receptor 6,6.62,6.62,240.0,2,8
276734,CHEMBL1336,SORAFENIB,11720,CHEMBL2793,Casein kinase I isoform alpha,6.6,6.6,250.0,1,8
276734,CHEMBL1336,SORAFENIB,30049,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,6.5,5.93,316.23,5,9
276734,CHEMBL1336,SORAFENIB,30019,CHEMBL3987,Ephrin type-A receptor 5,6.44,6.44,360.0,2,9
276734,CHEMBL1336,SORAFENIB,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,6.41,6.41,390.0,1,8
276734,CHEMBL1336,SORAFENIB,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,6.4,5.74,398.11,4,9
276734,CHEMBL1336,SORAFENIB,12944,CHEMBL4501,Ribosomal protein S6 kinase beta-1,6.4,6.4,398.11,1,8
276734,CHEMBL1336,SORAFENIB,30003,CHEMBL3788,Serine/threonine-protein kinase PLK4,6.4,6.4,398.11,1,8
276734,CHEMBL1336,SORAFENIB,101131,CHEMBL5261,Serine/threonine-protein kinase TAO1,6.4,6.06,398.11,3,8
276734,CHEMBL1336,SORAFENIB,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.38,6.38,417.0,1,8
276734,CHEMBL1336,SORAFENIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,6.36,6.33,440.0,6,9
276734,CHEMBL1336,SORAFENIB,103446,CHEMBL1163117,Cyclin-dependent kinase-like 3,6.31,6.31,490.0,2,8
276734,CHEMBL1336,SORAFENIB,11785,CHEMBL3234,Tyrosine-protein kinase HCK,6.28,6.28,530.0,2,8
276734,CHEMBL1336,SORAFENIB,103140,CHEMBL1075195,Serine/threonine-protein kinase TAO2,6.27,6.27,540.0,1,8
276734,CHEMBL1336,SORAFENIB,101324,CHEMBL5776,Mitogen-activated protein kinase kinase kinase 7,6.22,6.11,600.0,4,9
276734,CHEMBL1336,SORAFENIB,30018,CHEMBL3836,LIM domain kinase 1,6.2,5.85,630.96,5,9
276734,CHEMBL1336,SORAFENIB,100413,CHEMBL4898,BDNF/NT-3 growth factors receptor,6.2,5.81,630.96,4,9
276734,CHEMBL1336,SORAFENIB,100931,CHEMBL5364,Serine/threonine-protein kinase NLK,6.19,6.19,640.0,3,9
276734,CHEMBL1336,SORAFENIB,30027,CHEMBL4602,Ephrin type-A receptor 7,6.17,6.17,670.0,2,9
276734,CHEMBL1336,SORAFENIB,11691,CHEMBL2250,Tyrosine-protein kinase Blk,6.1,6.1,794.33,1,8
276734,CHEMBL1336,SORAFENIB,20014,CHEMBL4722,Aurora kinase A,6.1,6.1,794.33,1,8
276734,CHEMBL1336,SORAFENIB,30008,CHEMBL2068,Ephrin type-A receptor 2,6.1,5.8,794.33,4,9
276734,CHEMBL1336,SORAFENIB,30010,CHEMBL4134,Ephrin type-A receptor 8,6.02,5.78,960.0,5,9
276734,CHEMBL1336,SORAFENIB,11407,CHEMBL4179,Mitogen-activated protein kinase 9,6.0,6.0,1000.0,1,9
276734,CHEMBL1336,SORAFENIB,30035,CHEMBL4202,STE20-like serine/threonine-protein kinase,6.0,5.92,1000.0,5,9
276734,CHEMBL1336,SORAFENIB,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.93,5.93,1181.0,1,8
276734,CHEMBL1336,SORAFENIB,10605,CHEMBL3860,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta",5.91,5.91,1230.0,1,9
276734,CHEMBL1336,SORAFENIB,11926,CHEMBL2742,Fibroblast growth factor receptor 3,5.9,5.9,1258.93,1,8
276734,CHEMBL1336,SORAFENIB,11209,CHEMBL4014,Tyrosine-protein kinase ABL2,5.89,5.63,1300.0,4,9
276734,CHEMBL1336,SORAFENIB,12037,CHEMBL2777,"Myosin light chain kinase 2, skeletal/cardiac muscle",5.89,5.89,1300.0,1,9
276734,CHEMBL1336,SORAFENIB,30021,CHEMBL3988,Ephrin type-A receptor 4,5.89,5.61,1300.0,4,9
276734,CHEMBL1336,SORAFENIB,100948,CHEMBL5331,Tyrosine-protein kinase Mer,5.86,5.86,1370.0,1,9
276734,CHEMBL1336,SORAFENIB,100990,CHEMBL5464,Receptor-interacting serine/threonine-protein kinase 1,5.82,5.82,1500.0,2,9
276734,CHEMBL1336,SORAFENIB,101220,CHEMBL5518,Misshapen-like kinase 1,5.8,5.8,1584.89,1,8
276734,CHEMBL1336,SORAFENIB,101553,CHEMBL5790,Cyclin-dependent kinase 17,5.8,5.8,1600.0,3,9
276734,CHEMBL1336,SORAFENIB,30020,CHEMBL5072,Ephrin type-B receptor 1,5.77,5.58,1700.0,4,9
276734,CHEMBL1336,SORAFENIB,280,CHEMBL256,Adenosine receptor A3,5.73,5.73,1880.1,1,8
276734,CHEMBL1336,SORAFENIB,11569,CHEMBL3290,Ephrin type-B receptor 2,5.72,5.72,1900.0,3,9
276734,CHEMBL1336,SORAFENIB,30009,CHEMBL4954,Ephrin type-A receptor 3,5.72,5.72,1900.0,3,9
276734,CHEMBL1336,SORAFENIB,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.71,5.71,1959.0,1,8
276734,CHEMBL1336,SORAFENIB,100851,CHEMBL4575,Dual specificity tyrosine-phosphorylation-regulated kinase 3,5.7,5.7,1995.26,1,8
276734,CHEMBL1336,SORAFENIB,102394,CHEMBL6020,Bile salt export pump,5.7,5.7,2000.0,1,8
276734,CHEMBL1336,SORAFENIB,100951,CHEMBL5334,Non-receptor tyrosine-protein kinase TNK1,5.64,5.64,2300.0,3,9
276734,CHEMBL1336,SORAFENIB,101410,CHEMBL6005,Serine/threonine-protein kinase 33,5.62,5.62,2400.0,3,9
276734,CHEMBL1336,SORAFENIB,10264,CHEMBL4142,Fibroblast growth factor receptor 2,5.57,5.57,2700.0,3,9
276734,CHEMBL1336,SORAFENIB,101506,CHEMBL5701,Serine/threonine-protein kinase TAO3,5.57,5.57,2700.0,2,8
276734,CHEMBL1336,SORAFENIB,11061,CHEMBL2203,Motilin receptor,5.55,5.55,2800.0,1,8
276734,CHEMBL1336,SORAFENIB,10844,CHEMBL2634,Tyrosine-protein kinase CSK,5.54,5.54,2900.0,1,8
276734,CHEMBL1336,SORAFENIB,101360,CHEMBL5856,Cyclin-dependent kinase 15,5.54,5.54,2900.0,2,8
276734,CHEMBL1336,SORAFENIB,101460,CHEMBL6162,Cyclin-dependent kinase 14,5.54,5.54,2900.0,3,9
276734,CHEMBL1336,SORAFENIB,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,5.51,5.51,3100.0,1,9
276734,CHEMBL1336,SORAFENIB,101340,CHEMBL5810,Ephrin type-A receptor 1,5.51,5.51,3100.0,3,9
281549,CHEMBL1337,NITISINONE,123,CHEMBL1861,4-hydroxyphenylpyruvate dioxygenase,7.43,7.43,37.0,1,9
283529,CHEMBL1339,VARDENAFIL HYDROCHLORIDE,3,CHEMBL1827,"cGMP-specific 3',5'-cyclic phosphodiesterase",9.15,9.15,0.7,1,9
27609,CHEMBL134,CLONIDINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,9.54,7.73,0.29,22,9
27609,CHEMBL134,CLONIDINE,125,CHEMBL229,Alpha-1A adrenergic receptor,8.77,6.98,1.7,6,9
27609,CHEMBL134,CLONIDINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,8.21,7.28,6.166,10,9
27609,CHEMBL134,CLONIDINE,11684,CHEMBL3923,Nischarin,8.05,7.52,8.9,3,9
27609,CHEMBL134,CLONIDINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,8.03,7.15,9.333,10,9
27609,CHEMBL134,CLONIDINE,103668,CHEMBL1293235,Prelamin-A/C,6.55,6.55,281.8,1,9
27609,CHEMBL134,CLONIDINE,102,CHEMBL1941,Histamine H2 receptor,6.41,6.41,390.0,1,8
27609,CHEMBL134,CLONIDINE,101283,CHEMBL5685,Solute carrier family 22 member 1,6.26,6.26,550.0,1,8
27609,CHEMBL134,CLONIDINE,103,CHEMBL223,Alpha-1D adrenergic receptor,6.22,5.91,595.0,3,9
27609,CHEMBL134,CLONIDINE,137,CHEMBL237,Kappa-type opioid receptor,5.96,5.96,1090.3,1,8
291960,CHEMBL1346,DARIFENACIN,219,CHEMBL245,Muscarinic acetylcholine receptor M3,9.13,8.24,0.74,7,9
291960,CHEMBL1346,DARIFENACIN,43,CHEMBL210,Beta-2 adrenergic receptor,9.1,8.28,0.7943,6,9
291960,CHEMBL1346,DARIFENACIN,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,8.64,8.64,2.3,1,9
291960,CHEMBL1346,DARIFENACIN,61,CHEMBL216,Muscarinic acetylcholine receptor M1,8.26,7.56,5.5,3,9
291960,CHEMBL1346,DARIFENACIN,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,8.07,8.07,8.6,1,9
291960,CHEMBL1346,DARIFENACIN,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.92,7.18,12.0,6,9
291960,CHEMBL1346,DARIFENACIN,50,CHEMBL213,Beta-1 adrenergic receptor,7.4,6.88,39.81,3,9
291960,CHEMBL1346,DARIFENACIN,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,7.1,6.46,79.43,3,8
291960,CHEMBL1346,DARIFENACIN,121,CHEMBL228,Sodium-dependent serotonin transporter,7.02,7.02,96.0,1,8
291960,CHEMBL1346,DARIFENACIN,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.39,6.39,410.0,1,8
291960,CHEMBL1346,DARIFENACIN,102,CHEMBL1941,Histamine H2 receptor,6.2,6.2,628.4,1,8
291960,CHEMBL1346,DARIFENACIN,129,CHEMBL233,Mu-type opioid receptor,6.19,6.1,640.0,2,8
291960,CHEMBL1346,DARIFENACIN,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.14,6.14,720.0,1,8
291960,CHEMBL1346,DARIFENACIN,125,CHEMBL229,Alpha-1A adrenergic receptor,6.04,6.04,901.1,1,8
291960,CHEMBL1346,DARIFENACIN,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.86,5.86,1392.2,1,8
291960,CHEMBL1346,DARIFENACIN,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,5.8,5.8,1584.89,1,8
291960,CHEMBL1346,DARIFENACIN,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.65,5.65,2228.8,1,8
291960,CHEMBL1346,DARIFENACIN,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.58,5.58,2633.0,1,8
27626,CHEMBL135,ESTRADIOL,19,CHEMBL206,Estrogen receptor,11.34,9.02,0.00456,149,9
27626,CHEMBL135,ESTRADIOL,174,CHEMBL242,Estrogen receptor beta,11.0,9.04,0.01,128,9
27626,CHEMBL135,ESTRADIOL,102690,CHEMBL5872,G-protein coupled estrogen receptor 1,9.52,8.82,0.3,5,9
27626,CHEMBL135,ESTRADIOL,103665,CHEMBL1293232,Survival motor neuron protein,8.85,7.47,1.4,2,9
27626,CHEMBL135,ESTRADIOL,12643,CHEMBL3305,Sex hormone-binding globulin,8.83,8.06,1.479,2,9
27626,CHEMBL135,ESTRADIOL,11254,CHEMBL3751,Steroid hormone receptor ERR2,8.49,8.3,3.2,3,9
27626,CHEMBL135,ESTRADIOL,10133,CHEMBL3429,Steroid hormone receptor ERR1,8.44,8.3,3.6,3,9
27626,CHEMBL135,ESTRADIOL,12056,CHEMBL3257,Aldehyde oxidase,8.3,7.15,5.0,3,9
27626,CHEMBL135,ESTRADIOL,56,CHEMBL1871,Androgen receptor,7.72,7.64,19.1,4,9
27626,CHEMBL135,ESTRADIOL,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,7.65,7.65,22.4,2,9
27626,CHEMBL135,ESTRADIOL,121,CHEMBL228,Sodium-dependent serotonin transporter,6.95,6.95,112.0,1,8
27626,CHEMBL135,ESTRADIOL,36,CHEMBL208,Progesterone receptor,6.75,6.75,177.6,1,8
27626,CHEMBL135,ESTRADIOL,17045,CHEMBL340,Cytochrome P450 3A4,6.0,6.0,1000.0,2,9
27626,CHEMBL135,ESTRADIOL,104076,CHEMBL1743291,Sulfotransferase 1A1,5.92,5.78,1200.0,2,9
27626,CHEMBL135,ESTRADIOL,10147,CHEMBL4878,Cytochrome P450 1B1,5.72,5.72,1900.0,1,9
27626,CHEMBL135,ESTRADIOL,25,CHEMBL2034,Glucocorticoid receptor,5.7,5.7,2014.7,1,8
27626,CHEMBL135,ESTRADIOL,103657,CHEMBL1293224,Microtubule-associated protein tau,5.7,5.7,1995.3,1,9
27626,CHEMBL135,ESTRADIOL,155,CHEMBL238,Sodium-dependent dopamine transporter,5.63,5.63,2337.9,1,8
27626,CHEMBL135,ESTRADIOL,104614,CHEMBL2073673,Solute carrier family 22 member 3,5.54,5.54,2880.0,1,8
300022,CHEMBL1351,CARBOPLATIN,12054,CHEMBL2903,Polyunsaturated fatty acid lipoxygenase ALOX15,6.4,6.4,398.1,1,9
300022,CHEMBL1351,CARBOPLATIN,103657,CHEMBL1293224,Microtubule-associated protein tau,5.5,5.5,3162.3,1,9
224263,CHEMBL135400,ZOPICLONE,103657,CHEMBL1293224,Microtubule-associated protein tau,6.05,6.03,891.3,2,9
224263,CHEMBL135400,ZOPICLONE,103669,CHEMBL1293236,ATP-dependent DNA helicase Q1,5.85,5.85,1412.5,1,9
778083,CHEMBL1354199,METHSCOPOLAMINE BROMIDE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,10.01,9.58,0.098,2,8
778083,CHEMBL1354199,METHSCOPOLAMINE BROMIDE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,9.82,9.6,0.15,2,8
778083,CHEMBL1354199,METHSCOPOLAMINE BROMIDE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,9.62,9.29,0.239,2,8
778083,CHEMBL1354199,METHSCOPOLAMINE BROMIDE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,9.49,9.19,0.321,2,8
778083,CHEMBL1354199,METHSCOPOLAMINE BROMIDE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,9.49,9.42,0.32,2,8
304390,CHEMBL1355,SODIUM CITRATE,12896,CHEMBL3729,Carbonic anhydrase 4,7.0,7.0,99.0,1,9
779620,CHEMBL1355736,THEOPHYLLINE,114,CHEMBL226,Adenosine receptor A1,9.22,9.22,0.6,1,9
779620,CHEMBL1355736,THEOPHYLLINE,252,CHEMBL251,Adenosine receptor A2a,9.22,6.08,0.6,10,9
779620,CHEMBL1355736,THEOPHYLLINE,280,CHEMBL256,Adenosine receptor A3,7.85,7.85,14.0,1,9
779620,CHEMBL1355736,THEOPHYLLINE,278,CHEMBL255,Adenosine receptor A2b,5.57,5.57,2700.0,1,9
779620,CHEMBL1355736,THEOPHYLLINE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,5.5,5.5,3162.3,2,9
780122,CHEMBL1356238,PYRITHIONE,103985,CHEMBL1741189,FAD-linked sulfhydryl oxidase ALR,6.37,6.37,432.0,1,8
780122,CHEMBL1356238,PYRITHIONE,11213,CHEMBL3880,Heat shock protein HSP 90-alpha,6.0,6.0,1008.0,1,8
781532,CHEMBL1357648,AMODIAQUINE HYDROCHLORIDE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,5.9,5.9,1258.9,1,9
304798,CHEMBL1358,FULVESTRANT,19,CHEMBL206,Estrogen receptor,10.22,8.74,0.06,45,9
304798,CHEMBL1358,FULVESTRANT,36,CHEMBL208,Progesterone receptor,9.68,9.68,0.2089,1,9
304798,CHEMBL1358,FULVESTRANT,174,CHEMBL242,Estrogen receptor beta,9.52,8.25,0.3,12,9
304798,CHEMBL1358,FULVESTRANT,10133,CHEMBL3429,Steroid hormone receptor ERR1,8.7,8.7,2.0,1,9
304798,CHEMBL1358,FULVESTRANT,11727,CHEMBL2409,Bifunctional epoxide hydrolase 2,8.22,7.9,6.0,2,9
304798,CHEMBL1358,FULVESTRANT,11180,CHEMBL2047,Bile acid receptor,6.1,6.1,790.0,1,9
304798,CHEMBL1358,FULVESTRANT,25,CHEMBL2034,Glucocorticoid receptor,5.96,5.96,1100.0,1,8
304798,CHEMBL1358,FULVESTRANT,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.71,5.71,1950.0,1,9
304798,CHEMBL1358,FULVESTRANT,105223,CHEMBL2163183,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",5.58,5.58,2600.0,1,9
304903,CHEMBL1359,ERTAPENEM,276,CHEMBL254,"3',5'-cyclic-AMP phosphodiesterase 4A",5.79,5.79,1620.0,1,8
306485,CHEMBL1360,ATRACURIUM,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.8,6.8,160.0,1,8
306485,CHEMBL1360,ATRACURIUM,121,CHEMBL228,Sodium-dependent serotonin transporter,6.12,6.12,760.0,1,8
306485,CHEMBL1360,ATRACURIUM,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.57,5.57,2700.0,1,8
308174,CHEMBL1363,ARFORMOTEROL,43,CHEMBL210,Beta-2 adrenergic receptor,9.5,8.5,0.3162,3,9
308174,CHEMBL1363,ARFORMOTEROL,125,CHEMBL229,Alpha-1A adrenergic receptor,7.3,6.46,50.0,2,8
308174,CHEMBL1363,ARFORMOTEROL,50,CHEMBL213,Beta-1 adrenergic receptor,6.96,6.46,109.0,2,9
308174,CHEMBL1363,ARFORMOTEROL,121,CHEMBL228,Sodium-dependent serotonin transporter,6.21,6.21,621.3,1,8
788028,CHEMBL1364144,METHYLPREDNISOLONE ACETATE,36,CHEMBL208,Progesterone receptor,5.52,5.52,3030.0,1,8
308917,CHEMBL1366,AURANOFIN,130,CHEMBL234,D(3) dopamine receptor,6.65,6.42,224.0,2,8
308917,CHEMBL1366,AURANOFIN,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.48,6.27,331.0,2,8
308917,CHEMBL1366,AURANOFIN,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.44,6.27,363.0,2,8
308917,CHEMBL1366,AURANOFIN,90,CHEMBL219,D(4) dopamine receptor,6.41,6.18,394.0,2,8
308917,CHEMBL1366,AURANOFIN,25,CHEMBL2034,Glucocorticoid receptor,6.22,6.05,599.0,2,8
308917,CHEMBL1366,AURANOFIN,280,CHEMBL256,Adenosine receptor A3,6.02,5.89,954.0,2,8
308917,CHEMBL1366,AURANOFIN,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,5.92,5.92,1197.0,1,8
791489,CHEMBL1367605,RITODRINE HYDROCHLORIDE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,8.0,8.0,10.0,2,9
27912,CHEMBL137,METRONIDAZOLE,103668,CHEMBL1293235,Prelamin-A/C,5.6,5.6,2511.9,1,9
313314,CHEMBL1370,BUDESONIDE,25,CHEMBL2034,Glucocorticoid receptor,9.3,8.47,0.5,14,9
313314,CHEMBL1370,BUDESONIDE,48,CHEMBL1994,Mineralocorticoid receptor,8.32,8.09,4.8,2,9
313314,CHEMBL1370,BUDESONIDE,36,CHEMBL208,Progesterone receptor,8.05,7.7,9.0,3,9
313314,CHEMBL1370,BUDESONIDE,103689,CHEMBL1293256,Thrombopoietin,8.0,8.0,10.0,2,9
313314,CHEMBL1370,BUDESONIDE,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,7.25,7.25,56.2,2,9
313314,CHEMBL1370,BUDESONIDE,56,CHEMBL1871,Androgen receptor,6.16,6.16,694.4,1,8
313314,CHEMBL1370,BUDESONIDE,103665,CHEMBL1293232,Survival motor neuron protein,5.95,5.95,1122.0,1,9
313314,CHEMBL1370,BUDESONIDE,12592,CHEMBL321,Matrix metalloproteinase-9,5.7,5.7,1989.0,1,8
794445,CHEMBL1370561,AMINOPHYLLINE,103668,CHEMBL1293235,Prelamin-A/C,6.0,6.0,1000.0,1,9
315123,CHEMBL1371,CHLORZOXAZONE,103668,CHEMBL1293235,Prelamin-A/C,7.4,7.2,39.8,2,9
315123,CHEMBL1371,CHLORZOXAZONE,103689,CHEMBL1293256,Thrombopoietin,6.9,6.9,125.9,2,9
315123,CHEMBL1371,CHLORZOXAZONE,12594,CHEMBL3356,Cytochrome P450 1A2,6.4,6.4,398.11,1,8
317124,CHEMBL1373,MODAFINIL,103668,CHEMBL1293235,Prelamin-A/C,8.74,8.74,1.8,1,9
317124,CHEMBL1373,MODAFINIL,155,CHEMBL238,Sodium-dependent dopamine transporter,6.03,5.76,927.0,5,9
798263,CHEMBL1374379,BENZONATATE,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,5.8,5.8,1600.0,1,8
320522,CHEMBL1377,PROGUANIL,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.97,5.97,1066.8,1,8
320522,CHEMBL1377,PROGUANIL,103668,CHEMBL1293235,Prelamin-A/C,5.7,5.7,1995.3,1,9
320810,CHEMBL1378,THIETHYLPERAZINE,130,CHEMBL234,D(3) dopamine receptor,8.51,8.51,3.1,1,8
320810,CHEMBL1378,THIETHYLPERAZINE,88,CHEMBL2056,D(1A) dopamine receptor,8.1,8.1,7.9,1,8
320810,CHEMBL1378,THIETHYLPERAZINE,72,CHEMBL217,D(2) dopamine receptor,7.0,7.0,100.0,1,8
320810,CHEMBL1378,THIETHYLPERAZINE,127,CHEMBL231,Histamine H1 receptor,6.77,6.77,170.0,1,8
320810,CHEMBL1378,THIETHYLPERAZINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.68,6.68,210.7,1,8
320810,CHEMBL1378,THIETHYLPERAZINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.35,6.35,449.3,1,8
320810,CHEMBL1378,THIETHYLPERAZINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.92,5.92,1200.0,1,8
320810,CHEMBL1378,THIETHYLPERAZINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.8,5.8,1600.0,1,8
320810,CHEMBL1378,THIETHYLPERAZINE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.8,5.8,1600.0,1,8
320810,CHEMBL1378,THIETHYLPERAZINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.78,5.78,1654.1,1,8
320810,CHEMBL1378,THIETHYLPERAZINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.66,5.66,2200.0,1,8
320810,CHEMBL1378,THIETHYLPERAZINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.65,5.65,2239.0,1,8
320810,CHEMBL1378,THIETHYLPERAZINE,129,CHEMBL233,Mu-type opioid receptor,5.57,5.57,2687.8,1,8
321964,CHEMBL1382,TOLTERODINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,8.85,8.28,1.4,3,9
321964,CHEMBL1382,TOLTERODINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,8.66,8.43,2.2,2,9
321964,CHEMBL1382,TOLTERODINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,8.57,8.07,2.7,7,9
321964,CHEMBL1382,TOLTERODINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,8.51,8.51,3.1,1,9
321964,CHEMBL1382,TOLTERODINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,8.49,8.3,3.2,5,9
321964,CHEMBL1382,TOLTERODINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,7.9,7.38,12.59,5,8
321964,CHEMBL1382,TOLTERODINE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.56,5.56,2744.4,1,8
321964,CHEMBL1382,TOLTERODINE,102,CHEMBL1941,Histamine H2 receptor,5.5,5.5,3196.5,1,8
806511,CHEMBL1382627,"SULFADIAZINE, SILVER",12911,CHEMBL3397,Cytochrome P450 2C9,5.9,5.9,1258.9,2,9
806511,CHEMBL1382627,"SULFADIAZINE, SILVER",12912,CHEMBL3622,Cytochrome P450 2C19,5.9,5.9,1258.9,2,9
806511,CHEMBL1382627,"SULFADIAZINE, SILVER",100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,5.8,5.65,1584.9,2,9
806511,CHEMBL1382627,"SULFADIAZINE, SILVER",12054,CHEMBL2903,Polyunsaturated fatty acid lipoxygenase ALOX15,5.6,5.6,2511.9,1,9
806511,CHEMBL1382627,"SULFADIAZINE, SILVER",12594,CHEMBL3356,Cytochrome P450 1A2,5.5,5.5,3162.28,1,8
328153,CHEMBL1387,NORETHYNODREL,36,CHEMBL208,Progesterone receptor,7.6,7.6,25.1,1,8
328153,CHEMBL1387,NORETHYNODREL,56,CHEMBL1871,Androgen receptor,7.52,7.52,30.0,1,8
328153,CHEMBL1387,NORETHYNODREL,19,CHEMBL206,Estrogen receptor,6.99,6.99,103.2,1,8
328153,CHEMBL1387,NORETHYNODREL,121,CHEMBL228,Sodium-dependent serotonin transporter,6.74,6.74,182.3,1,8
328153,CHEMBL1387,NORETHYNODREL,103665,CHEMBL1293232,Survival motor neuron protein,5.75,5.75,1778.3,1,9
328153,CHEMBL1387,NORETHYNODREL,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.56,5.56,2760.2,1,8
328158,CHEMBL1388,MONOBENZONE,11307,CHEMBL1865,Histone deacetylase 6,6.0,6.0,988.8,1,9
328158,CHEMBL1388,MONOBENZONE,96,CHEMBL221,Prostaglandin G/H synthase 1,5.99,5.99,1019.0,1,9
328158,CHEMBL1388,MONOBENZONE,12594,CHEMBL3356,Cytochrome P450 1A2,5.8,5.8,1584.89,1,8
328164,CHEMBL1389,LEVONORGESTREL,36,CHEMBL208,Progesterone receptor,9.0,8.84,1.0,3,9
328164,CHEMBL1389,LEVONORGESTREL,56,CHEMBL1871,Androgen receptor,8.04,8.04,9.2,1,8
29890,CHEMBL139,DICLOFENAC,96,CHEMBL221,Prostaglandin G/H synthase 1,8.52,7.67,3.0,12,9
29890,CHEMBL139,DICLOFENAC,126,CHEMBL230,Prostaglandin G/H synthase 2,8.3,6.99,5.0,25,9
29890,CHEMBL139,DICLOFENAC,10040,CHEMBL2157,Interleukin-8,8.1,8.1,8.0,1,9
29890,CHEMBL139,DICLOFENAC,11574,CHEMBL4029,C-X-C chemokine receptor type 1,7.92,7.92,12.0,1,8
29890,CHEMBL139,DICLOFENAC,12704,CHEMBL3194,Transthyretin,7.22,6.61,60.0,2,9
29890,CHEMBL139,DICLOFENAC,102631,CHEMBL5983,Aldo-keto reductase family 1 member B10,5.72,5.72,1900.0,1,9
29890,CHEMBL139,DICLOFENAC,10697,CHEMBL3253,Albumin,5.61,5.61,2454.71,1,9
328201,CHEMBL1393,SPIRONOLACTONE,48,CHEMBL1994,Mineralocorticoid receptor,8.8,7.8,1.6,15,9
328201,CHEMBL1393,SPIRONOLACTONE,25,CHEMBL2034,Glucocorticoid receptor,7.49,6.37,32.6,5,9
328201,CHEMBL1393,SPIRONOLACTONE,56,CHEMBL1871,Androgen receptor,7.41,6.74,39.4,7,9
328201,CHEMBL1393,SPIRONOLACTONE,36,CHEMBL208,Progesterone receptor,7.3,6.39,50.0,5,9
328201,CHEMBL1393,SPIRONOLACTONE,12912,CHEMBL3622,Cytochrome P450 2C19,5.52,5.52,3000.0,1,8
328400,CHEMBL1395,METHYLTESTOSTERONE,12643,CHEMBL3305,Sex hormone-binding globulin,8.43,8.43,3.715,1,9
328400,CHEMBL1395,METHYLTESTOSTERONE,36,CHEMBL208,Progesterone receptor,6.7,6.7,200.0,1,8
328400,CHEMBL1395,METHYLTESTOSTERONE,25,CHEMBL2034,Glucocorticoid receptor,6.36,6.06,440.0,3,8
334337,CHEMBL1397,POSACONAZOLE,11541,CHEMBL2722,"Cytochrome P450 11B2, mitochondrial",7.68,7.68,21.0,1,9
334337,CHEMBL1397,POSACONAZOLE,12949,CHEMBL3522,"Steroid 17-alpha-hydroxylase/17,20 lyase",7.38,6.56,42.0,2,9
334337,CHEMBL1397,POSACONAZOLE,17045,CHEMBL340,Cytochrome P450 3A4,7.3,6.83,50.0,6,9
334337,CHEMBL1397,POSACONAZOLE,76,CHEMBL1908,"Cytochrome P450 11B1, mitochondrial",6.51,6.51,310.0,1,9
337366,CHEMBL1399,ANASTROZOLE,65,CHEMBL1978,Aromatase,9.89,8.23,0.13,12,9
892,CHEMBL14,CARBACHOL,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,9.4,6.76,0.4,13,9
892,CHEMBL14,CARBACHOL,47,CHEMBL211,Muscarinic acetylcholine receptor M2,8.42,6.68,3.8,26,9
892,CHEMBL14,CARBACHOL,219,CHEMBL245,Muscarinic acetylcholine receptor M3,7.68,6.8,21.0,10,9
892,CHEMBL14,CARBACHOL,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.77,6.02,170.0,8,9
892,CHEMBL14,CARBACHOL,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.44,5.96,360.0,4,9
338934,CHEMBL1401,NITAZOXANIDE,96,CHEMBL221,Prostaglandin G/H synthase 1,7.94,7.94,11.4,1,8
338934,CHEMBL1401,NITAZOXANIDE,104568,CHEMBL2046267,Anoctamin-1,6.37,6.37,424.0,1,9
338934,CHEMBL1401,NITAZOXANIDE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.35,6.35,450.0,1,8
338934,CHEMBL1401,NITAZOXANIDE,103710,CHEMBL1293277,NPC intracellular cholesterol transporter 1,6.3,6.3,501.2,1,9
338934,CHEMBL1401,NITAZOXANIDE,103727,CHEMBL1293294,Ras-related protein Rab-9A,6.3,6.3,501.2,1,9
338934,CHEMBL1401,NITAZOXANIDE,11307,CHEMBL1865,Histone deacetylase 6,6.0,6.0,1011.0,1,9
338934,CHEMBL1401,NITAZOXANIDE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.85,5.85,1400.0,1,8
338934,CHEMBL1401,NITAZOXANIDE,175,CHEMBL1997,Equilibrative nucleoside transporter 1,5.72,5.72,1900.0,1,8
338934,CHEMBL1401,NITAZOXANIDE,144,CHEMBL1899,5-hydroxytryptamine receptor 3A,5.51,5.51,3100.0,1,8
338934,CHEMBL1401,NITAZOXANIDE,101097,CHEMBL5162,Neuropeptide S receptor,5.5,5.5,3162.3,1,9
341382,CHEMBL1404,RANOLAZINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.85,5.85,1400.0,1,8
341382,CHEMBL1404,RANOLAZINE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.77,5.77,1700.0,1,8
342897,CHEMBL1405,ESTRONE,174,CHEMBL242,Estrogen receptor beta,9.3,7.61,0.5,10,9
342897,CHEMBL1405,ESTRONE,19,CHEMBL206,Estrogen receptor,9.15,7.71,0.7,12,9
342897,CHEMBL1405,ESTRONE,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,8.89,8.89,1.3,1,9
342897,CHEMBL1405,ESTRONE,11512,CHEMBL3181,17-beta-hydroxysteroid dehydrogenase type 1,8.52,6.82,3.0,6,9
342897,CHEMBL1405,ESTRONE,12643,CHEMBL3305,Sex hormone-binding globulin,8.18,8.18,6.607,1,9
342897,CHEMBL1405,ESTRONE,103668,CHEMBL1293235,Prelamin-A/C,7.95,7.95,11.2,1,9
342897,CHEMBL1405,ESTRONE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,7.8,7.8,15.8,2,9
342897,CHEMBL1405,ESTRONE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,6.7,6.7,199.5,2,9
342897,CHEMBL1405,ESTRONE,129,CHEMBL233,Mu-type opioid receptor,6.11,6.11,769.4,1,8
342897,CHEMBL1405,ESTRONE,12594,CHEMBL3356,Cytochrome P450 1A2,5.9,5.9,1258.93,1,8
342897,CHEMBL1405,ESTRONE,17045,CHEMBL340,Cytochrome P450 3A4,5.7,5.7,1995.3,2,9
342897,CHEMBL1405,ESTRONE,56,CHEMBL1871,Androgen receptor,5.68,5.68,2083.5,1,8
342897,CHEMBL1405,ESTRONE,65,CHEMBL1978,Aromatase,5.6,5.6,2500.0,1,9
342897,CHEMBL1405,ESTRONE,103731,CHEMBL1293298,Peripheral myelin protein 22,5.57,5.57,2685.5,1,9
342897,CHEMBL1405,ESTRONE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.55,5.55,2816.0,1,8
342897,CHEMBL1405,ESTRONE,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,5.52,5.52,3000.0,1,8
13456,CHEMBL14060,PHENOL,10139,CHEMBL2885,Carbonic anhydrase 3,5.57,5.57,2700.0,4,9
345595,CHEMBL1409,FLUVOXAMINE MALEATE,103668,CHEMBL1293235,Prelamin-A/C,6.6,6.05,251.2,2,9
345595,CHEMBL1409,FLUVOXAMINE MALEATE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,6.55,6.55,281.8,2,9
345595,CHEMBL1409,FLUVOXAMINE MALEATE,103665,CHEMBL1293232,Survival motor neuron protein,5.7,5.7,1995.3,1,9
345872,CHEMBL1410,NONOXYNOL 9,103668,CHEMBL1293235,Prelamin-A/C,8.05,8.05,8.9,1,9
345872,CHEMBL1410,NONOXYNOL 9,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,5.72,5.72,1920.0,1,8
345872,CHEMBL1410,NONOXYNOL 9,103660,CHEMBL1293227,Ubiquitin carboxyl-terminal hydrolase 2,5.6,5.6,2511.9,1,9
345872,CHEMBL1410,NONOXYNOL 9,104062,CHEMBL1743121,Solute carrier organic anion transporter family member 1B3,5.54,5.54,2870.0,1,8
835863,CHEMBL1411979,METHAPYRILENE,127,CHEMBL231,Histamine H1 receptor,8.74,8.27,1.802,2,8
835863,CHEMBL1411979,METHAPYRILENE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.97,6.41,106.0,3,8
835863,CHEMBL1411979,METHAPYRILENE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.75,6.47,180.0,2,8
835863,CHEMBL1411979,METHAPYRILENE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.41,6.27,390.0,2,8
835863,CHEMBL1411979,METHAPYRILENE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.36,6.14,437.0,2,8
835863,CHEMBL1411979,METHAPYRILENE,11365,CHEMBL289,Cytochrome P450 2D6,6.3,5.95,501.19,5,9
835863,CHEMBL1411979,METHAPYRILENE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.27,6.17,537.0,2,8
835863,CHEMBL1411979,METHAPYRILENE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.23,5.85,592.0,3,8
835863,CHEMBL1411979,METHAPYRILENE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.94,5.94,1150.0,1,8
835863,CHEMBL1411979,METHAPYRILENE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.86,5.86,1380.0,2,8
835863,CHEMBL1411979,METHAPYRILENE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,5.84,5.67,1435.0,2,8
835863,CHEMBL1411979,METHAPYRILENE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.82,5.82,1515.0,1,8
835863,CHEMBL1411979,METHAPYRILENE,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,5.75,5.75,1778.3,2,9
835863,CHEMBL1411979,METHAPYRILENE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.66,5.61,2190.0,2,8
835863,CHEMBL1411979,METHAPYRILENE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,5.63,5.63,2346.0,1,8
835863,CHEMBL1411979,METHAPYRILENE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.57,5.57,2700.0,1,8
231925,CHEMBL141305,CYCLOFENIL,19,CHEMBL206,Estrogen receptor,7.58,7.25,26.0,3,9
231925,CHEMBL141305,CYCLOFENIL,155,CHEMBL238,Sodium-dependent dopamine transporter,6.82,6.82,150.0,1,8
231925,CHEMBL141305,CYCLOFENIL,36,CHEMBL208,Progesterone receptor,5.88,5.88,1320.0,1,8
231925,CHEMBL141305,CYCLOFENIL,56,CHEMBL1871,Androgen receptor,5.79,5.79,1630.0,1,8
231925,CHEMBL141305,CYCLOFENIL,280,CHEMBL256,Adenosine receptor A3,5.61,5.61,2470.0,1,8
231925,CHEMBL141305,CYCLOFENIL,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.5,5.5,3200.0,1,8
840903,CHEMBL1417019,MITOXANTRONE HYDROCHLORIDE,10839,CHEMBL2147,Serine/threonine-protein kinase pim-1,7.29,7.29,50.9,1,9
840903,CHEMBL1417019,MITOXANTRONE HYDROCHLORIDE,103665,CHEMBL1293232,Survival motor neuron protein,6.7,6.65,199.5,2,9
840903,CHEMBL1417019,MITOXANTRONE HYDROCHLORIDE,105692,CHEMBL2362980,Paired box protein Pax-8,6.16,6.16,690.0,1,8
840903,CHEMBL1417019,MITOXANTRONE HYDROCHLORIDE,10206,CHEMBL2392,DNA polymerase beta,6.1,6.1,794.3,1,9
840903,CHEMBL1417019,MITOXANTRONE HYDROCHLORIDE,103732,CHEMBL1293299,Histone-lysine N-methyltransferase 2A,5.95,5.95,1122.0,1,9
840903,CHEMBL1417019,MITOXANTRONE HYDROCHLORIDE,101476,CHEMBL5619,DNA repair nuclease/redox regulator APEX1,5.7,5.7,1995.3,3,9
840903,CHEMBL1417019,MITOXANTRONE HYDROCHLORIDE,109564,CHEMBL3396943,DNA-3-methyladenine glycosylase,5.6,5.6,2500.0,1,9
840903,CHEMBL1417019,MITOXANTRONE HYDROCHLORIDE,103669,CHEMBL1293236,ATP-dependent DNA helicase Q1,5.55,5.53,2818.4,2,9
840903,CHEMBL1417019,MITOXANTRONE HYDROCHLORIDE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,5.5,5.5,3162.3,1,9
840903,CHEMBL1417019,MITOXANTRONE HYDROCHLORIDE,103657,CHEMBL1293224,Microtubule-associated protein tau,5.5,5.5,3162.3,2,9
842060,CHEMBL1418176,METHANDROSTENOLONE,103668,CHEMBL1293235,Prelamin-A/C,6.5,6.5,316.2,1,9
842060,CHEMBL1418176,METHANDROSTENOLONE,103657,CHEMBL1293224,Microtubule-associated protein tau,6.0,6.0,1000.0,1,9
358192,CHEMBL1419,SIBUTRAMINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.44,6.44,360.0,1,8
358192,CHEMBL1419,SIBUTRAMINE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.3,6.21,502.0,3,8
358192,CHEMBL1419,SIBUTRAMINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.12,6.12,758.5,1,8
358192,CHEMBL1419,SIBUTRAMINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.99,5.99,1019.5,1,8
358192,CHEMBL1419,SIBUTRAMINE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.96,5.85,1108.0,3,8
358192,CHEMBL1419,SIBUTRAMINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.96,5.79,1091.0,2,8
358192,CHEMBL1419,SIBUTRAMINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.67,5.67,2137.9,1,8
359778,CHEMBL1420,PRALIDOXIME,78,CHEMBL1963,Thyrotropin receptor,6.2,6.2,631.0,1,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,8,CHEMBL1862,Tyrosine-protein kinase ABL1,10.0,9.0,0.1,37,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,30009,CHEMBL4954,Ephrin type-A receptor 3,9.52,9.52,0.3,1,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,9.1,7.04,0.8,10,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,30010,CHEMBL4134,Ephrin type-A receptor 8,8.89,8.89,1.3,1,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,12840,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,8.7,8.21,2.0,2,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,30019,CHEMBL3987,Ephrin type-A receptor 5,8.68,8.52,2.1,3,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,100129,CHEMBL5147,Ephrin type-B receptor 4,8.68,8.51,2.07,3,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,11569,CHEMBL3290,Ephrin type-B receptor 2,8.57,8.46,2.7,3,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,8.55,8.28,2.8,4,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,30008,CHEMBL2068,Ephrin type-A receptor 2,8.49,8.32,3.26,4,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,11209,CHEMBL4014,Tyrosine-protein kinase ABL2,8.44,8.42,3.631,2,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,8.43,8.41,3.715,2,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,18033,CHEMBL2073,Tyrosine-protein kinase Yes,8.43,8.41,3.715,2,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,30021,CHEMBL3988,Ephrin type-A receptor 4,8.39,8.22,4.1,3,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,30012,CHEMBL4223,Tyrosine-protein kinase FRK,8.34,8.32,4.571,2,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,10140,CHEMBL258,Tyrosine-protein kinase Lck,8.15,8.14,7.0,2,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,101340,CHEMBL5810,Ephrin type-A receptor 1,7.83,7.72,14.79,3,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,100416,CHEMBL4901,Ephrin type-B receptor 3,7.76,7.61,17.4,3,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,100917,CHEMBL5319,Epithelial discoidin domain-containing receptor 1,7.58,7.44,26.0,3,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,11785,CHEMBL3234,Tyrosine-protein kinase HCK,7.54,7.54,28.84,2,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,102676,CHEMBL5836,Ephrin type-B receptor 6,7.47,7.25,34.0,3,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,101079,CHEMBL5122,Discoidin domain-containing receptor 2,7.27,7.19,54.0,3,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,7.26,6.31,55.0,8,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,30026,CHEMBL4601,Protein-tyrosine kinase 6,7.26,7.26,55.0,2,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,20007,CHEMBL3886,Mitogen-activated protein kinase kinase kinase 20,6.66,6.66,217.0,2,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,105640,CHEMBL2331044,Myelin transcription factor 1,6.65,6.65,226.0,1,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,6.26,6.26,550.0,1,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,9,CHEMBL203,Epidermal growth factor receptor,6.23,6.2,584.0,2,9
361469,CHEMBL1421,DASATINIB ANHYDROUS,10188,CHEMBL260,Mitogen-activated protein kinase 14,6.03,6.03,945.0,2,9
363589,CHEMBL1422,SITAGLIPTIN,11140,CHEMBL284,Dipeptidyl peptidase 4,9.06,7.77,0.87,66,9
363589,CHEMBL1422,SITAGLIPTIN,20151,CHEMBL4657,Dipeptidyl peptidase 8,5.74,5.74,1820.0,1,9
363589,CHEMBL1422,SITAGLIPTIN,20154,CHEMBL4793,Dipeptidyl peptidase 9,5.51,5.51,3060.0,1,9
363589,CHEMBL1422,SITAGLIPTIN,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.5,5.5,3175.0,1,8
364141,CHEMBL1423,PIMOZIDE,72,CHEMBL217,D(2) dopamine receptor,8.85,8.01,1.4,5,9
364141,CHEMBL1423,PIMOZIDE,130,CHEMBL234,D(3) dopamine receptor,8.6,8.22,2.5,3,9
364141,CHEMBL1423,PIMOZIDE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,8.52,7.48,3.02,16,9
364141,CHEMBL1423,PIMOZIDE,100100,CHEMBL4641,Voltage-dependent T-type calcium channel subunit alpha-1G,7.4,6.96,40.0,2,9
364141,CHEMBL1423,PIMOZIDE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.31,7.31,48.6,1,8
364141,CHEMBL1423,PIMOZIDE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,7.2,7.2,63.1,1,9
364141,CHEMBL1423,PIMOZIDE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,7.15,7.15,71.0,1,8
364141,CHEMBL1423,PIMOZIDE,90,CHEMBL219,D(4) dopamine receptor,7.14,7.14,72.8,1,8
364141,CHEMBL1423,PIMOZIDE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.1,6.88,79.3,3,8
364141,CHEMBL1423,PIMOZIDE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.03,6.54,94.3,2,8
364141,CHEMBL1423,PIMOZIDE,129,CHEMBL233,Mu-type opioid receptor,6.93,6.68,116.5,2,9
364141,CHEMBL1423,PIMOZIDE,4,CHEMBL1859,Voltage-dependent T-type calcium channel subunit alpha-1H,6.8,6.8,157.0,1,9
364141,CHEMBL1423,PIMOZIDE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.8,6.44,159.9,2,8
364141,CHEMBL1423,PIMOZIDE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.6,6.6,252.3,1,8
364141,CHEMBL1423,PIMOZIDE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.6,6.6,251.2,1,9
364141,CHEMBL1423,PIMOZIDE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.45,6.4,356.4,2,8
364141,CHEMBL1423,PIMOZIDE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.32,6.32,480.0,1,8
364141,CHEMBL1423,PIMOZIDE,88,CHEMBL2056,D(1A) dopamine receptor,6.3,6.27,497.6,2,9
364141,CHEMBL1423,PIMOZIDE,137,CHEMBL237,Kappa-type opioid receptor,6.25,6.13,566.0,2,8
364141,CHEMBL1423,PIMOZIDE,102,CHEMBL1941,Histamine H2 receptor,6.19,6.19,640.2,1,8
364141,CHEMBL1423,PIMOZIDE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.13,5.83,743.4,2,8
364141,CHEMBL1423,PIMOZIDE,11398,CHEMBL4302,ATP-dependent translocase ABCB1,6.1,5.73,800.0,3,8
364141,CHEMBL1423,PIMOZIDE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,5.9,5.75,1258.9,4,9
364141,CHEMBL1423,PIMOZIDE,127,CHEMBL231,Histamine H1 receptor,5.85,5.85,1400.0,1,8
364141,CHEMBL1423,PIMOZIDE,102688,CHEMBL5845,Glycine receptor subunit alpha-1,5.77,5.77,1700.0,1,9
364141,CHEMBL1423,PIMOZIDE,105604,CHEMBL2321615,Potassium channel subfamily K member 2,5.75,5.75,1800.0,1,9
364141,CHEMBL1423,PIMOZIDE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.72,5.72,1920.2,1,8
364141,CHEMBL1423,PIMOZIDE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.7,5.7,2000.0,1,8
364141,CHEMBL1423,PIMOZIDE,11290,CHEMBL3759,Histamine H4 receptor,5.7,5.7,2000.0,1,9
364141,CHEMBL1423,PIMOZIDE,104169,CHEMBL1795087,Ubiquitin carboxyl-terminal hydrolase 1,5.7,5.7,2000.0,1,9
364141,CHEMBL1423,PIMOZIDE,103660,CHEMBL1293227,Ubiquitin carboxyl-terminal hydrolase 2,5.6,5.6,2511.9,1,9
364141,CHEMBL1423,PIMOZIDE,11365,CHEMBL289,Cytochrome P450 2D6,5.5,5.5,3162.28,2,9
364141,CHEMBL1423,PIMOZIDE,17045,CHEMBL340,Cytochrome P450 3A4,5.5,5.5,3162.3,2,9
364693,CHEMBL1425,MERCAPTOPURINE ANHYDROUS,11544,CHEMBL4331,Hemoglobin subunit beta,5.5,5.5,3162.3,1,9
237007,CHEMBL142635,NAFTOPIDIL,103,CHEMBL223,Alpha-1D adrenergic receptor,8.92,7.81,1.202,3,9
237007,CHEMBL142635,NAFTOPIDIL,125,CHEMBL229,Alpha-1A adrenergic receptor,8.43,7.35,3.7,9,9
237007,CHEMBL142635,NAFTOPIDIL,51,CHEMBL214,5-hydroxytryptamine receptor 1A,8.07,7.0,8.6,2,8
237007,CHEMBL142635,NAFTOPIDIL,128,CHEMBL232,Alpha-1B adrenergic receptor,7.7,6.7,19.95,3,9
237007,CHEMBL142635,NAFTOPIDIL,130,CHEMBL234,D(3) dopamine receptor,7.4,6.89,40.0,2,8
237007,CHEMBL142635,NAFTOPIDIL,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.33,6.71,47.0,2,8
237007,CHEMBL142635,NAFTOPIDIL,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.7,6.7,200.0,1,8
237007,CHEMBL142635,NAFTOPIDIL,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.54,6.54,290.0,1,8
237007,CHEMBL142635,NAFTOPIDIL,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.52,6.52,300.0,1,8
237007,CHEMBL142635,NAFTOPIDIL,127,CHEMBL231,Histamine H1 receptor,6.12,6.12,750.0,1,8
237007,CHEMBL142635,NAFTOPIDIL,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.06,6.06,870.0,1,8
237007,CHEMBL142635,NAFTOPIDIL,129,CHEMBL233,Mu-type opioid receptor,6.05,6.05,900.0,1,8
237007,CHEMBL142635,NAFTOPIDIL,103668,CHEMBL1293235,Prelamin-A/C,6.05,6.05,891.3,1,9
237007,CHEMBL142635,NAFTOPIDIL,72,CHEMBL217,D(2) dopamine receptor,6.0,6.0,1000.0,1,8
237007,CHEMBL142635,NAFTOPIDIL,50,CHEMBL213,Beta-1 adrenergic receptor,5.96,5.96,1100.0,1,8
237007,CHEMBL142635,NAFTOPIDIL,102,CHEMBL1941,Histamine H2 receptor,5.89,5.89,1300.0,1,8
237007,CHEMBL142635,NAFTOPIDIL,121,CHEMBL228,Sodium-dependent serotonin transporter,5.84,5.84,1430.0,1,8
237007,CHEMBL142635,NAFTOPIDIL,88,CHEMBL2056,D(1A) dopamine receptor,5.68,5.68,2080.0,1,8
237007,CHEMBL142635,NAFTOPIDIL,137,CHEMBL237,Kappa-type opioid receptor,5.66,5.66,2200.0,1,8
234541,CHEMBL142703,VILDAGLIPTIN,20154,CHEMBL4793,Dipeptidyl peptidase 9,9.92,6.91,0.12,17,9
234541,CHEMBL142703,VILDAGLIPTIN,11140,CHEMBL284,Dipeptidyl peptidase 4,9.24,7.72,0.58,43,9
234541,CHEMBL142703,VILDAGLIPTIN,20151,CHEMBL4657,Dipeptidyl peptidase 8,8.73,6.1,1.85,12,9
365248,CHEMBL1428,NIMODIPINE,103668,CHEMBL1293235,Prelamin-A/C,8.74,8.54,1.8,2,9
365248,CHEMBL1428,NIMODIPINE,169,CHEMBL1940,Voltage-dependent L-type calcium channel subunit alpha-1C,6.96,6.67,110.0,2,9
365248,CHEMBL1428,NIMODIPINE,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,6.41,6.21,390.0,3,9
365248,CHEMBL1428,NIMODIPINE,12911,CHEMBL3397,Cytochrome P450 2C9,6.0,5.88,1000.0,2,9
365248,CHEMBL1428,NIMODIPINE,11176,CHEMBL4619,"Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",5.91,5.91,1243.0,2,9
365248,CHEMBL1428,NIMODIPINE,87,CHEMBL218,Cannabinoid receptor 1,5.86,5.81,1371.0,2,8
365248,CHEMBL1428,NIMODIPINE,101097,CHEMBL5162,Neuropeptide S receptor,5.8,5.8,1584.9,1,9
365248,CHEMBL1428,NIMODIPINE,17045,CHEMBL340,Cytochrome P450 3A4,5.75,5.75,1780.0,1,9
365248,CHEMBL1428,NIMODIPINE,10177,CHEMBL3421,"Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",5.7,5.7,2000.0,1,9
365248,CHEMBL1428,NIMODIPINE,12912,CHEMBL3622,Cytochrome P450 2C19,5.66,5.66,2170.0,1,9
365248,CHEMBL1428,NIMODIPINE,175,CHEMBL1997,Equilibrative nucleoside transporter 1,5.5,5.5,3200.0,1,8
366868,CHEMBL1429,DESMOPRESSIN,112,CHEMBL1790,Vasopressin V2 receptor,9.7,8.4,0.2,5,9
366868,CHEMBL1429,DESMOPRESSIN,148,CHEMBL1921,Vasopressin V1b receptor,9.43,8.4,0.37,4,9
366868,CHEMBL1429,DESMOPRESSIN,134,CHEMBL1889,Vasopressin V1a receptor,8.42,7.81,3.8,2,8
366868,CHEMBL1429,DESMOPRESSIN,116,CHEMBL2049,Oxytocin receptor,8.3,7.47,5.0,3,9
369179,CHEMBL1430,PENICILLAMINE,96,CHEMBL221,Prostaglandin G/H synthase 1,6.08,6.06,839.3,2,8
369464,CHEMBL1431,METFORMIN,103668,CHEMBL1293235,Prelamin-A/C,8.46,8.46,3.5,1,9
371561,CHEMBL1434,MINOCYCLINE,96,CHEMBL221,Prostaglandin G/H synthase 1,5.6,5.6,2503.2,1,8
858397,CHEMBL1434513,NOREPINEPHRINE BITARTRATE,103624,CHEMBL1287622,Lethal(3)malignant brain tumor-like protein 1,6.0,6.0,1000.0,1,9
371631,CHEMBL1435,CEFAZOLIN,103829,CHEMBL1641347,Solute carrier family 22 member 6,6.75,6.75,180.0,1,8
371631,CHEMBL1435,CEFAZOLIN,103830,CHEMBL1641348,Organic anion transporter 3,6.26,6.26,550.0,1,8
371631,CHEMBL1435,CEFAZOLIN,103668,CHEMBL1293235,Prelamin-A/C,6.05,6.05,891.3,1,9
371631,CHEMBL1435,CEFAZOLIN,104618,CHEMBL2073677,Solute carrier family 22 member 11,5.76,5.76,1740.0,1,8
372912,CHEMBL1437,NOREPINEPHRINE,125,CHEMBL229,Alpha-1A adrenergic receptor,8.92,7.4,1.2,7,9
372912,CHEMBL1437,NOREPINEPHRINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,8.28,6.93,5.3,11,9
372912,CHEMBL1437,NOREPINEPHRINE,226,CHEMBL246,Beta-3 adrenergic receptor,8.26,8.23,5.5,2,9
372912,CHEMBL1437,NOREPINEPHRINE,103668,CHEMBL1293235,Prelamin-A/C,7.95,7.95,11.2,1,9
372912,CHEMBL1437,NOREPINEPHRINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.92,7.22,12.0,5,9
372912,CHEMBL1437,NOREPINEPHRINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.2,6.36,63.0,7,9
372912,CHEMBL1437,NOREPINEPHRINE,88,CHEMBL2056,D(1A) dopamine receptor,6.51,6.51,310.0,1,8
372912,CHEMBL1437,NOREPINEPHRINE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.3,6.0,501.2,3,9
372912,CHEMBL1437,NOREPINEPHRINE,103669,CHEMBL1293236,ATP-dependent DNA helicase Q1,6.15,5.9,707.9,2,9
372912,CHEMBL1437,NOREPINEPHRINE,101476,CHEMBL5619,DNA repair nuclease/redox regulator APEX1,6.1,6.1,794.3,1,9
372912,CHEMBL1437,NOREPINEPHRINE,103657,CHEMBL1293224,Microtubule-associated protein tau,5.9,5.7,1258.9,2,9
372912,CHEMBL1437,NOREPINEPHRINE,72,CHEMBL217,D(2) dopamine receptor,5.89,5.89,1300.0,1,9
372912,CHEMBL1437,NOREPINEPHRINE,126,CHEMBL230,Prostaglandin G/H synthase 2,5.62,5.62,2400.0,1,8
14263,CHEMBL14370,REBOXETINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,8.96,8.38,1.1,11,9
14263,CHEMBL14370,REBOXETINE,121,CHEMBL228,Sodium-dependent serotonin transporter,8.05,6.58,9.0,11,9
14263,CHEMBL14370,REBOXETINE,155,CHEMBL238,Sodium-dependent dopamine transporter,7.22,7.22,60.0,1,8
13949,CHEMBL14376,ILOPERIDONE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,9.52,9.02,0.3,2,8
13949,CHEMBL14376,ILOPERIDONE,125,CHEMBL229,Alpha-1A adrenergic receptor,8.74,8.43,1.8,3,8
13949,CHEMBL14376,ILOPERIDONE,88,CHEMBL2056,D(1A) dopamine receptor,8.0,7.58,10.0,2,8
13949,CHEMBL14376,ILOPERIDONE,130,CHEMBL234,D(3) dopamine receptor,8.0,7.71,9.9,2,8
13949,CHEMBL14376,ILOPERIDONE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.75,7.75,18.0,1,8
13949,CHEMBL14376,ILOPERIDONE,90,CHEMBL219,D(4) dopamine receptor,7.68,7.68,20.9,1,8
13949,CHEMBL14376,ILOPERIDONE,127,CHEMBL231,Histamine H1 receptor,7.35,7.35,44.7,1,8
13949,CHEMBL14376,ILOPERIDONE,72,CHEMBL217,D(2) dopamine receptor,7.34,7.15,45.4,2,8
13949,CHEMBL14376,ILOPERIDONE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.26,7.11,55.0,3,8
13949,CHEMBL14376,ILOPERIDONE,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.22,6.77,60.0,3,8
13949,CHEMBL14376,ILOPERIDONE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,7.19,7.19,64.0,1,8
13949,CHEMBL14376,ILOPERIDONE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.98,6.98,105.5,1,8
13949,CHEMBL14376,ILOPERIDONE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.82,6.82,150.0,1,8
13949,CHEMBL14376,ILOPERIDONE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.59,6.59,257.0,1,8
13949,CHEMBL14376,ILOPERIDONE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.54,6.49,290.0,2,8
13949,CHEMBL14376,ILOPERIDONE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.09,6.09,802.7,1,8
13949,CHEMBL14376,ILOPERIDONE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.92,5.86,1190.0,2,8
13949,CHEMBL14376,ILOPERIDONE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.75,5.75,1800.0,1,8
13949,CHEMBL14376,ILOPERIDONE,10670,CHEMBL1882,Neuronal acetylcholine receptor subunit alpha-4,5.7,5.7,2000.0,1,8
13949,CHEMBL14376,ILOPERIDONE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.66,5.66,2180.0,1,8
866306,CHEMBL1442422,DIBENZEPIN,127,CHEMBL231,Histamine H1 receptor,7.7,7.7,20.0,1,9
866306,CHEMBL1442422,DIBENZEPIN,103657,CHEMBL1293224,Microtubule-associated protein tau,6.8,6.8,158.5,1,9
866306,CHEMBL1442422,DIBENZEPIN,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.67,6.67,211.8,1,8
866306,CHEMBL1442422,DIBENZEPIN,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.51,6.05,306.0,2,9
866306,CHEMBL1442422,DIBENZEPIN,121,CHEMBL228,Sodium-dependent serotonin transporter,5.88,5.88,1319.5,1,8
866306,CHEMBL1442422,DIBENZEPIN,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.58,5.58,2621.3,1,8
374548,CHEMBL1444,LETROZOLE,65,CHEMBL1978,Aromatase,10.7,8.36,0.02,48,9
374548,CHEMBL1444,LETROZOLE,11541,CHEMBL2722,"Cytochrome P450 11B2, mitochondrial",5.85,5.85,1420.0,1,9
374548,CHEMBL1444,LETROZOLE,76,CHEMBL1908,"Cytochrome P450 11B1, mitochondrial",5.58,5.58,2620.0,1,9
377718,CHEMBL1445,FLUOXYMESTERONE,56,CHEMBL1871,Androgen receptor,9.52,8.88,0.3,2,9
377718,CHEMBL1445,FLUOXYMESTERONE,36,CHEMBL208,Progesterone receptor,7.13,7.13,74.0,1,8
377718,CHEMBL1445,FLUOXYMESTERONE,25,CHEMBL2034,Glucocorticoid receptor,7.06,7.06,88.0,1,8
871699,CHEMBL1447815,INDIUM CHLORIDE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,7.4,7.4,39.8,1,9
871699,CHEMBL1447815,INDIUM CHLORIDE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.3,6.3,501.2,1,9
378218,CHEMBL1448,NICLOSAMIDE,103668,CHEMBL1293235,Prelamin-A/C,7.6,6.3,25.1,4,9
378218,CHEMBL1448,NICLOSAMIDE,104568,CHEMBL2046267,Anoctamin-1,7.55,7.55,28.0,1,9
378218,CHEMBL1448,NICLOSAMIDE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,7.4,7.4,39.8,1,9
378218,CHEMBL1448,NICLOSAMIDE,103710,CHEMBL1293277,NPC intracellular cholesterol transporter 1,7.4,7.29,39.8,2,9
378218,CHEMBL1448,NICLOSAMIDE,103727,CHEMBL1293294,Ras-related protein Rab-9A,7.1,7.05,79.4,2,9
378218,CHEMBL1448,NICLOSAMIDE,103689,CHEMBL1293256,Thrombopoietin,7.0,7.0,100.0,2,9
378218,CHEMBL1448,NICLOSAMIDE,103665,CHEMBL1293232,Survival motor neuron protein,6.9,6.9,125.9,1,9
378218,CHEMBL1448,NICLOSAMIDE,11472,CHEMBL4026,Signal transducer and activator of transcription 3,6.68,6.33,210.0,3,9
378218,CHEMBL1448,NICLOSAMIDE,103711,CHEMBL1293278,Geminin,6.5,6.5,316.2,1,9
378218,CHEMBL1448,NICLOSAMIDE,103731,CHEMBL1293298,Peripheral myelin protein 22,6.42,6.42,379.3,1,9
378218,CHEMBL1448,NICLOSAMIDE,12912,CHEMBL3622,Cytochrome P450 2C19,6.4,6.4,398.1,2,9
378218,CHEMBL1448,NICLOSAMIDE,78,CHEMBL1963,Thyrotropin receptor,6.3,6.15,501.2,4,9
378218,CHEMBL1448,NICLOSAMIDE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,6.3,6.3,501.2,1,9
378218,CHEMBL1448,NICLOSAMIDE,20053,CHEMBL4096,Cellular tumor antigen p53,6.3,6.07,501.2,3,9
378218,CHEMBL1448,NICLOSAMIDE,12911,CHEMBL3397,Cytochrome P450 2C9,6.2,5.9,630.96,4,9
378218,CHEMBL1448,NICLOSAMIDE,101216,CHEMBL5514,Huntingtin,6.1,6.1,794.3,1,9
378218,CHEMBL1448,NICLOSAMIDE,11400,CHEMBL2842,Serine/threonine-protein kinase mTOR,5.93,5.8,1166.8,2,9
378218,CHEMBL1448,NICLOSAMIDE,12594,CHEMBL3356,Cytochrome P450 1A2,5.9,5.9,1258.93,1,8
378218,CHEMBL1448,NICLOSAMIDE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.85,5.85,1400.0,1,8
378218,CHEMBL1448,NICLOSAMIDE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.82,5.82,1500.0,1,8
378218,CHEMBL1448,NICLOSAMIDE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,5.7,5.65,1995.3,4,9
378218,CHEMBL1448,NICLOSAMIDE,17045,CHEMBL340,Cytochrome P450 3A4,5.6,5.55,2511.89,6,9
378218,CHEMBL1448,NICLOSAMIDE,103134,CHEMBL1075189,Pyruvate kinase PKM,5.5,5.5,3162.3,2,9
378218,CHEMBL1448,NICLOSAMIDE,103657,CHEMBL1293224,Microtubule-associated protein tau,5.5,5.5,3162.3,1,9
872071,CHEMBL1448187,FLUPHENAZINE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,8.35,8.35,4.5,1,9
378315,CHEMBL1450,ATOVAQUONE,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,6.64,6.64,230.0,1,9
378315,CHEMBL1450,ATOVAQUONE,157,CHEMBL1966,"Dihydroorotate dehydrogenase (quinone), mitochondrial",5.58,5.58,2600.0,2,9
381691,CHEMBL1451,TRIAMCINOLONE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.35,8.35,4.5,2,9
381691,CHEMBL1451,TRIAMCINOLONE,25,CHEMBL2034,Glucocorticoid receptor,8.04,7.2,9.1,4,8
381691,CHEMBL1451,TRIAMCINOLONE,103668,CHEMBL1293235,Prelamin-A/C,7.65,7.65,22.4,1,9
381691,CHEMBL1451,TRIAMCINOLONE,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,7.55,7.55,28.2,2,9
381691,CHEMBL1451,TRIAMCINOLONE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,7.5,7.5,31.6,2,9
876580,CHEMBL1452696,FEPRAZONE,96,CHEMBL221,Prostaglandin G/H synthase 1,6.58,6.58,260.0,1,8
384948,CHEMBL1454,LEVAMISOLE,88,CHEMBL2056,D(1A) dopamine receptor,5.8,5.8,1600.0,1,8
878794,CHEMBL1454910,NITROXOLINE,10702,CHEMBL3922,Methionine aminopeptidase 2,7.26,7.26,55.0,2,9
878794,CHEMBL1454910,NITROXOLINE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.4,6.4,398.1,1,9
878794,CHEMBL1454910,NITROXOLINE,103668,CHEMBL1293235,Prelamin-A/C,6.05,6.05,891.3,1,9
878794,CHEMBL1454910,NITROXOLINE,103454,CHEMBL1163125,Bromodomain-containing protein 4,6.01,6.01,980.0,3,9
878794,CHEMBL1454910,NITROXOLINE,126,CHEMBL230,Prostaglandin G/H synthase 2,6.0,6.0,1000.0,1,9
878794,CHEMBL1454910,NITROXOLINE,11213,CHEMBL3880,Heat shock protein HSP 90-alpha,6.0,6.0,996.0,1,8
878794,CHEMBL1454910,NITROXOLINE,103659,CHEMBL1293226,Lysine-specific demethylase 4E,5.55,5.55,2818.4,1,9
878794,CHEMBL1454910,NITROXOLINE,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",5.5,5.5,3200.0,1,8
386327,CHEMBL1455,ALTRETAMINE,271,CHEMBL1947,Thyroid hormone receptor beta,8.8,8.8,1.6,1,9
386327,CHEMBL1455,ALTRETAMINE,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,6.5,6.5,316.2,1,9
386327,CHEMBL1455,ALTRETAMINE,103668,CHEMBL1293235,Prelamin-A/C,6.1,6.1,794.3,1,9
386327,CHEMBL1455,ALTRETAMINE,12594,CHEMBL3356,Cytochrome P450 1A2,5.7,5.7,1995.26,1,8
388373,CHEMBL1457,HYDROCODONE,129,CHEMBL233,Mu-type opioid receptor,8.02,7.08,9.5,3,9
388373,CHEMBL1457,HYDROCODONE,137,CHEMBL237,Kappa-type opioid receptor,6.58,6.35,260.0,2,9
244737,CHEMBL146095,GLAFENINE,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",6.77,6.77,170.0,1,8
244737,CHEMBL146095,GLAFENINE,280,CHEMBL256,Adenosine receptor A3,5.86,5.86,1395.3,1,8
244737,CHEMBL146095,GLAFENINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.85,5.85,1400.0,1,8
887229,CHEMBL1463345,CANRENONE,36,CHEMBL208,Progesterone receptor,6.7,6.7,200.0,1,8
887229,CHEMBL1463345,CANRENONE,25,CHEMBL2034,Glucocorticoid receptor,5.89,5.89,1300.0,1,8
394165,CHEMBL1464,WARFARIN,224,CHEMBL1930,Vitamin K epoxide reductase complex subunit 1,8.06,7.02,8.8,2,9
394165,CHEMBL1464,WARFARIN,10697,CHEMBL3253,Albumin,5.7,5.7,2000.0,1,9
394231,CHEMBL1466,DICUMAROL,13055,CHEMBL3623,NAD(P)H dehydrogenase [quinone] 1,8.59,7.07,2.6,6,9
394231,CHEMBL1466,DICUMAROL,12911,CHEMBL3397,Cytochrome P450 2C9,7.6,6.73,25.1,5,9
394231,CHEMBL1466,DICUMAROL,103700,CHEMBL1293267,G-protein coupled receptor 35,7.41,6.4,39.0,3,9
394231,CHEMBL1466,DICUMAROL,103668,CHEMBL1293235,Prelamin-A/C,7.3,7.3,50.1,1,9
394231,CHEMBL1466,DICUMAROL,11126,CHEMBL2232,Proprotein convertase subtilisin/kexin type 7,5.89,5.89,1300.0,1,8
395607,CHEMBL1467,ALLOPURINOL,149,CHEMBL1929,Xanthine dehydrogenase/oxidase,8.46,6.19,3.5,34,9
395607,CHEMBL1467,ALLOPURINOL,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,6.4,6.4,398.1,2,9
395607,CHEMBL1467,ALLOPURINOL,103665,CHEMBL1293232,Survival motor neuron protein,6.0,6.0,1000.0,1,9
395607,CHEMBL1467,ALLOPURINOL,103727,CHEMBL1293294,Ras-related protein Rab-9A,6.0,6.0,1000.0,1,9
395607,CHEMBL1467,ALLOPURINOL,125,CHEMBL229,Alpha-1A adrenergic receptor,5.54,5.54,2879.2,1,8
397873,CHEMBL1469,PHENYLBUTANOIC ACID,103665,CHEMBL1293232,Survival motor neuron protein,5.95,5.95,1122.0,1,9
397873,CHEMBL1469,PHENYLBUTANOIC ACID,155,CHEMBL238,Sodium-dependent dopamine transporter,5.5,5.5,3200.0,1,8
399361,CHEMBL1471,APREPITANT,250,CHEMBL249,Substance-P receptor,10.1,9.7,0.07943,16,9
399361,CHEMBL1471,APREPITANT,17045,CHEMBL340,Cytochrome P450 3A4,7.7,7.61,20.0,4,9
399361,CHEMBL1471,APREPITANT,10982,CHEMBL4429,Neuromedin-K receptor,6.34,6.34,454.1,1,9
399361,CHEMBL1471,APREPITANT,116042,CHEMBL3714081,Psychosine receptor,5.73,5.73,1873.6,1,9
400344,CHEMBL1472,PROTIRELIN,260,CHEMBL1810,Thyrotropin-releasing hormone receptor,8.52,8.11,3.0,2,8
896873,CHEMBL1472989,BISOPROLOL FUMARATE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,8.3,8.3,5.0,1,9
896873,CHEMBL1472989,BISOPROLOL FUMARATE,103668,CHEMBL1293235,Prelamin-A/C,7.3,7.3,50.1,1,9
896873,CHEMBL1472989,BISOPROLOL FUMARATE,271,CHEMBL1947,Thyroid hormone receptor beta,5.85,5.85,1412.5,1,9
401141,CHEMBL1473,FLUTICASONE PROPIONATE,25,CHEMBL2034,Glucocorticoid receptor,10.4,9.53,0.04,8,9
401141,CHEMBL1473,FLUTICASONE PROPIONATE,36,CHEMBL208,Progesterone receptor,8.42,8.03,3.8,3,9
401141,CHEMBL1473,FLUTICASONE PROPIONATE,56,CHEMBL1871,Androgen receptor,6.88,6.88,130.7,1,8
401141,CHEMBL1473,FLUTICASONE PROPIONATE,48,CHEMBL1994,Mineralocorticoid receptor,6.83,6.83,149.0,1,9
401141,CHEMBL1473,FLUTICASONE PROPIONATE,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,6.0,6.0,1000.0,1,8
898773,CHEMBL1474889,CLOBUTINOL,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,6.82,6.82,149.9,1,9
898847,CHEMBL1474963,BENZARONE,102767,CHEMBL6120,Solute carrier family 22 member 12,5.55,5.55,2800.0,1,9
402531,CHEMBL1475,TRIOXSALEN,103659,CHEMBL1293226,Lysine-specific demethylase 4E,6.55,6.55,281.8,1,9
402531,CHEMBL1475,TRIOXSALEN,86,CHEMBL1951,Amine oxidase [flavin-containing] A,6.14,6.11,720.0,2,8
402531,CHEMBL1475,TRIOXSALEN,252,CHEMBL251,Adenosine receptor A2a,6.13,6.0,737.0,2,8
402531,CHEMBL1475,TRIOXSALEN,12594,CHEMBL3356,Cytochrome P450 1A2,6.0,6.0,1000.0,1,8
402531,CHEMBL1475,TRIOXSALEN,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.91,5.77,1234.0,2,8
403465,CHEMBL1477,CERIVASTATIN,24,CHEMBL402,3-hydroxy-3-methylglutaryl-coenzyme A reductase,10.07,9.04,0.085,2,9
405364,CHEMBL1479,DANAZOL,12643,CHEMBL3305,Sex hormone-binding globulin,8.2,8.2,6.31,1,9
405364,CHEMBL1479,DANAZOL,100611,CHEMBL3491,Cytochrome P450 2J2,7.92,7.61,12.0,4,9
405364,CHEMBL1479,DANAZOL,36,CHEMBL208,Progesterone receptor,7.72,7.72,19.0,1,8
405364,CHEMBL1479,DANAZOL,25,CHEMBL2034,Glucocorticoid receptor,6.96,6.33,111.0,2,8
405364,CHEMBL1479,DANAZOL,12911,CHEMBL3397,Cytochrome P450 2C9,6.52,6.18,300.0,2,9
405364,CHEMBL1479,DANAZOL,10163,CHEMBL3721,Cytochrome P450 2C8,5.71,5.71,1950.0,1,9
405364,CHEMBL1479,DANAZOL,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.6,5.6,2528.0,1,8
405364,CHEMBL1479,DANAZOL,11365,CHEMBL289,Cytochrome P450 2D6,5.56,5.56,2740.0,1,9
405365,CHEMBL1480,FELODIPINE,280,CHEMBL256,Adenosine receptor A3,6.22,6.1,597.0,2,8
405365,CHEMBL1480,FELODIPINE,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.72,5.72,1900.0,1,9
405365,CHEMBL1480,FELODIPINE,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,5.6,5.6,2504.0,1,8
405365,CHEMBL1480,FELODIPINE,36,CHEMBL208,Progesterone receptor,5.58,5.58,2600.0,1,8
405365,CHEMBL1480,FELODIPINE,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",5.5,5.5,3200.0,1,8
405366,CHEMBL1481,GLIMEPIRIDE,100481,CHEMBL4681,Aldo-keto reductase family 1 member C3,6.07,6.07,850.0,1,9
406787,CHEMBL1483,ALBENDAZOLE,12594,CHEMBL3356,Cytochrome P450 1A2,6.4,6.4,398.11,1,8
406787,CHEMBL1483,ALBENDAZOLE,103668,CHEMBL1293235,Prelamin-A/C,6.4,6.18,398.1,2,9
406787,CHEMBL1483,ALBENDAZOLE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,6.0,6.0,1000.0,1,9
407549,CHEMBL1484,NICARDIPINE,169,CHEMBL1940,Voltage-dependent L-type calcium channel subunit alpha-1C,6.6,6.6,250.0,1,9
407549,CHEMBL1484,NICARDIPINE,12911,CHEMBL3397,Cytochrome P450 2C9,6.55,6.38,280.0,3,9
407549,CHEMBL1484,NICARDIPINE,17045,CHEMBL340,Cytochrome P450 3A4,6.42,6.4,380.0,2,9
407549,CHEMBL1484,NICARDIPINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.4,6.4,397.0,1,8
407549,CHEMBL1484,NICARDIPINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.37,6.37,424.4,1,8
407549,CHEMBL1484,NICARDIPINE,12912,CHEMBL3622,Cytochrome P450 2C19,6.25,6.25,560.0,1,9
407549,CHEMBL1484,NICARDIPINE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.13,6.13,746.9,1,8
407549,CHEMBL1484,NICARDIPINE,11398,CHEMBL4302,ATP-dependent translocase ABCB1,6.02,5.7,950.0,4,8
407549,CHEMBL1484,NICARDIPINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.91,5.91,1241.4,1,8
407549,CHEMBL1484,NICARDIPINE,36,CHEMBL208,Progesterone receptor,5.82,5.82,1511.5,1,8
407549,CHEMBL1484,NICARDIPINE,10163,CHEMBL3721,Cytochrome P450 2C8,5.81,5.81,1560.0,1,9
407549,CHEMBL1484,NICARDIPINE,11365,CHEMBL289,Cytochrome P450 2D6,5.8,5.78,1590.0,2,9
407549,CHEMBL1484,NICARDIPINE,280,CHEMBL256,Adenosine receptor A3,5.77,5.77,1695.5,1,8
407549,CHEMBL1484,NICARDIPINE,100611,CHEMBL3491,Cytochrome P450 2J2,5.77,5.77,1690.0,1,9
407549,CHEMBL1484,NICARDIPINE,88,CHEMBL2056,D(1A) dopamine receptor,5.72,5.72,1883.3,1,8
407549,CHEMBL1484,NICARDIPINE,103668,CHEMBL1293235,Prelamin-A/C,5.7,5.7,1995.3,1,9
407549,CHEMBL1484,NICARDIPINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.66,5.66,2174.8,1,8
407549,CHEMBL1484,NICARDIPINE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.56,5.56,2740.2,1,8
407549,CHEMBL1484,NICARDIPINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.5,5.5,3200.0,1,8
417180,CHEMBL1487,ATORVASTATIN,24,CHEMBL402,3-hydroxy-3-methylglutaryl-coenzyme A reductase,9.64,8.38,0.227,5,9
417180,CHEMBL1487,ATORVASTATIN,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,6.22,6.04,600.0,3,9
418401,CHEMBL1489,AZACITIDINE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.8,8.8,1.6,2,9
418401,CHEMBL1489,AZACITIDINE,11400,CHEMBL2842,Serine/threonine-protein kinase mTOR,6.93,6.53,116.7,2,9
418401,CHEMBL1489,AZACITIDINE,321,CHEMBL1993,DNA (cytosine-5)-methyltransferase 1,6.52,6.52,300.0,1,9
418401,CHEMBL1489,AZACITIDINE,11544,CHEMBL4331,Hemoglobin subunit beta,5.9,5.9,1258.9,1,9
418401,CHEMBL1489,AZACITIDINE,103668,CHEMBL1293235,Prelamin-A/C,5.8,5.65,1584.9,2,9
418401,CHEMBL1489,AZACITIDINE,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,5.65,5.65,2238.7,2,9
418401,CHEMBL1489,AZACITIDINE,20053,CHEMBL4096,Cellular tumor antigen p53,5.5,5.5,3162.3,1,9
418401,CHEMBL1489,AZACITIDINE,103689,CHEMBL1293256,Thrombopoietin,5.5,5.5,3162.3,2,9
418401,CHEMBL1489,AZACITIDINE,103711,CHEMBL1293278,Geminin,5.5,5.5,3162.3,1,9
418411,CHEMBL1490,TRIHEXYPHENIDYL,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,9.12,8.69,0.764,2,8
418411,CHEMBL1490,TRIHEXYPHENIDYL,61,CHEMBL216,Muscarinic acetylcholine receptor M1,8.87,8.55,1.351,3,8
418411,CHEMBL1490,TRIHEXYPHENIDYL,219,CHEMBL245,Muscarinic acetylcholine receptor M3,8.5,8.16,3.151,2,8
418411,CHEMBL1490,TRIHEXYPHENIDYL,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,8.06,7.99,8.679,2,8
418411,CHEMBL1490,TRIHEXYPHENIDYL,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.92,7.73,12.0,3,8
418411,CHEMBL1490,TRIHEXYPHENIDYL,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,7.35,7.16,45.0,2,8
418411,CHEMBL1490,TRIHEXYPHENIDYL,11365,CHEMBL289,Cytochrome P450 2D6,5.61,5.61,2449.8,1,8
418414,CHEMBL1491,AMLODIPINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.65,6.18,226.0,3,8
418414,CHEMBL1491,AMLODIPINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.58,6.17,261.0,2,8
418414,CHEMBL1491,AMLODIPINE,105604,CHEMBL2321615,Potassium channel subfamily K member 2,6.4,6.4,400.0,1,9
418414,CHEMBL1491,AMLODIPINE,137,CHEMBL237,Kappa-type opioid receptor,5.94,5.94,1155.4,1,8
418414,CHEMBL1491,AMLODIPINE,169,CHEMBL1940,Voltage-dependent L-type calcium channel subunit alpha-1C,5.92,5.92,1200.0,1,8
418414,CHEMBL1491,AMLODIPINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,5.87,5.7,1346.0,3,8
418414,CHEMBL1491,AMLODIPINE,43,CHEMBL210,Beta-2 adrenergic receptor,5.75,5.75,1800.0,1,8
418414,CHEMBL1491,AMLODIPINE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.72,5.67,1889.1,2,8
418414,CHEMBL1491,AMLODIPINE,144,CHEMBL1899,5-hydroxytryptamine receptor 3A,5.64,5.64,2300.0,1,8
418414,CHEMBL1491,AMLODIPINE,130,CHEMBL234,D(3) dopamine receptor,5.55,5.55,2800.0,1,8
418414,CHEMBL1491,AMLODIPINE,72,CHEMBL217,D(2) dopamine receptor,5.54,5.54,2900.0,1,8
418414,CHEMBL1491,AMLODIPINE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.51,5.51,3088.2,1,8
418482,CHEMBL1492,DIPHENYLPYRALINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.01,7.01,97.9,1,8
418482,CHEMBL1492,DIPHENYLPYRALINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.76,6.76,172.7,1,8
418482,CHEMBL1492,DIPHENYLPYRALINE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.36,6.36,437.4,1,8
418482,CHEMBL1492,DIPHENYLPYRALINE,130,CHEMBL234,D(3) dopamine receptor,6.14,6.14,723.2,1,8
418482,CHEMBL1492,DIPHENYLPYRALINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.72,5.72,1907.0,1,8
418484,CHEMBL1493,FLAVOXATE,130,CHEMBL234,D(3) dopamine receptor,6.05,6.05,880.1,1,8
418484,CHEMBL1493,FLAVOXATE,103668,CHEMBL1293235,Prelamin-A/C,5.9,5.9,1258.9,1,9
418484,CHEMBL1493,FLAVOXATE,129,CHEMBL233,Mu-type opioid receptor,5.52,5.52,3046.0,1,8
418484,CHEMBL1493,FLAVOXATE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.51,5.51,3112.9,1,8
418489,CHEMBL1495,OXYPHENCYCLIMINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.72,7.72,19.0,1,8
418489,CHEMBL1495,OXYPHENCYCLIMINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.58,7.37,26.3,2,8
418489,CHEMBL1495,OXYPHENCYCLIMINE,127,CHEMBL231,Histamine H1 receptor,6.0,6.0,990.0,1,8
418845,CHEMBL1496,ROSUVASTATIN,24,CHEMBL402,3-hydroxy-3-methylglutaryl-coenzyme A reductase,9.05,8.38,0.9,6,9
418845,CHEMBL1496,ROSUVASTATIN,10605,CHEMBL3860,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta",5.9,5.9,1250.0,1,9
419410,CHEMBL1497,BETAMETHASONE VALERATE,25,CHEMBL2034,Glucocorticoid receptor,8.4,8.4,4.0,1,8
419410,CHEMBL1497,BETAMETHASONE VALERATE,36,CHEMBL208,Progesterone receptor,6.89,6.89,130.0,1,8
419542,CHEMBL1501,FLUOCINONIDE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,9.0,9.0,1.0,2,9
419542,CHEMBL1501,FLUOCINONIDE,25,CHEMBL2034,Glucocorticoid receptor,8.62,8.45,2.392,2,8
419542,CHEMBL1501,FLUOCINONIDE,36,CHEMBL208,Progesterone receptor,7.7,7.7,20.2,1,8
419542,CHEMBL1501,FLUOCINONIDE,56,CHEMBL1871,Androgen receptor,6.2,6.2,627.1,1,8
419598,CHEMBL1502,PANTOPRAZOLE,103668,CHEMBL1293235,Prelamin-A/C,5.9,5.9,1258.9,1,9
419598,CHEMBL1502,PANTOPRAZOLE,104063,CHEMBL1743122,Solute carrier family 22 member 2,5.82,5.82,1500.0,1,9
419598,CHEMBL1502,PANTOPRAZOLE,104067,CHEMBL1743126,Multidrug and toxin extrusion protein 1,5.55,5.55,2800.0,2,9
419601,CHEMBL1503,OMEPRAZOLE,103665,CHEMBL1293232,Survival motor neuron protein,5.85,5.85,1412.5,1,9
419601,CHEMBL1503,OMEPRAZOLE,12912,CHEMBL3622,Cytochrome P450 2C19,5.68,5.62,2080.0,4,9
419601,CHEMBL1503,OMEPRAZOLE,280,CHEMBL256,Adenosine receptor A3,5.54,5.54,2876.8,1,8
419601,CHEMBL1503,OMEPRAZOLE,100468,CHEMBL4361,Induced myeloid leukemia cell differentiation protein Mcl-1,5.5,5.5,3144.81,1,9
419622,CHEMBL1504,TRIAMCINOLONE ACETONIDE,25,CHEMBL2034,Glucocorticoid receptor,8.7,8.49,2.006,4,8
419622,CHEMBL1504,TRIAMCINOLONE ACETONIDE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,8.0,8.0,10.0,2,9
419622,CHEMBL1504,TRIAMCINOLONE ACETONIDE,36,CHEMBL208,Progesterone receptor,7.7,7.7,20.0,1,8
420985,CHEMBL1505,ALMOTRIPTAN,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.29,6.29,510.0,1,8
421007,CHEMBL1508,ESCITALOPRAM,121,CHEMBL228,Sodium-dependent serotonin transporter,9.0,8.55,1.0,9,9
421007,CHEMBL1508,ESCITALOPRAM,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,9.0,8.13,1.0,2,9
421007,CHEMBL1508,ESCITALOPRAM,17045,CHEMBL340,Cytochrome P450 3A4,6.0,6.0,1000.0,3,9
421007,CHEMBL1508,ESCITALOPRAM,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,5.95,5.95,1122.0,2,9
421007,CHEMBL1508,ESCITALOPRAM,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.8,5.8,1600.0,1,8
421007,CHEMBL1508,ESCITALOPRAM,127,CHEMBL231,Histamine H1 receptor,5.57,5.57,2700.0,1,8
421007,CHEMBL1508,ESCITALOPRAM,12911,CHEMBL3397,Cytochrome P450 2C9,5.5,5.5,3162.28,2,9
421007,CHEMBL1508,ESCITALOPRAM,12912,CHEMBL3622,Cytochrome P450 2C19,5.5,5.5,3162.28,2,9
421032,CHEMBL1509,DROSPIRENONE,36,CHEMBL208,Progesterone receptor,8.21,7.79,6.1,2,8
421032,CHEMBL1509,DROSPIRENONE,25,CHEMBL2034,Glucocorticoid receptor,7.11,7.11,78.0,1,8
421032,CHEMBL1509,DROSPIRENONE,56,CHEMBL1871,Androgen receptor,6.2,6.2,630.0,1,9
421034,CHEMBL1510,ELETRIPTAN,106,CHEMBL1898,5-hydroxytryptamine receptor 1B,7.93,7.93,11.64,1,9
421034,CHEMBL1510,ELETRIPTAN,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.67,7.67,21.4,1,8
421038,CHEMBL1511,ESTRADIOL VALERATE,56,CHEMBL1871,Androgen receptor,7.34,7.34,46.0,1,8
421038,CHEMBL1511,ESTRADIOL VALERATE,19,CHEMBL206,Estrogen receptor,7.08,7.08,82.2,1,8
421038,CHEMBL1511,ESTRADIOL VALERATE,36,CHEMBL208,Progesterone receptor,6.63,6.63,234.4,1,8
421038,CHEMBL1511,ESTRADIOL VALERATE,103657,CHEMBL1293224,Microtubule-associated protein tau,5.8,5.8,1584.9,1,9
421058,CHEMBL1512,FLUNISOLIDE,25,CHEMBL2034,Glucocorticoid receptor,8.62,8.19,2.423,3,8
421058,CHEMBL1512,FLUNISOLIDE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.32,7.32,48.0,1,8
421058,CHEMBL1512,FLUNISOLIDE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.25,6.25,560.0,1,8
421058,CHEMBL1512,FLUNISOLIDE,36,CHEMBL208,Progesterone receptor,6.19,6.19,640.0,1,8
421058,CHEMBL1512,FLUNISOLIDE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.7,5.7,2000.0,1,8
421066,CHEMBL1513,IRBESARTAN,115,CHEMBL227,Type-1 angiotensin II receptor,9.1,8.72,0.8,11,9
421066,CHEMBL1513,IRBESARTAN,103668,CHEMBL1293235,Prelamin-A/C,6.4,6.4,398.1,1,9
421066,CHEMBL1513,IRBESARTAN,10868,CHEMBL3191,Leukotriene B4 receptor 2,6.39,6.39,410.0,1,9
421066,CHEMBL1513,IRBESARTAN,10977,CHEMBL2608,Lysosomal alpha-glucosidase,6.35,6.35,446.7,2,9
421070,CHEMBL1514,LEVOMETHADYL ACETATE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.66,5.66,2187.76,1,8
421089,CHEMBL1515,METHIMAZOLE,103668,CHEMBL1293235,Prelamin-A/C,8.7,8.7,2.0,1,9
421089,CHEMBL1515,METHIMAZOLE,101375,CHEMBL5898,Lactoperoxidase,6.29,6.29,510.0,1,9
421089,CHEMBL1515,METHIMAZOLE,96,CHEMBL221,Prostaglandin G/H synthase 1,6.27,6.27,541.1,1,8
421089,CHEMBL1515,METHIMAZOLE,103665,CHEMBL1293232,Survival motor neuron protein,6.15,6.15,707.9,1,9
940358,CHEMBL1516474,TEGASEROD MALEATE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.81,7.81,15.62,1,9
940358,CHEMBL1516474,TEGASEROD MALEATE,105,CHEMBL1983,5-hydroxytryptamine receptor 1D,7.3,7.3,50.13,1,9
940358,CHEMBL1516474,TEGASEROD MALEATE,117512,CHEMBL4105907,Sigma intracellular receptor 2,7.24,7.24,57.24,1,9
940358,CHEMBL1516474,TEGASEROD MALEATE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.08,7.08,83.91,1,9
940358,CHEMBL1516474,TEGASEROD MALEATE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.85,6.85,141.51,1,9
940358,CHEMBL1516474,TEGASEROD MALEATE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.75,6.75,177.15,1,9
940358,CHEMBL1516474,TEGASEROD MALEATE,90,CHEMBL219,D(4) dopamine receptor,6.72,6.72,190.63,1,9
940358,CHEMBL1516474,TEGASEROD MALEATE,10624,CHEMBL3426,5-hydroxytryptamine receptor 5A,6.7,6.7,200.91,1,9
940358,CHEMBL1516474,TEGASEROD MALEATE,72,CHEMBL217,D(2) dopamine receptor,6.53,6.53,296.96,1,9
940358,CHEMBL1516474,TEGASEROD MALEATE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.37,6.37,431.42,1,9
940358,CHEMBL1516474,TEGASEROD MALEATE,130,CHEMBL234,D(3) dopamine receptor,6.37,6.37,426.48,1,9
940358,CHEMBL1516474,TEGASEROD MALEATE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.25,6.25,565.85,1,9
940358,CHEMBL1516474,TEGASEROD MALEATE,103,CHEMBL223,Alpha-1D adrenergic receptor,5.79,5.79,1638.89,1,9
940358,CHEMBL1516474,TEGASEROD MALEATE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.79,5.79,1632.3,1,9
940358,CHEMBL1516474,TEGASEROD MALEATE,128,CHEMBL232,Alpha-1B adrenergic receptor,5.58,5.58,2613.36,1,9
940358,CHEMBL1516474,TEGASEROD MALEATE,129,CHEMBL233,Mu-type opioid receptor,5.55,5.55,2846.43,1,9
940358,CHEMBL1516474,TEGASEROD MALEATE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.55,5.55,2836.61,1,9
421157,CHEMBL1517,OXYTETRACYCLINE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.4,6.4,398.1,1,9
421157,CHEMBL1517,OXYTETRACYCLINE,10206,CHEMBL2392,DNA polymerase beta,5.55,5.55,2818.4,1,9
421208,CHEMBL1518,PROPYLTHIOURACIL,118998,CHEMBL4523248,Taste receptor type 2 member 38,5.7,5.7,2000.0,1,9
421208,CHEMBL1518,PROPYLTHIOURACIL,10567,CHEMBL2439,Myeloperoxidase,5.55,5.55,2810.0,1,9
421208,CHEMBL1518,PROPYLTHIOURACIL,12912,CHEMBL3622,Cytochrome P450 2C19,5.5,5.5,3162.3,1,9
421317,CHEMBL1519,TRANDOLAPRIL,69,CHEMBL1808,Angiotensin-converting enzyme,9.03,9.03,0.93,1,8
421326,CHEMBL1520,VARDENAFIL,3,CHEMBL1827,"cGMP-specific 3',5'-cyclic phosphodiesterase",10.54,9.35,0.029,11,9
421326,CHEMBL1520,VARDENAFIL,12448,CHEMBL2717,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",6.89,6.75,130.0,2,9
421326,CHEMBL1520,VARDENAFIL,20035,CHEMBL3535,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",6.34,6.25,460.0,2,9
421326,CHEMBL1520,VARDENAFIL,100010,CHEMBL4409,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",6.1,6.08,790.0,2,9
421326,CHEMBL1520,VARDENAFIL,114,CHEMBL226,Adenosine receptor A1,6.0,6.0,1010.0,1,8
421326,CHEMBL1520,VARDENAFIL,10594,CHEMBL2652,"cGMP-dependent 3',5'-cyclic phosphodiesterase",5.51,5.51,3100.0,1,9
421334,CHEMBL1522,ESZOPICLONE,74,CHEMBL1962,Gamma-aminobutyric acid receptor subunit alpha-1,7.3,7.3,50.1,1,8
421334,CHEMBL1522,ESZOPICLONE,11191,CHEMBL2472,Gamma-aminobutyric acid receptor subunit alpha-4,6.99,6.99,102.0,1,8
947848,CHEMBL1523964,EPHEDRINE SULFATE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.65,6.65,223.9,1,9
947848,CHEMBL1523964,EPHEDRINE SULFATE,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,6.3,6.3,501.2,1,9
947848,CHEMBL1523964,EPHEDRINE SULFATE,103688,CHEMBL1293255,15-hydroxyprostaglandin dehydrogenase [NAD(+)],6.1,5.97,794.3,2,9
948157,CHEMBL1524273,PHTHALYLSULFATHIAZOLE,17045,CHEMBL340,Cytochrome P450 3A4,8.9,8.89,1.259,3,9
426067,CHEMBL1529,DIPHENIDOL HYDROCHLORIDE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.37,6.37,426.58,1,9
426067,CHEMBL1529,DIPHENIDOL HYDROCHLORIDE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.04,6.04,912.01,1,9
426067,CHEMBL1529,DIPHENIDOL HYDROCHLORIDE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,5.95,5.95,1122.02,1,9
426067,CHEMBL1529,DIPHENIDOL HYDROCHLORIDE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,5.89,5.89,1288.25,1,9
426067,CHEMBL1529,DIPHENIDOL HYDROCHLORIDE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.55,5.55,2818.38,1,9
954312,CHEMBL1530428,DEXAMETHASONE ACETATE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,8.1,8.1,7.9,2,9
954312,CHEMBL1530428,DEXAMETHASONE ACETATE,25,CHEMBL2034,Glucocorticoid receptor,7.85,7.85,14.0,1,8
954312,CHEMBL1530428,DEXAMETHASONE ACETATE,103665,CHEMBL1293232,Survival motor neuron protein,5.6,5.6,2511.9,1,9
428747,CHEMBL1531,ETONOGESTREL,36,CHEMBL208,Progesterone receptor,8.52,8.52,3.0,1,8
428747,CHEMBL1531,ETONOGESTREL,12643,CHEMBL3305,Sex hormone-binding globulin,8.23,8.23,5.888,1,9
428747,CHEMBL1531,ETONOGESTREL,56,CHEMBL1871,Androgen receptor,8.11,8.11,7.8,1,8
429174,CHEMBL1533,DESOGESTREL,36,CHEMBL208,Progesterone receptor,8.52,8.52,3.0,2,8
429174,CHEMBL1533,DESOGESTREL,56,CHEMBL1871,Androgen receptor,6.92,6.92,120.0,1,8
429174,CHEMBL1533,DESOGESTREL,25,CHEMBL2034,Glucocorticoid receptor,6.85,6.85,140.0,1,8
429174,CHEMBL1533,DESOGESTREL,12643,CHEMBL3305,Sex hormone-binding globulin,6.6,6.6,251.19,1,9
429174,CHEMBL1533,DESOGESTREL,19,CHEMBL206,Estrogen receptor,6.25,5.89,560.0,2,8
429174,CHEMBL1533,DESOGESTREL,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.74,5.74,1830.0,1,8
429174,CHEMBL1533,DESOGESTREL,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.72,5.72,1890.0,1,8
429174,CHEMBL1533,DESOGESTREL,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.62,5.62,2400.0,1,8
957194,CHEMBL1533310,HISTAMINE DIHYDROCHLORIDE,10280,CHEMBL264,Histamine H3 receptor,8.48,7.5,3.311,6,9
957194,CHEMBL1533310,HISTAMINE DIHYDROCHLORIDE,11290,CHEMBL3759,Histamine H4 receptor,7.9,7.31,12.59,12,9
957194,CHEMBL1533310,HISTAMINE DIHYDROCHLORIDE,102,CHEMBL1941,Histamine H2 receptor,5.9,5.9,1258.93,1,9
429737,CHEMBL1535,HYDROXYCHLOROQUINE,101567,CHEMBL5804,Toll-like receptor 9,6.96,6.96,110.0,1,9
429737,CHEMBL1535,HYDROXYCHLOROQUINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.9,6.9,125.89,1,9
429737,CHEMBL1535,HYDROXYCHLOROQUINE,11848,CHEMBL3736,Angiotensin-converting enzyme 2,6.14,6.14,720.0,1,9
429737,CHEMBL1535,HYDROXYCHLOROQUINE,101608,CHEMBL5936,Toll-like receptor 7,6.1,6.1,800.0,2,9
429737,CHEMBL1535,HYDROXYCHLOROQUINE,117512,CHEMBL4105907,Sigma intracellular receptor 2,6.0,6.0,1000.0,1,9
429737,CHEMBL1535,HYDROXYCHLOROQUINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.98,5.76,1049.0,2,8
429737,CHEMBL1535,HYDROXYCHLOROQUINE,103,CHEMBL223,Alpha-1D adrenergic receptor,5.63,5.63,2346.0,1,8
429737,CHEMBL1535,HYDROXYCHLOROQUINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.6,5.6,2511.89,1,9
51056,CHEMBL154,NAPROXEN,96,CHEMBL221,Prostaglandin G/H synthase 1,7.18,6.52,65.9,5,9
51056,CHEMBL154,NAPROXEN,100481,CHEMBL4681,Aldo-keto reductase family 1 member C3,6.75,6.45,180.0,4,9
51056,CHEMBL154,NAPROXEN,78,CHEMBL1963,Thyrotropin receptor,6.1,6.1,794.3,2,9
51056,CHEMBL154,NAPROXEN,126,CHEMBL230,Prostaglandin G/H synthase 2,6.05,5.73,900.0,4,9
51056,CHEMBL154,NAPROXEN,101351,CHEMBL5847,Aldo-keto reductase family 1 member C2,5.9,5.9,1260.0,2,9
430642,CHEMBL1541,CEFIXIME,11943,CHEMBL3964,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",5.92,5.92,1212.0,1,8
431141,CHEMBL1542,AZATHIOPRINE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,6.7,6.7,199.5,2,9
431141,CHEMBL1542,AZATHIOPRINE,11544,CHEMBL4331,Hemoglobin subunit beta,6.5,5.91,316.2,7,9
431141,CHEMBL1542,AZATHIOPRINE,103668,CHEMBL1293235,Prelamin-A/C,6.4,6.4,398.1,1,9
431141,CHEMBL1542,AZATHIOPRINE,20053,CHEMBL4096,Cellular tumor antigen p53,6.1,5.8,794.3,2,9
431141,CHEMBL1542,AZATHIOPRINE,103665,CHEMBL1293232,Survival motor neuron protein,5.8,5.8,1584.9,1,9
431141,CHEMBL1542,AZATHIOPRINE,103711,CHEMBL1293278,Geminin,5.75,5.75,1778.3,1,9
433015,CHEMBL1544,LIOTHYRONINE,59,CHEMBL1860,Thyroid hormone receptor alpha,10.24,8.99,0.058,25,9
433015,CHEMBL1544,LIOTHYRONINE,271,CHEMBL1947,Thyroid hormone receptor beta,10.1,8.98,0.08,24,9
433015,CHEMBL1544,LIOTHYRONINE,11,CHEMBL204,Prothrombin,8.92,8.68,1.2,3,9
433015,CHEMBL1544,LIOTHYRONINE,114,CHEMBL226,Adenosine receptor A1,6.62,6.18,239.7,3,8
433015,CHEMBL1544,LIOTHYRONINE,133,CHEMBL235,Peroxisome proliferator-activated receptor gamma,6.15,6.15,710.0,1,9
433015,CHEMBL1544,LIOTHYRONINE,101097,CHEMBL5162,Neuropeptide S receptor,6.1,6.1,794.3,2,9
433015,CHEMBL1544,LIOTHYRONINE,103668,CHEMBL1293235,Prelamin-A/C,5.55,5.55,2818.4,1,9
442013,CHEMBL1551,URSODIOL,104248,CHEMBL1795168,CDGSH iron-sulfur domain-containing protein 1,5.95,5.95,1134.0,1,9
442013,CHEMBL1551,URSODIOL,100857,CHEMBL5409,G-protein coupled bile acid receptor 1,5.62,5.62,2390.0,1,9
442943,CHEMBL1554,DACTINOMYCIN,101216,CHEMBL5514,Huntingtin,7.5,7.5,31.6,1,9
442943,CHEMBL1554,DACTINOMYCIN,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,6.6,6.6,251.2,1,9
442943,CHEMBL1554,DACTINOMYCIN,103665,CHEMBL1293232,Survival motor neuron protein,6.5,6.5,316.2,1,9
442943,CHEMBL1554,DACTINOMYCIN,103669,CHEMBL1293236,ATP-dependent DNA helicase Q1,5.85,5.85,1412.5,1,9
443255,CHEMBL1555,GALANTAMINE HYDROBROMIDE,93,CHEMBL220,Acetylcholinesterase,5.58,5.54,2600.0,2,9
444077,CHEMBL1557,DOPAMINE HYDROCHLORIDE,72,CHEMBL217,D(2) dopamine receptor,9.2,7.17,0.631,9,9
444077,CHEMBL1557,DOPAMINE HYDROCHLORIDE,90,CHEMBL219,D(4) dopamine receptor,8.15,7.81,7.079,2,9
444077,CHEMBL1557,DOPAMINE HYDROCHLORIDE,130,CHEMBL234,D(3) dopamine receptor,7.9,7.76,12.59,2,9
444077,CHEMBL1557,DOPAMINE HYDROCHLORIDE,88,CHEMBL2056,D(1A) dopamine receptor,7.43,7.43,37.0,1,9
444077,CHEMBL1557,DOPAMINE HYDROCHLORIDE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.85,6.52,141.3,3,9
444077,CHEMBL1557,DOPAMINE HYDROCHLORIDE,103657,CHEMBL1293224,Microtubule-associated protein tau,6.45,6.08,354.8,3,9
444077,CHEMBL1557,DOPAMINE HYDROCHLORIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,6.0,6.0,1000.0,2,9
444077,CHEMBL1557,DOPAMINE HYDROCHLORIDE,220,CHEMBL1850,D(1B) dopamine receptor,5.99,5.96,1023.29,2,9
444077,CHEMBL1557,DOPAMINE HYDROCHLORIDE,103669,CHEMBL1293236,ATP-dependent DNA helicase Q1,5.95,5.95,1122.0,1,9
444077,CHEMBL1557,DOPAMINE HYDROCHLORIDE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.94,5.94,1144.73,1,9
444077,CHEMBL1557,DOPAMINE HYDROCHLORIDE,103985,CHEMBL1741189,FAD-linked sulfhydryl oxidase ALR,5.85,5.85,1422.0,1,8
444077,CHEMBL1557,DOPAMINE HYDROCHLORIDE,10977,CHEMBL2608,Lysosomal alpha-glucosidase,5.7,5.7,1980.0,1,9
444191,CHEMBL1558,PRAZOSIN HYDROCHLORIDE,125,CHEMBL229,Alpha-1A adrenergic receptor,8.79,8.79,1.626,1,9
444191,CHEMBL1558,PRAZOSIN HYDROCHLORIDE,128,CHEMBL232,Alpha-1B adrenergic receptor,8.69,8.69,2.033,1,9
444191,CHEMBL1558,PRAZOSIN HYDROCHLORIDE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.4,6.4,396.5,1,9
444191,CHEMBL1558,PRAZOSIN HYDROCHLORIDE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.21,6.21,617.94,1,9
444191,CHEMBL1558,PRAZOSIN HYDROCHLORIDE,10624,CHEMBL3426,5-hydroxytryptamine receptor 5A,6.1,6.1,799.65,1,9
444191,CHEMBL1558,PRAZOSIN HYDROCHLORIDE,129,CHEMBL233,Mu-type opioid receptor,5.75,5.75,1791.02,1,9
444191,CHEMBL1558,PRAZOSIN HYDROCHLORIDE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,5.53,5.53,2966.54,1,9
444419,CHEMBL1559,MICONAZOLE NITRATE,103669,CHEMBL1293236,ATP-dependent DNA helicase Q1,7.55,7.55,28.2,1,9
444419,CHEMBL1559,MICONAZOLE NITRATE,17045,CHEMBL340,Cytochrome P450 3A4,6.4,6.4,398.1,2,9
444750,CHEMBL1560,CAPTOPRIL,69,CHEMBL1808,Angiotensin-converting enzyme,9.92,7.74,0.12,34,9
444750,CHEMBL1560,CAPTOPRIL,11225,CHEMBL286,Renin,8.77,8.77,1.7,1,9
444750,CHEMBL1560,CAPTOPRIL,11,CHEMBL204,Prothrombin,7.32,7.32,48.0,1,8
444750,CHEMBL1560,CAPTOPRIL,237,CHEMBL4618,Leukotriene A-4 hydrolase,7.16,7.16,70.0,1,9
444750,CHEMBL1560,CAPTOPRIL,127,CHEMBL231,Histamine H1 receptor,6.28,6.28,530.0,1,8
445681,CHEMBL1561,MIGLITOL,10977,CHEMBL2608,Lysosomal alpha-glucosidase,6.46,5.89,350.0,5,9
445681,CHEMBL1561,MIGLITOL,11997,CHEMBL2748,"Sucrase-isomaltase, intestinal",6.3,6.3,500.0,1,8
445681,CHEMBL1561,MIGLITOL,1,CHEMBL2074,Maltase-glucoamylase,6.0,6.0,1000.0,1,9
986494,CHEMBL1562610,MECLOFENAMATE SODIUM,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.4,8.4,4.0,2,9
986494,CHEMBL1562610,MECLOFENAMATE SODIUM,126,CHEMBL230,Prostaglandin G/H synthase 2,8.25,8.25,5.64,1,9
986494,CHEMBL1562610,MECLOFENAMATE SODIUM,271,CHEMBL1947,Thyroid hormone receptor beta,6.35,6.35,446.7,1,9
986494,CHEMBL1562610,MECLOFENAMATE SODIUM,12911,CHEMBL3397,Cytochrome P450 2C9,5.9,5.9,1258.9,2,9
446279,CHEMBL1563,DAUNORUBICIN HYDROCHLORIDE,103665,CHEMBL1293232,Survival motor neuron protein,6.65,6.35,223.9,2,9
446279,CHEMBL1563,DAUNORUBICIN HYDROCHLORIDE,105688,CHEMBL2362976,Protein S100-A4,6.63,6.63,235.0,1,8
446279,CHEMBL1563,DAUNORUBICIN HYDROCHLORIDE,103710,CHEMBL1293277,NPC intracellular cholesterol transporter 1,6.5,6.5,316.2,1,9
446279,CHEMBL1563,DAUNORUBICIN HYDROCHLORIDE,103727,CHEMBL1293294,Ras-related protein Rab-9A,6.3,6.3,501.2,1,9
446279,CHEMBL1563,DAUNORUBICIN HYDROCHLORIDE,105692,CHEMBL2362980,Paired box protein Pax-8,5.81,5.81,1550.0,1,8
446279,CHEMBL1563,DAUNORUBICIN HYDROCHLORIDE,78,CHEMBL1963,Thyrotropin receptor,5.7,5.7,1995.3,2,9
446279,CHEMBL1563,DAUNORUBICIN HYDROCHLORIDE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,5.6,5.6,2511.9,2,9
450864,CHEMBL1567,SUNITINIB MALATE,197,CHEMBL1913,Platelet-derived growth factor receptor beta,8.7,8.7,2.0,1,9
450864,CHEMBL1567,SUNITINIB MALATE,12840,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,7.92,7.92,12.0,1,8
450864,CHEMBL1567,SUNITINIB MALATE,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,7.1,7.1,80.0,1,9
991941,CHEMBL1568057,METAPROTERENOL SULFATE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,5.6,5.6,2511.9,2,9
992160,CHEMBL1568276,NAFCILLIN SODIUM,103668,CHEMBL1293235,Prelamin-A/C,6.2,5.93,631.0,2,9
452635,CHEMBL1569,AMANTADINE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,8.35,8.35,4.5,1,9
452635,CHEMBL1569,AMANTADINE HYDROCHLORIDE,271,CHEMBL1947,Thyroid hormone receptor beta,8.05,8.05,8.9,1,9
452635,CHEMBL1569,AMANTADINE HYDROCHLORIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,7.95,7.95,11.2,2,9
452635,CHEMBL1569,AMANTADINE HYDROCHLORIDE,103665,CHEMBL1293232,Survival motor neuron protein,5.8,5.8,1584.9,1,9
255904,CHEMBL157101,KETOCONAZOLE,17045,CHEMBL340,Cytochrome P450 3A4,9.05,7.32,0.9,153,9
255904,CHEMBL157101,KETOCONAZOLE,11365,CHEMBL289,Cytochrome P450 2D6,8.73,7.64,1.86,3,9
255904,CHEMBL157101,KETOCONAZOLE,103668,CHEMBL1293235,Prelamin-A/C,7.95,7.95,11.2,1,9
255904,CHEMBL157101,KETOCONAZOLE,11188,CHEMBL3849,Lanosterol 14-alpha demethylase,7.61,7.09,24.5,5,9
255904,CHEMBL157101,KETOCONAZOLE,12949,CHEMBL3522,"Steroid 17-alpha-hydroxylase/17,20 lyase",7.58,6.41,26.0,38,9
255904,CHEMBL157101,KETOCONAZOLE,100474,CHEMBL4521,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",7.48,6.6,33.0,12,9
255904,CHEMBL157101,KETOCONAZOLE,65,CHEMBL1978,Aromatase,7.4,6.07,40.0,15,9
255904,CHEMBL157101,KETOCONAZOLE,11541,CHEMBL2722,"Cytochrome P450 11B2, mitochondrial",7.17,7.06,67.0,14,9
255904,CHEMBL157101,KETOCONAZOLE,76,CHEMBL1908,"Cytochrome P450 11B1, mitochondrial",6.94,6.79,116.0,11,9
255904,CHEMBL157101,KETOCONAZOLE,12739,CHEMBL3019,Cytochrome P450 3A5,6.92,6.52,120.0,7,9
255904,CHEMBL157101,KETOCONAZOLE,115648,CHEMBL3713687,Cytochrome P450 26B1,6.85,6.85,140.0,1,8
255904,CHEMBL157101,KETOCONAZOLE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.55,6.39,282.0,3,8
255904,CHEMBL157101,KETOCONAZOLE,102646,CHEMBL5993,"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial",6.47,6.47,340.0,1,9
255904,CHEMBL157101,KETOCONAZOLE,11213,CHEMBL3880,Heat shock protein HSP 90-alpha,6.36,6.36,435.0,1,8
255904,CHEMBL157101,KETOCONAZOLE,100146,CHEMBL5141,Cytochrome P450 26A1,6.18,6.18,660.0,1,9
255904,CHEMBL157101,KETOCONAZOLE,10743,CHEMBL3379,Cytochrome P450 4F2,6.13,5.96,740.0,2,9
255904,CHEMBL157101,KETOCONAZOLE,11398,CHEMBL4302,ATP-dependent translocase ABCB1,6.0,5.95,1000.0,5,9
255904,CHEMBL157101,KETOCONAZOLE,103665,CHEMBL1293232,Survival motor neuron protein,5.85,5.85,1412.5,1,9
255904,CHEMBL157101,KETOCONAZOLE,10163,CHEMBL3721,Cytochrome P450 2C8,5.81,5.71,1560.0,2,9
255904,CHEMBL157101,KETOCONAZOLE,25,CHEMBL2034,Glucocorticoid receptor,5.72,5.72,1900.0,1,8
255904,CHEMBL157101,KETOCONAZOLE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.72,5.72,1900.0,6,9
255904,CHEMBL157101,KETOCONAZOLE,248,CHEMBL1835,Thromboxane-A synthase,5.67,5.67,2165.0,1,9
255904,CHEMBL157101,KETOCONAZOLE,119244,CHEMBL4523494,7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase,5.66,5.66,2200.0,1,9
255904,CHEMBL157101,KETOCONAZOLE,12911,CHEMBL3397,Cytochrome P450 2C9,5.59,5.59,2570.0,1,9
255904,CHEMBL157101,KETOCONAZOLE,101283,CHEMBL5685,Solute carrier family 22 member 1,5.58,5.58,2600.0,1,9
255904,CHEMBL157101,KETOCONAZOLE,102394,CHEMBL6020,Bile salt export pump,5.54,5.54,2900.0,1,9
16510,CHEMBL15770,SULINDAC,103668,CHEMBL1293235,Prelamin-A/C,8.25,8.25,5.6,1,9
16510,CHEMBL15770,SULINDAC,11638,CHEMBL4040,Mitogen-activated protein kinase 1,7.4,7.4,39.8,1,9
16510,CHEMBL15770,SULINDAC,12912,CHEMBL3622,Cytochrome P450 2C19,6.7,6.7,199.5,2,9
16510,CHEMBL15770,SULINDAC,242,CHEMBL1900,Aldo-keto reductase family 1 member B1,6.43,6.43,374.0,1,9
16510,CHEMBL15770,SULINDAC,102688,CHEMBL5845,Glycine receptor subunit alpha-1,6.42,6.42,380.0,1,9
16510,CHEMBL15770,SULINDAC,106142,CHEMBL2364163,Complement C5,6.24,6.24,570.0,1,9
16510,CHEMBL15770,SULINDAC,17045,CHEMBL340,Cytochrome P450 3A4,6.2,6.2,631.0,2,9
453573,CHEMBL1578,ANISOTROPINE METHYLBROMIDE,103665,CHEMBL1293232,Survival motor neuron protein,6.0,6.0,1000.0,1,9
453578,CHEMBL1580,PENTOSTATIN,14,CHEMBL1910,Adenosine deaminase,10.59,10.09,0.026,4,9
453578,CHEMBL1580,PENTOSTATIN,114,CHEMBL226,Adenosine receptor A1,6.39,6.39,410.0,1,8
453579,CHEMBL1581,PERINDOPRIL,69,CHEMBL1808,Angiotensin-converting enzyme,8.82,8.63,1.5,2,9
453721,CHEMBL1584,PIPERACETAZINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.92,7.22,12.0,2,8
453721,CHEMBL1584,PIPERACETAZINE,72,CHEMBL217,D(2) dopamine receptor,7.89,7.89,13.0,1,8
453721,CHEMBL1584,PIPERACETAZINE,130,CHEMBL234,D(3) dopamine receptor,7.77,7.77,17.0,1,8
453721,CHEMBL1584,PIPERACETAZINE,127,CHEMBL231,Histamine H1 receptor,7.47,7.47,34.0,1,8
453721,CHEMBL1584,PIPERACETAZINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.38,7.38,42.1,2,8
453721,CHEMBL1584,PIPERACETAZINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.17,7.17,68.0,1,8
453721,CHEMBL1584,PIPERACETAZINE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.85,6.8,140.0,2,8
453721,CHEMBL1584,PIPERACETAZINE,11365,CHEMBL289,Cytochrome P450 2D6,6.7,6.7,199.5,2,9
453721,CHEMBL1584,PIPERACETAZINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.43,6.43,370.0,1,8
453721,CHEMBL1584,PIPERACETAZINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.3,6.3,500.0,1,8
453721,CHEMBL1584,PIPERACETAZINE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.89,5.89,1300.0,1,8
453721,CHEMBL1584,PIPERACETAZINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.75,5.75,1800.0,1,8
453721,CHEMBL1584,PIPERACETAZINE,11307,CHEMBL1865,Histone deacetylase 6,5.66,5.66,2187.0,1,9
453722,CHEMBL1585,PIPOBROMAN,17045,CHEMBL340,Cytochrome P450 3A4,7.2,7.2,63.1,2,9
453722,CHEMBL1585,PIPOBROMAN,103668,CHEMBL1293235,Prelamin-A/C,6.3,6.3,501.2,1,9
453722,CHEMBL1585,PIPOBROMAN,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,6.05,6.05,891.3,1,9
16599,CHEMBL15870,INDOPROFEN,103710,CHEMBL1293277,NPC intracellular cholesterol transporter 1,7.05,7.05,89.1,1,9
16599,CHEMBL15870,INDOPROFEN,10977,CHEMBL2608,Lysosomal alpha-glucosidase,6.75,6.75,177.8,2,9
16599,CHEMBL15870,INDOPROFEN,103727,CHEMBL1293294,Ras-related protein Rab-9A,6.5,6.5,316.2,1,9
16599,CHEMBL15870,INDOPROFEN,88,CHEMBL2056,D(1A) dopamine receptor,6.29,6.29,510.0,1,8
16599,CHEMBL15870,INDOPROFEN,11307,CHEMBL1865,Histone deacetylase 6,6.29,6.29,512.7,1,9
16599,CHEMBL15870,INDOPROFEN,103665,CHEMBL1293232,Survival motor neuron protein,5.9,5.9,1258.9,1,9
16599,CHEMBL15870,INDOPROFEN,101216,CHEMBL5514,Huntingtin,5.7,5.68,1995.3,2,9
454070,CHEMBL1589,ACETOHEXAMIDE,271,CHEMBL1947,Thyroid hormone receptor beta,8.6,8.6,2.5,1,9
454070,CHEMBL1589,ACETOHEXAMIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.55,8.55,2.8,2,9
454070,CHEMBL1589,ACETOHEXAMIDE,78,CHEMBL1963,Thyrotropin receptor,8.2,8.2,6.3,2,9
16654,CHEMBL15891,LINDANE,11881,CHEMBL1847,Gamma-aminobutyric acid receptor subunit beta-3,9.05,9.05,0.9,1,9
16654,CHEMBL15891,LINDANE,13064,CHEMBL3561,Gamma-aminobutyric acid receptor subunit rho-1,7.04,7.04,91.0,1,9
71516,CHEMBL159,VINBLASTINE,11398,CHEMBL4302,ATP-dependent translocase ABCB1,7.0,5.96,100.0,5,8
71516,CHEMBL159,VINBLASTINE,96,CHEMBL221,Prostaglandin G/H synthase 1,6.21,6.21,623.8,1,8
71516,CHEMBL159,VINBLASTINE,248,CHEMBL1835,Thromboxane-A synthase,5.73,5.73,1870.0,1,9
454076,CHEMBL1590,PSEUDOEPHEDRINE,78,CHEMBL1963,Thyrotropin receptor,6.9,6.9,125.9,1,9
454076,CHEMBL1590,PSEUDOEPHEDRINE,12054,CHEMBL2903,Polyunsaturated fatty acid lipoxygenase ALOX15,6.4,6.4,398.1,1,9
454076,CHEMBL1590,PSEUDOEPHEDRINE,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,6.2,6.0,631.0,2,9
454076,CHEMBL1590,PSEUDOEPHEDRINE,12911,CHEMBL3397,Cytochrome P450 2C9,6.1,6.1,794.3,1,9
454076,CHEMBL1590,PSEUDOEPHEDRINE,12912,CHEMBL3622,Cytochrome P450 2C19,5.8,5.8,1584.9,1,9
454076,CHEMBL1590,PSEUDOEPHEDRINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.79,5.79,1624.7,1,8
454076,CHEMBL1590,PSEUDOEPHEDRINE,11134,CHEMBL3687,Polyunsaturated fatty acid lipoxygenase ALOX12,5.5,5.5,3162.3,1,9
454076,CHEMBL1590,PSEUDOEPHEDRINE,103689,CHEMBL1293256,Thrombopoietin,5.5,5.5,3162.3,2,9
454084,CHEMBL1591,DEMECLOCYCLINE,105661,CHEMBL2331065,Alpha-ketoglutarate-dependent dioxygenase FTO,5.86,5.86,1390.0,1,9
454141,CHEMBL1592,QUINAPRIL,69,CHEMBL1808,Angiotensin-converting enzyme,8.08,8.08,8.3,4,8
1015985,CHEMBL1592101,BISMUTH SUBGALLATE,103668,CHEMBL1293235,Prelamin-A/C,6.1,6.1,794.3,1,9
265957,CHEMBL159226,MOXISYLYTE,103134,CHEMBL1075189,Pyruvate kinase PKM,7.9,7.9,12.6,2,9
265957,CHEMBL159226,MOXISYLYTE,127,CHEMBL231,Histamine H1 receptor,5.96,5.96,1100.0,1,8
265957,CHEMBL159226,MOXISYLYTE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.52,5.52,3000.0,1,8
265957,CHEMBL159226,MOXISYLYTE,12594,CHEMBL3356,Cytochrome P450 1A2,5.5,5.5,3162.28,1,8
454382,CHEMBL1597,DIMERCAPROL,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,7.0,7.0,100.0,1,9
454382,CHEMBL1597,DIMERCAPROL,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,6.0,5.75,1000.0,2,9
921,CHEMBL16,PHENYTOIN,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.66,8.66,2.2,2,9
72873,CHEMBL160,CYCLOSPORINE,180,CHEMBL1949,Peptidyl-prolyl cis-trans isomerase A,8.82,7.79,1.5,35,9
72873,CHEMBL160,CYCLOSPORINE,103936,CHEMBL1697657,Peptidyl-prolyl cis-trans isomerase D,8.59,8.02,2.58,7,9
72873,CHEMBL160,CYCLOSPORINE,12579,CHEMBL4445,Protein phosphatase 3 catalytic subunit alpha,8.4,7.57,4.0,2,8
72873,CHEMBL160,CYCLOSPORINE,10257,CHEMBL2430,Peptidyl-prolyl cis-trans isomerase FKBP1B,8.22,8.22,6.0,1,8
72873,CHEMBL160,CYCLOSPORINE,97,CHEMBL2075,Peptidyl-prolyl cis-trans isomerase B,8.06,8.04,8.78,2,9
72873,CHEMBL160,CYCLOSPORINE,11751,CHEMBL4050,Peptidyl-prolyl cis-trans isomerase FKBP4,7.8,7.8,16.0,1,8
72873,CHEMBL160,CYCLOSPORINE,80,CHEMBL1902,Peptidyl-prolyl cis-trans isomerase FKBP1A,7.7,7.7,20.0,1,8
72873,CHEMBL160,CYCLOSPORINE,11398,CHEMBL4302,ATP-dependent translocase ABCB1,7.7,6.17,20.0,50,9
72873,CHEMBL160,CYCLOSPORINE,104062,CHEMBL1743121,Solute carrier organic anion transporter family member 1B3,6.89,6.23,130.0,3,9
72873,CHEMBL160,CYCLOSPORINE,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,6.7,6.22,200.0,10,9
72873,CHEMBL160,CYCLOSPORINE,17045,CHEMBL340,Cytochrome P450 3A4,6.52,5.99,300.0,5,9
72873,CHEMBL160,CYCLOSPORINE,102394,CHEMBL6020,Bile salt export pump,6.4,6.25,400.0,7,9
72873,CHEMBL160,CYCLOSPORINE,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,6.3,6.03,500.0,2,9
72873,CHEMBL160,CYCLOSPORINE,102723,CHEMBL5918,ATP-binding cassette sub-family C member 3,6.2,6.2,631.5,1,9
72873,CHEMBL160,CYCLOSPORINE,250,CHEMBL249,Substance-P receptor,6.0,6.0,987.5,1,8
72873,CHEMBL160,CYCLOSPORINE,100159,CHEMBL5287,Hepatic sodium/bile acid cotransporter,6.0,6.0,1000.0,1,8
72873,CHEMBL160,CYCLOSPORINE,101097,CHEMBL5162,Neuropeptide S receptor,6.0,6.0,1000.0,1,9
72873,CHEMBL160,CYCLOSPORINE,100997,CHEMBL5503,Nuclear receptor subfamily 1 group I member 3,5.92,5.92,1200.0,1,8
72873,CHEMBL160,CYCLOSPORINE,10184,CHEMBL2327,Substance-K receptor,5.86,5.86,1380.0,1,8
72873,CHEMBL160,CYCLOSPORINE,12030,CHEMBL3004,Multidrug resistance-associated protein 1,5.85,5.63,1412.0,6,9
72873,CHEMBL160,CYCLOSPORINE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.55,5.55,2826.9,1,8
72873,CHEMBL160,CYCLOSPORINE,101311,CHEMBL5748,ATP-binding cassette sub-family C member 2,5.51,5.51,3100.0,1,8
456266,CHEMBL1607,TOPOTECAN HYDROCHLORIDE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,6.6,6.6,251.2,2,9
456266,CHEMBL1607,TOPOTECAN HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,6.6,6.6,251.2,1,9
456266,CHEMBL1607,TOPOTECAN HYDROCHLORIDE,103665,CHEMBL1293232,Survival motor neuron protein,6.55,6.32,281.8,2,9
456266,CHEMBL1607,TOPOTECAN HYDROCHLORIDE,62,CHEMBL1781,DNA topoisomerase 1,5.97,5.97,1080.0,1,8
456266,CHEMBL1607,TOPOTECAN HYDROCHLORIDE,11624,CHEMBL4801,Caspase-1,5.5,5.5,3162.3,1,9
456266,CHEMBL1607,TOPOTECAN HYDROCHLORIDE,12067,CHEMBL3468,Caspase-7,5.5,5.5,3162.3,1,9
16498,CHEMBL16073,PHENACETIN,12594,CHEMBL3356,Cytochrome P450 1A2,8.31,7.84,4.9,5,9
1031364,CHEMBL1607480,OXYTETRACYCLINE HYDROCHLORIDE,12054,CHEMBL2903,Polyunsaturated fatty acid lipoxygenase ALOX15,6.4,6.4,398.1,1,9
1031364,CHEMBL1607480,OXYTETRACYCLINE HYDROCHLORIDE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.3,6.3,501.2,1,9
1031364,CHEMBL1607480,OXYTETRACYCLINE HYDROCHLORIDE,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,6.1,6.1,794.3,1,9
16727,CHEMBL16080,TRICHLOROETHANE,78,CHEMBL1963,Thyrotropin receptor,6.1,6.1,794.3,2,9
83724,CHEMBL161,CEFTRIAXONE,103829,CHEMBL1641347,Solute carrier family 22 member 6,6.64,6.64,230.0,1,8
83724,CHEMBL161,CEFTRIAXONE,102780,CHEMBL6152,Alpha-synuclein,6.28,6.28,530.0,1,9
83724,CHEMBL161,CEFTRIAXONE,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,6.21,6.0,620.0,2,8
83724,CHEMBL161,CEFTRIAXONE,133,CHEMBL235,Peroxisome proliferator-activated receptor gamma,5.85,5.85,1400.0,1,8
83724,CHEMBL161,CEFTRIAXONE,104618,CHEMBL2073677,Solute carrier family 22 member 11,5.62,5.62,2380.0,1,8
458912,CHEMBL1611,PHENYTOIN SODIUM,103732,CHEMBL1293299,Histone-lysine N-methyltransferase 2A,7.3,7.3,50.1,1,9
458912,CHEMBL1611,PHENYTOIN SODIUM,10693,CHEMBL2524,Alpha-galactosidase A,5.95,5.95,1122.0,1,9
465356,CHEMBL1614,DESLANOSIDE,103657,CHEMBL1293224,Microtubule-associated protein tau,7.1,7.1,79.4,1,9
1037712,CHEMBL1614701,SELUMETINIB,11409,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,8.05,7.46,9.0,10,9
1037712,CHEMBL1614701,SELUMETINIB,11046,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,7.28,6.53,52.0,4,9
1037712,CHEMBL1614701,SELUMETINIB,117495,CHEMBL4105890,Structural maintenance of chromosomes protein 2,6.68,6.68,209.0,1,9
1037712,CHEMBL1614701,SELUMETINIB,117352,CHEMBL4105747,Structural maintenance of chromosomes protein 1A,6.44,6.44,365.0,1,9
1037712,CHEMBL1614701,SELUMETINIB,117538,CHEMBL4105933,Uncharacterized protein FLJ45252,6.09,6.09,807.0,1,9
1037712,CHEMBL1614701,SELUMETINIB,30000,CHEMBL3830,AP2-associated protein kinase 1,5.89,5.89,1279.0,1,9
1037712,CHEMBL1614701,SELUMETINIB,30042,CHEMBL4522,BMP-2-inducible protein kinase,5.79,5.79,1624.0,1,9
1037712,CHEMBL1614701,SELUMETINIB,9,CHEMBL203,Epidermal growth factor receptor,5.66,5.59,2200.0,2,8
1037712,CHEMBL1614701,SELUMETINIB,12780,CHEMBL4070,Casein kinase II subunit alpha',5.55,5.55,2807.0,1,9
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,121,CHEMBL228,Sodium-dependent serotonin transporter,9.33,9.33,0.4705,1,9
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,7.85,7.85,14.21,1,9
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,7.81,7.81,15.48,1,9
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,155,CHEMBL238,Sodium-dependent dopamine transporter,7.66,7.66,21.81,1,9
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.5,7.5,31.64,1,9
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.19,7.19,65.01,1,9
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,130,CHEMBL234,D(3) dopamine receptor,6.88,6.88,133.28,1,9
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.56,6.56,278.07,1,9
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,127,CHEMBL231,Histamine H1 receptor,6.44,6.44,364.46,1,9
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,105,CHEMBL1983,5-hydroxytryptamine receptor 1D,6.43,6.43,368.59,1,9
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,72,CHEMBL217,D(2) dopamine receptor,6.26,6.26,552.71,1,9
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,103,CHEMBL223,Alpha-1D adrenergic receptor,6.14,6.14,716.31,1,9
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,129,CHEMBL233,Mu-type opioid receptor,6.14,6.14,729.62,1,9
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,6.1,6.1,793.78,1,9
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,90,CHEMBL219,D(4) dopamine receptor,6.08,6.08,823.76,1,9
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.02,6.02,960.06,1,9
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,117512,CHEMBL4105907,Sigma intracellular receptor 2,5.96,5.96,1089.05,1,9
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,106,CHEMBL1898,5-hydroxytryptamine receptor 1B,5.91,5.91,1244.8,1,9
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.86,5.86,1378.32,1,9
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,43,CHEMBL210,Beta-2 adrenergic receptor,5.6,5.6,2490.29,1,9
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.6,5.6,2494.41,1,9
1038357,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,128,CHEMBL232,Alpha-1B adrenergic receptor,5.54,5.54,2902.69,1,9
466768,CHEMBL1617,RIFAXIMIN,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.66,5.66,2200.0,1,9
467361,CHEMBL1619,CLADRIBINE,12690,CHEMBL4338,Purine nucleoside phosphorylase,8.64,8.64,2.3,1,9
467361,CHEMBL1619,CLADRIBINE,103668,CHEMBL1293235,Prelamin-A/C,7.3,6.52,50.1,3,9
467361,CHEMBL1619,CLADRIBINE,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",6.01,6.01,970.0,1,8
468199,CHEMBL1620,DIPHENHYDRAMINE HYDROCHLORIDE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,6.85,6.85,141.3,1,9
468199,CHEMBL1620,DIPHENHYDRAMINE HYDROCHLORIDE,103665,CHEMBL1293232,Survival motor neuron protein,5.95,5.95,1122.0,1,9
468656,CHEMBL1621,PALIPERIDONE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,9.08,8.68,0.83,2,9
468656,CHEMBL1621,PALIPERIDONE,72,CHEMBL217,D(2) dopamine receptor,8.8,8.44,1.6,2,9
468656,CHEMBL1621,PALIPERIDONE,218,CHEMBL1916,Alpha-2C adrenergic receptor,8.57,8.57,2.7,1,9
468656,CHEMBL1621,PALIPERIDONE,216,CHEMBL1942,Alpha-2B adrenergic receptor,8.4,8.4,4.0,1,9
468656,CHEMBL1621,PALIPERIDONE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,8.17,8.17,6.8,1,9
468656,CHEMBL1621,PALIPERIDONE,105,CHEMBL1983,5-hydroxytryptamine receptor 1D,8.14,8.14,7.3,1,9
468656,CHEMBL1621,PALIPERIDONE,130,CHEMBL234,D(3) dopamine receptor,8.12,8.12,7.5,1,9
468656,CHEMBL1621,PALIPERIDONE,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.96,7.96,11.0,1,9
468656,CHEMBL1621,PALIPERIDONE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.96,7.96,11.0,1,9
468656,CHEMBL1621,PALIPERIDONE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.72,7.72,19.0,1,9
468656,CHEMBL1621,PALIPERIDONE,220,CHEMBL1850,D(1B) dopamine receptor,7.54,7.54,29.0,1,9
468656,CHEMBL1621,PALIPERIDONE,127,CHEMBL231,Histamine H1 receptor,7.47,7.47,34.0,1,9
468656,CHEMBL1621,PALIPERIDONE,90,CHEMBL219,D(4) dopamine receptor,7.42,7.42,38.0,1,9
468656,CHEMBL1621,PALIPERIDONE,106,CHEMBL1898,5-hydroxytryptamine receptor 1B,6.96,6.96,111.0,1,9
468656,CHEMBL1621,PALIPERIDONE,88,CHEMBL2056,D(1A) dopamine receptor,6.26,6.26,554.0,1,9
468656,CHEMBL1621,PALIPERIDONE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.0,5.91,1000.0,6,9
1044548,CHEMBL1621597,IPRATROPIUM,47,CHEMBL211,Muscarinic acetylcholine receptor M2,9.1,8.9,0.7943,4,9
1044548,CHEMBL1621597,IPRATROPIUM,219,CHEMBL245,Muscarinic acetylcholine receptor M3,9.1,8.93,0.7943,2,9
1044548,CHEMBL1621597,IPRATROPIUM,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,8.89,8.89,1.3,1,8
1044548,CHEMBL1621597,IPRATROPIUM,61,CHEMBL216,Muscarinic acetylcholine receptor M1,8.68,8.54,2.11,3,9
1044548,CHEMBL1621597,IPRATROPIUM,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,8.52,8.52,3.0,1,8
469632,CHEMBL1623,MECLIZINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.38,6.38,413.3,1,8
469632,CHEMBL1623,MECLIZINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.11,6.11,777.5,1,8
469632,CHEMBL1623,MECLIZINE,130,CHEMBL234,D(3) dopamine receptor,6.02,6.02,950.0,1,8
469632,CHEMBL1623,MECLIZINE,127,CHEMBL231,Histamine H1 receptor,5.96,5.96,1100.0,1,8
469632,CHEMBL1623,MECLIZINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.94,5.94,1137.5,1,8
469632,CHEMBL1623,MECLIZINE,102,CHEMBL1941,Histamine H2 receptor,5.84,5.84,1454.3,1,8
469632,CHEMBL1623,MECLIZINE,87,CHEMBL218,Cannabinoid receptor 1,5.74,5.74,1839.8,1,8
469632,CHEMBL1623,MECLIZINE,104670,CHEMBL2079849,Serine protease hepsin,5.7,5.7,2020.0,1,8
469632,CHEMBL1623,MECLIZINE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.69,5.69,2062.2,1,8
469632,CHEMBL1623,MECLIZINE,72,CHEMBL217,D(2) dopamine receptor,5.51,5.51,3100.0,1,8
469690,CHEMBL1624,LEVOTHYROXINE,59,CHEMBL1860,Thyroid hormone receptor alpha,7.72,7.72,19.0,1,9
469690,CHEMBL1624,LEVOTHYROXINE,271,CHEMBL1947,Thyroid hormone receptor beta,6.62,6.62,240.0,1,9
469690,CHEMBL1624,LEVOTHYROXINE,133,CHEMBL235,Peroxisome proliferator-activated receptor gamma,6.4,6.4,400.0,1,9
469690,CHEMBL1624,LEVOTHYROXINE,103668,CHEMBL1293235,Prelamin-A/C,6.15,6.15,707.9,1,9
469690,CHEMBL1624,LEVOTHYROXINE,275,CHEMBL2061,Retinoic acid receptor RXR-alpha,6.03,6.03,930.0,1,9
469690,CHEMBL1624,LEVOTHYROXINE,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",5.75,5.75,1800.0,1,8
469690,CHEMBL1624,LEVOTHYROXINE,12704,CHEMBL3194,Transthyretin,5.66,5.66,2187.76,3,9
469732,CHEMBL1625,OXYBENZONE,12912,CHEMBL3622,Cytochrome P450 2C19,6.4,6.4,398.1,2,9
469732,CHEMBL1625,OXYBENZONE,12594,CHEMBL3356,Cytochrome P450 1A2,5.8,5.8,1584.89,1,8
469763,CHEMBL1626,CLEMASTINE,127,CHEMBL231,Histamine H1 receptor,10.31,9.39,0.049,3,8
469763,CHEMBL1626,CLEMASTINE,130,CHEMBL234,D(3) dopamine receptor,8.6,8.14,2.491,3,8
469763,CHEMBL1626,CLEMASTINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,8.56,7.84,2.773,3,9
469763,CHEMBL1626,CLEMASTINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,8.22,7.95,6.016,3,9
469763,CHEMBL1626,CLEMASTINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,8.15,7.62,7.1,3,9
469763,CHEMBL1626,CLEMASTINE,125,CHEMBL229,Alpha-1A adrenergic receptor,8.14,7.63,7.2,2,8
469763,CHEMBL1626,CLEMASTINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,8.08,7.17,8.253,4,9
469763,CHEMBL1626,CLEMASTINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.04,7.19,9.196,4,8
469763,CHEMBL1626,CLEMASTINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,8.0,7.77,10.0,3,9
469763,CHEMBL1626,CLEMASTINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.85,6.95,14.0,4,9
469763,CHEMBL1626,CLEMASTINE,103,CHEMBL223,Alpha-1D adrenergic receptor,7.82,7.66,15.0,2,8
469763,CHEMBL1626,CLEMASTINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.64,6.89,23.0,3,8
469763,CHEMBL1626,CLEMASTINE,117512,CHEMBL4105907,Sigma intracellular receptor 2,7.6,7.6,25.12,1,9
469763,CHEMBL1626,CLEMASTINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,7.44,7.28,36.0,2,8
469763,CHEMBL1626,CLEMASTINE,72,CHEMBL217,D(2) dopamine receptor,7.35,6.71,45.0,3,8
469763,CHEMBL1626,CLEMASTINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.28,7.14,52.0,2,8
469763,CHEMBL1626,CLEMASTINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.16,6.7,70.0,4,9
469763,CHEMBL1626,CLEMASTINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.16,6.7,69.0,4,9
469763,CHEMBL1626,CLEMASTINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,7.1,6.7,80.0,4,9
469763,CHEMBL1626,CLEMASTINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.85,6.56,142.0,3,9
469763,CHEMBL1626,CLEMASTINE,102,CHEMBL1941,Histamine H2 receptor,6.44,6.44,364.0,2,8
469763,CHEMBL1626,CLEMASTINE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.38,6.38,419.0,1,8
469763,CHEMBL1626,CLEMASTINE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.27,6.1,538.0,3,8
469763,CHEMBL1626,CLEMASTINE,137,CHEMBL237,Kappa-type opioid receptor,6.23,6.23,594.7,1,8
469763,CHEMBL1626,CLEMASTINE,12912,CHEMBL3622,Cytochrome P450 2C19,6.22,6.22,600.0,1,8
469763,CHEMBL1626,CLEMASTINE,88,CHEMBL2056,D(1A) dopamine receptor,6.12,5.93,767.0,3,8
469763,CHEMBL1626,CLEMASTINE,11365,CHEMBL289,Cytochrome P450 2D6,6.1,5.78,794.3,5,9
469763,CHEMBL1626,CLEMASTINE,17045,CHEMBL340,Cytochrome P450 3A4,5.6,5.6,2511.89,6,9
469763,CHEMBL1626,CLEMASTINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.51,5.51,3060.0,2,8
1051118,CHEMBL1628227,DOXEPIN,127,CHEMBL231,Histamine H1 receptor,10.18,9.55,0.066,5,9
1051118,CHEMBL1628227,DOXEPIN,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,8.23,7.3,5.842,3,8
1051118,CHEMBL1628227,DOXEPIN,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.96,7.12,11.0,4,8
1051118,CHEMBL1628227,DOXEPIN,219,CHEMBL245,Muscarinic acetylcholine receptor M3,7.82,7.14,15.0,3,8
1051118,CHEMBL1628227,DOXEPIN,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.75,6.94,18.0,4,8
1051118,CHEMBL1628227,DOXEPIN,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,7.72,7.32,19.0,3,8
1051118,CHEMBL1628227,DOXEPIN,125,CHEMBL229,Alpha-1A adrenergic receptor,7.67,7.02,21.5,4,8
1051118,CHEMBL1628227,DOXEPIN,121,CHEMBL228,Sodium-dependent serotonin transporter,7.66,6.75,22.0,4,8
1051118,CHEMBL1628227,DOXEPIN,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.62,7.37,24.0,3,8
1051118,CHEMBL1628227,DOXEPIN,100,CHEMBL222,Sodium-dependent noradrenaline transporter,7.54,7.19,29.0,4,8
1051118,CHEMBL1628227,DOXEPIN,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.5,7.11,32.0,3,8
1051118,CHEMBL1628227,DOXEPIN,102,CHEMBL1941,Histamine H2 receptor,7.28,6.25,52.0,3,8
1051118,CHEMBL1628227,DOXEPIN,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.25,6.77,56.0,4,8
1051118,CHEMBL1628227,DOXEPIN,103,CHEMBL223,Alpha-1D adrenergic receptor,7.24,7.08,58.0,2,8
1051118,CHEMBL1628227,DOXEPIN,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.04,6.34,92.0,5,8
1051118,CHEMBL1628227,DOXEPIN,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.98,6.74,105.0,4,9
1051118,CHEMBL1628227,DOXEPIN,130,CHEMBL234,D(3) dopamine receptor,6.96,6.28,110.0,4,8
1051118,CHEMBL1628227,DOXEPIN,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.82,6.3,150.0,3,8
1051118,CHEMBL1628227,DOXEPIN,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.58,6.39,265.0,2,8
1051118,CHEMBL1628227,DOXEPIN,88,CHEMBL2056,D(1A) dopamine receptor,6.54,6.42,286.2,4,8
1051118,CHEMBL1628227,DOXEPIN,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.3,6.09,501.0,2,8
1051118,CHEMBL1628227,DOXEPIN,90,CHEMBL219,D(4) dopamine receptor,6.14,6.14,725.5,1,8
1051118,CHEMBL1628227,DOXEPIN,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.11,6.07,775.8,2,8
1051118,CHEMBL1628227,DOXEPIN,10624,CHEMBL3426,5-hydroxytryptamine receptor 5A,5.9,5.9,1264.5,1,8
1051118,CHEMBL1628227,DOXEPIN,72,CHEMBL217,D(2) dopamine receptor,5.85,5.85,1400.0,1,8
1051118,CHEMBL1628227,DOXEPIN,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,5.82,5.82,1526.5,1,8
1051118,CHEMBL1628227,DOXEPIN,220,CHEMBL1850,D(1B) dopamine receptor,5.8,5.8,1569.3,1,8
1051118,CHEMBL1628227,DOXEPIN,137,CHEMBL237,Kappa-type opioid receptor,5.57,5.57,2700.0,1,8
88100,CHEMBL163,RITONAVIR,12911,CHEMBL3397,Cytochrome P450 2C9,7.8,7.8,16.0,1,8
88100,CHEMBL163,RITONAVIR,17045,CHEMBL340,Cytochrome P450 3A4,7.8,7.07,16.0,11,9
88100,CHEMBL163,RITONAVIR,248,CHEMBL1835,Thromboxane-A synthase,7.12,7.12,76.0,1,9
88100,CHEMBL163,RITONAVIR,104067,CHEMBL1743126,Multidrug and toxin extrusion protein 1,7.1,6.39,80.0,2,9
88100,CHEMBL163,RITONAVIR,12739,CHEMBL3019,Cytochrome P450 3A5,6.92,6.92,120.0,1,9
88100,CHEMBL163,RITONAVIR,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,6.16,5.98,700.0,4,9
88100,CHEMBL163,RITONAVIR,10184,CHEMBL2327,Substance-K receptor,6.06,5.82,874.0,2,8
88100,CHEMBL163,RITONAVIR,250,CHEMBL249,Substance-P receptor,5.94,5.94,1144.5,1,8
88100,CHEMBL163,RITONAVIR,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.85,5.85,1400.0,1,8
88100,CHEMBL163,RITONAVIR,11398,CHEMBL4302,ATP-dependent translocase ABCB1,5.82,5.82,1500.0,1,8
88100,CHEMBL163,RITONAVIR,103619,CHEMBL1287617,UDP-glucuronosyltransferase 1A1,5.77,5.64,1700.0,2,9
88100,CHEMBL163,RITONAVIR,102394,CHEMBL6020,Bile salt export pump,5.76,5.69,1740.0,4,9
88100,CHEMBL163,RITONAVIR,20085,CHEMBL4729,Cytochrome P450 2B6,5.7,5.7,2000.0,1,9
88100,CHEMBL163,RITONAVIR,11365,CHEMBL289,Cytochrome P450 2D6,5.64,5.64,2300.0,1,9
478059,CHEMBL1632,CEPHALOTHIN SODIUM,103665,CHEMBL1293232,Survival motor neuron protein,6.3,6.3,501.2,1,9
478059,CHEMBL1632,CEPHALOTHIN SODIUM,11521,CHEMBL2219,Tyrosine-protein phosphatase non-receptor type 7,6.04,6.04,920.0,1,9
479129,CHEMBL1633,KETOTIFEN FUMARATE,127,CHEMBL231,Histamine H1 receptor,9.0,8.97,1.0,2,9
479129,CHEMBL1633,KETOTIFEN FUMARATE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.36,7.36,43.93,1,9
479129,CHEMBL1633,KETOTIFEN FUMARATE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,7.01,7.01,98.53,1,9
479129,CHEMBL1633,KETOTIFEN FUMARATE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.71,6.71,197.38,1,9
479129,CHEMBL1633,KETOTIFEN FUMARATE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.61,6.61,243.81,1,9
479129,CHEMBL1633,KETOTIFEN FUMARATE,88,CHEMBL2056,D(1A) dopamine receptor,6.52,6.52,299.47,1,9
479129,CHEMBL1633,KETOTIFEN FUMARATE,144,CHEMBL1899,5-hydroxytryptamine receptor 3A,6.47,6.47,338.93,1,9
479129,CHEMBL1633,KETOTIFEN FUMARATE,117512,CHEMBL4105907,Sigma intracellular receptor 2,6.44,6.44,365.88,1,9
479129,CHEMBL1633,KETOTIFEN FUMARATE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,6.39,6.39,407.28,1,9
479129,CHEMBL1633,KETOTIFEN FUMARATE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.22,6.22,602.42,1,9
479129,CHEMBL1633,KETOTIFEN FUMARATE,130,CHEMBL234,D(3) dopamine receptor,6.14,6.14,717.13,1,9
479129,CHEMBL1633,KETOTIFEN FUMARATE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.08,6.08,824.71,1,9
479129,CHEMBL1633,KETOTIFEN FUMARATE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.04,6.04,917.28,1,9
479129,CHEMBL1633,KETOTIFEN FUMARATE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.0,6.0,995.75,1,9
479129,CHEMBL1633,KETOTIFEN FUMARATE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.98,5.98,1050.87,1,9
479129,CHEMBL1633,KETOTIFEN FUMARATE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.96,5.96,1084.43,1,9
479129,CHEMBL1633,KETOTIFEN FUMARATE,72,CHEMBL217,D(2) dopamine receptor,5.76,5.76,1726.64,1,9
479129,CHEMBL1633,KETOTIFEN FUMARATE,106,CHEMBL1898,5-hydroxytryptamine receptor 1B,5.76,5.76,1753.07,1,9
479129,CHEMBL1633,KETOTIFEN FUMARATE,220,CHEMBL1850,D(1B) dopamine receptor,5.58,5.58,2660.11,1,9
480746,CHEMBL1639,ALISKIREN,11225,CHEMBL286,Renin,9.4,9.1,0.4,25,9
485100,CHEMBL1642,IMATINIB MESYLATE,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,7.0,6.47,100.0,3,9
485100,CHEMBL1642,IMATINIB MESYLATE,8,CHEMBL1862,Tyrosine-protein kinase ABL1,6.72,6.54,190.0,2,9
485100,CHEMBL1642,IMATINIB MESYLATE,12627,CHEMBL2007,Platelet-derived growth factor receptor alpha,6.17,6.17,680.24,1,9
485738,CHEMBL1643,RIBAVIRIN,103668,CHEMBL1293235,Prelamin-A/C,8.4,8.4,4.0,1,9
485738,CHEMBL1643,RIBAVIRIN,17045,CHEMBL340,Cytochrome P450 3A4,6.1,6.1,794.3,2,9
1058607,CHEMBL1643895,RAMOSETRON,144,CHEMBL1899,5-hydroxytryptamine receptor 3A,10.22,9.95,0.06,3,9
1058607,CHEMBL1643895,RAMOSETRON,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.47,6.47,340.0,1,8
485902,CHEMBL1644,CEFADROXIL,104066,CHEMBL1743125,Solute carrier family 15 member 2,5.6,5.55,2500.0,4,9
486789,CHEMBL1648,ISRADIPINE,169,CHEMBL1940,Voltage-dependent L-type calcium channel subunit alpha-1C,8.66,7.84,2.2,2,9
486789,CHEMBL1648,ISRADIPINE,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,5.53,5.53,2984.9,1,8
487711,CHEMBL1650,CORTISONE ACETATE,25,CHEMBL2034,Glucocorticoid receptor,5.75,5.75,1778.0,1,8
487711,CHEMBL1650,CORTISONE ACETATE,56,CHEMBL1871,Androgen receptor,5.55,5.55,2810.0,1,8
1062164,CHEMBL1650443,TRELAGLIPTIN,11140,CHEMBL284,Dipeptidyl peptidase 4,8.89,8.63,1.3,7,9
490064,CHEMBL1652,AMBENONIUM,137,CHEMBL237,Kappa-type opioid receptor,6.16,6.16,700.0,1,8
490064,CHEMBL1652,AMBENONIUM,219,CHEMBL245,Muscarinic acetylcholine receptor M3,5.96,5.96,1100.0,1,8
490064,CHEMBL1652,AMBENONIUM,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.8,5.8,1600.0,1,8
490064,CHEMBL1652,AMBENONIUM,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.66,5.66,2200.0,1,8
490064,CHEMBL1652,AMBENONIUM,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.6,5.6,2500.0,1,8
490981,CHEMBL1653,PHENIRAMINE MALEATE,17045,CHEMBL340,Cytochrome P450 3A4,6.0,6.0,1000.0,2,9
495572,CHEMBL1657,TAZAROTENE,270,CHEMBL2008,Retinoic acid receptor beta,9.1,9.1,0.8,2,9
495572,CHEMBL1657,TAZAROTENE,240,CHEMBL2003,Retinoic acid receptor gamma,7.4,7.4,40.0,2,9
495572,CHEMBL1657,TAZAROTENE,57,CHEMBL2055,Retinoic acid receptor alpha,7.2,7.2,63.0,2,9
495572,CHEMBL1657,TAZAROTENE,17045,CHEMBL340,Cytochrome P450 3A4,5.5,5.5,3150.0,1,9
497291,CHEMBL1660,RIFAPENTINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.92,5.92,1210.0,1,8
503213,CHEMBL1668,RESCINNAMINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.0,6.0,988.0,1,8
504310,CHEMBL1670,MITOTANE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,7.65,7.65,22.4,2,9
504310,CHEMBL1670,MITOTANE,36,CHEMBL208,Progesterone receptor,6.35,6.35,450.0,1,8
504310,CHEMBL1670,MITOTANE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.19,6.02,651.0,2,8
504310,CHEMBL1670,MITOTANE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.1,6.05,795.0,2,8
504310,CHEMBL1670,MITOTANE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.09,6.09,812.0,2,8
504310,CHEMBL1670,MITOTANE,12700,CHEMBL2616,"Acetyl-CoA acetyltransferase, mitochondrial",5.89,5.89,1300.0,1,9
504310,CHEMBL1670,MITOTANE,25,CHEMBL2034,Glucocorticoid receptor,5.85,5.85,1400.0,1,8
504310,CHEMBL1670,MITOTANE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.8,5.66,1601.0,2,8
504310,CHEMBL1670,MITOTANE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.56,5.56,2755.0,1,8
504310,CHEMBL1670,MITOTANE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.51,5.51,3075.0,1,8
505776,CHEMBL1671,PROPRANOLOL HYDROCHLORIDE,43,CHEMBL210,Beta-2 adrenergic receptor,8.65,8.64,2.262,2,9
505776,CHEMBL1671,PROPRANOLOL HYDROCHLORIDE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,7.02,7.02,95.38,1,9
505776,CHEMBL1671,PROPRANOLOL HYDROCHLORIDE,117512,CHEMBL4105907,Sigma intracellular receptor 2,6.45,6.45,352.9,1,9
505776,CHEMBL1671,PROPRANOLOL HYDROCHLORIDE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.27,6.27,542.0,1,9
505776,CHEMBL1671,PROPRANOLOL HYDROCHLORIDE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.19,6.19,644.31,1,9
505776,CHEMBL1671,PROPRANOLOL HYDROCHLORIDE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.86,5.86,1373.1,1,9
505776,CHEMBL1671,PROPRANOLOL HYDROCHLORIDE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.75,5.75,1790.2,1,9
508532,CHEMBL1676,FLUTICASONE FUROATE,25,CHEMBL2034,Glucocorticoid receptor,10.4,9.14,0.03981,6,9
508532,CHEMBL1676,FLUTICASONE FUROATE,36,CHEMBL208,Progesterone receptor,8.52,7.65,3.0,3,9
508532,CHEMBL1676,FLUTICASONE FUROATE,56,CHEMBL1871,Androgen receptor,6.89,6.89,130.0,1,8
508532,CHEMBL1676,FLUTICASONE FUROATE,48,CHEMBL1994,Mineralocorticoid receptor,6.78,6.78,166.0,1,9
508604,CHEMBL1677,TACRINE HYDROCHLORIDE,10532,CHEMBL1914,Cholinesterase,7.64,7.42,23.0,5,9
508604,CHEMBL1677,TACRINE HYDROCHLORIDE,93,CHEMBL220,Acetylcholinesterase,7.03,6.67,93.0,10,9
508604,CHEMBL1677,TACRINE HYDROCHLORIDE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,5.9,5.9,1258.9,1,9
508667,CHEMBL1678,DONEPEZIL HYDROCHLORIDE,93,CHEMBL220,Acetylcholinesterase,7.94,7.51,11.6,5,9
510462,CHEMBL1679,LEUCOVORIN,6,CHEMBL202,Dihydrofolate reductase,5.62,5.62,2370.0,1,8
511465,CHEMBL1680,OCTREOTIDE,117,CHEMBL1804,Somatostatin receptor type 2,10.52,9.96,0.03,2,9
511465,CHEMBL1680,OCTREOTIDE,11265,CHEMBL1792,Somatostatin receptor type 5,7.66,7.66,22.0,1,9
511465,CHEMBL1680,OCTREOTIDE,10183,CHEMBL1853,Somatostatin receptor type 4,7.18,7.18,66.0,1,9
515027,CHEMBL1683,HYDROCORTISONE BUTYRATE,48,CHEMBL1994,Mineralocorticoid receptor,8.53,8.53,2.94,1,9
515027,CHEMBL1683,HYDROCORTISONE BUTYRATE,25,CHEMBL2034,Glucocorticoid receptor,8.1,8.1,8.0,1,8
515027,CHEMBL1683,HYDROCORTISONE BUTYRATE,36,CHEMBL208,Progesterone receptor,7.38,7.38,42.0,1,8
515239,CHEMBL1684,BENDROFLUMETHIAZIDE,103668,CHEMBL1293235,Prelamin-A/C,6.3,6.3,501.2,1,9
515239,CHEMBL1684,BENDROFLUMETHIAZIDE,15,CHEMBL205,Carbonic anhydrase 2,5.77,5.77,1700.0,1,9
515239,CHEMBL1684,BENDROFLUMETHIAZIDE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.5,5.5,3200.0,1,8
518361,CHEMBL1685,DEZOCINE,129,CHEMBL233,Mu-type opioid receptor,9.27,7.88,0.54,7,9
279727,CHEMBL168815,CEVIMELINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.07,5.79,851.14,2,9
279727,CHEMBL168815,CEVIMELINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,5.99,5.99,1023.29,1,9
279727,CHEMBL168815,CEVIMELINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,5.59,5.59,2570.4,1,9
524710,CHEMBL1689,TOLAZOLINE HYDROCHLORIDE,101361,CHEMBL5857,Trace amine-associated receptor 1,6.0,6.0,1011.0,1,8
1078379,CHEMBL1689772,OMADACYCLINE,96,CHEMBL221,Prostaglandin G/H synthase 1,6.8,6.7,160.0,2,8
1078379,CHEMBL1689772,OMADACYCLINE,126,CHEMBL230,Prostaglandin G/H synthase 2,6.07,6.07,844.9,1,8
543228,CHEMBL1691,BETAXOLOL HYDROCHLORIDE,50,CHEMBL213,Beta-1 adrenergic receptor,7.69,7.69,20.57,1,9
543228,CHEMBL1691,BETAXOLOL HYDROCHLORIDE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.61,6.61,247.91,1,9
543228,CHEMBL1691,BETAXOLOL HYDROCHLORIDE,43,CHEMBL210,Beta-2 adrenergic receptor,6.55,6.38,278.42,2,9
543228,CHEMBL1691,BETAXOLOL HYDROCHLORIDE,117512,CHEMBL4105907,Sigma intracellular receptor 2,5.78,5.78,1648.92,1,9
544765,CHEMBL1695,TIAGABINE HYDROCHLORIDE,113,CHEMBL1903,Sodium- and chloride-dependent GABA transporter 1,7.31,7.31,49.0,1,9
545075,CHEMBL1696,DESIPRAMINE HYDROCHLORIDE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,9.1,8.65,0.8,2,9
545509,CHEMBL1697,DILTIAZEM HYDROCHLORIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,6.6,6.6,251.2,2,9
545509,CHEMBL1697,DILTIAZEM HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,5.95,5.95,1122.0,1,9
545974,CHEMBL1699,MEMANTINE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,8.66,8.66,2.2,1,9
1085,CHEMBL17,DICHLORPHENAMIDE,11060,CHEMBL2326,Carbonic anhydrase 7,8.22,7.67,6.0,7,9
1085,CHEMBL17,DICHLORPHENAMIDE,15,CHEMBL205,Carbonic anhydrase 2,8.1,7.42,8.0,97,9
1085,CHEMBL17,DICHLORPHENAMIDE,11016,CHEMBL3969,"Carbonic anhydrase 5B, mitochondrial",7.68,7.57,21.0,6,9
1085,CHEMBL17,DICHLORPHENAMIDE,12923,CHEMBL3912,Carbonic anhydrase 13,7.64,7.64,23.0,1,9
1085,CHEMBL17,DICHLORPHENAMIDE,10193,CHEMBL261,Carbonic anhydrase 1,7.6,5.98,25.0,90,9
1085,CHEMBL17,DICHLORPHENAMIDE,12952,CHEMBL3594,Carbonic anhydrase 9,7.47,7.31,34.0,46,9
1085,CHEMBL17,DICHLORPHENAMIDE,12209,CHEMBL3242,Carbonic anhydrase 12,7.3,7.3,50.0,24,9
1085,CHEMBL17,DICHLORPHENAMIDE,10186,CHEMBL3025,Carbonic anhydrase 6,7.1,7.06,79.0,6,9
1085,CHEMBL17,DICHLORPHENAMIDE,11042,CHEMBL4789,"Carbonic anhydrase 5A, mitochondrial",7.09,6.35,81.0,6,9
1085,CHEMBL17,DICHLORPHENAMIDE,12896,CHEMBL3729,Carbonic anhydrase 4,7.02,7.02,95.0,1,9
1085,CHEMBL17,DICHLORPHENAMIDE,11063,CHEMBL3510,Carbonic anhydrase 14,6.46,6.39,345.0,9,9
1085,CHEMBL17,DICHLORPHENAMIDE,103668,CHEMBL1293235,Prelamin-A/C,6.45,6.45,354.8,1,9
1085,CHEMBL17,DICHLORPHENAMIDE,12911,CHEMBL3397,Cytochrome P450 2C9,6.2,6.2,631.0,1,9
255947,CHEMBL170,QUININE,11365,CHEMBL289,Cytochrome P450 2D6,8.0,6.65,10.0,3,9
255947,CHEMBL170,QUININE,11398,CHEMBL4302,ATP-dependent translocase ABCB1,5.77,5.77,1700.0,1,9
546564,CHEMBL1700,SOTALOL HYDROCHLORIDE,10693,CHEMBL2524,Alpha-galactosidase A,6.75,6.75,177.8,1,9
546564,CHEMBL1700,SOTALOL HYDROCHLORIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,6.05,6.05,891.3,2,9
547402,CHEMBL1701,MEPERIDINE HYDROCHLORIDE,129,CHEMBL233,Mu-type opioid receptor,6.04,6.04,920.0,2,8
547576,CHEMBL1702,ATOMOXETINE HYDROCHLORIDE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,7.7,7.7,20.0,1,9
548124,CHEMBL1705,CLONIDINE HYDROCHLORIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.55,8.55,2.8,2,9
548124,CHEMBL1705,CLONIDINE HYDROCHLORIDE,52,CHEMBL1867,Alpha-2A adrenergic receptor,8.28,7.58,5.259,3,9
548124,CHEMBL1705,CLONIDINE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,8.25,8.25,5.6,1,9
548124,CHEMBL1705,CLONIDINE HYDROCHLORIDE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.03,7.03,94.09,1,9
548124,CHEMBL1705,CLONIDINE HYDROCHLORIDE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.37,6.37,431.96,1,9
548124,CHEMBL1705,CLONIDINE HYDROCHLORIDE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.24,6.24,575.64,1,9
548124,CHEMBL1705,CLONIDINE HYDROCHLORIDE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,6.06,6.06,878.51,1,9
548124,CHEMBL1705,CLONIDINE HYDROCHLORIDE,103,CHEMBL223,Alpha-1D adrenergic receptor,5.7,5.7,1979.25,1,9
548124,CHEMBL1705,CLONIDINE HYDROCHLORIDE,128,CHEMBL232,Alpha-1B adrenergic receptor,5.58,5.58,2627.54,1,9
548124,CHEMBL1705,CLONIDINE HYDROCHLORIDE,117512,CHEMBL4105907,Sigma intracellular receptor 2,5.56,5.56,2775.87,1,9
548594,CHEMBL1706,NAPHAZOLINE HYDROCHLORIDE,101361,CHEMBL5857,Trace amine-associated receptor 1,6.85,6.39,140.18,2,8
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.89,8.89,1.3,2,9
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,129,CHEMBL233,Mu-type opioid receptor,8.82,8.71,1.5,2,9
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,117512,CHEMBL4105907,Sigma intracellular receptor 2,7.44,7.44,36.68,1,9
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,137,CHEMBL237,Kappa-type opioid receptor,7.14,6.97,71.57,2,9
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,136,CHEMBL236,Delta-type opioid receptor,6.91,6.75,123.0,2,9
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.77,6.77,168.6,1,9
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.44,6.44,362.25,1,9
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,103700,CHEMBL1293267,G-protein coupled receptor 35,6.35,6.35,444.0,1,9
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.3,6.3,497.89,1,9
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.29,6.29,517.19,1,9
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,101271,CHEMBL5652,Glucose-dependent insulinotropic receptor,6.23,6.23,588.7,1,9
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,12679,CHEMBL2373,C5a anaphylatoxin chemotactic receptor 1,6.18,6.18,652.79,1,9
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,13010,CHEMBL3359,fMet-Leu-Phe receptor,6.07,6.07,857.58,1,9
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,100956,CHEMBL5339,Free fatty acid receptor 4,6.03,6.03,944.41,1,9
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,11758,CHEMBL1784,Glucagon-like peptide 1 receptor,5.95,5.95,1136.31,1,9
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,100338,CHEMBL4227,N-formyl peptide receptor 2,5.94,5.94,1137.98,1,9
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,10785,CHEMBL4761,C3a anaphylatoxin chemotactic receptor,5.93,5.93,1161.85,1,9
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,119228,CHEMBL4523478,C5a anaphylatoxin chemotactic receptor 2,5.9,5.9,1251.33,1,9
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,43,CHEMBL210,Beta-2 adrenergic receptor,5.87,5.87,1336.92,1,9
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.85,5.85,1412.7,1,9
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,90,CHEMBL219,D(4) dopamine receptor,5.84,5.84,1458.14,1,9
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,108311,CHEMBL3259470,G-protein coupled receptor 183,5.77,5.77,1693.43,1,9
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,119589,CHEMBL4523872,Adhesion G-protein coupled receptor F1,5.69,5.69,2040.77,1,9
548913,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,105,CHEMBL1983,5-hydroxytryptamine receptor 1D,5.58,5.58,2603.16,1,9
282509,CHEMBL170988,PHENFORMIN,103668,CHEMBL1293235,Prelamin-A/C,6.4,6.4,398.1,1,9
550053,CHEMBL1711,ISOPROTERENOL HYDROCHLORIDE,43,CHEMBL210,Beta-2 adrenergic receptor,10.26,6.89,0.05495,8,9
550053,CHEMBL1711,ISOPROTERENOL HYDROCHLORIDE,50,CHEMBL213,Beta-1 adrenergic receptor,8.81,8.81,1.549,1,9
550053,CHEMBL1711,ISOPROTERENOL HYDROCHLORIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.1,8.1,7.9,2,9
550053,CHEMBL1711,ISOPROTERENOL HYDROCHLORIDE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,7.1,7.05,79.4,2,9
550053,CHEMBL1711,ISOPROTERENOL HYDROCHLORIDE,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,6.9,6.9,125.9,1,9
550053,CHEMBL1711,ISOPROTERENOL HYDROCHLORIDE,78,CHEMBL1963,Thyrotropin receptor,6.4,6.4,398.1,2,9
550053,CHEMBL1711,ISOPROTERENOL HYDROCHLORIDE,103657,CHEMBL1293224,Microtubule-associated protein tau,5.55,5.55,2818.4,1,9
550053,CHEMBL1711,ISOPROTERENOL HYDROCHLORIDE,10977,CHEMBL2608,Lysosomal alpha-glucosidase,5.5,5.5,3162.3,1,9
550053,CHEMBL1711,ISOPROTERENOL HYDROCHLORIDE,103749,CHEMBL1293316,Relaxin receptor 1,5.5,5.5,3162.3,1,9
1093573,CHEMBL1712842,MEPAZINE ACETATE,103985,CHEMBL1741189,FAD-linked sulfhydryl oxidase ALR,7.01,7.01,98.0,1,8
550303,CHEMBL1713,CHLORPROMAZINE HYDROCHLORIDE,72,CHEMBL217,D(2) dopamine receptor,8.52,8.13,3.0,2,9
550303,CHEMBL1713,CHLORPROMAZINE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,7.8,7.8,15.8,1,9
550303,CHEMBL1713,CHLORPROMAZINE HYDROCHLORIDE,11365,CHEMBL289,Cytochrome P450 2D6,6.3,6.3,501.19,1,8
550303,CHEMBL1713,CHLORPROMAZINE HYDROCHLORIDE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.17,6.17,673.0,1,8
550303,CHEMBL1713,CHLORPROMAZINE HYDROCHLORIDE,103985,CHEMBL1741189,FAD-linked sulfhydryl oxidase ALR,5.99,5.99,1013.0,1,8
550303,CHEMBL1713,CHLORPROMAZINE HYDROCHLORIDE,103665,CHEMBL1293232,Survival motor neuron protein,5.7,5.7,1995.3,1,9
1095305,CHEMBL1714574,TERCONAZOLE,103668,CHEMBL1293235,Prelamin-A/C,8.1,8.1,7.9,1,9
1095305,CHEMBL1714574,TERCONAZOLE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.21,6.79,61.0,2,8
1095305,CHEMBL1714574,TERCONAZOLE,10280,CHEMBL264,Histamine H3 receptor,7.02,7.02,96.0,1,8
1095305,CHEMBL1714574,TERCONAZOLE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.67,6.48,214.0,2,8
1095305,CHEMBL1714574,TERCONAZOLE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.43,6.05,369.0,3,8
1095305,CHEMBL1714574,TERCONAZOLE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.9,5.73,1246.0,2,8
1095305,CHEMBL1714574,TERCONAZOLE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.86,5.86,1375.0,1,8
1095305,CHEMBL1714574,TERCONAZOLE,11213,CHEMBL3880,Heat shock protein HSP 90-alpha,5.85,5.75,1415.0,2,8
1095305,CHEMBL1714574,TERCONAZOLE,130,CHEMBL234,D(3) dopamine receptor,5.8,5.8,1600.0,1,8
1095305,CHEMBL1714574,TERCONAZOLE,17045,CHEMBL340,Cytochrome P450 3A4,5.8,5.8,1584.89,3,9
1095305,CHEMBL1714574,TERCONAZOLE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,5.72,5.72,1913.0,1,8
1095305,CHEMBL1714574,TERCONAZOLE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.63,5.63,2336.0,1,8
1095305,CHEMBL1714574,TERCONAZOLE,11188,CHEMBL3849,Lanosterol 14-alpha demethylase,5.52,5.52,3000.0,1,9
1095305,CHEMBL1714574,TERCONAZOLE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,5.51,5.51,3081.0,1,8
1095305,CHEMBL1714574,TERCONAZOLE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,5.5,5.5,3134.0,1,8
19569,CHEMBL17157,TERFENADINE,127,CHEMBL231,Histamine H1 receptor,9.0,7.59,1.0,7,9
19569,CHEMBL17157,TERFENADINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,8.05,6.96,8.9,31,9
19569,CHEMBL17157,TERFENADINE,12912,CHEMBL3622,Cytochrome P450 2C19,8.0,8.0,10.0,2,9
19569,CHEMBL17157,TERFENADINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.52,7.01,30.0,3,8
19569,CHEMBL17157,TERFENADINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.14,6.56,73.0,3,8
19569,CHEMBL17157,TERFENADINE,103657,CHEMBL1293224,Microtubule-associated protein tau,6.95,6.95,112.2,1,9
19569,CHEMBL17157,TERFENADINE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.69,6.57,203.0,3,8
19569,CHEMBL17157,TERFENADINE,17045,CHEMBL340,Cytochrome P450 3A4,6.5,6.5,320.0,1,8
19569,CHEMBL17157,TERFENADINE,130,CHEMBL234,D(3) dopamine receptor,6.29,6.0,511.0,3,8
19569,CHEMBL17157,TERFENADINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.26,6.26,545.0,1,8
19569,CHEMBL17157,TERFENADINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.22,6.05,606.0,2,8
19569,CHEMBL17157,TERFENADINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.19,6.05,645.0,2,8
19569,CHEMBL17157,TERFENADINE,10580,CHEMBL274,C-C chemokine receptor type 5,6.07,6.02,852.0,2,8
19569,CHEMBL17157,TERFENADINE,10184,CHEMBL2327,Substance-K receptor,6.05,5.81,892.0,2,8
19569,CHEMBL17157,TERFENADINE,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,6.01,6.01,971.0,1,9
19569,CHEMBL17157,TERFENADINE,103668,CHEMBL1293235,Prelamin-A/C,6.0,6.0,1000.0,1,9
19569,CHEMBL17157,TERFENADINE,11398,CHEMBL4302,ATP-dependent translocase ABCB1,5.96,5.76,1100.0,6,8
19569,CHEMBL17157,TERFENADINE,100611,CHEMBL3491,Cytochrome P450 2J2,5.95,5.85,1130.0,2,9
19569,CHEMBL17157,TERFENADINE,169,CHEMBL1940,Voltage-dependent L-type calcium channel subunit alpha-1C,5.88,5.88,1320.0,1,9
19569,CHEMBL17157,TERFENADINE,88,CHEMBL2056,D(1A) dopamine receptor,5.87,5.66,1337.0,3,8
19569,CHEMBL17157,TERFENADINE,102,CHEMBL1941,Histamine H2 receptor,5.76,5.76,1734.1,1,8
19569,CHEMBL17157,TERFENADINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.72,5.71,1912.0,2,8
19569,CHEMBL17157,TERFENADINE,72,CHEMBL217,D(2) dopamine receptor,5.69,5.69,2056.0,1,8
19569,CHEMBL17157,TERFENADINE,103689,CHEMBL1293256,Thrombopoietin,5.6,5.6,2511.9,2,9
19569,CHEMBL17157,TERFENADINE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.57,5.57,2695.7,1,8
19569,CHEMBL17157,TERFENADINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.54,5.54,2900.0,1,8
19569,CHEMBL17157,TERFENADINE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,5.5,5.5,3162.3,2,9
19569,CHEMBL17157,TERFENADINE,101216,CHEMBL5514,Huntingtin,5.5,5.5,3162.3,1,9
550917,CHEMBL1716,CYPROHEPTADINE HYDROCHLORIDE,103657,CHEMBL1293224,Microtubule-associated protein tau,6.0,6.0,1000.0,1,9
551003,CHEMBL1717,TICLOPIDINE HYDROCHLORIDE,103665,CHEMBL1293232,Survival motor neuron protein,8.35,8.35,4.5,1,9
551003,CHEMBL1717,TICLOPIDINE HYDROCHLORIDE,103669,CHEMBL1293236,ATP-dependent DNA helicase Q1,7.55,7.55,28.2,1,9
551147,CHEMBL1718,NALOXONE HYDROCHLORIDE,137,CHEMBL237,Kappa-type opioid receptor,6.74,6.47,182.0,2,9
552883,CHEMBL1722,METHYLPHENIDATE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,8.55,8.55,2.8,1,9
552883,CHEMBL1722,METHYLPHENIDATE HYDROCHLORIDE,155,CHEMBL238,Sodium-dependent dopamine transporter,7.7,7.31,19.9,2,9
552883,CHEMBL1722,METHYLPHENIDATE HYDROCHLORIDE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,7.29,6.7,51.0,2,9
1102940,CHEMBL1722209,TOLTERODINE TARTRATE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,8.41,8.41,3.864,1,9
1102940,CHEMBL1722209,TOLTERODINE TARTRATE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,8.06,8.06,8.689,1,9
1102940,CHEMBL1722209,TOLTERODINE TARTRATE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.88,7.12,13.12,2,9
1102940,CHEMBL1722209,TOLTERODINE TARTRATE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,7.86,7.86,13.75,1,9
1102940,CHEMBL1722209,TOLTERODINE TARTRATE,127,CHEMBL231,Histamine H1 receptor,6.89,6.89,127.37,1,9
1102940,CHEMBL1722209,TOLTERODINE TARTRATE,117512,CHEMBL4105907,Sigma intracellular receptor 2,6.78,6.78,166.94,1,9
1102940,CHEMBL1722209,TOLTERODINE TARTRATE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.67,6.67,216.35,1,9
554127,CHEMBL1724,MEPENZOLATE BROMIDE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,9.17,8.93,0.68,2,9
554127,CHEMBL1724,MEPENZOLATE BROMIDE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,8.59,8.43,2.6,2,9
554892,CHEMBL1726,NISOLDIPINE,169,CHEMBL1940,Voltage-dependent L-type calcium channel subunit alpha-1C,8.52,8.52,3.0,1,8
554892,CHEMBL1726,NISOLDIPINE,280,CHEMBL256,Adenosine receptor A3,6.21,6.21,614.0,1,8
554892,CHEMBL1726,NISOLDIPINE,12594,CHEMBL3356,Cytochrome P450 1A2,6.0,6.0,1000.0,1,8
554892,CHEMBL1726,NISOLDIPINE,252,CHEMBL251,Adenosine receptor A2a,5.64,5.64,2278.0,1,8
557741,CHEMBL1729,CISAPRIDE,168,CHEMBL1875,5-hydroxytryptamine receptor 4,9.44,7.6,0.362,5,9
557741,CHEMBL1729,CISAPRIDE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.96,8.32,1.102,4,9
557741,CHEMBL1729,CISAPRIDE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,8.19,7.41,6.457,36,9
557741,CHEMBL1729,CISAPRIDE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.4,7.06,39.81,4,9
557741,CHEMBL1729,CISAPRIDE,130,CHEMBL234,D(3) dopamine receptor,7.31,7.07,49.0,2,8
557741,CHEMBL1729,CISAPRIDE,11365,CHEMBL289,Cytochrome P450 2D6,7.16,7.16,70.0,1,8
557741,CHEMBL1729,CISAPRIDE,103,CHEMBL223,Alpha-1D adrenergic receptor,7.03,6.88,93.0,2,8
557741,CHEMBL1729,CISAPRIDE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.95,6.53,113.0,2,8
557741,CHEMBL1729,CISAPRIDE,72,CHEMBL217,D(2) dopamine receptor,6.8,6.53,158.0,4,9
557741,CHEMBL1729,CISAPRIDE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.69,6.52,204.0,3,8
557741,CHEMBL1729,CISAPRIDE,17045,CHEMBL340,Cytochrome P450 3A4,6.52,6.52,300.0,1,8
557741,CHEMBL1729,CISAPRIDE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.4,6.26,402.0,2,8
557741,CHEMBL1729,CISAPRIDE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.38,6.19,418.0,2,8
557741,CHEMBL1729,CISAPRIDE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.28,6.11,524.0,2,8
557741,CHEMBL1729,CISAPRIDE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.23,6.23,592.6,1,8
557741,CHEMBL1729,CISAPRIDE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.18,5.96,666.0,2,8
557741,CHEMBL1729,CISAPRIDE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.1,6.1,794.33,1,9
557741,CHEMBL1729,CISAPRIDE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,6.0,6.0,1000.0,1,9
557741,CHEMBL1729,CISAPRIDE,88,CHEMBL2056,D(1A) dopamine receptor,5.77,5.77,1700.0,1,9
557741,CHEMBL1729,CISAPRIDE,11061,CHEMBL2203,Motilin receptor,5.75,5.75,1800.0,1,8
557741,CHEMBL1729,CISAPRIDE,144,CHEMBL1899,5-hydroxytryptamine receptor 3A,5.7,5.7,1995.26,2,9
558106,CHEMBL1730,CEFOTAXIME,103830,CHEMBL1641348,Organic anion transporter 3,6.54,6.54,290.0,1,8
558106,CHEMBL1730,CEFOTAXIME,103829,CHEMBL1641347,Solute carrier family 22 member 6,5.5,5.5,3130.0,1,8
558566,CHEMBL1732,DIHYDROERGOTAMINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,9.41,8.22,0.387,5,8
558566,CHEMBL1732,DIHYDROERGOTAMINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,8.83,8.66,1.486,2,8
558566,CHEMBL1732,DIHYDROERGOTAMINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,8.82,8.13,1.51,3,8
558566,CHEMBL1732,DIHYDROERGOTAMINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,8.75,8.19,1.766,3,8
558566,CHEMBL1732,DIHYDROERGOTAMINE,130,CHEMBL234,D(3) dopamine receptor,8.74,8.09,1.812,3,8
558566,CHEMBL1732,DIHYDROERGOTAMINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.64,7.46,2.273,4,8
558566,CHEMBL1732,DIHYDROERGOTAMINE,72,CHEMBL217,D(2) dopamine receptor,8.53,7.99,2.96,3,8
558566,CHEMBL1732,DIHYDROERGOTAMINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,8.43,7.51,3.7,6,9
558566,CHEMBL1732,DIHYDROERGOTAMINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.9,7.38,12.6,2,8
558566,CHEMBL1732,DIHYDROERGOTAMINE,103,CHEMBL223,Alpha-1D adrenergic receptor,7.85,7.7,14.0,2,8
558566,CHEMBL1732,DIHYDROERGOTAMINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.42,6.59,37.6,2,8
558566,CHEMBL1732,DIHYDROERGOTAMINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.33,6.89,47.0,3,8
558566,CHEMBL1732,DIHYDROERGOTAMINE,102,CHEMBL1941,Histamine H2 receptor,6.59,6.4,256.6,2,8
558566,CHEMBL1732,DIHYDROERGOTAMINE,226,CHEMBL246,Beta-3 adrenergic receptor,6.58,6.58,260.0,1,8
558566,CHEMBL1732,DIHYDROERGOTAMINE,88,CHEMBL2056,D(1A) dopamine receptor,6.45,6.0,357.9,3,8
558566,CHEMBL1732,DIHYDROERGOTAMINE,104067,CHEMBL1743126,Multidrug and toxin extrusion protein 1,5.55,5.55,2800.0,1,9
558566,CHEMBL1732,DIHYDROERGOTAMINE,17045,CHEMBL340,Cytochrome P450 3A4,5.52,5.52,2999.16,1,8
558566,CHEMBL1732,DIHYDROERGOTAMINE,103657,CHEMBL1293224,Microtubule-associated protein tau,5.5,5.5,3162.3,1,8
561914,CHEMBL1734,SOLIFENACIN,219,CHEMBL245,Muscarinic acetylcholine receptor M3,7.88,7.71,13.18,3,9
561914,CHEMBL1734,SOLIFENACIN,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,7.36,7.36,43.65,1,9
561914,CHEMBL1734,SOLIFENACIN,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.29,7.29,51.29,1,9
561914,CHEMBL1734,SOLIFENACIN,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.92,6.92,120.23,1,9
561914,CHEMBL1734,SOLIFENACIN,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.89,6.89,128.82,1,9
561914,CHEMBL1734,SOLIFENACIN,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.6,6.32,251.19,3,9
564291,CHEMBL1737,SILDENAFIL CITRATE,3,CHEMBL1827,"cGMP-specific 3',5'-cyclic phosphodiesterase",8.66,8.47,2.2,3,9
567195,CHEMBL1738,DEXRAZOXANE,96,CHEMBL221,Prostaglandin G/H synthase 1,5.67,5.67,2159.6,1,8
1117844,CHEMBL1738797,ALECTINIB,100417,CHEMBL4247,ALK tyrosine kinase receptor,9.23,8.37,0.59,15,9
1117844,CHEMBL1738797,ALECTINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,8.32,7.82,4.8,17,9
1117844,CHEMBL1738797,ALECTINIB,100789,CHEMBL4375,SRSF protein kinase 1,7.96,7.33,11.0,2,9
1117844,CHEMBL1738797,ALECTINIB,101496,CHEMBL5668,SRSF protein kinase 2,7.55,7.55,28.2,1,9
1117844,CHEMBL1738797,ALECTINIB,101340,CHEMBL5810,Ephrin type-A receptor 1,6.71,6.71,193.0,1,9
1117844,CHEMBL1738797,ALECTINIB,20020,CHEMBL4355,Cyclin-G-associated kinase,6.59,6.59,259.0,1,9
1117844,CHEMBL1738797,ALECTINIB,117353,CHEMBL4105748,Peroxisomal acyl-coenzyme A oxidase 1,6.57,6.57,271.0,1,9
1117844,CHEMBL1738797,ALECTINIB,130,CHEMBL234,D(3) dopamine receptor,6.32,6.32,484.7,1,8
1117844,CHEMBL1738797,ALECTINIB,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.32,6.32,480.0,1,8
1117844,CHEMBL1738797,ALECTINIB,11629,CHEMBL2543,Casein kinase I isoform gamma-2,6.29,6.29,514.0,1,9
1117844,CHEMBL1738797,ALECTINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,6.18,5.87,663.9,4,9
1117844,CHEMBL1738797,ALECTINIB,121,CHEMBL228,Sodium-dependent serotonin transporter,6.0,6.0,1010.5,1,8
1117844,CHEMBL1738797,ALECTINIB,30015,CHEMBL4226,Dual specificity protein kinase CLK3,5.86,5.86,1397.0,1,9
1117844,CHEMBL1738797,ALECTINIB,280,CHEMBL256,Adenosine receptor A3,5.85,5.85,1406.5,1,8
1117844,CHEMBL1738797,ALECTINIB,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,5.82,5.82,1500.0,1,9
1117844,CHEMBL1738797,ALECTINIB,12735,CHEMBL2349,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",5.77,5.77,1711.0,1,9
1117844,CHEMBL1738797,ALECTINIB,102394,CHEMBL6020,Bile salt export pump,5.75,5.75,1800.0,1,8
1117844,CHEMBL1738797,ALECTINIB,101019,CHEMBL5568,Proto-oncogene tyrosine-protein kinase ROS,5.7,5.66,2000.0,4,9
1117844,CHEMBL1738797,ALECTINIB,30014,CHEMBL4225,Dual specificity protein kinase CLK2,5.63,5.63,2320.0,1,9
1117844,CHEMBL1738797,ALECTINIB,117422,CHEMBL4105817,Peroxisomal acyl-coenzyme A oxidase 3,5.58,5.58,2602.0,1,9
1117844,CHEMBL1738797,ALECTINIB,19,CHEMBL206,Estrogen receptor,5.57,5.57,2700.0,1,8
1118041,CHEMBL1738990,LEVOPROPOXYPHENE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.56,5.56,2754.23,1,9
570147,CHEMBL1741,CLARITHROMYCIN,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,5.51,5.51,3090.3,1,8
317909,CHEMBL175,DEXIBUPROFEN,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.55,8.55,2.8,2,9
317909,CHEMBL175,DEXIBUPROFEN,96,CHEMBL221,Prostaglandin G/H synthase 1,7.01,6.52,98.65,3,9
317909,CHEMBL175,DEXIBUPROFEN,126,CHEMBL230,Prostaglandin G/H synthase 2,6.14,5.88,730.0,2,9
317909,CHEMBL175,DEXIBUPROFEN,78,CHEMBL1963,Thyrotropin receptor,5.6,5.6,2511.9,2,9
317909,CHEMBL175,DEXIBUPROFEN,103668,CHEMBL1293235,Prelamin-A/C,5.6,5.6,2511.9,1,9
581569,CHEMBL1750,CLOFARABINE,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",6.77,6.77,170.0,1,8
581569,CHEMBL1750,CLOFARABINE,114,CHEMBL226,Adenosine receptor A1,5.64,5.64,2300.0,1,8
581569,CHEMBL1750,CLOFARABINE,10594,CHEMBL2652,"cGMP-dependent 3',5'-cyclic phosphodiesterase",5.51,5.51,3120.0,2,9
581814,CHEMBL1751,DIGOXIN,103982,CHEMBL1741186,Nuclear receptor ROR-gamma,6.96,5.95,109.0,5,9
581814,CHEMBL1751,DIGOXIN,20053,CHEMBL4096,Cellular tumor antigen p53,6.8,6.75,158.5,2,9
581814,CHEMBL1751,DIGOXIN,103710,CHEMBL1293277,NPC intracellular cholesterol transporter 1,6.65,6.65,223.9,2,9
581814,CHEMBL1751,DIGOXIN,103727,CHEMBL1293294,Ras-related protein Rab-9A,6.65,6.6,223.9,2,9
581814,CHEMBL1751,DIGOXIN,29,CHEMBL1807,Sodium/potassium-transporting ATPase subunit alpha-1,6.54,6.54,290.0,1,9
581814,CHEMBL1751,DIGOXIN,105692,CHEMBL2362980,Paired box protein Pax-8,6.38,6.38,414.0,1,8
581814,CHEMBL1751,DIGOXIN,103668,CHEMBL1293235,Prelamin-A/C,6.25,6.25,562.3,1,9
581814,CHEMBL1751,DIGOXIN,11472,CHEMBL4026,Signal transducer and activator of transcription 3,5.73,5.73,1862.0,1,9
581819,CHEMBL1752,DYPHYLLINE,103665,CHEMBL1293232,Survival motor neuron protein,5.95,5.95,1122.0,1,9
293438,CHEMBL175247,ORLISTAT,77,CHEMBL1812,Pancreatic triacylglycerol lipase,8.8,7.47,1.57,5,9
293438,CHEMBL175247,ORLISTAT,10954,CHEMBL2127,Hepatic triacylglycerol lipase,8.52,8.52,3.0,1,9
293438,CHEMBL175247,ORLISTAT,101054,CHEMBL5080,Endothelial lipase,8.22,8.22,6.0,1,9
293438,CHEMBL175247,ORLISTAT,101016,CHEMBL5545,Diacylglycerol lipase-alpha,8.0,7.07,10.0,3,9
293438,CHEMBL175247,ORLISTAT,105457,CHEMBL2189127,Monoacylglycerol lipase ABHD6,7.88,7.55,13.18,7,9
293438,CHEMBL175247,ORLISTAT,101466,CHEMBL6168,Phosphatidylserine lipase ABHD16A,7.52,7.14,30.0,2,9
293438,CHEMBL175247,ORLISTAT,10138,CHEMBL3514,Platelet-activating factor acetylhydrolase,7.3,7.3,50.0,1,8
293438,CHEMBL175247,ORLISTAT,101223,CHEMBL5521,Diacylglycerol lipase-beta,7.22,6.8,60.0,2,9
293438,CHEMBL175247,ORLISTAT,232,CHEMBL2060,Lipoprotein lipase,7.18,7.18,66.0,1,9
293438,CHEMBL175247,ORLISTAT,101218,CHEMBL5516,Lysophosphatidylserine lipase ABHD12,7.1,6.8,80.0,5,9
293438,CHEMBL175247,ORLISTAT,11535,CHEMBL4158,Fatty acid synthase,6.55,6.55,280.0,1,8
293438,CHEMBL175247,ORLISTAT,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.8,5.8,1600.0,1,9
293438,CHEMBL175247,ORLISTAT,87,CHEMBL218,Cannabinoid receptor 1,5.6,5.6,2500.0,1,9
581848,CHEMBL1754,DOXAPRAM,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.15,7.15,71.0,1,8
581848,CHEMBL1754,DOXAPRAM,11365,CHEMBL289,Cytochrome P450 2D6,7.0,7.0,100.0,1,8
581850,CHEMBL1755,CONIVAPTAN,112,CHEMBL1790,Vasopressin V2 receptor,9.44,8.7,0.36,2,9
581850,CHEMBL1755,CONIVAPTAN,134,CHEMBL1889,Vasopressin V1a receptor,9.37,8.95,0.43,2,9
581858,CHEMBL1756,ESTRAMUSTINE PHOSPHATE,19,CHEMBL206,Estrogen receptor,5.69,5.69,2034.1,1,8
296388,CHEMBL175691,RILPIVIRINE,12912,CHEMBL3622,Cytochrome P450 2C19,6.47,6.47,335.0,8,9
296388,CHEMBL175691,RILPIVIRINE,12911,CHEMBL3397,Cytochrome P450 2C9,6.46,6.46,346.0,8,9
296388,CHEMBL175691,RILPIVIRINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.3,6.3,500.0,8,9
296388,CHEMBL175691,RILPIVIRINE,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,5.82,5.82,1500.0,1,9
296388,CHEMBL175691,RILPIVIRINE,17045,CHEMBL340,Cytochrome P450 3A4,5.66,5.66,2170.0,8,9
583322,CHEMBL1760,TERBUTALINE,43,CHEMBL210,Beta-2 adrenergic receptor,5.6,5.57,2510.0,3,9
583522,CHEMBL1763,HYDROFLUMETHIAZIDE,103668,CHEMBL1293235,Prelamin-A/C,6.0,6.0,1000.0,1,9
583530,CHEMBL1764,LEVOMEPROMAZINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.85,7.85,14.1,1,8
583530,CHEMBL1764,LEVOMEPROMAZINE,130,CHEMBL234,D(3) dopamine receptor,7.72,7.72,19.0,1,8
583530,CHEMBL1764,LEVOMEPROMAZINE,88,CHEMBL2056,D(1A) dopamine receptor,6.91,6.91,122.9,1,8
583530,CHEMBL1764,LEVOMEPROMAZINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.48,6.48,331.4,1,8
583530,CHEMBL1764,LEVOMEPROMAZINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.77,5.77,1682.6,1,8
583530,CHEMBL1764,LEVOMEPROMAZINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.68,5.68,2106.0,1,8
583530,CHEMBL1764,LEVOMEPROMAZINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.55,5.55,2842.2,1,8
591037,CHEMBL1766,DESOXIMETASONE,25,CHEMBL2034,Glucocorticoid receptor,8.93,8.76,1.169,2,8
591037,CHEMBL1766,DESOXIMETASONE,103668,CHEMBL1293235,Prelamin-A/C,8.6,8.6,2.5,1,9
591037,CHEMBL1766,DESOXIMETASONE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,8.3,8.3,5.0,2,9
591037,CHEMBL1766,DESOXIMETASONE,36,CHEMBL208,Progesterone receptor,7.48,7.48,33.1,1,8
591037,CHEMBL1766,DESOXIMETASONE,56,CHEMBL1871,Androgen receptor,6.02,6.02,952.2,1,8
591037,CHEMBL1766,DESOXIMETASONE,103665,CHEMBL1293232,Survival motor neuron protein,5.95,5.95,1122.0,1,9
1142451,CHEMBL1767408,DIQUAFOSOL TETRASODIUM,11907,CHEMBL4398,P2Y purinoceptor 2,7.0,6.64,100.0,4,9
1142451,CHEMBL1767408,DIQUAFOSOL TETRASODIUM,10541,CHEMBL2123,P2Y purinoceptor 4,6.89,6.45,130.0,3,9
1142451,CHEMBL1767408,DIQUAFOSOL TETRASODIUM,10012,CHEMBL4714,P2Y purinoceptor 6,5.7,5.7,2000.0,1,8
594843,CHEMBL1768,BETHANECHOL CHLORIDE,103657,CHEMBL1293224,Microtubule-associated protein tau,5.8,5.8,1584.9,1,9
333157,CHEMBL177,AMIKACIN,103668,CHEMBL1293235,Prelamin-A/C,6.8,6.8,158.5,1,9
596044,CHEMBL1770,LEVAMISOLE HYDROCHLORIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,7.8,7.8,15.8,2,9
1142547,CHEMBL1770248,ERTUGLIFLOZIN,20092,CHEMBL3884,Sodium/glucose cotransporter 2,9.06,8.97,0.87,5,9
1142547,CHEMBL1770248,ERTUGLIFLOZIN,18036,CHEMBL4979,Sodium/glucose cotransporter 1,6.41,5.88,392.0,4,9
1143222,CHEMBL1770916,NIROGACESTAT,109948,CHEMBL3638343,Gamma-secretase-activating protein,8.21,8.21,6.2,1,9
598402,CHEMBL1771,CLOPIDOGREL,121,CHEMBL228,Sodium-dependent serotonin transporter,6.52,6.38,299.0,2,8
598402,CHEMBL1771,CLOPIDOGREL,20085,CHEMBL4729,Cytochrome P450 2B6,6.3,6.19,500.0,3,9
598402,CHEMBL1771,CLOPIDOGREL,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.7,5.7,2000.0,1,8
598402,CHEMBL1771,CLOPIDOGREL,176,CHEMBL2001,P2Y purinoceptor 12,5.62,5.62,2400.0,1,9
1145509,CHEMBL1774461,FLORBETAPIR F 18,10656,CHEMBL2487,Amyloid-beta precursor protein,8.54,8.54,2.87,6,9
1148185,CHEMBL1779710,EVOGLIPTIN,11140,CHEMBL284,Dipeptidyl peptidase 4,9.05,9.05,0.9,1,9
336913,CHEMBL178,DAUNORUBICIN,63,CHEMBL1806,DNA topoisomerase 2-alpha,8.0,8.0,10.0,1,9
336913,CHEMBL178,DAUNORUBICIN,11307,CHEMBL1865,Histone deacetylase 6,7.7,7.7,20.0,1,9
336913,CHEMBL178,DAUNORUBICIN,12697,CHEMBL325,Histone deacetylase 1,7.33,7.33,47.0,1,9
336913,CHEMBL178,DAUNORUBICIN,12030,CHEMBL3004,Multidrug resistance-associated protein 1,7.16,6.59,70.0,2,8
336913,CHEMBL178,DAUNORUBICIN,25,CHEMBL2034,Glucocorticoid receptor,6.96,6.96,110.0,1,8
336913,CHEMBL178,DAUNORUBICIN,10869,CHEMBL3192,Histone deacetylase 8,6.66,6.66,220.0,1,9
336913,CHEMBL178,DAUNORUBICIN,11453,CHEMBL4185,Xaa-Pro dipeptidase,6.52,6.52,300.0,1,9
336913,CHEMBL178,DAUNORUBICIN,13001,CHEMBL333,72 kDa type IV collagenase,5.72,5.72,1900.0,1,8
336913,CHEMBL178,DAUNORUBICIN,101216,CHEMBL5514,Huntingtin,5.65,5.65,2238.7,1,9
336913,CHEMBL178,DAUNORUBICIN,11398,CHEMBL4302,ATP-dependent translocase ABCB1,5.6,5.6,2500.0,1,8
336913,CHEMBL178,DAUNORUBICIN,126,CHEMBL230,Prostaglandin G/H synthase 2,5.55,5.55,2800.0,1,8
20130,CHEMBL17860,LOFEXIDINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,8.86,7.47,1.38,3,9
20130,CHEMBL17860,LOFEXIDINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,8.36,7.81,4.365,4,9
20130,CHEMBL17860,LOFEXIDINE,125,CHEMBL229,Alpha-1A adrenergic receptor,8.15,7.12,7.1,2,8
20130,CHEMBL17860,LOFEXIDINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.17,6.73,67.61,3,9
20130,CHEMBL17860,LOFEXIDINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.9,6.47,125.89,3,9
20100,CHEMBL17879,MARALIXIBAT CHLORIDE,12909,CHEMBL2778,Ileal sodium/bile acid cotransporter,6.05,6.05,890.0,1,8
300585,CHEMBL178803,BLONANSERIN,72,CHEMBL217,D(2) dopamine receptor,9.85,9.85,0.14,1,9
300585,CHEMBL178803,BLONANSERIN,107,CHEMBL224,5-hydroxytryptamine receptor 2A,9.09,9.09,0.81,1,9
1153572,CHEMBL1789941,RUXOLITINIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,10.44,8.56,0.036,61,9
1153572,CHEMBL1789941,RUXOLITINIB,10919,CHEMBL2835,Tyrosine-protein kinase JAK1,10.05,8.53,0.09,43,9
1153572,CHEMBL1789941,RUXOLITINIB,12694,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,9.4,8.23,0.4,26,9
1153572,CHEMBL1789941,RUXOLITINIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,8.7,7.13,2.0,30,9
1153572,CHEMBL1789941,RUXOLITINIB,11307,CHEMBL1865,Histone deacetylase 6,7.82,7.82,15.0,1,9
1153572,CHEMBL1789941,RUXOLITINIB,102711,CHEMBL5914,Mitogen-activated protein kinase kinase kinase 2,7.39,7.39,41.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,12415,CHEMBL4147,Calcium/calmodulin-dependent protein kinase type II subunit alpha,7.34,7.34,46.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,11149,CHEMBL2973,Rho-associated protein kinase 2,7.28,7.28,52.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,10811,CHEMBL3231,Rho-associated protein kinase 1,7.22,6.65,60.0,2,9
1153572,CHEMBL1789941,RUXOLITINIB,101281,CHEMBL5683,Serine/threonine-protein kinase DCLK1,7.17,7.17,68.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,11150,CHEMBL2558,Death-associated protein kinase 1,7.14,7.14,72.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,10051,CHEMBL2468,Death-associated protein kinase 3,7.05,7.05,89.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,11622,CHEMBL2801,Calcium/calmodulin-dependent protein kinase type II subunit delta,7.05,6.78,90.0,2,9
1153572,CHEMBL1789941,RUXOLITINIB,103154,CHEMBL1075104,Leucine-rich repeat serine/threonine-protein kinase 2,7.05,6.79,90.0,2,8
1153572,CHEMBL1789941,RUXOLITINIB,10778,CHEMBL3123,Death-associated protein kinase 2,7.01,7.01,97.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,20020,CHEMBL4355,Cyclin-G-associated kinase,7.0,6.96,99.0,2,9
1153572,CHEMBL1789941,RUXOLITINIB,30000,CHEMBL3830,AP2-associated protein kinase 1,7.0,6.6,100.0,3,9
1153572,CHEMBL1789941,RUXOLITINIB,30002,CHEMBL3829,Calcium/calmodulin-dependent protein kinase type II subunit gamma,7.0,6.79,100.0,2,9
1153572,CHEMBL1789941,RUXOLITINIB,10929,CHEMBL2553,Ribosomal protein S6 kinase alpha-1,6.92,6.92,120.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,30028,CHEMBL5073,Calcium/calmodulin-dependent protein kinase type 1D,6.92,6.92,120.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,10907,CHEMBL3024,Serine/threonine-protein kinase PLK1,6.89,6.41,130.0,2,9
1153572,CHEMBL1789941,RUXOLITINIB,10850,CHEMBL4237,Ribosomal protein S6 kinase alpha-5,6.85,6.85,140.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,10939,CHEMBL4924,Ribosomal protein S6 kinase alpha-6,6.82,6.33,150.0,2,8
1153572,CHEMBL1789941,RUXOLITINIB,11843,CHEMBL3906,Ribosomal protein S6 kinase alpha-2,6.82,6.82,150.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,101399,CHEMBL5970,Mitogen-activated protein kinase kinase kinase 3,6.82,6.82,150.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,6.72,6.28,190.0,5,9
1153572,CHEMBL1789941,RUXOLITINIB,101191,CHEMBL5435,Serine/threonine-protein kinase ULK2,6.72,6.72,190.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,10971,CHEMBL2494,Calcium/calmodulin-dependent protein kinase type IV,6.71,6.71,196.0,1,9
1153572,CHEMBL1789941,RUXOLITINIB,117538,CHEMBL4105933,Uncharacterized protein FLJ45252,6.71,6.71,196.0,1,9
1153572,CHEMBL1789941,RUXOLITINIB,30003,CHEMBL3788,Serine/threonine-protein kinase PLK4,6.7,6.7,200.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,30037,CHEMBL4204,MAP kinase-interacting serine/threonine-protein kinase 2,6.7,6.7,200.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,30042,CHEMBL4522,BMP-2-inducible protein kinase,6.68,6.68,210.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,101448,CHEMBL6123,Serine/threonine-protein kinase DCLK3,6.58,6.58,260.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,102799,CHEMBL6191,Mitogen-activated protein kinase kinase kinase 19,6.57,6.57,270.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,19623,CHEMBL3357,Interleukin-1 receptor-associated kinase 1,6.54,6.54,290.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,101411,CHEMBL6006,Serine/threonine-protein kinase ULK1,6.52,6.52,300.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,10396,CHEMBL4121,Calcium/calmodulin-dependent protein kinase type II subunit beta,6.51,6.51,310.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,103140,CHEMBL1075195,Serine/threonine-protein kinase TAO2,6.51,6.51,310.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,101503,CHEMBL5698,NUAK family SNF1-like kinase 2,6.5,6.5,320.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,101034,CHEMBL5608,NT-3 growth factor receptor,6.48,6.48,330.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,10782,CHEMBL3125,Ribosomal protein S6 kinase alpha-4,6.47,6.47,340.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,10250,CHEMBL2428,"Myosin light chain kinase, smooth muscle",6.44,6.44,360.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,100413,CHEMBL4898,BDNF/NT-3 growth factors receptor,6.44,6.44,360.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,30014,CHEMBL4225,Dual specificity protein kinase CLK2,6.43,6.37,375.0,3,9
1153572,CHEMBL1789941,RUXOLITINIB,101226,CHEMBL5547,Ankyrin repeat and protein kinase domain-containing protein 1,6.41,6.41,390.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,101484,CHEMBL5627,Leukocyte tyrosine kinase receptor,6.36,6.36,440.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,10478,CHEMBL2109,Dual specificity mitogen-activated protein kinase kinase 3,6.33,6.33,470.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,10970,CHEMBL2493,Calcium/calmodulin-dependent protein kinase type 1,6.33,6.33,470.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,30011,CHEMBL3983,Dual specificity protein kinase TTK,6.32,6.32,480.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,30004,CHEMBL3938,Serine/threonine-protein kinase 16,6.31,6.31,490.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,10878,CHEMBL3582,Protein kinase C epsilon type,6.28,6.28,530.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,103457,CHEMBL1163128,Microtubule-associated serine/threonine-protein kinase 1,6.28,6.28,520.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,103062,CHEMBL1075133,Rhodopsin kinase GRK7,6.27,6.27,540.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,101506,CHEMBL5701,Serine/threonine-protein kinase TAO3,6.23,6.23,590.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,30001,CHEMBL3831,Serine/threonine-protein kinase MARK2,6.18,6.18,660.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,11018,CHEMBL2896,cGMP-dependent protein kinase 2,6.16,6.16,690.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,100412,CHEMBL4897,Serine/threonine-protein kinase PLK3,6.15,6.15,710.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,101033,CHEMBL5607,Rhodopsin kinase GRK1,6.14,6.14,730.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,101324,CHEMBL5776,Mitogen-activated protein kinase kinase kinase 7,6.14,6.14,730.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,101221,CHEMBL5519,Serine/threonine-protein kinase DCLK2,6.12,6.12,760.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,10262,CHEMBL2426,Casein kinase I isoform gamma-1,6.07,6.07,851.0,1,9
1153572,CHEMBL1789941,RUXOLITINIB,12090,CHEMBL2292,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,6.04,5.79,910.0,2,9
1153572,CHEMBL1789941,RUXOLITINIB,100993,CHEMBL5467,Bone morphogenetic protein receptor type-2,6.03,6.03,930.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,12735,CHEMBL2349,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",6.0,6.0,1000.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,100852,CHEMBL4576,Homeodomain-interacting protein kinase 2,6.0,6.0,1000.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,5.96,5.75,1100.0,4,8
1153572,CHEMBL1789941,RUXOLITINIB,102421,CHEMBL5679,Serine/threonine-protein kinase Nek3,5.96,5.96,1100.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,103456,CHEMBL1163127,Mitogen-activated protein kinase kinase kinase 15,5.96,5.96,1100.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,12915,CHEMBL3529,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,5.92,5.92,1200.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,100853,CHEMBL4577,Homeodomain-interacting protein kinase 3,5.92,5.92,1200.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,101183,CHEMBL5427,Homeodomain-interacting protein kinase 1,5.92,5.92,1200.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,101405,CHEMBL6000,Serine/threonine-protein kinase RIO2,5.92,5.92,1200.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,30044,CHEMBL4524,Serine/threonine-protein kinase PAK 5,5.89,5.89,1300.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,101131,CHEMBL5261,Serine/threonine-protein kinase TAO1,5.89,5.89,1300.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,102770,CHEMBL6149,Serine/threonine-protein kinase SIK3,5.89,5.89,1300.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,103458,CHEMBL1163129,Serine/threonine-protein kinase SBK1,5.89,5.89,1300.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,11902,CHEMBL2815,High affinity nerve growth factor receptor,5.82,5.82,1500.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,100417,CHEMBL4247,ALK tyrosine kinase receptor,5.82,5.82,1500.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,101610,CHEMBL5938,Serine/threonine-protein kinase PLK2,5.82,5.82,1500.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,104312,CHEMBL1908381,Peripheral plasma membrane protein CASK,5.82,5.82,1500.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,30023,CHEMBL4599,Activated CDC42 kinase 1,5.8,5.69,1597.0,2,9
1153572,CHEMBL1789941,RUXOLITINIB,100080,CHEMBL4482,Serine/threonine-protein kinase PAK 4,5.8,5.8,1600.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,30036,CHEMBL4203,Dual specificity protein kinase CLK4,5.77,5.77,1700.0,2,9
1153572,CHEMBL1789941,RUXOLITINIB,100856,CHEMBL5408,Serine/threonine-protein kinase TBK1,5.77,5.77,1700.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,11047,CHEMBL2897,Dual specificity mitogen-activated protein kinase kinase 4,5.75,5.75,1800.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,11720,CHEMBL2793,Casein kinase I isoform alpha,5.75,5.75,1800.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,101204,CHEMBL5476,Bone morphogenetic protein receptor type-1B,5.75,5.75,1800.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,11409,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,5.72,5.72,1900.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,11870,CHEMBL2708,Mitogen-activated protein kinase kinase kinase 11,5.72,5.72,1900.0,1,9
1153572,CHEMBL1789941,RUXOLITINIB,103437,CHEMBL1163108,STE20/SPS1-related proline-alanine-rich protein kinase,5.72,5.72,1900.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,100947,CHEMBL5330,Mitogen-activated protein kinase kinase kinase kinase 2,5.7,5.7,2000.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,101278,CHEMBL5659,Serine/threonine-protein kinase RIO3,5.7,5.7,1995.26,3,9
1153572,CHEMBL1789941,RUXOLITINIB,100789,CHEMBL4375,SRSF protein kinase 1,5.68,5.68,2100.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,101434,CHEMBL6083,Receptor-interacting serine/threonine-protein kinase 4,5.68,5.68,2100.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,30031,CHEMBL5258,Calcium/calmodulin-dependent protein kinase type 1G,5.66,5.66,2200.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,100126,CHEMBL5145,Serine/threonine-protein kinase B-raf,5.66,5.66,2200.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,100854,CHEMBL4578,Maternal embryonic leucine zipper kinase,5.66,5.66,2200.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,10752,CHEMBL1991,Inhibitor of nuclear factor kappa-B kinase subunit beta,5.64,5.64,2300.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,101048,CHEMBL5047,Serine/threonine-protein kinase ULK3,5.62,5.62,2400.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,101404,CHEMBL5975,Serine/threonine-protein kinase RIO1,5.6,5.6,2500.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,103430,CHEMBL1163101,Serine/threonine-protein kinase/endoribonuclease IRE1,5.6,5.6,2500.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,103433,CHEMBL1163104,Serine/threonine-protein kinase OSR1,5.57,5.57,2700.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,30040,CHEMBL4311,Serine/threonine-protein kinase PAK 6,5.54,5.54,2900.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,11637,CHEMBL3384,Serine/threonine-protein kinase N1,5.52,5.52,3050.0,1,9
1153572,CHEMBL1789941,RUXOLITINIB,11105,CHEMBL3094,MAP kinase-activated protein kinase 5,5.51,5.51,3118.0,1,9
1153572,CHEMBL1789941,RUXOLITINIB,101613,CHEMBL5941,Serine/threonine-protein kinase 26,5.51,5.51,3100.0,1,8
1153572,CHEMBL1789941,RUXOLITINIB,102676,CHEMBL5836,Ephrin type-B receptor 6,5.51,5.51,3100.0,1,8
1153672,CHEMBL1790041,RANITIDINE,102,CHEMBL1941,Histamine H2 receptor,7.2,6.96,63.0,3,9
1153672,CHEMBL1790041,RANITIDINE,103668,CHEMBL1293235,Prelamin-A/C,7.1,7.1,79.4,1,9
1153672,CHEMBL1790041,RANITIDINE,93,CHEMBL220,Acetylcholinesterase,6.19,5.95,650.0,3,8
1153672,CHEMBL1790041,RANITIDINE,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,6.15,6.15,707.9,2,9
1153672,CHEMBL1790041,RANITIDINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.59,5.59,2550.0,1,8
1153672,CHEMBL1790041,RANITIDINE,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,5.5,5.5,3162.3,1,9
1158402,CHEMBL1795071,RUXOLITINIB PHOSPHATE,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,8.55,8.05,2.8,2,9
1158402,CHEMBL1795071,RUXOLITINIB PHOSPHATE,10919,CHEMBL2835,Tyrosine-protein kinase JAK1,8.48,8.24,3.3,2,9
1158402,CHEMBL1795071,RUXOLITINIB PHOSPHATE,12694,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,6.94,6.94,116.0,1,8
1158402,CHEMBL1795071,RUXOLITINIB PHOSPHATE,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,6.09,6.09,810.0,1,8
1096,CHEMBL18,ETHOXZOLAMIDE,12952,CHEMBL3594,Carbonic anhydrase 9,9.6,7.53,0.25,53,9
1096,CHEMBL18,ETHOXZOLAMIDE,15,CHEMBL205,Carbonic anhydrase 2,9.52,8.11,0.3,113,9
1096,CHEMBL18,ETHOXZOLAMIDE,11060,CHEMBL2326,Carbonic anhydrase 7,9.15,9.11,0.71,13,9
1096,CHEMBL18,ETHOXZOLAMIDE,11063,CHEMBL3510,Carbonic anhydrase 14,8.6,7.85,2.5,12,9
1096,CHEMBL18,ETHOXZOLAMIDE,10193,CHEMBL261,Carbonic anhydrase 1,8.1,7.59,8.0,100,9
1096,CHEMBL18,ETHOXZOLAMIDE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,8.0,8.0,10.0,2,9
1096,CHEMBL18,ETHOXZOLAMIDE,12923,CHEMBL3912,Carbonic anhydrase 13,7.89,7.89,13.0,2,9
1096,CHEMBL18,ETHOXZOLAMIDE,11016,CHEMBL3969,"Carbonic anhydrase 5B, mitochondrial",7.72,7.72,19.0,8,9
1096,CHEMBL18,ETHOXZOLAMIDE,12209,CHEMBL3242,Carbonic anhydrase 12,7.66,7.63,22.0,29,9
1096,CHEMBL18,ETHOXZOLAMIDE,11042,CHEMBL4789,"Carbonic anhydrase 5A, mitochondrial",7.6,7.6,25.0,8,9
1096,CHEMBL18,ETHOXZOLAMIDE,10186,CHEMBL3025,Carbonic anhydrase 6,7.48,7.09,33.0,11,9
1096,CHEMBL18,ETHOXZOLAMIDE,12896,CHEMBL3729,Carbonic anhydrase 4,7.03,6.82,93.0,9,9
1161221,CHEMBL1800159,RELUGOLIX,118,CHEMBL1855,Gonadotropin-releasing hormone receptor,10.1,9.16,0.08,9,9
299120,CHEMBL180022,NERATINIB,9,CHEMBL203,Epidermal growth factor receptor,10.7,8.42,0.02,43,9
299120,CHEMBL180022,NERATINIB,30049,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,9.19,8.54,0.65,2,9
299120,CHEMBL180022,NERATINIB,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,9.0,7.89,1.0,23,9
299120,CHEMBL180022,NERATINIB,12699,CHEMBL3009,Receptor tyrosine-protein kinase erbB-4,8.62,8.17,2.4,2,9
299120,CHEMBL180022,NERATINIB,101056,CHEMBL5082,Serine/threonine-protein kinase 24,8.19,8.17,6.5,2,9
299120,CHEMBL180022,NERATINIB,101613,CHEMBL5941,Serine/threonine-protein kinase 26,8.15,7.44,7.0,3,9
299120,CHEMBL180022,NERATINIB,101188,CHEMBL5432,Mitogen-activated protein kinase kinase kinase kinase 3,8.11,6.93,7.7,2,9
299120,CHEMBL180022,NERATINIB,102678,CHEMBL5838,Receptor tyrosine-protein kinase erbB-3,8.11,8.11,7.7,1,8
299120,CHEMBL180022,NERATINIB,101231,CHEMBL5552,Serine/threonine-protein kinase 25,7.92,7.92,12.0,1,8
299120,CHEMBL180022,NERATINIB,30006,CHEMBL3981,Serine/threonine-protein kinase 10,7.89,7.89,13.0,1,8
299120,CHEMBL180022,NERATINIB,11409,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,7.85,6.67,14.0,2,9
299120,CHEMBL180022,NERATINIB,102799,CHEMBL6191,Mitogen-activated protein kinase kinase kinase 19,7.8,7.8,16.0,1,8
299120,CHEMBL180022,NERATINIB,11046,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,7.58,7.58,26.0,1,8
299120,CHEMBL180022,NERATINIB,101220,CHEMBL5518,Misshapen-like kinase 1,7.54,7.54,29.0,1,8
299120,CHEMBL180022,NERATINIB,30050,CHEMBL4853,Mitogen-activated protein kinase kinase kinase 4,7.41,6.73,39.0,2,9
299120,CHEMBL180022,NERATINIB,10277,CHEMBL4708,Serine/threonine-protein kinase 3,7.24,7.24,58.0,2,9
299120,CHEMBL180022,NERATINIB,10371,CHEMBL4948,Dual specificity mitogen-activated protein kinase kinase 5,7.2,7.2,63.0,1,8
299120,CHEMBL180022,NERATINIB,30035,CHEMBL4202,STE20-like serine/threonine-protein kinase,7.18,6.58,66.0,2,9
299120,CHEMBL180022,NERATINIB,100071,CHEMBL4487,Serine/threonine-protein kinase PAK 2,7.1,7.1,79.0,1,8
299120,CHEMBL180022,NERATINIB,11691,CHEMBL2250,Tyrosine-protein kinase Blk,7.07,7.07,85.0,1,8
299120,CHEMBL180022,NERATINIB,101312,CHEMBL5749,Mitogen-activated protein kinase kinase kinase kinase 1,7.03,7.03,93.0,1,8
299120,CHEMBL180022,NERATINIB,100925,CHEMBL5358,eIF-2-alpha kinase GCN2,7.02,7.02,96.0,1,8
299120,CHEMBL180022,NERATINIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,6.92,6.46,120.0,2,9
299120,CHEMBL180022,NERATINIB,101399,CHEMBL5970,Mitogen-activated protein kinase kinase kinase 3,6.89,6.89,130.0,1,8
299120,CHEMBL180022,NERATINIB,30047,CHEMBL4527,TRAF2 and NCK-interacting protein kinase,6.85,6.85,140.0,1,8
299120,CHEMBL180022,NERATINIB,101503,CHEMBL5698,NUAK family SNF1-like kinase 2,6.85,6.85,140.0,1,8
299120,CHEMBL180022,NERATINIB,100097,CHEMBL5251,Tyrosine-protein kinase BTK,6.8,6.36,160.0,2,9
299120,CHEMBL180022,NERATINIB,100410,CHEMBL4895,Tyrosine-protein kinase receptor UFO,6.72,6.72,190.0,1,8
299120,CHEMBL180022,NERATINIB,30025,CHEMBL4600,Serine/threonine-protein kinase PAK 1,6.68,6.68,210.0,1,8
299120,CHEMBL180022,NERATINIB,100947,CHEMBL5330,Mitogen-activated protein kinase kinase kinase kinase 2,6.66,6.35,220.0,2,9
299120,CHEMBL180022,NERATINIB,101433,CHEMBL6082,Serine/threonine-protein kinase SIK1,6.66,6.66,220.0,1,8
299120,CHEMBL180022,NERATINIB,18033,CHEMBL2073,Tyrosine-protein kinase Yes,6.62,6.62,240.0,1,8
299120,CHEMBL180022,NERATINIB,20020,CHEMBL4355,Cyclin-G-associated kinase,6.6,6.6,250.0,2,9
299120,CHEMBL180022,NERATINIB,30017,CHEMBL3835,Serine/threonine-protein kinase Nek2,6.6,6.57,250.0,4,9
299120,CHEMBL180022,NERATINIB,30024,CHEMBL4598,Serine/threonine-protein kinase 4,6.57,6.57,270.0,2,9
299120,CHEMBL180022,NERATINIB,10967,CHEMBL4937,Casein kinase I isoform epsilon,6.54,6.54,290.0,1,8
299120,CHEMBL180022,NERATINIB,101464,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,6.48,6.21,330.0,2,9
299120,CHEMBL180022,NERATINIB,30045,CHEMBL4525,Serine/threonine-protein kinase 17A,6.47,6.47,340.0,1,8
299120,CHEMBL180022,NERATINIB,101499,CHEMBL5671,Protein delta homolog 1,6.43,6.43,370.0,1,9
299120,CHEMBL180022,NERATINIB,104320,CHEMBL1908389,Mitogen-activated protein kinase kinase kinase 12,6.43,6.43,370.0,1,8
299120,CHEMBL180022,NERATINIB,100906,CHEMBL5274,Tyrosine-protein kinase receptor Tie-1,6.41,6.41,390.0,1,8
299120,CHEMBL180022,NERATINIB,100948,CHEMBL5331,Tyrosine-protein kinase Mer,6.4,6.4,400.0,1,8
299120,CHEMBL180022,NERATINIB,102711,CHEMBL5914,Mitogen-activated protein kinase kinase kinase 2,6.35,6.35,450.0,1,8
299120,CHEMBL180022,NERATINIB,11785,CHEMBL3234,Tyrosine-protein kinase HCK,6.31,6.14,490.0,2,9
299120,CHEMBL180022,NERATINIB,30007,CHEMBL3982,Tyrosine-protein kinase Fer,6.29,6.29,510.0,1,8
299120,CHEMBL180022,NERATINIB,12919,CHEMBL3530,Dual specificity mitogen-activated protein kinase kinase 7,6.28,6.28,530.0,1,8
299120,CHEMBL180022,NERATINIB,10844,CHEMBL2634,Tyrosine-protein kinase CSK,6.26,6.26,550.0,1,8
299120,CHEMBL180022,NERATINIB,100069,CHEMBL5455,Tyrosine-protein kinase Fes/Fps,6.23,6.23,590.0,1,8
299120,CHEMBL180022,NERATINIB,12840,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,6.17,6.17,670.0,1,8
299120,CHEMBL180022,NERATINIB,30023,CHEMBL4599,Activated CDC42 kinase 1,6.17,6.17,680.0,1,8
299120,CHEMBL180022,NERATINIB,103453,CHEMBL1163124,Mitogen-activated protein kinase kinase kinase 13,6.13,6.13,740.0,1,8
299120,CHEMBL180022,NERATINIB,117491,CHEMBL4105886,Uncharacterized aarF domain-containing protein kinase 5,6.1,6.1,796.0,1,9
299120,CHEMBL180022,NERATINIB,10903,CHEMBL3863,Serine/threonine-protein kinase D1,6.09,6.09,820.0,1,8
299120,CHEMBL180022,NERATINIB,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,6.09,5.95,820.0,2,9
299120,CHEMBL180022,NERATINIB,10531,CHEMBL2527,Serine/threonine-protein kinase Chk2,6.07,6.07,850.0,1,8
299120,CHEMBL180022,NERATINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,6.07,6.07,858.2,1,9
299120,CHEMBL180022,NERATINIB,101410,CHEMBL6005,Serine/threonine-protein kinase 33,6.03,6.03,940.0,1,8
299120,CHEMBL180022,NERATINIB,30005,CHEMBL3980,Serine/threonine-protein kinase 17B,5.96,5.96,1100.0,1,8
299120,CHEMBL180022,NERATINIB,100415,CHEMBL4900,Serine/threonine-protein kinase D2,5.96,5.96,1100.0,1,8
299120,CHEMBL180022,NERATINIB,102,CHEMBL1941,Histamine H2 receptor,5.91,5.91,1219.7,1,8
299120,CHEMBL180022,NERATINIB,101069,CHEMBL5095,Wee1-like protein kinase 2,5.89,5.89,1300.0,1,8
299120,CHEMBL180022,NERATINIB,20007,CHEMBL3886,Mitogen-activated protein kinase kinase kinase 20,5.82,5.82,1500.0,1,8
299120,CHEMBL180022,NERATINIB,101332,CHEMBL5784,NUAK family SNF1-like kinase 1,5.82,5.82,1500.0,1,8
299120,CHEMBL180022,NERATINIB,103106,CHEMBL1075167,Homeodomain-interacting protein kinase 4,5.82,5.82,1500.0,1,8
299120,CHEMBL180022,NERATINIB,100854,CHEMBL4578,Maternal embryonic leucine zipper kinase,5.8,5.8,1600.0,1,8
299120,CHEMBL180022,NERATINIB,11242,CHEMBL2695,Focal adhesion kinase 1,5.72,5.72,1900.0,1,8
299120,CHEMBL180022,NERATINIB,100127,CHEMBL4454,Tyrosine-protein kinase Fgr,5.72,5.72,1900.0,1,8
299120,CHEMBL180022,NERATINIB,175,CHEMBL1997,Equilibrative nucleoside transporter 1,5.71,5.71,1960.0,1,8
299120,CHEMBL180022,NERATINIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,5.7,5.7,2000.0,1,8
299120,CHEMBL180022,NERATINIB,19623,CHEMBL3357,Interleukin-1 receptor-associated kinase 1,5.64,5.64,2300.0,1,8
299120,CHEMBL180022,NERATINIB,30022,CHEMBL4597,Cyclin-dependent kinase 16,5.64,5.64,2300.0,1,8
299120,CHEMBL180022,NERATINIB,10885,CHEMBL2595,Serine/threonine-protein kinase D3,5.62,5.62,2400.0,1,8
299120,CHEMBL180022,NERATINIB,102421,CHEMBL5679,Serine/threonine-protein kinase Nek3,5.62,5.62,2400.0,1,8
299120,CHEMBL180022,NERATINIB,11408,CHEMBL2637,Mitogen-activated protein kinase 10,5.6,5.6,2500.0,1,8
299120,CHEMBL180022,NERATINIB,102676,CHEMBL5836,Ephrin type-B receptor 6,5.55,5.55,2800.0,1,8
299120,CHEMBL180022,NERATINIB,35,CHEMBL1981,Insulin receptor,5.52,5.52,3000.0,1,8
299120,CHEMBL180022,NERATINIB,12913,CHEMBL4128,Angiopoietin-1 receptor,5.52,5.52,3000.0,1,8
299120,CHEMBL180022,NERATINIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,5.51,5.51,3100.0,1,8
299120,CHEMBL180022,NERATINIB,11536,CHEMBL4616,Growth hormone secretagogue receptor type 1,5.5,5.5,3200.0,1,8
1166082,CHEMBL1808388,BEXAGLIFLOZIN,20092,CHEMBL3884,Sodium/glucose cotransporter 2,8.7,8.67,2.0,2,9
364859,CHEMBL181,DIAZOXIDE,103668,CHEMBL1293235,Prelamin-A/C,6.95,6.88,112.2,2,9
364859,CHEMBL181,DIAZOXIDE,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,6.94,6.94,113.8,1,9
364859,CHEMBL181,DIAZOXIDE,103665,CHEMBL1293232,Survival motor neuron protein,5.8,5.8,1584.9,1,9
364859,CHEMBL181,DIAZOXIDE,12594,CHEMBL3356,Cytochrome P450 1A2,5.7,5.6,1995.26,2,8
20372,CHEMBL18116,TOLOXATONE,86,CHEMBL1951,Amine oxidase [flavin-containing] A,6.04,5.87,920.0,10,9
365284,CHEMBL182,GANCICLOVIR,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.49,8.49,3.2,2,9
365284,CHEMBL182,GANCICLOVIR,103079,CHEMBL1075145,Transitional endoplasmic reticulum ATPase,5.89,5.89,1300.0,1,9
365284,CHEMBL182,GANCICLOVIR,103665,CHEMBL1293232,Survival motor neuron protein,5.8,5.8,1584.9,1,9
365284,CHEMBL182,GANCICLOVIR,103668,CHEMBL1293235,Prelamin-A/C,5.5,5.5,3162.3,1,9
1178704,CHEMBL1834657,INFIGRATINIB PHOSPHATE,11926,CHEMBL2742,Fibroblast growth factor receptor 3,9.15,8.42,0.7,8,9
1178704,CHEMBL1834657,INFIGRATINIB PHOSPHATE,10266,CHEMBL3650,Fibroblast growth factor receptor 1,9.05,8.64,0.9,3,8
1178704,CHEMBL1834657,INFIGRATINIB PHOSPHATE,10264,CHEMBL4142,Fibroblast growth factor receptor 2,8.85,8.62,1.4,3,8
1178704,CHEMBL1834657,INFIGRATINIB PHOSPHATE,11925,CHEMBL3973,Fibroblast growth factor receptor 4,7.22,7.0,60.0,2,8
1178704,CHEMBL1834657,INFIGRATINIB PHOSPHATE,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,6.75,6.21,180.0,3,8
1178704,CHEMBL1834657,INFIGRATINIB PHOSPHATE,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,6.52,6.02,300.0,2,8
1178704,CHEMBL1834657,INFIGRATINIB PHOSPHATE,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,6.12,5.86,750.0,2,8
1178704,CHEMBL1834657,INFIGRATINIB PHOSPHATE,18033,CHEMBL2073,Tyrosine-protein kinase Yes,5.96,5.96,1100.0,1,8
1178704,CHEMBL1834657,INFIGRATINIB PHOSPHATE,10979,CHEMBL1868,Vascular endothelial growth factor receptor 1,5.82,5.82,1510.0,1,8
1178704,CHEMBL1834657,INFIGRATINIB PHOSPHATE,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,5.72,5.72,1900.0,1,8
1178704,CHEMBL1834657,INFIGRATINIB PHOSPHATE,12913,CHEMBL4128,Angiopoietin-1 receptor,5.69,5.69,2051.0,1,8
1178704,CHEMBL1834657,INFIGRATINIB PHOSPHATE,11752,CHEMBL1955,Vascular endothelial growth factor receptor 3,5.68,5.68,2072.0,1,8
1178704,CHEMBL1834657,INFIGRATINIB PHOSPHATE,8,CHEMBL1862,Tyrosine-protein kinase ABL1,5.64,5.64,2300.0,1,8
1178704,CHEMBL1834657,INFIGRATINIB PHOSPHATE,10140,CHEMBL258,Tyrosine-protein kinase Lck,5.6,5.6,2500.0,1,8
1178704,CHEMBL1834657,INFIGRATINIB PHOSPHATE,12627,CHEMBL2007,Platelet-derived growth factor receptor alpha,5.57,5.57,2718.0,1,8
1178704,CHEMBL1834657,INFIGRATINIB PHOSPHATE,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,5.54,5.54,2882.0,1,8
1178704,CHEMBL1834657,INFIGRATINIB PHOSPHATE,11379,CHEMBL2689,Macrophage-stimulating protein receptor,5.54,5.54,2891.0,1,8
1178704,CHEMBL1834657,INFIGRATINIB PHOSPHATE,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,5.53,5.53,2969.0,1,8
1178704,CHEMBL1834657,INFIGRATINIB PHOSPHATE,11451,CHEMBL3717,Hepatocyte growth factor receptor,5.52,5.52,3011.0,1,8
1178704,CHEMBL1834657,INFIGRATINIB PHOSPHATE,30020,CHEMBL5072,Ephrin type-B receptor 1,5.52,5.52,3039.0,1,8
1178704,CHEMBL1834657,INFIGRATINIB PHOSPHATE,100417,CHEMBL4247,ALK tyrosine kinase receptor,5.51,5.51,3078.0,1,8
1178704,CHEMBL1834657,INFIGRATINIB PHOSPHATE,100413,CHEMBL4898,BDNF/NT-3 growth factors receptor,5.5,5.5,3139.0,1,8
365538,CHEMBL184,ACYCLOVIR,12690,CHEMBL4338,Purine nucleoside phosphorylase,7.0,7.0,100.0,1,9
365538,CHEMBL184,ACYCLOVIR,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,6.3,6.3,501.2,2,9
365538,CHEMBL184,ACYCLOVIR,103669,CHEMBL1293236,ATP-dependent DNA helicase Q1,6.1,6.1,794.3,1,9
308422,CHEMBL184412,DRONEDARONE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.5,6.01,316.23,2,9
308422,CHEMBL184412,DRONEDARONE,36,CHEMBL208,Progesterone receptor,6.19,6.19,639.7,1,8
308422,CHEMBL184412,DRONEDARONE,130,CHEMBL234,D(3) dopamine receptor,6.19,6.19,641.8,1,8
308422,CHEMBL184412,DRONEDARONE,280,CHEMBL256,Adenosine receptor A3,5.81,5.81,1536.7,1,8
308422,CHEMBL184412,DRONEDARONE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.76,5.76,1721.3,1,8
308422,CHEMBL184412,DRONEDARONE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.76,5.76,1730.9,1,8
308422,CHEMBL184412,DRONEDARONE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.62,5.62,2386.2,1,8
308422,CHEMBL184412,DRONEDARONE,129,CHEMBL233,Mu-type opioid receptor,5.51,5.51,3094.0,1,8
20346,CHEMBL18442,PLERIXAFOR,11575,CHEMBL4015,C-C chemokine receptor type 2,10.4,10.23,0.04,2,8
20346,CHEMBL18442,PLERIXAFOR,10473,CHEMBL2107,C-X-C chemokine receptor type 4,9.09,6.71,0.81,66,9
20346,CHEMBL18442,PLERIXAFOR,10280,CHEMBL264,Histamine H3 receptor,8.56,7.54,2.744,2,9
20346,CHEMBL18442,PLERIXAFOR,108376,CHEMBL3286074,Stromal cell-derived factor 1,8.24,7.23,5.7,2,9
20346,CHEMBL18442,PLERIXAFOR,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.09,6.09,803.62,1,9
20346,CHEMBL18442,PLERIXAFOR,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.99,5.99,1013.99,1,9
20346,CHEMBL18442,PLERIXAFOR,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.75,5.75,1776.03,1,9
368538,CHEMBL185,FLUOROURACIL,103668,CHEMBL1293235,Prelamin-A/C,7.95,6.89,11.2,4,9
368538,CHEMBL185,FLUOROURACIL,103689,CHEMBL1293256,Thrombopoietin,7.9,7.9,12.6,2,9
368538,CHEMBL185,FLUOROURACIL,65,CHEMBL1978,Aromatase,6.2,6.2,630.0,1,9
368538,CHEMBL185,FLUOROURACIL,103665,CHEMBL1293232,Survival motor neuron protein,6.2,6.2,631.0,1,9
368538,CHEMBL185,FLUOROURACIL,78,CHEMBL1963,Thyrotropin receptor,6.1,6.1,794.3,2,9
368538,CHEMBL185,FLUOROURACIL,101216,CHEMBL5514,Huntingtin,5.7,5.7,1995.3,1,9
306486,CHEMBL185073,PANCURONIUM,11400,CHEMBL2842,Serine/threonine-protein kinase mTOR,6.68,6.68,207.5,1,9
306486,CHEMBL185073,PANCURONIUM,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.9,5.9,1260.0,1,8
1193367,CHEMBL1852688,INFIGRATINIB,10266,CHEMBL3650,Fibroblast growth factor receptor 1,9.23,8.27,0.59,21,9
1193367,CHEMBL1852688,INFIGRATINIB,11926,CHEMBL2742,Fibroblast growth factor receptor 3,9.18,7.87,0.66,23,9
1193367,CHEMBL1852688,INFIGRATINIB,10264,CHEMBL4142,Fibroblast growth factor receptor 2,9.17,8.14,0.68,15,9
1193367,CHEMBL1852688,INFIGRATINIB,11925,CHEMBL3973,Fibroblast growth factor receptor 4,9.09,7.43,0.82,14,9
1193367,CHEMBL1852688,INFIGRATINIB,101400,CHEMBL5971,Protein smoothened,7.33,7.33,46.5,1,9
1193367,CHEMBL1852688,INFIGRATINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,6.75,6.21,180.0,3,9
1193367,CHEMBL1852688,INFIGRATINIB,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,6.52,6.02,300.0,2,9
1193367,CHEMBL1852688,INFIGRATINIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,6.12,5.86,750.0,2,9
1193367,CHEMBL1852688,INFIGRATINIB,18033,CHEMBL2073,Tyrosine-protein kinase Yes,5.96,5.96,1100.0,1,9
1193367,CHEMBL1852688,INFIGRATINIB,10979,CHEMBL1868,Vascular endothelial growth factor receptor 1,5.82,5.82,1510.0,1,9
1193367,CHEMBL1852688,INFIGRATINIB,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,5.72,5.72,1900.0,1,9
1193367,CHEMBL1852688,INFIGRATINIB,12913,CHEMBL4128,Angiopoietin-1 receptor,5.69,5.69,2051.0,1,9
1193367,CHEMBL1852688,INFIGRATINIB,11752,CHEMBL1955,Vascular endothelial growth factor receptor 3,5.68,5.68,2072.0,1,9
1193367,CHEMBL1852688,INFIGRATINIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,5.64,5.64,2300.0,1,9
1193367,CHEMBL1852688,INFIGRATINIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,5.61,5.61,2482.0,2,9
1193367,CHEMBL1852688,INFIGRATINIB,12627,CHEMBL2007,Platelet-derived growth factor receptor alpha,5.57,5.57,2718.0,1,9
1193367,CHEMBL1852688,INFIGRATINIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,5.54,5.54,2882.0,1,9
1193367,CHEMBL1852688,INFIGRATINIB,11379,CHEMBL2689,Macrophage-stimulating protein receptor,5.54,5.54,2891.0,1,9
1193367,CHEMBL1852688,INFIGRATINIB,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,5.53,5.53,2969.0,1,9
1193367,CHEMBL1852688,INFIGRATINIB,11451,CHEMBL3717,Hepatocyte growth factor receptor,5.52,5.52,3011.0,1,9
1193367,CHEMBL1852688,INFIGRATINIB,30020,CHEMBL5072,Ephrin type-B receptor 1,5.52,5.52,3039.0,1,9
1193367,CHEMBL1852688,INFIGRATINIB,100417,CHEMBL4247,ALK tyrosine kinase receptor,5.51,5.51,3078.0,1,9
1193367,CHEMBL1852688,INFIGRATINIB,100413,CHEMBL4898,BDNF/NT-3 growth factors receptor,5.5,5.5,3139.0,1,9
372385,CHEMBL186,CEFEPIME,216,CHEMBL1942,Alpha-2B adrenergic receptor,9.3,9.3,0.5,1,8
1204084,CHEMBL1863513,INGENOL MEBUTATE,12247,CHEMBL2996,Protein kinase C delta type,8.39,8.39,4.1,2,9
1214046,CHEMBL1873475,IBRUTINIB,100097,CHEMBL5251,Tyrosine-protein kinase BTK,10.1,8.71,0.08,136,9
1214046,CHEMBL1873475,IBRUTINIB,11691,CHEMBL2250,Tyrosine-protein kinase Blk,10.0,9.43,0.1,14,9
1214046,CHEMBL1873475,IBRUTINIB,12699,CHEMBL3009,Receptor tyrosine-protein kinase erbB-4,10.0,8.88,0.1,17,9
1214046,CHEMBL1873475,IBRUTINIB,30016,CHEMBL3834,Cytoplasmic tyrosine-protein kinase BMX,9.4,8.99,0.4,18,9
1214046,CHEMBL1873475,IBRUTINIB,9,CHEMBL203,Epidermal growth factor receptor,9.3,8.02,0.5,44,9
1214046,CHEMBL1873475,IBRUTINIB,100418,CHEMBL4246,Tyrosine-protein kinase Tec,9.3,8.19,0.5,17,9
1214046,CHEMBL1873475,IBRUTINIB,100424,CHEMBL4367,Tyrosine-protein kinase TXK,9.21,8.7,0.62,7,9
1214046,CHEMBL1873475,IBRUTINIB,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,9.12,8.12,0.75,14,9
1214046,CHEMBL1873475,IBRUTINIB,100127,CHEMBL4454,Tyrosine-protein kinase Fgr,8.74,8.54,1.82,6,9
1214046,CHEMBL1873475,IBRUTINIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,8.7,8.2,2.0,14,9
1214046,CHEMBL1873475,IBRUTINIB,10844,CHEMBL2634,Tyrosine-protein kinase CSK,8.66,7.96,2.2,5,9
1214046,CHEMBL1873475,IBRUTINIB,10918,CHEMBL2959,Tyrosine-protein kinase ITK/TSK,8.57,7.74,2.7,25,9
1214046,CHEMBL1873475,IBRUTINIB,30026,CHEMBL4601,Protein-tyrosine kinase 6,8.48,8.05,3.3,4,9
1214046,CHEMBL1873475,IBRUTINIB,11785,CHEMBL3234,Tyrosine-protein kinase HCK,8.43,7.79,3.7,8,9
1214046,CHEMBL1873475,IBRUTINIB,18033,CHEMBL2073,Tyrosine-protein kinase Yes,8.39,8.11,4.1,5,9
1214046,CHEMBL1873475,IBRUTINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,8.28,7.72,5.2,3,9
1214046,CHEMBL1873475,IBRUTINIB,104477,CHEMBL1961792,Nuclear receptor subfamily 4 group A member 3,8.24,7.68,5.7,2,9
1214046,CHEMBL1873475,IBRUTINIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,8.1,7.65,8.0,20,9
1214046,CHEMBL1873475,IBRUTINIB,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,7.85,7.26,14.0,8,9
1214046,CHEMBL1873475,IBRUTINIB,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,7.8,7.13,15.88,9,9
1214046,CHEMBL1873475,IBRUTINIB,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,7.54,7.02,29.0,5,9
1214046,CHEMBL1873475,IBRUTINIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,7.54,6.96,29.2,3,9
1214046,CHEMBL1873475,IBRUTINIB,20025,CHEMBL5014,Receptor-interacting serine/threonine-protein kinase 2,7.24,7.24,57.0,1,9
1214046,CHEMBL1873475,IBRUTINIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,7.14,6.53,73.0,3,9
1214046,CHEMBL1873475,IBRUTINIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,7.07,6.64,86.1,3,9
1214046,CHEMBL1873475,IBRUTINIB,104279,CHEMBL1795199,Receptor-interacting serine/threonine-protein kinase 3,7.07,7.07,85.0,1,9
1214046,CHEMBL1873475,IBRUTINIB,109099,CHEMBL3308912,Platelet glycoprotein VI,6.92,6.92,120.0,1,9
1214046,CHEMBL1873475,IBRUTINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,6.7,6.58,198.0,2,8
1214046,CHEMBL1873475,IBRUTINIB,117318,CHEMBL4105713,ADP-sugar pyrophosphatase,6.7,6.19,200.0,4,9
1214046,CHEMBL1873475,IBRUTINIB,155,CHEMBL238,Sodium-dependent dopamine transporter,6.63,6.48,236.5,2,8
1214046,CHEMBL1873475,IBRUTINIB,10371,CHEMBL4948,Dual specificity mitogen-activated protein kinase kinase 5,6.61,6.61,243.0,1,9
1214046,CHEMBL1873475,IBRUTINIB,10264,CHEMBL4142,Fibroblast growth factor receptor 2,6.55,6.55,280.0,3,9
1214046,CHEMBL1873475,IBRUTINIB,116949,CHEMBL3879824,Peroxiredoxin-like 2A,6.05,6.05,900.0,1,9
1214046,CHEMBL1873475,IBRUTINIB,11209,CHEMBL4014,Tyrosine-protein kinase ABL2,6.04,6.04,919.0,1,9
1214046,CHEMBL1873475,IBRUTINIB,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.01,5.98,970.0,3,9
1214046,CHEMBL1873475,IBRUTINIB,117548,CHEMBL4105943,Uridine diphosphate glucose pyrophosphatase NUDT14,6.0,6.0,990.0,1,9
1214046,CHEMBL1873475,IBRUTINIB,100128,CHEMBL5146,Breakpoint cluster region protein,5.84,5.84,1459.0,1,9
1214046,CHEMBL1873475,IBRUTINIB,246,CHEMBL2069,Thromboxane A2 receptor,5.82,5.66,1532.8,2,8
1214046,CHEMBL1873475,IBRUTINIB,20007,CHEMBL3886,Mitogen-activated protein kinase kinase kinase 20,5.77,5.77,1705.0,1,9
1214046,CHEMBL1873475,IBRUTINIB,101465,CHEMBL6167,Serine/threonine-protein kinase LATS1,5.72,5.72,1884.0,1,9
1214046,CHEMBL1873475,IBRUTINIB,280,CHEMBL256,Adenosine receptor A3,5.54,5.54,2898.1,1,8
316600,CHEMBL187709,TRIPARANOL,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,8.1,8.1,8.0,1,8
316600,CHEMBL187709,TRIPARANOL,11165,CHEMBL4931,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",7.96,7.96,11.0,1,9
1228747,CHEMBL1888176,TROSPIUM,61,CHEMBL216,Muscarinic acetylcholine receptor M1,8.57,8.06,2.7,2,8
1228747,CHEMBL1888176,TROSPIUM,47,CHEMBL211,Muscarinic acetylcholine receptor M2,8.21,7.9,6.1,2,8
1228747,CHEMBL1888176,TROSPIUM,219,CHEMBL245,Muscarinic acetylcholine receptor M3,8.05,8.05,8.9,1,8
1228747,CHEMBL1888176,TROSPIUM,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.2,6.2,630.0,1,8
316539,CHEMBL188921,BUFLOMEDIL,11165,CHEMBL4931,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",7.22,7.22,60.0,1,9
316539,CHEMBL188921,BUFLOMEDIL,103668,CHEMBL1293235,Prelamin-A/C,6.5,6.5,316.2,1,9
316539,CHEMBL188921,BUFLOMEDIL,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.04,5.86,912.2,3,8
316539,CHEMBL188921,BUFLOMEDIL,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.58,5.58,2600.0,1,8
314827,CHEMBL188952,PIRPROFEN,96,CHEMBL221,Prostaglandin G/H synthase 1,7.49,7.21,32.5,2,8
380567,CHEMBL189,MILRINONE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,7.65,7.65,22.4,2,9
380567,CHEMBL189,MILRINONE,170,CHEMBL241,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",6.6,6.38,250.0,4,9
380567,CHEMBL189,MILRINONE,11395,CHEMBL290,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B",6.55,6.55,280.0,1,8
380567,CHEMBL189,MILRINONE,3,CHEMBL1827,"cGMP-specific 3',5'-cyclic phosphodiesterase",6.13,6.13,740.0,1,8
319858,CHEMBL189963,PALBOCICLIB,119127,CHEMBL4523377,Stimulator of interferon genes protein,8.22,8.22,6.01,1,9
319858,CHEMBL189963,PALBOCICLIB,12946,CHEMBL331,Cyclin-dependent kinase 4,8.09,7.44,8.2,31,9
319858,CHEMBL189963,PALBOCICLIB,10480,CHEMBL2508,Cyclin-dependent kinase 6,8.03,7.37,9.3,30,9
319858,CHEMBL189963,PALBOCICLIB,11678,CHEMBL301,Cyclin-dependent kinase 2,8.0,8.0,10.0,1,8
319858,CHEMBL189963,PALBOCICLIB,30036,CHEMBL4203,Dual specificity protein kinase CLK4,7.7,7.7,19.95,2,8
319858,CHEMBL189963,PALBOCICLIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,7.2,7.2,63.1,1,9
319858,CHEMBL189963,PALBOCICLIB,101014,CHEMBL5543,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,7.0,7.0,100.0,2,8
319858,CHEMBL189963,PALBOCICLIB,10051,CHEMBL2468,Death-associated protein kinase 3,6.9,6.9,125.89,2,8
319858,CHEMBL189963,PALBOCICLIB,11149,CHEMBL2973,Rho-associated protein kinase 2,6.9,6.9,125.89,2,8
319858,CHEMBL189963,PALBOCICLIB,104274,CHEMBL1795194,Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha,6.68,6.68,208.0,3,9
319858,CHEMBL189963,PALBOCICLIB,30013,CHEMBL4224,Dual specificity protein kinase CLK1,6.56,6.56,276.0,2,9
319858,CHEMBL189963,PALBOCICLIB,12947,CHEMBL4036,Cyclin-dependent kinase 5,6.5,6.5,316.23,2,8
319858,CHEMBL189963,PALBOCICLIB,30014,CHEMBL4225,Dual specificity protein kinase CLK2,6.5,6.5,316.23,1,8
319858,CHEMBL189963,PALBOCICLIB,10885,CHEMBL2595,Serine/threonine-protein kinase D3,6.4,6.4,398.11,1,8
319858,CHEMBL189963,PALBOCICLIB,11626,CHEMBL3116,Cyclin-dependent kinase 9,6.4,6.18,398.11,3,9
319858,CHEMBL189963,PALBOCICLIB,12781,CHEMBL2358,Casein kinase II subunit beta,6.35,6.35,448.0,1,9
319858,CHEMBL189963,PALBOCICLIB,12780,CHEMBL4070,Casein kinase II subunit alpha',6.31,6.31,488.0,2,9
319858,CHEMBL189963,PALBOCICLIB,101131,CHEMBL5261,Serine/threonine-protein kinase TAO1,6.3,6.3,501.19,1,8
319858,CHEMBL189963,PALBOCICLIB,11622,CHEMBL2801,Calcium/calmodulin-dependent protein kinase type II subunit delta,6.21,6.21,610.0,1,9
319858,CHEMBL189963,PALBOCICLIB,10044,CHEMBL3629,Casein kinase II subunit alpha,6.12,6.12,760.0,1,9
319858,CHEMBL189963,PALBOCICLIB,12090,CHEMBL2292,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,6.1,6.1,794.33,1,8
319858,CHEMBL189963,PALBOCICLIB,12724,CHEMBL2345,Ribosomal protein S6 kinase alpha-3,6.1,6.1,794.33,1,8
319858,CHEMBL189963,PALBOCICLIB,11364,CHEMBL4045,5'-AMP-activated protein kinase catalytic subunit alpha-1,6.0,6.0,1000.0,1,8
319858,CHEMBL189963,PALBOCICLIB,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",5.96,5.96,1100.0,1,8
319858,CHEMBL189963,PALBOCICLIB,11047,CHEMBL2897,Dual specificity mitogen-activated protein kinase kinase 4,5.9,5.9,1251.0,2,9
319858,CHEMBL189963,PALBOCICLIB,101464,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,5.9,5.9,1258.93,1,8
319858,CHEMBL189963,PALBOCICLIB,101553,CHEMBL5790,Cyclin-dependent kinase 17,5.9,5.9,1272.0,2,9
319858,CHEMBL189963,PALBOCICLIB,10396,CHEMBL4121,Calcium/calmodulin-dependent protein kinase type II subunit beta,5.8,5.8,1600.0,1,9
319858,CHEMBL189963,PALBOCICLIB,12261,CHEMBL2276,Mitogen-activated protein kinase 8,5.8,5.8,1584.89,1,8
319858,CHEMBL189963,PALBOCICLIB,30049,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,5.8,5.8,1584.89,1,8
319858,CHEMBL189963,PALBOCICLIB,100417,CHEMBL4247,ALK tyrosine kinase receptor,5.8,5.8,1584.89,1,8
319858,CHEMBL189963,PALBOCICLIB,104126,CHEMBL1770034,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,5.76,5.76,1721.0,2,9
319858,CHEMBL189963,PALBOCICLIB,129,CHEMBL233,Mu-type opioid receptor,5.61,5.61,2470.0,1,8
319858,CHEMBL189963,PALBOCICLIB,11451,CHEMBL3717,Hepatocyte growth factor receptor,5.6,5.6,2511.89,1,8
319858,CHEMBL189963,PALBOCICLIB,12967,CHEMBL4630,Serine/threonine-protein kinase Chk1,5.6,5.6,2511.89,1,8
319858,CHEMBL189963,PALBOCICLIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,5.6,5.6,2511.89,1,8
319858,CHEMBL189963,PALBOCICLIB,100947,CHEMBL5330,Mitogen-activated protein kinase kinase kinase kinase 2,5.6,5.6,2511.89,1,8
319858,CHEMBL189963,PALBOCICLIB,101348,CHEMBL5818,cAMP-dependent protein kinase catalytic subunit PRKX,5.6,5.6,2511.89,1,8
319858,CHEMBL189963,PALBOCICLIB,103154,CHEMBL1075104,Leucine-rich repeat serine/threonine-protein kinase 2,5.6,5.6,2511.89,1,8
319858,CHEMBL189963,PALBOCICLIB,30022,CHEMBL4597,Cyclin-dependent kinase 16,5.56,5.56,2778.0,2,9
319858,CHEMBL189963,PALBOCICLIB,3,CHEMBL1827,"cGMP-specific 3',5'-cyclic phosphodiesterase",5.54,5.54,2900.0,1,9
319858,CHEMBL189963,PALBOCICLIB,11407,CHEMBL4179,Mitogen-activated protein kinase 9,5.54,5.54,2856.0,2,9
319858,CHEMBL189963,PALBOCICLIB,12414,CHEMBL4146,Mediator of RNA polymerase II transcription subunit 23,5.52,5.52,2998.0,1,9
319858,CHEMBL189963,PALBOCICLIB,10670,CHEMBL1882,Neuronal acetylcholine receptor subunit alpha-4,5.5,5.5,3200.0,1,8
319858,CHEMBL189963,PALBOCICLIB,11379,CHEMBL2689,Macrophage-stimulating protein receptor,5.5,5.5,3162.28,1,8
319858,CHEMBL189963,PALBOCICLIB,30017,CHEMBL3835,Serine/threonine-protein kinase Nek2,5.5,5.5,3162.28,1,8
1124,CHEMBL19,METHAZOLAMIDE,12952,CHEMBL3594,Carbonic anhydrase 9,9.6,7.61,0.25,50,9
1124,CHEMBL19,METHAZOLAMIDE,10139,CHEMBL2885,Carbonic anhydrase 3,8.96,8.96,1.1,1,9
1124,CHEMBL19,METHAZOLAMIDE,11060,CHEMBL2326,Carbonic anhydrase 7,8.68,8.68,2.1,10,9
1124,CHEMBL19,METHAZOLAMIDE,12209,CHEMBL3242,Carbonic anhydrase 12,8.47,8.43,3.4,25,9
1124,CHEMBL19,METHAZOLAMIDE,15,CHEMBL205,Carbonic anhydrase 2,8.32,7.84,4.8,110,9
1124,CHEMBL19,METHAZOLAMIDE,10186,CHEMBL3025,Carbonic anhydrase 6,8.0,8.0,10.0,7,9
1124,CHEMBL19,METHAZOLAMIDE,10193,CHEMBL261,Carbonic anhydrase 1,7.85,6.89,14.0,100,9
1124,CHEMBL19,METHAZOLAMIDE,12923,CHEMBL3912,Carbonic anhydrase 13,7.72,7.72,19.0,1,9
1124,CHEMBL19,METHAZOLAMIDE,11063,CHEMBL3510,Carbonic anhydrase 14,7.37,7.37,43.0,9,9
1124,CHEMBL19,METHAZOLAMIDE,11016,CHEMBL3969,"Carbonic anhydrase 5B, mitochondrial",7.21,7.21,62.0,8,9
1124,CHEMBL19,METHAZOLAMIDE,11042,CHEMBL4789,"Carbonic anhydrase 5A, mitochondrial",7.19,7.19,65.0,8,9
1124,CHEMBL19,METHAZOLAMIDE,12896,CHEMBL3729,Carbonic anhydrase 4,6.62,6.62,240.0,1,8
1241099,CHEMBL1900528,TIOTROPIUM,219,CHEMBL245,Muscarinic acetylcholine receptor M3,10.5,10.5,0.03162,1,9
21459,CHEMBL19019,NALTREXONE,137,CHEMBL237,Kappa-type opioid receptor,10.38,8.83,0.042,35,9
21459,CHEMBL19019,NALTREXONE,129,CHEMBL233,Mu-type opioid receptor,10.3,9.13,0.05012,59,9
21459,CHEMBL19019,NALTREXONE,136,CHEMBL236,Delta-type opioid receptor,8.8,7.67,1.585,57,9
21459,CHEMBL19019,NALTREXONE,11365,CHEMBL289,Cytochrome P450 2D6,6.0,6.0,1000.0,1,8
318390,CHEMBL190461,CANNABIDIOL,259,CHEMBL253,Cannabinoid receptor 2,8.1,7.06,7.943,24,9
318390,CHEMBL190461,CANNABIDIOL,11624,CHEMBL4801,Caspase-1,7.73,7.73,18.8,1,9
318390,CHEMBL190461,CANNABIDIOL,103167,CHEMBL1075319,Transient receptor potential cation channel subfamily M member 8,7.22,7.22,60.0,1,9
318390,CHEMBL190461,CANNABIDIOL,20035,CHEMBL3535,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",6.96,6.96,110.0,1,9
318390,CHEMBL190461,CANNABIDIOL,221,CHEMBL1920,Gamma-aminobutyric acid receptor subunit beta-2,6.89,6.89,130.0,1,9
318390,CHEMBL190461,CANNABIDIOL,87,CHEMBL218,Cannabinoid receptor 1,6.82,6.01,151.0,5,9
318390,CHEMBL190461,CANNABIDIOL,11113,CHEMBL2231,Cytochrome P450 1A1,6.82,6.81,150.0,2,9
318390,CHEMBL190461,CANNABIDIOL,12739,CHEMBL3019,Cytochrome P450 3A5,6.72,6.72,190.0,1,9
318390,CHEMBL190461,CANNABIDIOL,11839,CHEMBL4304,Calcium-activated potassium channel subunit alpha-1,6.55,6.55,280.0,1,9
318390,CHEMBL190461,CANNABIDIOL,129,CHEMBL233,Mu-type opioid receptor,6.51,6.05,311.0,3,9
318390,CHEMBL190461,CANNABIDIOL,103170,CHEMBL1075322,G-protein coupled receptor 55,6.35,6.35,445.0,1,8
318390,CHEMBL190461,CANNABIDIOL,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,6.17,6.17,670.0,1,8
318390,CHEMBL190461,CANNABIDIOL,20085,CHEMBL4729,Cytochrome P450 2B6,6.16,6.16,690.0,1,9
318390,CHEMBL190461,CANNABIDIOL,12912,CHEMBL3622,Cytochrome P450 2C19,6.1,6.1,790.0,1,9
318390,CHEMBL190461,CANNABIDIOL,17045,CHEMBL340,Cytochrome P450 3A4,6.0,6.0,1000.0,1,9
318390,CHEMBL190461,CANNABIDIOL,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.96,5.96,1100.0,1,9
318390,CHEMBL190461,CANNABIDIOL,246,CHEMBL2069,Thromboxane A2 receptor,5.89,5.89,1300.0,1,8
318390,CHEMBL190461,CANNABIDIOL,126,CHEMBL230,Prostaglandin G/H synthase 2,5.8,5.8,1587.4,1,8
318390,CHEMBL190461,CANNABIDIOL,137,CHEMBL237,Kappa-type opioid receptor,5.64,5.64,2300.0,1,9
318390,CHEMBL190461,CANNABIDIOL,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.64,5.64,2280.3,1,8
318390,CHEMBL190461,CANNABIDIOL,11365,CHEMBL289,Cytochrome P450 2D6,5.62,5.62,2420.0,1,9
318390,CHEMBL190461,CANNABIDIOL,88,CHEMBL2056,D(1A) dopamine receptor,5.57,5.57,2700.0,1,9
318390,CHEMBL190461,CANNABIDIOL,12594,CHEMBL3356,Cytochrome P450 1A2,5.57,5.57,2690.0,1,9
318390,CHEMBL190461,CANNABIDIOL,102689,CHEMBL5871,Glycine receptor subunit alpha-2,5.57,5.57,2700.0,1,9
318390,CHEMBL190461,CANNABIDIOL,10280,CHEMBL264,Histamine H3 receptor,5.51,5.51,3100.0,1,9
318390,CHEMBL190461,CANNABIDIOL,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.5,5.5,3200.0,1,9
1248731,CHEMBL1908360,EVEROLIMUS,11400,CHEMBL2842,Serine/threonine-protein kinase mTOR,8.8,7.93,1.6,7,9
1248731,CHEMBL1908360,EVEROLIMUS,102394,CHEMBL6020,Bile salt export pump,5.7,5.7,2000.0,1,9
1248838,CHEMBL1908919,FLORBETAPIR,10656,CHEMBL2487,Amyloid-beta precursor protein,7.94,7.92,11.4,2,9
1248838,CHEMBL1908919,FLORBETAPIR,103657,CHEMBL1293224,Microtubule-associated protein tau,7.71,7.61,19.6,2,8
1248838,CHEMBL1908919,FLORBETAPIR,102780,CHEMBL6152,Alpha-synuclein,7.61,7.45,24.3,3,8
1248996,CHEMBL1909072,PIPAMAZINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,9.26,8.98,0.554,2,8
1248996,CHEMBL1909072,PIPAMAZINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,9.11,8.93,0.786,2,8
1248996,CHEMBL1909072,PIPAMAZINE,103,CHEMBL223,Alpha-1D adrenergic receptor,9.02,8.87,0.955,2,8
1248996,CHEMBL1909072,PIPAMAZINE,127,CHEMBL231,Histamine H1 receptor,8.94,8.47,1.154,2,8
1248996,CHEMBL1909072,PIPAMAZINE,72,CHEMBL217,D(2) dopamine receptor,8.87,8.63,1.35,2,8
1248996,CHEMBL1909072,PIPAMAZINE,130,CHEMBL234,D(3) dopamine receptor,8.8,8.57,1.586,2,8
1248996,CHEMBL1909072,PIPAMAZINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,8.19,7.77,6.468,2,8
1248996,CHEMBL1909072,PIPAMAZINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.96,7.81,11.0,2,8
1248996,CHEMBL1909072,PIPAMAZINE,88,CHEMBL2056,D(1A) dopamine receptor,7.8,7.65,16.0,2,8
1248996,CHEMBL1909072,PIPAMAZINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.6,7.39,25.0,2,8
1248996,CHEMBL1909072,PIPAMAZINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.51,7.41,31.0,2,8
1248996,CHEMBL1909072,PIPAMAZINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,7.32,7.13,48.0,2,8
1248996,CHEMBL1909072,PIPAMAZINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,7.28,7.12,52.0,2,8
1248996,CHEMBL1909072,PIPAMAZINE,11365,CHEMBL289,Cytochrome P450 2D6,7.0,7.0,100.0,1,8
1248996,CHEMBL1909072,PIPAMAZINE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.46,6.33,346.0,2,8
1248996,CHEMBL1909072,PIPAMAZINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.35,6.35,446.0,2,8
1248996,CHEMBL1909072,PIPAMAZINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,5.65,5.58,2259.0,2,8
1249056,CHEMBL1909286,PHENOXYPROPAZINE,96,CHEMBL221,Prostaglandin G/H synthase 1,6.43,6.42,371.3,2,8
408842,CHEMBL191,LOSARTAN,115,CHEMBL227,Type-1 angiotensin II receptor,9.48,7.93,0.33,24,9
408842,CHEMBL191,LOSARTAN,87,CHEMBL218,Cannabinoid receptor 1,8.92,8.92,1.2,1,8
408842,CHEMBL191,LOSARTAN,10692,CHEMBL4607,Type-2 angiotensin II receptor,8.26,7.74,5.5,6,8
408842,CHEMBL191,LOSARTAN,69,CHEMBL1808,Angiotensin-converting enzyme,7.72,7.72,19.0,1,8
408842,CHEMBL191,LOSARTAN,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,6.8,6.67,160.0,2,8
408842,CHEMBL191,LOSARTAN,104062,CHEMBL1743121,Solute carrier organic anion transporter family member 1B3,6.05,6.0,890.0,2,8
408842,CHEMBL191,LOSARTAN,12911,CHEMBL3397,Cytochrome P450 2C9,5.54,5.54,2882.0,1,8
316765,CHEMBL191083,METHYLENE BLUE CATION,86,CHEMBL1951,Amine oxidase [flavin-containing] A,7.16,7.16,70.0,1,9
316765,CHEMBL191083,METHYLENE BLUE CATION,10656,CHEMBL2487,Amyloid-beta precursor protein,6.26,6.26,550.0,1,9
316765,CHEMBL191083,METHYLENE BLUE CATION,103657,CHEMBL1293224,Microtubule-associated protein tau,5.7,5.64,1995.3,3,9
410802,CHEMBL192,SILDENAFIL,3,CHEMBL1827,"cGMP-specific 3',5'-cyclic phosphodiesterase",9.0,8.35,1.0,62,9
410802,CHEMBL192,SILDENAFIL,11360,CHEMBL3977,"Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'",7.62,7.32,24.0,4,9
410802,CHEMBL192,SILDENAFIL,252,CHEMBL251,Adenosine receptor A2a,6.85,6.63,142.0,4,9
410802,CHEMBL192,SILDENAFIL,11515,CHEMBL3878,"Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha",6.67,6.67,211.3,1,8
410802,CHEMBL192,SILDENAFIL,10177,CHEMBL3421,"Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",6.22,6.22,600.0,1,9
410802,CHEMBL192,SILDENAFIL,114,CHEMBL226,Adenosine receptor A1,6.06,5.95,871.0,2,8
410802,CHEMBL192,SILDENAFIL,104559,CHEMBL2046258,ATP-binding cassette sub-family C member 5,5.92,5.92,1200.0,1,9
410802,CHEMBL192,SILDENAFIL,12448,CHEMBL2717,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",5.64,5.56,2300.0,3,9
410802,CHEMBL192,SILDENAFIL,100010,CHEMBL4409,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",5.51,5.51,3100.0,1,9
21698,CHEMBL19236,MOXONIDINE,11684,CHEMBL3923,Nischarin,8.45,8.03,3.548,3,9
21698,CHEMBL19236,MOXONIDINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.06,6.94,88.0,2,9
21698,CHEMBL19236,MOXONIDINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.05,7.05,90.0,1,8
21698,CHEMBL19236,MOXONIDINE,103668,CHEMBL1293235,Prelamin-A/C,6.4,6.4,398.1,1,9
21698,CHEMBL19236,MOXONIDINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.7,5.7,2000.0,1,9
1270372,CHEMBL1929396,ANAGLIPTIN,11140,CHEMBL284,Dipeptidyl peptidase 4,8.48,8.48,3.3,1,9
22873,CHEMBL19299,LOXOPROFEN,137,CHEMBL237,Kappa-type opioid receptor,6.18,6.18,660.0,1,8
419596,CHEMBL193,NIFEDIPINE,169,CHEMBL1940,Voltage-dependent L-type calcium channel subunit alpha-1C,9.4,8.12,0.4,5,9
419596,CHEMBL193,NIFEDIPINE,12594,CHEMBL3356,Cytochrome P450 1A2,7.4,6.71,39.81,4,9
419596,CHEMBL193,NIFEDIPINE,78,CHEMBL1963,Thyrotropin receptor,6.8,6.8,158.5,1,9
419596,CHEMBL193,NIFEDIPINE,280,CHEMBL256,Adenosine receptor A3,6.32,6.32,480.0,1,8
419596,CHEMBL193,NIFEDIPINE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,6.3,6.2,501.2,6,9
419596,CHEMBL193,NIFEDIPINE,11575,CHEMBL4015,C-C chemokine receptor type 2,6.07,5.87,847.0,2,8
419596,CHEMBL193,NIFEDIPINE,103668,CHEMBL1293235,Prelamin-A/C,5.95,5.95,1122.0,1,9
419596,CHEMBL193,NIFEDIPINE,11158,CHEMBL4138,Voltage-dependent L-type calcium channel subunit alpha-1D,5.87,5.87,1350.0,1,9
419596,CHEMBL193,NIFEDIPINE,103689,CHEMBL1293256,Thrombopoietin,5.8,5.8,1584.9,2,9
419596,CHEMBL193,NIFEDIPINE,10250,CHEMBL2428,"Myosin light chain kinase, smooth muscle",5.7,5.7,2020.0,1,9
419596,CHEMBL193,NIFEDIPINE,252,CHEMBL251,Adenosine receptor A2a,5.58,5.58,2630.0,1,8
419596,CHEMBL193,NIFEDIPINE,100611,CHEMBL3491,Cytochrome P450 2J2,5.51,5.51,3060.0,1,9
321696,CHEMBL193240,ROFLUMILAST,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",9.89,8.91,0.13,21,9
321696,CHEMBL193240,ROFLUMILAST,10599,CHEMBL275,"3',5'-cyclic-AMP phosphodiesterase 4B",9.82,9.01,0.15,29,9
321696,CHEMBL193240,ROFLUMILAST,276,CHEMBL254,"3',5'-cyclic-AMP phosphodiesterase 4A",9.68,9.38,0.21,4,9
321696,CHEMBL193240,ROFLUMILAST,11396,CHEMBL291,"3',5'-cyclic-AMP phosphodiesterase 4C",8.77,8.64,1.7,2,9
328137,CHEMBL193482,ESTRIOL,174,CHEMBL242,Estrogen receptor beta,9.9,9.9,0.1259,1,9
328137,CHEMBL193482,ESTRIOL,19,CHEMBL206,Estrogen receptor,9.32,8.76,0.483,4,9
328137,CHEMBL193482,ESTRIOL,12643,CHEMBL3305,Sex hormone-binding globulin,6.63,6.63,234.42,1,9
23198,CHEMBL19393,LEVAMFETAMINE,101361,CHEMBL5857,Trace amine-associated receptor 1,6.6,6.07,250.0,4,9
23745,CHEMBL19449,IBUDILAST,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,7.6,7.6,25.1,2,9
23745,CHEMBL19449,IBUDILAST,11365,CHEMBL289,Cytochrome P450 2D6,7.4,7.4,39.8,2,9
23745,CHEMBL19449,IBUDILAST,276,CHEMBL254,"3',5'-cyclic-AMP phosphodiesterase 4A",7.27,6.75,54.0,5,9
23745,CHEMBL19449,IBUDILAST,10599,CHEMBL275,"3',5'-cyclic-AMP phosphodiesterase 4B",7.19,7.19,65.0,3,9
23745,CHEMBL19449,IBUDILAST,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",6.78,6.69,166.0,4,9
23745,CHEMBL19449,IBUDILAST,11396,CHEMBL291,"3',5'-cyclic-AMP phosphodiesterase 4C",6.62,6.62,239.0,3,9
23745,CHEMBL19449,IBUDILAST,12594,CHEMBL3356,Cytochrome P450 1A2,6.2,6.2,630.96,1,8
23745,CHEMBL19449,IBUDILAST,12911,CHEMBL3397,Cytochrome P450 2C9,6.2,6.2,631.0,1,9
23745,CHEMBL19449,IBUDILAST,10200,CHEMBL2085,Macrophage migration inhibitory factor,5.85,5.85,1400.0,1,9
23745,CHEMBL19449,IBUDILAST,170,CHEMBL241,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",5.8,5.8,1600.0,1,9
23745,CHEMBL19449,IBUDILAST,11395,CHEMBL290,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B",5.57,5.57,2700.0,1,9
23745,CHEMBL19449,IBUDILAST,12912,CHEMBL3622,Cytochrome P450 2C19,5.5,5.5,3162.28,2,9
1277157,CHEMBL1945778,IOFLUPANE,155,CHEMBL238,Sodium-dependent dopamine transporter,7.55,7.55,28.18,1,9
1277553,CHEMBL1946170,REGORAFENIB,11727,CHEMBL2409,Bifunctional epoxide hydrolase 2,9.3,9.3,0.5,1,9
1277553,CHEMBL1946170,REGORAFENIB,197,CHEMBL1913,Platelet-derived growth factor receptor beta,8.82,8.24,1.5,2,9
1277553,CHEMBL1946170,REGORAFENIB,10266,CHEMBL3650,Fibroblast growth factor receptor 1,8.82,7.76,1.5,2,9
1277553,CHEMBL1946170,REGORAFENIB,10904,CHEMBL1906,RAF proto-oncogene serine/threonine-protein kinase,8.82,8.65,1.5,4,9
1277553,CHEMBL1946170,REGORAFENIB,10979,CHEMBL1868,Vascular endothelial growth factor receptor 1,8.82,8.04,1.5,6,9
1277553,CHEMBL1946170,REGORAFENIB,12913,CHEMBL4128,Angiopoietin-1 receptor,8.82,7.67,1.5,2,9
1277553,CHEMBL1946170,REGORAFENIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,8.82,7.89,1.5,20,9
1277553,CHEMBL1946170,REGORAFENIB,100126,CHEMBL5145,Serine/threonine-protein kinase B-raf,8.82,7.47,1.5,7,9
1277553,CHEMBL1946170,REGORAFENIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,8.4,8.37,4.0,9,9
1277553,CHEMBL1946170,REGORAFENIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,8.21,7.11,6.1,10,9
1277553,CHEMBL1946170,REGORAFENIB,101340,CHEMBL5810,Ephrin type-A receptor 1,8.15,8.15,7.0,1,9
1277553,CHEMBL1946170,REGORAFENIB,20025,CHEMBL5014,Receptor-interacting serine/threonine-protein kinase 2,7.39,6.75,41.0,2,9
1277553,CHEMBL1946170,REGORAFENIB,11752,CHEMBL1955,Vascular endothelial growth factor receptor 3,7.38,7.36,42.0,2,9
1277553,CHEMBL1946170,REGORAFENIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,7.09,6.67,82.0,2,9
1277553,CHEMBL1946170,REGORAFENIB,20007,CHEMBL3886,Mitogen-activated protein kinase kinase kinase 20,6.56,6.56,274.0,1,9
1277553,CHEMBL1946170,REGORAFENIB,100917,CHEMBL5319,Epithelial discoidin domain-containing receptor 1,6.45,6.45,358.0,1,9
1277553,CHEMBL1946170,REGORAFENIB,104279,CHEMBL1795199,Receptor-interacting serine/threonine-protein kinase 3,6.43,6.43,368.0,1,9
1277553,CHEMBL1946170,REGORAFENIB,101079,CHEMBL5122,Discoidin domain-containing receptor 2,6.38,6.38,421.0,1,9
1277553,CHEMBL1946170,REGORAFENIB,12276,CHEMBL3956,Mitogen-activated protein kinase kinase kinase 1,6.33,6.33,465.0,1,9
1277553,CHEMBL1946170,REGORAFENIB,30018,CHEMBL3836,LIM domain kinase 1,6.21,6.21,616.0,1,9
1277553,CHEMBL1946170,REGORAFENIB,11082,CHEMBL2208,MAP kinase-activated protein kinase 2,6.17,6.17,682.0,1,9
1277553,CHEMBL1946170,REGORAFENIB,10188,CHEMBL260,Mitogen-activated protein kinase 14,6.15,6.15,705.0,1,9
1277553,CHEMBL1946170,REGORAFENIB,101553,CHEMBL5790,Cyclin-dependent kinase 17,6.14,6.14,719.0,1,9
1277553,CHEMBL1946170,REGORAFENIB,100128,CHEMBL5146,Breakpoint cluster region protein,6.13,6.13,739.0,1,9
1277553,CHEMBL1946170,REGORAFENIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,6.12,6.12,753.0,1,9
1277553,CHEMBL1946170,REGORAFENIB,12627,CHEMBL2007,Platelet-derived growth factor receptor alpha,6.09,6.09,810.0,1,9
1277553,CHEMBL1946170,REGORAFENIB,30008,CHEMBL2068,Ephrin type-A receptor 2,6.08,6.08,832.0,1,9
1277553,CHEMBL1946170,REGORAFENIB,155,CHEMBL238,Sodium-dependent dopamine transporter,5.98,5.98,1040.0,1,8
1277553,CHEMBL1946170,REGORAFENIB,30019,CHEMBL3987,Ephrin type-A receptor 5,5.95,5.95,1123.0,1,9
1277553,CHEMBL1946170,REGORAFENIB,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.85,5.85,1420.0,1,8
1277553,CHEMBL1946170,REGORAFENIB,102688,CHEMBL5845,Glycine receptor subunit alpha-1,5.75,5.75,1800.0,1,9
1277553,CHEMBL1946170,REGORAFENIB,10120,CHEMBL3961,Mitogen-activated protein kinase 11,5.72,5.72,1911.0,1,9
1277553,CHEMBL1946170,REGORAFENIB,30013,CHEMBL4224,Dual specificity protein kinase CLK1,5.68,5.68,2107.0,1,9
1277553,CHEMBL1946170,REGORAFENIB,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.62,5.62,2370.0,1,8
1277553,CHEMBL1946170,REGORAFENIB,280,CHEMBL256,Adenosine receptor A3,5.6,5.6,2508.0,1,8
1277553,CHEMBL1946170,REGORAFENIB,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,5.52,5.52,3000.0,1,9
1277553,CHEMBL1946170,REGORAFENIB,102394,CHEMBL6020,Bile salt export pump,5.52,5.52,3000.0,1,8
23001,CHEMBL19490,ZOMEPIRAC,126,CHEMBL230,Prostaglandin G/H synthase 2,5.92,5.92,1200.0,1,8
443348,CHEMBL196,ASCORBIC ACID,216,CHEMBL1942,Alpha-2B adrenergic receptor,9.3,9.3,0.5,1,9
443348,CHEMBL196,ASCORBIC ACID,96,CHEMBL221,Prostaglandin G/H synthase 1,6.27,6.24,533.2,2,8
1285392,CHEMBL1963681,AVANAFIL,3,CHEMBL1827,"cGMP-specific 3',5'-cyclic phosphodiesterase",8.3,7.84,5.0,25,9
1304559,CHEMBL1983268,ENTRECTINIB,101019,CHEMBL5568,Proto-oncogene tyrosine-protein kinase ROS,9.7,8.26,0.2,9,9
1304559,CHEMBL1983268,ENTRECTINIB,11902,CHEMBL2815,High affinity nerve growth factor receptor,9.66,8.65,0.22,21,9
1304559,CHEMBL1983268,ENTRECTINIB,100413,CHEMBL4898,BDNF/NT-3 growth factors receptor,9.0,8.58,1.0,10,9
1304559,CHEMBL1983268,ENTRECTINIB,100417,CHEMBL4247,ALK tyrosine kinase receptor,9.0,7.57,1.0,39,9
1304559,CHEMBL1983268,ENTRECTINIB,101034,CHEMBL5608,NT-3 growth factor receptor,9.0,8.48,1.0,11,9
1304559,CHEMBL1983268,ENTRECTINIB,101484,CHEMBL5627,Leukocyte tyrosine kinase receptor,8.8,8.8,1.585,1,8
1304559,CHEMBL1983268,ENTRECTINIB,30007,CHEMBL3982,Tyrosine-protein kinase Fer,8.3,8.3,5.012,1,8
1304559,CHEMBL1983268,ENTRECTINIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,7.8,7.8,15.85,1,8
1304559,CHEMBL1983268,ENTRECTINIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,7.7,7.55,19.95,2,9
1304559,CHEMBL1983268,ENTRECTINIB,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,7.5,7.5,31.62,1,8
1304559,CHEMBL1983268,ENTRECTINIB,30023,CHEMBL4599,Activated CDC42 kinase 1,7.5,7.01,31.62,3,9
1304559,CHEMBL1983268,ENTRECTINIB,12840,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,7.4,7.4,39.81,1,8
1304559,CHEMBL1983268,ENTRECTINIB,30003,CHEMBL3788,Serine/threonine-protein kinase PLK4,7.4,7.4,39.81,1,8
1304559,CHEMBL1983268,ENTRECTINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,7.4,6.91,39.81,2,9
1304559,CHEMBL1983268,ENTRECTINIB,100410,CHEMBL4895,Tyrosine-protein kinase receptor UFO,7.4,7.4,39.81,1,8
1304559,CHEMBL1983268,ENTRECTINIB,234,CHEMBL1957,Insulin-like growth factor 1 receptor,7.2,6.77,63.1,5,9
1304559,CHEMBL1983268,ENTRECTINIB,11242,CHEMBL2695,Focal adhesion kinase 1,7.0,6.92,100.0,2,9
1304559,CHEMBL1983268,ENTRECTINIB,10919,CHEMBL2835,Tyrosine-protein kinase JAK1,6.95,6.95,112.0,1,9
1304559,CHEMBL1983268,ENTRECTINIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,6.8,6.8,158.49,1,8
1304559,CHEMBL1983268,ENTRECTINIB,11926,CHEMBL2742,Fibroblast growth factor receptor 3,6.8,6.8,158.49,1,8
1304559,CHEMBL1983268,ENTRECTINIB,30035,CHEMBL4202,STE20-like serine/threonine-protein kinase,6.8,6.8,158.49,1,8
1304559,CHEMBL1983268,ENTRECTINIB,100097,CHEMBL5251,Tyrosine-protein kinase BTK,6.8,6.8,158.49,1,8
1304559,CHEMBL1983268,ENTRECTINIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,6.79,6.64,164.0,2,9
1304559,CHEMBL1983268,ENTRECTINIB,30026,CHEMBL4601,Protein-tyrosine kinase 6,6.71,6.71,195.0,1,9
1304559,CHEMBL1983268,ENTRECTINIB,11691,CHEMBL2250,Tyrosine-protein kinase Blk,6.7,6.7,199.53,1,8
1304559,CHEMBL1983268,ENTRECTINIB,11752,CHEMBL1955,Vascular endothelial growth factor receptor 3,6.7,6.7,199.53,1,8
1304559,CHEMBL1983268,ENTRECTINIB,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,6.7,6.7,199.53,1,8
1304559,CHEMBL1983268,ENTRECTINIB,30036,CHEMBL4203,Dual specificity protein kinase CLK4,6.7,6.7,199.53,1,8
1304559,CHEMBL1983268,ENTRECTINIB,35,CHEMBL1981,Insulin receptor,6.68,6.68,209.0,1,9
1304559,CHEMBL1983268,ENTRECTINIB,20014,CHEMBL4722,Aurora kinase A,6.67,6.54,215.0,5,9
1304559,CHEMBL1983268,ENTRECTINIB,10266,CHEMBL3650,Fibroblast growth factor receptor 1,6.6,6.6,251.19,1,8
1304559,CHEMBL1983268,ENTRECTINIB,11364,CHEMBL4045,5'-AMP-activated protein kinase catalytic subunit alpha-1,6.6,6.6,251.19,1,8
1304559,CHEMBL1983268,ENTRECTINIB,11379,CHEMBL2689,Macrophage-stimulating protein receptor,6.6,6.6,251.19,1,8
1304559,CHEMBL1983268,ENTRECTINIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,6.5,6.5,316.23,1,8
1304559,CHEMBL1983268,ENTRECTINIB,10781,CHEMBL2185,Aurora kinase B,6.47,6.33,338.0,2,9
1304559,CHEMBL1983268,ENTRECTINIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,6.46,6.38,349.0,2,9
1304559,CHEMBL1983268,ENTRECTINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,6.4,6.4,398.11,1,8
1304559,CHEMBL1983268,ENTRECTINIB,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,6.4,6.4,398.11,1,8
1304559,CHEMBL1983268,ENTRECTINIB,100947,CHEMBL5330,Mitogen-activated protein kinase kinase kinase kinase 2,6.4,6.4,398.11,1,8
1304559,CHEMBL1983268,ENTRECTINIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,6.3,6.3,501.19,1,8
1304559,CHEMBL1983268,ENTRECTINIB,10880,CHEMBL2938,Protein kinase C gamma type,6.2,6.2,630.96,1,8
1304559,CHEMBL1983268,ENTRECTINIB,10906,CHEMBL2599,Tyrosine-protein kinase SYK,6.2,6.2,630.96,1,8
1304559,CHEMBL1983268,ENTRECTINIB,30049,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,6.2,6.2,630.96,1,8
1304559,CHEMBL1983268,ENTRECTINIB,10979,CHEMBL1868,Vascular endothelial growth factor receptor 1,6.1,6.1,794.33,1,8
1304559,CHEMBL1983268,ENTRECTINIB,11451,CHEMBL3717,Hepatocyte growth factor receptor,6.1,6.1,794.33,1,8
1304559,CHEMBL1983268,ENTRECTINIB,30014,CHEMBL4225,Dual specificity protein kinase CLK2,6.0,6.0,1000.0,1,8
1304559,CHEMBL1983268,ENTRECTINIB,10842,CHEMBL3032,Serine/threonine-protein kinase N2,5.9,5.9,1258.93,1,8
1304559,CHEMBL1983268,ENTRECTINIB,12724,CHEMBL2345,Ribosomal protein S6 kinase alpha-3,5.9,5.9,1258.93,1,8
1304559,CHEMBL1983268,ENTRECTINIB,12829,CHEMBL3055,Cyclin-dependent kinase 7,5.9,5.9,1258.93,1,8
1304559,CHEMBL1983268,ENTRECTINIB,100951,CHEMBL5334,Non-receptor tyrosine-protein kinase TNK1,5.83,5.83,1486.0,1,9
1304559,CHEMBL1983268,ENTRECTINIB,12665,CHEMBL3920,Protein kinase C theta type,5.8,5.8,1584.89,1,8
1304559,CHEMBL1983268,ENTRECTINIB,100852,CHEMBL4576,Homeodomain-interacting protein kinase 2,5.8,5.8,1584.89,1,8
1304559,CHEMBL1983268,ENTRECTINIB,10277,CHEMBL4708,Serine/threonine-protein kinase 3,5.7,5.7,1995.26,1,8
1304559,CHEMBL1983268,ENTRECTINIB,101464,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,5.7,5.7,1995.26,1,8
1304559,CHEMBL1983268,ENTRECTINIB,10051,CHEMBL2468,Death-associated protein kinase 3,5.6,5.6,2511.89,1,8
1304559,CHEMBL1983268,ENTRECTINIB,30028,CHEMBL5073,Calcium/calmodulin-dependent protein kinase type 1D,5.6,5.6,2511.89,1,8
1304559,CHEMBL1983268,ENTRECTINIB,100856,CHEMBL5408,Serine/threonine-protein kinase TBK1,5.6,5.6,2511.89,1,8
1304559,CHEMBL1983268,ENTRECTINIB,102420,CHEMBL5678,G protein-coupled receptor kinase 5,5.6,5.6,2511.89,1,8
1304559,CHEMBL1983268,ENTRECTINIB,103154,CHEMBL1075104,Leucine-rich repeat serine/threonine-protein kinase 2,5.6,5.6,2511.89,1,8
1304559,CHEMBL1983268,ENTRECTINIB,101131,CHEMBL5261,Serine/threonine-protein kinase TAO1,5.5,5.5,3162.28,1,8
1304641,CHEMBL1983350,STIRIPENTOL,56,CHEMBL1871,Androgen receptor,5.52,5.52,3009.8,1,8
328601,CHEMBL198362,RIVAROXABAN,194,CHEMBL244,Coagulation factor X,9.4,8.74,0.4,20,9
328601,CHEMBL198362,RIVAROXABAN,11,CHEMBL204,Prothrombin,6.11,6.11,770.0,1,8
97,CHEMBL2,PRAZOSIN,128,CHEMBL232,Alpha-1B adrenergic receptor,10.57,9.33,0.027,19,9
97,CHEMBL2,PRAZOSIN,125,CHEMBL229,Alpha-1A adrenergic receptor,10.4,9.19,0.04,26,9
97,CHEMBL2,PRAZOSIN,103,CHEMBL223,Alpha-1D adrenergic receptor,9.77,9.5,0.17,19,9
97,CHEMBL2,PRAZOSIN,105,CHEMBL1983,5-hydroxytryptamine receptor 1D,9.48,9.48,0.33,1,8
97,CHEMBL2,PRAZOSIN,10170,CHEMBL3959,Ribosyldihydronicotinamide dehydrogenase [quinone],8.11,8.11,7.8,1,8
97,CHEMBL2,PRAZOSIN,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.89,6.85,13.0,5,9
97,CHEMBL2,PRAZOSIN,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.62,6.96,24.0,5,9
97,CHEMBL2,PRAZOSIN,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.68,5.98,210.0,4,9
97,CHEMBL2,PRAZOSIN,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.8,5.8,1584.89,2,9
97,CHEMBL2,PRAZOSIN,104067,CHEMBL1743126,Multidrug and toxin extrusion protein 1,5.8,5.8,1600.0,1,9
97,CHEMBL2,PRAZOSIN,101283,CHEMBL5685,Solute carrier family 22 member 1,5.74,5.74,1840.0,1,8
97,CHEMBL2,PRAZOSIN,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.59,5.58,2565.9,2,8
1125,CHEMBL20,ACETAZOLAMIDE,12952,CHEMBL3594,Carbonic anhydrase 9,10.22,7.48,0.06,417,9
1125,CHEMBL20,ACETAZOLAMIDE,15,CHEMBL205,Carbonic anhydrase 2,9.46,7.8,0.3434,578,9
1125,CHEMBL20,ACETAZOLAMIDE,10193,CHEMBL261,Carbonic anhydrase 1,9.13,6.58,0.7472,504,9
1125,CHEMBL20,ACETAZOLAMIDE,11060,CHEMBL2326,Carbonic anhydrase 7,8.7,8.42,2.0,99,9
1125,CHEMBL20,ACETAZOLAMIDE,11063,CHEMBL3510,Carbonic anhydrase 14,8.67,7.43,2.13,51,9
1125,CHEMBL20,ACETAZOLAMIDE,12209,CHEMBL3242,Carbonic anhydrase 12,8.6,8.15,2.5,275,9
1125,CHEMBL20,ACETAZOLAMIDE,10139,CHEMBL2885,Carbonic anhydrase 3,8.51,7.29,3.1,2,9
1125,CHEMBL20,ACETAZOLAMIDE,12923,CHEMBL3912,Carbonic anhydrase 13,8.24,7.63,5.7,30,9
1125,CHEMBL20,ACETAZOLAMIDE,12954,CHEMBL2420,Carbonic anhydrase-related protein 11,8.24,8.24,5.7,1,9
1125,CHEMBL20,ACETAZOLAMIDE,12896,CHEMBL3729,Carbonic anhydrase 4,8.07,7.13,8.6,99,9
1125,CHEMBL20,ACETAZOLAMIDE,10186,CHEMBL3025,Carbonic anhydrase 6,8.01,7.67,9.8,37,9
1125,CHEMBL20,ACETAZOLAMIDE,11016,CHEMBL3969,"Carbonic anhydrase 5B, mitochondrial",7.61,7.23,24.6,42,9
1125,CHEMBL20,ACETAZOLAMIDE,11042,CHEMBL4789,"Carbonic anhydrase 5A, mitochondrial",7.22,7.11,60.0,55,9
1125,CHEMBL20,ACETAZOLAMIDE,103665,CHEMBL1293232,Survival motor neuron protein,6.25,6.25,562.3,1,9
1125,CHEMBL20,ACETAZOLAMIDE,271,CHEMBL1947,Thyroid hormone receptor beta,5.75,5.75,1778.3,1,9
1326477,CHEMBL2005186,BELUMOSUDIL,10811,CHEMBL3231,Rho-associated protein kinase 1,7.4,6.48,40.0,6,9
1326477,CHEMBL2005186,BELUMOSUDIL,11149,CHEMBL2973,Rho-associated protein kinase 2,7.4,6.89,40.0,19,9
1326477,CHEMBL2005186,BELUMOSUDIL,10044,CHEMBL3629,Casein kinase II subunit alpha,7.0,7.0,100.0,1,8
1326477,CHEMBL2005186,BELUMOSUDIL,11691,CHEMBL2250,Tyrosine-protein kinase Blk,6.0,6.0,1000.0,1,8
1326477,CHEMBL2005186,BELUMOSUDIL,10277,CHEMBL4708,Serine/threonine-protein kinase 3,5.6,5.6,2511.89,1,8
1326477,CHEMBL2005186,BELUMOSUDIL,12090,CHEMBL2292,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,5.6,5.6,2511.89,1,8
1326477,CHEMBL2005186,BELUMOSUDIL,30036,CHEMBL4203,Dual specificity protein kinase CLK4,5.5,5.5,3162.28,1,8
1326477,CHEMBL2005186,BELUMOSUDIL,30045,CHEMBL4525,Serine/threonine-protein kinase 17A,5.5,5.5,3162.28,1,8
1331852,CHEMBL2010601,IVACAFTOR,11540,CHEMBL4051,Cystic fibrosis transmembrane conductance regulator,8.52,7.35,3.0,18,9
1331852,CHEMBL2010601,IVACAFTOR,280,CHEMBL256,Adenosine receptor A3,5.64,5.64,2300.0,1,8
1335827,CHEMBL2018096,IPRAGLIFLOZIN,20092,CHEMBL3884,Sodium/glucose cotransporter 2,8.13,8.12,7.38,5,9
1335827,CHEMBL2018096,IPRAGLIFLOZIN,18036,CHEMBL4979,Sodium/glucose cotransporter 1,5.73,5.72,1876.0,2,9
339024,CHEMBL201960,PYROVALERONE,155,CHEMBL238,Sodium-dependent dopamine transporter,8.1,7.64,8.0,4,9
339024,CHEMBL201960,PYROVALERONE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,7.55,7.13,28.3,2,9
339024,CHEMBL201960,PYROVALERONE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.56,5.56,2780.0,1,9
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,130,CHEMBL234,D(3) dopamine receptor,10.05,9.53,0.09,2,9
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,72,CHEMBL217,D(2) dopamine receptor,9.09,8.51,0.81,3,9
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,127,CHEMBL231,Histamine H1 receptor,7.77,7.77,16.81,1,9
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.27,7.27,53.67,1,9
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.21,7.21,61.19,1,9
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,7.12,7.12,76.08,1,9
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,105,CHEMBL1983,5-hydroxytryptamine receptor 1D,7.11,7.11,76.84,1,9
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,106,CHEMBL1898,5-hydroxytryptamine receptor 1B,6.89,6.89,128.52,1,9
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,50,CHEMBL213,Beta-1 adrenergic receptor,6.65,6.65,222.08,1,9
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.63,6.63,234.34,1,9
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.62,6.62,242.57,1,9
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,103,CHEMBL223,Alpha-1D adrenergic receptor,6.49,6.49,323.0,1,9
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,90,CHEMBL219,D(4) dopamine receptor,6.39,6.39,408.6,1,9
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,117512,CHEMBL4105907,Sigma intracellular receptor 2,6.31,6.31,488.09,1,9
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.11,6.11,778.76,1,9
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.96,5.96,1085.3,1,9
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.9,5.9,1253.72,1,9
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,5.89,5.89,1301.37,1,9
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,5.84,5.84,1432.02,1,9
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.76,5.76,1742.21,1,9
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,128,CHEMBL232,Alpha-1B adrenergic receptor,5.71,5.71,1969.7,1,9
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.71,5.71,1964.27,1,9
1339907,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.51,5.51,3076.1,1,9
1340277,CHEMBL2028019,CARIPRAZINE,130,CHEMBL234,D(3) dopamine receptor,10.07,9.25,0.085,16,9
1340277,CHEMBL2028019,CARIPRAZINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,9.82,9.82,0.151,1,9
1340277,CHEMBL2028019,CARIPRAZINE,72,CHEMBL217,D(2) dopamine receptor,9.74,8.9,0.18,32,9
1340277,CHEMBL2028019,CARIPRAZINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,8.74,8.48,1.81,8,9
1340277,CHEMBL2028019,CARIPRAZINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.73,7.25,18.8,8,9
1340277,CHEMBL2028019,CARIPRAZINE,127,CHEMBL231,Histamine H1 receptor,7.63,7.63,23.2,1,9
1340277,CHEMBL2028019,CARIPRAZINE,90,CHEMBL219,D(4) dopamine receptor,6.96,6.63,110.0,5,9
1340277,CHEMBL2028019,CARIPRAZINE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,6.96,6.96,111.0,1,9
1340277,CHEMBL2028019,CARIPRAZINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.7,6.69,198.2,3,9
1340277,CHEMBL2028019,CARIPRAZINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.69,5.69,2040.8,1,8
1340277,CHEMBL2028019,CARIPRAZINE,88,CHEMBL2056,D(1A) dopamine receptor,5.68,5.61,2100.0,4,9
1340277,CHEMBL2028019,CARIPRAZINE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.54,5.54,2876.8,1,8
1340892,CHEMBL2028661,AZILSARTAN MEDOXOMIL,10692,CHEMBL4607,Type-2 angiotensin II receptor,8.59,8.59,2.6,1,9
1340894,CHEMBL2028663,DABRAFENIB,100126,CHEMBL5145,Serine/threonine-protein kinase B-raf,9.4,8.63,0.4,29,9
1340894,CHEMBL2028663,DABRAFENIB,104279,CHEMBL1795199,Receptor-interacting serine/threonine-protein kinase 3,8.7,7.28,2.0,3,9
1340894,CHEMBL2028663,DABRAFENIB,10904,CHEMBL1906,RAF proto-oncogene serine/threonine-protein kinase,8.3,7.81,5.0,3,9
1340894,CHEMBL2028663,DABRAFENIB,30022,CHEMBL4597,Cyclin-dependent kinase 16,7.89,7.89,13.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,11678,CHEMBL301,Cyclin-dependent kinase 2,7.72,7.72,19.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,103465,CHEMBL1169596,Serine/threonine-protein kinase A-Raf,7.58,7.46,26.0,2,9
1340894,CHEMBL2028663,DABRAFENIB,30018,CHEMBL3836,LIM domain kinase 1,7.48,7.48,33.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,100415,CHEMBL4900,Serine/threonine-protein kinase D2,7.47,7.47,34.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,101553,CHEMBL5790,Cyclin-dependent kinase 17,7.44,7.44,36.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,30030,CHEMBL5257,Serine/threonine-protein kinase Nek9,7.28,7.28,53.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,100951,CHEMBL5334,Non-receptor tyrosine-protein kinase TNK1,7.18,7.18,66.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,20025,CHEMBL5014,Receptor-interacting serine/threonine-protein kinase 2,7.11,7.04,77.0,2,9
1340894,CHEMBL2028663,DABRAFENIB,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,7.09,7.07,82.0,3,9
1340894,CHEMBL2028663,DABRAFENIB,101386,CHEMBL5932,LIM domain kinase 2,7.09,7.09,82.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,117537,CHEMBL4105932,Serine/threonine-protein kinase/endoribonuclease IRE2,6.94,6.94,116.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,10885,CHEMBL2595,Serine/threonine-protein kinase D3,6.92,6.92,120.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,12946,CHEMBL331,Cyclin-dependent kinase 4,6.9,6.9,126.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,20007,CHEMBL3886,Mitogen-activated protein kinase kinase kinase 20,6.74,6.74,184.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,101411,CHEMBL6006,Serine/threonine-protein kinase ULK1,6.73,6.73,188.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,11209,CHEMBL4014,Tyrosine-protein kinase ABL2,6.52,6.52,305.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,10480,CHEMBL2508,Cyclin-dependent kinase 6,6.5,6.5,318.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,12071,CHEMBL308,Cyclin-dependent kinase 1,6.44,6.44,364.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,102676,CHEMBL5836,Ephrin type-B receptor 6,6.38,6.38,412.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,101359,CHEMBL5855,Serine/threonine-protein kinase Nek1,6.32,6.32,477.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,30003,CHEMBL3788,Serine/threonine-protein kinase PLK4,6.28,6.28,520.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,100908,CHEMBL5310,Activin receptor type-1B,6.22,6.22,601.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,101504,CHEMBL5699,Serine/threonine-protein kinase SIK2,6.19,6.19,649.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,101340,CHEMBL5810,Ephrin type-A receptor 1,6.15,6.15,705.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,6.14,6.14,727.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,6.11,6.11,783.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,6.09,6.09,817.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,10844,CHEMBL2634,Tyrosine-protein kinase CSK,6.07,6.07,851.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,102667,CHEMBL6029,Eukaryotic translation initiation factor 2-alpha kinase 1,6.02,6.02,949.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,11870,CHEMBL2708,Mitogen-activated protein kinase kinase kinase 11,6.0,6.0,1011.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,12947,CHEMBL4036,Cyclin-dependent kinase 5,5.97,5.97,1068.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,18033,CHEMBL2073,Tyrosine-protein kinase Yes,5.89,5.89,1276.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,5.87,5.87,1353.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,30026,CHEMBL4601,Protein-tyrosine kinase 6,5.85,5.85,1414.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,103430,CHEMBL1163101,Serine/threonine-protein kinase/endoribonuclease IRE1,5.84,5.84,1453.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,101048,CHEMBL5047,Serine/threonine-protein kinase ULK3,5.83,5.83,1480.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,5.81,5.81,1545.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,19623,CHEMBL3357,Interleukin-1 receptor-associated kinase 1,5.81,5.81,1564.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,100127,CHEMBL4454,Tyrosine-protein kinase Fgr,5.81,5.81,1549.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,11451,CHEMBL3717,Hepatocyte growth factor receptor,5.79,5.79,1634.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,11785,CHEMBL3234,Tyrosine-protein kinase HCK,5.78,5.78,1646.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,100854,CHEMBL4578,Maternal embryonic leucine zipper kinase,5.74,5.74,1816.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,102770,CHEMBL6149,Serine/threonine-protein kinase SIK3,5.7,5.7,2005.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,10371,CHEMBL4948,Dual specificity mitogen-activated protein kinase kinase 5,5.64,5.64,2294.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,10971,CHEMBL2494,Calcium/calmodulin-dependent protein kinase type IV,5.64,5.64,2274.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,13004,CHEMBL4439,TGF-beta receptor type-1,5.62,5.62,2384.0,1,9
1340894,CHEMBL2028663,DABRAFENIB,100075,CHEMBL4267,TGF-beta receptor type-2,5.6,5.6,2534.0,1,9
1341082,CHEMBL2028850,ICATIBANT,10034,CHEMBL3157,B2 bradykinin receptor,10.6,9.42,0.02512,12,9
1344709,CHEMBL2035187,PACRITINIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,9.0,7.77,1.0,16,9
1344709,CHEMBL2035187,PACRITINIB,101032,CHEMBL5606,Serine/threonine-protein kinase STK11,8.52,8.52,3.0,1,9
1344709,CHEMBL2035187,PACRITINIB,10170,CHEMBL3959,Ribosyldihydronicotinamide dehydrogenase [quinone],8.4,8.4,4.0,1,9
1344709,CHEMBL2035187,PACRITINIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,8.22,7.59,6.0,22,9
1344709,CHEMBL2035187,PACRITINIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,7.74,6.63,18.3,8,9
1344709,CHEMBL2035187,PACRITINIB,101598,CHEMBL5903,Activin receptor type-1,7.66,7.66,22.0,1,9
1344709,CHEMBL2035187,PACRITINIB,117490,CHEMBL4105885,AarF domain-containing protein kinase 1,7.48,7.48,33.0,1,9
1344709,CHEMBL2035187,PACRITINIB,101055,CHEMBL5081,Interleukin-1 receptor-associated kinase 3,7.46,7.46,35.0,1,9
1344709,CHEMBL2035187,PACRITINIB,12694,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,7.42,7.14,38.0,8,9
1344709,CHEMBL2035187,PACRITINIB,30042,CHEMBL4522,BMP-2-inducible protein kinase,7.41,7.41,39.0,1,9
1344709,CHEMBL2035187,PACRITINIB,12840,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,7.4,7.4,39.5,1,9
1344709,CHEMBL2035187,PACRITINIB,19623,CHEMBL3357,Interleukin-1 receptor-associated kinase 1,7.4,7.0,39.5,2,9
1344709,CHEMBL2035187,PACRITINIB,30000,CHEMBL3830,AP2-associated protein kinase 1,7.38,7.38,42.0,1,9
1344709,CHEMBL2035187,PACRITINIB,117538,CHEMBL4105933,Uncharacterized protein FLJ45252,7.28,7.28,52.0,1,9
1344709,CHEMBL2035187,PACRITINIB,30047,CHEMBL4527,TRAF2 and NCK-interacting protein kinase,7.05,7.05,89.0,1,9
1344709,CHEMBL2035187,PACRITINIB,30013,CHEMBL4224,Dual specificity protein kinase CLK1,6.86,6.86,138.0,1,9
1344709,CHEMBL2035187,PACRITINIB,101312,CHEMBL5749,Mitogen-activated protein kinase kinase kinase kinase 1,6.8,6.8,160.0,1,9
1344709,CHEMBL2035187,PACRITINIB,103455,CHEMBL1163126,Serine/threonine-protein kinase ICK,6.57,6.57,270.0,1,9
1344709,CHEMBL2035187,PACRITINIB,101464,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,6.53,6.53,293.0,1,9
1344709,CHEMBL2035187,PACRITINIB,10919,CHEMBL2835,Tyrosine-protein kinase JAK1,6.5,6.05,318.0,7,9
1344709,CHEMBL2035187,PACRITINIB,12780,CHEMBL4070,Casein kinase II subunit alpha',6.41,6.41,394.0,1,9
1344709,CHEMBL2035187,PACRITINIB,10781,CHEMBL2185,Aurora kinase B,6.19,6.19,641.0,1,9
1344709,CHEMBL2035187,PACRITINIB,20020,CHEMBL4355,Cyclin-G-associated kinase,6.17,6.17,674.0,1,9
1344709,CHEMBL2035187,PACRITINIB,12915,CHEMBL3529,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,6.15,6.15,715.0,1,9
1344709,CHEMBL2035187,PACRITINIB,100951,CHEMBL5334,Non-receptor tyrosine-protein kinase TNK1,6.05,6.05,888.0,1,9
1344709,CHEMBL2035187,PACRITINIB,11635,CHEMBL299,Protein kinase C alpha type,6.03,6.03,934.0,1,9
1344709,CHEMBL2035187,PACRITINIB,11626,CHEMBL3116,Cyclin-dependent kinase 9,6.0,6.0,1006.0,1,9
1344709,CHEMBL2035187,PACRITINIB,11019,CHEMBL4273,cGMP-dependent protein kinase 1,5.82,5.82,1516.0,1,9
1344709,CHEMBL2035187,PACRITINIB,30030,CHEMBL5257,Serine/threonine-protein kinase Nek9,5.75,5.75,1780.0,1,9
1344709,CHEMBL2035187,PACRITINIB,30004,CHEMBL3938,Serine/threonine-protein kinase 16,5.73,5.73,1867.0,1,9
1344709,CHEMBL2035187,PACRITINIB,12261,CHEMBL2276,Mitogen-activated protein kinase 8,5.71,5.71,1957.0,1,9
1344709,CHEMBL2035187,PACRITINIB,101131,CHEMBL5261,Serine/threonine-protein kinase TAO1,5.66,5.66,2195.0,1,9
1344709,CHEMBL2035187,PACRITINIB,197,CHEMBL1913,Platelet-derived growth factor receptor beta,5.57,5.57,2666.0,1,9
1344709,CHEMBL2035187,PACRITINIB,30006,CHEMBL3981,Serine/threonine-protein kinase 10,5.54,5.54,2919.0,1,9
1344709,CHEMBL2035187,PACRITINIB,20007,CHEMBL3886,Mitogen-activated protein kinase kinase kinase 20,5.53,5.53,2978.0,1,9
1344709,CHEMBL2035187,PACRITINIB,30022,CHEMBL4597,Cyclin-dependent kinase 16,5.51,5.51,3097.0,1,9
1347273,CHEMBL2040682,CICLESONIDE,25,CHEMBL2034,Glucocorticoid receptor,8.7,7.97,2.0,3,9
1348550,CHEMBL2042122,FLUTEMETAMOL F 18,10656,CHEMBL2487,Amyloid-beta precursor protein,9.15,9.14,0.7,2,9
340684,CHEMBL204656,ELVITEGRAVIR,120160,CHEMBL4739695,N6-adenosine-methyltransferase catalytic subunit,8.32,8.32,4.79,2,9
1351456,CHEMBL2048028,LIFITEGRAST,11088,CHEMBL3070,Intercellular adhesion molecule 1,8.53,8.53,2.98,1,9
1351456,CHEMBL2048028,LIFITEGRAST,12911,CHEMBL3397,Cytochrome P450 2C9,5.52,5.52,3000.0,1,8
1351917,CHEMBL2048484,CANAGLIFLOZIN ANHYDROUS,20092,CHEMBL3884,Sodium/glucose cotransporter 2,8.66,8.51,2.2,8,9
1351917,CHEMBL2048484,CANAGLIFLOZIN ANHYDROUS,18036,CHEMBL4979,Sodium/glucose cotransporter 1,6.58,6.15,265.0,6,9
1355926,CHEMBL2062335,METOPROLOL TARTRATE,101097,CHEMBL5162,Neuropeptide S receptor,7.3,7.3,50.1,1,9
1355926,CHEMBL2062335,METOPROLOL TARTRATE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.05,6.05,891.3,1,9
341603,CHEMBL206253,NETUPITANT,250,CHEMBL249,Substance-P receptor,9.02,9.02,0.95,2,9
1360388,CHEMBL2070241,BREMELANOTIDE,11869,CHEMBL3795,Melanocyte-stimulating hormone receptor,10.11,9.23,0.07762,7,9
1360388,CHEMBL2070241,BREMELANOTIDE,10142,CHEMBL259,Melanocortin receptor 4,9.92,8.79,0.1202,10,9
1360388,CHEMBL2070241,BREMELANOTIDE,11003,CHEMBL4644,Melanocortin receptor 3,9.17,7.77,0.6761,7,9
1360388,CHEMBL2070241,BREMELANOTIDE,11006,CHEMBL4608,Melanocortin receptor 5,7.77,6.97,17.0,4,9
348726,CHEMBL207538,BREXANOLONE,101097,CHEMBL5162,Neuropeptide S receptor,5.5,5.5,3162.3,1,9
1363818,CHEMBL2079587,STANOZOLOL,19,CHEMBL206,Estrogen receptor,7.5,7.22,32.0,2,8
1363818,CHEMBL2079587,STANOZOLOL,12912,CHEMBL3622,Cytochrome P450 2C19,7.32,7.32,48.0,1,8
1363818,CHEMBL2079587,STANOZOLOL,12911,CHEMBL3397,Cytochrome P450 2C9,5.95,5.95,1127.6,1,8
1369604,CHEMBL2095208,COBICISTAT,17045,CHEMBL340,Cytochrome P450 3A4,6.82,6.82,150.0,1,9
1369605,CHEMBL2095209,ICOSAPENT ETHYL,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.52,5.52,3000.0,1,8
1369608,CHEMBL2095212,MIRABEGRON,226,CHEMBL246,Beta-3 adrenergic receptor,7.65,7.65,22.4,1,9
1159,CHEMBL21,SULFANILAMIDE,12923,CHEMBL3912,Carbonic anhydrase 13,7.5,7.48,32.0,2,9
1159,CHEMBL21,SULFANILAMIDE,12209,CHEMBL3242,Carbonic anhydrase 12,7.43,7.43,37.0,12,9
1159,CHEMBL21,SULFANILAMIDE,11060,CHEMBL2326,Carbonic anhydrase 7,7.16,7.16,70.0,3,9
1159,CHEMBL21,SULFANILAMIDE,15,CHEMBL205,Carbonic anhydrase 2,6.62,6.57,240.0,72,9
1159,CHEMBL21,SULFANILAMIDE,12952,CHEMBL3594,Carbonic anhydrase 9,6.62,6.55,238.0,23,9
1159,CHEMBL21,SULFANILAMIDE,10193,CHEMBL261,Carbonic anhydrase 1,6.52,6.52,300.0,1,9
1159,CHEMBL21,SULFANILAMIDE,10186,CHEMBL3025,Carbonic anhydrase 6,6.03,6.03,941.0,5,9
1159,CHEMBL21,SULFANILAMIDE,78,CHEMBL1963,Thyrotropin receptor,6.0,6.0,1000.0,2,9
1159,CHEMBL21,SULFANILAMIDE,12896,CHEMBL3729,Carbonic anhydrase 4,5.52,5.52,3000.0,1,8
1376005,CHEMBL2103735,CETRORELIX ACETATE,102394,CHEMBL6020,Bile salt export pump,5.83,5.83,1470.0,1,9
1376013,CHEMBL2103743,TOFACITINIB CITRATE,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,9.7,7.19,0.2,27,9
1376013,CHEMBL2103743,TOFACITINIB CITRATE,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,9.22,7.12,0.6,27,9
1376013,CHEMBL2103743,TOFACITINIB CITRATE,10919,CHEMBL2835,Tyrosine-protein kinase JAK1,9.17,7.07,0.68,26,9
1376013,CHEMBL2103743,TOFACITINIB CITRATE,12694,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,8.36,6.95,4.39,27,9
1376013,CHEMBL2103743,TOFACITINIB CITRATE,101448,CHEMBL6123,Serine/threonine-protein kinase DCLK3,8.35,8.13,4.5,2,9
1376013,CHEMBL2103743,TOFACITINIB CITRATE,100951,CHEMBL5334,Non-receptor tyrosine-protein kinase TNK1,6.92,6.92,120.0,1,9
1376013,CHEMBL2103743,TOFACITINIB CITRATE,11637,CHEMBL3384,Serine/threonine-protein kinase N1,6.77,6.73,170.0,2,9
1376013,CHEMBL2103743,TOFACITINIB CITRATE,101503,CHEMBL5698,NUAK family SNF1-like kinase 2,6.62,6.5,240.0,2,9
1376013,CHEMBL2103743,TOFACITINIB CITRATE,11149,CHEMBL2973,Rho-associated protein kinase 2,6.38,6.38,420.0,1,9
1376013,CHEMBL2103743,TOFACITINIB CITRATE,10140,CHEMBL258,Tyrosine-protein kinase Lck,6.34,6.04,460.0,2,9
1376013,CHEMBL2103743,TOFACITINIB CITRATE,10811,CHEMBL3231,Rho-associated protein kinase 1,6.33,6.33,470.0,1,9
1376013,CHEMBL2103743,TOFACITINIB CITRATE,10939,CHEMBL4924,Ribosomal protein S6 kinase alpha-6,6.27,6.09,540.0,2,9
1376013,CHEMBL2103743,TOFACITINIB CITRATE,103154,CHEMBL1075104,Leucine-rich repeat serine/threonine-protein kinase 2,6.26,6.07,550.0,2,9
1376013,CHEMBL2103743,TOFACITINIB CITRATE,11843,CHEMBL3906,Ribosomal protein S6 kinase alpha-2,6.22,6.04,600.0,2,9
1376013,CHEMBL2103743,TOFACITINIB CITRATE,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,5.96,5.96,1100.0,1,9
1376013,CHEMBL2103743,TOFACITINIB CITRATE,10842,CHEMBL3032,Serine/threonine-protein kinase N2,5.92,5.92,1200.0,1,9
1376013,CHEMBL2103743,TOFACITINIB CITRATE,10970,CHEMBL2493,Calcium/calmodulin-dependent protein kinase type 1,5.92,5.92,1200.0,1,9
1376013,CHEMBL2103743,TOFACITINIB CITRATE,100918,CHEMBL5320,Myotonin-protein kinase,5.92,5.92,1200.0,1,9
1376013,CHEMBL2103743,TOFACITINIB CITRATE,10929,CHEMBL2553,Ribosomal protein S6 kinase alpha-1,5.85,5.85,1400.0,1,9
1376013,CHEMBL2103743,TOFACITINIB CITRATE,30028,CHEMBL5073,Calcium/calmodulin-dependent protein kinase type 1D,5.8,5.8,1600.0,1,9
1376013,CHEMBL2103743,TOFACITINIB CITRATE,30037,CHEMBL4204,MAP kinase-interacting serine/threonine-protein kinase 2,5.8,5.8,1600.0,1,9
1376013,CHEMBL2103743,TOFACITINIB CITRATE,12247,CHEMBL2996,Protein kinase C delta type,5.7,5.7,2000.0,1,9
1376013,CHEMBL2103743,TOFACITINIB CITRATE,8,CHEMBL1862,Tyrosine-protein kinase ABL1,5.66,5.66,2200.0,1,9
1376013,CHEMBL2103743,TOFACITINIB CITRATE,11622,CHEMBL2801,Calcium/calmodulin-dependent protein kinase type II subunit delta,5.57,5.57,2700.0,1,9
1376028,CHEMBL2103758,PRAMLINTIDE,119,CHEMBL1832,Calcitonin receptor,10.15,9.49,0.07,3,9
1376054,CHEMBL2103784,COSYNTROPIN,10142,CHEMBL259,Melanocortin receptor 4,9.19,9.19,0.65,1,9
1376092,CHEMBL2103822,TASIMELTEON,11085,CHEMBL1946,Melatonin receptor type 1B,10.15,10.15,0.07,1,9
1376097,CHEMBL2103827,DROXIDOPA,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,8.4,6.95,4.0,2,9
1376100,CHEMBL2103830,FOSTAMATINIB,10906,CHEMBL2599,Tyrosine-protein kinase SYK,7.77,7.4,17.0,5,9
1376100,CHEMBL2103830,FOSTAMATINIB,30030,CHEMBL5257,Serine/threonine-protein kinase Nek9,7.39,7.39,41.0,1,9
1376100,CHEMBL2103830,FOSTAMATINIB,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,7.3,7.3,50.0,1,9
1376100,CHEMBL2103830,FOSTAMATINIB,100951,CHEMBL5334,Non-receptor tyrosine-protein kinase TNK1,6.8,6.8,160.0,1,9
1376100,CHEMBL2103830,FOSTAMATINIB,20014,CHEMBL4722,Aurora kinase A,6.52,6.52,300.0,1,9
1376100,CHEMBL2103830,FOSTAMATINIB,30003,CHEMBL3788,Serine/threonine-protein kinase PLK4,6.24,6.24,570.0,1,9
1376100,CHEMBL2103830,FOSTAMATINIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,6.07,6.07,843.0,1,9
1376100,CHEMBL2103830,FOSTAMATINIB,117490,CHEMBL4105885,AarF domain-containing protein kinase 1,5.97,5.97,1071.0,1,9
1376100,CHEMBL2103830,FOSTAMATINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,5.94,5.94,1147.0,1,9
1376100,CHEMBL2103830,FOSTAMATINIB,101055,CHEMBL5081,Interleukin-1 receptor-associated kinase 3,5.89,5.89,1290.0,1,9
1376100,CHEMBL2103830,FOSTAMATINIB,12915,CHEMBL3529,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,5.88,5.88,1320.0,1,9
1376100,CHEMBL2103830,FOSTAMATINIB,11407,CHEMBL4179,Mitogen-activated protein kinase 9,5.81,5.81,1533.0,1,9
1376100,CHEMBL2103830,FOSTAMATINIB,12261,CHEMBL2276,Mitogen-activated protein kinase 8,5.7,5.7,2011.0,1,9
1376100,CHEMBL2103830,FOSTAMATINIB,11379,CHEMBL2689,Macrophage-stimulating protein receptor,5.67,5.67,2132.0,1,9
1376100,CHEMBL2103830,FOSTAMATINIB,101465,CHEMBL6167,Serine/threonine-protein kinase LATS1,5.67,5.67,2157.0,1,9
1376100,CHEMBL2103830,FOSTAMATINIB,30004,CHEMBL3938,Serine/threonine-protein kinase 16,5.61,5.61,2484.0,1,9
1376100,CHEMBL2103830,FOSTAMATINIB,11870,CHEMBL2708,Mitogen-activated protein kinase kinase kinase 11,5.6,5.6,2506.0,1,9
1376100,CHEMBL2103830,FOSTAMATINIB,10781,CHEMBL2185,Aurora kinase B,5.59,5.59,2550.0,1,9
1376100,CHEMBL2103830,FOSTAMATINIB,104126,CHEMBL1770034,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,5.58,5.58,2635.0,1,9
1376107,CHEMBL2103837,TAFAMIDIS,12704,CHEMBL3194,Transthyretin,8.57,6.74,2.7,25,9
1376107,CHEMBL2103837,TAFAMIDIS,10697,CHEMBL3253,Albumin,5.64,5.62,2300.0,2,9
1376138,CHEMBL2103868,CABOZANTINIB S-MALATE,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,8.52,8.52,3.0,1,9
1376138,CHEMBL2103868,CABOZANTINIB S-MALATE,11451,CHEMBL3717,Hepatocyte growth factor receptor,8.49,8.07,3.2,2,9
1376140,CHEMBL2103870,LUMACAFTOR,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,6.7,6.7,200.0,1,8
1376140,CHEMBL2103870,LUMACAFTOR,11540,CHEMBL4051,Cystic fibrosis transmembrane conductance regulator,5.59,5.58,2570.4,4,9
1376143,CHEMBL2103873,MACITENTAN,249,CHEMBL252,Endothelin-1 receptor,9.3,9.02,0.5,3,9
1376143,CHEMBL2103873,MACITENTAN,247,CHEMBL1785,Endothelin receptor type B,6.41,6.28,391.0,3,9
1376143,CHEMBL2103873,MACITENTAN,130,CHEMBL234,D(3) dopamine receptor,6.0,6.0,1004.5,1,9
1376143,CHEMBL2103873,MACITENTAN,101532,CHEMBL5742,Translocator protein,5.67,5.67,2118.36,1,9
1376145,CHEMBL2103875,TRAMETINIB,11046,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,9.32,8.43,0.48,16,9
1376145,CHEMBL2103875,TRAMETINIB,11409,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,9.32,8.43,0.48,16,9
1376145,CHEMBL2103875,TRAMETINIB,11398,CHEMBL4302,ATP-dependent translocase ABCB1,6.61,6.61,247.0,1,9
1377257,CHEMBL2104987,TEDUGLUTIDE,102687,CHEMBL5844,Glucagon-like peptide 2 receptor,11.0,10.53,0.01,2,9
1377263,CHEMBL2104993,VORTIOXETINE,121,CHEMBL228,Sodium-dependent serotonin transporter,8.8,8.54,1.6,2,9
1377263,CHEMBL2104993,VORTIOXETINE,126,CHEMBL230,Prostaglandin G/H synthase 2,8.51,8.51,3.11,1,9
1377263,CHEMBL2104993,VORTIOXETINE,144,CHEMBL1899,5-hydroxytryptamine receptor 3A,8.43,8.43,3.7,1,9
1377263,CHEMBL2104993,VORTIOXETINE,96,CHEMBL221,Prostaglandin G/H synthase 1,8.29,8.29,5.19,1,9
1377263,CHEMBL2104993,VORTIOXETINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,8.02,7.98,9.5,5,9
1377263,CHEMBL2104993,VORTIOXETINE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,7.72,7.61,19.0,5,9
1377728,CHEMBL2105458,THENALIDINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.4,6.4,398.7,1,8
1377728,CHEMBL2105458,THENALIDINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.16,6.16,699.2,1,8
1377728,CHEMBL2105458,THENALIDINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.12,6.12,761.6,1,8
1377728,CHEMBL2105458,THENALIDINE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.79,5.79,1607.6,1,8
1377728,CHEMBL2105458,THENALIDINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.54,5.54,2900.0,1,8
1377851,CHEMBL2105581,VERALIPRIDE,130,CHEMBL234,D(3) dopamine receptor,8.52,8.52,3.0,1,8
1377851,CHEMBL2105581,VERALIPRIDE,88,CHEMBL2056,D(1A) dopamine receptor,7.89,7.89,13.0,1,8
1377851,CHEMBL2105581,VERALIPRIDE,72,CHEMBL217,D(2) dopamine receptor,7.24,7.24,57.1,1,8
1377851,CHEMBL2105581,VERALIPRIDE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.5,5.5,3200.0,1,8
1377932,CHEMBL2105662,LOMITAPIDE MESYLATE,11452,CHEMBL2569,Microsomal triglyceride transfer protein large subunit,8.1,8.1,8.0,1,9
1377965,CHEMBL2105695,TELOTRISTAT ETHYL,101189,CHEMBL5433,Tryptophan 5-hydroxylase 2,6.14,6.14,730.0,1,9
1377965,CHEMBL2105695,TELOTRISTAT ETHYL,101287,CHEMBL5689,Tryptophan 5-hydroxylase 1,6.11,6.11,770.0,1,9
1377965,CHEMBL2105695,TELOTRISTAT ETHYL,280,CHEMBL256,Adenosine receptor A3,5.51,5.51,3100.0,1,8
1377979,CHEMBL2105709,QUIZARTINIB DIHYDROCHLORIDE,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,7.16,7.16,69.0,1,9
1377979,CHEMBL2105709,QUIZARTINIB DIHYDROCHLORIDE,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,6.37,6.37,430.0,1,9
1377982,CHEMBL2105712,AFATINIB DIMALEATE,9,CHEMBL203,Epidermal growth factor receptor,9.52,8.33,0.3,6,9
1377982,CHEMBL2105712,AFATINIB DIMALEATE,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,8.3,7.2,5.0,3,9
1377982,CHEMBL2105712,AFATINIB DIMALEATE,12699,CHEMBL3009,Receptor tyrosine-protein kinase erbB-4,8.2,7.3,6.3,3,9
1377982,CHEMBL2105712,AFATINIB DIMALEATE,20020,CHEMBL4355,Cyclin-G-associated kinase,7.1,7.1,79.0,1,9
1377982,CHEMBL2105712,AFATINIB DIMALEATE,11691,CHEMBL2250,Tyrosine-protein kinase Blk,6.66,6.66,220.0,1,9
1377982,CHEMBL2105712,AFATINIB DIMALEATE,8,CHEMBL1862,Tyrosine-protein kinase ABL1,6.64,6.23,230.0,11,9
1377982,CHEMBL2105712,AFATINIB DIMALEATE,19623,CHEMBL3357,Interleukin-1 receptor-associated kinase 1,6.62,6.62,240.0,1,9
1377982,CHEMBL2105712,AFATINIB DIMALEATE,30046,CHEMBL4526,Ephrin type-A receptor 6,6.47,6.47,340.0,1,9
1377982,CHEMBL2105712,AFATINIB DIMALEATE,103106,CHEMBL1075167,Homeodomain-interacting protein kinase 4,6.44,6.44,360.0,1,9
1377982,CHEMBL2105712,AFATINIB DIMALEATE,12735,CHEMBL2349,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",6.33,6.33,470.0,1,9
1377982,CHEMBL2105712,AFATINIB DIMALEATE,10140,CHEMBL258,Tyrosine-protein kinase Lck,6.24,6.19,570.0,2,9
1377982,CHEMBL2105712,AFATINIB DIMALEATE,12090,CHEMBL2292,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,6.01,6.01,970.0,1,9
1377987,CHEMBL2105717,CABOZANTINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,10.46,9.5,0.035,29,9
1377987,CHEMBL2105717,CABOZANTINIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,9.22,7.86,0.6,9,9
1377987,CHEMBL2105717,CABOZANTINIB,11451,CHEMBL3717,Hepatocyte growth factor receptor,8.89,8.28,1.3,35,9
1377987,CHEMBL2105717,CABOZANTINIB,119219,CHEMBL4523469,SAFB-like transcription modulator,8.89,8.89,1.3,1,9
1377987,CHEMBL2105717,CABOZANTINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,8.62,7.47,2.4,48,9
1377987,CHEMBL2105717,CABOZANTINIB,100410,CHEMBL4895,Tyrosine-protein kinase receptor UFO,8.47,8.17,3.4,11,9
1377987,CHEMBL2105717,CABOZANTINIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,8.4,8.21,4.0,9,9
1377987,CHEMBL2105717,CABOZANTINIB,11752,CHEMBL1955,Vascular endothelial growth factor receptor 3,8.22,8.22,6.0,1,9
1377987,CHEMBL2105717,CABOZANTINIB,10266,CHEMBL3650,Fibroblast growth factor receptor 1,7.95,7.95,11.3,2,9
1377987,CHEMBL2105717,CABOZANTINIB,10979,CHEMBL1868,Vascular endothelial growth factor receptor 1,7.92,7.92,12.0,2,9
1377987,CHEMBL2105717,CABOZANTINIB,12913,CHEMBL4128,Angiopoietin-1 receptor,7.84,7.84,14.3,5,9
1377987,CHEMBL2105717,CABOZANTINIB,9,CHEMBL203,Epidermal growth factor receptor,7.72,6.38,19.0,4,9
1377987,CHEMBL2105717,CABOZANTINIB,11379,CHEMBL2689,Macrophage-stimulating protein receptor,7.16,7.04,69.0,2,9
1377987,CHEMBL2105717,CABOZANTINIB,11902,CHEMBL2815,High affinity nerve growth factor receptor,7.14,7.12,72.3,2,9
1377987,CHEMBL2105717,CABOZANTINIB,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,6.75,6.75,178.0,1,9
1377987,CHEMBL2105717,CABOZANTINIB,100917,CHEMBL5319,Epithelial discoidin domain-containing receptor 1,6.68,6.68,209.0,1,9
1377987,CHEMBL2105717,CABOZANTINIB,100128,CHEMBL5146,Breakpoint cluster region protein,6.47,6.47,342.0,1,9
1377987,CHEMBL2105717,CABOZANTINIB,280,CHEMBL256,Adenosine receptor A3,6.42,6.42,379.4,1,8
1377987,CHEMBL2105717,CABOZANTINIB,101079,CHEMBL5122,Discoidin domain-containing receptor 2,6.3,6.3,501.0,1,9
1377987,CHEMBL2105717,CABOZANTINIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,6.25,6.25,560.0,1,9
1377987,CHEMBL2105717,CABOZANTINIB,30008,CHEMBL2068,Ephrin type-A receptor 2,6.13,6.13,746.0,1,9
1377987,CHEMBL2105717,CABOZANTINIB,20025,CHEMBL5014,Receptor-interacting serine/threonine-protein kinase 2,6.12,6.12,767.0,1,9
1377987,CHEMBL2105717,CABOZANTINIB,11209,CHEMBL4014,Tyrosine-protein kinase ABL2,6.04,6.04,918.0,1,9
1377987,CHEMBL2105717,CABOZANTINIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,5.98,5.98,1045.0,1,9
1377987,CHEMBL2105717,CABOZANTINIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,5.96,5.96,1098.0,1,9
1377987,CHEMBL2105717,CABOZANTINIB,11785,CHEMBL3234,Tyrosine-protein kinase HCK,5.96,5.96,1098.0,1,9
1377987,CHEMBL2105717,CABOZANTINIB,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,5.88,5.88,1333.0,1,9
1377987,CHEMBL2105717,CABOZANTINIB,30026,CHEMBL4601,Protein-tyrosine kinase 6,5.75,5.75,1763.0,1,9
1377987,CHEMBL2105717,CABOZANTINIB,10371,CHEMBL4948,Dual specificity mitogen-activated protein kinase kinase 5,5.62,5.62,2388.0,1,9
1377987,CHEMBL2105717,CABOZANTINIB,104279,CHEMBL1795199,Receptor-interacting serine/threonine-protein kinase 3,5.61,5.61,2459.0,1,9
1377987,CHEMBL2105717,CABOZANTINIB,116956,CHEMBL3879831,"Ferrochelatase, mitochondrial",5.58,5.58,2628.0,1,9
1377987,CHEMBL2105717,CABOZANTINIB,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.57,5.57,2718.2,1,8
1377987,CHEMBL2105717,CABOZANTINIB,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.54,5.54,2900.0,1,8
1377987,CHEMBL2105717,CABOZANTINIB,104126,CHEMBL1770034,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,5.54,5.54,2901.0,1,9
1377989,CHEMBL2105719,DACOMITINIB,9,CHEMBL203,Epidermal growth factor receptor,8.22,8.22,6.0,1,8
1377989,CHEMBL2105719,DACOMITINIB,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,7.34,7.34,46.0,1,8
1377989,CHEMBL2105719,DACOMITINIB,12699,CHEMBL3009,Receptor tyrosine-protein kinase erbB-4,7.13,7.13,74.0,1,8
1377990,CHEMBL2105720,LESINURAD,104618,CHEMBL2073677,Solute carrier family 22 member 11,5.69,5.69,2030.0,1,9
1378007,CHEMBL2105737,SONIDEGIB,101400,CHEMBL5971,Protein smoothened,8.22,8.22,6.0,1,9
1378007,CHEMBL2105737,SONIDEGIB,108311,CHEMBL3259470,G-protein coupled receptor 183,5.5,5.5,3173.51,1,9
1378013,CHEMBL2105743,OLODATEROL HYDROCHLORIDE,50,CHEMBL213,Beta-1 adrenergic receptor,7.56,7.56,27.54,1,9
1378024,CHEMBL2105754,TRELAGLIPTIN SUCCINATE,11140,CHEMBL284,Dipeptidyl peptidase 4,8.4,8.4,4.0,1,9
1378025,CHEMBL2105755,NALDEMEDINE,136,CHEMBL236,Delta-type opioid receptor,9.04,9.04,0.91,1,9
1378025,CHEMBL2105755,NALDEMEDINE,129,CHEMBL233,Mu-type opioid receptor,8.96,8.96,1.1,1,9
1378029,CHEMBL2105759,BARICITINIB,10919,CHEMBL2835,Tyrosine-protein kinase JAK1,9.15,8.33,0.7,26,9
1378029,CHEMBL2105759,BARICITINIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,9.1,8.01,0.8,30,9
1378029,CHEMBL2105759,BARICITINIB,30000,CHEMBL3830,AP2-associated protein kinase 1,8.09,7.97,8.2,9,9
1378029,CHEMBL2105759,BARICITINIB,12694,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,8.06,7.41,8.7,13,9
1378029,CHEMBL2105759,BARICITINIB,11472,CHEMBL4026,Signal transducer and activator of transcription 3,7.7,7.53,20.0,2,9
1378029,CHEMBL2105759,BARICITINIB,30042,CHEMBL4522,BMP-2-inducible protein kinase,7.7,7.36,20.0,3,9
1378029,CHEMBL2105759,BARICITINIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,7.6,6.52,25.0,9,9
1378029,CHEMBL2105759,BARICITINIB,117538,CHEMBL4105933,Uncharacterized protein FLJ45252,7.11,7.11,78.0,1,9
1378029,CHEMBL2105759,BARICITINIB,117496,CHEMBL4105891,Septin-9,7.08,7.08,84.0,1,9
1378029,CHEMBL2105759,BARICITINIB,11637,CHEMBL3384,Serine/threonine-protein kinase N1,6.98,6.98,104.0,1,9
1378029,CHEMBL2105759,BARICITINIB,100140,CHEMBL5600,MAP/microtubule affinity-regulating kinase 3,6.98,6.98,104.0,1,9
1378029,CHEMBL2105759,BARICITINIB,20020,CHEMBL4355,Cyclin-G-associated kinase,6.92,6.91,120.0,5,9
1378029,CHEMBL2105759,BARICITINIB,30001,CHEMBL3831,Serine/threonine-protein kinase MARK2,6.9,6.9,125.0,1,9
1378029,CHEMBL2105759,BARICITINIB,30002,CHEMBL3829,Calcium/calmodulin-dependent protein kinase type II subunit gamma,6.61,6.61,243.0,1,9
1378029,CHEMBL2105759,BARICITINIB,11629,CHEMBL2543,Casein kinase I isoform gamma-2,6.58,6.58,265.0,1,9
1378029,CHEMBL2105759,BARICITINIB,10842,CHEMBL3032,Serine/threonine-protein kinase N2,6.57,6.57,269.0,1,9
1378029,CHEMBL2105759,BARICITINIB,11622,CHEMBL2801,Calcium/calmodulin-dependent protein kinase type II subunit delta,6.51,6.51,312.0,1,9
1378029,CHEMBL2105759,BARICITINIB,102667,CHEMBL6029,Eukaryotic translation initiation factor 2-alpha kinase 1,6.47,6.47,335.0,1,9
1378029,CHEMBL2105759,BARICITINIB,10811,CHEMBL3231,Rho-associated protein kinase 1,6.32,6.32,482.0,1,9
1378029,CHEMBL2105759,BARICITINIB,100951,CHEMBL5334,Non-receptor tyrosine-protein kinase TNK1,6.21,6.21,622.0,1,9
1378029,CHEMBL2105759,BARICITINIB,11149,CHEMBL2973,Rho-associated protein kinase 2,6.12,6.12,756.0,1,9
1378029,CHEMBL2105759,BARICITINIB,30013,CHEMBL4224,Dual specificity protein kinase CLK1,6.11,6.11,778.0,1,9
1378029,CHEMBL2105759,BARICITINIB,101411,CHEMBL6006,Serine/threonine-protein kinase ULK1,6.09,6.09,810.0,1,9
1378029,CHEMBL2105759,BARICITINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,6.01,6.01,973.0,1,9
1378029,CHEMBL2105759,BARICITINIB,12247,CHEMBL2996,Protein kinase C delta type,5.97,5.97,1075.0,1,9
1378029,CHEMBL2105759,BARICITINIB,10262,CHEMBL2426,Casein kinase I isoform gamma-1,5.76,5.76,1753.0,1,9
1378029,CHEMBL2105759,BARICITINIB,12276,CHEMBL3956,Mitogen-activated protein kinase kinase kinase 1,5.72,5.72,1891.0,1,9
1378029,CHEMBL2105759,BARICITINIB,11635,CHEMBL299,Protein kinase C alpha type,5.68,5.68,2071.0,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,9.92,9.16,0.12,3,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,72,CHEMBL217,D(2) dopamine receptor,9.52,8.56,0.3,10,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,9.4,9.4,0.3981,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,9.33,8.8,0.47,3,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,8.43,7.97,3.7,2,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,127,CHEMBL231,Histamine H1 receptor,8.05,8.05,8.875,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,130,CHEMBL234,D(3) dopamine receptor,7.98,7.98,10.42,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,105,CHEMBL1983,5-hydroxytryptamine receptor 1D,7.62,7.62,24.05,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.53,7.53,29.27,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,90,CHEMBL219,D(4) dopamine receptor,7.44,7.44,35.98,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,88,CHEMBL2056,D(1A) dopamine receptor,7.43,7.43,37.46,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,106,CHEMBL1898,5-hydroxytryptamine receptor 1B,7.37,7.37,42.64,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,128,CHEMBL232,Alpha-1B adrenergic receptor,7.24,7.24,57.94,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.22,7.22,60.48,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.22,7.22,59.87,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,117512,CHEMBL4105907,Sigma intracellular receptor 2,7.2,7.2,63.01,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,121,CHEMBL228,Sodium-dependent serotonin transporter,7.18,7.18,65.55,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,103,CHEMBL223,Alpha-1D adrenergic receptor,7.12,7.12,76.44,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,10624,CHEMBL3426,5-hydroxytryptamine receptor 5A,6.75,6.75,177.79,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.72,6.72,191.49,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.67,6.67,212.25,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.51,6.51,308.35,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,220,CHEMBL1850,D(1B) dopamine receptor,6.46,6.46,344.47,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.44,6.44,363.83,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.34,6.34,451.49,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,10618,CHEMBL2182,5-hydroxytryptamine receptor 1E,6.32,6.32,477.97,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,50,CHEMBL213,Beta-1 adrenergic receptor,6.23,6.23,589.86,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.16,6.16,689.21,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,43,CHEMBL210,Beta-2 adrenergic receptor,6.01,6.01,968.73,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,144,CHEMBL1899,5-hydroxytryptamine receptor 3A,5.82,5.82,1528.1,1,9
1378030,CHEMBL2105760,BREXPIPRAZOLE,10280,CHEMBL264,Histamine H3 receptor,5.58,5.58,2607.35,1,9
1378032,CHEMBL2105762,OMARIGLIPTIN,11140,CHEMBL284,Dipeptidyl peptidase 4,9.1,8.67,0.8,12,9
1378465,CHEMBL2106195,DEXMEDETOMIDINE HYDROCHLORIDE,52,CHEMBL1867,Alpha-2A adrenergic receptor,9.17,8.23,0.6747,2,9
1378465,CHEMBL2106195,DEXMEDETOMIDINE HYDROCHLORIDE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.92,7.92,12.14,1,9
1378465,CHEMBL2106195,DEXMEDETOMIDINE HYDROCHLORIDE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.41,7.41,39.39,1,9
1378465,CHEMBL2106195,DEXMEDETOMIDINE HYDROCHLORIDE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.13,6.13,749.03,1,9
1378465,CHEMBL2106195,DEXMEDETOMIDINE HYDROCHLORIDE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,6.04,6.04,922.68,1,9
1378465,CHEMBL2106195,DEXMEDETOMIDINE HYDROCHLORIDE,128,CHEMBL232,Alpha-1B adrenergic receptor,5.53,5.53,2977.83,1,9
1379185,CHEMBL2106915,METHOPHOLINE,137,CHEMBL237,Kappa-type opioid receptor,5.92,5.92,1202.9,1,8
1379185,CHEMBL2106915,METHOPHOLINE,126,CHEMBL230,Prostaglandin G/H synthase 2,5.8,5.8,1600.0,1,8
1379603,CHEMBL2107333,DIMETHYL FUMARATE,100579,CHEMBL3785,Hydroxycarboxylic acid receptor 2,6.89,6.89,130.0,1,9
1379653,CHEMBL2107383,VERNAKALANT HYDROCHLORIDE,10198,CHEMBL4306,Potassium voltage-gated channel subfamily A member 5,5.5,5.5,3200.0,1,9
1379701,CHEMBL2107431,LYNESTRENOL,86,CHEMBL1951,Amine oxidase [flavin-containing] A,6.52,6.52,300.0,1,8
1379701,CHEMBL2107431,LYNESTRENOL,137,CHEMBL237,Kappa-type opioid receptor,5.82,5.82,1500.0,1,8
1380067,CHEMBL2107797,NORGESTREL,12643,CHEMBL3305,Sex hormone-binding globulin,8.91,8.91,1.23,1,9
1380067,CHEMBL2107797,NORGESTREL,25,CHEMBL2034,Glucocorticoid receptor,7.17,7.0,68.0,2,8
1380067,CHEMBL2107797,NORGESTREL,121,CHEMBL228,Sodium-dependent serotonin transporter,6.22,6.08,595.0,2,8
1380067,CHEMBL2107797,NORGESTREL,103668,CHEMBL1293235,Prelamin-A/C,5.55,5.55,2818.4,1,9
1380096,CHEMBL2107826,VIBEGRON,226,CHEMBL246,Beta-3 adrenergic receptor,8.96,8.88,1.1,2,9
1380100,CHEMBL2107830,EMPAGLIFLOZIN,20092,CHEMBL3884,Sodium/glucose cotransporter 2,8.52,8.51,3.0,7,9
1380101,CHEMBL2107831,LUSUTROMBOPAG,265,CHEMBL1864,Thrombopoietin receptor,8.96,8.96,1.09,1,9
1380101,CHEMBL2107831,LUSUTROMBOPAG,280,CHEMBL256,Adenosine receptor A3,6.48,6.48,333.8,1,8
1380101,CHEMBL2107831,LUSUTROMBOPAG,88,CHEMBL2056,D(1A) dopamine receptor,5.81,5.81,1540.3,1,8
1380101,CHEMBL2107831,LUSUTROMBOPAG,96,CHEMBL221,Prostaglandin G/H synthase 1,5.67,5.67,2151.3,1,8
1380101,CHEMBL2107831,LUSUTROMBOPAG,19,CHEMBL206,Estrogen receptor,5.54,5.54,2907.0,1,8
1380990,CHEMBL2108724,SEMAGLUTIDE,11758,CHEMBL1784,Glucagon-like peptide 1 receptor,10.73,8.87,0.0187,8,9
1382812,CHEMBL2110372,RANITIDINE HYDROCHLORIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,5.6,5.6,2511.9,2,9
1383028,CHEMBL2110588,ELIGLUSTAT,286,CHEMBL2063,Ceramide glucosyltransferase,7.8,7.8,16.0,1,9
1383171,CHEMBL2110731,TOFOGLIFLOZIN ANHYDROUS,20092,CHEMBL3884,Sodium/glucose cotransporter 2,8.54,8.49,2.9,3,9
1383172,CHEMBL2110732,DACOMITINIB ANHYDROUS,9,CHEMBL203,Epidermal growth factor receptor,9.2,8.08,0.63,24,9
1383172,CHEMBL2110732,DACOMITINIB ANHYDROUS,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,7.78,7.4,16.7,8,9
1383172,CHEMBL2110732,DACOMITINIB ANHYDROUS,12699,CHEMBL3009,Receptor tyrosine-protein kinase erbB-4,7.13,7.12,73.7,4,9
1383172,CHEMBL2110732,DACOMITINIB ANHYDROUS,10140,CHEMBL258,Tyrosine-protein kinase Lck,7.03,7.03,94.0,2,9
1383172,CHEMBL2110732,DACOMITINIB ANHYDROUS,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,6.96,6.96,110.0,2,9
1383172,CHEMBL2110732,DACOMITINIB ANHYDROUS,20020,CHEMBL4355,Cyclin-G-associated kinase,6.78,6.78,168.0,1,9
1383172,CHEMBL2110732,DACOMITINIB ANHYDROUS,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.19,6.19,640.0,1,8
1383172,CHEMBL2110732,DACOMITINIB ANHYDROUS,20025,CHEMBL5014,Receptor-interacting serine/threonine-protein kinase 2,6.0,6.0,988.0,1,9
1383541,CHEMBL2111101,PIMAVANSERIN,107,CHEMBL224,5-hydroxytryptamine receptor 2A,10.2,8.43,0.0631,14,9
1383541,CHEMBL2111101,PIMAVANSERIN,108,CHEMBL225,5-hydroxytryptamine receptor 2C,8.82,8.35,1.5,3,9
1383541,CHEMBL2111101,PIMAVANSERIN,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.48,6.34,330.0,3,9
1383541,CHEMBL2111101,PIMAVANSERIN,130,CHEMBL234,D(3) dopamine receptor,5.58,5.58,2658.3,1,8
1383552,CHEMBL2111112,VERNAKALANT,121,CHEMBL228,Sodium-dependent serotonin transporter,5.98,5.98,1040.0,1,8
353902,CHEMBL211471,NEOSTIGMINE METHYLSULFATE,93,CHEMBL220,Acetylcholinesterase,7.73,7.55,18.8,2,9
353902,CHEMBL211471,NEOSTIGMINE METHYLSULFATE,10532,CHEMBL1914,Cholinesterase,7.22,7.22,60.0,1,9
26451,CHEMBL21333,PRANLUKAST,179,CHEMBL1798,Cysteinyl leukotriene receptor 1,9.1,8.55,0.8,4,9
26451,CHEMBL21333,PRANLUKAST,104069,CHEMBL1743128,ATP-binding cassette sub-family C member 4,5.57,5.57,2700.0,1,9
26451,CHEMBL21333,PRANLUKAST,88,CHEMBL2056,D(1A) dopamine receptor,5.54,5.54,2880.0,1,8
26451,CHEMBL21333,PRANLUKAST,102394,CHEMBL6020,Bile salt export pump,5.53,5.53,2970.0,1,9
1410635,CHEMBL2138684,FROVATRIPTAN SUCCINATE,106,CHEMBL1898,5-hydroxytryptamine receptor 1B,7.64,7.64,22.87,1,9
1410635,CHEMBL2138684,FROVATRIPTAN SUCCINATE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,7.44,7.44,36.05,1,9
1410635,CHEMBL2138684,FROVATRIPTAN SUCCINATE,129,CHEMBL233,Mu-type opioid receptor,6.73,6.73,186.98,1,9
1410635,CHEMBL2138684,FROVATRIPTAN SUCCINATE,10618,CHEMBL2182,5-hydroxytryptamine receptor 1E,6.51,6.51,310.74,1,9
1410635,CHEMBL2138684,FROVATRIPTAN SUCCINATE,72,CHEMBL217,D(2) dopamine receptor,6.16,6.16,694.23,1,9
1410635,CHEMBL2138684,FROVATRIPTAN SUCCINATE,90,CHEMBL219,D(4) dopamine receptor,6.04,6.04,908.97,1,9
1410635,CHEMBL2138684,FROVATRIPTAN SUCCINATE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.83,5.83,1471.97,1,9
1418074,CHEMBL2146123,METHACYCLINE HYDROCHLORIDE,103624,CHEMBL1287622,Lethal(3)malignant brain tumor-like protein 1,6.05,6.05,891.3,1,9
1418074,CHEMBL2146123,METHACYCLINE HYDROCHLORIDE,105690,CHEMBL2362978,DNA repair protein RAD52 homolog,5.7,5.7,2000.0,1,9
1418074,CHEMBL2146123,METHACYCLINE HYDROCHLORIDE,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.5,5.5,3200.0,1,9
1418075,CHEMBL2146124,CEFUROXIME SODIUM,104180,CHEMBL1795098,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1,5.68,5.68,2086.0,1,8
1420377,CHEMBL2146883,COBIMETINIB,11409,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,9.05,8.21,0.9,8,9
1420377,CHEMBL2146883,COBIMETINIB,100126,CHEMBL5145,Serine/threonine-protein kinase B-raf,8.74,8.74,1.8,1,9
1420377,CHEMBL2146883,COBIMETINIB,11046,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,7.66,7.65,22.0,2,9
1420377,CHEMBL2146883,COBIMETINIB,117462,CHEMBL4105857,Actin-related protein 3,7.44,7.36,36.0,2,9
1420377,CHEMBL2146883,COBIMETINIB,129,CHEMBL233,Mu-type opioid receptor,6.57,6.57,271.4,1,8
1420377,CHEMBL2146883,COBIMETINIB,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.89,5.89,1300.0,1,8
1421280,CHEMBL2147777,TENELIGLIPTIN,11140,CHEMBL284,Dipeptidyl peptidase 4,9.43,8.91,0.37,3,9
1421280,CHEMBL2147777,TENELIGLIPTIN,20151,CHEMBL4657,Dipeptidyl peptidase 8,6.58,6.58,260.0,1,9
1421280,CHEMBL2147777,TENELIGLIPTIN,20154,CHEMBL4793,Dipeptidyl peptidase 9,6.27,6.27,540.0,1,9
26653,CHEMBL21536,XANOMELINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,8.8,7.18,1.6,26,9
26653,CHEMBL21536,XANOMELINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,8.22,7.53,6.0,13,9
26653,CHEMBL21536,XANOMELINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,8.11,7.35,7.762,6,9
26653,CHEMBL21536,XANOMELINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,8.09,6.85,8.128,19,9
26653,CHEMBL21536,XANOMELINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,8.03,6.71,9.333,9,9
26653,CHEMBL21536,XANOMELINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.7,7.7,20.0,1,9
26653,CHEMBL21536,XANOMELINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.61,6.61,243.4,1,8
26653,CHEMBL21536,XANOMELINE,130,CHEMBL234,D(3) dopamine receptor,6.56,6.56,272.6,1,8
26653,CHEMBL21536,XANOMELINE,88,CHEMBL2056,D(1A) dopamine receptor,5.91,5.91,1217.7,1,8
26653,CHEMBL21536,XANOMELINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.89,5.89,1300.0,1,8
26653,CHEMBL21536,XANOMELINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.86,5.86,1388.9,1,8
26653,CHEMBL21536,XANOMELINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.56,5.56,2739.1,1,8
1425665,CHEMBL2159122,ELUXADOLINE,129,CHEMBL233,Mu-type opioid receptor,9.0,9.0,1.0,1,8
1428762,CHEMBL2165326,APROCITENTAN,249,CHEMBL252,Endothelin-1 receptor,8.47,8.47,3.4,2,9
1428762,CHEMBL2165326,APROCITENTAN,247,CHEMBL1785,Endothelin receptor type B,6.01,6.01,987.0,2,9
27713,CHEMBL21731,MAPROTILINE,127,CHEMBL231,Histamine H1 receptor,8.99,8.48,1.021,4,9
27713,CHEMBL21731,MAPROTILINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,7.92,7.43,12.0,4,8
27713,CHEMBL21731,MAPROTILINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.75,6.85,18.0,3,8
27713,CHEMBL21731,MAPROTILINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.39,7.25,41.0,2,8
27713,CHEMBL21731,MAPROTILINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,7.24,6.81,58.0,2,8
27713,CHEMBL21731,MAPROTILINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,7.0,6.38,100.0,3,8
27713,CHEMBL21731,MAPROTILINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.94,6.87,115.0,2,8
27713,CHEMBL21731,MAPROTILINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.88,6.71,133.0,2,8
27713,CHEMBL21731,MAPROTILINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.84,6.31,143.0,3,8
27713,CHEMBL21731,MAPROTILINE,88,CHEMBL2056,D(1A) dopamine receptor,6.73,6.52,187.0,3,9
27713,CHEMBL21731,MAPROTILINE,103,CHEMBL223,Alpha-1D adrenergic receptor,6.71,6.55,195.0,2,8
27713,CHEMBL21731,MAPROTILINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.67,6.35,214.0,3,8
27713,CHEMBL21731,MAPROTILINE,130,CHEMBL234,D(3) dopamine receptor,6.66,6.17,219.0,4,9
27713,CHEMBL21731,MAPROTILINE,102,CHEMBL1941,Histamine H2 receptor,6.41,6.41,393.0,2,8
27713,CHEMBL21731,MAPROTILINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.38,6.21,414.0,2,8
27713,CHEMBL21731,MAPROTILINE,220,CHEMBL1850,D(1B) dopamine receptor,6.37,6.37,429.0,1,9
27713,CHEMBL21731,MAPROTILINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.36,5.94,442.0,2,8
27713,CHEMBL21731,MAPROTILINE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.32,6.32,480.0,1,8
27713,CHEMBL21731,MAPROTILINE,11400,CHEMBL2842,Serine/threonine-protein kinase mTOR,6.28,6.28,521.2,1,9
27713,CHEMBL21731,MAPROTILINE,72,CHEMBL217,D(2) dopamine receptor,6.18,6.06,665.0,2,9
27713,CHEMBL21731,MAPROTILINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.17,5.96,684.0,2,8
27713,CHEMBL21731,MAPROTILINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.16,5.94,685.0,2,8
27713,CHEMBL21731,MAPROTILINE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.64,5.59,2312.0,2,8
27713,CHEMBL21731,MAPROTILINE,17045,CHEMBL340,Cytochrome P450 3A4,5.6,5.57,2511.89,9,9
1439217,CHEMBL2178422,RIMEGEPANT,19904,CHEMBL3798,Calcitonin gene-related peptide type 1 receptor,10.57,10.21,0.027,2,9
1439217,CHEMBL2178422,RIMEGEPANT,43,CHEMBL210,Beta-2 adrenergic receptor,5.5,5.5,3200.0,1,9
1442757,CHEMBL2181927,FINERENONE,48,CHEMBL1994,Mineralocorticoid receptor,7.8,7.63,16.0,4,9
360237,CHEMBL218291,FORODESINE,12690,CHEMBL4338,Purine nucleoside phosphorylase,10.25,9.29,0.056,18,9
360720,CHEMBL218394,BOCEPREVIR,10074,CHEMBL4068,Chymase,7.5,7.5,32.0,1,9
360720,CHEMBL218394,BOCEPREVIR,10495,CHEMBL268,Cathepsin K,7.4,7.4,40.0,1,9
360720,CHEMBL218394,BOCEPREVIR,12587,CHEMBL3272,Cathepsin L2,7.12,7.12,75.0,1,9
360720,CHEMBL218394,BOCEPREVIR,11534,CHEMBL2954,Cathepsin S,6.92,6.92,120.0,1,9
360720,CHEMBL218394,BOCEPREVIR,10498,CHEMBL3837,Procathepsin L,6.12,6.12,760.0,1,9
360720,CHEMBL218394,BOCEPREVIR,10493,CHEMBL2517,Cathepsin F,5.96,5.96,1100.0,1,9
366274,CHEMBL218490,DORZOLAMIDE,15,CHEMBL205,Carbonic anhydrase 2,10.37,8.2,0.043,99,9
366274,CHEMBL218490,DORZOLAMIDE,12209,CHEMBL3242,Carbonic anhydrase 12,8.52,8.46,3.0,19,9
366274,CHEMBL218490,DORZOLAMIDE,11060,CHEMBL2326,Carbonic anhydrase 7,8.46,8.46,3.5,9,9
366274,CHEMBL218490,DORZOLAMIDE,10186,CHEMBL3025,Carbonic anhydrase 6,8.0,8.0,10.0,7,9
366274,CHEMBL218490,DORZOLAMIDE,12923,CHEMBL3912,Carbonic anhydrase 13,7.75,7.75,18.0,1,9
366274,CHEMBL218490,DORZOLAMIDE,11063,CHEMBL3510,Carbonic anhydrase 14,7.57,7.57,27.0,7,9
366274,CHEMBL218490,DORZOLAMIDE,11016,CHEMBL3969,"Carbonic anhydrase 5B, mitochondrial",7.48,7.48,33.0,5,9
366274,CHEMBL218490,DORZOLAMIDE,11042,CHEMBL4789,"Carbonic anhydrase 5A, mitochondrial",7.38,7.38,42.0,5,9
366274,CHEMBL218490,DORZOLAMIDE,12896,CHEMBL3729,Carbonic anhydrase 4,7.37,7.37,43.0,3,9
366274,CHEMBL218490,DORZOLAMIDE,12952,CHEMBL3594,Carbonic anhydrase 9,7.28,7.28,52.0,30,9
366274,CHEMBL218490,DORZOLAMIDE,56,CHEMBL1871,Androgen receptor,7.19,7.19,65.0,1,9
366274,CHEMBL218490,DORZOLAMIDE,10193,CHEMBL261,Carbonic anhydrase 1,6.3,6.17,500.0,4,9
365195,CHEMBL218650,DELAMANID,121,CHEMBL228,Sodium-dependent serotonin transporter,5.7,5.7,2020.0,1,8
1216,CHEMBL22,TRIMETHOPRIM,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.49,8.49,3.2,2,9
1216,CHEMBL22,TRIMETHOPRIM,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,8.2,8.2,6.3,1,9
1216,CHEMBL22,TRIMETHOPRIM,6,CHEMBL202,Dihydrofolate reductase,8.0,6.59,10.0,18,9
1216,CHEMBL22,TRIMETHOPRIM,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,6.6,6.6,251.2,2,9
366278,CHEMBL220491,BRINZOLAMIDE,15,CHEMBL205,Carbonic anhydrase 2,10.05,8.5,0.089,68,9
366278,CHEMBL220491,BRINZOLAMIDE,10186,CHEMBL3025,Carbonic anhydrase 6,9.05,9.05,0.9,6,9
366278,CHEMBL220491,BRINZOLAMIDE,11060,CHEMBL2326,Carbonic anhydrase 7,8.55,8.55,2.8,8,9
366278,CHEMBL220491,BRINZOLAMIDE,10193,CHEMBL261,Carbonic anhydrase 1,8.52,7.58,3.0,11,9
366278,CHEMBL220491,BRINZOLAMIDE,12209,CHEMBL3242,Carbonic anhydrase 12,8.52,8.51,3.0,13,9
366278,CHEMBL220491,BRINZOLAMIDE,12923,CHEMBL3912,Carbonic anhydrase 13,7.96,7.96,11.0,1,9
366278,CHEMBL220491,BRINZOLAMIDE,11063,CHEMBL3510,Carbonic anhydrase 14,7.62,7.62,24.0,6,9
366278,CHEMBL220491,BRINZOLAMIDE,11016,CHEMBL3969,"Carbonic anhydrase 5B, mitochondrial",7.52,7.52,30.0,4,9
366278,CHEMBL220491,BRINZOLAMIDE,12952,CHEMBL3594,Carbonic anhydrase 9,7.44,7.41,36.0,23,9
366278,CHEMBL220491,BRINZOLAMIDE,12896,CHEMBL3729,Carbonic anhydrase 4,7.34,7.34,45.3,1,8
366278,CHEMBL220491,BRINZOLAMIDE,11042,CHEMBL4789,"Carbonic anhydrase 5A, mitochondrial",7.3,7.3,50.0,4,9
366279,CHEMBL220492,TOPIRAMATE,11060,CHEMBL2326,Carbonic anhydrase 7,9.06,8.9,0.87,21,9
366279,CHEMBL220492,TOPIRAMATE,15,CHEMBL205,Carbonic anhydrase 2,8.3,7.85,5.0,87,9
366279,CHEMBL220492,TOPIRAMATE,11042,CHEMBL4789,"Carbonic anhydrase 5A, mitochondrial",7.59,7.23,25.4,13,9
366279,CHEMBL220492,TOPIRAMATE,11016,CHEMBL3969,"Carbonic anhydrase 5B, mitochondrial",7.52,7.52,30.0,11,9
366279,CHEMBL220492,TOPIRAMATE,10186,CHEMBL3025,Carbonic anhydrase 6,7.35,7.35,45.0,7,9
366279,CHEMBL220492,TOPIRAMATE,12923,CHEMBL3912,Carbonic anhydrase 13,7.33,7.33,47.0,1,9
366279,CHEMBL220492,TOPIRAMATE,10193,CHEMBL261,Carbonic anhydrase 1,7.25,6.61,56.0,67,9
366279,CHEMBL220492,TOPIRAMATE,12952,CHEMBL3594,Carbonic anhydrase 9,7.24,7.0,58.0,24,9
366279,CHEMBL220492,TOPIRAMATE,11063,CHEMBL3510,Carbonic anhydrase 14,5.84,5.84,1460.0,12,9
1445435,CHEMBL2205807,ABAMETAPIR,11307,CHEMBL1865,Histone deacetylase 6,5.99,5.99,1022.0,1,9
1445435,CHEMBL2205807,ABAMETAPIR,10580,CHEMBL274,C-C chemokine receptor type 5,5.64,5.62,2300.0,2,9
370168,CHEMBL221326,DIQUAFOSOL,11907,CHEMBL4398,P2Y purinoceptor 2,7.22,6.73,60.0,13,9
370168,CHEMBL221326,DIQUAFOSOL,10541,CHEMBL2123,P2Y purinoceptor 4,6.89,6.89,130.0,2,9
370168,CHEMBL221326,DIQUAFOSOL,10012,CHEMBL4714,P2Y purinoceptor 6,5.94,5.94,1160.0,1,9
1448219,CHEMBL2216870,IDELALISIB,11177,CHEMBL3130,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",9.0,8.31,1.0,51,9
1448219,CHEMBL2216870,IDELALISIB,11939,CHEMBL3267,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",7.56,6.87,27.4,33,9
1448219,CHEMBL2216870,IDELALISIB,12576,CHEMBL3145,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",6.92,6.38,120.1,23,9
1448219,CHEMBL2216870,IDELALISIB,11362,CHEMBL4005,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",6.75,6.2,177.2,18,9
1448219,CHEMBL2216870,IDELALISIB,103104,CHEMBL1075165,Phosphatidylinositol 3-kinase catalytic subunit type 3,6.01,6.01,980.0,1,9
1449134,CHEMBL2218861,QUINAGOLIDE,130,CHEMBL234,D(3) dopamine receptor,8.55,8.55,2.8,1,8
1449134,CHEMBL2218861,QUINAGOLIDE,72,CHEMBL217,D(2) dopamine receptor,7.82,7.82,15.2,1,8
1449134,CHEMBL2218861,QUINAGOLIDE,88,CHEMBL2056,D(1A) dopamine receptor,6.82,6.82,150.0,1,8
1449134,CHEMBL2218861,QUINAGOLIDE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.49,6.49,324.1,1,8
1449134,CHEMBL2218861,QUINAGOLIDE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.35,6.35,450.0,1,8
1449134,CHEMBL2218861,QUINAGOLIDE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.96,5.96,1100.0,1,8
1449134,CHEMBL2218861,QUINAGOLIDE,137,CHEMBL237,Kappa-type opioid receptor,5.77,5.77,1700.0,1,8
1449134,CHEMBL2218861,QUINAGOLIDE,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.57,5.57,2700.0,1,8
1449134,CHEMBL2218861,QUINAGOLIDE,127,CHEMBL231,Histamine H1 receptor,5.55,5.55,2800.0,1,8
1449150,CHEMBL2218877,ERYTHROMYCIN ESTOLATE,104062,CHEMBL1743121,Solute carrier organic anion transporter family member 1B3,5.63,5.57,2350.0,2,8
1449150,CHEMBL2218877,ERYTHROMYCIN ESTOLATE,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,5.62,5.62,2410.0,1,8
1449169,CHEMBL2218896,NABILONE,259,CHEMBL253,Cannabinoid receptor 2,8.73,8.24,1.84,5,9
1449169,CHEMBL2218896,NABILONE,87,CHEMBL218,Cannabinoid receptor 1,8.66,8.23,2.19,7,9
1449169,CHEMBL2218896,NABILONE,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.6,5.6,2500.0,1,8
367860,CHEMBL221959,TOFACITINIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,9.8,8.53,0.16,81,9
367860,CHEMBL221959,TOFACITINIB,12694,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,9.4,7.32,0.4,44,9
367860,CHEMBL221959,TOFACITINIB,10919,CHEMBL2835,Tyrosine-protein kinase JAK1,9.3,8.28,0.496,78,9
367860,CHEMBL221959,TOFACITINIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,9.3,7.83,0.5,97,9
367860,CHEMBL221959,TOFACITINIB,101448,CHEMBL6123,Serine/threonine-protein kinase DCLK3,8.35,8.21,4.5,3,9
367860,CHEMBL221959,TOFACITINIB,11637,CHEMBL3384,Serine/threonine-protein kinase N1,7.24,6.85,58.0,4,9
367860,CHEMBL221959,TOFACITINIB,100951,CHEMBL5334,Non-receptor tyrosine-protein kinase TNK1,6.92,6.27,120.0,4,9
367860,CHEMBL221959,TOFACITINIB,101503,CHEMBL5698,NUAK family SNF1-like kinase 2,6.62,6.46,240.0,3,9
367860,CHEMBL221959,TOFACITINIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,6.47,6.19,340.0,3,9
367860,CHEMBL221959,TOFACITINIB,11149,CHEMBL2973,Rho-associated protein kinase 2,6.38,5.96,420.0,2,9
367860,CHEMBL221959,TOFACITINIB,11409,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,6.37,6.37,429.0,1,9
367860,CHEMBL221959,TOFACITINIB,10811,CHEMBL3231,Rho-associated protein kinase 1,6.33,5.95,470.0,2,9
367860,CHEMBL221959,TOFACITINIB,10781,CHEMBL2185,Aurora kinase B,6.28,6.28,525.0,1,9
367860,CHEMBL221959,TOFACITINIB,10939,CHEMBL4924,Ribosomal protein S6 kinase alpha-6,6.27,6.04,540.0,3,9
367860,CHEMBL221959,TOFACITINIB,103154,CHEMBL1075104,Leucine-rich repeat serine/threonine-protein kinase 2,6.26,6.07,550.0,2,8
367860,CHEMBL221959,TOFACITINIB,11843,CHEMBL3906,Ribosomal protein S6 kinase alpha-2,6.22,5.97,600.0,3,9
367860,CHEMBL221959,TOFACITINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,6.0,6.0,1000.0,1,8
367860,CHEMBL221959,TOFACITINIB,30023,CHEMBL4599,Activated CDC42 kinase 1,5.97,5.97,1062.0,1,9
367860,CHEMBL221959,TOFACITINIB,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,5.96,5.96,1100.0,1,8
367860,CHEMBL221959,TOFACITINIB,10842,CHEMBL3032,Serine/threonine-protein kinase N2,5.92,5.92,1200.0,1,8
367860,CHEMBL221959,TOFACITINIB,10970,CHEMBL2493,Calcium/calmodulin-dependent protein kinase type 1,5.92,5.92,1200.0,1,8
367860,CHEMBL221959,TOFACITINIB,100918,CHEMBL5320,Myotonin-protein kinase,5.92,5.92,1200.0,1,8
367860,CHEMBL221959,TOFACITINIB,10929,CHEMBL2553,Ribosomal protein S6 kinase alpha-1,5.85,5.85,1400.0,1,8
367860,CHEMBL221959,TOFACITINIB,30028,CHEMBL5073,Calcium/calmodulin-dependent protein kinase type 1D,5.8,5.8,1600.0,1,8
367860,CHEMBL221959,TOFACITINIB,30037,CHEMBL4204,MAP kinase-interacting serine/threonine-protein kinase 2,5.8,5.8,1600.0,1,8
367860,CHEMBL221959,TOFACITINIB,12247,CHEMBL2996,Protein kinase C delta type,5.7,5.7,2000.0,1,8
367860,CHEMBL221959,TOFACITINIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,5.66,5.66,2200.0,1,8
367860,CHEMBL221959,TOFACITINIB,11622,CHEMBL2801,Calcium/calmodulin-dependent protein kinase type II subunit delta,5.57,5.57,2700.0,1,8
1450253,CHEMBL2220442,FLUVASTATIN,24,CHEMBL402,3-hydroxy-3-methylglutaryl-coenzyme A reductase,9.45,8.5,0.353,2,9
1450253,CHEMBL2220442,FLUVASTATIN,12911,CHEMBL3397,Cytochrome P450 2C9,6.4,6.4,400.0,1,8
1450253,CHEMBL2220442,FLUVASTATIN,101254,CHEMBL5002,Nuclear receptor subfamily 4 group A member 2,5.72,5.72,1900.0,3,9
27616,CHEMBL22242,REMOXIPRIDE,72,CHEMBL217,D(2) dopamine receptor,8.92,6.97,1.202,3,8
27616,CHEMBL22242,REMOXIPRIDE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,7.26,7.26,55.0,1,8
27616,CHEMBL22242,REMOXIPRIDE,11365,CHEMBL289,Cytochrome P450 2D6,6.7,6.7,199.5,2,9
27616,CHEMBL22242,REMOXIPRIDE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.99,5.75,1031.7,2,8
27616,CHEMBL22242,REMOXIPRIDE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,5.7,5.7,1995.3,2,9
372438,CHEMBL222559,TIPRANAVIR,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,6.58,6.58,260.0,1,8
372438,CHEMBL222559,TIPRANAVIR,12327,CHEMBL3295,Pepsin A,5.7,5.7,2000.0,1,9
372438,CHEMBL222559,TIPRANAVIR,102394,CHEMBL6020,Bile salt export pump,5.5,5.5,3200.0,1,8
373806,CHEMBL222813,ZANAMIVIR,11652,CHEMBL3046,Sialidase-3,6.21,6.21,620.0,3,9
374719,CHEMBL223228,EFAVIRENZ,119260,CHEMBL4523510,Cholesterol 24-hydroxylase,6.1,6.1,800.0,1,9
374719,CHEMBL223228,EFAVIRENZ,25,CHEMBL2034,Glucocorticoid receptor,5.57,5.57,2710.0,1,8
373973,CHEMBL223448,BROXYQUINOLINE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.2,6.2,631.0,1,9
373973,CHEMBL223448,BROXYQUINOLINE,11213,CHEMBL3880,Heat shock protein HSP 90-alpha,6.16,6.16,700.0,1,8
374007,CHEMBL225071,RALTITREXED,10123,CHEMBL4833,Reduced folate transporter,8.2,8.2,6.3,2,9
374007,CHEMBL225071,RALTITREXED,6,CHEMBL202,Dihydrofolate reductase,8.05,8.05,9.0,1,9
374007,CHEMBL225071,RALTITREXED,28,CHEMBL1952,Thymidylate synthase,8.05,6.45,9.0,16,9
374007,CHEMBL225071,RALTITREXED,10103,CHEMBL2121,Folate receptor alpha,7.82,7.82,15.0,2,9
374007,CHEMBL225071,RALTITREXED,20077,CHEMBL5064,Folate receptor beta,7.66,6.89,22.0,4,9
374007,CHEMBL225071,RALTITREXED,104268,CHEMBL1795188,Proton-coupled folate transporter,7.0,7.0,99.5,2,9
374007,CHEMBL225071,RALTITREXED,102672,CHEMBL6032,Histone-lysine N-methyltransferase EHMT2,6.92,6.92,120.0,1,9
374008,CHEMBL225072,PEMETREXED,28,CHEMBL1952,Thymidylate synthase,8.89,7.74,1.3,4,9
374008,CHEMBL225072,PEMETREXED,6,CHEMBL202,Dihydrofolate reductase,8.15,6.59,7.0,11,9
374008,CHEMBL225072,PEMETREXED,104268,CHEMBL1795188,Proton-coupled folate transporter,8.08,7.07,8.3,12,9
374008,CHEMBL225072,PEMETREXED,12291,CHEMBL3972,Trifunctional purine biosynthetic protein adenosine-3,7.93,7.01,11.74,8,9
374008,CHEMBL225072,PEMETREXED,10123,CHEMBL4833,Reduced folate transporter,7.62,7.16,23.8,5,9
374008,CHEMBL225072,PEMETREXED,10103,CHEMBL2121,Folate receptor alpha,7.38,7.0,42.0,6,9
374008,CHEMBL225072,PEMETREXED,20077,CHEMBL5064,Folate receptor beta,7.22,6.82,60.0,6,9
374008,CHEMBL225072,PEMETREXED,10732,CHEMBL2518,Bifunctional purine biosynthesis protein ATIC,6.06,6.06,880.0,1,9
1278,CHEMBL23,DILTIAZEM,17045,CHEMBL340,Cytochrome P450 3A4,7.0,6.45,100.0,6,9
1278,CHEMBL23,DILTIAZEM,10818,CHEMBL3805,Voltage-dependent L-type calcium channel subunit alpha-1S,6.42,6.42,380.0,1,8
1278,CHEMBL23,DILTIAZEM,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.59,5.59,2565.0,1,8
1278,CHEMBL23,DILTIAZEM,169,CHEMBL1940,Voltage-dependent L-type calcium channel subunit alpha-1C,5.57,5.57,2700.0,1,8
384165,CHEMBL230158,SELADELPAR,12227,CHEMBL3979,Peroxisome proliferator-activated receptor delta,8.72,8.71,1.9,3,9
384165,CHEMBL230158,SELADELPAR,163,CHEMBL239,Peroxisome proliferator-activated receptor alpha,5.82,5.82,1500.0,1,9
388819,CHEMBL231068,FLIBANSERIN,51,CHEMBL214,5-hydroxytryptamine receptor 1A,8.52,7.55,3.0,3,9
388819,CHEMBL231068,FLIBANSERIN,130,CHEMBL234,D(3) dopamine receptor,6.54,6.54,286.0,1,8
388819,CHEMBL231068,FLIBANSERIN,125,CHEMBL229,Alpha-1A adrenergic receptor,6.41,6.41,391.2,1,8
388819,CHEMBL231068,FLIBANSERIN,129,CHEMBL233,Mu-type opioid receptor,5.88,5.88,1304.9,1,8
388819,CHEMBL231068,FLIBANSERIN,88,CHEMBL2056,D(1A) dopamine receptor,5.61,5.61,2434.6,1,8
397524,CHEMBL231779,APIXABAN,194,CHEMBL244,Coagulation factor X,10.1,9.41,0.08,12,9
397524,CHEMBL231779,APIXABAN,11,CHEMBL204,Prothrombin,5.51,5.51,3100.0,2,9
394996,CHEMBL231813,TELAPREVIR,10074,CHEMBL4068,Chymase,7.58,7.58,26.0,1,9
394996,CHEMBL231813,TELAPREVIR,208,CHEMBL3000,Chymotrypsin-like elastase family member 1,7.52,7.52,30.0,1,9
394996,CHEMBL231813,TELAPREVIR,10378,CHEMBL4072,Cathepsin B,6.68,6.16,210.0,2,9
394996,CHEMBL231813,TELAPREVIR,11534,CHEMBL2954,Cathepsin S,6.52,6.52,300.0,1,9
394996,CHEMBL231813,TELAPREVIR,10495,CHEMBL268,Cathepsin K,6.2,6.2,630.0,1,9
394996,CHEMBL231813,TELAPREVIR,235,CHEMBL248,Neutrophil elastase,6.17,6.17,680.0,1,9
394996,CHEMBL231813,TELAPREVIR,12587,CHEMBL3272,Cathepsin L2,5.87,5.87,1350.0,1,9
395946,CHEMBL232201,BENZIODARONE,12704,CHEMBL3194,Transthyretin,7.11,6.75,78.0,2,9
395946,CHEMBL232201,BENZIODARONE,276,CHEMBL254,"3',5'-cyclic-AMP phosphodiesterase 4A",5.62,5.62,2370.0,1,8
1519923,CHEMBL2325741,CAPIVASERTIB,12666,CHEMBL4282,RAC-alpha serine/threonine-protein kinase,9.05,8.36,0.9,12,9
1519923,CHEMBL2325741,CAPIVASERTIB,10695,CHEMBL2431,RAC-beta serine/threonine-protein kinase,8.3,7.79,5.0,7,9
1519923,CHEMBL2325741,CAPIVASERTIB,10696,CHEMBL4816,RAC-gamma serine/threonine-protein kinase,8.15,8.12,7.0,5,9
1519923,CHEMBL2325741,CAPIVASERTIB,11149,CHEMBL2973,Rho-associated protein kinase 2,7.25,6.87,56.0,2,9
1519923,CHEMBL2325741,CAPIVASERTIB,10207,CHEMBL2918,cAMP-dependent protein kinase catalytic subunit beta,6.62,6.62,239.0,1,9
1519923,CHEMBL2325741,CAPIVASERTIB,11019,CHEMBL4273,cGMP-dependent protein kinase 1,6.53,6.53,297.0,1,9
1519923,CHEMBL2325741,CAPIVASERTIB,30018,CHEMBL3836,LIM domain kinase 1,6.45,6.45,357.0,1,9
1519923,CHEMBL2325741,CAPIVASERTIB,11969,CHEMBL4101,cAMP-dependent protein kinase catalytic subunit alpha,6.41,6.41,387.0,1,9
1519923,CHEMBL2325741,CAPIVASERTIB,10811,CHEMBL3231,Rho-associated protein kinase 1,6.33,6.24,470.0,2,9
1519923,CHEMBL2325741,CAPIVASERTIB,30013,CHEMBL4224,Dual specificity protein kinase CLK1,6.32,6.32,475.0,1,9
1519923,CHEMBL2325741,CAPIVASERTIB,101386,CHEMBL5932,LIM domain kinase 2,6.32,6.32,477.0,1,9
1519923,CHEMBL2325741,CAPIVASERTIB,30036,CHEMBL4203,Dual specificity protein kinase CLK4,6.29,6.29,513.0,1,9
1519923,CHEMBL2325741,CAPIVASERTIB,10266,CHEMBL3650,Fibroblast growth factor receptor 1,6.06,6.06,865.0,1,9
1519923,CHEMBL2325741,CAPIVASERTIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,5.96,5.96,1107.0,1,9
1519923,CHEMBL2325741,CAPIVASERTIB,11637,CHEMBL3384,Serine/threonine-protein kinase N1,5.8,5.8,1577.0,1,9
1519923,CHEMBL2325741,CAPIVASERTIB,11635,CHEMBL299,Protein kinase C alpha type,5.76,5.76,1733.0,1,9
1519923,CHEMBL2325741,CAPIVASERTIB,11364,CHEMBL4045,5'-AMP-activated protein kinase catalytic subunit alpha-1,5.74,5.74,1821.0,1,9
1519923,CHEMBL2325741,CAPIVASERTIB,101188,CHEMBL5432,Mitogen-activated protein kinase kinase kinase kinase 3,5.72,5.72,1900.0,1,9
1519923,CHEMBL2325741,CAPIVASERTIB,11870,CHEMBL2708,Mitogen-activated protein kinase kinase kinase 11,5.7,5.7,1999.0,1,9
1519923,CHEMBL2325741,CAPIVASERTIB,10885,CHEMBL2595,Serine/threonine-protein kinase D3,5.66,5.66,2207.0,1,9
1519923,CHEMBL2325741,CAPIVASERTIB,100415,CHEMBL4900,Serine/threonine-protein kinase D2,5.65,5.65,2246.0,1,9
1519923,CHEMBL2325741,CAPIVASERTIB,10341,CHEMBL2393,5'-AMP-activated protein kinase subunit gamma-1,5.61,5.61,2445.0,1,9
1519923,CHEMBL2325741,CAPIVASERTIB,11636,CHEMBL3045,Protein kinase C beta type,5.61,5.61,2431.0,1,9
1519923,CHEMBL2325741,CAPIVASERTIB,10662,CHEMBL2453,5'-AMP-activated protein kinase subunit gamma-2,5.57,5.57,2711.0,1,9
1519923,CHEMBL2325741,CAPIVASERTIB,12247,CHEMBL2996,Protein kinase C delta type,5.55,5.55,2809.0,1,9
1525737,CHEMBL2336071,SIPONIMOD,11631,CHEMBL4333,Sphingosine 1-phosphate receptor 1,9.4,9.4,0.3981,2,9
1525737,CHEMBL2336071,SIPONIMOD,12023,CHEMBL2274,Sphingosine 1-phosphate receptor 5,9.01,9.01,0.98,1,9
1525737,CHEMBL2336071,SIPONIMOD,10809,CHEMBL3230,Sphingosine 1-phosphate receptor 4,6.12,6.12,750.0,1,9
1528018,CHEMBL2338329,ROXADUSTAT,271,CHEMBL1947,Thyroid hormone receptor beta,7.89,7.89,12.9,1,9
1528018,CHEMBL2338329,ROXADUSTAT,101502,CHEMBL5697,Egl nine homolog 1,7.85,6.63,14.0,14,9
1528018,CHEMBL2338329,ROXADUSTAT,59,CHEMBL1860,Thyroid hormone receptor alpha,7.49,7.49,32.7,1,9
1528018,CHEMBL2338329,ROXADUSTAT,155,CHEMBL238,Sodium-dependent dopamine transporter,5.54,5.54,2880.0,1,8
1532240,CHEMBL2355051,CLOMIPHENE,19,CHEMBL206,Estrogen receptor,8.48,8.48,3.3,1,8
1532240,CHEMBL2355051,CLOMIPHENE,96,CHEMBL221,Prostaglandin G/H synthase 1,7.18,7.18,66.1,1,8
1532240,CHEMBL2355051,CLOMIPHENE,130,CHEMBL234,D(3) dopamine receptor,6.45,6.45,357.3,1,8
1532240,CHEMBL2355051,CLOMIPHENE,56,CHEMBL1871,Androgen receptor,6.25,6.25,565.8,1,8
1532240,CHEMBL2355051,CLOMIPHENE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.1,6.1,800.0,1,8
1532240,CHEMBL2355051,CLOMIPHENE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.03,6.03,928.8,1,8
1532240,CHEMBL2355051,CLOMIPHENE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.89,5.89,1294.7,1,8
1532240,CHEMBL2355051,CLOMIPHENE,36,CHEMBL208,Progesterone receptor,5.86,5.86,1388.4,1,8
1532240,CHEMBL2355051,CLOMIPHENE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,5.71,5.71,1956.0,1,9
1532240,CHEMBL2355051,CLOMIPHENE,280,CHEMBL256,Adenosine receptor A3,5.62,5.62,2381.3,1,8
1532240,CHEMBL2355051,CLOMIPHENE,104004,CHEMBL1741208,"NACHT, LRR and PYD domains-containing protein 3",5.62,5.62,2410.0,1,9
1532240,CHEMBL2355051,CLOMIPHENE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.52,5.52,3023.2,1,8
399292,CHEMBL235668,TIPIRACIL,11723,CHEMBL3106,Thymidine phosphorylase,8.89,8.0,1.3,8,9
1537653,CHEMBL2360464,PEMETREXED DISODIUM,28,CHEMBL1952,Thymidylate synthase,5.69,5.69,2040.0,1,9
1540510,CHEMBL2364638,UBROGEPANT,19904,CHEMBL3798,Calcitonin gene-related peptide type 1 receptor,10.17,10.17,0.067,2,9
1540511,CHEMBL2364639,VALBENAZINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.85,5.85,1410.0,1,8
1540511,CHEMBL2364639,VALBENAZINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.77,5.77,1700.0,1,9
1543312,CHEMBL2368861,BUPRENORPHINE HYDROCHLORIDE,136,CHEMBL236,Delta-type opioid receptor,9.05,9.05,0.9,1,8
1543312,CHEMBL2368861,BUPRENORPHINE HYDROCHLORIDE,137,CHEMBL237,Kappa-type opioid receptor,8.92,8.92,1.2,1,8
1543312,CHEMBL2368861,BUPRENORPHINE HYDROCHLORIDE,129,CHEMBL233,Mu-type opioid receptor,8.77,8.77,1.7,1,8
1543376,CHEMBL2368925,DOLASETRON,144,CHEMBL1899,5-hydroxytryptamine receptor 3A,6.02,6.02,950.0,1,8
399873,CHEMBL237500,LINAGLIPTIN,11140,CHEMBL284,Dipeptidyl peptidase 4,10.0,9.05,0.1,28,9
399873,CHEMBL237500,LINAGLIPTIN,100186,CHEMBL4683,Prolyl endopeptidase FAP,7.15,6.92,70.8,4,9
399873,CHEMBL237500,LINAGLIPTIN,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.53,6.53,295.0,3,9
406189,CHEMBL238804,SELEXIPAG,143,CHEMBL1995,Prostacyclin receptor,8.22,7.71,6.0,2,9
406189,CHEMBL238804,SELEXIPAG,12659,CHEMBL4427,Prostaglandin D2 receptor,7.0,7.0,100.0,1,9
406189,CHEMBL238804,SELEXIPAG,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,6.35,5.95,450.0,2,8
1567700,CHEMBL2396661,ALPELISIB,11362,CHEMBL4005,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",8.77,8.04,1.7,20,9
1567700,CHEMBL2396661,ALPELISIB,11177,CHEMBL3130,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",7.16,6.39,69.0,10,9
1567700,CHEMBL2396661,ALPELISIB,11939,CHEMBL3267,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",7.03,6.73,94.0,8,9
1567700,CHEMBL2396661,ALPELISIB,12576,CHEMBL3145,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",6.72,5.96,190.0,8,9
1567700,CHEMBL2396661,ALPELISIB,11400,CHEMBL2842,Serine/threonine-protein kinase mTOR,5.83,5.67,1461.0,2,9
1567700,CHEMBL2396661,ALPELISIB,11970,CHEMBL2743,cAMP-dependent protein kinase catalytic subunit gamma,5.7,5.7,1990.0,1,9
1567926,CHEMBL2397415,ZAVEGEPANT,19904,CHEMBL3798,Calcitonin gene-related peptide type 1 receptor,10.64,10.64,0.023,1,9
1279,CHEMBL24,ATENOLOL,50,CHEMBL213,Beta-1 adrenergic receptor,8.75,6.49,1.77,16,9
1279,CHEMBL24,ATENOLOL,103668,CHEMBL1293235,Prelamin-A/C,8.3,8.3,5.0,1,9
1279,CHEMBL24,ATENOLOL,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,7.15,7.15,70.8,1,9
1279,CHEMBL24,ATENOLOL,43,CHEMBL210,Beta-2 adrenergic receptor,6.58,6.25,260.0,2,9
1570706,CHEMBL2403108,CERITINIB,100417,CHEMBL4247,ALK tyrosine kinase receptor,9.7,8.08,0.2,76,9
1570706,CHEMBL2403108,CERITINIB,101019,CHEMBL5568,Proto-oncogene tyrosine-protein kinase ROS,9.4,8.31,0.4,14,9
1570706,CHEMBL2403108,CERITINIB,35,CHEMBL1981,Insulin receptor,8.15,7.16,7.0,5,9
1570706,CHEMBL2403108,CERITINIB,234,CHEMBL1957,Insulin-like growth factor 1 receptor,8.1,7.24,8.0,2,9
1570706,CHEMBL2403108,CERITINIB,9,CHEMBL203,Epidermal growth factor receptor,7.72,6.16,19.0,8,9
1570706,CHEMBL2403108,CERITINIB,101408,CHEMBL6003,Testis-specific serine/threonine-protein kinase 1,7.64,7.64,23.0,1,9
1570706,CHEMBL2403108,CERITINIB,100951,CHEMBL5334,Non-receptor tyrosine-protein kinase TNK1,7.57,7.57,27.0,1,9
1570706,CHEMBL2403108,CERITINIB,30023,CHEMBL4599,Activated CDC42 kinase 1,7.47,6.75,33.6,2,9
1570706,CHEMBL2403108,CERITINIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,7.22,6.59,60.0,3,9
1570706,CHEMBL2403108,CERITINIB,11398,CHEMBL4302,ATP-dependent translocase ABCB1,7.05,7.05,89.0,1,9
1570706,CHEMBL2403108,CERITINIB,30007,CHEMBL3982,Tyrosine-protein kinase Fer,6.67,6.67,214.0,1,9
1570706,CHEMBL2403108,CERITINIB,11242,CHEMBL2695,Focal adhesion kinase 1,6.66,6.66,218.0,1,9
1570706,CHEMBL2403108,CERITINIB,10264,CHEMBL4142,Fibroblast growth factor receptor 2,6.58,6.58,260.0,1,9
1570706,CHEMBL2403108,CERITINIB,11451,CHEMBL3717,Hepatocyte growth factor receptor,6.57,5.98,271.0,3,9
1570706,CHEMBL2403108,CERITINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,6.4,6.02,400.0,2,9
1570706,CHEMBL2403108,CERITINIB,11926,CHEMBL2742,Fibroblast growth factor receptor 3,6.37,6.37,430.0,1,9
1570706,CHEMBL2403108,CERITINIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,6.25,6.21,560.0,2,9
1570706,CHEMBL2403108,CERITINIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,6.21,5.94,610.0,2,9
1570706,CHEMBL2403108,CERITINIB,10971,CHEMBL2494,Calcium/calmodulin-dependent protein kinase type IV,6.2,6.2,635.0,1,9
1570706,CHEMBL2403108,CERITINIB,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,6.08,5.86,840.0,2,9
1570706,CHEMBL2403108,CERITINIB,11925,CHEMBL3973,Fibroblast growth factor receptor 4,6.02,6.02,950.0,1,9
1570706,CHEMBL2403108,CERITINIB,30013,CHEMBL4224,Dual specificity protein kinase CLK1,5.97,5.97,1059.0,1,9
1570706,CHEMBL2403108,CERITINIB,12627,CHEMBL2007,Platelet-derived growth factor receptor alpha,5.94,5.94,1140.0,1,9
1570706,CHEMBL2403108,CERITINIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,5.9,5.9,1250.0,1,9
1570706,CHEMBL2403108,CERITINIB,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.9,5.9,1250.0,1,9
1570706,CHEMBL2403108,CERITINIB,11149,CHEMBL2973,Rho-associated protein kinase 2,5.9,5.9,1270.0,1,9
1570706,CHEMBL2403108,CERITINIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,5.89,5.71,1280.0,2,9
1570706,CHEMBL2403108,CERITINIB,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,5.77,5.77,1694.0,1,9
1570706,CHEMBL2403108,CERITINIB,100069,CHEMBL5455,Tyrosine-protein kinase Fes/Fps,5.76,5.76,1742.0,1,9
1570706,CHEMBL2403108,CERITINIB,100413,CHEMBL4898,BDNF/NT-3 growth factors receptor,5.74,5.74,1829.0,1,9
1570706,CHEMBL2403108,CERITINIB,100127,CHEMBL4454,Tyrosine-protein kinase Fgr,5.71,5.71,1947.0,1,9
1570706,CHEMBL2403108,CERITINIB,30037,CHEMBL4204,MAP kinase-interacting serine/threonine-protein kinase 2,5.65,5.65,2240.0,1,9
1570706,CHEMBL2403108,CERITINIB,11902,CHEMBL2815,High affinity nerve growth factor receptor,5.56,5.56,2727.0,1,9
1570706,CHEMBL2403108,CERITINIB,10906,CHEMBL2599,Tyrosine-protein kinase SYK,5.52,5.52,3050.0,1,9
404691,CHEMBL240597,CHENODIOL,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.52,5.52,3000.0,1,8
31171,CHEMBL24072,PRENYLAMINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,7.19,6.66,65.0,2,9
31171,CHEMBL24072,PRENYLAMINE,137,CHEMBL237,Kappa-type opioid receptor,6.42,6.42,381.6,1,8
31171,CHEMBL24072,PRENYLAMINE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.06,6.06,876.6,1,8
31171,CHEMBL24072,PRENYLAMINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.02,6.02,957.1,1,8
31171,CHEMBL24072,PRENYLAMINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.77,5.77,1700.0,1,8
31171,CHEMBL24072,PRENYLAMINE,129,CHEMBL233,Mu-type opioid receptor,5.75,5.75,1800.0,1,8
31171,CHEMBL24072,PRENYLAMINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.64,5.64,2300.0,1,8
31171,CHEMBL24072,PRENYLAMINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.64,5.64,2300.0,1,8
31171,CHEMBL24072,PRENYLAMINE,130,CHEMBL234,D(3) dopamine receptor,5.62,5.62,2400.0,1,8
31171,CHEMBL24072,PRENYLAMINE,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,5.6,5.6,2520.0,1,9
31171,CHEMBL24072,PRENYLAMINE,72,CHEMBL217,D(2) dopamine receptor,5.54,5.54,2900.0,1,8
31171,CHEMBL24072,PRENYLAMINE,11536,CHEMBL4616,Growth hormone secretagogue receptor type 1,5.52,5.52,3000.0,1,8
389011,CHEMBL243712,AMISULPRIDE,72,CHEMBL217,D(2) dopamine receptor,8.82,8.27,1.5,9,9
389011,CHEMBL243712,AMISULPRIDE,130,CHEMBL234,D(3) dopamine receptor,8.46,8.43,3.5,2,9
389011,CHEMBL243712,AMISULPRIDE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,7.94,7.77,11.5,2,9
389011,CHEMBL243712,AMISULPRIDE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.89,6.85,13.0,3,9
389011,CHEMBL243712,AMISULPRIDE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.2,6.2,630.96,1,9
389011,CHEMBL243712,AMISULPRIDE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.15,6.15,710.0,1,8
389011,CHEMBL243712,AMISULPRIDE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.82,5.82,1500.0,1,8
1589794,CHEMBL2443262,OLICERIDINE,129,CHEMBL233,Mu-type opioid receptor,8.84,8.17,1.456,11,9
1589794,CHEMBL2443262,OLICERIDINE,137,CHEMBL237,Kappa-type opioid receptor,5.85,5.85,1400.0,1,9
1589794,CHEMBL2443262,OLICERIDINE,136,CHEMBL236,Delta-type opioid receptor,5.55,5.55,2800.0,1,9
33307,CHEMBL24778,SILODOSIN,125,CHEMBL229,Alpha-1A adrenergic receptor,10.44,8.98,0.036,7,9
33307,CHEMBL24778,SILODOSIN,103,CHEMBL223,Alpha-1D adrenergic receptor,8.7,7.95,1.995,4,9
33307,CHEMBL24778,SILODOSIN,51,CHEMBL214,5-hydroxytryptamine receptor 1A,8.52,7.92,3.0,2,9
33307,CHEMBL24778,SILODOSIN,128,CHEMBL232,Alpha-1B adrenergic receptor,7.7,6.91,19.95,4,9
33307,CHEMBL24778,SILODOSIN,43,CHEMBL210,Beta-2 adrenergic receptor,7.48,7.08,32.83,2,9
33307,CHEMBL24778,SILODOSIN,130,CHEMBL234,D(3) dopamine receptor,7.32,7.23,48.3,2,9
33307,CHEMBL24778,SILODOSIN,105,CHEMBL1983,5-hydroxytryptamine receptor 1D,7.04,7.04,91.69,1,9
33307,CHEMBL24778,SILODOSIN,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.44,6.44,360.04,1,9
33307,CHEMBL24778,SILODOSIN,106,CHEMBL1898,5-hydroxytryptamine receptor 1B,6.43,6.43,372.99,1,9
33307,CHEMBL24778,SILODOSIN,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,6.32,6.32,480.34,1,9
33307,CHEMBL24778,SILODOSIN,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.17,6.03,682.73,2,9
33307,CHEMBL24778,SILODOSIN,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.11,6.11,786.05,1,9
33307,CHEMBL24778,SILODOSIN,72,CHEMBL217,D(2) dopamine receptor,6.0,6.0,989.13,1,9
33307,CHEMBL24778,SILODOSIN,90,CHEMBL219,D(4) dopamine receptor,5.8,5.8,1578.34,1,9
33307,CHEMBL24778,SILODOSIN,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.68,5.68,2091.7,1,9
411854,CHEMBL247951,PEMAFIBRATE,163,CHEMBL239,Peroxisome proliferator-activated receptor alpha,9.0,9.0,1.0,3,9
411854,CHEMBL247951,PEMAFIBRATE,133,CHEMBL235,Peroxisome proliferator-activated receptor gamma,5.96,5.87,1100.0,2,9
411854,CHEMBL247951,PEMAFIBRATE,12227,CHEMBL3979,Peroxisome proliferator-activated receptor delta,5.8,5.8,1580.0,1,9
33576,CHEMBL24828,VANDETANIB,11752,CHEMBL1955,Vascular endothelial growth factor receptor 3,9.96,7.01,0.11,5,9
33576,CHEMBL24828,VANDETANIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,9.89,7.22,0.13,23,9
33576,CHEMBL24828,VANDETANIB,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,9.1,7.38,0.79,6,9
33576,CHEMBL24828,VANDETANIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,8.4,7.16,4.0,53,9
33576,CHEMBL24828,VANDETANIB,20025,CHEMBL5014,Receptor-interacting serine/threonine-protein kinase 2,8.34,7.83,4.6,4,9
33576,CHEMBL24828,VANDETANIB,9,CHEMBL203,Epidermal growth factor receptor,8.32,7.32,4.8,48,9
33576,CHEMBL24828,VANDETANIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,8.05,7.11,9.0,33,9
33576,CHEMBL24828,VANDETANIB,100917,CHEMBL5319,Epithelial discoidin domain-containing receptor 1,7.96,7.26,11.0,3,9
33576,CHEMBL24828,VANDETANIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,7.77,7.13,17.0,5,9
33576,CHEMBL24828,VANDETANIB,10979,CHEMBL1868,Vascular endothelial growth factor receptor 1,7.66,6.73,22.0,12,9
33576,CHEMBL24828,VANDETANIB,30026,CHEMBL4601,Protein-tyrosine kinase 6,7.48,6.75,33.0,4,9
33576,CHEMBL24828,VANDETANIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,7.47,6.46,34.0,17,9
33576,CHEMBL24828,VANDETANIB,10371,CHEMBL4948,Dual specificity mitogen-activated protein kinase kinase 5,7.31,7.31,49.0,1,8
33576,CHEMBL24828,VANDETANIB,30046,CHEMBL4526,Ephrin type-A receptor 6,7.3,7.26,50.0,3,9
33576,CHEMBL24828,VANDETANIB,101270,CHEMBL5651,Serine/threonine-protein kinase 35,7.25,7.25,56.0,1,8
33576,CHEMBL24828,VANDETANIB,100912,CHEMBL5314,Tyrosine-protein kinase receptor TYRO3,7.2,7.07,63.1,4,9
33576,CHEMBL24828,VANDETANIB,11691,CHEMBL2250,Tyrosine-protein kinase Blk,7.18,7.18,66.0,2,9
33576,CHEMBL24828,VANDETANIB,11209,CHEMBL4014,Tyrosine-protein kinase ABL2,7.16,7.07,69.0,3,9
33576,CHEMBL24828,VANDETANIB,19639,CHEMBL3778,Interleukin-1 receptor-associated kinase 4,7.12,7.12,75.0,1,8
33576,CHEMBL24828,VANDETANIB,102676,CHEMBL5836,Ephrin type-B receptor 6,7.12,7.12,76.0,1,8
33576,CHEMBL24828,VANDETANIB,30006,CHEMBL3981,Serine/threonine-protein kinase 10,7.09,6.49,81.0,5,9
33576,CHEMBL24828,VANDETANIB,20020,CHEMBL4355,Cyclin-G-associated kinase,7.07,6.92,86.0,4,9
33576,CHEMBL24828,VANDETANIB,197,CHEMBL1913,Platelet-derived growth factor receptor beta,7.06,6.42,88.0,7,9
33576,CHEMBL24828,VANDETANIB,30010,CHEMBL4134,Ephrin type-A receptor 8,7.04,6.96,91.0,3,9
33576,CHEMBL24828,VANDETANIB,30035,CHEMBL4202,STE20-like serine/threonine-protein kinase,7.02,7.02,95.0,3,9
33576,CHEMBL24828,VANDETANIB,11149,CHEMBL2973,Rho-associated protein kinase 2,7.0,7.0,100.0,1,8
33576,CHEMBL24828,VANDETANIB,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,6.96,6.69,110.0,3,9
33576,CHEMBL24828,VANDETANIB,18033,CHEMBL2073,Tyrosine-protein kinase Yes,6.92,6.8,120.0,3,9
33576,CHEMBL24828,VANDETANIB,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,6.85,6.0,140.0,3,9
33576,CHEMBL24828,VANDETANIB,101598,CHEMBL5903,Activin receptor type-1,6.82,6.78,150.0,3,9
33576,CHEMBL24828,VANDETANIB,12627,CHEMBL2007,Platelet-derived growth factor receptor alpha,6.8,6.69,158.49,3,9
33576,CHEMBL24828,VANDETANIB,101464,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,6.8,6.17,158.49,3,9
33576,CHEMBL24828,VANDETANIB,102678,CHEMBL5838,Receptor tyrosine-protein kinase erbB-3,6.8,6.8,160.0,1,8
33576,CHEMBL24828,VANDETANIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,6.77,6.54,170.0,4,9
33576,CHEMBL24828,VANDETANIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,6.72,6.05,190.0,13,9
33576,CHEMBL24828,VANDETANIB,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,6.7,6.7,200.0,1,9
33576,CHEMBL24828,VANDETANIB,101340,CHEMBL5810,Ephrin type-A receptor 1,6.64,6.64,230.0,2,9
33576,CHEMBL24828,VANDETANIB,10939,CHEMBL4924,Ribosomal protein S6 kinase alpha-6,6.62,6.62,240.0,2,9
33576,CHEMBL24828,VANDETANIB,11926,CHEMBL2742,Fibroblast growth factor receptor 3,6.62,6.07,240.0,3,9
33576,CHEMBL24828,VANDETANIB,30019,CHEMBL3987,Ephrin type-A receptor 5,6.62,6.58,240.0,3,9
33576,CHEMBL24828,VANDETANIB,101204,CHEMBL5476,Bone morphogenetic protein receptor type-1B,6.62,6.62,240.0,1,8
33576,CHEMBL24828,VANDETANIB,100410,CHEMBL4895,Tyrosine-protein kinase receptor UFO,6.6,6.6,250.0,4,9
33576,CHEMBL24828,VANDETANIB,100127,CHEMBL4454,Tyrosine-protein kinase Fgr,6.57,6.27,270.0,3,9
33576,CHEMBL24828,VANDETANIB,127,CHEMBL231,Histamine H1 receptor,6.55,6.21,282.8,2,8
33576,CHEMBL24828,VANDETANIB,30020,CHEMBL5072,Ephrin type-B receptor 1,6.54,6.45,290.0,3,9
33576,CHEMBL24828,VANDETANIB,30049,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,6.5,6.37,316.23,4,9
33576,CHEMBL24828,VANDETANIB,101079,CHEMBL5122,Discoidin domain-containing receptor 2,6.5,6.5,320.0,2,9
33576,CHEMBL24828,VANDETANIB,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.45,6.45,354.1,1,8
33576,CHEMBL24828,VANDETANIB,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,6.44,6.36,360.0,3,9
33576,CHEMBL24828,VANDETANIB,11785,CHEMBL3234,Tyrosine-protein kinase HCK,6.44,6.44,360.0,2,9
33576,CHEMBL24828,VANDETANIB,100835,CHEMBL4718,MAP kinase-interacting serine/threonine-protein kinase 1,6.44,6.44,360.0,2,9
33576,CHEMBL24828,VANDETANIB,10929,CHEMBL2553,Ribosomal protein S6 kinase alpha-1,6.4,6.4,400.0,2,9
33576,CHEMBL24828,VANDETANIB,101484,CHEMBL5627,Leukocyte tyrosine kinase receptor,6.4,6.31,398.11,3,9
33576,CHEMBL24828,VANDETANIB,101504,CHEMBL5699,Serine/threonine-protein kinase SIK2,6.37,6.37,430.0,2,9
33576,CHEMBL24828,VANDETANIB,11569,CHEMBL3290,Ephrin type-B receptor 2,6.36,6.36,440.0,2,9
33576,CHEMBL24828,VANDETANIB,100909,CHEMBL5311,Activin receptor type-1-like,6.33,6.33,470.0,2,9
33576,CHEMBL24828,VANDETANIB,12699,CHEMBL3009,Receptor tyrosine-protein kinase erbB-4,6.32,6.32,480.0,1,8
33576,CHEMBL24828,VANDETANIB,100129,CHEMBL5147,Ephrin type-B receptor 4,6.28,6.05,520.0,3,9
33576,CHEMBL24828,VANDETANIB,10266,CHEMBL3650,Fibroblast growth factor receptor 1,6.25,5.96,560.0,4,9
33576,CHEMBL24828,VANDETANIB,12913,CHEMBL4128,Angiopoietin-1 receptor,6.25,5.96,567.0,4,9
33576,CHEMBL24828,VANDETANIB,30003,CHEMBL3788,Serine/threonine-protein kinase PLK4,6.21,6.08,620.0,3,9
33576,CHEMBL24828,VANDETANIB,101434,CHEMBL6083,Receptor-interacting serine/threonine-protein kinase 4,6.21,6.21,620.0,1,8
33576,CHEMBL24828,VANDETANIB,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.17,6.17,682.3,1,8
33576,CHEMBL24828,VANDETANIB,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.07,6.07,855.6,1,8
33576,CHEMBL24828,VANDETANIB,100128,CHEMBL5146,Breakpoint cluster region protein,6.06,6.06,879.0,1,9
33576,CHEMBL24828,VANDETANIB,102799,CHEMBL6191,Mitogen-activated protein kinase kinase kinase 19,6.01,6.01,980.0,1,8
33576,CHEMBL24828,VANDETANIB,11409,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,6.0,5.83,1000.0,3,9
33576,CHEMBL24828,VANDETANIB,10264,CHEMBL4142,Fibroblast growth factor receptor 2,5.96,5.96,1100.0,2,9
33576,CHEMBL24828,VANDETANIB,11046,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,5.96,5.91,1100.0,3,9
33576,CHEMBL24828,VANDETANIB,11361,CHEMBL4004,"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",5.96,5.96,1100.0,2,9
33576,CHEMBL24828,VANDETANIB,30008,CHEMBL2068,Ephrin type-A receptor 2,5.96,5.88,1100.0,3,9
33576,CHEMBL24828,VANDETANIB,12840,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,5.92,5.88,1200.0,3,9
33576,CHEMBL24828,VANDETANIB,19623,CHEMBL3357,Interleukin-1 receptor-associated kinase 1,5.92,5.92,1200.0,1,8
33576,CHEMBL24828,VANDETANIB,100097,CHEMBL5251,Tyrosine-protein kinase BTK,5.9,5.83,1258.93,2,8
33576,CHEMBL24828,VANDETANIB,100948,CHEMBL5331,Tyrosine-protein kinase Mer,5.85,5.85,1400.0,3,9
33576,CHEMBL24828,VANDETANIB,101410,CHEMBL6005,Serine/threonine-protein kinase 33,5.85,5.85,1400.0,2,9
33576,CHEMBL24828,VANDETANIB,10967,CHEMBL4937,Casein kinase I isoform epsilon,5.82,5.62,1500.0,3,9
33576,CHEMBL24828,VANDETANIB,20171,CHEMBL3935,Aurora kinase C,5.82,5.82,1500.0,2,9
33576,CHEMBL24828,VANDETANIB,100906,CHEMBL5274,Tyrosine-protein kinase receptor Tie-1,5.82,5.82,1500.0,2,9
33576,CHEMBL24828,VANDETANIB,101078,CHEMBL5121,Mitogen-activated protein kinase 6,5.82,5.82,1500.0,2,9
33576,CHEMBL24828,VANDETANIB,101188,CHEMBL5432,Mitogen-activated protein kinase kinase kinase kinase 3,5.82,5.82,1500.0,2,9
33576,CHEMBL24828,VANDETANIB,12944,CHEMBL4501,Ribosomal protein S6 kinase beta-1,5.8,5.8,1600.0,1,8
33576,CHEMBL24828,VANDETANIB,30021,CHEMBL3988,Ephrin type-A receptor 4,5.8,5.8,1600.0,2,9
33576,CHEMBL24828,VANDETANIB,100417,CHEMBL4247,ALK tyrosine kinase receptor,5.8,5.72,1584.89,3,9
33576,CHEMBL24828,VANDETANIB,100947,CHEMBL5330,Mitogen-activated protein kinase kinase kinase kinase 2,5.8,5.8,1600.0,1,8
33576,CHEMBL24828,VANDETANIB,30037,CHEMBL4204,MAP kinase-interacting serine/threonine-protein kinase 2,5.77,5.77,1700.0,2,9
33576,CHEMBL24828,VANDETANIB,101316,CHEMBL5753,"Atypical kinase COQ8B, mitochondrial",5.77,5.77,1700.0,2,9
33576,CHEMBL24828,VANDETANIB,30009,CHEMBL4954,Ephrin type-A receptor 3,5.75,5.72,1800.0,3,9
33576,CHEMBL24828,VANDETANIB,101239,CHEMBL5579,Citron Rho-interacting kinase,5.75,5.75,1800.0,2,9
33576,CHEMBL24828,VANDETANIB,101433,CHEMBL6082,Serine/threonine-protein kinase SIK1,5.72,5.72,1900.0,2,9
33576,CHEMBL24828,VANDETANIB,101508,CHEMBL5703,Tyrosine-protein kinase Srms,5.72,5.72,1900.0,2,9
33576,CHEMBL24828,VANDETANIB,103154,CHEMBL1075104,Leucine-rich repeat serine/threonine-protein kinase 2,5.7,5.7,1995.26,1,8
33576,CHEMBL24828,VANDETANIB,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.68,5.68,2100.0,1,8
33576,CHEMBL24828,VANDETANIB,10280,CHEMBL264,Histamine H3 receptor,5.68,5.68,2100.0,1,8
33576,CHEMBL24828,VANDETANIB,101041,CHEMBL5615,Serine/threonine-protein kinase MRCK gamma,5.66,5.66,2200.0,2,9
33576,CHEMBL24828,VANDETANIB,11925,CHEMBL3973,Fibroblast growth factor receptor 4,5.64,5.64,2300.0,1,8
33576,CHEMBL24828,VANDETANIB,30047,CHEMBL4527,TRAF2 and NCK-interacting protein kinase,5.64,5.64,2300.0,2,9
33576,CHEMBL24828,VANDETANIB,30027,CHEMBL4602,Ephrin type-A receptor 7,5.62,5.62,2400.0,2,9
33576,CHEMBL24828,VANDETANIB,10188,CHEMBL260,Mitogen-activated protein kinase 14,5.6,5.6,2511.89,1,8
33576,CHEMBL24828,VANDETANIB,10781,CHEMBL2185,Aurora kinase B,5.6,5.6,2511.89,1,8
33576,CHEMBL24828,VANDETANIB,10844,CHEMBL2634,Tyrosine-protein kinase CSK,5.6,5.6,2500.0,2,9
33576,CHEMBL24828,VANDETANIB,101053,CHEMBL5052,Serine/threonine-protein kinase MRCK beta,5.6,5.6,2500.0,2,9
33576,CHEMBL24828,VANDETANIB,100845,CHEMBL4516,Serine/threonine-protein kinase MRCK alpha,5.58,5.58,2600.0,2,9
33576,CHEMBL24828,VANDETANIB,101130,CHEMBL5260,Serine/threonine-protein kinase TNNI3K,5.55,5.55,2800.0,2,9
33576,CHEMBL24828,VANDETANIB,11364,CHEMBL4045,5'-AMP-activated protein kinase catalytic subunit alpha-1,5.52,5.52,3000.0,1,8
33576,CHEMBL24828,VANDETANIB,30050,CHEMBL4853,Mitogen-activated protein kinase kinase kinase 4,5.52,5.52,3000.0,1,8
421350,CHEMBL248702,DEXFENFLURAMINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.66,6.47,217.0,2,8
27105,CHEMBL24944,TRIBROMSALAN,11638,CHEMBL4040,Mitogen-activated protein kinase 1,6.21,6.21,623.0,1,8
27105,CHEMBL24944,TRIBROMSALAN,10188,CHEMBL260,Mitogen-activated protein kinase 14,6.15,6.15,715.0,1,8
27105,CHEMBL24944,TRIBROMSALAN,12594,CHEMBL3356,Cytochrome P450 1A2,5.7,5.7,2000.0,1,8
27105,CHEMBL24944,TRIBROMSALAN,12911,CHEMBL3397,Cytochrome P450 2C9,5.7,5.7,2000.0,1,8
27105,CHEMBL24944,TRIBROMSALAN,96,CHEMBL221,Prostaglandin G/H synthase 1,5.68,5.68,2065.0,1,9
27105,CHEMBL24944,TRIBROMSALAN,9,CHEMBL203,Epidermal growth factor receptor,5.53,5.53,2987.0,1,8
1280,CHEMBL25,ASPIRIN,119104,CHEMBL4523354,Nicotinate phosphoribosyltransferase,9.3,9.3,0.5,1,9
1280,CHEMBL25,ASPIRIN,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.55,8.55,2.8,2,9
1280,CHEMBL25,ASPIRIN,78,CHEMBL1963,Thyrotropin receptor,7.3,7.3,50.1,2,9
1280,CHEMBL25,ASPIRIN,96,CHEMBL221,Prostaglandin G/H synthase 1,6.46,6.12,350.0,2,9
1280,CHEMBL25,ASPIRIN,126,CHEMBL230,Prostaglandin G/H synthase 2,5.62,5.62,2400.0,8,9
33589,CHEMBL25202,TAMIBAROTENE,57,CHEMBL2055,Retinoic acid receptor alpha,8.19,7.49,6.5,4,9
33589,CHEMBL25202,TAMIBAROTENE,270,CHEMBL2008,Retinoic acid receptor beta,7.52,6.95,30.0,3,9
33589,CHEMBL25202,TAMIBAROTENE,240,CHEMBL2003,Retinoic acid receptor gamma,6.23,6.22,591.0,2,9
33589,CHEMBL25202,TAMIBAROTENE,100283,CHEMBL5019,Flavin reductase (NADPH),5.86,5.86,1380.0,2,9
418736,CHEMBL252556,IDEBENONE,12912,CHEMBL3622,Cytochrome P450 2C19,6.1,6.1,800.0,1,8
418736,CHEMBL252556,IDEBENONE,11365,CHEMBL289,Cytochrome P450 2D6,5.52,5.52,3000.0,1,8
419508,CHEMBL254219,DIGITOXIN,20053,CHEMBL4096,Cellular tumor antigen p53,7.5,7.5,31.6,1,9
419508,CHEMBL254219,DIGITOXIN,104631,CHEMBL2073690,Solute carrier organic anion transporter family member 4C1,6.92,6.92,120.0,1,8
419508,CHEMBL254219,DIGITOXIN,103727,CHEMBL1293294,Ras-related protein Rab-9A,6.65,6.65,223.9,1,9
419508,CHEMBL254219,DIGITOXIN,103710,CHEMBL1293277,NPC intracellular cholesterol transporter 1,6.6,6.6,251.2,1,9
419508,CHEMBL254219,DIGITOXIN,11472,CHEMBL4026,Signal transducer and activator of transcription 3,6.16,6.16,700.0,1,9
419508,CHEMBL254219,DIGITOXIN,103668,CHEMBL1293235,Prelamin-A/C,6.15,6.05,707.9,2,9
422253,CHEMBL254316,RALTEGRAVIR,10547,CHEMBL2413,C-C chemokine receptor type 1,8.3,8.3,5.0,1,8
418438,CHEMBL254857,FIPEXIDE,11365,CHEMBL289,Cytochrome P450 2D6,6.7,6.7,199.5,2,9
418438,CHEMBL254857,FIPEXIDE,17045,CHEMBL340,Cytochrome P450 3A4,6.2,6.2,630.96,3,9
418485,CHEMBL255044,FLUPIRTINE,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,7.55,7.55,28.2,2,9
418485,CHEMBL255044,FLUPIRTINE,117992,CHEMBL4295747,"Serine hydroxymethyltransferase, mitochondrial",6.03,6.03,933.25,1,9
418485,CHEMBL255044,FLUPIRTINE,126,CHEMBL230,Prostaglandin G/H synthase 2,5.64,5.64,2300.0,1,8
418485,CHEMBL255044,FLUPIRTINE,19,CHEMBL206,Estrogen receptor,5.52,5.52,3000.0,1,8
426660,CHEMBL255863,NILOTINIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,9.06,7.6,0.87,67,9
426660,CHEMBL255863,NILOTINIB,100917,CHEMBL5319,Epithelial discoidin domain-containing receptor 1,8.96,7.84,1.1,5,9
426660,CHEMBL255863,NILOTINIB,101079,CHEMBL5122,Discoidin domain-containing receptor 2,8.7,7.65,2.0,10,9
426660,CHEMBL255863,NILOTINIB,15,CHEMBL205,Carbonic anhydrase 2,8.39,8.39,4.1,1,9
426660,CHEMBL255863,NILOTINIB,20007,CHEMBL3886,Mitogen-activated protein kinase kinase kinase 20,7.96,6.97,11.0,2,9
426660,CHEMBL255863,NILOTINIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,7.83,7.04,14.7,13,9
426660,CHEMBL255863,NILOTINIB,197,CHEMBL1913,Platelet-derived growth factor receptor beta,7.8,7.38,16.0,5,9
426660,CHEMBL255863,NILOTINIB,100104,CHEMBL5247,Integrin-linked protein kinase,7.7,7.7,20.0,1,9
426660,CHEMBL255863,NILOTINIB,11209,CHEMBL4014,Tyrosine-protein kinase ABL2,7.58,7.06,26.0,2,9
426660,CHEMBL255863,NILOTINIB,10193,CHEMBL261,Carbonic anhydrase 1,7.53,7.53,29.3,1,9
426660,CHEMBL255863,NILOTINIB,10120,CHEMBL3961,Mitogen-activated protein kinase 11,7.44,7.44,36.0,1,8
426660,CHEMBL255863,NILOTINIB,30010,CHEMBL4134,Ephrin type-A receptor 8,7.43,7.43,37.0,1,8
426660,CHEMBL255863,NILOTINIB,12952,CHEMBL3594,Carbonic anhydrase 9,7.38,7.38,41.9,1,9
426660,CHEMBL255863,NILOTINIB,12840,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,7.35,6.76,45.0,2,8
426660,CHEMBL255863,NILOTINIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,7.33,7.15,47.0,2,9
426660,CHEMBL255863,NILOTINIB,12627,CHEMBL2007,Platelet-derived growth factor receptor alpha,7.15,7.01,71.0,3,9
426660,CHEMBL255863,NILOTINIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,7.07,6.66,86.0,2,9
426660,CHEMBL255863,NILOTINIB,11060,CHEMBL2326,Carbonic anhydrase 7,7.0,7.0,99.0,1,9
426660,CHEMBL255863,NILOTINIB,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,7.0,6.23,100.0,3,9
426660,CHEMBL255863,NILOTINIB,30009,CHEMBL4954,Ephrin type-A receptor 3,6.96,6.96,110.0,1,8
426660,CHEMBL255863,NILOTINIB,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.9,6.3,125.89,3,9
426660,CHEMBL255863,NILOTINIB,10371,CHEMBL4948,Dual specificity mitogen-activated protein kinase kinase 5,6.72,6.72,190.0,1,8
426660,CHEMBL255863,NILOTINIB,11063,CHEMBL3510,Carbonic anhydrase 14,6.65,6.65,223.0,1,9
426660,CHEMBL255863,NILOTINIB,30008,CHEMBL2068,Ephrin type-A receptor 2,6.64,6.38,230.0,2,9
426660,CHEMBL255863,NILOTINIB,12209,CHEMBL3242,Carbonic anhydrase 12,6.52,6.52,302.0,1,9
426660,CHEMBL255863,NILOTINIB,100127,CHEMBL4454,Tyrosine-protein kinase Fgr,6.5,6.5,320.0,1,8
426660,CHEMBL255863,NILOTINIB,12735,CHEMBL2349,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",6.48,6.48,331.0,1,9
426660,CHEMBL255863,NILOTINIB,30021,CHEMBL3988,Ephrin type-A receptor 4,6.48,6.48,330.0,1,8
426660,CHEMBL255863,NILOTINIB,101130,CHEMBL5260,Serine/threonine-protein kinase TNNI3K,6.44,6.44,360.0,1,8
426660,CHEMBL255863,NILOTINIB,10170,CHEMBL3959,Ribosyldihydronicotinamide dehydrogenase [quinone],6.42,6.11,380.0,4,9
426660,CHEMBL255863,NILOTINIB,11785,CHEMBL3234,Tyrosine-protein kinase HCK,6.41,6.41,390.0,1,8
426660,CHEMBL255863,NILOTINIB,10139,CHEMBL2885,Carbonic anhydrase 3,6.35,6.35,443.0,1,9
426660,CHEMBL255863,NILOTINIB,12261,CHEMBL2276,Mitogen-activated protein kinase 8,6.35,6.35,450.0,1,8
426660,CHEMBL255863,NILOTINIB,12896,CHEMBL3729,Carbonic anhydrase 4,6.35,6.35,446.0,1,9
426660,CHEMBL255863,NILOTINIB,10186,CHEMBL3025,Carbonic anhydrase 6,6.34,6.34,461.0,1,9
426660,CHEMBL255863,NILOTINIB,10188,CHEMBL260,Mitogen-activated protein kinase 14,6.34,6.24,460.0,3,9
426660,CHEMBL255863,NILOTINIB,100413,CHEMBL4898,BDNF/NT-3 growth factors receptor,6.31,6.31,490.0,1,8
426660,CHEMBL255863,NILOTINIB,11691,CHEMBL2250,Tyrosine-protein kinase Blk,6.3,6.3,500.0,1,8
426660,CHEMBL255863,NILOTINIB,102676,CHEMBL5836,Ephrin type-B receptor 6,6.3,6.3,500.0,1,8
426660,CHEMBL255863,NILOTINIB,104614,CHEMBL2073673,Solute carrier family 22 member 3,6.3,6.3,500.0,1,9
426660,CHEMBL255863,NILOTINIB,17045,CHEMBL340,Cytochrome P450 3A4,6.24,6.24,580.0,1,9
426660,CHEMBL255863,NILOTINIB,100126,CHEMBL5145,Serine/threonine-protein kinase B-raf,6.24,6.0,570.0,2,8
426660,CHEMBL255863,NILOTINIB,101340,CHEMBL5810,Ephrin type-A receptor 1,6.23,6.23,590.0,1,8
426660,CHEMBL255863,NILOTINIB,101034,CHEMBL5608,NT-3 growth factor receptor,6.22,6.22,600.0,1,8
426660,CHEMBL255863,NILOTINIB,11569,CHEMBL3290,Ephrin type-B receptor 2,6.19,6.19,640.0,1,8
426660,CHEMBL255863,NILOTINIB,30046,CHEMBL4526,Ephrin type-A receptor 6,6.19,6.19,640.0,1,8
426660,CHEMBL255863,NILOTINIB,100128,CHEMBL5146,Breakpoint cluster region protein,6.19,6.19,651.0,1,9
426660,CHEMBL255863,NILOTINIB,100129,CHEMBL5147,Ephrin type-B receptor 4,6.14,6.14,730.0,1,8
426660,CHEMBL255863,NILOTINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,6.06,6.01,870.0,2,8
426660,CHEMBL255863,NILOTINIB,101312,CHEMBL5749,Mitogen-activated protein kinase kinase kinase kinase 1,6.05,6.05,890.0,1,8
426660,CHEMBL255863,NILOTINIB,101053,CHEMBL5052,Serine/threonine-protein kinase MRCK beta,6.04,6.04,910.0,1,8
426660,CHEMBL255863,NILOTINIB,12913,CHEMBL4128,Angiopoietin-1 receptor,6.0,6.0,1000.0,1,8
426660,CHEMBL255863,NILOTINIB,100416,CHEMBL4901,Ephrin type-B receptor 3,6.0,6.0,1000.0,1,8
426660,CHEMBL255863,NILOTINIB,100906,CHEMBL5274,Tyrosine-protein kinase receptor Tie-1,6.0,6.0,1000.0,1,8
426660,CHEMBL255863,NILOTINIB,10904,CHEMBL1906,RAF proto-oncogene serine/threonine-protein kinase,5.96,5.96,1100.0,1,8
426660,CHEMBL255863,NILOTINIB,18033,CHEMBL2073,Tyrosine-protein kinase Yes,5.96,5.96,1100.0,1,8
426660,CHEMBL255863,NILOTINIB,30020,CHEMBL5072,Ephrin type-B receptor 1,5.89,5.89,1300.0,1,8
426660,CHEMBL255863,NILOTINIB,104279,CHEMBL1795199,Receptor-interacting serine/threonine-protein kinase 3,5.89,5.89,1274.0,1,9
426660,CHEMBL255863,NILOTINIB,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,5.8,5.8,1600.0,1,8
426660,CHEMBL255863,NILOTINIB,101506,CHEMBL5701,Serine/threonine-protein kinase TAO3,5.77,5.77,1700.0,1,8
426660,CHEMBL255863,NILOTINIB,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,5.72,5.72,1900.0,2,9
426660,CHEMBL255863,NILOTINIB,30019,CHEMBL3987,Ephrin type-A receptor 5,5.72,5.72,1900.0,1,8
426660,CHEMBL255863,NILOTINIB,11408,CHEMBL2637,Mitogen-activated protein kinase 10,5.7,5.7,2000.0,1,8
426660,CHEMBL255863,NILOTINIB,30013,CHEMBL4224,Dual specificity protein kinase CLK1,5.68,5.68,2100.0,2,9
426660,CHEMBL255863,NILOTINIB,10844,CHEMBL2634,Tyrosine-protein kinase CSK,5.62,5.62,2400.0,1,8
426660,CHEMBL255863,NILOTINIB,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,5.6,5.6,2500.0,1,9
426660,CHEMBL255863,NILOTINIB,175,CHEMBL1997,Equilibrative nucleoside transporter 1,5.58,5.58,2618.0,1,8
426660,CHEMBL255863,NILOTINIB,280,CHEMBL256,Adenosine receptor A3,5.5,5.5,3201.3,1,8
425650,CHEMBL256087,MENTHOL,103167,CHEMBL1075319,Transient receptor potential cation channel subfamily M member 8,5.52,5.52,3000.0,1,9
437583,CHEMBL256907,MARAVIROC,10580,CHEMBL274,C-C chemokine receptor type 5,9.7,8.77,0.2,23,9
437583,CHEMBL256907,MARAVIROC,129,CHEMBL233,Mu-type opioid receptor,6.71,6.71,196.2,1,8
437583,CHEMBL256907,MARAVIROC,17045,CHEMBL340,Cytochrome P450 3A4,5.51,5.51,3100.0,1,9
426110,CHEMBL256997,ATALUREN,100283,CHEMBL5019,Flavin reductase (NADPH),6.7,6.7,199.53,2,9
426110,CHEMBL256997,ATALUREN,11307,CHEMBL1865,Histone deacetylase 6,6.52,6.52,300.9,1,9
427379,CHEMBL259209,MILNACIPRAN,100,CHEMBL222,Sodium-dependent noradrenaline transporter,9.1,7.34,0.7943,7,9
427379,CHEMBL259209,MILNACIPRAN,121,CHEMBL228,Sodium-dependent serotonin transporter,8.19,7.18,6.5,10,9
427379,CHEMBL259209,MILNACIPRAN,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.23,6.23,590.0,1,8
427670,CHEMBL259571,TAPINAROF,10694,CHEMBL3201,Aryl hydrocarbon receptor,7.89,7.67,13.0,3,9
429475,CHEMBL259972,MOFEZOLAC,96,CHEMBL221,Prostaglandin G/H synthase 1,8.85,8.6,1.4,3,9
429475,CHEMBL259972,MOFEZOLAC,126,CHEMBL230,Prostaglandin G/H synthase 2,6.36,6.36,440.0,2,9
431376,CHEMBL260538,ULIPRISTAL ACETATE,36,CHEMBL208,Progesterone receptor,9.7,9.11,0.2,2,9
431376,CHEMBL260538,ULIPRISTAL ACETATE,56,CHEMBL1871,Androgen receptor,7.52,7.52,30.0,1,8
321172,CHEMBL262135,GALLIUM OXODOTREOTIDE,117,CHEMBL1804,Somatostatin receptor type 2,9.7,9.7,0.2,1,9
321172,CHEMBL262135,GALLIUM OXODOTREOTIDE,10183,CHEMBL1853,Somatostatin receptor type 4,6.52,6.52,300.0,1,9
321172,CHEMBL262135,GALLIUM OXODOTREOTIDE,11265,CHEMBL1792,Somatostatin receptor type 5,6.42,6.42,377.0,1,9
70140,CHEMBL262777,VANCOMYCIN,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.3,7.3,50.12,1,9
2451,CHEMBL266349,MELAGATRAN,11,CHEMBL204,Prothrombin,8.92,7.86,1.2,13,9
2451,CHEMBL266349,MELAGATRAN,12,CHEMBL1801,Plasminogen,6.16,5.81,700.0,3,9
2451,CHEMBL266349,MELAGATRAN,11399,CHEMBL1873,Tissue-type plasminogen activator,6.05,5.94,900.0,2,9
2451,CHEMBL266349,MELAGATRAN,12847,CHEMBL4444,Vitamin K-dependent protein C,5.89,5.89,1300.0,1,9
8873,CHEMBL267345,AMPHOTERICIN B,103668,CHEMBL1293235,Prelamin-A/C,7.1,7.1,79.4,1,9
438664,CHEMBL267495,NALFURAFINE,137,CHEMBL237,Kappa-type opioid receptor,10.72,9.33,0.019,9,9
438664,CHEMBL267495,NALFURAFINE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,9.26,9.26,0.55,1,9
438664,CHEMBL267495,NALFURAFINE,11639,CHEMBL3385,Mitogen-activated protein kinase 3,9.26,9.26,0.55,1,9
438664,CHEMBL267495,NALFURAFINE,129,CHEMBL233,Mu-type opioid receptor,9.15,9.14,0.7,2,9
438664,CHEMBL267495,NALFURAFINE,136,CHEMBL236,Delta-type opioid receptor,7.44,7.29,36.5,2,9
438664,CHEMBL267495,NALFURAFINE,10009,CHEMBL5113,Orexin/Hypocretin receptor type 1,7.08,6.43,82.8,2,9
880,CHEMBL267936,MECAMYLAMINE,103134,CHEMBL1075189,Pyruvate kinase PKM,8.0,8.0,10.0,2,9
880,CHEMBL267936,MECAMYLAMINE,10635,CHEMBL2492,Neuronal acetylcholine receptor subunit alpha-7,5.75,5.75,1800.0,1,9
880,CHEMBL267936,MECAMYLAMINE,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,5.5,5.5,3162.3,2,9
2516,CHEMBL268869,SULFAMETHOXYPYRIDAZINE,103668,CHEMBL1293235,Prelamin-A/C,8.46,8.46,3.5,1,9
2516,CHEMBL268869,SULFAMETHOXYPYRIDAZINE,103665,CHEMBL1293232,Survival motor neuron protein,7.35,7.35,44.7,1,9
9953,CHEMBL269644,ACETANILIDE,119104,CHEMBL4523354,Nicotinate phosphoribosyltransferase,9.0,9.0,1.0,1,9
924,CHEMBL269732,TACROLIMUS ANHYDROUS,80,CHEMBL1902,Peptidyl-prolyl cis-trans isomerase FKBP1A,9.7,8.8,0.2,11,9
924,CHEMBL269732,TACROLIMUS ANHYDROUS,10257,CHEMBL2430,Peptidyl-prolyl cis-trans isomerase FKBP1B,9.4,9.12,0.4,2,9
924,CHEMBL269732,TACROLIMUS ANHYDROUS,11400,CHEMBL2842,Serine/threonine-protein kinase mTOR,9.02,8.76,0.95,2,9
924,CHEMBL269732,TACROLIMUS ANHYDROUS,103511,CHEMBL1250378,Splicing factor 3B subunit 3,7.96,7.91,10.9,2,9
924,CHEMBL269732,TACROLIMUS ANHYDROUS,12579,CHEMBL4445,Protein phosphatase 3 catalytic subunit alpha,7.83,7.77,14.8,2,8
924,CHEMBL269732,TACROLIMUS ANHYDROUS,11751,CHEMBL4050,Peptidyl-prolyl cis-trans isomerase FKBP4,7.64,7.23,23.0,2,9
924,CHEMBL269732,TACROLIMUS ANHYDROUS,104573,CHEMBL2052031,Peptidyl-prolyl cis-trans isomerase FKBP5,7.12,7.07,75.93,5,9
924,CHEMBL269732,TACROLIMUS ANHYDROUS,17045,CHEMBL340,Cytochrome P450 3A4,6.92,6.18,120.0,4,9
924,CHEMBL269732,TACROLIMUS ANHYDROUS,12739,CHEMBL3019,Cytochrome P450 3A5,6.85,6.21,140.0,3,9
1370,CHEMBL27,PROPRANOLOL,43,CHEMBL210,Beta-2 adrenergic receptor,10.0,8.87,0.1,15,9
1370,CHEMBL27,PROPRANOLOL,50,CHEMBL213,Beta-1 adrenergic receptor,8.85,8.05,1.4,11,9
1370,CHEMBL27,PROPRANOLOL,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.11,6.54,77.9,3,8
1370,CHEMBL27,PROPRANOLOL,226,CHEMBL246,Beta-3 adrenergic receptor,7.0,6.7,99.0,5,9
1370,CHEMBL27,PROPRANOLOL,121,CHEMBL228,Sodium-dependent serotonin transporter,6.7,6.28,202.0,3,8
1370,CHEMBL27,PROPRANOLOL,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.68,6.6,208.3,3,8
1370,CHEMBL27,PROPRANOLOL,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.38,6.09,419.0,3,8
1370,CHEMBL27,PROPRANOLOL,104473,CHEMBL1961788,Nuclear receptor subfamily 2 group E member 1,6.3,6.3,500.0,1,9
1370,CHEMBL27,PROPRANOLOL,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.92,5.71,1202.0,3,8
1370,CHEMBL27,PROPRANOLOL,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,5.92,5.73,1206.0,2,8
1370,CHEMBL27,PROPRANOLOL,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,5.85,5.68,1423.0,2,8
1370,CHEMBL27,PROPRANOLOL,11365,CHEMBL289,Cytochrome P450 2D6,5.72,5.71,1900.0,2,9
1370,CHEMBL27,PROPRANOLOL,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,5.7,5.69,2000.0,2,9
1370,CHEMBL27,PROPRANOLOL,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.55,5.55,2828.0,1,8
435293,CHEMBL270190,ALVIMOPAN,129,CHEMBL233,Mu-type opioid receptor,9.5,8.89,0.3162,7,9
435293,CHEMBL270190,ALVIMOPAN,136,CHEMBL236,Delta-type opioid receptor,8.3,8.11,5.012,2,9
435293,CHEMBL270190,ALVIMOPAN,137,CHEMBL237,Kappa-type opioid receptor,7.0,7.0,100.0,1,9
438435,CHEMBL271227,ABIRATERONE ACETATE,12949,CHEMBL3522,"Steroid 17-alpha-hydroxylase/17,20 lyase",8.6,7.98,2.5,4,9
438435,CHEMBL271227,ABIRATERONE ACETATE,36,CHEMBL208,Progesterone receptor,5.51,5.51,3100.0,1,8
16225,CHEMBL273575,NOMIFENSINE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,9.0,9.0,1.0,1,9
16225,CHEMBL273575,NOMIFENSINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,8.42,7.39,3.8,7,9
16225,CHEMBL273575,NOMIFENSINE,155,CHEMBL238,Sodium-dependent dopamine transporter,8.0,7.23,10.0,13,9
16225,CHEMBL273575,NOMIFENSINE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.06,5.83,874.0,6,9
16225,CHEMBL273575,NOMIFENSINE,129,CHEMBL233,Mu-type opioid receptor,5.85,5.85,1400.0,1,8
16580,CHEMBL276520,INDALPINE,121,CHEMBL228,Sodium-dependent serotonin transporter,7.52,7.52,30.0,1,8
8788,CHEMBL276832,HYDRALAZINE,103689,CHEMBL1293256,Thrombopoietin,7.4,7.4,39.8,2,9
8788,CHEMBL276832,HYDRALAZINE,117353,CHEMBL4105748,Peroxisomal acyl-coenzyme A oxidase 1,6.38,6.38,420.0,1,9
8788,CHEMBL276832,HYDRALAZINE,10567,CHEMBL2439,Myeloperoxidase,6.05,5.95,900.0,4,9
8788,CHEMBL276832,HYDRALAZINE,12594,CHEMBL3356,Cytochrome P450 1A2,6.0,5.75,1000.0,2,8
8788,CHEMBL276832,HYDRALAZINE,20053,CHEMBL4096,Cellular tumor antigen p53,5.8,5.67,1584.9,3,9
8788,CHEMBL276832,HYDRALAZINE,103727,CHEMBL1293294,Ras-related protein Rab-9A,5.64,5.64,2310.9,1,9
8788,CHEMBL276832,HYDRALAZINE,103710,CHEMBL1293277,NPC intracellular cholesterol transporter 1,5.59,5.59,2592.9,1,9
8788,CHEMBL276832,HYDRALAZINE,103668,CHEMBL1293235,Prelamin-A/C,5.5,5.5,3162.3,1,9
14126,CHEMBL278020,NEOSTIGMINE,93,CHEMBL220,Acetylcholinesterase,7.06,6.57,87.3,3,9
22393,CHEMBL278623,MACIMORELIN,11536,CHEMBL4616,Growth hormone secretagogue receptor type 1,7.64,7.28,22.9,2,8
22393,CHEMBL278623,MACIMORELIN,129,CHEMBL233,Mu-type opioid receptor,6.12,6.12,750.0,1,8
33583,CHEMBL278819,MINAPRINE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,7.95,7.95,11.2,1,9
33583,CHEMBL278819,MINAPRINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.86,5.86,1395.8,1,8
22572,CHEMBL282052,METHAQUALONE,103668,CHEMBL1293235,Prelamin-A/C,6.5,6.5,316.2,1,9
23417,CHEMBL282724,SITAXENTAN,249,CHEMBL252,Endothelin-1 receptor,9.37,9.02,0.43,6,9
50290,CHEMBL284092,GEPIRONE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.89,7.19,13.0,5,9
50290,CHEMBL284092,GEPIRONE,72,CHEMBL217,D(2) dopamine receptor,7.24,7.24,58.0,1,9
31289,CHEMBL284348,DALFAMPRIDINE,11365,CHEMBL289,Cytochrome P450 2D6,7.2,7.2,63.1,2,9
31289,CHEMBL284348,DALFAMPRIDINE,78,CHEMBL1963,Thyrotropin receptor,6.9,6.9,125.9,1,9
31289,CHEMBL284348,DALFAMPRIDINE,103668,CHEMBL1293235,Prelamin-A/C,6.05,6.05,891.3,1,9
31289,CHEMBL284348,DALFAMPRIDINE,103665,CHEMBL1293232,Survival motor neuron protein,6.0,6.0,1000.0,1,9
62111,CHEMBL288441,BOSUTINIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,10.54,9.21,0.029,26,9
62111,CHEMBL288441,BOSUTINIB,30049,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,9.52,8.87,0.3,3,9
62111,CHEMBL288441,BOSUTINIB,18033,CHEMBL2073,Tyrosine-protein kinase Yes,9.4,8.19,0.4,3,9
62111,CHEMBL288441,BOSUTINIB,11209,CHEMBL4014,Tyrosine-protein kinase ABL2,9.3,8.61,0.5,3,9
62111,CHEMBL288441,BOSUTINIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,9.23,8.53,0.59,3,9
62111,CHEMBL288441,BOSUTINIB,102678,CHEMBL5838,Receptor tyrosine-protein kinase erbB-3,9.11,9.11,0.77,1,8
62111,CHEMBL288441,BOSUTINIB,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,9.0,8.27,1.0,43,9
62111,CHEMBL288441,BOSUTINIB,11409,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,9.0,8.36,1.0,2,9
62111,CHEMBL288441,BOSUTINIB,30016,CHEMBL3834,Cytoplasmic tyrosine-protein kinase BMX,9.0,7.93,1.0,3,9
62111,CHEMBL288441,BOSUTINIB,100127,CHEMBL4454,Tyrosine-protein kinase Fgr,8.96,8.58,1.1,2,8
62111,CHEMBL288441,BOSUTINIB,20020,CHEMBL4355,Cyclin-G-associated kinase,8.89,8.51,1.3,4,9
62111,CHEMBL288441,BOSUTINIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,8.85,8.36,1.4,3,9
62111,CHEMBL288441,BOSUTINIB,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,8.74,7.25,1.8,5,9
62111,CHEMBL288441,BOSUTINIB,101270,CHEMBL5651,Serine/threonine-protein kinase 35,8.7,8.7,2.0,1,8
62111,CHEMBL288441,BOSUTINIB,100097,CHEMBL5251,Tyrosine-protein kinase BTK,8.6,8.17,2.5,3,9
62111,CHEMBL288441,BOSUTINIB,30023,CHEMBL4599,Activated CDC42 kinase 1,8.57,8.02,2.7,5,9
62111,CHEMBL288441,BOSUTINIB,100128,CHEMBL5146,Breakpoint cluster region protein,8.52,8.52,3.0,1,9
62111,CHEMBL288441,BOSUTINIB,100947,CHEMBL5330,Mitogen-activated protein kinase kinase kinase kinase 2,8.51,7.87,3.1,3,9
62111,CHEMBL288441,BOSUTINIB,11785,CHEMBL3234,Tyrosine-protein kinase HCK,8.49,8.08,3.2,4,9
62111,CHEMBL288441,BOSUTINIB,101220,CHEMBL5518,Misshapen-like kinase 1,8.49,8.07,3.2,2,8
62111,CHEMBL288441,BOSUTINIB,11691,CHEMBL2250,Tyrosine-protein kinase Blk,8.48,8.48,3.3,1,8
62111,CHEMBL288441,BOSUTINIB,101056,CHEMBL5082,Serine/threonine-protein kinase 24,8.41,7.48,3.9,3,9
62111,CHEMBL288441,BOSUTINIB,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,8.38,7.95,4.2,4,9
62111,CHEMBL288441,BOSUTINIB,30035,CHEMBL4202,STE20-like serine/threonine-protein kinase,8.33,7.2,4.7,2,9
62111,CHEMBL288441,BOSUTINIB,101188,CHEMBL5432,Mitogen-activated protein kinase kinase kinase kinase 3,8.29,7.94,5.1,3,9
62111,CHEMBL288441,BOSUTINIB,100129,CHEMBL5147,Ephrin type-B receptor 4,8.26,7.77,5.5,3,9
62111,CHEMBL288441,BOSUTINIB,30009,CHEMBL4954,Ephrin type-A receptor 3,8.24,8.24,5.8,1,8
62111,CHEMBL288441,BOSUTINIB,30006,CHEMBL3981,Serine/threonine-protein kinase 10,8.15,7.16,7.0,3,9
62111,CHEMBL288441,BOSUTINIB,10371,CHEMBL4948,Dual specificity mitogen-activated protein kinase kinase 5,8.09,6.94,8.2,2,9
62111,CHEMBL288441,BOSUTINIB,101464,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,8.09,8.09,8.2,1,8
62111,CHEMBL288441,BOSUTINIB,11569,CHEMBL3290,Ephrin type-B receptor 2,8.08,7.58,8.4,3,9
62111,CHEMBL288441,BOSUTINIB,30010,CHEMBL4134,Ephrin type-A receptor 8,8.05,8.05,9.0,1,8
62111,CHEMBL288441,BOSUTINIB,11046,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,8.0,6.96,9.9,2,9
62111,CHEMBL288441,BOSUTINIB,30033,CHEMBL3984,Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase,7.9,6.71,12.7,12,9
62111,CHEMBL288441,BOSUTINIB,101312,CHEMBL5749,Mitogen-activated protein kinase kinase kinase kinase 1,7.82,6.96,15.0,2,9
62111,CHEMBL288441,BOSUTINIB,102799,CHEMBL6191,Mitogen-activated protein kinase kinase kinase 19,7.8,7.8,16.0,1,8
62111,CHEMBL288441,BOSUTINIB,9,CHEMBL203,Epidermal growth factor receptor,7.75,7.2,18.0,15,9
62111,CHEMBL288441,BOSUTINIB,30008,CHEMBL2068,Ephrin type-A receptor 2,7.75,7.34,18.0,2,9
62111,CHEMBL288441,BOSUTINIB,30021,CHEMBL3988,Ephrin type-A receptor 4,7.75,7.49,18.0,2,9
62111,CHEMBL288441,BOSUTINIB,102770,CHEMBL6149,Serine/threonine-protein kinase SIK3,7.75,7.25,18.0,3,9
62111,CHEMBL288441,BOSUTINIB,11902,CHEMBL2815,High affinity nerve growth factor receptor,7.66,6.58,22.0,2,8
62111,CHEMBL288441,BOSUTINIB,30047,CHEMBL4527,TRAF2 and NCK-interacting protein kinase,7.64,7.57,23.0,2,9
62111,CHEMBL288441,BOSUTINIB,12699,CHEMBL3009,Receptor tyrosine-protein kinase erbB-4,7.58,7.58,26.0,1,8
62111,CHEMBL288441,BOSUTINIB,30019,CHEMBL3987,Ephrin type-A receptor 5,7.57,7.57,27.0,1,8
62111,CHEMBL288441,BOSUTINIB,100413,CHEMBL4898,BDNF/NT-3 growth factors receptor,7.57,6.75,27.0,2,8
62111,CHEMBL288441,BOSUTINIB,101504,CHEMBL5699,Serine/threonine-protein kinase SIK2,7.54,7.12,29.0,2,9
62111,CHEMBL288441,BOSUTINIB,101433,CHEMBL6082,Serine/threonine-protein kinase SIK1,7.52,7.52,30.0,1,8
62111,CHEMBL288441,BOSUTINIB,102711,CHEMBL5914,Mitogen-activated protein kinase kinase kinase 2,7.52,6.86,30.0,2,9
62111,CHEMBL288441,BOSUTINIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,7.5,6.64,32.0,11,9
62111,CHEMBL288441,BOSUTINIB,10844,CHEMBL2634,Tyrosine-protein kinase CSK,7.5,7.14,32.0,3,9
62111,CHEMBL288441,BOSUTINIB,30020,CHEMBL5072,Ephrin type-B receptor 1,7.48,7.48,33.0,1,8
62111,CHEMBL288441,BOSUTINIB,101410,CHEMBL6005,Serine/threonine-protein kinase 33,7.43,7.43,37.0,1,8
62111,CHEMBL288441,BOSUTINIB,101613,CHEMBL5941,Serine/threonine-protein kinase 26,7.43,7.43,37.0,1,8
62111,CHEMBL288441,BOSUTINIB,100424,CHEMBL4367,Tyrosine-protein kinase TXK,7.4,7.27,40.0,2,8
62111,CHEMBL288441,BOSUTINIB,100098,CHEMBL5491,Wee1-like protein kinase,7.36,6.61,43.7,4,9
62111,CHEMBL288441,BOSUTINIB,10906,CHEMBL2599,Tyrosine-protein kinase SYK,7.28,6.91,52.0,2,8
62111,CHEMBL288441,BOSUTINIB,12915,CHEMBL3529,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,7.28,6.68,53.0,2,9
62111,CHEMBL288441,BOSUTINIB,100410,CHEMBL4895,Tyrosine-protein kinase receptor UFO,7.28,6.54,52.0,6,9
62111,CHEMBL288441,BOSUTINIB,101399,CHEMBL5970,Mitogen-activated protein kinase kinase kinase 3,7.27,6.57,54.0,2,9
62111,CHEMBL288441,BOSUTINIB,100912,CHEMBL5314,Tyrosine-protein kinase receptor TYRO3,7.21,7.21,61.0,1,8
62111,CHEMBL288441,BOSUTINIB,20007,CHEMBL3886,Mitogen-activated protein kinase kinase kinase 20,7.1,6.51,80.0,2,9
62111,CHEMBL288441,BOSUTINIB,30028,CHEMBL5073,Calcium/calmodulin-dependent protein kinase type 1D,7.04,6.65,92.0,2,8
62111,CHEMBL288441,BOSUTINIB,100918,CHEMBL5320,Myotonin-protein kinase,7.04,7.04,91.0,1,8
62111,CHEMBL288441,BOSUTINIB,101069,CHEMBL5095,Wee1-like protein kinase 2,7.03,7.0,94.0,2,9
62111,CHEMBL288441,BOSUTINIB,101324,CHEMBL5776,Mitogen-activated protein kinase kinase kinase 7,7.0,7.0,100.0,1,8
62111,CHEMBL288441,BOSUTINIB,101508,CHEMBL5703,Tyrosine-protein kinase Srms,7.0,7.0,100.0,1,8
62111,CHEMBL288441,BOSUTINIB,12276,CHEMBL3956,Mitogen-activated protein kinase kinase kinase 1,6.97,6.97,107.0,1,9
62111,CHEMBL288441,BOSUTINIB,10967,CHEMBL4937,Casein kinase I isoform epsilon,6.96,6.96,110.0,1,8
62111,CHEMBL288441,BOSUTINIB,30050,CHEMBL4853,Mitogen-activated protein kinase kinase kinase 4,6.96,6.38,110.0,2,9
62111,CHEMBL288441,BOSUTINIB,100948,CHEMBL5331,Tyrosine-protein kinase Mer,6.96,6.96,110.0,1,8
62111,CHEMBL288441,BOSUTINIB,10531,CHEMBL2527,Serine/threonine-protein kinase Chk2,6.92,6.92,120.0,1,8
62111,CHEMBL288441,BOSUTINIB,100917,CHEMBL5319,Epithelial discoidin domain-containing receptor 1,6.92,6.92,120.0,1,8
62111,CHEMBL288441,BOSUTINIB,103106,CHEMBL1075167,Homeodomain-interacting protein kinase 4,6.89,6.89,130.0,1,8
62111,CHEMBL288441,BOSUTINIB,100995,CHEMBL5469,Protein-tyrosine kinase 2-beta,6.87,6.64,134.0,2,8
62111,CHEMBL288441,BOSUTINIB,101079,CHEMBL5122,Discoidin domain-containing receptor 2,6.85,6.85,140.0,1,8
62111,CHEMBL288441,BOSUTINIB,101130,CHEMBL5260,Serine/threonine-protein kinase TNNI3K,6.77,6.77,170.0,1,8
62111,CHEMBL288441,BOSUTINIB,30002,CHEMBL3829,Calcium/calmodulin-dependent protein kinase type II subunit gamma,6.74,6.74,184.0,1,8
62111,CHEMBL288441,BOSUTINIB,30024,CHEMBL4598,Serine/threonine-protein kinase 4,6.72,6.72,190.0,2,8
62111,CHEMBL288441,BOSUTINIB,197,CHEMBL1913,Platelet-derived growth factor receptor beta,6.7,6.14,200.0,2,9
62111,CHEMBL288441,BOSUTINIB,100416,CHEMBL4901,Ephrin type-B receptor 3,6.68,6.25,210.0,2,9
62111,CHEMBL288441,BOSUTINIB,101503,CHEMBL5698,NUAK family SNF1-like kinase 2,6.66,6.66,220.0,1,8
62111,CHEMBL288441,BOSUTINIB,10368,CHEMBL2828,Casein kinase I isoform delta,6.62,6.62,240.0,1,8
62111,CHEMBL288441,BOSUTINIB,100856,CHEMBL5408,Serine/threonine-protein kinase TBK1,6.6,6.31,250.0,3,9
62111,CHEMBL288441,BOSUTINIB,100925,CHEMBL5358,eIF-2-alpha kinase GCN2,6.57,6.57,270.0,1,8
62111,CHEMBL288441,BOSUTINIB,11720,CHEMBL2793,Casein kinase I isoform alpha,6.55,6.55,280.0,1,8
62111,CHEMBL288441,BOSUTINIB,100418,CHEMBL4246,Tyrosine-protein kinase Tec,6.55,6.03,282.0,2,8
62111,CHEMBL288441,BOSUTINIB,30015,CHEMBL4226,Dual specificity protein kinase CLK3,6.52,6.52,300.0,2,9
62111,CHEMBL288441,BOSUTINIB,100069,CHEMBL5455,Tyrosine-protein kinase Fes/Fps,6.48,6.46,330.0,2,8
62111,CHEMBL288441,BOSUTINIB,11361,CHEMBL4004,"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",6.47,6.47,340.0,1,8
62111,CHEMBL288441,BOSUTINIB,101506,CHEMBL5701,Serine/threonine-protein kinase TAO3,6.47,6.47,340.0,1,8
62111,CHEMBL288441,BOSUTINIB,30042,CHEMBL4522,BMP-2-inducible protein kinase,6.46,6.26,350.0,2,9
62111,CHEMBL288441,BOSUTINIB,103457,CHEMBL1163128,Microtubule-associated serine/threonine-protein kinase 1,6.46,6.46,350.0,1,8
62111,CHEMBL288441,BOSUTINIB,11149,CHEMBL2973,Rho-associated protein kinase 2,6.44,6.44,360.0,1,8
62111,CHEMBL288441,BOSUTINIB,19639,CHEMBL3778,Interleukin-1 receptor-associated kinase 4,6.44,6.34,360.0,2,8
62111,CHEMBL288441,BOSUTINIB,30007,CHEMBL3982,Tyrosine-protein kinase Fer,6.44,6.29,360.0,3,9
62111,CHEMBL288441,BOSUTINIB,10277,CHEMBL4708,Serine/threonine-protein kinase 3,6.43,6.43,370.0,1,8
62111,CHEMBL288441,BOSUTINIB,12840,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,6.42,6.42,380.0,1,8
62111,CHEMBL288441,BOSUTINIB,104317,CHEMBL1908386,Dual serine/threonine and tyrosine protein kinase,6.42,6.42,380.0,1,8
62111,CHEMBL288441,BOSUTINIB,101191,CHEMBL5435,Serine/threonine-protein kinase ULK2,6.35,6.35,450.0,1,8
62111,CHEMBL288441,BOSUTINIB,101048,CHEMBL5047,Serine/threonine-protein kinase ULK3,6.34,6.34,460.0,1,8
62111,CHEMBL288441,BOSUTINIB,103453,CHEMBL1163124,Mitogen-activated protein kinase kinase kinase 13,6.32,6.32,480.0,1,8
62111,CHEMBL288441,BOSUTINIB,10250,CHEMBL2428,"Myosin light chain kinase, smooth muscle",6.31,6.31,490.0,1,8
62111,CHEMBL288441,BOSUTINIB,103154,CHEMBL1075104,Leucine-rich repeat serine/threonine-protein kinase 2,6.3,6.19,500.0,2,8
62111,CHEMBL288441,BOSUTINIB,101183,CHEMBL5427,Homeodomain-interacting protein kinase 1,6.28,6.28,520.0,1,8
62111,CHEMBL288441,BOSUTINIB,11242,CHEMBL2695,Focal adhesion kinase 1,6.27,6.25,538.0,3,9
62111,CHEMBL288441,BOSUTINIB,30041,CHEMBL4312,Serine/threonine-protein kinase 36,6.24,6.24,570.0,1,8
62111,CHEMBL288441,BOSUTINIB,100969,CHEMBL5388,Serine/threonine-protein kinase tousled-like 1,6.24,6.24,570.0,1,8
62111,CHEMBL288441,BOSUTINIB,100993,CHEMBL5467,Bone morphogenetic protein receptor type-2,6.24,6.24,580.0,1,8
62111,CHEMBL288441,BOSUTINIB,19623,CHEMBL3357,Interleukin-1 receptor-associated kinase 1,6.22,6.22,600.0,1,8
62111,CHEMBL288441,BOSUTINIB,30013,CHEMBL4224,Dual specificity protein kinase CLK1,6.22,6.22,598.0,3,9
62111,CHEMBL288441,BOSUTINIB,102667,CHEMBL6029,Eukaryotic translation initiation factor 2-alpha kinase 1,6.2,6.2,630.0,1,8
62111,CHEMBL288441,BOSUTINIB,102473,CHEMBL5638,Serine/threonine-protein kinase Nek11,6.19,6.19,650.0,1,8
62111,CHEMBL288441,BOSUTINIB,12944,CHEMBL4501,Ribosomal protein S6 kinase beta-1,6.18,6.18,660.0,1,8
62111,CHEMBL288441,BOSUTINIB,101499,CHEMBL5671,Protein delta homolog 1,6.17,6.17,670.0,1,9
62111,CHEMBL288441,BOSUTINIB,104320,CHEMBL1908389,Mitogen-activated protein kinase kinase kinase 12,6.17,6.17,670.0,1,8
62111,CHEMBL288441,BOSUTINIB,10280,CHEMBL264,Histamine H3 receptor,6.16,5.86,690.0,2,8
62111,CHEMBL288441,BOSUTINIB,100417,CHEMBL4247,ALK tyrosine kinase receptor,6.16,6.16,690.0,1,8
62111,CHEMBL288441,BOSUTINIB,103855,CHEMBL1649059,Serine/threonine-protein kinase VRK2,6.15,6.15,710.0,1,8
62111,CHEMBL288441,BOSUTINIB,30032,CHEMBL5284,Calcium/calmodulin-dependent protein kinase kinase 2,6.11,6.11,780.0,1,8
62111,CHEMBL288441,BOSUTINIB,104312,CHEMBL1908381,Peripheral plasma membrane protein CASK,6.08,6.08,830.0,1,8
62111,CHEMBL288441,BOSUTINIB,10811,CHEMBL3231,Rho-associated protein kinase 1,6.06,6.06,870.0,1,8
62111,CHEMBL288441,BOSUTINIB,101231,CHEMBL5552,Serine/threonine-protein kinase 25,6.05,6.05,900.0,1,8
62111,CHEMBL288441,BOSUTINIB,12665,CHEMBL3920,Protein kinase C theta type,6.04,6.04,910.0,1,8
62111,CHEMBL288441,BOSUTINIB,72,CHEMBL217,D(2) dopamine receptor,6.03,6.03,930.0,1,8
62111,CHEMBL288441,BOSUTINIB,101610,CHEMBL5938,Serine/threonine-protein kinase PLK2,6.02,6.02,960.0,1,8
62111,CHEMBL288441,BOSUTINIB,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.0,5.93,1010.0,2,9
62111,CHEMBL288441,BOSUTINIB,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.0,6.0,1000.0,1,8
62111,CHEMBL288441,BOSUTINIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,6.0,5.75,1000.0,6,9
62111,CHEMBL288441,BOSUTINIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,5.96,5.96,1100.0,1,8
62111,CHEMBL288441,BOSUTINIB,30046,CHEMBL4526,Ephrin type-A receptor 6,5.96,5.96,1100.0,1,8
62111,CHEMBL288441,BOSUTINIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,5.92,5.92,1200.0,1,8
62111,CHEMBL288441,BOSUTINIB,12724,CHEMBL2345,Ribosomal protein S6 kinase alpha-3,5.92,5.92,1200.0,1,8
62111,CHEMBL288441,BOSUTINIB,12829,CHEMBL3055,Cyclin-dependent kinase 7,5.92,5.92,1200.0,1,8
62111,CHEMBL288441,BOSUTINIB,12913,CHEMBL4128,Angiopoietin-1 receptor,5.92,5.92,1191.0,1,8
62111,CHEMBL288441,BOSUTINIB,101411,CHEMBL6006,Serine/threonine-protein kinase ULK1,5.92,5.92,1200.0,1,8
62111,CHEMBL288441,BOSUTINIB,10235,CHEMBL2171,Dual specificity mitogen-activated protein kinase kinase 6,5.89,5.89,1300.0,1,8
62111,CHEMBL288441,BOSUTINIB,12735,CHEMBL2349,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",5.89,5.89,1300.0,1,8
62111,CHEMBL288441,BOSUTINIB,101131,CHEMBL5261,Serine/threonine-protein kinase TAO1,5.89,5.89,1300.0,1,8
62111,CHEMBL288441,BOSUTINIB,117538,CHEMBL4105933,Uncharacterized protein FLJ45252,5.87,5.87,1357.0,1,9
62111,CHEMBL288441,BOSUTINIB,101460,CHEMBL6162,Cyclin-dependent kinase 14,5.85,5.85,1400.0,1,8
62111,CHEMBL288441,BOSUTINIB,30000,CHEMBL3830,AP2-associated protein kinase 1,5.83,5.73,1471.0,2,9
62111,CHEMBL288441,BOSUTINIB,100824,CHEMBL3542,Serine/threonine-protein kinase NIM1,5.82,5.82,1500.0,1,8
62111,CHEMBL288441,BOSUTINIB,12214,CHEMBL2803,Tyrosine-protein kinase ZAP-70,5.8,5.8,1600.0,1,8
62111,CHEMBL288441,BOSUTINIB,12247,CHEMBL2996,Protein kinase C delta type,5.8,5.8,1600.0,1,8
62111,CHEMBL288441,BOSUTINIB,30017,CHEMBL3835,Serine/threonine-protein kinase Nek2,5.8,5.8,1600.0,1,8
62111,CHEMBL288441,BOSUTINIB,101278,CHEMBL5659,Serine/threonine-protein kinase RIO3,5.8,5.8,1600.0,1,8
62111,CHEMBL288441,BOSUTINIB,101360,CHEMBL5856,Cyclin-dependent kinase 15,5.8,5.8,1600.0,1,8
62111,CHEMBL288441,BOSUTINIB,10918,CHEMBL2959,Tyrosine-protein kinase ITK/TSK,5.77,5.77,1700.0,1,8
62111,CHEMBL288441,BOSUTINIB,30014,CHEMBL4225,Dual specificity protein kinase CLK2,5.77,5.77,1700.0,2,9
62111,CHEMBL288441,BOSUTINIB,103062,CHEMBL1075133,Rhodopsin kinase GRK7,5.77,5.77,1700.0,1,8
62111,CHEMBL288441,BOSUTINIB,10907,CHEMBL3024,Serine/threonine-protein kinase PLK1,5.75,5.75,1800.0,1,8
62111,CHEMBL288441,BOSUTINIB,102774,CHEMBL6150,Serine/threonine-protein kinase 32A,5.75,5.75,1800.0,1,8
62111,CHEMBL288441,BOSUTINIB,100071,CHEMBL4487,Serine/threonine-protein kinase PAK 2,5.72,5.72,1900.0,1,8
62111,CHEMBL288441,BOSUTINIB,100852,CHEMBL4576,Homeodomain-interacting protein kinase 2,5.72,5.72,1900.0,1,8
62111,CHEMBL288441,BOSUTINIB,103140,CHEMBL1075195,Serine/threonine-protein kinase TAO2,5.72,5.72,1900.0,1,8
62111,CHEMBL288441,BOSUTINIB,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,5.7,5.7,2000.0,1,9
62111,CHEMBL288441,BOSUTINIB,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.68,5.68,2070.6,1,8
62111,CHEMBL288441,BOSUTINIB,101179,CHEMBL5404,Serine/threonine-protein kinase tousled-like 2,5.68,5.68,2100.0,1,8
62111,CHEMBL288441,BOSUTINIB,101226,CHEMBL5547,Ankyrin repeat and protein kinase domain-containing protein 1,5.68,5.68,2100.0,1,8
62111,CHEMBL288441,BOSUTINIB,102,CHEMBL1941,Histamine H2 receptor,5.67,5.67,2143.1,1,8
62111,CHEMBL288441,BOSUTINIB,11451,CHEMBL3717,Hepatocyte growth factor receptor,5.66,5.58,2200.0,2,8
62111,CHEMBL288441,BOSUTINIB,100931,CHEMBL5364,Serine/threonine-protein kinase NLK,5.66,5.66,2200.0,1,8
62111,CHEMBL288441,BOSUTINIB,101404,CHEMBL5975,Serine/threonine-protein kinase RIO1,5.66,5.66,2200.0,1,8
62111,CHEMBL288441,BOSUTINIB,30025,CHEMBL4600,Serine/threonine-protein kinase PAK 1,5.64,5.64,2300.0,1,8
62111,CHEMBL288441,BOSUTINIB,100949,CHEMBL5332,Mitogen-activated protein kinase 7,5.64,5.64,2300.0,1,8
62111,CHEMBL288441,BOSUTINIB,101273,CHEMBL5654,Myosin-IIIb,5.64,5.64,2300.0,1,8
62111,CHEMBL288441,BOSUTINIB,101340,CHEMBL5810,Ephrin type-A receptor 1,5.64,5.64,2300.0,1,8
62111,CHEMBL288441,BOSUTINIB,10878,CHEMBL3582,Protein kinase C epsilon type,5.62,5.62,2400.0,1,8
62111,CHEMBL288441,BOSUTINIB,30022,CHEMBL4597,Cyclin-dependent kinase 16,5.62,5.62,2400.0,1,8
62111,CHEMBL288441,BOSUTINIB,101239,CHEMBL5579,Citron Rho-interacting kinase,5.62,5.62,2400.0,1,8
62111,CHEMBL288441,BOSUTINIB,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,5.6,5.59,2500.0,2,8
62111,CHEMBL288441,BOSUTINIB,10478,CHEMBL2109,Dual specificity mitogen-activated protein kinase kinase 3,5.58,5.58,2600.0,1,8
62111,CHEMBL288441,BOSUTINIB,11047,CHEMBL2897,Dual specificity mitogen-activated protein kinase kinase 4,5.58,5.58,2600.0,1,8
62111,CHEMBL288441,BOSUTINIB,101222,CHEMBL5520,Casein kinase I isoform alpha-like,5.58,5.58,2600.0,1,8
62111,CHEMBL288441,BOSUTINIB,10939,CHEMBL4924,Ribosomal protein S6 kinase alpha-6,5.57,5.57,2700.0,1,8
62111,CHEMBL288441,BOSUTINIB,11870,CHEMBL2708,Mitogen-activated protein kinase kinase kinase 11,5.57,5.57,2700.0,1,8
62111,CHEMBL288441,BOSUTINIB,12038,CHEMBL2872,Mitogen-activated protein kinase kinase kinase 9,5.57,5.57,2700.0,1,8
62111,CHEMBL288441,BOSUTINIB,125,CHEMBL229,Alpha-1A adrenergic receptor,5.56,5.54,2740.0,2,8
62111,CHEMBL288441,BOSUTINIB,11637,CHEMBL3384,Serine/threonine-protein kinase N1,5.54,5.54,2900.0,1,8
62111,CHEMBL288441,BOSUTINIB,100906,CHEMBL5274,Tyrosine-protein kinase receptor Tie-1,5.54,5.54,2900.0,1,8
62111,CHEMBL288441,BOSUTINIB,130,CHEMBL234,D(3) dopamine receptor,5.52,5.52,3010.0,1,8
62111,CHEMBL288441,BOSUTINIB,12967,CHEMBL4630,Serine/threonine-protein kinase Chk1,5.52,5.52,3000.0,1,8
62111,CHEMBL288441,BOSUTINIB,101484,CHEMBL5627,Leukocyte tyrosine kinase receptor,5.52,5.52,3000.0,1,8
62111,CHEMBL288441,BOSUTINIB,102676,CHEMBL5836,Ephrin type-B receptor 6,5.52,5.52,3000.0,1,8
62111,CHEMBL288441,BOSUTINIB,10842,CHEMBL3032,Serine/threonine-protein kinase N2,5.5,5.5,3200.0,1,8
62111,CHEMBL288441,BOSUTINIB,11843,CHEMBL3906,Ribosomal protein S6 kinase alpha-2,5.5,5.5,3200.0,1,8
62111,CHEMBL288441,BOSUTINIB,30036,CHEMBL4203,Dual specificity protein kinase CLK4,5.5,5.5,3200.0,1,8
62111,CHEMBL288441,BOSUTINIB,100853,CHEMBL4577,Homeodomain-interacting protein kinase 3,5.5,5.5,3200.0,1,8
60246,CHEMBL288470,AMINOPYRINE,119104,CHEMBL4523354,Nicotinate phosphoribosyltransferase,9.0,9.0,1.0,1,9
60246,CHEMBL288470,AMINOPYRINE,103668,CHEMBL1293235,Prelamin-A/C,7.2,7.2,63.1,1,9
54547,CHEMBL289469,GRANISETRON,11305,CHEMBL3895,5-hydroxytryptamine receptor 3B,9.8,9.57,0.16,5,9
54547,CHEMBL289469,GRANISETRON,144,CHEMBL1899,5-hydroxytryptamine receptor 3A,9.72,8.2,0.19,23,9
60422,CHEMBL289480,RILMENIDINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.9,7.05,12.59,3,9
60422,CHEMBL289480,RILMENIDINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.44,6.5,36.31,7,9
60422,CHEMBL289480,RILMENIDINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.37,6.89,42.66,3,9
60422,CHEMBL289480,RILMENIDINE,11684,CHEMBL3923,Nischarin,7.23,7.2,59.16,3,9
60422,CHEMBL289480,RILMENIDINE,11365,CHEMBL289,Cytochrome P450 2D6,6.4,6.4,398.1,2,9
60422,CHEMBL289480,RILMENIDINE,137,CHEMBL237,Kappa-type opioid receptor,5.76,5.76,1721.1,1,8
46656,CHEMBL290106,BITHIONOL,12704,CHEMBL3194,Transthyretin,7.21,6.08,62.0,4,9
46656,CHEMBL290106,BITHIONOL,10188,CHEMBL260,Mitogen-activated protein kinase 14,6.5,6.5,318.0,1,8
46656,CHEMBL290106,BITHIONOL,11638,CHEMBL4040,Mitogen-activated protein kinase 1,6.42,6.42,385.0,1,8
46656,CHEMBL290106,BITHIONOL,280,CHEMBL256,Adenosine receptor A3,6.33,5.98,468.0,3,8
46656,CHEMBL290106,BITHIONOL,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.25,6.08,560.0,2,8
46656,CHEMBL290106,BITHIONOL,36,CHEMBL208,Progesterone receptor,6.22,6.22,607.8,1,8
46656,CHEMBL290106,BITHIONOL,9,CHEMBL203,Epidermal growth factor receptor,6.21,6.21,614.0,1,8
46656,CHEMBL290106,BITHIONOL,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.2,6.2,638.0,1,8
46656,CHEMBL290106,BITHIONOL,252,CHEMBL251,Adenosine receptor A2a,6.18,6.05,655.0,2,8
46656,CHEMBL290106,BITHIONOL,11134,CHEMBL3687,Polyunsaturated fatty acid lipoxygenase ALOX12,6.15,5.93,707.9,2,9
46656,CHEMBL290106,BITHIONOL,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,6.0,6.0,1000.0,1,9
46656,CHEMBL290106,BITHIONOL,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.91,5.91,1225.0,2,8
46656,CHEMBL290106,BITHIONOL,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.84,5.84,1434.0,1,8
46656,CHEMBL290106,BITHIONOL,130,CHEMBL234,D(3) dopamine receptor,5.84,5.84,1433.0,1,8
46656,CHEMBL290106,BITHIONOL,10184,CHEMBL2327,Substance-K receptor,5.81,5.81,1553.0,1,8
46656,CHEMBL290106,BITHIONOL,155,CHEMBL238,Sodium-dependent dopamine transporter,5.76,5.71,1733.0,2,8
46656,CHEMBL290106,BITHIONOL,248,CHEMBL1835,Thromboxane-A synthase,5.74,5.74,1840.0,1,9
46656,CHEMBL290106,BITHIONOL,100468,CHEMBL4361,Induced myeloid leukemia cell differentiation protein Mcl-1,5.72,5.72,1898.89,1,9
46656,CHEMBL290106,BITHIONOL,104063,CHEMBL1743122,Solute carrier family 22 member 2,5.72,5.72,1900.0,1,9
46656,CHEMBL290106,BITHIONOL,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,5.67,5.67,2147.0,1,8
46656,CHEMBL290106,BITHIONOL,129,CHEMBL233,Mu-type opioid receptor,5.65,5.65,2236.0,1,8
46656,CHEMBL290106,BITHIONOL,10140,CHEMBL258,Tyrosine-protein kinase Lck,5.65,5.65,2255.0,1,8
46656,CHEMBL290106,BITHIONOL,101283,CHEMBL5685,Solute carrier family 22 member 1,5.65,5.65,2230.0,1,9
46656,CHEMBL290106,BITHIONOL,125,CHEMBL229,Alpha-1A adrenergic receptor,5.54,5.54,2877.5,1,8
46656,CHEMBL290106,BITHIONOL,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.51,5.51,3078.2,1,8
46656,CHEMBL290106,BITHIONOL,103668,CHEMBL1293235,Prelamin-A/C,5.5,5.5,3162.3,1,9
60371,CHEMBL290916,EDARAVONE,103665,CHEMBL1293232,Survival motor neuron protein,6.15,6.15,707.9,1,9
60371,CHEMBL290916,EDARAVONE,103659,CHEMBL1293226,Lysine-specific demethylase 4E,5.95,5.95,1122.0,1,9
60371,CHEMBL290916,EDARAVONE,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,5.6,5.6,2511.9,1,9
60371,CHEMBL290916,EDARAVONE,103657,CHEMBL1293224,Microtubule-associated protein tau,5.55,5.55,2818.4,1,9
88648,CHEMBL291338,"3,3',4',5-TETRACHLOROSALICYLANILIDE",126,CHEMBL230,Prostaglandin G/H synthase 2,6.27,6.27,542.0,1,8
88648,CHEMBL291338,"3,3',4',5-TETRACHLOROSALICYLANILIDE",96,CHEMBL221,Prostaglandin G/H synthase 1,6.18,6.18,666.0,1,9
88648,CHEMBL291338,"3,3',4',5-TETRACHLOROSALICYLANILIDE",11638,CHEMBL4040,Mitogen-activated protein kinase 1,6.05,6.05,886.0,1,8
88648,CHEMBL291338,"3,3',4',5-TETRACHLOROSALICYLANILIDE",10188,CHEMBL260,Mitogen-activated protein kinase 14,5.66,5.66,2176.0,1,8
102752,CHEMBL291657,CRINECERFONT,124,CHEMBL1800,Corticotropin-releasing factor receptor 1,6.62,6.62,240.0,1,8
91783,CHEMBL294199,CAPSAICIN,10260,CHEMBL4794,Transient receptor potential cation channel subfamily V member 1,8.6,7.35,2.512,25,9
91783,CHEMBL294199,CAPSAICIN,130,CHEMBL234,D(3) dopamine receptor,7.64,7.64,23.0,1,8
91783,CHEMBL294199,CAPSAICIN,102439,CHEMBL6136,Lysine-specific histone demethylase 1A,6.22,6.22,600.0,4,9
91783,CHEMBL294199,CAPSAICIN,103167,CHEMBL1075319,Transient receptor potential cation channel subfamily M member 8,6.0,6.0,1000.0,1,9
91783,CHEMBL294199,CAPSAICIN,96,CHEMBL221,Prostaglandin G/H synthase 1,5.81,5.81,1551.0,1,9
91783,CHEMBL294199,CAPSAICIN,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,5.7,5.7,1995.3,1,9
91783,CHEMBL294199,CAPSAICIN,17045,CHEMBL340,Cytochrome P450 3A4,5.6,5.6,2511.9,2,9
91783,CHEMBL294199,CAPSAICIN,12594,CHEMBL3356,Cytochrome P450 1A2,5.52,5.52,3000.0,1,8
91783,CHEMBL294199,CAPSAICIN,126,CHEMBL230,Prostaglandin G/H synthase 2,5.5,5.5,3200.0,1,8
66831,CHEMBL295124,BERBERINE,11356,CHEMBL2140,"Tryptophan 2,3-dioxygenase",7.52,7.52,30.0,1,9
66831,CHEMBL295124,BERBERINE,10147,CHEMBL4878,Cytochrome P450 1B1,7.36,6.62,44.0,4,9
66831,CHEMBL295124,BERBERINE,93,CHEMBL220,Acetylcholinesterase,7.0,6.35,100.0,3,9
66831,CHEMBL295124,BERBERINE,100643,CHEMBL4685,"Indoleamine 2,3-dioxygenase 1",6.58,6.58,260.0,1,9
66831,CHEMBL295124,BERBERINE,163,CHEMBL239,Peroxisome proliferator-activated receptor alpha,6.24,6.19,580.0,2,9
66831,CHEMBL295124,BERBERINE,10532,CHEMBL1914,Cholinesterase,5.96,5.96,1090.0,1,9
66831,CHEMBL295124,BERBERINE,11365,CHEMBL289,Cytochrome P450 2D6,5.6,5.6,2511.89,2,9
66831,CHEMBL295124,BERBERINE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,5.6,5.6,2511.9,2,9
72036,CHEMBL295698,LEVOKETOCONAZOLE,17045,CHEMBL340,Cytochrome P450 3A4,7.57,7.57,26.9,1,9
65605,CHEMBL296419,ASTEMIZOLE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,9.05,8.01,0.9,31,9
65605,CHEMBL296419,ASTEMIZOLE,127,CHEMBL231,Histamine H1 receptor,8.79,7.83,1.611,6,9
65605,CHEMBL296419,ASTEMIZOLE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.25,7.59,5.575,3,8
65605,CHEMBL296419,ASTEMIZOLE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,8.13,7.3,7.487,4,8
65605,CHEMBL296419,ASTEMIZOLE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.54,6.86,29.0,4,8
65605,CHEMBL296419,ASTEMIZOLE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.03,6.45,94.0,3,8
65605,CHEMBL296419,ASTEMIZOLE,117512,CHEMBL4105907,Sigma intracellular receptor 2,7.02,7.02,95.0,2,9
65605,CHEMBL296419,ASTEMIZOLE,130,CHEMBL234,D(3) dopamine receptor,6.83,6.42,148.0,4,8
65605,CHEMBL296419,ASTEMIZOLE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.77,6.14,170.1,2,8
65605,CHEMBL296419,ASTEMIZOLE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.75,6.42,178.0,2,8
65605,CHEMBL296419,ASTEMIZOLE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.59,6.28,257.0,2,8
65605,CHEMBL296419,ASTEMIZOLE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.59,6.16,259.0,2,8
65605,CHEMBL296419,ASTEMIZOLE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.54,6.13,285.0,2,8
65605,CHEMBL296419,ASTEMIZOLE,11398,CHEMBL4302,ATP-dependent translocase ABCB1,6.52,6.1,300.0,3,8
65605,CHEMBL296419,ASTEMIZOLE,103,CHEMBL223,Alpha-1D adrenergic receptor,6.42,6.27,378.0,2,8
65605,CHEMBL296419,ASTEMIZOLE,102,CHEMBL1941,Histamine H2 receptor,6.39,5.98,411.5,3,8
65605,CHEMBL296419,ASTEMIZOLE,129,CHEMBL233,Mu-type opioid receptor,6.33,6.17,466.8,4,8
65605,CHEMBL296419,ASTEMIZOLE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.3,5.98,501.0,3,8
65605,CHEMBL296419,ASTEMIZOLE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.3,6.22,505.0,2,8
65605,CHEMBL296419,ASTEMIZOLE,11061,CHEMBL2203,Motilin receptor,6.2,6.2,630.0,1,8
65605,CHEMBL296419,ASTEMIZOLE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.16,6.0,700.0,3,8
65605,CHEMBL296419,ASTEMIZOLE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.1,6.02,793.0,3,8
65605,CHEMBL296419,ASTEMIZOLE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.03,5.87,944.0,4,9
65605,CHEMBL296419,ASTEMIZOLE,88,CHEMBL2056,D(1A) dopamine receptor,6.0,5.85,998.3,2,8
65605,CHEMBL296419,ASTEMIZOLE,10184,CHEMBL2327,Substance-K receptor,6.0,5.77,995.0,2,8
65605,CHEMBL296419,ASTEMIZOLE,90,CHEMBL219,D(4) dopamine receptor,5.89,5.78,1289.8,2,8
65605,CHEMBL296419,ASTEMIZOLE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.87,5.75,1364.0,3,8
65605,CHEMBL296419,ASTEMIZOLE,72,CHEMBL217,D(2) dopamine receptor,5.82,5.82,1507.0,1,8
65605,CHEMBL296419,ASTEMIZOLE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,5.82,5.68,1516.0,2,8
65605,CHEMBL296419,ASTEMIZOLE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,5.8,5.8,1600.0,1,8
65605,CHEMBL296419,ASTEMIZOLE,10624,CHEMBL3426,5-hydroxytryptamine receptor 5A,5.8,5.8,1600.0,1,8
65605,CHEMBL296419,ASTEMIZOLE,103657,CHEMBL1293224,Microtubule-associated protein tau,5.8,5.8,1584.9,1,9
65605,CHEMBL296419,ASTEMIZOLE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.76,5.76,1753.0,1,8
65605,CHEMBL296419,ASTEMIZOLE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.74,5.74,1817.0,1,8
65605,CHEMBL296419,ASTEMIZOLE,103665,CHEMBL1293232,Survival motor neuron protein,5.7,5.7,1995.3,1,9
65605,CHEMBL296419,ASTEMIZOLE,11006,CHEMBL4608,Melanocortin receptor 5,5.67,5.65,2123.0,2,8
65605,CHEMBL296419,ASTEMIZOLE,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,5.62,5.62,2400.0,1,8
65605,CHEMBL296419,ASTEMIZOLE,10804,CHEMBL2632,"HLA class I histocompatibility antigen, A alpha chain",5.6,5.6,2500.0,1,9
65605,CHEMBL296419,ASTEMIZOLE,137,CHEMBL237,Kappa-type opioid receptor,5.58,5.58,2646.0,1,8
65605,CHEMBL296419,ASTEMIZOLE,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,5.55,5.55,2847.0,1,8
72505,CHEMBL298470,TAFENOQUINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.65,5.65,2260.0,1,8
72505,CHEMBL298470,TAFENOQUINE,130,CHEMBL234,D(3) dopamine receptor,5.59,5.59,2570.0,1,8
84655,CHEMBL298734,LONAFARNIB,105451,CHEMBL2189121,GTPase KRas,7.4,7.4,40.0,1,9
84655,CHEMBL298734,LONAFARNIB,10093,CHEMBL2167,GTPase HRas,7.16,7.16,70.0,1,8
84655,CHEMBL298734,LONAFARNIB,11398,CHEMBL4302,ATP-dependent translocase ABCB1,5.57,5.57,2700.0,1,8
115,CHEMBL3,NICOTINE,11184,CHEMBL3068,Neuronal acetylcholine receptor subunit alpha-3,7.35,7.0,45.0,2,9
115,CHEMBL3,NICOTINE,10635,CHEMBL2492,Neuronal acetylcholine receptor subunit alpha-7,6.21,5.84,620.0,13,9
115,CHEMBL3,NICOTINE,101412,CHEMBL6007,Transient receptor potential cation channel subfamily A member 1,5.7,5.7,2000.0,1,9
1620,CHEMBL30,CIMETIDINE,102,CHEMBL1941,Histamine H2 receptor,7.16,6.53,70.0,15,9
1620,CHEMBL30,CIMETIDINE,103665,CHEMBL1293232,Survival motor neuron protein,6.05,6.05,891.3,1,9
1620,CHEMBL30,CIMETIDINE,104067,CHEMBL1743126,Multidrug and toxin extrusion protein 1,5.92,5.79,1200.0,2,9
1620,CHEMBL30,CIMETIDINE,78,CHEMBL1963,Thyrotropin receptor,5.8,5.8,1584.9,2,9
1620,CHEMBL30,CIMETIDINE,276,CHEMBL254,"3',5'-cyclic-AMP phosphodiesterase 4A",5.6,5.6,2509.2,1,8
88815,CHEMBL301265,PRAMIPEXOLE,72,CHEMBL217,D(2) dopamine receptor,10.83,7.61,0.0149,25,9
88815,CHEMBL301265,PRAMIPEXOLE,130,CHEMBL234,D(3) dopamine receptor,10.59,8.63,0.0258,27,9
88815,CHEMBL301265,PRAMIPEXOLE,90,CHEMBL219,D(4) dopamine receptor,9.31,7.89,0.49,12,9
88815,CHEMBL301265,PRAMIPEXOLE,127,CHEMBL231,Histamine H1 receptor,8.35,8.35,4.5,1,9
88815,CHEMBL301265,PRAMIPEXOLE,102,CHEMBL1941,Histamine H2 receptor,7.91,6.6,12.2,4,9
88815,CHEMBL301265,PRAMIPEXOLE,11290,CHEMBL3759,Histamine H4 receptor,7.8,7.8,16.0,1,9
88815,CHEMBL301265,PRAMIPEXOLE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.28,7.28,52.2,1,9
88815,CHEMBL301265,PRAMIPEXOLE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.17,7.17,67.7,1,9
88815,CHEMBL301265,PRAMIPEXOLE,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.12,7.12,75.7,1,9
88815,CHEMBL301265,PRAMIPEXOLE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.93,5.93,1174.9,1,9
88815,CHEMBL301265,PRAMIPEXOLE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,5.92,5.92,1188.0,1,9
1592320,CHEMBL3039502,DUVELISIB,11177,CHEMBL3130,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",9.62,8.24,0.24,12,9
1592320,CHEMBL3039502,DUVELISIB,11939,CHEMBL3267,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",8.7,7.86,2.0,12,9
1592320,CHEMBL3039502,DUVELISIB,12576,CHEMBL3145,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",7.68,7.08,21.0,4,9
1592320,CHEMBL3039502,DUVELISIB,11362,CHEMBL4005,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",6.15,5.88,711.0,4,9
1592322,CHEMBL3039504,NINTEDANIB ESYLATE,11752,CHEMBL1955,Vascular endothelial growth factor receptor 3,7.89,7.89,13.0,1,9
1592322,CHEMBL3039504,NINTEDANIB ESYLATE,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,7.68,7.68,21.0,1,9
1592322,CHEMBL3039504,NINTEDANIB ESYLATE,10979,CHEMBL1868,Vascular endothelial growth factor receptor 1,7.47,7.47,34.0,1,9
1592322,CHEMBL3039504,NINTEDANIB ESYLATE,10264,CHEMBL4142,Fibroblast growth factor receptor 2,7.43,7.43,37.0,1,9
1592322,CHEMBL3039504,NINTEDANIB ESYLATE,12627,CHEMBL2007,Platelet-derived growth factor receptor alpha,7.23,7.23,59.0,1,9
1592322,CHEMBL3039504,NINTEDANIB ESYLATE,197,CHEMBL1913,Platelet-derived growth factor receptor beta,7.19,7.19,65.0,1,9
1592322,CHEMBL3039504,NINTEDANIB ESYLATE,10266,CHEMBL3650,Fibroblast growth factor receptor 1,7.16,7.16,69.0,1,9
1592322,CHEMBL3039504,NINTEDANIB ESYLATE,11926,CHEMBL2742,Fibroblast growth factor receptor 3,6.97,6.97,108.0,1,9
1592322,CHEMBL3039504,NINTEDANIB ESYLATE,11925,CHEMBL3973,Fibroblast growth factor receptor 4,6.21,6.21,610.0,1,9
1592325,CHEMBL3039507,SOTAGLIFLOZIN,20092,CHEMBL3884,Sodium/glucose cotransporter 2,8.82,8.78,1.5,6,9
1592325,CHEMBL3039507,SOTAGLIFLOZIN,18036,CHEMBL4979,Sodium/glucose cotransporter 1,7.46,7.45,34.6,6,9
1592338,CHEMBL3039520,LASMIDITAN,279,CHEMBL1805,5-hydroxytryptamine receptor 1F,8.66,7.86,2.21,2,9
1592338,CHEMBL3039520,LASMIDITAN,10618,CHEMBL2182,5-hydroxytryptamine receptor 1E,6.9,6.9,126.87,1,9
1592338,CHEMBL3039520,LASMIDITAN,117512,CHEMBL4105907,Sigma intracellular receptor 2,6.74,6.74,184.06,1,9
1592338,CHEMBL3039520,LASMIDITAN,220,CHEMBL1850,D(1B) dopamine receptor,6.6,6.6,252.67,1,9
1592338,CHEMBL3039520,LASMIDITAN,137,CHEMBL237,Kappa-type opioid receptor,6.45,6.45,356.57,1,9
1592338,CHEMBL3039520,LASMIDITAN,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.2,6.2,632.05,1,9
1592338,CHEMBL3039520,LASMIDITAN,105,CHEMBL1983,5-hydroxytryptamine receptor 1D,6.06,6.06,869.36,1,9
1592338,CHEMBL3039520,LASMIDITAN,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,5.5,5.5,3132.56,1,9
1592409,CHEMBL3039598,FOSINOPRIL,69,CHEMBL1808,Angiotensin-converting enzyme,9.0,9.0,1.0,1,8
111060,CHEMBL305660,EBASTINE,127,CHEMBL231,Histamine H1 receptor,8.48,8.02,3.287,2,8
111060,CHEMBL305660,EBASTINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.59,7.31,25.8,2,8
111060,CHEMBL305660,EBASTINE,10659,CHEMBL2116,5'-AMP-activated protein kinase catalytic subunit alpha-2,7.58,7.58,26.0,1,9
111060,CHEMBL305660,EBASTINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.4,6.98,40.1,2,8
111060,CHEMBL305660,EBASTINE,130,CHEMBL234,D(3) dopamine receptor,7.38,6.67,41.3,3,8
111060,CHEMBL305660,EBASTINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.33,7.33,47.0,1,8
111060,CHEMBL305660,EBASTINE,72,CHEMBL217,D(2) dopamine receptor,7.21,6.52,61.0,3,8
111060,CHEMBL305660,EBASTINE,155,CHEMBL238,Sodium-dependent dopamine transporter,7.11,6.55,78.4,3,8
111060,CHEMBL305660,EBASTINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,7.07,6.49,85.8,5,9
111060,CHEMBL305660,EBASTINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.0,6.45,101.2,3,8
111060,CHEMBL305660,EBASTINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.94,6.51,115.5,2,8
111060,CHEMBL305660,EBASTINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.91,6.37,124.4,3,8
111060,CHEMBL305660,EBASTINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.86,6.21,137.2,3,8
111060,CHEMBL305660,EBASTINE,11061,CHEMBL2203,Motilin receptor,6.8,6.8,160.0,1,8
111060,CHEMBL305660,EBASTINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.7,6.6,198.9,2,8
111060,CHEMBL305660,EBASTINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.62,6.54,242.7,2,8
111060,CHEMBL305660,EBASTINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.55,6.33,279.5,2,8
111060,CHEMBL305660,EBASTINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.51,6.29,311.9,2,8
111060,CHEMBL305660,EBASTINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.47,6.3,337.3,2,8
111060,CHEMBL305660,EBASTINE,90,CHEMBL219,D(4) dopamine receptor,6.34,6.12,455.7,2,8
111060,CHEMBL305660,EBASTINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.34,6.34,456.4,2,8
111060,CHEMBL305660,EBASTINE,9,CHEMBL203,Epidermal growth factor receptor,6.25,6.25,559.1,1,8
111060,CHEMBL305660,EBASTINE,88,CHEMBL2056,D(1A) dopamine receptor,6.22,6.07,596.5,2,8
111060,CHEMBL305660,EBASTINE,10184,CHEMBL2327,Substance-K receptor,6.19,5.95,644.3,2,8
111060,CHEMBL305660,EBASTINE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.18,6.04,652.8,2,8
111060,CHEMBL305660,EBASTINE,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,6.09,6.09,810.1,1,8
111060,CHEMBL305660,EBASTINE,103,CHEMBL223,Alpha-1D adrenergic receptor,6.06,5.9,870.6,2,8
111060,CHEMBL305660,EBASTINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,5.99,5.83,1020.2,2,8
111060,CHEMBL305660,EBASTINE,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,5.98,5.98,1057.5,1,8
111060,CHEMBL305660,EBASTINE,11398,CHEMBL4302,ATP-dependent translocase ABCB1,5.82,5.82,1500.0,1,9
111060,CHEMBL305660,EBASTINE,280,CHEMBL256,Adenosine receptor A3,5.74,5.62,1806.1,2,8
111060,CHEMBL305660,EBASTINE,226,CHEMBL246,Beta-3 adrenergic receptor,5.72,5.65,1909.1,2,8
111060,CHEMBL305660,EBASTINE,102,CHEMBL1941,Histamine H2 receptor,5.54,5.54,2867.1,2,8
114406,CHEMBL306700,VILOXAZINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.81,6.42,155.0,3,8
114406,CHEMBL306700,VILOXAZINE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.81,6.81,155.0,1,8
114406,CHEMBL306700,VILOXAZINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.63,5.63,2343.3,1,8
1594639,CHEMBL3084748,TROSPIUM CHLORIDE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,8.99,8.99,1.023,1,9
1594639,CHEMBL3084748,TROSPIUM CHLORIDE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,8.94,8.94,1.148,1,9
1594639,CHEMBL3084748,TROSPIUM CHLORIDE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,8.84,8.84,1.445,1,9
1594639,CHEMBL3084748,TROSPIUM CHLORIDE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,8.46,8.46,3.467,1,9
1594639,CHEMBL3084748,TROSPIUM CHLORIDE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,8.22,8.22,6.026,1,9
113138,CHEMBL308954,ETRAVIRINE,36,CHEMBL208,Progesterone receptor,7.1,7.1,80.0,1,8
113138,CHEMBL308954,ETRAVIRINE,12911,CHEMBL3397,Cytochrome P450 2C9,6.56,6.56,277.0,2,9
113138,CHEMBL308954,ETRAVIRINE,12912,CHEMBL3622,Cytochrome P450 2C19,6.3,6.3,496.0,2,9
113138,CHEMBL308954,ETRAVIRINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.57,5.57,2710.0,1,8
1610476,CHEMBL3099695,OSILODROSTAT,11541,CHEMBL2722,"Cytochrome P450 11B2, mitochondrial",9.7,9.26,0.2,13,9
1610476,CHEMBL3099695,OSILODROSTAT,76,CHEMBL1908,"Cytochrome P450 11B1, mitochondrial",8.6,8.44,2.5,10,9
1610476,CHEMBL3099695,OSILODROSTAT,65,CHEMBL1978,Aromatase,6.07,5.94,856.0,2,9
128555,CHEMBL311498,CIANIDANOL,109783,CHEMBL3580487,Sclerostin,5.8,5.77,1579.0,2,9
1626739,CHEMBL3137308,PEFICITINIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,9.15,8.86,0.7,5,9
1626739,CHEMBL3137308,PEFICITINIB,10919,CHEMBL2835,Tyrosine-protein kinase JAK1,8.41,8.19,3.9,5,9
1626739,CHEMBL3137308,PEFICITINIB,12694,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,8.32,8.03,4.8,5,9
1626739,CHEMBL3137308,PEFICITINIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,8.3,8.09,5.0,5,9
1626740,CHEMBL3137309,VENETOCLAX,100304,CHEMBL4860,Apoptosis regulator Bcl-2,10.74,8.39,0.018,22,9
1626740,CHEMBL3137309,VENETOCLAX,100217,CHEMBL4625,Bcl-2-like protein 1,9.0,7.33,1.0,18,9
1626740,CHEMBL3137309,VENETOCLAX,10032,CHEMBL3817,Bcl2-associated agonist of cell death,7.26,7.26,55.0,2,9
1626740,CHEMBL3137309,VENETOCLAX,100476,CHEMBL4677,Bcl-2-like protein 2,6.61,6.61,245.0,5,9
1626740,CHEMBL3137309,VENETOCLAX,108006,CHEMBL3108646,Histone-lysine N-methyltransferase NSD3,5.89,5.89,1300.0,1,9
1626740,CHEMBL3137309,VENETOCLAX,120098,CHEMBL4680030,Aspartyl/asparaginyl beta-hydroxylase,5.89,5.84,1290.0,4,9
1626740,CHEMBL3137309,VENETOCLAX,108005,CHEMBL3108645,Histone-lysine N-methyltransferase NSD2,5.77,5.77,1700.0,1,9
1626740,CHEMBL3137309,VENETOCLAX,12911,CHEMBL3397,Cytochrome P450 2C9,5.75,5.75,1770.0,1,9
1626740,CHEMBL3137309,VENETOCLAX,280,CHEMBL256,Adenosine receptor A3,5.64,5.64,2300.0,1,8
1626740,CHEMBL3137309,VENETOCLAX,109827,CHEMBL3588738,"Histone-lysine N-methyltransferase, H3 lysine-36 specific",5.62,5.62,2400.0,1,9
1626748,CHEMBL3137317,SONIDEGIB PHOSPHATE,101400,CHEMBL5971,Protein smoothened,8.6,8.6,2.5,1,9
1626751,CHEMBL3137320,TALAZOPARIB,100933,CHEMBL5366,Poly [ADP-ribose] polymerase 2,9.7,9.01,0.2,9,9
1626751,CHEMBL3137320,TALAZOPARIB,11663,CHEMBL3105,Poly [ADP-ribose] polymerase 1,9.24,8.99,0.57,22,9
1626751,CHEMBL3137320,TALAZOPARIB,102445,CHEMBL6142,Protein mono-ADP-ribosyltransferase PARP4,9.15,9.15,0.7,1,9
1626751,CHEMBL3137320,TALAZOPARIB,101462,CHEMBL6164,Poly [ADP-ribose] polymerase tankyrase-1,7.85,6.95,14.0,3,9
1626751,CHEMBL3137320,TALAZOPARIB,101057,CHEMBL5083,Protein mono-ADP-ribosyltransferase PARP3,7.62,7.62,24.0,1,9
1626751,CHEMBL3137320,TALAZOPARIB,107591,CHEMBL2380189,Protein mono-ADP-ribosyltransferase PARP11,6.85,6.85,140.0,1,9
1626751,CHEMBL3137320,TALAZOPARIB,117586,CHEMBL4105981,Protein mono-ADP-ribosyltransferase PARP16,6.0,6.0,1000.0,1,9
1626751,CHEMBL3137320,TALAZOPARIB,107973,CHEMBL3091262,Protein mono-ADP-ribosyltransferase PARP8,5.96,5.96,1100.0,1,9
144744,CHEMBL313972,MASOPROCOL,17045,CHEMBL340,Cytochrome P450 3A4,7.0,7.0,100.0,2,9
144744,CHEMBL313972,MASOPROCOL,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,6.9,6.17,125.9,3,9
144744,CHEMBL313972,MASOPROCOL,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,6.8,6.8,158.5,1,9
144744,CHEMBL313972,MASOPROCOL,133,CHEMBL235,Peroxisome proliferator-activated receptor gamma,6.4,6.4,400.0,2,8
144744,CHEMBL313972,MASOPROCOL,12054,CHEMBL2903,Polyunsaturated fatty acid lipoxygenase ALOX15,6.2,6.05,631.0,2,9
144744,CHEMBL313972,MASOPROCOL,19,CHEMBL206,Estrogen receptor,6.13,6.13,749.0,1,8
144744,CHEMBL313972,MASOPROCOL,10206,CHEMBL2392,DNA polymerase beta,6.1,6.1,794.3,1,9
144744,CHEMBL313972,MASOPROCOL,36,CHEMBL208,Progesterone receptor,6.03,6.03,945.0,1,8
144744,CHEMBL313972,MASOPROCOL,12911,CHEMBL3397,Cytochrome P450 2C9,5.8,5.8,1584.9,1,9
144744,CHEMBL313972,MASOPROCOL,130,CHEMBL234,D(3) dopamine receptor,5.75,5.75,1800.0,1,8
144744,CHEMBL313972,MASOPROCOL,103669,CHEMBL1293236,ATP-dependent DNA helicase Q1,5.6,5.6,2511.9,1,9
144744,CHEMBL313972,MASOPROCOL,11134,CHEMBL3687,Polyunsaturated fatty acid lipoxygenase ALOX12,5.55,5.55,2818.4,1,9
144744,CHEMBL313972,MASOPROCOL,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",5.55,5.53,2800.0,2,8
144744,CHEMBL313972,MASOPROCOL,126,CHEMBL230,Prostaglandin G/H synthase 2,5.51,5.51,3100.0,1,8
144744,CHEMBL313972,MASOPROCOL,103688,CHEMBL1293255,15-hydroxyprostaglandin dehydrogenase [NAD(+)],5.5,5.5,3162.3,1,9
144940,CHEMBL314854,FINGOLIMOD,10809,CHEMBL3230,Sphingosine 1-phosphate receptor 4,9.52,9.52,0.3,1,9
144940,CHEMBL314854,FINGOLIMOD,11631,CHEMBL4333,Sphingosine 1-phosphate receptor 1,9.52,7.42,0.3,7,9
144940,CHEMBL314854,FINGOLIMOD,12023,CHEMBL2274,Sphingosine 1-phosphate receptor 5,9.52,6.9,0.3,3,9
144940,CHEMBL314854,FINGOLIMOD,10950,CHEMBL3892,Sphingosine 1-phosphate receptor 3,8.52,7.06,3.0,2,9
144940,CHEMBL314854,FINGOLIMOD,120920,CHEMBL5291553,Ceramide synthase 2,5.67,5.67,2150.0,1,9
139046,CHEMBL315838,ENCAINIDE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.99,6.33,103.2,2,8
139046,CHEMBL315838,ENCAINIDE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.09,6.09,810.0,1,8
139046,CHEMBL315838,ENCAINIDE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.62,5.62,2416.0,1,8
134695,CHEMBL316157,CEPHALORIDINE,103829,CHEMBL1641347,Solute carrier family 22 member 6,6.13,6.13,740.0,1,8
134695,CHEMBL316157,CEPHALORIDINE,103830,CHEMBL1641348,Organic anion transporter 3,5.61,5.61,2460.0,1,8
134695,CHEMBL316157,CEPHALORIDINE,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.5,5.5,3200.0,1,9
162546,CHEMBL317052,REGADENOSON ANHYDROUS,252,CHEMBL251,Adenosine receptor A2a,6.54,6.42,290.0,5,9
162546,CHEMBL317052,REGADENOSON ANHYDROUS,280,CHEMBL256,Adenosine receptor A3,6.32,6.32,480.9,1,8
1672024,CHEMBL3182733,PRAMIPEXOLE DIHYDROCHLORIDE,130,CHEMBL234,D(3) dopamine receptor,9.3,9.3,0.5,1,9
1672024,CHEMBL3182733,PRAMIPEXOLE DIHYDROCHLORIDE,90,CHEMBL219,D(4) dopamine receptor,8.89,8.89,1.3,1,9
1672024,CHEMBL3182733,PRAMIPEXOLE DIHYDROCHLORIDE,72,CHEMBL217,D(2) dopamine receptor,8.41,8.41,3.9,1,9
1672700,CHEMBL3183409,APALUTAMIDE,56,CHEMBL1871,Androgen receptor,7.8,6.92,16.0,10,9
1675249,CHEMBL3185958,CLOMIPHENE CITRATE,12911,CHEMBL3397,Cytochrome P450 2C9,7.1,7.1,79.4,1,9
1676656,CHEMBL3187365,ASENAPINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,9.7,9.26,0.2,3,9
1676656,CHEMBL3187365,ASENAPINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,9.68,9.29,0.21,2,9
1676656,CHEMBL3187365,ASENAPINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,9.6,9.6,0.25,1,9
1676656,CHEMBL3187365,ASENAPINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,9.22,8.81,0.6,3,9
1676656,CHEMBL3187365,ASENAPINE,127,CHEMBL231,Histamine H1 receptor,9.0,8.84,1.0,2,9
1676656,CHEMBL3187365,ASENAPINE,125,CHEMBL229,Alpha-1A adrenergic receptor,8.85,8.85,1.4,1,8
1676656,CHEMBL3187365,ASENAPINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,8.85,8.85,1.4,1,8
1676656,CHEMBL3187365,ASENAPINE,130,CHEMBL234,D(3) dopamine receptor,8.36,8.2,4.4,2,9
1676656,CHEMBL3187365,ASENAPINE,72,CHEMBL217,D(2) dopamine receptor,8.05,7.65,8.9,2,9
1676656,CHEMBL3187365,ASENAPINE,88,CHEMBL2056,D(1A) dopamine receptor,8.05,7.55,8.9,3,9
1676656,CHEMBL3187365,ASENAPINE,90,CHEMBL219,D(4) dopamine receptor,8.05,8.05,9.0,1,9
1676656,CHEMBL3187365,ASENAPINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,8.01,8.01,9.7,1,8
1676656,CHEMBL3187365,ASENAPINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.86,7.48,13.7,2,8
1676656,CHEMBL3187365,ASENAPINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.52,6.52,300.0,1,8
1676656,CHEMBL3187365,ASENAPINE,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,5.7,5.7,2000.0,1,8
1676656,CHEMBL3187365,ASENAPINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.58,5.58,2600.0,1,8
1677014,CHEMBL3187723,BINIMETINIB,11409,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,7.92,7.63,12.0,2,9
1677014,CHEMBL3187723,BINIMETINIB,11046,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,7.44,7.44,36.0,1,9
1677276,CHEMBL3187985,APOMORPHINE HYDROCHLORIDE,103134,CHEMBL1075189,Pyruvate kinase PKM,6.05,6.05,891.3,2,9
1677558,CHEMBL3188267,CAPMATINIB,11451,CHEMBL3717,Hepatocyte growth factor receptor,9.89,9.72,0.13,5,9
1677558,CHEMBL3188267,CAPMATINIB,103441,CHEMBL1163112,Cyclin-dependent kinase-like 5,5.69,5.69,2042.0,1,9
161549,CHEMBL319144,MINODRONIC ACID,71,CHEMBL1782,Farnesyl pyrophosphate synthase,8.72,8.59,1.9,3,9
161549,CHEMBL319144,MINODRONIC ACID,10108,CHEMBL4769,Geranylgeranyl pyrophosphate synthase,6.17,5.96,670.0,2,9
1788,CHEMBL32,MOXIFLOXACIN,137,CHEMBL237,Kappa-type opioid receptor,6.5,6.5,320.0,1,8
1724957,CHEMBL3218576,COPANLISIB,11362,CHEMBL4005,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",9.96,9.34,0.11,6,9
1724957,CHEMBL3218576,COPANLISIB,11177,CHEMBL3130,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",9.74,8.56,0.18,6,9
1724957,CHEMBL3218576,COPANLISIB,11939,CHEMBL3267,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",9.15,8.58,0.7,7,9
1724957,CHEMBL3218576,COPANLISIB,12576,CHEMBL3145,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",8.43,8.35,3.7,6,9
1724957,CHEMBL3218576,COPANLISIB,11400,CHEMBL2842,Serine/threonine-protein kinase mTOR,7.35,7.35,45.0,3,9
1731642,CHEMBL3233142,LUMATEPERONE TOSYLATE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,9.27,8.71,0.54,2,9
1731642,CHEMBL3233142,LUMATEPERONE TOSYLATE,128,CHEMBL232,Alpha-1B adrenergic receptor,7.51,7.51,31.0,1,9
1731642,CHEMBL3233142,LUMATEPERONE TOSYLATE,88,CHEMBL2056,D(1A) dopamine receptor,7.28,7.28,52.0,1,9
1731642,CHEMBL3233142,LUMATEPERONE TOSYLATE,121,CHEMBL228,Sodium-dependent serotonin transporter,7.21,7.17,61.0,2,9
1731642,CHEMBL3233142,LUMATEPERONE TOSYLATE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.14,7.14,73.0,1,9
1731642,CHEMBL3233142,LUMATEPERONE TOSYLATE,90,CHEMBL219,D(4) dopamine receptor,6.97,6.97,108.0,1,9
1731642,CHEMBL3233142,LUMATEPERONE TOSYLATE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.76,6.76,173.0,1,9
1731642,CHEMBL3233142,LUMATEPERONE TOSYLATE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.83,5.83,1480.0,1,9
1736091,CHEMBL3237547,CEDAZURIDINE,12945,CHEMBL4502,Cytidine deaminase,6.4,6.4,400.0,1,9
47006,CHEMBL32479,BROTIZOLAM,251,CHEMBL250,Platelet-activating factor receptor,6.52,6.52,300.0,1,8
1746288,CHEMBL3261331,RESMETIROM,271,CHEMBL1947,Thyroid hormone receptor beta,7.14,6.49,73.0,6,9
1746288,CHEMBL3261331,RESMETIROM,10163,CHEMBL3721,Cytochrome P450 2C8,6.05,6.05,900.0,1,9
1746288,CHEMBL3261331,RESMETIROM,59,CHEMBL1860,Thyroid hormone receptor alpha,6.03,5.71,934.0,3,9
49226,CHEMBL32800,FENOTEROL,43,CHEMBL210,Beta-2 adrenergic receptor,9.61,7.44,0.2455,6,9
49226,CHEMBL32800,FENOTEROL,50,CHEMBL213,Beta-1 adrenergic receptor,7.96,7.96,10.96,1,9
49226,CHEMBL32800,FENOTEROL,226,CHEMBL246,Beta-3 adrenergic receptor,7.66,7.66,21.88,1,9
49226,CHEMBL32800,FENOTEROL,125,CHEMBL229,Alpha-1A adrenergic receptor,5.81,5.81,1550.2,1,8
162444,CHEMBL328190,LASOFOXIFENE,19,CHEMBL206,Estrogen receptor,8.89,8.23,1.3,6,9
162444,CHEMBL328190,LASOFOXIFENE,174,CHEMBL242,Estrogen receptor beta,8.74,8.25,1.8,4,9
162444,CHEMBL328190,LASOFOXIFENE,137,CHEMBL237,Kappa-type opioid receptor,7.07,7.07,84.9,1,8
162444,CHEMBL328190,LASOFOXIFENE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.93,6.93,116.8,1,8
162444,CHEMBL328190,LASOFOXIFENE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.57,6.57,272.0,1,8
162444,CHEMBL328190,LASOFOXIFENE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.14,6.14,730.0,1,8
162444,CHEMBL328190,LASOFOXIFENE,10280,CHEMBL264,Histamine H3 receptor,6.0,6.0,990.0,1,8
162444,CHEMBL328190,LASOFOXIFENE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.8,5.8,1600.0,1,8
162444,CHEMBL328190,LASOFOXIFENE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.8,5.8,1600.0,1,8
162444,CHEMBL328190,LASOFOXIFENE,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.8,5.8,1600.0,1,8
162444,CHEMBL328190,LASOFOXIFENE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.7,5.7,2000.0,1,8
162444,CHEMBL328190,LASOFOXIFENE,130,CHEMBL234,D(3) dopamine receptor,5.66,5.66,2200.0,1,8
162444,CHEMBL328190,LASOFOXIFENE,11061,CHEMBL2203,Motilin receptor,5.54,5.54,2900.0,1,8
1757351,CHEMBL3286830,LORLATINIB,101019,CHEMBL5568,Proto-oncogene tyrosine-protein kinase ROS,10.0,8.65,0.1,5,9
1757351,CHEMBL3286830,LORLATINIB,100417,CHEMBL4247,ALK tyrosine kinase receptor,9.7,8.13,0.2,34,9
1757351,CHEMBL3286830,LORLATINIB,101484,CHEMBL5627,Leukocyte tyrosine kinase receptor,8.57,8.57,2.7,2,9
1757351,CHEMBL3286830,LORLATINIB,30007,CHEMBL3982,Tyrosine-protein kinase Fer,8.48,8.48,3.3,2,9
1757351,CHEMBL3286830,LORLATINIB,100069,CHEMBL5455,Tyrosine-protein kinase Fes/Fps,8.22,8.22,6.0,2,9
1757351,CHEMBL3286830,LORLATINIB,100995,CHEMBL5469,Protein-tyrosine kinase 2-beta,7.85,7.85,14.0,2,9
1757351,CHEMBL3286830,LORLATINIB,11242,CHEMBL2695,Focal adhesion kinase 1,7.77,7.77,17.0,2,9
1757351,CHEMBL3286830,LORLATINIB,30023,CHEMBL4599,Activated CDC42 kinase 1,7.77,7.77,17.0,2,9
1757351,CHEMBL3286830,LORLATINIB,100413,CHEMBL4898,BDNF/NT-3 growth factors receptor,7.64,7.64,23.0,3,9
1757351,CHEMBL3286830,LORLATINIB,11902,CHEMBL2815,High affinity nerve growth factor receptor,7.62,7.62,24.0,2,9
1757351,CHEMBL3286830,LORLATINIB,101598,CHEMBL5903,Activin receptor type-1,7.54,7.54,29.0,1,9
1757351,CHEMBL3286830,LORLATINIB,101034,CHEMBL5608,NT-3 growth factor receptor,7.34,7.34,46.0,2,9
1757351,CHEMBL3286830,LORLATINIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,7.28,7.28,53.0,2,9
1757351,CHEMBL3286830,LORLATINIB,9,CHEMBL203,Epidermal growth factor receptor,7.25,6.43,56.0,3,9
1757351,CHEMBL3286830,LORLATINIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,6.28,6.28,529.0,1,9
1757351,CHEMBL3286830,LORLATINIB,280,CHEMBL256,Adenosine receptor A3,5.92,5.92,1200.0,1,8
1757351,CHEMBL3286830,LORLATINIB,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.8,5.8,1600.0,1,8
1757351,CHEMBL3286830,LORLATINIB,93,CHEMBL220,Acetylcholinesterase,5.75,5.75,1800.0,1,8
1761965,CHEMBL3291398,LEFAMULIN,17045,CHEMBL340,Cytochrome P450 3A4,6.12,6.1,750.0,2,9
163172,CHEMBL329522,EXIFONE,12697,CHEMBL325,Histone deacetylase 1,7.35,7.35,45.0,1,9
1763543,CHEMBL3301581,ABALOPARATIDE,160,CHEMBL1793,Parathyroid hormone/parathyroid hormone-related peptide receptor,10.7,10.7,0.02,1,9
1763569,CHEMBL3301607,FILGOTINIB,10919,CHEMBL2835,Tyrosine-protein kinase JAK1,8.0,7.24,10.0,37,9
1763569,CHEMBL3301607,FILGOTINIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,7.6,7.08,25.0,27,9
1763569,CHEMBL3301607,FILGOTINIB,12694,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,7.18,6.76,65.3,22,9
1763569,CHEMBL3301607,FILGOTINIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,6.83,6.37,149.0,21,9
1763569,CHEMBL3301607,FILGOTINIB,11752,CHEMBL1955,Vascular endothelial growth factor receptor 3,6.56,6.56,274.0,3,9
1763569,CHEMBL3301607,FILGOTINIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,6.47,6.47,338.0,3,9
1763569,CHEMBL3301607,FILGOTINIB,12840,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,6.31,6.31,488.9,3,9
1763569,CHEMBL3301607,FILGOTINIB,100948,CHEMBL5331,Tyrosine-protein kinase Mer,5.89,5.89,1274.0,1,9
1763569,CHEMBL3301607,FILGOTINIB,10979,CHEMBL1868,Vascular endothelial growth factor receptor 1,5.88,5.88,1327.0,1,9
1763569,CHEMBL3301607,FILGOTINIB,100856,CHEMBL5408,Serine/threonine-protein kinase TBK1,5.75,5.75,1791.0,1,9
1763569,CHEMBL3301607,FILGOTINIB,30006,CHEMBL3981,Serine/threonine-protein kinase 10,5.72,5.72,1912.0,1,9
1763569,CHEMBL3301607,FILGOTINIB,117490,CHEMBL4105885,AarF domain-containing protein kinase 1,5.69,5.69,2028.0,1,9
1763569,CHEMBL3301607,FILGOTINIB,11408,CHEMBL2637,Mitogen-activated protein kinase 10,5.67,5.67,2140.0,1,9
1763569,CHEMBL3301607,FILGOTINIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,5.64,5.64,2302.0,1,9
1763572,CHEMBL3301610,ABEMACICLIB,12946,CHEMBL331,Cyclin-dependent kinase 4,9.59,8.61,0.26,13,9
1763572,CHEMBL3301610,ABEMACICLIB,30013,CHEMBL4224,Dual specificity protein kinase CLK1,9.07,7.88,0.851,4,9
1763572,CHEMBL3301610,ABEMACICLIB,10480,CHEMBL2508,Cyclin-dependent kinase 6,8.72,8.01,1.9,15,9
1763572,CHEMBL3301610,ABEMACICLIB,11622,CHEMBL2801,Calcium/calmodulin-dependent protein kinase type II subunit delta,8.59,8.15,2.6,2,9
1763572,CHEMBL3301610,ABEMACICLIB,12090,CHEMBL2292,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,8.47,7.61,3.349,4,9
1763572,CHEMBL3301610,ABEMACICLIB,10396,CHEMBL4121,Calcium/calmodulin-dependent protein kinase type II subunit beta,8.46,8.46,3.5,1,9
1763572,CHEMBL3301610,ABEMACICLIB,101014,CHEMBL5543,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,8.46,8.18,3.5,2,9
1763572,CHEMBL3301610,ABEMACICLIB,10839,CHEMBL2147,Serine/threonine-protein kinase pim-1,8.41,7.91,3.92,5,9
1763572,CHEMBL3301610,ABEMACICLIB,10197,CHEMBL262,Glycogen synthase kinase-3 beta,8.12,7.45,7.673,6,9
1763572,CHEMBL3301610,ABEMACICLIB,11017,CHEMBL2850,Glycogen synthase kinase-3 alpha,7.89,7.89,13.0,1,9
1763572,CHEMBL3301610,ABEMACICLIB,30036,CHEMBL4203,Dual specificity protein kinase CLK4,7.89,7.47,13.0,2,9
1763572,CHEMBL3301610,ABEMACICLIB,30002,CHEMBL3829,Calcium/calmodulin-dependent protein kinase type II subunit gamma,7.75,7.52,18.0,2,9
1763572,CHEMBL3301610,ABEMACICLIB,12780,CHEMBL4070,Casein kinase II subunit alpha',7.72,7.72,19.0,1,9
1763572,CHEMBL3301610,ABEMACICLIB,100851,CHEMBL4575,Dual specificity tyrosine-phosphorylation-regulated kinase 3,7.69,7.69,20.6,1,9
1763572,CHEMBL3301610,ABEMACICLIB,100790,CHEMBL4376,Dual specificity tyrosine-phosphorylation-regulated kinase 2,7.59,7.34,25.4,3,9
1763572,CHEMBL3301610,ABEMACICLIB,100852,CHEMBL4576,Homeodomain-interacting protein kinase 2,7.51,7.51,31.0,2,9
1763572,CHEMBL3301610,ABEMACICLIB,11626,CHEMBL3116,Cyclin-dependent kinase 9,7.46,7.23,34.5,4,9
1763572,CHEMBL3301610,ABEMACICLIB,117490,CHEMBL4105885,AarF domain-containing protein kinase 1,7.4,7.4,40.0,1,9
1763572,CHEMBL3301610,ABEMACICLIB,30022,CHEMBL4597,Cyclin-dependent kinase 16,7.3,7.3,50.0,1,9
1763572,CHEMBL3301610,ABEMACICLIB,11678,CHEMBL301,Cyclin-dependent kinase 2,7.28,6.89,52.2,4,9
1763572,CHEMBL3301610,ABEMACICLIB,103455,CHEMBL1163126,Serine/threonine-protein kinase ICK,7.28,7.28,53.0,1,9
1763572,CHEMBL3301610,ABEMACICLIB,12947,CHEMBL4036,Cyclin-dependent kinase 5,7.09,6.9,81.8,4,9
1763572,CHEMBL3301610,ABEMACICLIB,117538,CHEMBL4105933,Uncharacterized protein FLJ45252,7.06,7.06,88.0,1,9
1763572,CHEMBL3301610,ABEMACICLIB,30000,CHEMBL3830,AP2-associated protein kinase 1,6.99,6.99,102.0,1,9
1763572,CHEMBL3301610,ABEMACICLIB,101131,CHEMBL5261,Serine/threonine-protein kinase TAO1,6.97,6.97,107.0,1,9
1763572,CHEMBL3301610,ABEMACICLIB,10044,CHEMBL3629,Casein kinase II subunit alpha,6.93,6.93,117.0,1,9
1763572,CHEMBL3301610,ABEMACICLIB,19623,CHEMBL3357,Interleukin-1 receptor-associated kinase 1,6.9,6.9,126.0,1,9
1763572,CHEMBL3301610,ABEMACICLIB,30014,CHEMBL4225,Dual specificity protein kinase CLK2,6.73,6.73,185.3,1,9
1763572,CHEMBL3301610,ABEMACICLIB,12071,CHEMBL308,Cyclin-dependent kinase 1,6.58,6.33,263.0,3,9
1763572,CHEMBL3301610,ABEMACICLIB,12829,CHEMBL3055,Cyclin-dependent kinase 7,6.52,6.29,300.0,3,9
1763572,CHEMBL3301610,ABEMACICLIB,10280,CHEMBL264,Histamine H3 receptor,6.51,6.51,310.0,1,8
1763572,CHEMBL3301610,ABEMACICLIB,11408,CHEMBL2637,Mitogen-activated protein kinase 10,6.41,6.41,389.0,2,9
1763572,CHEMBL3301610,ABEMACICLIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,6.39,6.39,403.0,2,9
1763572,CHEMBL3301610,ABEMACICLIB,30004,CHEMBL3938,Serine/threonine-protein kinase 16,6.3,6.3,495.0,1,9
1763572,CHEMBL3301610,ABEMACICLIB,11635,CHEMBL299,Protein kinase C alpha type,6.28,6.28,530.0,1,9
1763572,CHEMBL3301610,ABEMACICLIB,30045,CHEMBL4525,Serine/threonine-protein kinase 17A,6.18,6.18,659.0,2,9
1763572,CHEMBL3301610,ABEMACICLIB,12247,CHEMBL2996,Protein kinase C delta type,6.1,6.1,795.0,1,9
1763572,CHEMBL3301610,ABEMACICLIB,101239,CHEMBL5579,Citron Rho-interacting kinase,6.1,6.1,798.0,1,9
1763572,CHEMBL3301610,ABEMACICLIB,11902,CHEMBL2815,High affinity nerve growth factor receptor,5.99,5.99,1030.0,2,9
1763572,CHEMBL3301610,ABEMACICLIB,101464,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,5.88,5.88,1322.0,1,9
1763572,CHEMBL3301610,ABEMACICLIB,11636,CHEMBL3045,Protein kinase C beta type,5.79,5.79,1624.0,1,9
1763572,CHEMBL3301610,ABEMACICLIB,101506,CHEMBL5701,Serine/threonine-protein kinase TAO3,5.76,5.76,1721.0,1,9
1763572,CHEMBL3301610,ABEMACICLIB,10885,CHEMBL2595,Serine/threonine-protein kinase D3,5.74,5.74,1841.0,1,9
1763572,CHEMBL3301610,ABEMACICLIB,100415,CHEMBL4900,Serine/threonine-protein kinase D2,5.68,5.68,2064.0,1,9
1763572,CHEMBL3301610,ABEMACICLIB,20020,CHEMBL4355,Cyclin-G-associated kinase,5.66,5.66,2194.0,1,9
1763572,CHEMBL3301610,ABEMACICLIB,30006,CHEMBL3981,Serine/threonine-protein kinase 10,5.61,5.61,2470.0,1,9
1763572,CHEMBL3301610,ABEMACICLIB,30032,CHEMBL5284,Calcium/calmodulin-dependent protein kinase kinase 2,5.58,5.58,2598.0,1,9
1763572,CHEMBL3301610,ABEMACICLIB,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",5.5,5.5,3200.0,1,8
1763574,CHEMBL3301612,ENCORAFENIB,100126,CHEMBL5145,Serine/threonine-protein kinase B-raf,9.52,8.95,0.3,10,9
1763574,CHEMBL3301612,ENCORAFENIB,30018,CHEMBL3836,LIM domain kinase 1,7.58,7.58,26.0,1,9
1763574,CHEMBL3301612,ENCORAFENIB,117460,CHEMBL4105855,Choline-phosphate cytidylyltransferase A,7.39,7.39,41.0,1,9
1763574,CHEMBL3301612,ENCORAFENIB,101386,CHEMBL5932,LIM domain kinase 2,7.02,7.02,96.0,1,9
1763574,CHEMBL3301612,ENCORAFENIB,12946,CHEMBL331,Cyclin-dependent kinase 4,6.95,6.95,112.0,1,9
1763574,CHEMBL3301612,ENCORAFENIB,117311,CHEMBL4105706,Membrane-associated progesterone receptor component 1,6.69,6.69,204.0,1,9
1763574,CHEMBL3301612,ENCORAFENIB,19623,CHEMBL3357,Interleukin-1 receptor-associated kinase 1,6.61,6.61,247.0,1,9
1763574,CHEMBL3301612,ENCORAFENIB,20025,CHEMBL5014,Receptor-interacting serine/threonine-protein kinase 2,6.49,6.49,323.0,1,9
1763574,CHEMBL3301612,ENCORAFENIB,10197,CHEMBL262,Glycogen synthase kinase-3 beta,6.37,6.37,425.0,1,9
1763574,CHEMBL3301612,ENCORAFENIB,100931,CHEMBL5364,Serine/threonine-protein kinase NLK,6.13,6.13,732.0,1,9
1763574,CHEMBL3301612,ENCORAFENIB,20007,CHEMBL3886,Mitogen-activated protein kinase kinase kinase 20,6.11,6.11,785.0,1,9
1763574,CHEMBL3301612,ENCORAFENIB,11870,CHEMBL2708,Mitogen-activated protein kinase kinase kinase 11,6.09,6.09,812.0,1,9
1763574,CHEMBL3301612,ENCORAFENIB,11407,CHEMBL4179,Mitogen-activated protein kinase 9,6.04,6.04,915.0,1,9
1763574,CHEMBL3301612,ENCORAFENIB,104279,CHEMBL1795199,Receptor-interacting serine/threonine-protein kinase 3,6.01,6.01,967.0,1,9
1763574,CHEMBL3301612,ENCORAFENIB,30050,CHEMBL4853,Mitogen-activated protein kinase kinase kinase 4,5.84,5.84,1437.0,1,9
1763574,CHEMBL3301612,ENCORAFENIB,12261,CHEMBL2276,Mitogen-activated protein kinase 8,5.73,5.73,1865.0,1,9
1763574,CHEMBL3301612,ENCORAFENIB,10188,CHEMBL260,Mitogen-activated protein kinase 14,5.66,5.66,2200.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,9.8,8.79,0.16,27,9
1763584,CHEMBL3301622,GILTERITINIB,101484,CHEMBL5627,Leukocyte tyrosine kinase receptor,9.46,9.46,0.35,1,9
1763584,CHEMBL3301622,GILTERITINIB,100410,CHEMBL4895,Tyrosine-protein kinase receptor UFO,9.14,8.5,0.73,18,9
1763584,CHEMBL3301622,GILTERITINIB,100417,CHEMBL4247,ALK tyrosine kinase receptor,8.92,8.89,1.2,3,9
1763584,CHEMBL3301622,GILTERITINIB,101019,CHEMBL5568,Proto-oncogene tyrosine-protein kinase ROS,8.72,8.72,1.9,1,8
1763584,CHEMBL3301622,GILTERITINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,8.47,7.88,3.4,2,9
1763584,CHEMBL3301622,GILTERITINIB,101048,CHEMBL5047,Serine/threonine-protein kinase ULK3,8.22,8.22,6.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,101055,CHEMBL5081,Interleukin-1 receptor-associated kinase 3,8.15,8.15,7.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,20020,CHEMBL4355,Cyclin-G-associated kinase,8.05,8.05,9.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,117538,CHEMBL4105933,Uncharacterized protein FLJ45252,7.96,7.96,11.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,30003,CHEMBL3788,Serine/threonine-protein kinase PLK4,7.75,7.75,18.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,30000,CHEMBL3830,AP2-associated protein kinase 1,7.6,7.6,25.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,100951,CHEMBL5334,Non-receptor tyrosine-protein kinase TNK1,7.41,7.41,39.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,101598,CHEMBL5903,Activin receptor type-1,7.41,7.41,39.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,30042,CHEMBL4522,BMP-2-inducible protein kinase,7.34,7.34,46.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,12735,CHEMBL2349,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",7.32,7.32,48.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,30035,CHEMBL4202,STE20-like serine/threonine-protein kinase,7.17,7.17,68.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,101312,CHEMBL5749,Mitogen-activated protein kinase kinase kinase kinase 1,6.97,6.97,108.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,100907,CHEMBL5275,Bone morphogenetic protein receptor type-1A,6.92,6.92,121.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,30006,CHEMBL3981,Serine/threonine-protein kinase 10,6.83,6.83,149.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,117490,CHEMBL4105885,AarF domain-containing protein kinase 1,6.82,6.82,152.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,30002,CHEMBL3829,Calcium/calmodulin-dependent protein kinase type II subunit gamma,6.77,6.77,169.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,20014,CHEMBL4722,Aurora kinase A,6.74,6.74,184.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,10250,CHEMBL2428,"Myosin light chain kinase, smooth muscle",6.73,6.73,188.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,30007,CHEMBL3982,Tyrosine-protein kinase Fer,6.73,6.73,188.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,104146,CHEMBL1772932,Mitotic checkpoint serine/threonine-protein kinase BUB1,6.72,6.72,191.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,101464,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,6.7,6.7,202.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,117580,CHEMBL4105975,"Cytochrome c1, heme protein, mitochondrial",6.7,6.7,202.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,11622,CHEMBL2801,Calcium/calmodulin-dependent protein kinase type II subunit delta,6.68,6.68,207.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,117423,CHEMBL4105818,Long-chain-fatty-acid--CoA ligase 5,6.68,6.68,208.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,101465,CHEMBL6167,Serine/threonine-protein kinase LATS1,6.66,6.66,221.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,101056,CHEMBL5082,Serine/threonine-protein kinase 24,6.64,6.64,230.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,102676,CHEMBL5836,Ephrin type-B receptor 6,6.62,6.62,241.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,30017,CHEMBL3835,Serine/threonine-protein kinase Nek2,6.61,6.61,247.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,100947,CHEMBL5330,Mitogen-activated protein kinase kinase kinase kinase 2,6.61,6.61,244.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,100833,CHEMBL5198,Mitogen-activated protein kinase 15,6.58,6.58,263.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,30004,CHEMBL3938,Serine/threonine-protein kinase 16,6.53,6.53,295.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,10971,CHEMBL2494,Calcium/calmodulin-dependent protein kinase type IV,6.38,6.38,421.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,11407,CHEMBL4179,Mitogen-activated protein kinase 9,6.37,6.37,430.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,105655,CHEMBL2331059,Delta(24)-sterol reductase,6.37,6.37,432.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,18033,CHEMBL2073,Tyrosine-protein kinase Yes,6.35,6.35,445.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,111631,CHEMBL3709670,ADP/ATP translocase 2,6.35,6.35,451.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,117575,CHEMBL4105970,"Elongation factor Tu, mitochondrial",6.33,6.33,464.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,20025,CHEMBL5014,Receptor-interacting serine/threonine-protein kinase 2,6.32,6.32,482.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,11046,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,6.3,6.3,502.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,117459,CHEMBL4105854,ADP/ATP translocase 3,6.3,6.3,495.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,197,CHEMBL1913,Platelet-derived growth factor receptor beta,6.29,6.29,510.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,11408,CHEMBL2637,Mitogen-activated protein kinase 10,6.29,6.29,512.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,100995,CHEMBL5469,Protein-tyrosine kinase 2-beta,6.29,6.29,510.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,102711,CHEMBL5914,Mitogen-activated protein kinase kinase kinase 2,6.27,6.27,536.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,101204,CHEMBL5476,Bone morphogenetic protein receptor type-1B,6.24,6.24,572.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,11635,CHEMBL299,Protein kinase C alpha type,6.23,6.23,591.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,11870,CHEMBL2708,Mitogen-activated protein kinase kinase kinase 11,6.22,6.22,600.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,101188,CHEMBL5432,Mitogen-activated protein kinase kinase kinase kinase 3,6.22,6.22,605.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,12261,CHEMBL2276,Mitogen-activated protein kinase 8,6.13,6.13,736.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,103986,CHEMBL1741190,GTP-binding nuclear protein Ran,6.12,6.12,759.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,11379,CHEMBL2689,Macrophage-stimulating protein receptor,6.09,6.09,804.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,12780,CHEMBL4070,Casein kinase II subunit alpha',6.02,6.02,960.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,101613,CHEMBL5941,Serine/threonine-protein kinase 26,5.94,5.94,1143.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,104279,CHEMBL1795199,Receptor-interacting serine/threonine-protein kinase 3,5.88,5.88,1304.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,117577,CHEMBL4105972,U5 small nuclear ribonucleoprotein 200 kDa helicase,5.86,5.86,1382.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,12915,CHEMBL3529,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,5.83,5.83,1468.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,11785,CHEMBL3234,Tyrosine-protein kinase HCK,5.8,5.8,1594.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,10170,CHEMBL3959,Ribosyldihydronicotinamide dehydrogenase [quinone],5.77,5.77,1701.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,19639,CHEMBL3778,Interleukin-1 receptor-associated kinase 4,5.75,5.75,1757.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,10235,CHEMBL2171,Dual specificity mitogen-activated protein kinase kinase 6,5.72,5.72,1895.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,12946,CHEMBL331,Cyclin-dependent kinase 4,5.71,5.71,1955.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,10371,CHEMBL4948,Dual specificity mitogen-activated protein kinase kinase 5,5.69,5.69,2040.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,103140,CHEMBL1075195,Serine/threonine-protein kinase TAO2,5.68,5.68,2092.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,101239,CHEMBL5579,Citron Rho-interacting kinase,5.63,5.63,2346.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,276,CHEMBL254,"3',5'-cyclic-AMP phosphodiesterase 4A",5.61,5.61,2440.0,1,8
1763584,CHEMBL3301622,GILTERITINIB,12724,CHEMBL2345,Ribosomal protein S6 kinase alpha-3,5.58,5.58,2661.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,30032,CHEMBL5284,Calcium/calmodulin-dependent protein kinase kinase 2,5.58,5.58,2648.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,104434,CHEMBL1938223,EKC/KEOPS complex subunit TP53RK,5.57,5.57,2716.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,11409,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,5.56,5.56,2755.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,102421,CHEMBL5679,Serine/threonine-protein kinase Nek3,5.55,5.55,2840.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,30027,CHEMBL4602,Ephrin type-A receptor 7,5.53,5.53,2980.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,30049,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,5.51,5.51,3115.0,1,9
1763584,CHEMBL3301622,GILTERITINIB,30023,CHEMBL4599,Activated CDC42 kinase 1,5.5,5.5,3149.0,1,9
1763586,CHEMBL3301624,SETMELANOTIDE,11003,CHEMBL4644,Melanocortin receptor 3,9.82,8.85,0.1514,4,9
1763586,CHEMBL3301624,SETMELANOTIDE,11869,CHEMBL3795,Melanocyte-stimulating hormone receptor,9.8,9.07,0.1585,4,9
1763586,CHEMBL3301624,SETMELANOTIDE,10142,CHEMBL259,Melanocortin receptor 4,9.57,9.03,0.27,5,9
1763586,CHEMBL3301624,SETMELANOTIDE,11006,CHEMBL4608,Melanocortin receptor 5,5.73,5.72,1862.09,2,9
1763589,CHEMBL3301627,TENAPANOR HYDROCHLORIDE,12588,CHEMBL3273,Sodium/hydrogen exchanger 3,8.2,8.13,6.31,3,9
1763646,CHEMBL3301675,LINACLOTIDE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.89,6.89,130.0,1,8
1766456,CHEMBL3304485,TENAPANOR,12588,CHEMBL3273,Sodium/hydrogen exchanger 3,9.3,8.4,0.5012,6,9
1768774,CHEMBL3306803,LUMATEPERONE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,9.27,9.27,0.54,2,9
1768774,CHEMBL3306803,LUMATEPERONE,72,CHEMBL217,D(2) dopamine receptor,8.49,8.44,3.2,2,9
1768774,CHEMBL3306803,LUMATEPERONE,121,CHEMBL228,Sodium-dependent serotonin transporter,8.48,8.48,3.3,1,9
192290,CHEMBL333826,DEQUALINIUM,93,CHEMBL220,Acetylcholinesterase,7.58,7.58,26.4,1,8
192290,CHEMBL333826,DEQUALINIUM,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.3,7.3,49.7,1,8
192290,CHEMBL333826,DEQUALINIUM,130,CHEMBL234,D(3) dopamine receptor,7.1,7.1,79.8,1,8
192290,CHEMBL333826,DEQUALINIUM,10280,CHEMBL264,Histamine H3 receptor,7.09,7.09,81.3,1,8
192290,CHEMBL333826,DEQUALINIUM,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.88,6.88,132.7,1,8
192290,CHEMBL333826,DEQUALINIUM,121,CHEMBL228,Sodium-dependent serotonin transporter,6.73,6.73,185.4,1,8
192290,CHEMBL333826,DEQUALINIUM,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.33,6.33,464.2,1,8
192290,CHEMBL333826,DEQUALINIUM,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.21,6.21,611.3,1,8
192290,CHEMBL333826,DEQUALINIUM,129,CHEMBL233,Mu-type opioid receptor,6.17,6.17,683.8,1,8
192290,CHEMBL333826,DEQUALINIUM,103668,CHEMBL1293235,Prelamin-A/C,6.1,6.1,794.3,1,9
192290,CHEMBL333826,DEQUALINIUM,155,CHEMBL238,Sodium-dependent dopamine transporter,6.05,6.05,890.3,1,8
192290,CHEMBL333826,DEQUALINIUM,88,CHEMBL2056,D(1A) dopamine receptor,5.98,5.98,1043.3,1,8
192290,CHEMBL333826,DEQUALINIUM,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.83,5.83,1465.2,1,8
192290,CHEMBL333826,DEQUALINIUM,96,CHEMBL221,Prostaglandin G/H synthase 1,5.8,5.8,1566.6,1,8
192290,CHEMBL333826,DEQUALINIUM,17045,CHEMBL340,Cytochrome P450 3A4,5.8,5.65,1584.89,6,9
192290,CHEMBL333826,DEQUALINIUM,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,5.7,5.7,1995.3,2,9
192290,CHEMBL333826,DEQUALINIUM,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.6,5.6,2525.9,1,8
192290,CHEMBL333826,DEQUALINIUM,276,CHEMBL254,"3',5'-cyclic-AMP phosphodiesterase 4A",5.5,5.5,3156.7,1,8
192290,CHEMBL333826,DEQUALINIUM,103657,CHEMBL1293224,Microtubule-associated protein tau,5.5,5.5,3162.3,1,9
1797534,CHEMBL3348923,TOVORAFENIB,100917,CHEMBL5319,Epithelial discoidin domain-containing receptor 1,7.2,7.2,63.0,1,9
1797534,CHEMBL3348923,TOVORAFENIB,10904,CHEMBL1906,RAF proto-oncogene serine/threonine-protein kinase,7.03,6.67,94.0,2,9
1797534,CHEMBL3348923,TOVORAFENIB,100126,CHEMBL5145,Serine/threonine-protein kinase B-raf,7.03,6.62,94.2,2,9
1797534,CHEMBL3348923,TOVORAFENIB,11209,CHEMBL4014,Tyrosine-protein kinase ABL2,7.0,7.0,99.0,1,9
1797534,CHEMBL3348923,TOVORAFENIB,11047,CHEMBL2897,Dual specificity mitogen-activated protein kinase kinase 4,6.84,6.84,146.0,1,9
1797534,CHEMBL3348923,TOVORAFENIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,6.76,6.76,172.0,1,9
1797534,CHEMBL3348923,TOVORAFENIB,101079,CHEMBL5122,Discoidin domain-containing receptor 2,6.64,6.64,227.0,1,9
1797534,CHEMBL3348923,TOVORAFENIB,100098,CHEMBL5491,Wee1-like protein kinase,6.6,6.6,252.0,1,9
1797534,CHEMBL3348923,TOVORAFENIB,100128,CHEMBL5146,Breakpoint cluster region protein,6.53,6.53,296.0,1,9
1797534,CHEMBL3348923,TOVORAFENIB,10188,CHEMBL260,Mitogen-activated protein kinase 14,6.45,6.45,358.0,1,9
1797534,CHEMBL3348923,TOVORAFENIB,20007,CHEMBL3886,Mitogen-activated protein kinase kinase kinase 20,6.35,6.35,450.0,1,9
1797534,CHEMBL3348923,TOVORAFENIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,6.3,6.3,498.0,1,9
1797534,CHEMBL3348923,TOVORAFENIB,10120,CHEMBL3961,Mitogen-activated protein kinase 11,6.17,6.17,684.0,1,9
1797534,CHEMBL3348923,TOVORAFENIB,30008,CHEMBL2068,Ephrin type-A receptor 2,6.09,6.09,807.0,1,9
1797534,CHEMBL3348923,TOVORAFENIB,30013,CHEMBL4224,Dual specificity protein kinase CLK1,6.03,6.03,942.0,1,9
1797534,CHEMBL3348923,TOVORAFENIB,30018,CHEMBL3836,LIM domain kinase 1,5.99,5.99,1021.0,1,9
1797534,CHEMBL3348923,TOVORAFENIB,101340,CHEMBL5810,Ephrin type-A receptor 1,5.97,5.97,1067.0,1,9
1797534,CHEMBL3348923,TOVORAFENIB,100075,CHEMBL4267,TGF-beta receptor type-2,5.79,5.79,1641.0,1,9
1797534,CHEMBL3348923,TOVORAFENIB,104279,CHEMBL1795199,Receptor-interacting serine/threonine-protein kinase 3,5.75,5.75,1800.0,1,9
1797534,CHEMBL3348923,TOVORAFENIB,12276,CHEMBL3956,Mitogen-activated protein kinase kinase kinase 1,5.68,5.68,2090.0,1,9
1797574,CHEMBL3348963,TELOTRISTAT ETIPRATE,101287,CHEMBL5689,Tryptophan 5-hydroxylase 1,6.16,6.16,700.0,1,9
1798218,CHEMBL3349607,PASIREOTIDE,11265,CHEMBL1792,Somatostatin receptor type 5,9.9,9.9,0.1259,1,8
1798218,CHEMBL3349607,PASIREOTIDE,11261,CHEMBL2028,Somatostatin receptor type 3,9.1,9.1,0.7943,1,8
1798218,CHEMBL3349607,PASIREOTIDE,117,CHEMBL1804,Somatostatin receptor type 2,9.0,9.0,1.0,1,8
1798218,CHEMBL3349607,PASIREOTIDE,12786,CHEMBL1917,Somatostatin receptor type 1,8.2,8.2,6.31,1,8
1798218,CHEMBL3349607,PASIREOTIDE,137,CHEMBL237,Kappa-type opioid receptor,7.28,7.28,52.4,1,8
1798218,CHEMBL3349607,PASIREOTIDE,11536,CHEMBL4616,Growth hormone secretagogue receptor type 1,6.59,6.59,255.9,1,8
1798218,CHEMBL3349607,PASIREOTIDE,129,CHEMBL233,Mu-type opioid receptor,6.26,6.26,550.0,1,8
1798218,CHEMBL3349607,PASIREOTIDE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.09,6.09,807.7,1,8
1798218,CHEMBL3349607,PASIREOTIDE,136,CHEMBL236,Delta-type opioid receptor,5.51,5.51,3100.0,1,8
217548,CHEMBL334966,CANGRELOR,176,CHEMBL2001,P2Y purinoceptor 12,9.4,9.06,0.3981,7,9
1817518,CHEMBL3353410,OSIMERTINIB,9,CHEMBL203,Epidermal growth factor receptor,10.7,7.81,0.02,258,9
1817518,CHEMBL3353410,OSIMERTINIB,102678,CHEMBL5838,Receptor tyrosine-protein kinase erbB-3,8.68,8.68,2.1,1,9
1817518,CHEMBL3353410,OSIMERTINIB,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,8.33,7.85,4.7,3,9
1817518,CHEMBL3353410,OSIMERTINIB,117542,CHEMBL4105937,"Cysteine--tRNA ligase, cytoplasmic",7.92,7.92,12.0,1,9
1817518,CHEMBL3353410,OSIMERTINIB,30023,CHEMBL4599,Activated CDC42 kinase 1,7.15,7.15,71.0,1,9
1817518,CHEMBL3353410,OSIMERTINIB,100417,CHEMBL4247,ALK tyrosine kinase receptor,6.75,6.75,177.0,1,9
1817518,CHEMBL3353410,OSIMERTINIB,100418,CHEMBL4246,Tyrosine-protein kinase Tec,6.49,6.49,321.0,1,9
1817518,CHEMBL3353410,OSIMERTINIB,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.43,6.43,370.0,1,8
1817518,CHEMBL3353410,OSIMERTINIB,100097,CHEMBL5251,Tyrosine-protein kinase BTK,6.28,6.28,525.0,1,9
1817518,CHEMBL3353410,OSIMERTINIB,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.24,5.96,570.0,2,9
1817518,CHEMBL3353410,OSIMERTINIB,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.21,6.21,610.0,1,8
1817518,CHEMBL3353410,OSIMERTINIB,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.15,6.15,710.0,1,8
1817518,CHEMBL3353410,OSIMERTINIB,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.08,6.08,832.5,1,8
1817518,CHEMBL3353410,OSIMERTINIB,35,CHEMBL1981,Insulin receptor,6.04,6.04,912.0,1,9
1817518,CHEMBL3353410,OSIMERTINIB,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.94,5.94,1148.9,1,8
1817518,CHEMBL3353410,OSIMERTINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,5.89,5.89,1300.0,1,8
1817518,CHEMBL3353410,OSIMERTINIB,104126,CHEMBL1770034,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,5.53,5.53,2973.0,1,9
1823083,CHEMBL3358920,ETRASIMOD,11631,CHEMBL4333,Sphingosine 1-phosphate receptor 1,10.4,9.11,0.04,5,9
1823083,CHEMBL3358920,ETRASIMOD,12023,CHEMBL2274,Sphingosine 1-phosphate receptor 5,7.61,7.61,24.4,1,9
1823083,CHEMBL3358920,ETRASIMOD,10809,CHEMBL3230,Sphingosine 1-phosphate receptor 4,6.83,6.83,147.0,1,9
204090,CHEMBL338802,SULFAGUANIDINE,103668,CHEMBL1293235,Prelamin-A/C,7.75,7.75,17.8,1,9
204090,CHEMBL338802,SULFAGUANIDINE,11,CHEMBL204,Prothrombin,7.02,7.02,95.0,1,8
45838,CHEMBL33986,BUTORPHANOL,129,CHEMBL233,Mu-type opioid receptor,9.92,8.76,0.12,15,9
45838,CHEMBL33986,BUTORPHANOL,137,CHEMBL237,Kappa-type opioid receptor,9.92,9.13,0.12,5,9
45838,CHEMBL33986,BUTORPHANOL,136,CHEMBL236,Delta-type opioid receptor,7.92,7.63,12.0,4,9
1832976,CHEMBL3402762,TEPOTINIB,11451,CHEMBL3717,Hepatocyte growth factor receptor,9.0,8.4,1.0,6,9
1832976,CHEMBL3402762,TEPOTINIB,10170,CHEMBL3959,Ribosyldihydronicotinamide dehydrogenase [quinone],6.06,6.06,875.0,1,9
1837803,CHEMBL3414621,TAZEMETOSTAT,105440,CHEMBL2189110,Histone-lysine N-methyltransferase EZH2,9.47,8.05,0.34,50,9
1837803,CHEMBL3414621,TAZEMETOSTAT,105447,CHEMBL2189117,Polycomb protein EED,8.7,8.05,2.0,2,9
1837803,CHEMBL3414621,TAZEMETOSTAT,105446,CHEMBL2189116,Histone-lysine N-methyltransferase EZH1,7.03,6.55,93.0,4,9
49931,CHEMBL34259,METHOTREXATE,6,CHEMBL202,Dihydrofolate reductase,11.0,8.17,0.01,85,9
49931,CHEMBL34259,METHOTREXATE,103668,CHEMBL1293235,Prelamin-A/C,8.35,7.55,4.5,3,9
49931,CHEMBL34259,METHOTREXATE,10123,CHEMBL4833,Reduced folate transporter,7.92,7.92,12.0,2,9
49931,CHEMBL34259,METHOTREXATE,105589,CHEMBL2311236,High mobility group protein B1,7.62,6.96,24.0,2,9
49931,CHEMBL34259,METHOTREXATE,103665,CHEMBL1293232,Survival motor neuron protein,7.05,6.95,89.1,2,9
49931,CHEMBL34259,METHOTREXATE,20053,CHEMBL4096,Cellular tumor antigen p53,7.0,7.0,100.0,2,9
49931,CHEMBL34259,METHOTREXATE,20077,CHEMBL5064,Folate receptor beta,6.97,6.82,106.0,4,9
49931,CHEMBL34259,METHOTREXATE,10103,CHEMBL2121,Folate receptor alpha,6.94,6.72,114.0,4,9
49931,CHEMBL34259,METHOTREXATE,104268,CHEMBL1795188,Proton-coupled folate transporter,6.92,6.92,120.5,2,9
49931,CHEMBL34259,METHOTREXATE,103768,CHEMBL1615382,Nuclear receptor coactivator 3,6.68,6.68,210.97,1,8
49931,CHEMBL34259,METHOTREXATE,28,CHEMBL1952,Thymidylate synthase,6.22,6.22,600.0,1,9
49931,CHEMBL34259,METHOTREXATE,10732,CHEMBL2518,Bifunctional purine biosynthesis protein ATIC,6.06,6.06,880.0,1,9
49931,CHEMBL34259,METHOTREXATE,100444,CHEMBL5255,Toll-like receptor 4,5.98,5.98,1040.0,2,9
49931,CHEMBL34259,METHOTREXATE,11152,CHEMBL3171,"Folylpolyglutamate synthase, mitochondrial",5.5,5.5,3200.0,1,8
246935,CHEMBL343448,ROMIDEPSIN,11206,CHEMBL1937,Histone deacetylase 2,10.42,8.42,0.038,18,9
246935,CHEMBL343448,ROMIDEPSIN,10869,CHEMBL3192,Histone deacetylase 8,9.82,8.76,0.15,4,9
246935,CHEMBL343448,ROMIDEPSIN,11208,CHEMBL1829,Histone deacetylase 3,9.82,8.86,0.15,8,9
246935,CHEMBL343448,ROMIDEPSIN,12697,CHEMBL325,Histone deacetylase 1,9.7,8.26,0.2,29,9
246935,CHEMBL343448,ROMIDEPSIN,12021,CHEMBL3310,Histone deacetylase 11,9.52,9.52,0.3,3,9
246935,CHEMBL343448,ROMIDEPSIN,10945,CHEMBL5103,Polyamine deacetylase HDAC10,9.05,8.8,0.9,5,9
246935,CHEMBL343448,ROMIDEPSIN,11307,CHEMBL1865,Histone deacetylase 6,8.04,6.57,9.1,20,9
246935,CHEMBL343448,ROMIDEPSIN,11232,CHEMBL3524,Histone deacetylase 4,7.69,6.47,20.5,13,9
246935,CHEMBL343448,ROMIDEPSIN,103454,CHEMBL1163125,Bromodomain-containing protein 4,7.44,7.44,36.0,1,9
246935,CHEMBL343448,ROMIDEPSIN,12283,CHEMBL2563,Histone deacetylase 5,6.26,6.26,550.0,2,9
246935,CHEMBL343448,ROMIDEPSIN,11797,CHEMBL4145,Histone deacetylase 9,5.96,5.96,1100.0,2,9
246935,CHEMBL343448,ROMIDEPSIN,12443,CHEMBL2716,Histone deacetylase 7,5.9,5.9,1250.0,2,9
246935,CHEMBL343448,ROMIDEPSIN,246,CHEMBL2069,Thromboxane A2 receptor,5.77,5.77,1708.6,1,8
227437,CHEMBL344159,TOLVAPTAN,112,CHEMBL1790,Vasopressin V2 receptor,9.37,8.68,0.43,6,9
227437,CHEMBL344159,TOLVAPTAN,134,CHEMBL1889,Vasopressin V1a receptor,7.5,6.79,32.0,3,9
227437,CHEMBL344159,TOLVAPTAN,129,CHEMBL233,Mu-type opioid receptor,6.39,6.39,410.01,1,9
227437,CHEMBL344159,TOLVAPTAN,117512,CHEMBL4105907,Sigma intracellular receptor 2,5.99,5.99,1031.22,1,9
252029,CHEMBL348000,CINCHOPHEN,103665,CHEMBL1293232,Survival motor neuron protein,6.35,6.35,446.7,1,9
2046,CHEMBL35,FUROSEMIDE,11063,CHEMBL3510,Carbonic anhydrase 14,7.28,7.28,52.0,1,9
2046,CHEMBL35,FUROSEMIDE,10193,CHEMBL261,Carbonic anhydrase 1,7.21,7.15,62.0,2,9
2046,CHEMBL35,FUROSEMIDE,15,CHEMBL205,Carbonic anhydrase 2,7.19,6.3,65.0,3,9
2046,CHEMBL35,FUROSEMIDE,10186,CHEMBL3025,Carbonic anhydrase 6,6.61,6.61,245.0,1,9
2046,CHEMBL35,FUROSEMIDE,12209,CHEMBL3242,Carbonic anhydrase 12,6.58,6.58,261.0,1,9
2046,CHEMBL35,FUROSEMIDE,11016,CHEMBL3969,"Carbonic anhydrase 5B, mitochondrial",6.49,6.49,322.0,1,9
2046,CHEMBL35,FUROSEMIDE,12952,CHEMBL3594,Carbonic anhydrase 9,6.38,6.38,420.0,1,9
2046,CHEMBL35,FUROSEMIDE,11042,CHEMBL4789,"Carbonic anhydrase 5A, mitochondrial",6.3,6.3,499.0,1,9
2046,CHEMBL35,FUROSEMIDE,11060,CHEMBL2326,Carbonic anhydrase 7,6.29,6.29,513.0,1,9
2046,CHEMBL35,FUROSEMIDE,12896,CHEMBL3729,Carbonic anhydrase 4,6.25,6.25,564.0,1,9
2046,CHEMBL35,FUROSEMIDE,104248,CHEMBL1795168,CDGSH iron-sulfur domain-containing protein 1,5.64,5.64,2285.0,1,9
2046,CHEMBL35,FUROSEMIDE,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,5.5,5.5,3200.0,1,9
1926763,CHEMBL3544914,TEZACAFTOR,11540,CHEMBL4051,Cystic fibrosis transmembrane conductance regulator,6.57,6.37,272.0,3,9
1926823,CHEMBL3544974,ASENAPINE MALEATE,102,CHEMBL1941,Histamine H2 receptor,8.24,8.24,5.7,2,9
1926837,CHEMBL3544988,DAPRODUSTAT,101502,CHEMBL5697,Egl nine homolog 1,7.17,7.17,67.0,1,9
1926908,CHEMBL3545059,ALISKIREN FUMARATE,11225,CHEMBL286,Renin,8.82,8.68,1.5,2,9
1926917,CHEMBL3545068,COPANLISIB HYDROCHLORIDE,11362,CHEMBL4005,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",9.3,9.3,0.5,1,9
1926917,CHEMBL3545068,COPANLISIB HYDROCHLORIDE,11177,CHEMBL3130,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",9.15,9.15,0.7,1,9
1926917,CHEMBL3545068,COPANLISIB HYDROCHLORIDE,12576,CHEMBL3145,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",8.43,8.43,3.7,1,9
1926917,CHEMBL3545068,COPANLISIB HYDROCHLORIDE,11939,CHEMBL3267,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",8.19,8.19,6.4,1,9
1926959,CHEMBL3545110,RIBOCICLIB,12946,CHEMBL331,Cyclin-dependent kinase 4,8.7,8.15,2.0,9,9
1926959,CHEMBL3545110,RIBOCICLIB,10480,CHEMBL2508,Cyclin-dependent kinase 6,8.22,7.4,6.0,10,9
1926959,CHEMBL3545110,RIBOCICLIB,30002,CHEMBL3829,Calcium/calmodulin-dependent protein kinase type II subunit gamma,6.61,6.61,247.0,1,9
1926959,CHEMBL3545110,RIBOCICLIB,11622,CHEMBL2801,Calcium/calmodulin-dependent protein kinase type II subunit delta,6.53,6.53,293.0,1,9
1926959,CHEMBL3545110,RIBOCICLIB,20020,CHEMBL4355,Cyclin-G-associated kinase,6.18,6.18,658.0,1,9
1926959,CHEMBL3545110,RIBOCICLIB,101504,CHEMBL5699,Serine/threonine-protein kinase SIK2,5.6,5.6,2492.0,1,9
1927030,CHEMBL3545181,TIOTROPIUM BROMIDE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,11.0,10.24,0.01,23,9
1927030,CHEMBL3545181,TIOTROPIUM BROMIDE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,10.89,9.74,0.013,8,9
1927030,CHEMBL3545181,TIOTROPIUM BROMIDE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,10.7,9.7,0.01995,13,9
1927030,CHEMBL3545181,TIOTROPIUM BROMIDE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,10.58,9.58,0.0266,4,9
1927030,CHEMBL3545181,TIOTROPIUM BROMIDE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,10.4,9.71,0.03981,3,9
1927030,CHEMBL3545181,TIOTROPIUM BROMIDE,127,CHEMBL231,Histamine H1 receptor,7.68,7.07,20.8,3,9
1927030,CHEMBL3545181,TIOTROPIUM BROMIDE,117512,CHEMBL4105907,Sigma intracellular receptor 2,5.69,5.69,2058.73,1,9
1927030,CHEMBL3545181,TIOTROPIUM BROMIDE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.54,5.54,2869.3,1,8
1927034,CHEMBL3545185,SELINEXOR,101280,CHEMBL5661,Exportin-1,7.92,7.59,12.0,4,9
1927034,CHEMBL3545185,SELINEXOR,126,CHEMBL230,Prostaglandin G/H synthase 2,7.21,7.21,61.0,1,8
1927034,CHEMBL3545185,SELINEXOR,96,CHEMBL221,Prostaglandin G/H synthase 1,6.64,6.64,230.0,1,8
1927101,CHEMBL3545252,DOCETAXEL,158,CHEMBL2032,Growth hormone-releasing hormone receptor,9.85,9.85,0.14,1,8
1927101,CHEMBL3545252,DOCETAXEL,9,CHEMBL203,Epidermal growth factor receptor,9.09,9.09,0.82,1,8
1927101,CHEMBL3545252,DOCETAXEL,10184,CHEMBL2327,Substance-K receptor,6.28,6.04,521.0,2,8
1927101,CHEMBL3545252,DOCETAXEL,17045,CHEMBL340,Cytochrome P450 3A4,5.7,5.7,2000.0,1,8
1927160,CHEMBL3545311,BRIGATINIB,100417,CHEMBL4247,ALK tyrosine kinase receptor,9.43,8.62,0.37,20,9
1927160,CHEMBL3545311,BRIGATINIB,9,CHEMBL203,Epidermal growth factor receptor,9.15,7.7,0.7,74,9
1927160,CHEMBL3545311,BRIGATINIB,30007,CHEMBL3982,Tyrosine-protein kinase Fer,8.89,8.89,1.3,1,9
1927160,CHEMBL3545311,BRIGATINIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,8.82,7.45,1.5,7,9
1927160,CHEMBL3545311,BRIGATINIB,101019,CHEMBL5568,Proto-oncogene tyrosine-protein kinase ROS,8.72,8.72,1.9,2,9
1927160,CHEMBL3545311,BRIGATINIB,100069,CHEMBL5455,Tyrosine-protein kinase Fes/Fps,8.46,8.46,3.5,1,9
1927160,CHEMBL3545311,BRIGATINIB,11242,CHEMBL2695,Focal adhesion kinase 1,8.41,8.41,3.9,1,9
1927160,CHEMBL3545311,BRIGATINIB,30026,CHEMBL4601,Protein-tyrosine kinase 6,8.39,8.39,4.1,1,9
1927160,CHEMBL3545311,BRIGATINIB,101408,CHEMBL6003,Testis-specific serine/threonine-protein kinase 1,8.36,8.36,4.4,1,9
1927160,CHEMBL3545311,BRIGATINIB,10531,CHEMBL2527,Serine/threonine-protein kinase Chk2,8.25,8.22,5.6,2,9
1927160,CHEMBL3545311,BRIGATINIB,11843,CHEMBL3906,Ribosomal protein S6 kinase alpha-2,7.89,7.89,13.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,101484,CHEMBL5627,Leukocyte tyrosine kinase receptor,7.85,7.85,14.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,18033,CHEMBL2073,Tyrosine-protein kinase Yes,7.72,7.72,19.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,7.66,7.47,22.0,3,9
1927160,CHEMBL3545311,BRIGATINIB,30013,CHEMBL4224,Dual specificity protein kinase CLK1,7.64,7.64,23.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,100995,CHEMBL5469,Protein-tyrosine kinase 2-beta,7.62,7.62,24.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,234,CHEMBL1957,Insulin-like growth factor 1 receptor,7.6,7.19,24.9,3,9
1927160,CHEMBL3545311,BRIGATINIB,12724,CHEMBL2345,Ribosomal protein S6 kinase alpha-3,7.58,7.58,26.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,12699,CHEMBL3009,Receptor tyrosine-protein kinase erbB-4,7.57,7.57,27.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,11622,CHEMBL2801,Calcium/calmodulin-dependent protein kinase type II subunit delta,7.54,7.54,29.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,10929,CHEMBL2553,Ribosomal protein S6 kinase alpha-1,7.52,7.52,30.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,12967,CHEMBL4630,Serine/threonine-protein kinase Chk1,7.52,7.52,30.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,10266,CHEMBL3650,Fibroblast growth factor receptor 1,7.39,7.14,41.0,2,9
1927160,CHEMBL3545311,BRIGATINIB,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,7.38,7.38,42.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,10939,CHEMBL4924,Ribosomal protein S6 kinase alpha-6,7.38,7.38,42.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,101211,CHEMBL5483,Insulin receptor-related protein,7.35,7.35,45.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,101332,CHEMBL5784,NUAK family SNF1-like kinase 1,7.33,7.33,47.0,2,9
1927160,CHEMBL3545311,BRIGATINIB,30002,CHEMBL3829,Calcium/calmodulin-dependent protein kinase type II subunit gamma,7.32,7.32,48.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,103154,CHEMBL1075104,Leucine-rich repeat serine/threonine-protein kinase 2,7.29,7.29,51.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,7.28,7.28,52.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,11752,CHEMBL1955,Vascular endothelial growth factor receptor 3,7.24,7.24,58.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,11451,CHEMBL3717,Hepatocyte growth factor receptor,7.16,7.16,70.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,30032,CHEMBL5284,Calcium/calmodulin-dependent protein kinase kinase 2,7.09,7.09,82.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,7.08,6.92,83.0,3,9
1927160,CHEMBL3545311,BRIGATINIB,100835,CHEMBL4718,MAP kinase-interacting serine/threonine-protein kinase 1,7.06,7.06,88.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,30001,CHEMBL3831,Serine/threonine-protein kinase MARK2,7.03,7.03,93.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,10885,CHEMBL2595,Serine/threonine-protein kinase D3,7.02,7.02,95.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,12735,CHEMBL2349,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",6.97,6.97,108.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,30006,CHEMBL3981,Serine/threonine-protein kinase 10,6.91,6.91,123.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,100140,CHEMBL5600,MAP/microtubule affinity-regulating kinase 3,6.9,6.9,127.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,100850,CHEMBL4574,Serine/threonine-protein kinase BRSK2,6.9,6.9,125.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,101612,CHEMBL5940,Serine/threonine-protein kinase MARK1,6.9,6.9,127.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,11691,CHEMBL2250,Tyrosine-protein kinase Blk,6.87,6.87,136.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,102391,CHEMBL6014,Testis-specific serine/threonine-protein kinase 2,6.86,6.86,138.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,20014,CHEMBL4722,Aurora kinase A,6.84,6.84,146.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,6.81,6.81,154.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,35,CHEMBL1981,Insulin receptor,6.8,6.75,160.0,2,9
1927160,CHEMBL3545311,BRIGATINIB,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,6.8,6.8,160.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,6.77,6.56,171.0,3,9
1927160,CHEMBL3545311,BRIGATINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,6.74,6.42,183.4,2,9
1927160,CHEMBL3545311,BRIGATINIB,11925,CHEMBL3973,Fibroblast growth factor receptor 4,6.74,6.74,181.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,10903,CHEMBL3863,Serine/threonine-protein kinase D1,6.71,6.71,197.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,6.7,6.7,198.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,11785,CHEMBL3234,Tyrosine-protein kinase HCK,6.7,6.7,198.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,10264,CHEMBL4142,Fibroblast growth factor receptor 2,6.69,6.67,203.0,2,9
1927160,CHEMBL3545311,BRIGATINIB,12038,CHEMBL2872,Mitogen-activated protein kinase kinase kinase 9,6.66,6.66,218.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,6.62,6.62,241.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,30014,CHEMBL4225,Dual specificity protein kinase CLK2,6.62,6.62,240.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,100415,CHEMBL4900,Serine/threonine-protein kinase D2,6.54,6.54,285.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,10844,CHEMBL2634,Tyrosine-protein kinase CSK,6.48,6.48,329.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,101269,CHEMBL5650,Serine/threonine-protein kinase BRSK1,6.47,6.47,338.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,11926,CHEMBL2742,Fibroblast growth factor receptor 3,6.45,6.45,358.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,12840,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,6.45,6.45,358.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,101504,CHEMBL5699,Serine/threonine-protein kinase SIK2,6.33,6.33,466.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,100127,CHEMBL4454,Tyrosine-protein kinase Fgr,6.31,6.31,492.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,101131,CHEMBL5261,Serine/threonine-protein kinase TAO1,6.31,6.31,493.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,6.29,6.29,512.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,10907,CHEMBL3024,Serine/threonine-protein kinase PLK1,6.21,6.21,611.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,100097,CHEMBL5251,Tyrosine-protein kinase BTK,6.17,6.17,674.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,100854,CHEMBL4578,Maternal embryonic leucine zipper kinase,6.05,6.05,895.0,1,9
1927160,CHEMBL3545311,BRIGATINIB,10280,CHEMBL264,Histamine H3 receptor,5.6,5.6,2534.3,1,8
1927216,CHEMBL3545367,LEMBOREXANT,12968,CHEMBL4792,Orexin receptor type 2,9.36,9.06,0.44,3,9
1927216,CHEMBL3545367,LEMBOREXANT,10009,CHEMBL5113,Orexin/Hypocretin receptor type 1,8.6,8.35,2.512,3,9
1927225,CHEMBL3545376,ERDAFITINIB,10266,CHEMBL3650,Fibroblast growth factor receptor 1,9.6,8.41,0.25,9,9
1927225,CHEMBL3545376,ERDAFITINIB,11926,CHEMBL2742,Fibroblast growth factor receptor 3,9.38,8.5,0.42,14,9
1927225,CHEMBL3545376,ERDAFITINIB,10264,CHEMBL4142,Fibroblast growth factor receptor 2,8.82,8.3,1.5,9,9
1927225,CHEMBL3545376,ERDAFITINIB,11925,CHEMBL3973,Fibroblast growth factor receptor 4,8.7,8.3,2.0,9,9
1927225,CHEMBL3545376,ERDAFITINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,7.43,7.4,36.8,4,9
1927225,CHEMBL3545376,ERDAFITINIB,121,CHEMBL228,Sodium-dependent serotonin transporter,5.64,5.64,2300.0,1,8
282991,CHEMBL354541,LOMITAPIDE,105195,CHEMBL2150844,Methionine synthase,9.3,9.3,0.5,1,9
282991,CHEMBL354541,LOMITAPIDE,11452,CHEMBL2569,Microsomal triglyceride transfer protein large subunit,9.1,8.43,0.8,3,9
282991,CHEMBL354541,LOMITAPIDE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.62,6.62,239.1,1,8
282991,CHEMBL354541,LOMITAPIDE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.07,6.07,860.0,1,8
282991,CHEMBL354541,LOMITAPIDE,88,CHEMBL2056,D(1A) dopamine receptor,5.83,5.83,1491.7,1,8
282991,CHEMBL354541,LOMITAPIDE,130,CHEMBL234,D(3) dopamine receptor,5.75,5.75,1757.5,1,8
282991,CHEMBL354541,LOMITAPIDE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.66,5.66,2203.8,1,8
282991,CHEMBL354541,LOMITAPIDE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.62,5.62,2404.2,1,8
1927281,CHEMBL3545432,IXAZOMIB CITRATE,100624,CHEMBL4662,Proteasome Macropain subunit MB1,9.03,8.75,0.93,2,9
1927831,CHEMBL3545985,BENZPHETAMINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,7.44,7.44,36.0,1,8
1927831,CHEMBL3545985,BENZPHETAMINE,121,CHEMBL228,Sodium-dependent serotonin transporter,7.12,7.12,75.0,1,8
1927831,CHEMBL3545985,BENZPHETAMINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.17,6.17,680.0,1,8
1927831,CHEMBL3545985,BENZPHETAMINE,137,CHEMBL237,Kappa-type opioid receptor,5.71,5.71,1974.1,1,8
1927831,CHEMBL3545985,BENZPHETAMINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.55,5.55,2800.0,1,8
1941483,CHEMBL3559672,RAUWOLFIA SERPENTINA,11365,CHEMBL289,Cytochrome P450 2D6,8.7,8.29,1.995,11,9
1941483,CHEMBL3559672,RAUWOLFIA SERPENTINA,218,CHEMBL1916,Alpha-2C adrenergic receptor,8.3,8.3,5.0,1,8
1941483,CHEMBL3559672,RAUWOLFIA SERPENTINA,103668,CHEMBL1293235,Prelamin-A/C,8.15,7.65,7.1,2,9
1941483,CHEMBL3559672,RAUWOLFIA SERPENTINA,52,CHEMBL1867,Alpha-2A adrenergic receptor,8.09,8.09,8.2,1,8
1941483,CHEMBL3559672,RAUWOLFIA SERPENTINA,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.84,7.84,14.5,1,8
1946519,CHEMBL3578202,GOZETOTIDE,184,CHEMBL1892,Glutamate carboxypeptidase 2,10.74,9.33,0.018,2,9
1951344,CHEMBL3590187,CLASCOTERONE,56,CHEMBL1871,Androgen receptor,7.4,7.35,40.0,2,9
462435,CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,103710,CHEMBL1293277,NPC intracellular cholesterol transporter 1,6.6,6.6,251.2,1,9
462435,CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,105688,CHEMBL2362976,Protein S100-A4,6.49,6.49,323.0,1,8
462435,CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,103727,CHEMBL1293294,Ras-related protein Rab-9A,6.35,6.35,446.7,1,9
462435,CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,103665,CHEMBL1293232,Survival motor neuron protein,6.3,6.17,501.2,2,9
462435,CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,101097,CHEMBL5162,Neuropeptide S receptor,6.2,6.2,631.0,1,9
462435,CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,63,CHEMBL1806,DNA topoisomerase 2-alpha,6.03,6.03,940.0,1,9
462435,CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,271,CHEMBL1947,Thyroid hormone receptor beta,5.55,5.55,2818.4,1,9
462435,CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,103657,CHEMBL1293224,Microtubule-associated protein tau,5.5,5.5,3162.3,1,9
2080,CHEMBL36,PYRIMETHAMINE,6,CHEMBL202,Dihydrofolate reductase,8.1,6.88,8.0,13,9
2080,CHEMBL36,PYRIMETHAMINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.19,6.19,649.0,1,8
2080,CHEMBL36,PYRIMETHAMINE,103665,CHEMBL1293232,Survival motor neuron protein,5.75,5.75,1778.3,1,9
2080,CHEMBL36,PYRIMETHAMINE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.66,5.66,2200.0,1,8
306429,CHEMBL360055,GALLAMINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.9,5.9,1270.3,1,8
301194,CHEMBL360328,LORCASERIN,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.89,6.78,1.3,19,9
301194,CHEMBL360328,LORCASERIN,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,8.89,6.6,1.3,21,9
301194,CHEMBL360328,LORCASERIN,108,CHEMBL225,5-hydroxytryptamine receptor 2C,8.74,7.97,1.82,29,9
301194,CHEMBL360328,LORCASERIN,87,CHEMBL218,Cannabinoid receptor 1,5.58,5.58,2600.0,1,8
301194,CHEMBL360328,LORCASERIN,121,CHEMBL228,Sodium-dependent serotonin transporter,5.58,5.58,2606.0,1,8
1959536,CHEMBL3608680,FEZOLINETANT,10982,CHEMBL4429,Neuromedin-K receptor,7.75,7.49,18.0,11,9
316347,CHEMBL361497,ARTESUNATE,100226,CHEMBL4411,Prostaglandin E synthase 2,5.8,5.8,1600.0,1,9
314132,CHEMBL361506,PENTAMIDINE ISETHIONATE,103134,CHEMBL1075189,Pyruvate kinase PKM,7.3,7.3,50.1,2,9
302297,CHEMBL361812,RAMATROBAN,246,CHEMBL2069,Thromboxane A2 receptor,9.24,8.03,0.58,8,9
302297,CHEMBL361812,RAMATROBAN,20174,CHEMBL5071,Prostaglandin D2 receptor 2,8.37,6.93,4.3,16,9
1966507,CHEMBL3622821,UPADACITINIB,10919,CHEMBL2835,Tyrosine-protein kinase JAK1,9.1,7.65,0.8,40,9
1966507,CHEMBL3622821,UPADACITINIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,8.8,6.85,1.6,27,9
1966507,CHEMBL3622821,UPADACITINIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,8.8,7.28,1.6,32,9
1966507,CHEMBL3622821,UPADACITINIB,12694,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,7.52,6.97,30.0,5,9
1966507,CHEMBL3622821,UPADACITINIB,11149,CHEMBL2973,Rho-associated protein kinase 2,6.38,6.38,420.0,2,9
1966507,CHEMBL3622821,UPADACITINIB,10811,CHEMBL3231,Rho-associated protein kinase 1,6.04,6.04,920.0,2,9
1966507,CHEMBL3622821,UPADACITINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,5.82,5.82,1500.0,1,9
1966507,CHEMBL3622821,UPADACITINIB,20020,CHEMBL4355,Cyclin-G-associated kinase,5.66,5.66,2200.0,1,9
1966507,CHEMBL3622821,UPADACITINIB,30028,CHEMBL5073,Calcium/calmodulin-dependent protein kinase type 1D,5.64,5.64,2300.0,2,9
1966507,CHEMBL3622821,UPADACITINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,5.62,5.62,2400.0,2,9
1966507,CHEMBL3622821,UPADACITINIB,101484,CHEMBL5627,Leukocyte tyrosine kinase receptor,5.57,5.57,2700.0,2,9
308699,CHEMBL363295,TERODILINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.3,6.25,500.0,2,8
308699,CHEMBL363295,TERODILINE,127,CHEMBL231,Histamine H1 receptor,6.12,6.12,760.0,1,8
308699,CHEMBL363295,TERODILINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,5.96,5.96,1100.0,1,8
308699,CHEMBL363295,TERODILINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.85,5.85,1400.0,1,8
308699,CHEMBL363295,TERODILINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.51,5.51,3100.0,1,8
328286,CHEMBL363392,MARALIXIBAT,12909,CHEMBL2778,Ileal sodium/bile acid cotransporter,9.55,9.55,0.28,2,9
1976141,CHEMBL3643413,LENIOLISIB,11177,CHEMBL3130,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",8.82,7.22,1.5,15,9
1976141,CHEMBL3643413,LENIOLISIB,11362,CHEMBL4005,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",7.12,6.52,75.5,4,9
1976141,CHEMBL3643413,LENIOLISIB,12576,CHEMBL3145,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",6.44,6.01,363.0,4,9
1976141,CHEMBL3643413,LENIOLISIB,10056,CHEMBL3142,DNA-dependent protein kinase catalytic subunit,6.06,6.06,880.0,2,9
1976141,CHEMBL3643413,LENIOLISIB,11939,CHEMBL3267,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",6.04,5.85,902.0,2,9
1978977,CHEMBL3646221,VADADUSTAT,101502,CHEMBL5697,Egl nine homolog 1,7.54,6.46,29.0,12,9
1978977,CHEMBL3646221,VADADUSTAT,101510,CHEMBL5705,Prolyl hydroxylase EGLN3,6.41,6.41,390.0,4,9
1978977,CHEMBL3646221,VADADUSTAT,119148,CHEMBL4523398,Prolyl 3-hydroxylase OGFOD1,5.85,5.85,1400.0,1,9
1987927,CHEMBL3655081,ABROCITINIB,10919,CHEMBL2835,Tyrosine-protein kinase JAK1,8.29,7.55,5.1,8,9
1987927,CHEMBL3655081,ABROCITINIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,7.44,6.29,36.0,7,9
1987927,CHEMBL3655081,ABROCITINIB,12694,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,6.8,6.21,160.0,4,9
1987927,CHEMBL3655081,ABROCITINIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,6.32,6.27,480.0,2,9
1987927,CHEMBL3655081,ABROCITINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,5.92,5.92,1200.0,1,9
2000990,CHEMBL3668014,LINZAGOLIX,118,CHEMBL1855,Gonadotropin-releasing hormone receptor,7.82,7.82,15.0,1,8
2034550,CHEMBL3701238,FUTIBATINIB,11926,CHEMBL2742,Fibroblast growth factor receptor 3,9.3,9.01,0.5,7,9
2034550,CHEMBL3701238,FUTIBATINIB,10264,CHEMBL4142,Fibroblast growth factor receptor 2,9.0,8.64,1.0,12,9
2034550,CHEMBL3701238,FUTIBATINIB,10266,CHEMBL3650,Fibroblast growth factor receptor 1,8.74,8.5,1.8,7,9
2034550,CHEMBL3701238,FUTIBATINIB,11925,CHEMBL3973,Fibroblast growth factor receptor 4,8.47,8.27,3.4,7,9
2034550,CHEMBL3701238,FUTIBATINIB,100097,CHEMBL5251,Tyrosine-protein kinase BTK,7.02,7.02,94.9,1,9
2034550,CHEMBL3701238,FUTIBATINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,5.63,5.63,2358.0,1,9
2039153,CHEMBL3707183,QUINIDINE SULFATE,11365,CHEMBL289,Cytochrome P450 2D6,7.7,7.7,20.0,2,9
2039218,CHEMBL3707247,OZANIMOD,11631,CHEMBL4333,Sphingosine 1-phosphate receptor 1,9.8,9.44,0.16,6,9
2039218,CHEMBL3707247,OZANIMOD,12023,CHEMBL2274,Sphingosine 1-phosphate receptor 5,8.37,7.81,4.3,2,9
2039284,CHEMBL3707313,TRIFAROTENE,240,CHEMBL2003,Retinoic acid receptor gamma,8.7,8.4,2.0,2,9
2039284,CHEMBL3707313,TRIFAROTENE,270,CHEMBL2008,Retinoic acid receptor beta,7.82,7.36,15.0,2,9
2039284,CHEMBL3707313,TRIFAROTENE,57,CHEMBL2055,Retinoic acid receptor alpha,6.3,6.3,500.0,2,9
2039302,CHEMBL3707331,ROLAPITANT,250,CHEMBL249,Substance-P receptor,9.18,9.18,0.66,1,9
2039319,CHEMBL3707348,ACALABRUTINIB,100097,CHEMBL5251,Tyrosine-protein kinase BTK,8.59,7.82,2.6,27,9
2039319,CHEMBL3707348,ACALABRUTINIB,100418,CHEMBL4246,Tyrosine-protein kinase Tec,8.26,7.38,5.5,8,9
2039319,CHEMBL3707348,ACALABRUTINIB,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,8.13,6.65,7.4,4,9
2039319,CHEMBL3707348,ACALABRUTINIB,12699,CHEMBL3009,Receptor tyrosine-protein kinase erbB-4,7.8,7.49,16.0,5,9
2039319,CHEMBL3707348,ACALABRUTINIB,11691,CHEMBL2250,Tyrosine-protein kinase Blk,7.75,7.75,18.0,1,9
2039319,CHEMBL3707348,ACALABRUTINIB,30016,CHEMBL3834,Cytoplasmic tyrosine-protein kinase BMX,7.72,7.03,19.0,6,9
2039319,CHEMBL3707348,ACALABRUTINIB,100424,CHEMBL4367,Tyrosine-protein kinase TXK,7.62,6.73,24.0,4,9
2039319,CHEMBL3707348,ACALABRUTINIB,9,CHEMBL203,Epidermal growth factor receptor,6.77,6.77,170.0,1,9
2039319,CHEMBL3707348,ACALABRUTINIB,109099,CHEMBL3308912,Platelet glycoprotein VI,5.92,5.92,1210.0,1,9
2039319,CHEMBL3707348,ACALABRUTINIB,280,CHEMBL256,Adenosine receptor A3,5.83,5.83,1483.7,1,8
2039319,CHEMBL3707348,ACALABRUTINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,5.7,5.7,2012.0,1,8
2039319,CHEMBL3707348,ACALABRUTINIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,5.52,5.52,3000.0,1,9
2039366,CHEMBL3707395,ELAFIBRANOR,163,CHEMBL239,Peroxisome proliferator-activated receptor alpha,8.0,6.79,10.0,7,9
2039366,CHEMBL3707395,ELAFIBRANOR,12227,CHEMBL3979,Peroxisome proliferator-activated receptor delta,8.0,6.74,10.0,6,9
2039366,CHEMBL3707395,ELAFIBRANOR,133,CHEMBL235,Peroxisome proliferator-activated receptor gamma,6.76,6.02,175.0,5,9
333370,CHEMBL370805,COCAINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,8.36,8.36,4.4,1,9
333370,CHEMBL370805,COCAINE,155,CHEMBL238,Sodium-dependent dopamine transporter,7.5,6.51,32.0,67,9
333370,CHEMBL370805,COCAINE,121,CHEMBL228,Sodium-dependent serotonin transporter,7.35,6.47,45.0,54,9
333370,CHEMBL370805,COCAINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.97,6.12,108.0,45,9
2041038,CHEMBL3716057,GEFAPIXANT,11904,CHEMBL2998,P2X purinoceptor 3,7.52,7.41,30.0,3,9
366860,CHEMBL373742,VASOPRESSIN,112,CHEMBL1790,Vasopressin V2 receptor,10.3,8.93,0.05,10,9
366860,CHEMBL373742,VASOPRESSIN,116,CHEMBL2049,Oxytocin receptor,10.0,8.29,0.1,11,9
366860,CHEMBL373742,VASOPRESSIN,134,CHEMBL1889,Vasopressin V1a receptor,9.63,9.04,0.2344,16,9
366860,CHEMBL373742,VASOPRESSIN,148,CHEMBL1921,Vasopressin V1b receptor,9.31,8.6,0.49,9,9
365189,CHEMBL374478,RIFAMPIN,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,6.72,6.03,190.0,12,9
365189,CHEMBL374478,RIFAMPIN,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,6.52,5.94,300.0,5,9
365189,CHEMBL374478,RIFAMPIN,20085,CHEMBL4729,Cytochrome P450 2B6,5.89,5.89,1300.0,1,9
365189,CHEMBL374478,RIFAMPIN,104062,CHEMBL1743121,Solute carrier organic anion transporter family member 1B3,5.85,5.83,1400.0,2,9
365189,CHEMBL374478,RIFAMPIN,125,CHEMBL229,Alpha-1A adrenergic receptor,5.63,5.63,2331.5,1,8
373970,CHEMBL376140,TIGECYCLINE,126,CHEMBL230,Prostaglandin G/H synthase 2,6.72,6.72,189.0,1,8
373970,CHEMBL376140,TIGECYCLINE,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.62,5.62,2390.0,1,8
377721,CHEMBL376359,ALOGLIPTIN,11140,CHEMBL284,Dipeptidyl peptidase 4,9.0,8.27,1.0,32,9
373981,CHEMBL376488,BEDAQUILINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.43,5.96,370.0,9,9
370289,CHEMBL376897,METHSCOPOLAMINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,10.2,8.69,0.0631,16,9
370289,CHEMBL376897,METHSCOPOLAMINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,10.02,9.36,0.0955,7,9
370289,CHEMBL376897,METHSCOPOLAMINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,9.87,9.64,0.1349,4,9
370289,CHEMBL376897,METHSCOPOLAMINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,9.85,9.28,0.1413,5,9
370289,CHEMBL376897,METHSCOPOLAMINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,9.68,9.33,0.2089,5,9
370289,CHEMBL376897,METHSCOPOLAMINE,78,CHEMBL1963,Thyrotropin receptor,6.1,6.1,794.3,1,9
54070,CHEMBL37744,ZIMELDINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.85,6.85,140.0,1,8
54070,CHEMBL37744,ZIMELDINE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.5,6.5,320.0,1,8
54070,CHEMBL37744,ZIMELDINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.21,6.21,620.0,1,8
54070,CHEMBL37744,ZIMELDINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.19,6.19,650.0,1,8
54070,CHEMBL37744,ZIMELDINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.8,5.8,1600.0,1,8
54070,CHEMBL37744,ZIMELDINE,129,CHEMBL233,Mu-type opioid receptor,5.51,5.51,3100.0,1,8
355917,CHEMBL378544,VINBLASTINE SULFATE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,7.5,7.5,31.6,2,9
355917,CHEMBL378544,VINBLASTINE SULFATE,101216,CHEMBL5514,Huntingtin,6.95,6.95,112.2,1,9
355917,CHEMBL378544,VINBLASTINE SULFATE,103727,CHEMBL1293294,Ras-related protein Rab-9A,6.5,6.5,316.2,1,9
355917,CHEMBL378544,VINBLASTINE SULFATE,103710,CHEMBL1293277,NPC intracellular cholesterol transporter 1,6.0,6.0,1000.0,1,9
355917,CHEMBL378544,VINBLASTINE SULFATE,103668,CHEMBL1293235,Prelamin-A/C,5.55,5.55,2818.4,1,9
2077913,CHEMBL3786343,OLMUTINIB,9,CHEMBL203,Epidermal growth factor receptor,9.05,7.72,0.9,10,9
2077913,CHEMBL3786343,OLMUTINIB,100097,CHEMBL5251,Tyrosine-protein kinase BTK,9.0,9.0,1.0,1,9
2077913,CHEMBL3786343,OLMUTINIB,280,CHEMBL256,Adenosine receptor A3,8.52,8.52,3.0,1,8
2077913,CHEMBL3786343,OLMUTINIB,155,CHEMBL238,Sodium-dependent dopamine transporter,7.25,7.25,55.9,1,8
2077913,CHEMBL3786343,OLMUTINIB,130,CHEMBL234,D(3) dopamine receptor,6.34,6.34,453.5,1,8
2077913,CHEMBL3786343,OLMUTINIB,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.27,6.27,540.0,1,8
2077913,CHEMBL3786343,OLMUTINIB,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.05,6.05,881.2,1,8
2077913,CHEMBL3786343,OLMUTINIB,10280,CHEMBL264,Histamine H3 receptor,6.03,6.03,940.0,1,8
2077913,CHEMBL3786343,OLMUTINIB,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.78,5.78,1642.6,1,8
2077913,CHEMBL3786343,OLMUTINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,5.69,5.69,2057.7,1,8
2077913,CHEMBL3786343,OLMUTINIB,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.64,5.64,2285.5,1,8
2077913,CHEMBL3786343,OLMUTINIB,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.61,5.61,2442.8,1,8
2077913,CHEMBL3786343,OLMUTINIB,276,CHEMBL254,"3',5'-cyclic-AMP phosphodiesterase 4A",5.5,5.5,3186.8,1,8
2208,CHEMBL38,TRETINOIN,240,CHEMBL2003,Retinoic acid receptor gamma,10.4,8.36,0.04,44,9
2208,CHEMBL38,TRETINOIN,57,CHEMBL2055,Retinoic acid receptor alpha,10.0,7.65,0.1,41,9
2208,CHEMBL38,TRETINOIN,107979,CHEMBL3091268,Nuclear receptor ROR-beta,9.82,7.76,0.15,3,9
2208,CHEMBL38,TRETINOIN,270,CHEMBL2008,Retinoic acid receptor beta,9.4,7.95,0.4,46,9
2208,CHEMBL38,TRETINOIN,275,CHEMBL2061,Retinoic acid receptor RXR-alpha,9.4,6.7,0.4,14,9
2208,CHEMBL38,TRETINOIN,277,CHEMBL1870,Retinoic acid receptor RXR-beta,9.3,6.69,0.5,9,9
2208,CHEMBL38,TRETINOIN,266,CHEMBL2004,Retinoic acid receptor RXR-gamma,8.85,6.68,1.4,12,9
2208,CHEMBL38,TRETINOIN,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,7.65,7.65,22.4,2,9
2208,CHEMBL38,TRETINOIN,10656,CHEMBL2487,Amyloid-beta precursor protein,6.75,6.75,180.0,1,9
2208,CHEMBL38,TRETINOIN,101591,CHEMBL5868,Nuclear receptor ROR-alpha,6.7,6.7,199.53,1,9
2208,CHEMBL38,TRETINOIN,103982,CHEMBL1741186,Nuclear receptor ROR-gamma,6.7,6.7,199.53,1,9
2208,CHEMBL38,TRETINOIN,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.64,6.54,228.0,2,8
2208,CHEMBL38,TRETINOIN,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,6.6,6.6,251.2,2,9
2208,CHEMBL38,TRETINOIN,11638,CHEMBL4040,Mitogen-activated protein kinase 1,6.24,6.24,576.0,1,8
2208,CHEMBL38,TRETINOIN,12883,CHEMBL2288,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1,6.24,6.12,580.0,6,9
2208,CHEMBL38,TRETINOIN,103665,CHEMBL1293232,Survival motor neuron protein,6.1,6.1,794.3,1,9
2208,CHEMBL38,TRETINOIN,276,CHEMBL254,"3',5'-cyclic-AMP phosphodiesterase 4A",5.89,5.89,1273.9,1,8
2208,CHEMBL38,TRETINOIN,280,CHEMBL256,Adenosine receptor A3,5.53,5.53,2982.0,1,8
2208,CHEMBL38,TRETINOIN,102780,CHEMBL6152,Alpha-synuclein,5.52,5.52,3000.0,1,9
2089491,CHEMBL3813873,PEXIDARTINIB,12840,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,8.77,7.82,1.7,38,9
2089491,CHEMBL3813873,PEXIDARTINIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,8.3,7.58,5.0,17,9
2089491,CHEMBL3813873,PEXIDARTINIB,12665,CHEMBL3920,Protein kinase C theta type,8.22,8.22,6.0,1,9
2089491,CHEMBL3813873,PEXIDARTINIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,8.16,7.62,6.9,12,9
2089491,CHEMBL3813873,PEXIDARTINIB,12627,CHEMBL2007,Platelet-derived growth factor receptor alpha,8.02,7.5,9.6,4,9
2089491,CHEMBL3813873,PEXIDARTINIB,101034,CHEMBL5608,NT-3 growth factor receptor,7.7,6.88,20.0,2,9
2089491,CHEMBL3813873,PEXIDARTINIB,197,CHEMBL1913,Platelet-derived growth factor receptor beta,7.44,7.11,36.0,3,9
2089491,CHEMBL3813873,PEXIDARTINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,6.88,6.25,130.9,4,9
2089491,CHEMBL3813873,PEXIDARTINIB,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.52,6.46,300.0,2,8
2089491,CHEMBL3813873,PEXIDARTINIB,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.3,6.3,496.3,1,8
2089491,CHEMBL3813873,PEXIDARTINIB,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.2,6.2,626.5,1,8
2089491,CHEMBL3813873,PEXIDARTINIB,10781,CHEMBL2185,Aurora kinase B,6.19,6.19,643.0,1,9
2089491,CHEMBL3813873,PEXIDARTINIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,6.07,6.07,860.0,1,9
2089491,CHEMBL3813873,PEXIDARTINIB,10979,CHEMBL1868,Vascular endothelial growth factor receptor 1,6.06,6.06,880.0,1,9
2089491,CHEMBL3813873,PEXIDARTINIB,125,CHEMBL229,Alpha-1A adrenergic receptor,5.88,5.81,1310.0,2,8
2089491,CHEMBL3813873,PEXIDARTINIB,117538,CHEMBL4105933,Uncharacterized protein FLJ45252,5.84,5.84,1452.0,1,9
332615,CHEMBL382301,ATOSIBAN,134,CHEMBL1889,Vasopressin V1a receptor,9.82,8.76,0.15,4,9
332615,CHEMBL382301,ATOSIBAN,116,CHEMBL2049,Oxytocin receptor,7.96,7.21,11.0,7,9
332615,CHEMBL382301,ATOSIBAN,148,CHEMBL1921,Vasopressin V1b receptor,7.36,7.36,44.0,1,9
332615,CHEMBL382301,ATOSIBAN,112,CHEMBL1790,Vasopressin V2 receptor,6.48,6.48,330.0,1,9
2096370,CHEMBL3833319,REVEFENACIN,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.33,7.33,46.88,1,9
2096419,CHEMBL3833368,RUCAPARIB CAMSYLATE,11663,CHEMBL3105,Poly [ADP-ribose] polymerase 1,8.85,8.85,1.4,1,9
365281,CHEMBL384467,DEXAMETHASONE,25,CHEMBL2034,Glucocorticoid receptor,10.0,8.54,0.1,115,9
365281,CHEMBL384467,DEXAMETHASONE,48,CHEMBL1994,Mineralocorticoid receptor,9.44,7.73,0.36,10,9
365281,CHEMBL384467,DEXAMETHASONE,10751,CHEMBL3476,Inhibitor of nuclear factor kappa-B kinase subunit alpha,9.3,9.3,0.5,1,9
365281,CHEMBL384467,DEXAMETHASONE,10752,CHEMBL1991,Inhibitor of nuclear factor kappa-B kinase subunit beta,9.3,9.3,0.5,1,9
365281,CHEMBL384467,DEXAMETHASONE,43,CHEMBL210,Beta-2 adrenergic receptor,8.66,8.66,2.2,1,9
365281,CHEMBL384467,DEXAMETHASONE,78,CHEMBL1963,Thyrotropin receptor,7.9,7.9,12.6,2,9
365281,CHEMBL384467,DEXAMETHASONE,36,CHEMBL208,Progesterone receptor,6.7,6.36,200.0,4,9
365281,CHEMBL384467,DEXAMETHASONE,10584,CHEMBL3474,"Phospholipase A2, membrane associated",6.23,6.23,590.0,1,9
365281,CHEMBL384467,DEXAMETHASONE,56,CHEMBL1871,Androgen receptor,5.85,5.85,1410.0,1,9
360723,CHEMBL385517,SAXAGLIPTIN ANHYDROUS,11140,CHEMBL284,Dipeptidyl peptidase 4,9.52,8.56,0.3,18,9
360723,CHEMBL385517,SAXAGLIPTIN ANHYDROUS,20154,CHEMBL4793,Dipeptidyl peptidase 9,7.15,7.04,71.0,4,9
360723,CHEMBL385517,SAXAGLIPTIN ANHYDROUS,20151,CHEMBL4657,Dipeptidyl peptidase 8,6.89,6.6,130.0,4,9
364520,CHEMBL386630,TESTOSTERONE,56,CHEMBL1871,Androgen receptor,9.4,8.45,0.4,13,9
364520,CHEMBL386630,TESTOSTERONE,12643,CHEMBL3305,Sex hormone-binding globulin,9.2,8.52,0.631,2,9
364520,CHEMBL386630,TESTOSTERONE,78,CHEMBL1963,Thyrotropin receptor,7.5,7.5,31.6,2,9
364520,CHEMBL386630,TESTOSTERONE,169,CHEMBL1940,Voltage-dependent L-type calcium channel subunit alpha-1C,7.47,7.45,34.0,2,9
364520,CHEMBL386630,TESTOSTERONE,17045,CHEMBL340,Cytochrome P450 3A4,7.43,7.34,37.0,5,9
364520,CHEMBL386630,TESTOSTERONE,36,CHEMBL208,Progesterone receptor,7.04,7.04,92.0,1,8
364520,CHEMBL386630,TESTOSTERONE,10503,CHEMBL2421,Corticosteroid-binding globulin,6.72,6.72,190.55,1,8
364520,CHEMBL386630,TESTOSTERONE,25,CHEMBL2034,Glucocorticoid receptor,6.61,6.22,246.0,2,8
364520,CHEMBL386630,TESTOSTERONE,65,CHEMBL1978,Aromatase,6.22,6.22,600.0,1,9
364520,CHEMBL386630,TESTOSTERONE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,5.92,5.92,1200.0,1,8
56095,CHEMBL38827,LUMEFANTRINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.42,6.42,377.0,2,9
374182,CHEMBL388590,BENZBROMARONE,12911,CHEMBL3397,Cytochrome P450 2C9,8.1,7.7,7.9,9,9
374182,CHEMBL388590,BENZBROMARONE,102767,CHEMBL6120,Solute carrier family 22 member 12,7.66,6.84,22.0,14,9
374182,CHEMBL388590,BENZBROMARONE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.43,6.49,37.3,2,8
374182,CHEMBL388590,BENZBROMARONE,103668,CHEMBL1293235,Prelamin-A/C,7.35,7.35,44.7,1,9
374182,CHEMBL388590,BENZBROMARONE,101600,CHEMBL5905,Aldo-keto reductase family 1 member C1,7.32,7.32,48.0,1,8
374182,CHEMBL388590,BENZBROMARONE,12030,CHEMBL3004,Multidrug resistance-associated protein 1,6.72,6.72,190.0,1,9
374182,CHEMBL388590,BENZBROMARONE,12704,CHEMBL3194,Transthyretin,6.7,6.7,200.0,1,9
374182,CHEMBL388590,BENZBROMARONE,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,6.7,6.58,200.0,2,9
374182,CHEMBL388590,BENZBROMARONE,103660,CHEMBL1293227,Ubiquitin carboxyl-terminal hydrolase 2,6.2,6.2,631.0,1,9
374182,CHEMBL388590,BENZBROMARONE,133,CHEMBL235,Peroxisome proliferator-activated receptor gamma,6.03,6.03,940.0,1,8
374182,CHEMBL388590,BENZBROMARONE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,6.0,5.75,1000.0,4,9
374182,CHEMBL388590,BENZBROMARONE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.94,5.83,1148.0,3,8
374182,CHEMBL388590,BENZBROMARONE,10188,CHEMBL260,Mitogen-activated protein kinase 14,5.91,5.91,1235.0,1,8
374182,CHEMBL388590,BENZBROMARONE,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",5.75,5.71,1777.4,2,9
374182,CHEMBL388590,BENZBROMARONE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,5.71,5.71,1946.0,1,8
374182,CHEMBL388590,BENZBROMARONE,103829,CHEMBL1641347,Solute carrier family 22 member 6,5.67,5.67,2120.0,1,9
374182,CHEMBL388590,BENZBROMARONE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.58,5.58,2649.5,1,8
374182,CHEMBL388590,BENZBROMARONE,280,CHEMBL256,Adenosine receptor A3,5.53,5.53,2952.0,1,8
374182,CHEMBL388590,BENZBROMARONE,102394,CHEMBL6020,Bile salt export pump,5.52,5.52,3000.0,1,8
2099025,CHEMBL3889654,LAROTRECTINIB,101034,CHEMBL5608,NT-3 growth factor receptor,9.7,8.6,0.2,26,9
2099025,CHEMBL3889654,LAROTRECTINIB,100413,CHEMBL4898,BDNF/NT-3 growth factors receptor,9.48,8.62,0.33,21,9
2099025,CHEMBL3889654,LAROTRECTINIB,11902,CHEMBL2815,High affinity nerve growth factor receptor,9.4,7.98,0.4,66,9
2099025,CHEMBL3889654,LAROTRECTINIB,30023,CHEMBL4599,Activated CDC42 kinase 1,6.24,6.24,576.0,1,9
2099025,CHEMBL3889654,LAROTRECTINIB,119220,CHEMBL4523470,Sphingomyelin phosphodiesterase 3,5.58,5.58,2600.0,1,9
2104231,CHEMBL3894860,TRILACICLIB,11678,CHEMBL301,Cyclin-dependent kinase 2,8.78,7.28,1.66,4,8
374052,CHEMBL389621,HYDROCORTISONE,48,CHEMBL1994,Mineralocorticoid receptor,9.3,8.92,0.5,2,9
374052,CHEMBL389621,HYDROCORTISONE,25,CHEMBL2034,Glucocorticoid receptor,7.92,7.31,12.0,4,8
374052,CHEMBL389621,HYDROCORTISONE,10503,CHEMBL2421,Corticosteroid-binding globulin,7.88,7.88,13.18,1,8
374052,CHEMBL389621,HYDROCORTISONE,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,7.85,7.85,14.1,2,9
374052,CHEMBL389621,HYDROCORTISONE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,6.7,6.7,199.5,2,9
374052,CHEMBL389621,HYDROCORTISONE,12643,CHEMBL3305,Sex hormone-binding globulin,6.2,6.2,630.96,1,9
374052,CHEMBL389621,HYDROCORTISONE,103665,CHEMBL1293232,Survival motor neuron protein,6.1,6.1,794.3,1,9
407354,CHEMBL393220,ATORVASTATIN CALCIUM,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,6.35,6.22,450.0,2,8
407354,CHEMBL393220,ATORVASTATIN CALCIUM,104062,CHEMBL1743121,Solute carrier organic anion transporter family member 1B3,5.59,5.59,2580.0,1,8
2146132,CHEMBL3936761,ZANUBRUTINIB,100097,CHEMBL5251,Tyrosine-protein kinase BTK,9.52,8.84,0.3,19,9
2146132,CHEMBL3936761,ZANUBRUTINIB,30016,CHEMBL3834,Cytoplasmic tyrosine-protein kinase BMX,9.21,7.81,0.62,6,9
2146132,CHEMBL3936761,ZANUBRUTINIB,11691,CHEMBL2250,Tyrosine-protein kinase Blk,8.95,8.11,1.13,3,9
2146132,CHEMBL3936761,ZANUBRUTINIB,12699,CHEMBL3009,Receptor tyrosine-protein kinase erbB-4,8.8,7.81,1.58,4,9
2146132,CHEMBL3936761,ZANUBRUTINIB,100418,CHEMBL4246,Tyrosine-protein kinase Tec,8.77,7.81,1.7,7,9
2146132,CHEMBL3936761,ZANUBRUTINIB,9,CHEMBL203,Epidermal growth factor receptor,8.62,7.65,2.4,10,9
2146132,CHEMBL3936761,ZANUBRUTINIB,100424,CHEMBL4367,Tyrosine-protein kinase TXK,8.53,7.38,2.95,4,9
2146132,CHEMBL3936761,ZANUBRUTINIB,30026,CHEMBL4601,Protein-tyrosine kinase 6,7.48,7.48,33.0,2,9
2146132,CHEMBL3936761,ZANUBRUTINIB,10918,CHEMBL2959,Tyrosine-protein kinase ITK/TSK,7.3,7.13,50.0,5,9
2146132,CHEMBL3936761,ZANUBRUTINIB,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,7.12,6.56,76.0,3,9
2146132,CHEMBL3936761,ZANUBRUTINIB,100127,CHEMBL4454,Tyrosine-protein kinase Fgr,6.81,6.81,155.0,2,9
2146132,CHEMBL3936761,ZANUBRUTINIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,6.73,6.73,187.0,2,9
2146132,CHEMBL3936761,ZANUBRUTINIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,6.42,6.42,379.0,2,9
2146132,CHEMBL3936761,ZANUBRUTINIB,109099,CHEMBL3308912,Platelet glycoprotein VI,6.29,6.29,510.0,1,9
2146132,CHEMBL3936761,ZANUBRUTINIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,6.24,6.24,580.0,2,9
2150261,CHEMBL3940890,ACORAMIDIS,12704,CHEMBL3194,Transthyretin,8.32,7.62,4.8,5,9
2158101,CHEMBL3948730,UMBRALISIB,11177,CHEMBL3130,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",8.21,7.58,6.2,7,9
2158101,CHEMBL3948730,UMBRALISIB,11939,CHEMBL3267,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",5.85,5.85,1400.0,1,9
396101,CHEMBL395110,MEPAZINE,127,CHEMBL231,Histamine H1 receptor,8.51,8.04,3.126,2,8
396101,CHEMBL395110,MEPAZINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.72,7.16,19.0,3,8
396101,CHEMBL395110,MEPAZINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,7.72,7.29,19.0,2,8
396101,CHEMBL395110,MEPAZINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,7.55,7.47,28.0,2,8
396101,CHEMBL395110,MEPAZINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,7.4,7.06,40.0,2,8
396101,CHEMBL395110,MEPAZINE,103,CHEMBL223,Alpha-1D adrenergic receptor,7.17,7.02,67.0,2,8
396101,CHEMBL395110,MEPAZINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,7.12,6.94,76.0,2,8
396101,CHEMBL395110,MEPAZINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.96,6.69,110.0,2,8
396101,CHEMBL395110,MEPAZINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.74,6.57,181.0,2,8
396101,CHEMBL395110,MEPAZINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.7,6.47,201.0,3,8
396101,CHEMBL395110,MEPAZINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.59,6.45,259.0,2,8
396101,CHEMBL395110,MEPAZINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.49,6.39,327.0,2,8
396101,CHEMBL395110,MEPAZINE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.41,6.41,391.2,1,8
396101,CHEMBL395110,MEPAZINE,109917,CHEMBL3632452,Mucosa-associated lymphoid tissue lymphoma translocation protein 1,6.38,6.16,420.0,4,9
396101,CHEMBL395110,MEPAZINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.26,6.05,546.0,2,8
396101,CHEMBL395110,MEPAZINE,130,CHEMBL234,D(3) dopamine receptor,6.17,5.94,681.0,2,8
396101,CHEMBL395110,MEPAZINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.07,5.91,853.0,2,8
396101,CHEMBL395110,MEPAZINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.73,5.69,1861.0,3,8
392195,CHEMBL395429,OXYTOCIN,116,CHEMBL2049,Oxytocin receptor,11.0,8.79,0.01,32,9
392195,CHEMBL395429,OXYTOCIN,134,CHEMBL1889,Vasopressin V1a receptor,9.74,7.96,0.18,13,9
392195,CHEMBL395429,OXYTOCIN,148,CHEMBL1921,Vasopressin V1b receptor,9.7,7.44,0.2,7,9
392195,CHEMBL395429,OXYTOCIN,112,CHEMBL1790,Vasopressin V2 receptor,8.14,6.85,7.3,5,9
388574,CHEMBL396778,SAFINAMIDE,104,CHEMBL2039,Amine oxidase [flavin-containing] B,8.64,7.62,2.29,61,9
388574,CHEMBL396778,SAFINAMIDE,86,CHEMBL1951,Amine oxidase [flavin-containing] A,7.52,7.52,30.0,1,9
56090,CHEMBL39736,BUFORMIN,103668,CHEMBL1293235,Prelamin-A/C,5.5,5.5,3162.3,1,9
416772,CHEMBL398435,TICAGRELOR,176,CHEMBL2001,P2Y purinoceptor 12,8.7,7.32,1.995,10,9
416772,CHEMBL398435,TICAGRELOR,280,CHEMBL256,Adenosine receptor A3,6.97,6.97,106.5,1,8
416772,CHEMBL398435,TICAGRELOR,175,CHEMBL1997,Equilibrative nucleoside transporter 1,6.44,6.44,364.7,1,8
416772,CHEMBL398435,TICAGRELOR,155,CHEMBL238,Sodium-dependent dopamine transporter,6.37,6.33,424.5,2,9
416772,CHEMBL398435,TICAGRELOR,117512,CHEMBL4105907,Sigma intracellular receptor 2,5.89,5.89,1295.39,1,9
416772,CHEMBL398435,TICAGRELOR,109463,CHEMBL3321651,P2Y purinoceptor 13,5.85,5.85,1398.0,1,9
419580,CHEMBL398707,HYDROMORPHONE,129,CHEMBL233,Mu-type opioid receptor,9.55,9.07,0.28,2,9
419580,CHEMBL398707,HYDROMORPHONE,137,CHEMBL237,Kappa-type opioid receptor,8.55,8.26,2.8,2,9
419580,CHEMBL398707,HYDROMORPHONE,136,CHEMBL236,Delta-type opioid receptor,7.42,7.42,38.0,1,9
2197274,CHEMBL3989403,ZOMEPIRAC SODIUM,103668,CHEMBL1293235,Prelamin-A/C,7.05,7.05,89.1,1,9
2197387,CHEMBL3989516,FOSTAMATINIB DISODIUM,10906,CHEMBL2599,Tyrosine-protein kinase SYK,7.77,7.77,17.0,1,9
2197387,CHEMBL3989516,FOSTAMATINIB DISODIUM,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,7.16,7.16,70.0,1,8
2197568,CHEMBL3989697,RIBOFLAVIN 5'-PHOSPHATE SODIUM,118080,CHEMBL4295835,Thiosulfate sulfurtransferase,6.42,6.42,380.0,1,9
2197638,CHEMBL3989767,CALCITONIN SALMON,119,CHEMBL1832,Calcitonin receptor,10.18,10.18,0.066,1,9
2197714,CHEMBL3989843,TRANYLCYPROMINE,102439,CHEMBL6136,Lysine-specific histone demethylase 1A,8.35,8.35,4.5,1,9
2197714,CHEMBL3989843,TRANYLCYPROMINE,104,CHEMBL2039,Amine oxidase [flavin-containing] B,8.03,6.38,9.4,11,9
2197714,CHEMBL3989843,TRANYLCYPROMINE,20073,CHEMBL5282,Cytochrome P450 2A6,7.1,6.4,80.0,7,9
2197714,CHEMBL3989843,TRANYLCYPROMINE,86,CHEMBL1951,Amine oxidase [flavin-containing] A,7.07,6.0,85.0,11,9
2197714,CHEMBL3989843,TRANYLCYPROMINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.25,6.25,567.2,1,8
2197714,CHEMBL3989843,TRANYLCYPROMINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.08,6.08,827.5,1,8
2197714,CHEMBL3989843,TRANYLCYPROMINE,12912,CHEMBL3622,Cytochrome P450 2C19,5.72,5.58,1900.0,7,9
2197714,CHEMBL3989843,TRANYLCYPROMINE,109702,CHEMBL3542436,Cytochrome P450 2A13,5.64,5.64,2300.0,1,9
2197714,CHEMBL3989843,TRANYLCYPROMINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.57,5.57,2697.0,1,9
2197737,CHEMBL3989866,BICTEGRAVIR,104063,CHEMBL1743122,Solute carrier family 22 member 2,6.31,6.31,487.0,2,9
2197739,CHEMBL3989868,TUCATINIB,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,8.7,8.2,2.0,5,9
2197739,CHEMBL3989868,TUCATINIB,117493,CHEMBL4105888,Myosin-14,6.73,6.73,188.0,1,9
2197739,CHEMBL3989868,TUCATINIB,9,CHEMBL203,Epidermal growth factor receptor,6.35,6.1,449.0,3,9
2197739,CHEMBL3989868,TUCATINIB,104279,CHEMBL1795199,Receptor-interacting serine/threonine-protein kinase 3,5.97,5.97,1065.0,1,9
2197739,CHEMBL3989868,TUCATINIB,10170,CHEMBL3959,Ribosyldihydronicotinamide dehydrogenase [quinone],5.61,5.61,2463.0,1,9
2197758,CHEMBL3989887,TACROLIMUS,80,CHEMBL1902,Peptidyl-prolyl cis-trans isomerase FKBP1A,8.0,8.0,10.0,1,9
2197779,CHEMBL3989908,ENASIDENIB,280,CHEMBL256,Adenosine receptor A3,8.52,8.52,3.0,1,8
2197779,CHEMBL3989908,ENASIDENIB,117303,CHEMBL3991501,"Isocitrate dehydrogenase [NADP], mitochondrial",8.05,6.81,9.0,15,9
2197779,CHEMBL3989908,ENASIDENIB,104483,CHEMBL2007625,Isocitrate dehydrogenase [NADP] cytoplasmic,6.17,6.17,677.0,1,9
2197779,CHEMBL3989908,ENASIDENIB,114,CHEMBL226,Adenosine receptor A1,5.89,5.89,1290.0,1,8
2197786,CHEMBL3989915,DIFELIKEFALIN,137,CHEMBL237,Kappa-type opioid receptor,9.8,9.8,0.16,1,8
2197802,CHEMBL3989931,ENASIDENIB MESYLATE,117303,CHEMBL3991501,"Isocitrate dehydrogenase [NADP], mitochondrial",6.91,6.71,123.6,2,9
2197810,CHEMBL3989939,LAROTRECTINIB SULFATE,11902,CHEMBL2815,High affinity nerve growth factor receptor,8.7,8.5,2.0,2,9
2197810,CHEMBL3989939,LAROTRECTINIB SULFATE,100413,CHEMBL4898,BDNF/NT-3 growth factors receptor,8.3,8.3,5.0,1,9
2197810,CHEMBL3989939,LAROTRECTINIB SULFATE,101034,CHEMBL5608,NT-3 growth factor receptor,8.3,8.3,5.0,1,9
2197829,CHEMBL3989958,IVOSIDENIB,104483,CHEMBL2007625,Isocitrate dehydrogenase [NADP] cytoplasmic,8.46,7.58,3.5,26,9
2197845,CHEMBL3989974,CEFIDEROCOL,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,7.38,7.38,42.0,1,9
2198936,CHEMBL3991065,ATOGEPANT,19904,CHEMBL3798,Calcitonin gene-related peptide type 1 receptor,10.82,10.82,0.015,2,9
146,CHEMBL4,OFLOXACIN,103659,CHEMBL1293226,Lysine-specific demethylase 4E,5.5,5.5,3162.3,1,9
146,CHEMBL4,OFLOXACIN,103688,CHEMBL1293255,15-hydroxyprostaglandin dehydrogenase [NAD(+)],5.5,5.5,3162.3,1,9
418415,CHEMBL400599,BENFLUOREX,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.3,6.17,494.9,2,8
418415,CHEMBL400599,BENFLUOREX,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.66,5.66,2200.0,1,8
418415,CHEMBL400599,BENFLUOREX,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.62,5.62,2408.3,1,8
418415,CHEMBL400599,BENFLUOREX,130,CHEMBL234,D(3) dopamine receptor,5.58,5.58,2626.8,1,8
424824,CHEMBL404108,LUMIRACOXIB,96,CHEMBL221,Prostaglandin G/H synthase 1,8.15,8.15,7.0,1,8
424824,CHEMBL404108,LUMIRACOXIB,126,CHEMBL230,Prostaglandin G/H synthase 2,8.15,7.06,7.0,8,9
424824,CHEMBL404108,LUMIRACOXIB,100997,CHEMBL5503,Nuclear receptor subfamily 1 group I member 3,6.26,6.26,550.0,1,8
424824,CHEMBL404108,LUMIRACOXIB,133,CHEMBL235,Peroxisome proliferator-activated receptor gamma,5.82,5.82,1500.0,1,8
436875,CHEMBL404271,ACARBOSE,1,CHEMBL2074,Maltase-glucoamylase,6.38,6.38,421.0,1,9
436875,CHEMBL404271,ACARBOSE,10706,CHEMBL2478,Alpha-amylase 1A,6.37,6.22,430.0,3,9
418491,CHEMBL404849,SULOCTIDIL,12911,CHEMBL3397,Cytochrome P450 2C9,8.3,8.3,5.0,2,9
418491,CHEMBL404849,SULOCTIDIL,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,7.31,7.12,49.3,2,8
418491,CHEMBL404849,SULOCTIDIL,102,CHEMBL1941,Histamine H2 receptor,7.05,7.01,88.5,2,8
418491,CHEMBL404849,SULOCTIDIL,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.67,6.67,216.2,1,8
418491,CHEMBL404849,SULOCTIDIL,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.37,6.37,430.0,1,8
418491,CHEMBL404849,SULOCTIDIL,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.3,6.3,500.7,1,8
418491,CHEMBL404849,SULOCTIDIL,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.22,6.13,597.5,2,8
418491,CHEMBL404849,SULOCTIDIL,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.2,6.2,636.1,1,8
418491,CHEMBL404849,SULOCTIDIL,121,CHEMBL228,Sodium-dependent serotonin transporter,6.18,6.0,665.8,3,8
418491,CHEMBL404849,SULOCTIDIL,130,CHEMBL234,D(3) dopamine receptor,6.17,6.0,671.0,3,8
418491,CHEMBL404849,SULOCTIDIL,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,6.14,6.14,722.1,1,8
418491,CHEMBL404849,SULOCTIDIL,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.12,5.91,758.7,2,8
418491,CHEMBL404849,SULOCTIDIL,9,CHEMBL203,Epidermal growth factor receptor,6.1,6.1,794.4,1,8
418491,CHEMBL404849,SULOCTIDIL,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.01,6.01,980.0,1,8
418491,CHEMBL404849,SULOCTIDIL,11365,CHEMBL289,Cytochrome P450 2D6,6.0,6.0,1000.0,2,9
418491,CHEMBL404849,SULOCTIDIL,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.96,5.96,1085.0,1,8
418491,CHEMBL404849,SULOCTIDIL,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.86,5.86,1388.8,3,8
418491,CHEMBL404849,SULOCTIDIL,155,CHEMBL238,Sodium-dependent dopamine transporter,5.69,5.65,2041.9,3,8
418491,CHEMBL404849,SULOCTIDIL,280,CHEMBL256,Adenosine receptor A3,5.68,5.68,2094.6,1,8
418491,CHEMBL404849,SULOCTIDIL,10184,CHEMBL2327,Substance-K receptor,5.64,5.64,2264.3,1,8
418491,CHEMBL404849,SULOCTIDIL,127,CHEMBL231,Histamine H1 receptor,5.61,5.61,2475.9,1,8
431806,CHEMBL405110,METHYLENE BLUE ANHYDROUS,86,CHEMBL1951,Amine oxidase [flavin-containing] A,7.16,7.16,70.0,1,9
431806,CHEMBL405110,METHYLENE BLUE ANHYDROUS,103657,CHEMBL1293224,Microtubule-associated protein tau,6.89,6.02,130.0,6,9
431806,CHEMBL405110,METHYLENE BLUE ANHYDROUS,10656,CHEMBL2487,Amyloid-beta precursor protein,6.3,6.3,500.0,1,9
431806,CHEMBL405110,METHYLENE BLUE ANHYDROUS,105690,CHEMBL2362978,DNA repair protein RAD52 homolog,6.03,6.03,936.0,1,8
431806,CHEMBL405110,METHYLENE BLUE ANHYDROUS,12013,CHEMBL3308,Caspase-6,5.8,5.8,1600.0,1,8
431806,CHEMBL405110,METHYLENE BLUE ANHYDROUS,101097,CHEMBL5162,Neuropeptide S receptor,5.8,5.8,1584.9,1,9
619,CHEMBL406,INDAPAMIDE,11060,CHEMBL2326,Carbonic anhydrase 7,9.64,7.64,0.23,7,9
619,CHEMBL406,INDAPAMIDE,12896,CHEMBL3729,Carbonic anhydrase 4,9.48,7.75,0.33,3,9
619,CHEMBL406,INDAPAMIDE,11063,CHEMBL3510,Carbonic anhydrase 14,9.42,8.31,0.38,2,9
619,CHEMBL406,INDAPAMIDE,11016,CHEMBL3969,"Carbonic anhydrase 5B, mitochondrial",9.34,7.71,0.46,3,9
619,CHEMBL406,INDAPAMIDE,10186,CHEMBL3025,Carbonic anhydrase 6,9.0,6.88,1.01,4,9
619,CHEMBL406,INDAPAMIDE,12952,CHEMBL3594,Carbonic anhydrase 9,8.69,7.5,2.03,3,9
619,CHEMBL406,INDAPAMIDE,15,CHEMBL205,Carbonic anhydrase 2,8.42,6.6,3.77,8,9
619,CHEMBL406,INDAPAMIDE,12923,CHEMBL3912,Carbonic anhydrase 13,8.39,7.13,4.11,5,9
619,CHEMBL406,INDAPAMIDE,11042,CHEMBL4789,"Carbonic anhydrase 5A, mitochondrial",8.16,6.79,6.96,3,9
619,CHEMBL406,INDAPAMIDE,12209,CHEMBL3242,Carbonic anhydrase 12,8.0,6.87,10.0,4,9
619,CHEMBL406,INDAPAMIDE,10139,CHEMBL2885,Carbonic anhydrase 3,6.98,6.98,105.0,1,9
619,CHEMBL406,INDAPAMIDE,10193,CHEMBL261,Carbonic anhydrase 1,6.58,6.58,261.0,1,9
619,CHEMBL406,INDAPAMIDE,103665,CHEMBL1293232,Survival motor neuron protein,6.05,6.05,891.3,1,9
442077,CHEMBL406393,DEOXYCHOLIC ACID,100857,CHEMBL5409,G-protein coupled bile acid receptor 1,6.0,5.95,1010.0,2,9
635,CHEMBL407,FLUMAZENIL,11440,CHEMBL5112,Gamma-aminobutyric acid receptor subunit alpha-5,9.3,9.25,0.5,2,9
635,CHEMBL407,FLUMAZENIL,74,CHEMBL1962,Gamma-aminobutyric acid receptor subunit alpha-1,9.1,8.76,0.7943,3,9
635,CHEMBL407,FLUMAZENIL,12770,CHEMBL4956,Gamma-aminobutyric acid receptor subunit alpha-2,9.1,9.1,0.7943,1,9
635,CHEMBL407,FLUMAZENIL,12757,CHEMBL3026,Gamma-aminobutyric acid receptor subunit alpha-3,9.0,9.0,1.0,1,9
635,CHEMBL407,FLUMAZENIL,11191,CHEMBL2472,Gamma-aminobutyric acid receptor subunit alpha-4,8.7,8.7,2.0,1,8
635,CHEMBL407,FLUMAZENIL,78,CHEMBL1963,Thyrotropin receptor,7.5,7.5,31.6,1,9
635,CHEMBL407,FLUMAZENIL,11463,CHEMBL2579,Gamma-aminobutyric acid receptor subunit alpha-6,6.8,6.8,158.49,1,9
635,CHEMBL407,FLUMAZENIL,103665,CHEMBL1293232,Survival motor neuron protein,5.9,5.9,1258.9,1,9
635,CHEMBL407,FLUMAZENIL,12912,CHEMBL3622,Cytochrome P450 2C19,5.8,5.8,1584.89,2,9
2211072,CHEMBL4071161,TIRABRUTINIB,30016,CHEMBL3834,Cytoplasmic tyrosine-protein kinase BMX,8.37,7.85,4.3,2,9
2211072,CHEMBL4071161,TIRABRUTINIB,100097,CHEMBL5251,Tyrosine-protein kinase BTK,8.28,7.1,5.2,11,9
2211072,CHEMBL4071161,TIRABRUTINIB,100418,CHEMBL4246,Tyrosine-protein kinase Tec,8.21,7.72,6.2,3,9
2211072,CHEMBL4071161,TIRABRUTINIB,100424,CHEMBL4367,Tyrosine-protein kinase TXK,6.94,6.94,116.0,1,9
2211072,CHEMBL4071161,TIRABRUTINIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,6.43,6.43,375.0,1,8
2211072,CHEMBL4071161,TIRABRUTINIB,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,6.21,6.21,610.0,1,9
2211072,CHEMBL4071161,TIRABRUTINIB,12699,CHEMBL3009,Receptor tyrosine-protein kinase erbB-4,6.0,6.0,991.0,1,9
2211072,CHEMBL4071161,TIRABRUTINIB,11691,CHEMBL2250,Tyrosine-protein kinase Blk,5.95,5.95,1133.0,1,9
2211072,CHEMBL4071161,TIRABRUTINIB,109099,CHEMBL3308912,Platelet glycoprotein VI,5.92,5.92,1200.0,1,9
666,CHEMBL408,TROGLITAZONE,120188,CHEMBL4739852,Forkhead box protein M1,7.28,7.28,51.97,1,9
666,CHEMBL408,TROGLITAZONE,133,CHEMBL235,Peroxisome proliferator-activated receptor gamma,6.7,6.17,200.0,32,9
666,CHEMBL408,TROGLITAZONE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.08,5.89,835.0,3,8
666,CHEMBL408,TROGLITAZONE,15,CHEMBL205,Carbonic anhydrase 2,6.01,6.01,970.0,1,9
666,CHEMBL408,TROGLITAZONE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,5.91,5.91,1238.0,1,8
666,CHEMBL408,TROGLITAZONE,104,CHEMBL2039,Amine oxidase [flavin-containing] B,5.68,5.68,2070.0,2,9
666,CHEMBL408,TROGLITAZONE,102394,CHEMBL6020,Bile salt export pump,5.57,5.54,2700.0,2,9
666,CHEMBL408,TROGLITAZONE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.55,5.55,2800.0,1,8
666,CHEMBL408,TROGLITAZONE,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",5.54,5.54,2884.4,1,8
666,CHEMBL408,TROGLITAZONE,248,CHEMBL1835,Thromboxane-A synthase,5.53,5.53,2966.0,1,9
666,CHEMBL408,TROGLITAZONE,280,CHEMBL256,Adenosine receptor A3,5.53,5.53,2943.0,1,8
666,CHEMBL408,TROGLITAZONE,126,CHEMBL230,Prostaglandin G/H synthase 2,5.52,5.52,3029.2,1,8
429156,CHEMBL408403,ANGIOTENSIN II,10692,CHEMBL4607,Type-2 angiotensin II receptor,10.1,9.34,0.08,12,9
429156,CHEMBL408403,ANGIOTENSIN II,115,CHEMBL227,Type-1 angiotensin II receptor,9.8,8.98,0.16,11,9
2224030,CHEMBL4084119,LIRAGLUTIDE,11758,CHEMBL1784,Glucagon-like peptide 1 receptor,10.2,8.78,0.063,12,9
435188,CHEMBL408513,BELINOSTAT,11206,CHEMBL1937,Histone deacetylase 2,9.07,7.75,0.85,10,9
435188,CHEMBL408513,BELINOSTAT,12697,CHEMBL325,Histone deacetylase 1,9.07,7.83,0.85,16,9
435188,CHEMBL408513,BELINOSTAT,11208,CHEMBL1829,Histone deacetylase 3,8.82,7.95,1.5,10,9
435188,CHEMBL408513,BELINOSTAT,11307,CHEMBL1865,Histone deacetylase 6,8.8,7.61,1.6,17,9
435188,CHEMBL408513,BELINOSTAT,11232,CHEMBL3524,Histone deacetylase 4,7.82,7.1,15.0,8,9
435188,CHEMBL408513,BELINOSTAT,10869,CHEMBL3192,Histone deacetylase 8,7.66,7.15,22.0,12,9
435188,CHEMBL408513,BELINOSTAT,11797,CHEMBL4145,Histone deacetylase 9,7.62,7.11,24.0,6,9
435188,CHEMBL408513,BELINOSTAT,12283,CHEMBL2563,Histone deacetylase 5,7.6,7.17,25.0,5,9
435188,CHEMBL408513,BELINOSTAT,12021,CHEMBL3310,Histone deacetylase 11,7.57,7.5,27.0,3,9
435188,CHEMBL408513,BELINOSTAT,103454,CHEMBL1163125,Bromodomain-containing protein 4,7.57,7.57,27.0,1,9
435188,CHEMBL408513,BELINOSTAT,10945,CHEMBL5103,Polyamine deacetylase HDAC10,7.51,7.3,31.0,4,9
435188,CHEMBL408513,BELINOSTAT,12443,CHEMBL2716,Histone deacetylase 7,7.29,7.04,51.0,6,9
435188,CHEMBL408513,BELINOSTAT,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,5.61,5.61,2473.2,1,8
435188,CHEMBL408513,BELINOSTAT,120098,CHEMBL4680030,Aspartyl/asparaginyl beta-hydroxylase,5.51,5.51,3100.0,1,9
2225368,CHEMBL4085457,RITLECITINIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,9.52,8.03,0.3,23,9
2225368,CHEMBL4085457,RITLECITINIB,10918,CHEMBL2959,Tyrosine-protein kinase ITK/TSK,7.57,7.57,26.9,1,9
2225368,CHEMBL4085457,RITLECITINIB,100424,CHEMBL4367,Tyrosine-protein kinase TXK,6.88,6.79,131.0,2,9
2225368,CHEMBL4085457,RITLECITINIB,100418,CHEMBL4246,Tyrosine-protein kinase Tec,6.81,6.4,155.0,3,9
2225368,CHEMBL4085457,RITLECITINIB,30016,CHEMBL3834,Cytoplasmic tyrosine-protein kinase BMX,6.26,6.24,545.0,2,9
2225368,CHEMBL4085457,RITLECITINIB,100097,CHEMBL5251,Tyrosine-protein kinase BTK,6.22,6.22,607.0,1,9
2225368,CHEMBL4085457,RITLECITINIB,10919,CHEMBL2835,Tyrosine-protein kinase JAK1,5.79,5.79,1640.0,2,9
717,CHEMBL409,BICALUTAMIDE,56,CHEMBL1871,Androgen receptor,7.96,6.75,11.0,76,9
717,CHEMBL409,BICALUTAMIDE,36,CHEMBL208,Progesterone receptor,6.34,6.04,460.0,2,8
717,CHEMBL409,BICALUTAMIDE,11536,CHEMBL4616,Growth hormone secretagogue receptor type 1,5.66,5.66,2200.0,1,8
2223,CHEMBL41,FLUOXETINE,121,CHEMBL228,Sodium-dependent serotonin transporter,9.57,8.09,0.271,53,9
2223,CHEMBL41,FLUOXETINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,8.2,8.2,6.31,1,9
2223,CHEMBL41,FLUOXETINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,8.0,6.22,10.0,6,9
2223,CHEMBL41,FLUOXETINE,12912,CHEMBL3622,Cytochrome P450 2C19,7.4,7.29,40.0,2,9
2223,CHEMBL41,FLUOXETINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.26,6.79,55.0,4,9
2223,CHEMBL41,FLUOXETINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.21,6.99,62.0,4,9
2223,CHEMBL41,FLUOXETINE,93,CHEMBL220,Acetylcholinesterase,6.89,6.89,130.0,1,8
2223,CHEMBL41,FLUOXETINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.68,6.35,210.0,3,8
2223,CHEMBL41,FLUOXETINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.62,5.95,240.0,16,9
2223,CHEMBL41,FLUOXETINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.16,5.99,698.0,2,8
2223,CHEMBL41,FLUOXETINE,11365,CHEMBL289,Cytochrome P450 2D6,6.16,6.16,700.0,1,8
2223,CHEMBL41,FLUOXETINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.12,6.12,762.0,1,8
2223,CHEMBL41,FLUOXETINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.11,6.11,771.0,1,8
2223,CHEMBL41,FLUOXETINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.11,5.9,771.0,3,8
2223,CHEMBL41,FLUOXETINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.01,5.94,976.0,2,8
2223,CHEMBL41,FLUOXETINE,103668,CHEMBL1293235,Prelamin-A/C,5.85,5.85,1412.5,1,9
2223,CHEMBL41,FLUOXETINE,102,CHEMBL1941,Histamine H2 receptor,5.81,5.81,1549.3,1,8
2223,CHEMBL41,FLUOXETINE,137,CHEMBL237,Kappa-type opioid receptor,5.81,5.81,1544.0,1,8
2223,CHEMBL41,FLUOXETINE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.72,5.72,1900.0,1,9
2223,CHEMBL41,FLUOXETINE,87,CHEMBL218,Cannabinoid receptor 1,5.71,5.71,1943.1,1,8
2223,CHEMBL41,FLUOXETINE,88,CHEMBL2056,D(1A) dopamine receptor,5.64,5.64,2300.0,1,8
860,CHEMBL411,DIETHYLSTILBESTROL,174,CHEMBL242,Estrogen receptor beta,10.7,8.42,0.02,6,9
860,CHEMBL411,DIETHYLSTILBESTROL,19,CHEMBL206,Estrogen receptor,10.22,9.09,0.06,16,9
860,CHEMBL411,DIETHYLSTILBESTROL,11638,CHEMBL4040,Mitogen-activated protein kinase 1,6.5,6.5,316.2,1,9
860,CHEMBL411,DIETHYLSTILBESTROL,12056,CHEMBL3257,Aldehyde oxidase,6.34,6.34,460.0,1,9
860,CHEMBL411,DIETHYLSTILBESTROL,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,6.3,6.3,500.0,1,8
860,CHEMBL411,DIETHYLSTILBESTROL,11255,CHEMBL4245,Estrogen-related receptor gamma,6.2,6.2,630.0,1,9
860,CHEMBL411,DIETHYLSTILBESTROL,36,CHEMBL208,Progesterone receptor,6.18,6.18,659.1,1,8
860,CHEMBL411,DIETHYLSTILBESTROL,155,CHEMBL238,Sodium-dependent dopamine transporter,6.07,5.95,851.0,3,8
860,CHEMBL411,DIETHYLSTILBESTROL,136,CHEMBL236,Delta-type opioid receptor,6.02,5.79,958.0,2,8
860,CHEMBL411,DIETHYLSTILBESTROL,280,CHEMBL256,Adenosine receptor A3,5.9,5.72,1248.0,3,8
860,CHEMBL411,DIETHYLSTILBESTROL,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.86,5.86,1369.0,1,8
860,CHEMBL411,DIETHYLSTILBESTROL,114,CHEMBL226,Adenosine receptor A1,5.78,5.66,1666.0,2,8
860,CHEMBL411,DIETHYLSTILBESTROL,25,CHEMBL2034,Glucocorticoid receptor,5.75,5.75,1759.8,1,8
860,CHEMBL411,DIETHYLSTILBESTROL,56,CHEMBL1871,Androgen receptor,5.75,5.75,1766.9,1,8
860,CHEMBL411,DIETHYLSTILBESTROL,137,CHEMBL237,Kappa-type opioid receptor,5.74,5.74,1825.0,1,8
860,CHEMBL411,DIETHYLSTILBESTROL,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.7,5.6,1998.0,2,8
860,CHEMBL411,DIETHYLSTILBESTROL,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.66,5.66,2201.0,1,8
860,CHEMBL411,DIETHYLSTILBESTROL,129,CHEMBL233,Mu-type opioid receptor,5.63,5.59,2345.0,2,8
860,CHEMBL411,DIETHYLSTILBESTROL,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.59,5.59,2594.3,1,8
860,CHEMBL411,DIETHYLSTILBESTROL,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.53,5.53,2980.9,1,8
860,CHEMBL411,DIETHYLSTILBESTROL,130,CHEMBL234,D(3) dopamine receptor,5.53,5.53,2987.0,1,8
860,CHEMBL411,DIETHYLSTILBESTROL,10184,CHEMBL2327,Substance-K receptor,5.5,5.5,3184.0,1,8
2252482,CHEMBL4113131,ENSARTINIB,11451,CHEMBL3717,Hepatocyte growth factor receptor,9.13,9.13,0.74,1,9
923,CHEMBL413,SIROLIMUS,11400,CHEMBL2842,Serine/threonine-protein kinase mTOR,10.3,8.72,0.05,16,9
923,CHEMBL413,SIROLIMUS,80,CHEMBL1902,Peptidyl-prolyl cis-trans isomerase FKBP1A,9.89,8.84,0.13,13,9
923,CHEMBL413,SIROLIMUS,10257,CHEMBL2430,Peptidyl-prolyl cis-trans isomerase FKBP1B,9.7,9.46,0.2,2,9
923,CHEMBL413,SIROLIMUS,100147,CHEMBL4848,Eukaryotic translation initiation factor 4E,9.3,9.3,0.5,1,8
923,CHEMBL413,SIROLIMUS,104573,CHEMBL2052031,Peptidyl-prolyl cis-trans isomerase FKBP5,8.52,8.34,3.0,3,9
923,CHEMBL413,SIROLIMUS,11751,CHEMBL4050,Peptidyl-prolyl cis-trans isomerase FKBP4,8.38,8.15,4.2,2,9
923,CHEMBL413,SIROLIMUS,103134,CHEMBL1075189,Pyruvate kinase PKM,7.3,7.3,50.0,2,9
923,CHEMBL413,SIROLIMUS,104160,CHEMBL1781868,Programmed cell death protein 4,7.3,7.3,50.0,1,8
923,CHEMBL413,SIROLIMUS,125,CHEMBL229,Alpha-1A adrenergic receptor,6.8,6.8,156.5,1,8
923,CHEMBL413,SIROLIMUS,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.6,6.6,253.7,1,8
923,CHEMBL413,SIROLIMUS,127,CHEMBL231,Histamine H1 receptor,6.07,6.07,860.0,1,8
923,CHEMBL413,SIROLIMUS,130,CHEMBL234,D(3) dopamine receptor,6.06,6.06,870.0,1,8
923,CHEMBL413,SIROLIMUS,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,6.05,6.05,890.0,1,9
923,CHEMBL413,SIROLIMUS,72,CHEMBL217,D(2) dopamine receptor,6.01,6.01,980.0,1,8
923,CHEMBL413,SIROLIMUS,102394,CHEMBL6020,Bile salt export pump,6.0,6.0,1011.9,1,8
923,CHEMBL413,SIROLIMUS,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,5.96,5.96,1100.0,1,8
923,CHEMBL413,SIROLIMUS,11398,CHEMBL4302,ATP-dependent translocase ABCB1,5.9,5.9,1250.0,1,8
923,CHEMBL413,SIROLIMUS,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,5.72,5.72,1900.0,1,9
923,CHEMBL413,SIROLIMUS,12911,CHEMBL3397,Cytochrome P450 2C9,5.7,5.7,2000.0,1,8
923,CHEMBL413,SIROLIMUS,17045,CHEMBL340,Cytochrome P450 3A4,5.7,5.7,2000.0,1,8
61945,CHEMBL41355,EZOGABINE,10397,CHEMBL2476,Potassium voltage-gated channel subfamily KQT member 2,6.46,6.16,350.0,4,9
61945,CHEMBL41355,EZOGABINE,12005,CHEMBL2925,Potassium voltage-gated channel subfamily KQT member 5,6.1,6.1,800.0,1,9
61945,CHEMBL41355,EZOGABINE,11125,CHEMBL3576,Potassium voltage-gated channel subfamily KQT member 4,5.7,5.7,1980.0,1,9
390990,CHEMBL414357,EXENATIDE,11758,CHEMBL1784,Glucagon-like peptide 1 receptor,10.8,8.95,0.016,15,9
996,CHEMBL415,CLOMIPRAMINE,121,CHEMBL228,Sodium-dependent serotonin transporter,10.33,9.0,0.047,6,9
996,CHEMBL415,CLOMIPRAMINE,127,CHEMBL231,Histamine H1 receptor,8.01,7.42,9.827,3,8
996,CHEMBL415,CLOMIPRAMINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,7.89,7.46,13.0,2,8
996,CHEMBL415,CLOMIPRAMINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.81,7.0,15.4,3,8
996,CHEMBL415,CLOMIPRAMINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.75,7.17,18.0,3,8
996,CHEMBL415,CLOMIPRAMINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.72,7.0,19.0,4,8
996,CHEMBL415,CLOMIPRAMINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.66,6.92,22.0,4,8
996,CHEMBL415,CLOMIPRAMINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,7.44,6.66,36.0,3,8
996,CHEMBL415,CLOMIPRAMINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,7.42,7.35,38.0,2,8
996,CHEMBL415,CLOMIPRAMINE,130,CHEMBL234,D(3) dopamine receptor,7.41,7.03,39.3,4,8
996,CHEMBL415,CLOMIPRAMINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.34,6.7,46.0,3,8
996,CHEMBL415,CLOMIPRAMINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,7.23,6.99,59.1,5,9
996,CHEMBL415,CLOMIPRAMINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.07,6.68,86.0,3,8
996,CHEMBL415,CLOMIPRAMINE,103,CHEMBL223,Alpha-1D adrenergic receptor,7.06,6.9,88.0,2,8
996,CHEMBL415,CLOMIPRAMINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.95,6.83,112.0,3,9
996,CHEMBL415,CLOMIPRAMINE,72,CHEMBL217,D(2) dopamine receptor,6.86,6.55,138.0,3,8
996,CHEMBL415,CLOMIPRAMINE,88,CHEMBL2056,D(1A) dopamine receptor,6.84,6.35,143.4,3,8
996,CHEMBL415,CLOMIPRAMINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.82,6.72,152.0,2,8
996,CHEMBL415,CLOMIPRAMINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.69,6.27,205.0,2,8
996,CHEMBL415,CLOMIPRAMINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.28,6.06,530.0,2,8
996,CHEMBL415,CLOMIPRAMINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.24,6.05,572.0,2,8
996,CHEMBL415,CLOMIPRAMINE,78,CHEMBL1963,Thyrotropin receptor,6.2,6.2,631.0,2,9
996,CHEMBL415,CLOMIPRAMINE,129,CHEMBL233,Mu-type opioid receptor,5.72,5.72,1900.3,1,8
996,CHEMBL415,CLOMIPRAMINE,102,CHEMBL1941,Histamine H2 receptor,5.7,5.7,2015.0,2,8
996,CHEMBL415,CLOMIPRAMINE,11365,CHEMBL289,Cytochrome P450 2D6,5.7,5.7,1995.26,4,9
996,CHEMBL415,CLOMIPRAMINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.69,5.69,2029.4,1,8
996,CHEMBL415,CLOMIPRAMINE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.66,5.59,2182.0,3,9
237139,CHEMBL415606,DEGARELIX,118,CHEMBL1855,Gonadotropin-releasing hormone receptor,9.24,8.91,0.5754,5,9
1063,CHEMBL416,METHOXSALEN,12594,CHEMBL3356,Cytochrome P450 1A2,7.8,7.6,15.85,2,8
1063,CHEMBL416,METHOXSALEN,109702,CHEMBL3542436,Cytochrome P450 2A13,7.4,6.6,40.0,2,9
1063,CHEMBL416,METHOXSALEN,20073,CHEMBL5282,Cytochrome P450 2A6,7.05,6.3,90.0,7,9
1063,CHEMBL416,METHOXSALEN,93,CHEMBL220,Acetylcholinesterase,6.12,6.12,760.0,1,9
1063,CHEMBL416,METHOXSALEN,276,CHEMBL254,"3',5'-cyclic-AMP phosphodiesterase 4A",5.94,5.94,1146.0,1,8
1063,CHEMBL416,METHOXSALEN,17045,CHEMBL340,Cytochrome P450 3A4,5.66,5.66,2200.0,1,9
6706,CHEMBL416146,ETORICOXIB,126,CHEMBL230,Prostaglandin G/H synthase 2,7.16,6.33,69.0,18,9
6706,CHEMBL416146,ETORICOXIB,10188,CHEMBL260,Mitogen-activated protein kinase 14,6.28,6.28,530.0,1,9
2267090,CHEMBL4164059,PITOLISANT HYDROCHLORIDE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,9.04,9.04,0.9043,1,9
2267090,CHEMBL4164059,PITOLISANT HYDROCHLORIDE,10280,CHEMBL264,Histamine H3 receptor,8.36,7.96,4.361,2,9
2267090,CHEMBL4164059,PITOLISANT HYDROCHLORIDE,117512,CHEMBL4105907,Sigma intracellular receptor 2,8.15,8.15,7.014,1,9
2267090,CHEMBL4164059,PITOLISANT HYDROCHLORIDE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.05,6.05,899.29,1,9
2267090,CHEMBL4164059,PITOLISANT HYDROCHLORIDE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,5.96,5.96,1100.4,1,9
2267090,CHEMBL4164059,PITOLISANT HYDROCHLORIDE,127,CHEMBL231,Histamine H1 receptor,5.92,5.92,1200.47,1,9
2267090,CHEMBL4164059,PITOLISANT HYDROCHLORIDE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.72,5.72,1919.11,1,9
2267090,CHEMBL4164059,PITOLISANT HYDROCHLORIDE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.7,5.7,1987.93,1,9
51162,CHEMBL416956,MEFLOQUINE,121,CHEMBL228,Sodium-dependent serotonin transporter,7.05,6.91,89.8,2,8
51162,CHEMBL416956,MEFLOQUINE,252,CHEMBL251,Adenosine receptor A2a,6.68,6.25,210.0,5,8
51162,CHEMBL416956,MEFLOQUINE,114,CHEMBL226,Adenosine receptor A1,5.83,5.77,1464.6,2,8
51162,CHEMBL416956,MEFLOQUINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.8,5.69,1590.0,2,8
51162,CHEMBL416956,MEFLOQUINE,102688,CHEMBL5845,Glycine receptor subunit alpha-1,5.6,5.6,2500.0,1,9
1114,CHEMBL417,EPIRUBICIN,63,CHEMBL1806,DNA topoisomerase 2-alpha,8.52,8.52,3.0,1,9
1114,CHEMBL417,EPIRUBICIN,96,CHEMBL221,Prostaglandin G/H synthase 1,5.61,5.61,2440.8,1,8
2276425,CHEMBL4173394,BRILLIANT BLUE G,10417,CHEMBL4805,P2X purinoceptor 7,6.27,6.13,536.0,3,9
176014,CHEMBL418995,AMINEPTINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.77,6.77,170.0,1,8
176014,CHEMBL418995,AMINEPTINE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.82,5.82,1500.0,1,8
1148,CHEMBL419,MAFENIDE,12209,CHEMBL3242,Carbonic anhydrase 12,9.52,9.52,0.3,4,9
1148,CHEMBL419,MAFENIDE,11060,CHEMBL2326,Carbonic anhydrase 7,7.12,7.12,75.0,1,9
1148,CHEMBL419,MAFENIDE,12952,CHEMBL3594,Carbonic anhydrase 9,6.99,6.99,103.0,10,9
1148,CHEMBL419,MAFENIDE,15,CHEMBL205,Carbonic anhydrase 2,6.77,6.76,170.0,50,9
1148,CHEMBL419,MAFENIDE,12896,CHEMBL3729,Carbonic anhydrase 4,5.55,5.55,2800.0,1,8
1148,CHEMBL419,MAFENIDE,11063,CHEMBL3510,Carbonic anhydrase 14,5.5,5.5,3200.0,2,9
189204,CHEMBL419213,LISINOPRIL,103668,CHEMBL1293235,Prelamin-A/C,9.0,9.0,1.0,1,9
2261,CHEMBL42,CLOZAPINE,127,CHEMBL231,Histamine H1 receptor,9.4,8.66,0.4,14,9
2261,CHEMBL42,CLOZAPINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,9.01,8.14,0.98,11,9
2261,CHEMBL42,CLOZAPINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,8.94,8.06,1.144,5,9
2261,CHEMBL42,CLOZAPINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.92,8.05,1.199,45,9
2261,CHEMBL42,CLOZAPINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,8.54,7.86,2.884,30,9
2261,CHEMBL42,CLOZAPINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,8.5,7.98,3.162,7,9
2261,CHEMBL42,CLOZAPINE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.46,8.46,3.5,2,9
2261,CHEMBL42,CLOZAPINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,8.4,8.03,4.0,21,9
2261,CHEMBL42,CLOZAPINE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,8.26,7.58,5.5,32,9
2261,CHEMBL42,CLOZAPINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,8.2,6.81,6.38,19,9
2261,CHEMBL42,CLOZAPINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,8.2,7.61,6.303,4,9
2261,CHEMBL42,CLOZAPINE,72,CHEMBL217,D(2) dopamine receptor,8.15,6.96,7.11,90,9
2261,CHEMBL42,CLOZAPINE,88,CHEMBL2056,D(1A) dopamine receptor,8.12,6.94,7.5,20,9
2261,CHEMBL42,CLOZAPINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,8.02,7.51,9.532,4,9
2261,CHEMBL42,CLOZAPINE,90,CHEMBL219,D(4) dopamine receptor,8.0,7.55,10.0,67,9
2261,CHEMBL42,CLOZAPINE,125,CHEMBL229,Alpha-1A adrenergic receptor,8.0,7.57,10.0,8,9
2261,CHEMBL42,CLOZAPINE,128,CHEMBL232,Alpha-1B adrenergic receptor,8.0,8.0,10.0,1,9
2261,CHEMBL42,CLOZAPINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.96,7.48,11.0,4,9
2261,CHEMBL42,CLOZAPINE,11290,CHEMBL3759,Histamine H4 receptor,7.92,7.19,11.9,7,9
2261,CHEMBL42,CLOZAPINE,103,CHEMBL223,Alpha-1D adrenergic receptor,7.77,7.62,17.0,2,8
2261,CHEMBL42,CLOZAPINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,7.77,7.04,17.0,4,9
2261,CHEMBL42,CLOZAPINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.62,6.79,24.0,8,9
2261,CHEMBL42,CLOZAPINE,102,CHEMBL1941,Histamine H2 receptor,7.3,7.3,49.8,1,8
2261,CHEMBL42,CLOZAPINE,130,CHEMBL234,D(3) dopamine receptor,7.22,6.43,60.1,41,9
2261,CHEMBL42,CLOZAPINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.0,6.51,100.0,6,9
2261,CHEMBL42,CLOZAPINE,144,CHEMBL1899,5-hydroxytryptamine receptor 3A,6.73,6.32,186.21,4,9
2261,CHEMBL42,CLOZAPINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.72,6.29,190.55,11,9
2261,CHEMBL42,CLOZAPINE,220,CHEMBL1850,D(1B) dopamine receptor,6.7,6.36,198.0,4,9
2261,CHEMBL42,CLOZAPINE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.54,6.18,290.0,3,8
2261,CHEMBL42,CLOZAPINE,10280,CHEMBL264,Histamine H3 receptor,6.2,6.2,631.0,1,9
2261,CHEMBL42,CLOZAPINE,106,CHEMBL1898,5-hydroxytryptamine receptor 1B,6.0,6.0,1000.0,1,9
2261,CHEMBL42,CLOZAPINE,10618,CHEMBL2182,5-hydroxytryptamine receptor 1E,6.0,6.0,1000.0,1,9
2261,CHEMBL42,CLOZAPINE,10624,CHEMBL3426,5-hydroxytryptamine receptor 5A,6.0,6.0,1000.0,1,9
2261,CHEMBL42,CLOZAPINE,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,6.0,6.0,1000.0,2,9
2261,CHEMBL42,CLOZAPINE,136,CHEMBL236,Delta-type opioid receptor,5.95,5.95,1123.8,1,8
2261,CHEMBL42,CLOZAPINE,103668,CHEMBL1293235,Prelamin-A/C,5.95,5.95,1122.0,1,9
2261,CHEMBL42,CLOZAPINE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,5.9,5.9,1258.9,1,9
2261,CHEMBL42,CLOZAPINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.84,5.83,1458.0,2,8
1202,CHEMBL420,GUANABENZ,52,CHEMBL1867,Alpha-2A adrenergic receptor,8.09,7.77,8.1,3,8
1202,CHEMBL420,GUANABENZ,11684,CHEMBL3923,Nischarin,7.46,7.46,34.67,2,9
1202,CHEMBL420,GUANABENZ,125,CHEMBL229,Alpha-1A adrenergic receptor,7.37,7.37,42.3,1,8
1202,CHEMBL420,GUANABENZ,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.21,7.11,62.0,2,8
1202,CHEMBL420,GUANABENZ,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.17,7.0,68.0,2,8
1202,CHEMBL420,GUANABENZ,101361,CHEMBL5857,Trace amine-associated receptor 1,7.05,6.49,90.0,2,9
1202,CHEMBL420,GUANABENZ,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.97,6.83,107.0,2,8
1202,CHEMBL420,GUANABENZ,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.95,6.68,112.0,2,8
1202,CHEMBL420,GUANABENZ,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.79,6.38,161.0,2,8
1202,CHEMBL420,GUANABENZ,103,CHEMBL223,Alpha-1D adrenergic receptor,6.63,6.48,232.0,2,8
1202,CHEMBL420,GUANABENZ,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.22,6.22,603.8,1,8
1202,CHEMBL420,GUANABENZ,86,CHEMBL1951,Amine oxidase [flavin-containing] A,5.75,5.75,1787.0,1,8
1202,CHEMBL420,GUANABENZ,11400,CHEMBL2842,Serine/threonine-protein kinase mTOR,5.68,5.68,2074.9,1,9
2282945,CHEMBL4204794,AVAPRITINIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,9.62,9.59,0.24,2,9
2282945,CHEMBL4204794,AVAPRITINIB,12627,CHEMBL2007,Platelet-derived growth factor receptor alpha,9.62,9.62,0.24,1,9
2282945,CHEMBL4204794,AVAPRITINIB,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,8.82,8.82,1.5,1,9
129399,CHEMBL420762,MOZAVAPTAN,112,CHEMBL1790,Vasopressin V2 receptor,8.03,7.45,9.42,3,9
129399,CHEMBL420762,MOZAVAPTAN,134,CHEMBL1889,Vasopressin V1a receptor,6.71,6.71,195.0,1,8
129399,CHEMBL420762,MOZAVAPTAN,116,CHEMBL2049,Oxytocin receptor,6.18,6.18,660.0,1,8
129399,CHEMBL420762,MOZAVAPTAN,121,CHEMBL228,Sodium-dependent serotonin transporter,5.9,5.9,1260.8,1,8
129399,CHEMBL420762,MOZAVAPTAN,129,CHEMBL233,Mu-type opioid receptor,5.61,5.61,2483.6,1,8
2286380,CHEMBL4208229,ASCIMINIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,9.3,8.8,0.5,3,9
1223,CHEMBL421,SULFASALAZINE,103668,CHEMBL1293235,Prelamin-A/C,7.5,7.5,31.6,1,9
1223,CHEMBL421,SULFASALAZINE,103088,CHEMBL1075149,Cystine/glutamate transporter,6.8,6.8,160.0,1,9
1223,CHEMBL421,SULFASALAZINE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,6.65,6.65,223.9,1,9
1223,CHEMBL421,SULFASALAZINE,100283,CHEMBL5019,Flavin reductase (NADPH),6.36,6.36,436.52,2,9
1223,CHEMBL421,SULFASALAZINE,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,6.34,6.34,460.0,1,9
1223,CHEMBL421,SULFASALAZINE,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,6.28,6.27,530.0,2,9
1223,CHEMBL421,SULFASALAZINE,11398,CHEMBL4302,ATP-dependent translocase ABCB1,6.04,6.04,916.0,1,9
1223,CHEMBL421,SULFASALAZINE,104069,CHEMBL1743128,ATP-binding cassette sub-family C member 4,5.82,5.82,1500.0,1,9
1223,CHEMBL421,SULFASALAZINE,78,CHEMBL1963,Thyrotropin receptor,5.8,5.8,1584.9,2,9
1223,CHEMBL421,SULFASALAZINE,10193,CHEMBL261,Carbonic anhydrase 1,5.52,5.52,3040.0,1,9
1223,CHEMBL421,SULFASALAZINE,104065,CHEMBL1743124,Solute carrier organic anion transporter family member 2B1,5.52,5.52,3000.0,2,9
2294618,CHEMBL4216467,RIPRETINIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,8.04,7.6,9.2,5,9
128275,CHEMBL421701,DITHIAZANINE IODIDE,103710,CHEMBL1293277,NPC intracellular cholesterol transporter 1,6.55,6.55,281.8,1,9
128275,CHEMBL421701,DITHIAZANINE IODIDE,103727,CHEMBL1293294,Ras-related protein Rab-9A,6.5,6.5,316.2,1,9
128275,CHEMBL421701,DITHIAZANINE IODIDE,103665,CHEMBL1293232,Survival motor neuron protein,6.0,6.0,1000.0,1,9
128275,CHEMBL421701,DITHIAZANINE IODIDE,103972,CHEMBL1741176,X-box-binding protein 1,5.62,5.62,2400.0,1,8
1325,CHEMBL422,TRIFLUOPERAZINE,105591,CHEMBL2311238,Emopamil-binding protein-like,8.41,8.41,3.9,1,9
1325,CHEMBL422,TRIFLUOPERAZINE,11165,CHEMBL4931,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",8.1,8.1,8.0,1,9
1325,CHEMBL422,TRIFLUOPERAZINE,72,CHEMBL217,D(2) dopamine receptor,7.83,7.83,14.8,1,8
1325,CHEMBL422,TRIFLUOPERAZINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,7.82,7.82,15.0,1,8
1325,CHEMBL422,TRIFLUOPERAZINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.78,6.95,16.5,2,8
1325,CHEMBL422,TRIFLUOPERAZINE,130,CHEMBL234,D(3) dopamine receptor,7.69,7.69,20.3,1,8
1325,CHEMBL422,TRIFLUOPERAZINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.26,6.47,54.8,2,8
1325,CHEMBL422,TRIFLUOPERAZINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.07,6.4,84.4,2,8
1325,CHEMBL422,TRIFLUOPERAZINE,127,CHEMBL231,Histamine H1 receptor,6.95,6.33,112.0,2,8
1325,CHEMBL422,TRIFLUOPERAZINE,88,CHEMBL2056,D(1A) dopamine receptor,6.89,6.62,129.3,2,8
1325,CHEMBL422,TRIFLUOPERAZINE,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,6.7,6.7,199.5,1,9
1325,CHEMBL422,TRIFLUOPERAZINE,11365,CHEMBL289,Cytochrome P450 2D6,6.5,5.98,316.2,5,9
1325,CHEMBL422,TRIFLUOPERAZINE,102,CHEMBL1941,Histamine H2 receptor,6.33,6.33,470.2,1,8
1325,CHEMBL422,TRIFLUOPERAZINE,12594,CHEMBL3356,Cytochrome P450 1A2,6.2,6.1,630.96,2,8
1325,CHEMBL422,TRIFLUOPERAZINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.13,6.13,749.0,1,8
1325,CHEMBL422,TRIFLUOPERAZINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.01,6.01,979.8,1,8
1325,CHEMBL422,TRIFLUOPERAZINE,101444,CHEMBL6093,Calmodulin-1,6.0,6.0,1000.0,1,8
1325,CHEMBL422,TRIFLUOPERAZINE,100338,CHEMBL4227,N-formyl peptide receptor 2,5.97,5.97,1060.0,3,8
1325,CHEMBL422,TRIFLUOPERAZINE,103657,CHEMBL1293224,Microtubule-associated protein tau,5.9,5.9,1258.9,1,8
1325,CHEMBL422,TRIFLUOPERAZINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.83,5.83,1483.2,1,8
1325,CHEMBL422,TRIFLUOPERAZINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.7,5.7,2000.0,1,8
1325,CHEMBL422,TRIFLUOPERAZINE,12912,CHEMBL3622,Cytochrome P450 2C19,5.7,5.7,1995.3,1,9
1354,CHEMBL423,BETAXOLOL,50,CHEMBL213,Beta-1 adrenergic receptor,8.8,8.12,1.585,2,9
1369,CHEMBL425,OLSALAZINE,100283,CHEMBL5019,Flavin reductase (NADPH),7.16,7.16,70.0,2,9
2315431,CHEMBL4250860,DANICOPAN,105346,CHEMBL2176771,Complement factor D,8.4,8.21,4.0,3,9
324544,CHEMBL426084,SAMIDORPHAN,129,CHEMBL233,Mu-type opioid receptor,10.28,10.28,0.052,1,9
324544,CHEMBL426084,SAMIDORPHAN,137,CHEMBL237,Kappa-type opioid receptor,9.64,9.64,0.23,1,9
324544,CHEMBL426084,SAMIDORPHAN,136,CHEMBL236,Delta-type opioid receptor,8.59,8.59,2.6,1,9
367314,CHEMBL426559,LAROPIPRANT,12659,CHEMBL4427,Prostaglandin D2 receptor,10.52,9.41,0.03,5,9
367314,CHEMBL426559,LAROPIPRANT,246,CHEMBL2069,Thromboxane A2 receptor,8.53,7.34,2.95,6,9
367314,CHEMBL426559,LAROPIPRANT,142,CHEMBL1881,Prostaglandin E2 receptor EP2 subtype,6.87,6.87,136.0,1,9
367314,CHEMBL426559,LAROPIPRANT,101532,CHEMBL5742,Translocator protein,6.54,6.54,286.42,1,9
367314,CHEMBL426559,LAROPIPRANT,20174,CHEMBL5071,Prostaglandin D2 receptor 2,6.13,6.13,745.0,1,9
367314,CHEMBL426559,LAROPIPRANT,10329,CHEMBL3710,Prostaglandin E2 receptor EP3 subtype,6.05,6.05,892.0,1,9
367314,CHEMBL426559,LAROPIPRANT,276,CHEMBL254,"3',5'-cyclic-AMP phosphodiesterase 4A",6.02,6.02,960.0,1,8
367314,CHEMBL426559,LAROPIPRANT,130,CHEMBL234,D(3) dopamine receptor,5.95,5.95,1122.15,1,9
367314,CHEMBL426559,LAROPIPRANT,261,CHEMBL1811,Prostaglandin E2 receptor EP1 subtype,5.94,5.94,1160.0,1,9
367314,CHEMBL426559,LAROPIPRANT,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",5.6,5.6,2500.0,1,8
2318498,CHEMBL4279047,VORASIDENIB,104483,CHEMBL2007625,Isocitrate dehydrogenase [NADP] cytoplasmic,10.4,8.49,0.04,8,9
2318498,CHEMBL4279047,VORASIDENIB,117303,CHEMBL3991501,"Isocitrate dehydrogenase [NADP], mitochondrial",8.15,7.06,7.0,5,9
8062,CHEMBL428647,PACLITAXEL,103668,CHEMBL1293235,Prelamin-A/C,8.74,7.5,1.8,5,9
8062,CHEMBL428647,PACLITAXEL,10893,CHEMBL2597,Tubulin beta-3 chain,8.11,8.09,7.7,3,9
8062,CHEMBL428647,PACLITAXEL,103711,CHEMBL1293278,Geminin,7.65,7.65,22.4,1,9
8062,CHEMBL428647,PACLITAXEL,103731,CHEMBL1293298,Peripheral myelin protein 22,7.32,7.32,47.8,1,9
8062,CHEMBL428647,PACLITAXEL,103727,CHEMBL1293294,Ras-related protein Rab-9A,7.05,7.05,89.1,1,9
8062,CHEMBL428647,PACLITAXEL,11400,CHEMBL2842,Serine/threonine-protein kinase mTOR,6.88,6.65,130.9,2,9
8062,CHEMBL428647,PACLITAXEL,104062,CHEMBL1743121,Solute carrier organic anion transporter family member 1B3,6.58,6.17,260.0,2,9
8062,CHEMBL428647,PACLITAXEL,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,6.55,6.31,280.0,2,9
8062,CHEMBL428647,PACLITAXEL,103710,CHEMBL1293277,NPC intracellular cholesterol transporter 1,6.25,6.25,562.3,1,9
8062,CHEMBL428647,PACLITAXEL,271,CHEMBL1947,Thyroid hormone receptor beta,6.15,6.15,707.9,1,9
8062,CHEMBL428647,PACLITAXEL,17045,CHEMBL340,Cytochrome P450 3A4,5.9,5.9,1258.9,3,9
8062,CHEMBL428647,PACLITAXEL,136,CHEMBL236,Delta-type opioid receptor,5.83,5.83,1481.0,1,8
8062,CHEMBL428647,PACLITAXEL,10184,CHEMBL2327,Substance-K receptor,5.69,5.69,2042.0,1,8
8062,CHEMBL428647,PACLITAXEL,88,CHEMBL2056,D(1A) dopamine receptor,5.67,5.67,2160.0,1,8
8062,CHEMBL428647,PACLITAXEL,10472,CHEMBL1901,Cholecystokinin receptor type A,5.64,5.64,2276.0,1,8
8062,CHEMBL428647,PACLITAXEL,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,5.6,5.6,2511.9,1,9
8062,CHEMBL428647,PACLITAXEL,11398,CHEMBL4302,ATP-dependent translocase ABCB1,5.59,5.58,2596.0,2,9
7725,CHEMBL428880,CROMOLYN,103700,CHEMBL1293267,G-protein coupled receptor 35,7.28,6.28,52.0,6,9
7725,CHEMBL428880,CROMOLYN,103668,CHEMBL1293235,Prelamin-A/C,6.15,6.15,707.9,1,9
7725,CHEMBL428880,CROMOLYN,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,5.75,5.75,1778.3,1,9
1785,CHEMBL429,LABETALOL,50,CHEMBL213,Beta-1 adrenergic receptor,8.23,8.12,5.837,2,8
1785,CHEMBL429,LABETALOL,43,CHEMBL210,Beta-2 adrenergic receptor,7.96,7.88,11.0,2,8
1785,CHEMBL429,LABETALOL,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.98,6.98,104.0,1,8
1785,CHEMBL429,LABETALOL,103,CHEMBL223,Alpha-1D adrenergic receptor,6.59,6.44,256.0,2,8
1785,CHEMBL429,LABETALOL,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.12,5.93,763.0,2,8
1785,CHEMBL429,LABETALOL,11365,CHEMBL289,Cytochrome P450 2D6,6.1,6.1,800.0,1,8
1785,CHEMBL429,LABETALOL,155,CHEMBL238,Sodium-dependent dopamine transporter,5.89,5.78,1277.0,3,8
1785,CHEMBL429,LABETALOL,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.71,5.62,1933.0,2,8
1785,CHEMBL429,LABETALOL,129,CHEMBL233,Mu-type opioid receptor,5.62,5.62,2421.9,1,8
2335156,CHEMBL4297185,DAROLUTAMIDE,56,CHEMBL1871,Androgen receptor,7.96,7.55,11.0,6,9
2335480,CHEMBL4297509,ELACESTRANT,19,CHEMBL206,Estrogen receptor,7.32,7.32,48.0,2,9
2335480,CHEMBL4297509,ELACESTRANT,174,CHEMBL242,Estrogen receptor beta,6.06,6.06,870.0,2,9
2335488,CHEMBL4297517,MAVACAMTEN,17045,CHEMBL340,Cytochrome P450 3A4,5.66,5.66,2200.0,1,9
2335493,CHEMBL4297522,PEMIGATINIB,11926,CHEMBL2742,Fibroblast growth factor receptor 3,10.0,8.2,0.1,10,9
2335493,CHEMBL4297522,PEMIGATINIB,10264,CHEMBL4142,Fibroblast growth factor receptor 2,9.4,8.7,0.4,7,9
2335493,CHEMBL4297522,PEMIGATINIB,10266,CHEMBL3650,Fibroblast growth factor receptor 1,9.4,8.72,0.4,7,9
2335493,CHEMBL4297522,PEMIGATINIB,11925,CHEMBL3973,Fibroblast growth factor receptor 4,7.57,7.45,27.0,6,9
2335559,CHEMBL4297588,ODEVIXIBAT,11180,CHEMBL2047,Bile acid receptor,9.8,9.8,0.16,1,9
2335561,CHEMBL4297590,DARIDOREXANT,10009,CHEMBL5113,Orexin/Hypocretin receptor type 1,8.96,8.79,1.1,4,9
2335561,CHEMBL4297590,DARIDOREXANT,12968,CHEMBL4792,Orexin receptor type 2,8.9,8.68,1.259,4,9
2335581,CHEMBL4297610,OLUTASIDENIB,104483,CHEMBL2007625,Isocitrate dehydrogenase [NADP] cytoplasmic,9.0,7.59,1.0,21,9
2335637,CHEMBL4297666,OMIDENEPAG ISOPROPYL,142,CHEMBL1881,Prostaglandin E2 receptor EP2 subtype,8.96,8.96,1.1,1,9
2335810,CHEMBL4297839,TIRZEPATIDE,100290,CHEMBL4383,Gastric inhibitory polypeptide receptor,10.52,10.52,0.03,1,9
2335810,CHEMBL4297839,TIRZEPATIDE,11758,CHEMBL1784,Glucagon-like peptide 1 receptor,9.11,9.11,0.77,1,9
2336109,CHEMBL4298138,REPOTRECTINIB,101034,CHEMBL5608,NT-3 growth factor receptor,11.0,9.8,0.01,6,9
2336109,CHEMBL4298138,REPOTRECTINIB,100413,CHEMBL4898,BDNF/NT-3 growth factors receptor,10.3,10.3,0.05,3,9
2336109,CHEMBL4298138,REPOTRECTINIB,101019,CHEMBL5568,Proto-oncogene tyrosine-protein kinase ROS,10.15,9.46,0.07,6,9
2336109,CHEMBL4298138,REPOTRECTINIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,10.09,9.42,0.082,5,9
2336109,CHEMBL4298138,REPOTRECTINIB,11902,CHEMBL2815,High affinity nerve growth factor receptor,9.96,8.83,0.11,24,9
2336109,CHEMBL4298138,REPOTRECTINIB,100417,CHEMBL4247,ALK tyrosine kinase receptor,9.0,8.51,1.01,16,9
2336109,CHEMBL4298138,REPOTRECTINIB,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,8.28,7.84,5.29,3,9
2336109,CHEMBL4298138,REPOTRECTINIB,11242,CHEMBL2695,Focal adhesion kinase 1,8.16,8.16,6.96,1,9
441579,CHEMBL429910,DAPAGLIFLOZIN,20092,CHEMBL3884,Sodium/glucose cotransporter 2,9.31,8.8,0.49,42,9
441579,CHEMBL429910,DAPAGLIFLOZIN,18036,CHEMBL4979,Sodium/glucose cotransporter 1,6.43,6.01,370.0,24,9
441579,CHEMBL429910,DAPAGLIFLOZIN,104105,CHEMBL1744524,Sodium/myo-inositol cotransporter 2,6.42,6.42,380.0,1,8
2337802,CHEMBL4299851,PIFLUFOLASTAT,184,CHEMBL1892,Glutamate carboxypeptidase 2,8.81,8.31,1.56,2,9
2337891,CHEMBL4299940,MITAPIVAT,103134,CHEMBL1075189,Pyruvate kinase PKM,7.7,7.51,20.0,4,9
2337891,CHEMBL4299940,MITAPIVAT,103054,CHEMBL1075126,Pyruvate kinase PKLR,7.54,7.54,29.0,1,9
2580,CHEMBL43,AMSACRINE,11400,CHEMBL2842,Serine/threonine-protein kinase mTOR,6.88,6.58,130.9,2,9
2580,CHEMBL43,AMSACRINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.68,6.46,208.93,3,9
2580,CHEMBL43,AMSACRINE,102439,CHEMBL6136,Lysine-specific histone demethylase 1A,6.06,6.06,880.0,1,9
2580,CHEMBL43,AMSACRINE,20053,CHEMBL4096,Cellular tumor antigen p53,6.0,6.0,1000.0,1,9
2580,CHEMBL43,AMSACRINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.89,5.89,1300.0,1,8
2580,CHEMBL43,AMSACRINE,103689,CHEMBL1293256,Thrombopoietin,5.6,5.6,2511.9,2,9
2580,CHEMBL43,AMSACRINE,12026,CHEMBL3396,DNA topoisomerase 2-beta,5.56,5.56,2760.0,1,9
2580,CHEMBL43,AMSACRINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.55,5.55,2800.0,1,8
2580,CHEMBL43,AMSACRINE,126,CHEMBL230,Prostaglandin G/H synthase 2,5.54,5.54,2900.0,1,8
2580,CHEMBL43,AMSACRINE,12056,CHEMBL3257,Aldehyde oxidase,5.5,5.5,3200.0,1,9
1853,CHEMBL430,GEMIFLOXACIN,11140,CHEMBL284,Dipeptidyl peptidase 4,5.57,5.57,2700.0,1,9
2341085,CHEMBL4303214,FRUQUINTINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,9.46,8.79,0.35,3,9
2341085,CHEMBL4303214,FRUQUINTINIB,10979,CHEMBL1868,Vascular endothelial growth factor receptor 1,7.48,7.47,33.0,3,9
2341085,CHEMBL4303214,FRUQUINTINIB,11752,CHEMBL1955,Vascular endothelial growth factor receptor 3,7.46,7.46,35.0,3,9
2341540,CHEMBL4303669,ZOLEDRONIC ACID,71,CHEMBL1782,Farnesyl pyrophosphate synthase,10.15,7.65,0.07,25,9
2341540,CHEMBL4303669,ZOLEDRONIC ACID,15,CHEMBL205,Carbonic anhydrase 2,7.21,7.21,62.0,2,9
2341540,CHEMBL4303669,ZOLEDRONIC ACID,11063,CHEMBL3510,Carbonic anhydrase 14,7.04,7.04,92.0,2,9
2341540,CHEMBL4303669,ZOLEDRONIC ACID,12209,CHEMBL3242,Carbonic anhydrase 12,6.5,6.5,316.0,2,9
2341540,CHEMBL4303669,ZOLEDRONIC ACID,117363,CHEMBL4105758,Butyrophilin subfamily 3 member A1,6.31,5.91,486.6,2,9
2341540,CHEMBL4303669,ZOLEDRONIC ACID,103668,CHEMBL1293235,Prelamin-A/C,6.2,6.2,631.0,1,9
2341540,CHEMBL4303669,ZOLEDRONIC ACID,10108,CHEMBL4769,Geranylgeranyl pyrophosphate synthase,5.57,5.57,2700.0,1,9
122252,CHEMBL431770,ISTRADEFYLLINE,252,CHEMBL251,Adenosine receptor A2a,8.66,7.45,2.2,22,9
122252,CHEMBL431770,ISTRADEFYLLINE,104,CHEMBL2039,Amine oxidase [flavin-containing] B,7.57,7.57,27.0,1,9
122252,CHEMBL431770,ISTRADEFYLLINE,114,CHEMBL226,Adenosine receptor A1,6.08,5.77,841.0,12,9
122252,CHEMBL431770,ISTRADEFYLLINE,278,CHEMBL255,Adenosine receptor A2b,5.75,5.75,1800.0,2,9
122252,CHEMBL431770,ISTRADEFYLLINE,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",5.75,5.75,1800.0,1,8
122252,CHEMBL431770,ISTRADEFYLLINE,276,CHEMBL254,"3',5'-cyclic-AMP phosphodiesterase 4A",5.56,5.56,2772.8,1,8
1991,CHEMBL433,VALPROATE SODIUM,101097,CHEMBL5162,Neuropeptide S receptor,7.7,7.7,20.0,1,9
1991,CHEMBL433,VALPROATE SODIUM,17045,CHEMBL340,Cytochrome P450 3A4,5.8,5.8,1584.89,3,9
1991,CHEMBL433,VALPROATE SODIUM,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,5.55,5.55,2818.4,2,9
1994,CHEMBL434,ISOPROTERENOL,50,CHEMBL213,Beta-1 adrenergic receptor,10.08,8.38,0.084,24,9
1994,CHEMBL434,ISOPROTERENOL,43,CHEMBL210,Beta-2 adrenergic receptor,9.8,7.94,0.1585,40,9
1994,CHEMBL434,ISOPROTERENOL,226,CHEMBL246,Beta-3 adrenergic receptor,9.01,7.82,0.97,25,9
1994,CHEMBL434,ISOPROTERENOL,104544,CHEMBL2034804,Taste receptor type 2 member 31,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,109434,CHEMBL3309105,Taste receptor type 2 member 14,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,109435,CHEMBL3309106,Taste receptor type 2 member 16,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,109436,CHEMBL3309107,Taste receptor type 2 member 4,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,109437,CHEMBL3309108,Taste receptor type 2 member 41,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,109438,CHEMBL3309109,Taste receptor type 2 member 60,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,109439,CHEMBL3309110,Taste receptor type 2 member 9,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,109751,CHEMBL3559704,Taste receptor type 2 member 10,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,109752,CHEMBL3559705,Taste receptor type 2 member 20,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,109753,CHEMBL3559706,Taste receptor type 2 member 50,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,117259,CHEMBL3988599,Taste receptor type 2 member 8,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,118998,CHEMBL4523248,Taste receptor type 2 member 38,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,118999,CHEMBL4523249,Taste receptor type 2 member 39,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,119000,CHEMBL4523250,Taste receptor type 2 member 40,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,119001,CHEMBL4523251,Taste receptor type 2 member 43,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,119002,CHEMBL4523252,Taste receptor type 2 member 45,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,119003,CHEMBL4523253,Taste receptor type 2 member 46,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,119004,CHEMBL4523254,Taste receptor type 2 member 30,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,119005,CHEMBL4523255,Taste receptor type 2 member 19,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,119110,CHEMBL4523360,Taste receptor type 2 member 42,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,119221,CHEMBL4523471,Taste receptor type 2 member 13,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,119222,CHEMBL4523472,Taste receptor type 2 member 7,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,119223,CHEMBL4523473,Taste receptor type 2 member 5,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,119224,CHEMBL4523474,Taste receptor type 2 member 3,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,119225,CHEMBL4523475,Taste receptor type 2 member 1,8.31,8.31,4.9,1,9
1994,CHEMBL434,ISOPROTERENOL,125,CHEMBL229,Alpha-1A adrenergic receptor,5.67,5.67,2116.6,1,8
1994,CHEMBL434,ISOPROTERENOL,90,CHEMBL219,D(4) dopamine receptor,5.54,5.54,2900.0,1,9
27569,CHEMBL434394,NEBIVOLOL,50,CHEMBL213,Beta-1 adrenergic receptor,8.52,8.52,3.0,1,8
27569,CHEMBL434394,NEBIVOLOL,43,CHEMBL210,Beta-2 adrenergic receptor,7.16,7.16,70.0,1,8
27569,CHEMBL434394,NEBIVOLOL,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.85,6.32,140.0,2,8
27569,CHEMBL434394,NEBIVOLOL,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.5,6.29,316.23,2,8
27569,CHEMBL434394,NEBIVOLOL,121,CHEMBL228,Sodium-dependent serotonin transporter,6.12,6.12,750.0,1,8
27569,CHEMBL434394,NEBIVOLOL,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.82,5.82,1500.0,1,8
27569,CHEMBL434394,NEBIVOLOL,130,CHEMBL234,D(3) dopamine receptor,5.7,5.7,2000.0,1,8
27569,CHEMBL434394,NEBIVOLOL,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.7,5.7,2000.0,1,8
27569,CHEMBL434394,NEBIVOLOL,125,CHEMBL229,Alpha-1A adrenergic receptor,5.51,5.51,3100.0,1,8
27569,CHEMBL434394,NEBIVOLOL,155,CHEMBL238,Sodium-dependent dopamine transporter,5.5,5.5,3200.0,1,8
63100,CHEMBL43452,POMALIDOMIDE,120172,CHEMBL4739707,Zinc finger protein Aiolos,7.7,7.7,20.0,1,9
63100,CHEMBL43452,POMALIDOMIDE,185,CHEMBL1825,Tumor necrosis factor,7.48,7.48,33.0,1,9
63100,CHEMBL43452,POMALIDOMIDE,104335,CHEMBL1909490,Interleukin-1 beta,7.33,7.33,47.0,1,9
63100,CHEMBL43452,POMALIDOMIDE,120150,CHEMBL4739685,DNA-binding protein Ikaros,7.3,7.3,50.0,2,9
63100,CHEMBL43452,POMALIDOMIDE,116734,CHEMBL3763008,Protein cereblon,7.08,6.48,83.0,4,9
2045,CHEMBL435,HYDROCHLOROTHIAZIDE,103668,CHEMBL1293235,Prelamin-A/C,8.35,8.35,4.5,1,9
2045,CHEMBL435,HYDROCHLOROTHIAZIDE,271,CHEMBL1947,Thyroid hormone receptor beta,6.55,6.55,281.8,1,9
2045,CHEMBL435,HYDROCHLOROTHIAZIDE,15,CHEMBL205,Carbonic anhydrase 2,6.54,6.5,290.0,23,9
2045,CHEMBL435,HYDROCHLOROTHIAZIDE,10193,CHEMBL261,Carbonic anhydrase 1,6.48,6.48,328.0,18,9
2045,CHEMBL435,HYDROCHLOROTHIAZIDE,103665,CHEMBL1293232,Survival motor neuron protein,5.9,5.9,1258.9,1,9
317541,CHEMBL435298,ESFLURBIPROFEN,126,CHEMBL230,Prostaglandin G/H synthase 2,6.04,6.04,910.0,1,9
317541,CHEMBL435298,ESFLURBIPROFEN,96,CHEMBL221,Prostaglandin G/H synthase 1,5.7,5.7,2000.0,1,9
2084,CHEMBL436,TOLRESTAT,242,CHEMBL1900,Aldo-keto reductase family 1 member B1,8.0,7.51,10.0,8,9
2084,CHEMBL436,TOLRESTAT,102631,CHEMBL5983,Aldo-keto reductase family 1 member B10,7.94,7.45,11.6,4,9
2084,CHEMBL436,TOLRESTAT,11308,CHEMBL2246,Aldo-keto reductase family 1 member A1,7.19,6.35,65.0,3,9
2095,CHEMBL437,SULFATHIAZOLE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,5.65,5.65,2238.7,1,9
2095,CHEMBL437,SULFATHIAZOLE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.58,5.58,2600.0,1,8
398458,CHEMBL437765,RIFAMYCIN,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,6.64,6.17,230.0,2,8
398458,CHEMBL437765,RIFAMYCIN,104062,CHEMBL1743121,Solute carrier organic anion transporter family member 1B3,5.52,5.52,3000.0,1,8
398458,CHEMBL437765,RIFAMYCIN,104065,CHEMBL1743124,Solute carrier organic anion transporter family member 2B1,5.52,5.52,3000.0,1,8
2130,CHEMBL438,SULFAMERAZINE,12911,CHEMBL3397,Cytochrome P450 2C9,8.3,8.3,5.0,1,9
2131,CHEMBL439,SULFADIAZINE,6,CHEMBL202,Dihydrofolate reductase,6.89,6.89,130.0,1,9
2131,CHEMBL439,SULFADIAZINE,103668,CHEMBL1293235,Prelamin-A/C,6.75,6.75,177.8,1,9
312971,CHEMBL439849,VILAZODONE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,9.96,9.26,0.11,11,9
312971,CHEMBL439849,VILAZODONE,121,CHEMBL228,Sodium-dependent serotonin transporter,9.4,9.24,0.4,7,9
312971,CHEMBL439849,VILAZODONE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.8,6.8,158.1,1,9
312971,CHEMBL439849,VILAZODONE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.53,6.53,295.0,1,9
312971,CHEMBL439849,VILAZODONE,72,CHEMBL217,D(2) dopamine receptor,6.18,6.18,666.0,1,9
2166,CHEMBL441,THIOPENTAL,103668,CHEMBL1293235,Prelamin-A/C,6.45,6.45,354.8,1,9
54825,CHEMBL441738,AFAMELANOTIDE,10142,CHEMBL259,Melanocortin receptor 4,10.77,9.12,0.017,55,9
54825,CHEMBL441738,AFAMELANOTIDE,11869,CHEMBL3795,Melanocyte-stimulating hormone receptor,10.64,9.74,0.023,13,9
54825,CHEMBL441738,AFAMELANOTIDE,11003,CHEMBL4644,Melanocortin receptor 3,9.89,8.98,0.13,18,9
54825,CHEMBL441738,AFAMELANOTIDE,11006,CHEMBL4608,Melanocortin receptor 5,9.64,9.02,0.23,14,9
54825,CHEMBL441738,AFAMELANOTIDE,14,CHEMBL1910,Adenosine deaminase,7.8,7.8,16.0,1,8
2203,CHEMBL442,ERGOTAMINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,9.1,8.1,0.796,3,8
2203,CHEMBL442,ERGOTAMINE,105,CHEMBL1983,5-hydroxytryptamine receptor 1D,9.1,8.59,0.8,5,9
2203,CHEMBL442,ERGOTAMINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,9.02,8.86,0.948,2,8
2203,CHEMBL442,ERGOTAMINE,72,CHEMBL217,D(2) dopamine receptor,8.84,7.62,1.433,3,8
2203,CHEMBL442,ERGOTAMINE,130,CHEMBL234,D(3) dopamine receptor,8.83,7.67,1.464,3,8
2203,CHEMBL442,ERGOTAMINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,8.76,7.86,1.755,3,8
2203,CHEMBL442,ERGOTAMINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,8.74,7.84,1.809,3,8
2203,CHEMBL442,ERGOTAMINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.73,8.11,1.853,5,9
2203,CHEMBL442,ERGOTAMINE,106,CHEMBL1898,5-hydroxytryptamine receptor 1B,8.68,8.57,2.1,3,9
2203,CHEMBL442,ERGOTAMINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,8.66,8.56,2.203,2,8
2203,CHEMBL442,ERGOTAMINE,10624,CHEMBL3426,5-hydroxytryptamine receptor 5A,7.85,7.7,14.0,5,9
2203,CHEMBL442,ERGOTAMINE,103,CHEMBL223,Alpha-1D adrenergic receptor,7.62,7.46,24.0,2,8
2203,CHEMBL442,ERGOTAMINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.54,7.39,29.0,2,8
2203,CHEMBL442,ERGOTAMINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.66,6.66,220.0,1,8
2203,CHEMBL442,ERGOTAMINE,88,CHEMBL2056,D(1A) dopamine receptor,6.23,6.02,590.0,3,8
2203,CHEMBL442,ERGOTAMINE,17045,CHEMBL340,Cytochrome P450 3A4,6.0,6.0,1000.0,1,8
2203,CHEMBL442,ERGOTAMINE,43,CHEMBL210,Beta-2 adrenergic receptor,5.72,5.64,1898.0,2,8
2203,CHEMBL442,ERGOTAMINE,50,CHEMBL213,Beta-1 adrenergic receptor,5.62,5.62,2392.0,1,8
2203,CHEMBL442,ERGOTAMINE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.51,5.51,3100.0,1,8
2203,CHEMBL442,ERGOTAMINE,248,CHEMBL1835,Thromboxane-A synthase,5.51,5.51,3064.0,1,9
2203,CHEMBL442,ERGOTAMINE,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,5.5,5.5,3160.0,1,8
353270,CHEMBL443052,TAVABOROLE,15,CHEMBL205,Carbonic anhydrase 2,6.33,6.33,462.0,2,9
353270,CHEMBL443052,TAVABOROLE,10193,CHEMBL261,Carbonic anhydrase 1,5.7,5.7,2015.0,1,9
2342179,CHEMBL4435170,DEUCRAVACITINIB,12694,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,10.7,9.02,0.02,23,9
2342179,CHEMBL4435170,DEUCRAVACITINIB,10919,CHEMBL2835,Tyrosine-protein kinase JAK1,9.64,7.05,0.23,12,9
2342179,CHEMBL4435170,DEUCRAVACITINIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,8.52,6.82,3.0,3,9
2342179,CHEMBL4435170,DEUCRAVACITINIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,8.0,7.11,10.0,2,9
2342179,CHEMBL4435170,DEUCRAVACITINIB,11472,CHEMBL4026,Signal transducer and activator of transcription 3,7.05,7.05,89.0,1,9
2342179,CHEMBL4435170,DEUCRAVACITINIB,100993,CHEMBL5467,Bone morphogenetic protein receptor type-2,6.71,6.71,193.0,2,9
61682,CHEMBL44354,CEFTAZIDIME,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,6.75,6.62,180.0,2,8
61682,CHEMBL44354,CEFTAZIDIME,133,CHEMBL235,Peroxisome proliferator-activated receptor gamma,6.42,6.42,380.0,1,8
61682,CHEMBL44354,CEFTAZIDIME,36,CHEMBL208,Progesterone receptor,5.64,5.64,2300.0,1,8
2262,CHEMBL445,NORTRIPTYLINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,8.5,8.2,3.184,4,8
2262,CHEMBL445,NORTRIPTYLINE,127,CHEMBL231,Histamine H1 receptor,8.23,7.76,5.862,3,8
2262,CHEMBL445,NORTRIPTYLINE,121,CHEMBL228,Sodium-dependent serotonin transporter,8.16,7.65,6.977,3,8
2262,CHEMBL445,NORTRIPTYLINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,8.09,7.63,8.169,3,8
2262,CHEMBL445,NORTRIPTYLINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,7.89,7.02,13.0,3,8
2262,CHEMBL445,NORTRIPTYLINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.82,7.29,15.0,4,8
2262,CHEMBL445,NORTRIPTYLINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.76,6.96,17.2,4,8
2262,CHEMBL445,NORTRIPTYLINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.7,7.04,20.0,3,8
2262,CHEMBL445,NORTRIPTYLINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,7.7,7.28,20.0,3,8
2262,CHEMBL445,NORTRIPTYLINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.52,6.82,30.0,3,8
2262,CHEMBL445,NORTRIPTYLINE,103668,CHEMBL1293235,Prelamin-A/C,7.45,7.03,35.5,2,9
2262,CHEMBL445,NORTRIPTYLINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.44,7.19,36.0,2,8
2262,CHEMBL445,NORTRIPTYLINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,7.44,6.82,36.0,3,8
2262,CHEMBL445,NORTRIPTYLINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.37,6.93,43.0,3,8
2262,CHEMBL445,NORTRIPTYLINE,130,CHEMBL234,D(3) dopamine receptor,7.21,6.75,61.0,3,8
2262,CHEMBL445,NORTRIPTYLINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.91,6.32,123.0,4,8
2262,CHEMBL445,NORTRIPTYLINE,103,CHEMBL223,Alpha-1D adrenergic receptor,6.87,6.71,134.0,2,8
2262,CHEMBL445,NORTRIPTYLINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.67,6.53,214.0,4,9
2262,CHEMBL445,NORTRIPTYLINE,88,CHEMBL2056,D(1A) dopamine receptor,6.57,6.42,269.0,3,8
2262,CHEMBL445,NORTRIPTYLINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.56,6.34,275.0,2,8
2262,CHEMBL445,NORTRIPTYLINE,12912,CHEMBL3622,Cytochrome P450 2C19,6.5,6.01,316.2,2,9
2262,CHEMBL445,NORTRIPTYLINE,137,CHEMBL237,Kappa-type opioid receptor,6.16,6.16,690.0,1,8
2262,CHEMBL445,NORTRIPTYLINE,11365,CHEMBL289,Cytochrome P450 2D6,6.0,5.68,1000.0,4,9
2262,CHEMBL445,NORTRIPTYLINE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.88,5.72,1333.0,3,8
2262,CHEMBL445,NORTRIPTYLINE,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,5.82,5.82,1500.0,1,9
2262,CHEMBL445,NORTRIPTYLINE,102,CHEMBL1941,Histamine H2 receptor,5.64,5.63,2295.0,2,8
2262,CHEMBL445,NORTRIPTYLINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.59,5.59,2590.0,1,8
2265,CHEMBL446,SULFAMETHAZINE,103665,CHEMBL1293232,Survival motor neuron protein,6.0,6.0,1000.0,1,9
68607,CHEMBL44657,ETOPOSIDE,12026,CHEMBL3396,DNA topoisomerase 2-beta,7.16,6.63,69.8,2,9
68607,CHEMBL44657,ETOPOSIDE,103768,CHEMBL1615382,Nuclear receptor coactivator 3,6.43,6.43,374.72,1,8
68607,CHEMBL44657,ETOPOSIDE,103773,CHEMBL1615387,Nuclear receptor coactivator 1,5.94,5.94,1153.0,1,8
2326,CHEMBL447,SECOBARBITAL,12592,CHEMBL321,Matrix metalloproteinase-9,5.58,5.58,2643.0,1,8
3012,CHEMBL45,MELATONIN,11084,CHEMBL1945,Melatonin receptor type 1A,10.66,9.6,0.022,89,9
3012,CHEMBL45,MELATONIN,11085,CHEMBL1946,Melatonin receptor type 1B,10.16,9.47,0.069,77,9
3012,CHEMBL45,MELATONIN,10280,CHEMBL264,Histamine H3 receptor,9.3,9.3,0.5,1,9
3012,CHEMBL45,MELATONIN,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.8,8.8,1.6,2,9
3012,CHEMBL45,MELATONIN,10170,CHEMBL3959,Ribosyldihydronicotinamide dehydrogenase [quinone],7.56,7.3,27.6,4,9
3012,CHEMBL45,MELATONIN,10567,CHEMBL2439,Myeloperoxidase,5.52,5.52,3000.0,1,9
2431,CHEMBL451,CHLORDIAZEPOXIDE,127,CHEMBL231,Histamine H1 receptor,6.68,6.21,208.0,2,8
520664,CHEMBL451887,CARFILZOMIB,100624,CHEMBL4662,Proteasome Macropain subunit MB1,8.68,8.18,2.1,13,9
520664,CHEMBL451887,CARFILZOMIB,101477,CHEMBL5620,Proteasome subunit beta type-8,8.49,7.73,3.2,6,9
520664,CHEMBL451887,CARFILZOMIB,109455,CHEMBL3317334,Proteasome subunit beta type-10,7.89,7.05,13.0,2,9
520664,CHEMBL451887,CARFILZOMIB,109503,CHEMBL3347256,Proteasome subunit beta type-7,7.37,7.37,43.0,1,9
520664,CHEMBL451887,CARFILZOMIB,104445,CHEMBL1944495,Proteasome subunit beta type-9,7.16,6.1,69.0,3,9
520664,CHEMBL451887,CARFILZOMIB,11172,CHEMBL3174,Glutathione S-transferase omega-1,6.82,6.82,150.0,1,9
520664,CHEMBL451887,CARFILZOMIB,100613,CHEMBL3492,Proteasome Macropain subunit,6.69,6.17,203.0,3,9
520664,CHEMBL451887,CARFILZOMIB,104446,CHEMBL1944496,Proteasome subunit beta type-6,6.05,6.05,890.0,1,9
520664,CHEMBL451887,CARFILZOMIB,100633,CHEMBL4208,Proteasome component C5,5.84,5.69,1452.0,3,9
2484,CHEMBL453,SULFISOXAZOLE,12912,CHEMBL3622,Cytochrome P450 2C19,8.2,8.2,6.3,2,9
2484,CHEMBL453,SULFISOXAZOLE,78,CHEMBL1963,Thyrotropin receptor,6.4,6.25,398.1,4,9
2484,CHEMBL453,SULFISOXAZOLE,249,CHEMBL252,Endothelin-1 receptor,6.11,6.1,780.0,3,8
2406188,CHEMBL4535757,SOTORASIB,105451,CHEMBL2189121,GTPase KRas,8.02,7.58,9.66,4,9
506444,CHEMBL454446,CEFDITOREN PIVOXIL,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,6.45,6.45,354.8,1,9
2525,CHEMBL455,SULFACETAMIDE,78,CHEMBL1963,Thyrotropin receptor,6.2,6.2,631.0,2,9
2525,CHEMBL455,SULFACETAMIDE,103665,CHEMBL1293232,Survival motor neuron protein,5.95,5.95,1122.0,1,9
2428752,CHEMBL4558324,LAZERTINIB,9,CHEMBL203,Epidermal growth factor receptor,8.57,7.49,2.7,7,9
2428752,CHEMBL4558324,LAZERTINIB,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,6.36,6.36,437.0,1,9
2429562,CHEMBL4559134,SELPERCATINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,9.4,8.15,0.4,21,9
2429562,CHEMBL4559134,SELPERCATINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,7.0,7.0,100.0,1,9
2654,CHEMBL456,ETHACRYNIC ACID,12911,CHEMBL3397,Cytochrome P450 2C9,6.2,6.2,630.96,2,9
2654,CHEMBL456,ETHACRYNIC ACID,103668,CHEMBL1293235,Prelamin-A/C,5.5,5.5,3162.3,1,9
2994,CHEMBL457,GEMFIBROZIL,12704,CHEMBL3194,Transthyretin,7.0,7.0,100.0,1,9
72035,CHEMBL45816,MIBEFRADIL,4,CHEMBL1859,Voltage-dependent T-type calcium channel subunit alpha-1H,7.5,6.67,32.0,6,9
72035,CHEMBL45816,MIBEFRADIL,11365,CHEMBL289,Cytochrome P450 2D6,7.2,6.48,63.0,5,9
72035,CHEMBL45816,MIBEFRADIL,100100,CHEMBL4641,Voltage-dependent T-type calcium channel subunit alpha-1G,7.19,6.05,64.0,23,9
72035,CHEMBL45816,MIBEFRADIL,100101,CHEMBL5558,Voltage-dependent T-type calcium channel subunit alpha-1I,6.9,6.6,126.0,3,9
72035,CHEMBL45816,MIBEFRADIL,17045,CHEMBL340,Cytochrome P450 3A4,6.89,6.4,130.0,9,9
72035,CHEMBL45816,MIBEFRADIL,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.72,5.95,190.0,19,9
72035,CHEMBL45816,MIBEFRADIL,169,CHEMBL1940,Voltage-dependent L-type calcium channel subunit alpha-1C,6.7,6.65,202.0,2,9
72035,CHEMBL45816,MIBEFRADIL,10511,CHEMBL4478,Voltage-dependent N-type calcium channel subunit alpha-1B,6.38,6.13,416.0,2,8
72035,CHEMBL45816,MIBEFRADIL,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,6.3,6.18,500.0,2,9
72035,CHEMBL45816,MIBEFRADIL,18061,CHEMBL4296,Sodium channel protein type 9 subunit alpha,6.3,6.3,500.0,1,9
72035,CHEMBL45816,MIBEFRADIL,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.13,6.13,746.1,1,8
72035,CHEMBL45816,MIBEFRADIL,130,CHEMBL234,D(3) dopamine receptor,6.08,6.08,825.1,1,8
72035,CHEMBL45816,MIBEFRADIL,129,CHEMBL233,Mu-type opioid receptor,6.01,6.01,979.1,1,8
72035,CHEMBL45816,MIBEFRADIL,11398,CHEMBL4302,ATP-dependent translocase ABCB1,5.92,5.81,1200.0,5,8
72035,CHEMBL45816,MIBEFRADIL,12912,CHEMBL3622,Cytochrome P450 2C19,5.88,5.88,1320.0,1,9
72035,CHEMBL45816,MIBEFRADIL,125,CHEMBL229,Alpha-1A adrenergic receptor,5.8,5.8,1580.0,1,8
72035,CHEMBL45816,MIBEFRADIL,100611,CHEMBL3491,Cytochrome P450 2J2,5.67,5.67,2140.0,1,9
72035,CHEMBL45816,MIBEFRADIL,103657,CHEMBL1293224,Microtubule-associated protein tau,5.55,5.55,2818.4,1,8
2453082,CHEMBL4582651,PRALSETINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,9.52,9.16,0.3,8,9
2453082,CHEMBL4582651,PRALSETINIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,8.7,8.7,2.0,1,9
2453082,CHEMBL4582651,PRALSETINIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,8.19,8.19,6.5,1,9
2456099,CHEMBL4585668,BELZUTIFAN,104103,CHEMBL1744522,Endothelial PAS domain-containing protein 1,8.05,7.95,9.0,4,9
2456099,CHEMBL4585668,BELZUTIFAN,187,CHEMBL1783,"Vascular endothelial growth factor A, long form",7.75,7.75,18.0,3,9
3730,CHEMBL459,METHYLDOPA,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,6.9,6.9,125.9,1,9
3730,CHEMBL459,METHYLDOPA,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.3,6.2,501.2,2,9
3730,CHEMBL459,METHYLDOPA,10206,CHEMBL2392,DNA polymerase beta,5.95,5.9,1122.0,2,9
3730,CHEMBL459,METHYLDOPA,12054,CHEMBL2903,Polyunsaturated fatty acid lipoxygenase ALOX15,5.9,5.9,1258.9,1,9
3730,CHEMBL459,METHYLDOPA,103669,CHEMBL1293236,ATP-dependent DNA helicase Q1,5.85,5.75,1412.5,2,9
3730,CHEMBL459,METHYLDOPA,126,CHEMBL230,Prostaglandin G/H synthase 2,5.72,5.72,1900.0,1,8
3730,CHEMBL459,METHYLDOPA,103659,CHEMBL1293226,Lysine-specific demethylase 4E,5.52,5.52,3000.0,1,9
3730,CHEMBL459,METHYLDOPA,103657,CHEMBL1293224,Microtubule-associated protein tau,5.5,5.5,3162.3,2,9
2464645,CHEMBL4594214,ZICONOTIDE,10511,CHEMBL4478,Voltage-dependent N-type calcium channel subunit alpha-1B,6.3,6.26,500.0,2,8
2464681,CHEMBL4594250,NETARSUDIL,10811,CHEMBL3231,Rho-associated protein kinase 1,9.0,7.85,1.0,22,9
2464681,CHEMBL4594250,NETARSUDIL,11149,CHEMBL2973,Rho-associated protein kinase 2,9.0,8.37,1.0,10,9
2464781,CHEMBL4594350,ADAGRASIB,105451,CHEMBL2189121,GTPase KRas,8.3,8.09,5.0,5,9
2464879,CHEMBL4594448,IPTACOPAN,101521,CHEMBL5731,Complement factor B,11.0,7.71,0.01,6,9
2466823,CHEMBL4596392,CRAVACITINIB,12694,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,8.29,7.49,5.13,7,9
2466823,CHEMBL4596392,CRAVACITINIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,6.08,5.71,840.0,5,9
3183,CHEMBL46,ONDANSETRON,144,CHEMBL1899,5-hydroxytryptamine receptor 3A,10.05,8.53,0.09,5,9
3183,CHEMBL46,ONDANSETRON,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,8.6,7.03,2.5,3,9
3183,CHEMBL46,ONDANSETRON,104067,CHEMBL1743126,Multidrug and toxin extrusion protein 1,7.52,7.05,30.0,3,9
3183,CHEMBL46,ONDANSETRON,104068,CHEMBL1743127,Multidrug and toxin extrusion protein 2,6.8,6.66,160.0,2,9
3183,CHEMBL46,ONDANSETRON,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.4,6.15,400.0,5,9
3183,CHEMBL46,ONDANSETRON,104063,CHEMBL1743122,Solute carrier family 22 member 2,6.05,5.91,890.0,2,9
3799,CHEMBL460,MOLINDONE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.03,7.03,93.1,1,8
3799,CHEMBL460,MOLINDONE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.92,6.53,120.0,2,8
3799,CHEMBL460,MOLINDONE,72,CHEMBL217,D(2) dopamine receptor,6.68,6.68,209.4,1,8
3799,CHEMBL460,MOLINDONE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,6.58,6.58,265.0,1,9
3799,CHEMBL460,MOLINDONE,130,CHEMBL234,D(3) dopamine receptor,6.52,6.52,300.5,1,8
3799,CHEMBL460,MOLINDONE,88,CHEMBL2056,D(1A) dopamine receptor,6.11,6.11,770.0,1,8
3799,CHEMBL460,MOLINDONE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.7,5.7,2019.9,1,8
3799,CHEMBL460,MOLINDONE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.68,5.68,2066.1,1,8
457398,CHEMBL461101,ELTROMBOPAG,265,CHEMBL1864,Thrombopoietin receptor,7.42,7.42,38.0,2,9
457398,CHEMBL461101,ELTROMBOPAG,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.2,6.18,630.96,2,9
457398,CHEMBL461101,ELTROMBOPAG,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,5.51,5.51,3100.0,1,9
454365,CHEMBL462605,PITOLISANT,10280,CHEMBL264,Histamine H3 receptor,9.8,8.42,0.16,39,9
454365,CHEMBL462605,PITOLISANT,127,CHEMBL231,Histamine H1 receptor,5.94,5.94,1148.15,1,9
454365,CHEMBL462605,PITOLISANT,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.77,5.77,1700.0,2,9
4496,CHEMBL465,DRONABINOL,259,CHEMBL253,Cannabinoid receptor 2,8.85,7.56,1.42,31,9
4496,CHEMBL465,DRONABINOL,87,CHEMBL218,Cannabinoid receptor 1,8.55,7.64,2.8,27,9
4496,CHEMBL465,DRONABINOL,130,CHEMBL234,D(3) dopamine receptor,7.99,7.99,10.2,1,9
4496,CHEMBL465,DRONABINOL,108311,CHEMBL3259470,G-protein coupled receptor 183,7.42,7.42,38.0,1,9
4496,CHEMBL465,DRONABINOL,103167,CHEMBL1075319,Transient receptor potential cation channel subfamily M member 8,6.8,6.8,160.0,1,9
4496,CHEMBL465,DRONABINOL,100594,CHEMBL3691,Autotaxin,6.34,6.34,460.0,1,9
4496,CHEMBL465,DRONABINOL,107601,CHEMBL2384898,N-arachidonyl glycine receptor,6.02,6.02,960.0,1,9
4496,CHEMBL465,DRONABINOL,102688,CHEMBL5845,Glycine receptor subunit alpha-1,5.89,5.89,1300.0,1,9
2486475,CHEMBL4650215,INAVOLISIB,11362,CHEMBL4005,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",10.47,9.55,0.034,3,9
2486475,CHEMBL4650215,INAVOLISIB,11177,CHEMBL3130,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",7.91,7.85,12.2,3,9
2486475,CHEMBL4650215,INAVOLISIB,11939,CHEMBL3267,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",7.91,7.8,12.2,3,9
2486475,CHEMBL4650215,INAVOLISIB,12576,CHEMBL3145,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",7.0,7.0,99.7,2,9
2486475,CHEMBL4650215,INAVOLISIB,12993,CHEMBL4437,Phosphatidylinositol 3-kinase regulatory subunit beta,7.0,7.0,99.7,1,9
2486579,CHEMBL4650319,MOBOCERTINIB,9,CHEMBL203,Epidermal growth factor receptor,11.0,8.15,0.01,11,9
4730,CHEMBL467,HYDROXYUREA,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,5.5,5.5,3162.3,2,9
65648,CHEMBL46740,BAZEDOXIFENE,19,CHEMBL206,Estrogen receptor,9.22,7.59,0.6,8,9
65648,CHEMBL46740,BAZEDOXIFENE,174,CHEMBL242,Estrogen receptor beta,8.42,7.5,3.8,3,9
65648,CHEMBL46740,BAZEDOXIFENE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.65,6.65,225.8,1,8
65648,CHEMBL46740,BAZEDOXIFENE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.58,6.58,260.0,1,8
65648,CHEMBL46740,BAZEDOXIFENE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.2,5.87,631.0,2,8
65648,CHEMBL46740,BAZEDOXIFENE,126,CHEMBL230,Prostaglandin G/H synthase 2,6.06,6.06,870.0,1,8
65648,CHEMBL46740,BAZEDOXIFENE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.96,5.96,1090.0,1,8
65648,CHEMBL46740,BAZEDOXIFENE,11536,CHEMBL4616,Growth hormone secretagogue receptor type 1,5.96,5.96,1100.0,1,8
65648,CHEMBL46740,BAZEDOXIFENE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.85,5.85,1400.0,1,8
65648,CHEMBL46740,BAZEDOXIFENE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.72,5.72,1900.0,1,8
65648,CHEMBL46740,BAZEDOXIFENE,10280,CHEMBL264,Histamine H3 receptor,5.66,5.66,2200.0,1,8
65648,CHEMBL46740,BAZEDOXIFENE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.64,5.64,2300.8,1,8
65648,CHEMBL46740,BAZEDOXIFENE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.57,5.57,2700.0,1,8
65648,CHEMBL46740,BAZEDOXIFENE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.54,5.54,2900.0,1,8
65648,CHEMBL46740,BAZEDOXIFENE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.5,5.5,3200.0,1,8
5028,CHEMBL468,THALIDOMIDE,129,CHEMBL233,Mu-type opioid receptor,6.69,6.69,202.2,1,8
5028,CHEMBL468,THALIDOMIDE,116734,CHEMBL3763008,Protein cereblon,6.6,5.95,250.0,7,9
5028,CHEMBL468,THALIDOMIDE,120172,CHEMBL4739707,Zinc finger protein Aiolos,6.48,6.48,330.0,1,9
5080,CHEMBL469,KETOROLAC,129,CHEMBL233,Mu-type opioid receptor,8.89,8.89,1.3,1,8
5080,CHEMBL469,KETOROLAC,96,CHEMBL221,Prostaglandin G/H synthase 1,7.89,6.9,13.0,2,9
5080,CHEMBL469,KETOROLAC,126,CHEMBL230,Prostaglandin G/H synthase 2,6.85,6.44,140.0,3,9
66028,CHEMBL46917,CARBARIL,11638,CHEMBL4040,Mitogen-activated protein kinase 1,8.89,8.89,1.3,1,9
5528,CHEMBL471,SOTALOL,103668,CHEMBL1293235,Prelamin-A/C,8.46,8.46,3.5,1,9
5528,CHEMBL471,SOTALOL,43,CHEMBL210,Beta-2 adrenergic receptor,6.53,6.29,298.3,3,8
5528,CHEMBL471,SOTALOL,50,CHEMBL213,Beta-1 adrenergic receptor,6.08,5.96,833.5,2,8
448872,CHEMBL471737,IVABRADINE,130,CHEMBL234,D(3) dopamine receptor,5.58,5.58,2612.9,1,8
5582,CHEMBL472,GLYBURIDE,78,CHEMBL1963,Thyrotropin receptor,6.9,6.9,125.9,1,9
5582,CHEMBL472,GLYBURIDE,133,CHEMBL235,Peroxisome proliferator-activated receptor gamma,6.18,5.91,660.0,2,9
5582,CHEMBL472,GLYBURIDE,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,5.85,5.75,1400.0,2,9
5582,CHEMBL472,GLYBURIDE,102394,CHEMBL6020,Bile salt export pump,5.82,5.82,1500.0,1,9
5582,CHEMBL472,GLYBURIDE,12911,CHEMBL3397,Cytochrome P450 2C9,5.79,5.7,1602.0,4,9
5582,CHEMBL472,GLYBURIDE,104248,CHEMBL1795168,CDGSH iron-sulfur domain-containing protein 1,5.78,5.78,1671.0,1,9
5582,CHEMBL472,GLYBURIDE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,5.7,5.6,1995.3,4,9
5638,CHEMBL473,DOFETILIDE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,8.39,7.63,4.1,23,9
5638,CHEMBL473,DOFETILIDE,130,CHEMBL234,D(3) dopamine receptor,6.11,6.11,780.0,1,8
460092,CHEMBL473417,VISMODEGIB,101400,CHEMBL5971,Protein smoothened,9.4,8.0,0.4,15,9
460092,CHEMBL473417,VISMODEGIB,101028,CHEMBL5602,Sonic hedgehog protein,7.82,6.79,15.0,2,9
460092,CHEMBL473417,VISMODEGIB,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,5.85,5.85,1400.0,1,9
460092,CHEMBL473417,VISMODEGIB,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.57,5.57,2680.0,1,8
5772,CHEMBL476,DACARBAZINE,12592,CHEMBL321,Matrix metalloproteinase-9,6.25,6.25,556.0,1,8
490151,CHEMBL476960,VOGLIBOSE,10977,CHEMBL2608,Lysosomal alpha-glucosidase,7.16,7.16,70.0,1,9
490151,CHEMBL476960,VOGLIBOSE,1,CHEMBL2074,Maltase-glucoamylase,5.89,5.89,1300.0,2,9
5797,CHEMBL477,ADENOSINE,280,CHEMBL256,Adenosine receptor A3,8.94,6.74,1.148,10,9
5797,CHEMBL477,ADENOSINE,114,CHEMBL226,Adenosine receptor A1,8.63,6.66,2.344,11,9
5797,CHEMBL477,ADENOSINE,252,CHEMBL251,Adenosine receptor A2a,7.76,6.74,17.3,9,9
5797,CHEMBL477,ADENOSINE,278,CHEMBL255,Adenosine receptor A2b,7.28,7.28,52.48,1,9
5797,CHEMBL477,ADENOSINE,103665,CHEMBL1293232,Survival motor neuron protein,5.95,5.95,1122.0,1,9
5797,CHEMBL477,ADENOSINE,101176,CHEMBL5401,Signal transducer and activator of transcription 6,5.9,5.9,1258.9,2,9
5797,CHEMBL477,ADENOSINE,101230,CHEMBL5551,Sodium/nucleoside cotransporter 1,5.75,5.75,1800.0,1,9
5797,CHEMBL477,ADENOSINE,101512,CHEMBL5707,Solute carrier family 28 member 3,5.68,5.68,2100.0,1,9
489525,CHEMBL477772,PAZOPANIB,12209,CHEMBL3242,Carbonic anhydrase 12,9.05,9.05,0.9,1,9
489525,CHEMBL477772,PAZOPANIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,8.74,7.59,1.8,18,9
489525,CHEMBL477772,PAZOPANIB,197,CHEMBL1913,Platelet-derived growth factor receptor beta,8.7,7.63,2.0,7,9
489525,CHEMBL477772,PAZOPANIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,8.5,7.71,3.162,15,9
489525,CHEMBL477772,PAZOPANIB,12627,CHEMBL2007,Platelet-derived growth factor receptor alpha,8.31,7.49,4.9,4,9
489525,CHEMBL477772,PAZOPANIB,12840,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,8.1,7.46,7.9,5,9
489525,CHEMBL477772,PAZOPANIB,12952,CHEMBL3594,Carbonic anhydrase 9,8.04,8.04,9.1,2,9
489525,CHEMBL477772,PAZOPANIB,10979,CHEMBL1868,Vascular endothelial growth factor receptor 1,8.0,7.79,10.0,7,9
489525,CHEMBL477772,PAZOPANIB,10193,CHEMBL261,Carbonic anhydrase 1,7.92,7.92,12.1,1,9
489525,CHEMBL477772,PAZOPANIB,11752,CHEMBL1955,Vascular endothelial growth factor receptor 3,7.57,7.41,27.0,6,9
489525,CHEMBL477772,PAZOPANIB,15,CHEMBL205,Carbonic anhydrase 2,7.49,7.49,32.4,1,9
489525,CHEMBL477772,PAZOPANIB,101506,CHEMBL5701,Serine/threonine-protein kinase TAO3,7.35,7.35,45.0,1,8
489525,CHEMBL477772,PAZOPANIB,101079,CHEMBL5122,Discoidin domain-containing receptor 2,7.3,7.0,50.0,8,9
489525,CHEMBL477772,PAZOPANIB,100917,CHEMBL5319,Epithelial discoidin domain-containing receptor 1,7.24,7.12,57.0,3,9
489525,CHEMBL477772,PAZOPANIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,7.1,6.49,79.43,7,9
489525,CHEMBL477772,PAZOPANIB,102676,CHEMBL5836,Ephrin type-B receptor 6,7.09,7.09,81.0,1,8
489525,CHEMBL477772,PAZOPANIB,30006,CHEMBL3981,Serine/threonine-protein kinase 10,7.08,7.08,84.0,2,9
489525,CHEMBL477772,PAZOPANIB,10264,CHEMBL4142,Fibroblast growth factor receptor 2,6.85,6.74,140.0,3,9
489525,CHEMBL477772,PAZOPANIB,10266,CHEMBL3650,Fibroblast growth factor receptor 1,6.85,6.55,140.0,6,9
489525,CHEMBL477772,PAZOPANIB,30011,CHEMBL3983,Dual specificity protein kinase TTK,6.82,6.82,150.0,2,9
489525,CHEMBL477772,PAZOPANIB,20020,CHEMBL4355,Cyclin-G-associated kinase,6.7,6.7,200.0,2,9
489525,CHEMBL477772,PAZOPANIB,30035,CHEMBL4202,STE20-like serine/threonine-protein kinase,6.62,6.62,240.0,1,8
489525,CHEMBL477772,PAZOPANIB,101131,CHEMBL5261,Serine/threonine-protein kinase TAO1,6.62,6.36,240.0,2,8
489525,CHEMBL477772,PAZOPANIB,100990,CHEMBL5464,Receptor-interacting serine/threonine-protein kinase 1,6.58,6.45,260.0,4,9
489525,CHEMBL477772,PAZOPANIB,104126,CHEMBL1770034,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,6.55,6.55,280.0,1,8
489525,CHEMBL477772,PAZOPANIB,12038,CHEMBL2872,Mitogen-activated protein kinase kinase kinase 9,6.54,6.54,290.0,2,9
489525,CHEMBL477772,PAZOPANIB,30003,CHEMBL3788,Serine/threonine-protein kinase PLK4,6.54,6.54,290.0,2,9
489525,CHEMBL477772,PAZOPANIB,102711,CHEMBL5914,Mitogen-activated protein kinase kinase kinase 2,6.54,6.54,290.0,1,8
489525,CHEMBL477772,PAZOPANIB,30047,CHEMBL4527,TRAF2 and NCK-interacting protein kinase,6.51,6.51,310.0,2,9
489525,CHEMBL477772,PAZOPANIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,6.5,6.13,316.23,13,9
489525,CHEMBL477772,PAZOPANIB,101464,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,6.5,6.08,316.23,2,8
489525,CHEMBL477772,PAZOPANIB,30004,CHEMBL3938,Serine/threonine-protein kinase 16,6.44,6.44,360.0,2,9
489525,CHEMBL477772,PAZOPANIB,101386,CHEMBL5932,LIM domain kinase 2,6.41,6.41,390.0,2,9
489525,CHEMBL477772,PAZOPANIB,30017,CHEMBL3835,Serine/threonine-protein kinase Nek2,6.4,6.14,398.11,3,9
489525,CHEMBL477772,PAZOPANIB,100126,CHEMBL5145,Serine/threonine-protein kinase B-raf,6.37,6.25,430.0,4,9
489525,CHEMBL477772,PAZOPANIB,30041,CHEMBL4312,Serine/threonine-protein kinase 36,6.33,6.33,470.0,2,9
489525,CHEMBL477772,PAZOPANIB,10371,CHEMBL4948,Dual specificity mitogen-activated protein kinase kinase 5,6.32,6.32,480.0,1,8
489525,CHEMBL477772,PAZOPANIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,6.3,6.05,501.19,3,9
489525,CHEMBL477772,PAZOPANIB,12261,CHEMBL2276,Mitogen-activated protein kinase 8,6.3,6.0,501.19,2,8
489525,CHEMBL477772,PAZOPANIB,20025,CHEMBL5014,Receptor-interacting serine/threonine-protein kinase 2,6.24,6.24,580.0,2,9
489525,CHEMBL477772,PAZOPANIB,11047,CHEMBL2897,Dual specificity mitogen-activated protein kinase kinase 4,6.23,6.23,590.0,2,9
489525,CHEMBL477772,PAZOPANIB,11926,CHEMBL2742,Fibroblast growth factor receptor 3,6.21,6.17,620.0,4,9
489525,CHEMBL477772,PAZOPANIB,101405,CHEMBL6000,Serine/threonine-protein kinase RIO2,6.21,6.21,610.0,1,8
489525,CHEMBL477772,PAZOPANIB,20014,CHEMBL4722,Aurora kinase A,6.2,6.11,630.96,2,9
489525,CHEMBL477772,PAZOPANIB,100906,CHEMBL5274,Tyrosine-protein kinase receptor Tie-1,6.16,6.16,700.0,2,9
489525,CHEMBL477772,PAZOPANIB,30018,CHEMBL3836,LIM domain kinase 1,6.14,5.96,720.0,4,9
489525,CHEMBL477772,PAZOPANIB,11870,CHEMBL2708,Mitogen-activated protein kinase kinase kinase 11,6.13,6.03,740.0,4,9
489525,CHEMBL477772,PAZOPANIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,6.13,5.91,740.0,12,9
489525,CHEMBL477772,PAZOPANIB,20171,CHEMBL3935,Aurora kinase C,6.12,6.12,750.0,2,9
489525,CHEMBL477772,PAZOPANIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,6.12,6.12,750.0,2,9
489525,CHEMBL477772,PAZOPANIB,101312,CHEMBL5749,Mitogen-activated protein kinase kinase kinase kinase 1,6.12,6.12,750.0,2,9
489525,CHEMBL477772,PAZOPANIB,101055,CHEMBL5081,Interleukin-1 receptor-associated kinase 3,6.1,6.1,800.0,2,9
489525,CHEMBL477772,PAZOPANIB,10904,CHEMBL1906,RAF proto-oncogene serine/threonine-protein kinase,6.05,6.05,900.0,2,9
489525,CHEMBL477772,PAZOPANIB,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,6.05,6.0,890.0,2,9
489525,CHEMBL477772,PAZOPANIB,101019,CHEMBL5568,Proto-oncogene tyrosine-protein kinase ROS,6.04,6.04,920.0,2,9
489525,CHEMBL477772,PAZOPANIB,93,CHEMBL220,Acetylcholinesterase,6.03,6.03,930.0,1,9
489525,CHEMBL477772,PAZOPANIB,102799,CHEMBL6191,Mitogen-activated protein kinase kinase kinase 19,6.03,6.03,940.0,1,8
489525,CHEMBL477772,PAZOPANIB,11941,CHEMBL3268,Phosphatidylinositol 4-kinase beta,6.02,6.02,960.0,1,8
489525,CHEMBL477772,PAZOPANIB,100951,CHEMBL5334,Non-receptor tyrosine-protein kinase TNK1,6.01,6.01,980.0,1,9
489525,CHEMBL477772,PAZOPANIB,101204,CHEMBL5476,Bone morphogenetic protein receptor type-1B,6.0,6.0,1000.0,1,8
489525,CHEMBL477772,PAZOPANIB,30022,CHEMBL4597,Cyclin-dependent kinase 16,5.92,5.92,1200.0,2,9
489525,CHEMBL477772,PAZOPANIB,10781,CHEMBL2185,Aurora kinase B,5.9,5.9,1258.93,1,8
489525,CHEMBL477772,PAZOPANIB,100976,CHEMBL5416,Cyclin-dependent kinase 11A,5.89,5.89,1300.0,2,9
489525,CHEMBL477772,PAZOPANIB,100069,CHEMBL5455,Tyrosine-protein kinase Fes/Fps,5.85,5.85,1400.0,1,8
489525,CHEMBL477772,PAZOPANIB,11451,CHEMBL3717,Hepatocyte growth factor receptor,5.8,5.73,1584.89,3,8
489525,CHEMBL477772,PAZOPANIB,100127,CHEMBL4454,Tyrosine-protein kinase Fgr,5.8,5.8,1600.0,2,9
489525,CHEMBL477772,PAZOPANIB,100417,CHEMBL4247,ALK tyrosine kinase receptor,5.8,5.71,1584.89,3,9
489525,CHEMBL477772,PAZOPANIB,101188,CHEMBL5432,Mitogen-activated protein kinase kinase kinase kinase 3,5.8,5.8,1600.0,2,9
489525,CHEMBL477772,PAZOPANIB,101484,CHEMBL5627,Leukocyte tyrosine kinase receptor,5.8,5.8,1584.89,1,8
489525,CHEMBL477772,PAZOPANIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,5.77,5.77,1700.0,1,8
489525,CHEMBL477772,PAZOPANIB,103140,CHEMBL1075195,Serine/threonine-protein kinase TAO2,5.75,5.75,1800.0,1,8
489525,CHEMBL477772,PAZOPANIB,104279,CHEMBL1795199,Receptor-interacting serine/threonine-protein kinase 3,5.73,5.73,1856.0,1,9
489525,CHEMBL477772,PAZOPANIB,11408,CHEMBL2637,Mitogen-activated protein kinase 10,5.72,5.72,1900.0,2,9
489525,CHEMBL477772,PAZOPANIB,101333,CHEMBL5785,"Interferon-induced, double-stranded RNA-activated protein kinase",5.72,5.72,1900.0,2,9
489525,CHEMBL477772,PAZOPANIB,104314,CHEMBL1908383,Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma,5.72,5.72,1900.0,1,8
489525,CHEMBL477772,PAZOPANIB,234,CHEMBL1957,Insulin-like growth factor 1 receptor,5.7,5.7,1995.26,1,8
489525,CHEMBL477772,PAZOPANIB,11407,CHEMBL4179,Mitogen-activated protein kinase 9,5.7,5.7,1995.26,1,8
489525,CHEMBL477772,PAZOPANIB,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,5.7,5.61,1995.26,3,9
489525,CHEMBL477772,PAZOPANIB,12037,CHEMBL2777,"Myosin light chain kinase 2, skeletal/cardiac muscle",5.7,5.7,2000.0,2,9
489525,CHEMBL477772,PAZOPANIB,10970,CHEMBL2493,Calcium/calmodulin-dependent protein kinase type 1,5.68,5.68,2100.0,2,9
489525,CHEMBL477772,PAZOPANIB,11873,CHEMBL2873,Mitogen-activated protein kinase kinase kinase 10,5.68,5.68,2100.0,2,9
489525,CHEMBL477772,PAZOPANIB,101338,CHEMBL5808,Cyclin-dependent kinase 11B,5.68,5.68,2100.0,2,9
489525,CHEMBL477772,PAZOPANIB,101433,CHEMBL6082,Serine/threonine-protein kinase SIK1,5.66,5.66,2200.0,2,9
489525,CHEMBL477772,PAZOPANIB,30026,CHEMBL4601,Protein-tyrosine kinase 6,5.64,5.64,2300.0,2,9
489525,CHEMBL477772,PAZOPANIB,100992,CHEMBL5466,Activin receptor type-2B,5.62,5.62,2400.0,2,9
489525,CHEMBL477772,PAZOPANIB,101508,CHEMBL5703,Tyrosine-protein kinase Srms,5.6,5.6,2500.0,2,9
489525,CHEMBL477772,PAZOPANIB,11691,CHEMBL2250,Tyrosine-protein kinase Blk,5.58,5.58,2600.0,2,9
489525,CHEMBL477772,PAZOPANIB,100424,CHEMBL4367,Tyrosine-protein kinase TXK,5.58,5.58,2600.0,2,9
489525,CHEMBL477772,PAZOPANIB,30007,CHEMBL3982,Tyrosine-protein kinase Fer,5.57,5.57,2700.0,2,9
489525,CHEMBL477772,PAZOPANIB,100947,CHEMBL5330,Mitogen-activated protein kinase kinase kinase kinase 2,5.57,5.57,2700.0,1,8
489525,CHEMBL477772,PAZOPANIB,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,5.55,5.55,2800.0,2,9
489525,CHEMBL477772,PAZOPANIB,11925,CHEMBL3973,Fibroblast growth factor receptor 4,5.55,5.55,2800.0,2,9
489525,CHEMBL477772,PAZOPANIB,12276,CHEMBL3956,Mitogen-activated protein kinase kinase kinase 1,5.54,5.54,2900.0,1,8
489525,CHEMBL477772,PAZOPANIB,30000,CHEMBL3830,AP2-associated protein kinase 1,5.54,5.54,2900.0,3,9
489525,CHEMBL477772,PAZOPANIB,11209,CHEMBL4014,Tyrosine-protein kinase ABL2,5.52,5.52,3000.0,2,9
489525,CHEMBL477772,PAZOPANIB,30049,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,5.52,5.52,3000.0,2,9
489525,CHEMBL477772,PAZOPANIB,100075,CHEMBL4267,TGF-beta receptor type-2,5.52,5.52,3000.0,1,8
489525,CHEMBL477772,PAZOPANIB,30023,CHEMBL4599,Activated CDC42 kinase 1,5.5,5.5,3162.28,1,8
5970,CHEMBL479,THIORIDAZINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.9,7.6,1.247,5,9
5970,CHEMBL479,THIORIDAZINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,8.77,7.75,1.69,3,8
5970,CHEMBL479,THIORIDAZINE,103,CHEMBL223,Alpha-1D adrenergic receptor,8.54,8.38,2.895,2,8
5970,CHEMBL479,THIORIDAZINE,130,CHEMBL234,D(3) dopamine receptor,8.47,7.83,3.36,3,8
5970,CHEMBL479,THIORIDAZINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,8.18,8.11,6.643,2,8
5970,CHEMBL479,THIORIDAZINE,72,CHEMBL217,D(2) dopamine receptor,8.1,7.53,8.0,5,9
5970,CHEMBL479,THIORIDAZINE,127,CHEMBL231,Histamine H1 receptor,8.07,7.12,8.412,4,8
5970,CHEMBL479,THIORIDAZINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,7.96,7.53,11.0,2,8
5970,CHEMBL479,THIORIDAZINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.78,7.05,16.8,2,8
5970,CHEMBL479,THIORIDAZINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,7.72,6.95,19.0,3,8
5970,CHEMBL479,THIORIDAZINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.64,7.03,23.0,3,8
5970,CHEMBL479,THIORIDAZINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.6,7.18,25.0,2,8
5970,CHEMBL479,THIORIDAZINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,7.48,6.79,33.0,15,9
5970,CHEMBL479,THIORIDAZINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,7.48,7.26,33.0,3,9
5970,CHEMBL479,THIORIDAZINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.42,6.64,38.0,4,8
5970,CHEMBL479,THIORIDAZINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.3,7.09,50.0,2,8
5970,CHEMBL479,THIORIDAZINE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,7.16,6.95,70.0,2,9
5970,CHEMBL479,THIORIDAZINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.09,6.52,82.0,3,8
5970,CHEMBL479,THIORIDAZINE,88,CHEMBL2056,D(1A) dopamine receptor,7.01,6.86,97.0,2,8
5970,CHEMBL479,THIORIDAZINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.82,6.63,153.0,2,8
5970,CHEMBL479,THIORIDAZINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.76,6.32,174.0,3,8
5970,CHEMBL479,THIORIDAZINE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.4,6.26,399.0,2,8
5970,CHEMBL479,THIORIDAZINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.36,6.12,440.0,2,8
5970,CHEMBL479,THIORIDAZINE,90,CHEMBL219,D(4) dopamine receptor,6.29,6.06,515.0,2,8
5970,CHEMBL479,THIORIDAZINE,137,CHEMBL237,Kappa-type opioid receptor,6.27,5.96,534.0,3,8
5970,CHEMBL479,THIORIDAZINE,102,CHEMBL1941,Histamine H2 receptor,6.03,6.03,934.0,2,8
5970,CHEMBL479,THIORIDAZINE,169,CHEMBL1940,Voltage-dependent L-type calcium channel subunit alpha-1C,5.88,5.88,1320.0,1,9
5970,CHEMBL479,THIORIDAZINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.81,5.81,1538.0,2,8
5970,CHEMBL479,THIORIDAZINE,11365,CHEMBL289,Cytochrome P450 2D6,5.75,5.75,1772.6,1,8
5970,CHEMBL479,THIORIDAZINE,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,5.74,5.74,1830.0,1,9
5970,CHEMBL479,THIORIDAZINE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.72,5.67,1888.0,2,8
5970,CHEMBL479,THIORIDAZINE,10670,CHEMBL1882,Neuronal acetylcholine receptor subunit alpha-4,5.58,5.58,2600.0,1,8
5970,CHEMBL479,THIORIDAZINE,129,CHEMBL233,Mu-type opioid receptor,5.55,5.55,2800.0,1,8
5970,CHEMBL479,THIORIDAZINE,9,CHEMBL203,Epidermal growth factor receptor,5.53,5.53,2947.0,1,8
5975,CHEMBL480,LANSOPRAZOLE,103657,CHEMBL1293224,Microtubule-associated protein tau,8.6,8.6,2.5,1,9
5975,CHEMBL480,LANSOPRAZOLE,12912,CHEMBL3622,Cytochrome P450 2C19,7.0,6.59,100.0,4,9
5975,CHEMBL480,LANSOPRAZOLE,78,CHEMBL1963,Thyrotropin receptor,6.9,6.9,125.9,2,9
5975,CHEMBL480,LANSOPRAZOLE,103668,CHEMBL1293235,Prelamin-A/C,6.9,6.9,125.9,1,9
5975,CHEMBL480,LANSOPRAZOLE,102747,CHEMBL6113,Phosphoethanolamine/phosphocholine phosphatase,6.36,6.36,434.0,1,9
5975,CHEMBL480,LANSOPRAZOLE,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,6.3,6.0,501.2,2,9
5975,CHEMBL480,LANSOPRAZOLE,11535,CHEMBL4158,Fatty acid synthase,5.77,5.77,1700.0,1,9
5975,CHEMBL480,LANSOPRAZOLE,90,CHEMBL219,D(4) dopamine receptor,5.68,5.68,2106.8,1,8
5975,CHEMBL480,LANSOPRAZOLE,144,CHEMBL1899,5-hydroxytryptamine receptor 3A,5.64,5.64,2300.0,1,8
5975,CHEMBL480,LANSOPRAZOLE,103710,CHEMBL1293277,NPC intracellular cholesterol transporter 1,5.64,5.59,2310.9,2,9
5975,CHEMBL480,LANSOPRAZOLE,103727,CHEMBL1293294,Ras-related protein Rab-9A,5.64,5.57,2310.9,2,9
5975,CHEMBL480,LANSOPRAZOLE,11365,CHEMBL289,Cytochrome P450 2D6,5.54,5.54,2900.0,1,9
2537386,CHEMBL4802135,NIRMATRELVIR,10495,CHEMBL268,Cathepsin K,5.92,5.92,1200.0,1,9
2537386,CHEMBL4802135,NIRMATRELVIR,11534,CHEMBL2954,Cathepsin S,5.75,5.75,1800.0,1,9
5985,CHEMBL481,IRINOTECAN,93,CHEMBL220,Acetylcholinesterase,7.3,6.52,50.5,2,9
5985,CHEMBL481,IRINOTECAN,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.66,6.23,217.0,2,8
5985,CHEMBL481,IRINOTECAN,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.34,5.92,461.0,2,8
5985,CHEMBL481,IRINOTECAN,104067,CHEMBL1743126,Multidrug and toxin extrusion protein 1,5.68,5.68,2100.0,1,9
5985,CHEMBL481,IRINOTECAN,104063,CHEMBL1743122,Solute carrier family 22 member 2,5.57,5.57,2700.0,1,9
499179,CHEMBL483254,PANOBINOSTAT,11208,CHEMBL1829,Histone deacetylase 3,10.0,8.55,0.1,21,9
499179,CHEMBL483254,PANOBINOSTAT,12697,CHEMBL325,Histone deacetylase 1,9.3,8.5,0.5,32,9
499179,CHEMBL483254,PANOBINOSTAT,11232,CHEMBL3524,Histone deacetylase 4,9.22,6.9,0.6,18,9
499179,CHEMBL483254,PANOBINOSTAT,11206,CHEMBL1937,Histone deacetylase 2,9.19,8.13,0.65,22,9
499179,CHEMBL483254,PANOBINOSTAT,11307,CHEMBL1865,Histone deacetylase 6,9.15,8.06,0.7,27,9
499179,CHEMBL483254,PANOBINOSTAT,12283,CHEMBL2563,Histone deacetylase 5,9.15,7.41,0.7,15,9
499179,CHEMBL483254,PANOBINOSTAT,11797,CHEMBL4145,Histone deacetylase 9,8.92,6.84,1.2,14,9
499179,CHEMBL483254,PANOBINOSTAT,12021,CHEMBL3310,Histone deacetylase 11,8.8,7.62,1.6,9,9
499179,CHEMBL483254,PANOBINOSTAT,10945,CHEMBL5103,Polyamine deacetylase HDAC10,8.7,8.1,2.0,13,9
499179,CHEMBL483254,PANOBINOSTAT,12443,CHEMBL2716,Histone deacetylase 7,8.64,6.9,2.3,9,9
499179,CHEMBL483254,PANOBINOSTAT,10869,CHEMBL3192,Histone deacetylase 8,8.31,6.89,4.86,21,9
499179,CHEMBL483254,PANOBINOSTAT,103104,CHEMBL1075165,Phosphatidylinositol 3-kinase catalytic subunit type 3,8.3,8.3,5.0,1,9
499179,CHEMBL483254,PANOBINOSTAT,103454,CHEMBL1163125,Bromodomain-containing protein 4,8.3,8.3,5.0,1,9
499179,CHEMBL483254,PANOBINOSTAT,100945,CHEMBL5294,Forkhead box protein O1,6.38,6.38,420.0,1,9
69448,CHEMBL48449,CANTHARIDIN,12649,CHEMBL4703,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,6.8,6.8,160.0,1,9
69448,CHEMBL48449,CANTHARIDIN,109610,CHEMBL3425389,Serine/threonine-protein phosphatase 5,6.4,6.28,400.0,3,9
69448,CHEMBL48449,CANTHARIDIN,10420,CHEMBL2845,Protein phosphatase 1B,6.37,6.06,430.0,2,8
69448,CHEMBL48449,CANTHARIDIN,122129,CHEMBL6066240,Tissue factor pathway inhibitor 2,6.3,6.3,500.0,1,9
69448,CHEMBL48449,CANTHARIDIN,103668,CHEMBL1293235,Prelamin-A/C,5.95,5.95,1122.0,1,9
69448,CHEMBL48449,CANTHARIDIN,12999,CHEMBL4438,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,5.75,5.75,1780.0,1,8
69448,CHEMBL48449,CANTHARIDIN,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,5.6,5.6,2511.9,2,9
520269,CHEMBL484785,CRISABOROLE,276,CHEMBL254,"3',5'-cyclic-AMP phosphodiesterase 4A",7.26,6.87,55.0,2,9
520269,CHEMBL484785,CRISABOROLE,10599,CHEMBL275,"3',5'-cyclic-AMP phosphodiesterase 4B",7.26,7.18,55.0,4,9
520269,CHEMBL484785,CRISABOROLE,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",7.26,6.4,55.0,4,9
520269,CHEMBL484785,CRISABOROLE,11396,CHEMBL291,"3',5'-cyclic-AMP phosphodiesterase 4C",7.26,7.26,55.0,1,9
520269,CHEMBL484785,CRISABOROLE,11910,CHEMBL3012,"High affinity 3',5'-cyclic-AMP phosphodiesterase 7A",6.14,6.14,730.0,1,9
6167,CHEMBL485,CODEINE,129,CHEMBL233,Mu-type opioid receptor,6.98,6.34,105.0,4,8
6167,CHEMBL485,CODEINE,50,CHEMBL213,Beta-1 adrenergic receptor,6.05,6.05,900.0,1,8
6167,CHEMBL485,CODEINE,170,CHEMBL241,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",5.52,5.52,3000.0,1,8
453911,CHEMBL487253,BENDAMUSTINE,11307,CHEMBL1865,Histone deacetylase 6,8.22,8.11,6.0,2,9
453911,CHEMBL487253,BENDAMUSTINE,11206,CHEMBL1937,Histone deacetylase 2,8.05,8.03,9.0,2,9
453911,CHEMBL487253,BENDAMUSTINE,11208,CHEMBL1829,Histone deacetylase 3,8.0,7.8,10.0,2,9
453911,CHEMBL487253,BENDAMUSTINE,11232,CHEMBL3524,Histone deacetylase 4,8.0,8.0,10.0,1,9
453911,CHEMBL487253,BENDAMUSTINE,12283,CHEMBL2563,Histone deacetylase 5,8.0,8.0,10.0,1,9
453911,CHEMBL487253,BENDAMUSTINE,12697,CHEMBL325,Histone deacetylase 1,8.0,7.88,10.0,2,9
453911,CHEMBL487253,BENDAMUSTINE,10945,CHEMBL5103,Polyamine deacetylase HDAC10,7.14,7.14,72.0,1,9
453911,CHEMBL487253,BENDAMUSTINE,10869,CHEMBL3192,Histone deacetylase 8,6.97,6.97,107.0,1,9
6317,CHEMBL488,AMINOGLUTETHIMIDE,65,CHEMBL1978,Aromatase,6.57,5.99,270.0,16,9
3599,CHEMBL49,BUSPIRONE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,8.51,7.67,3.1,47,9
3599,CHEMBL49,BUSPIRONE,72,CHEMBL217,D(2) dopamine receptor,7.89,6.78,13.0,10,9
3599,CHEMBL49,BUSPIRONE,130,CHEMBL234,D(3) dopamine receptor,7.82,7.17,15.0,4,8
3599,CHEMBL49,BUSPIRONE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,7.44,6.75,36.31,4,8
3599,CHEMBL49,BUSPIRONE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.32,6.22,477.0,2,8
3599,CHEMBL49,BUSPIRONE,103,CHEMBL223,Alpha-1D adrenergic receptor,6.28,6.13,529.0,2,8
3599,CHEMBL49,BUSPIRONE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.18,5.96,653.0,3,8
3599,CHEMBL49,BUSPIRONE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,6.08,6.08,840.0,1,9
3599,CHEMBL49,BUSPIRONE,104067,CHEMBL1743126,Multidrug and toxin extrusion protein 1,5.77,5.77,1700.0,1,9
3599,CHEMBL49,BUSPIRONE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.64,5.64,2270.0,1,8
6643,CHEMBL490,PAROXETINE,121,CHEMBL228,Sodium-dependent serotonin transporter,10.4,9.49,0.04,19,9
6643,CHEMBL490,PAROXETINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,9.22,8.69,0.6,2,9
6643,CHEMBL490,PAROXETINE,10567,CHEMBL2439,Myeloperoxidase,7.7,7.7,20.0,1,9
6643,CHEMBL490,PAROXETINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,7.47,7.04,34.0,2,8
6643,CHEMBL490,PAROXETINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.46,6.71,35.0,3,8
6643,CHEMBL490,PAROXETINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,7.42,6.84,38.0,3,8
6643,CHEMBL490,PAROXETINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,7.4,6.99,40.0,8,9
6643,CHEMBL490,PAROXETINE,11365,CHEMBL289,Cytochrome P450 2D6,7.4,6.48,40.0,7,9
6643,CHEMBL490,PAROXETINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,7.05,6.64,89.0,3,8
6643,CHEMBL490,PAROXETINE,250,CHEMBL249,Substance-P receptor,6.74,6.39,180.9,2,9
6643,CHEMBL490,PAROXETINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.72,6.15,189.0,4,8
6643,CHEMBL490,PAROXETINE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.41,6.21,388.0,7,9
6643,CHEMBL490,PAROXETINE,136,CHEMBL236,Delta-type opioid receptor,6.08,6.08,830.0,1,8
6643,CHEMBL490,PAROXETINE,10711,CHEMBL4079,Beta-adrenergic receptor kinase 1,5.96,5.84,1100.0,6,9
6643,CHEMBL490,PAROXETINE,137,CHEMBL237,Kappa-type opioid receptor,5.84,5.84,1448.9,1,8
6643,CHEMBL490,PAROXETINE,129,CHEMBL233,Mu-type opioid receptor,5.82,5.82,1500.0,1,8
6643,CHEMBL490,PAROXETINE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.73,5.73,1860.5,1,8
6643,CHEMBL490,PAROXETINE,10410,CHEMBL2104,P2X purinoceptor 4,5.73,5.73,1870.0,2,9
6643,CHEMBL490,PAROXETINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,5.65,5.65,2255.0,1,8
6643,CHEMBL490,PAROXETINE,87,CHEMBL218,Cannabinoid receptor 1,5.57,5.57,2722.2,1,8
6643,CHEMBL490,PAROXETINE,11400,CHEMBL2842,Serine/threonine-protein kinase mTOR,5.53,5.53,2930.9,1,9
6643,CHEMBL490,PAROXETINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.52,5.52,3000.0,1,8
514258,CHEMBL490665,NALFURAFINE HYDROCHLORIDE,137,CHEMBL237,Kappa-type opioid receptor,10.3,9.88,0.05,3,9
514258,CHEMBL490665,NALFURAFINE HYDROCHLORIDE,129,CHEMBL233,Mu-type opioid receptor,9.14,8.71,0.72,3,9
514258,CHEMBL490665,NALFURAFINE HYDROCHLORIDE,136,CHEMBL236,Delta-type opioid receptor,6.94,6.65,115.9,3,9
514258,CHEMBL490665,NALFURAFINE HYDROCHLORIDE,10009,CHEMBL5113,Orexin/Hypocretin receptor type 1,6.6,6.6,250.0,1,9
460466,CHEMBL491571,DORIPENEM,169,CHEMBL1940,Voltage-dependent L-type calcium channel subunit alpha-1C,5.7,5.7,1995.26,1,8
7065,CHEMBL493,BROMOCRIPTINE,130,CHEMBL234,D(3) dopamine receptor,9.7,8.0,0.202,5,9
7065,CHEMBL493,BROMOCRIPTINE,72,CHEMBL217,D(2) dopamine receptor,9.3,8.42,0.5012,9,9
7065,CHEMBL493,BROMOCRIPTINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.75,7.24,1.778,6,9
7065,CHEMBL493,BROMOCRIPTINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,8.52,7.09,3.0,6,9
7065,CHEMBL493,BROMOCRIPTINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,8.28,7.25,5.292,4,8
7065,CHEMBL493,BROMOCRIPTINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,8.26,7.21,5.533,6,9
7065,CHEMBL493,BROMOCRIPTINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,8.0,7.83,10.0,2,8
7065,CHEMBL493,BROMOCRIPTINE,103,CHEMBL223,Alpha-1D adrenergic receptor,7.82,7.67,15.0,2,8
7065,CHEMBL493,BROMOCRIPTINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.8,7.13,16.0,3,8
7065,CHEMBL493,BROMOCRIPTINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.75,6.63,18.0,4,9
7065,CHEMBL493,BROMOCRIPTINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.12,6.4,76.0,3,8
7065,CHEMBL493,BROMOCRIPTINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.56,6.21,278.0,3,9
7065,CHEMBL493,BROMOCRIPTINE,90,CHEMBL219,D(4) dopamine receptor,6.43,6.43,373.0,1,9
7065,CHEMBL493,BROMOCRIPTINE,50,CHEMBL213,Beta-1 adrenergic receptor,5.86,5.74,1386.0,2,8
7065,CHEMBL493,BROMOCRIPTINE,88,CHEMBL2056,D(1A) dopamine receptor,5.84,5.71,1444.0,4,8
7065,CHEMBL493,BROMOCRIPTINE,102394,CHEMBL6020,Bile salt export pump,5.8,5.8,1600.0,1,8
7065,CHEMBL493,BROMOCRIPTINE,102,CHEMBL1941,Histamine H2 receptor,5.77,5.72,1692.1,2,8
7065,CHEMBL493,BROMOCRIPTINE,93,CHEMBL220,Acetylcholinesterase,5.75,5.75,1776.5,1,8
7065,CHEMBL493,BROMOCRIPTINE,280,CHEMBL256,Adenosine receptor A3,5.72,5.72,1919.1,1,8
7065,CHEMBL493,BROMOCRIPTINE,17045,CHEMBL340,Cytochrome P450 3A4,5.7,5.61,2000.0,2,8
7065,CHEMBL493,BROMOCRIPTINE,96,CHEMBL221,Prostaglandin G/H synthase 1,5.6,5.6,2493.5,1,8
7065,CHEMBL493,BROMOCRIPTINE,11398,CHEMBL4302,ATP-dependent translocase ABCB1,5.55,5.55,2810.0,1,8
486977,CHEMBL493982,VORAPAXAR,10653,CHEMBL3974,Proteinase-activated receptor 1,8.96,7.79,1.1,14,9
486977,CHEMBL493982,VORAPAXAR,129,CHEMBL233,Mu-type opioid receptor,6.09,6.09,820.2,1,8
486977,CHEMBL493982,VORAPAXAR,102394,CHEMBL6020,Bile salt export pump,5.66,5.66,2200.0,1,8
486977,CHEMBL493982,VORAPAXAR,280,CHEMBL256,Adenosine receptor A3,5.62,5.62,2429.0,1,8
7494,CHEMBL494,ILOPROST,261,CHEMBL1811,Prostaglandin E2 receptor EP1 subtype,9.52,9.52,0.3,1,9
7494,CHEMBL494,ILOPROST,143,CHEMBL1995,Prostacyclin receptor,9.4,8.15,0.4,15,9
7494,CHEMBL494,ILOPROST,12659,CHEMBL4427,Prostaglandin D2 receptor,6.83,6.26,147.0,2,9
7494,CHEMBL494,ILOPROST,142,CHEMBL1881,Prostaglandin E2 receptor EP2 subtype,5.68,5.68,2094.0,1,9
485955,CHEMBL494753,ESTRONE SULFURIC ACID,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,7.34,7.34,45.8,1,8
485955,CHEMBL494753,ESTRONE SULFURIC ACID,12030,CHEMBL3004,Multidrug resistance-associated protein 1,6.35,6.35,450.0,1,8
8130,CHEMBL495,ALPROSTADIL,143,CHEMBL1995,Prostacyclin receptor,8.74,7.01,1.8,5,9
8130,CHEMBL495,ALPROSTADIL,88,CHEMBL2056,D(1A) dopamine receptor,8.0,8.0,10.0,1,8
8130,CHEMBL495,ALPROSTADIL,104069,CHEMBL1743128,ATP-binding cassette sub-family C member 4,5.64,5.64,2300.0,1,9
8130,CHEMBL495,ALPROSTADIL,101254,CHEMBL5002,Nuclear receptor subfamily 4 group A member 2,5.52,5.52,3000.0,2,9
8167,CHEMBL496,HEXACHLOROPHENE,10188,CHEMBL260,Mitogen-activated protein kinase 14,7.06,7.06,87.6,1,8
8167,CHEMBL496,HEXACHLOROPHENE,174,CHEMBL242,Estrogen receptor beta,7.01,7.01,98.27,1,9
8167,CHEMBL496,HEXACHLOROPHENE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,6.71,6.71,196.0,1,8
8167,CHEMBL496,HEXACHLOROPHENE,280,CHEMBL256,Adenosine receptor A3,6.44,6.13,361.1,3,8
8167,CHEMBL496,HEXACHLOROPHENE,103668,CHEMBL1293235,Prelamin-A/C,6.35,6.03,446.7,2,9
8167,CHEMBL496,HEXACHLOROPHENE,126,CHEMBL230,Prostaglandin G/H synthase 2,6.19,6.19,644.3,1,8
8167,CHEMBL496,HEXACHLOROPHENE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.15,6.15,704.8,1,8
8167,CHEMBL496,HEXACHLOROPHENE,9,CHEMBL203,Epidermal growth factor receptor,6.13,6.13,748.6,1,8
8167,CHEMBL496,HEXACHLOROPHENE,36,CHEMBL208,Progesterone receptor,6.13,6.13,746.9,1,8
8167,CHEMBL496,HEXACHLOROPHENE,11213,CHEMBL3880,Heat shock protein HSP 90-alpha,6.11,6.11,770.0,1,8
8167,CHEMBL496,HEXACHLOROPHENE,252,CHEMBL251,Adenosine receptor A2a,6.04,5.92,906.0,2,8
8167,CHEMBL496,HEXACHLOROPHENE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.99,5.99,1013.5,1,8
8167,CHEMBL496,HEXACHLOROPHENE,12912,CHEMBL3622,Cytochrome P450 2C19,5.91,5.91,1226.5,1,8
8167,CHEMBL496,HEXACHLOROPHENE,12594,CHEMBL3356,Cytochrome P450 1A2,5.88,5.88,1313.3,1,8
8167,CHEMBL496,HEXACHLOROPHENE,10184,CHEMBL2327,Substance-K receptor,5.86,5.86,1379.7,1,8
8167,CHEMBL496,HEXACHLOROPHENE,119932,CHEMBL4630839,N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D,5.8,5.8,1600.0,1,9
8167,CHEMBL496,HEXACHLOROPHENE,96,CHEMBL221,Prostaglandin G/H synthase 1,5.72,5.63,1884.2,2,8
8167,CHEMBL496,HEXACHLOROPHENE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.69,5.69,2061.2,1,8
8167,CHEMBL496,HEXACHLOROPHENE,19,CHEMBL206,Estrogen receptor,5.67,5.67,2161.56,1,9
8167,CHEMBL496,HEXACHLOROPHENE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.64,5.64,2310.6,1,8
8167,CHEMBL496,HEXACHLOROPHENE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.62,5.62,2411.7,1,8
8167,CHEMBL496,HEXACHLOROPHENE,10140,CHEMBL258,Tyrosine-protein kinase Lck,5.61,5.61,2432.5,1,8
8167,CHEMBL496,HEXACHLOROPHENE,11639,CHEMBL3385,Mitogen-activated protein kinase 3,5.61,5.61,2484.4,1,8
8167,CHEMBL496,HEXACHLOROPHENE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.56,5.56,2741.3,1,8
8167,CHEMBL496,HEXACHLOROPHENE,103665,CHEMBL1293232,Survival motor neuron protein,5.55,5.55,2818.4,1,9
8167,CHEMBL496,HEXACHLOROPHENE,93,CHEMBL220,Acetylcholinesterase,5.52,5.52,3014.9,1,8
8167,CHEMBL496,HEXACHLOROPHENE,248,CHEMBL1835,Thromboxane-A synthase,5.51,5.51,3087.0,1,9
8167,CHEMBL496,HEXACHLOROPHENE,103710,CHEMBL1293277,NPC intracellular cholesterol transporter 1,5.5,5.5,3162.3,1,9
8193,CHEMBL497,CLIOQUINOL,12594,CHEMBL3356,Cytochrome P450 1A2,7.5,7.5,31.62,1,8
8193,CHEMBL497,CLIOQUINOL,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,7.4,7.4,39.8,2,9
8193,CHEMBL497,CLIOQUINOL,103668,CHEMBL1293235,Prelamin-A/C,7.0,7.0,100.0,1,9
8193,CHEMBL497,CLIOQUINOL,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.2,6.2,631.0,1,9
8193,CHEMBL497,CLIOQUINOL,11134,CHEMBL3687,Polyunsaturated fatty acid lipoxygenase ALOX12,6.15,6.15,707.9,1,9
8193,CHEMBL497,CLIOQUINOL,11213,CHEMBL3880,Heat shock protein HSP 90-alpha,5.94,5.94,1158.0,1,8
8193,CHEMBL497,CLIOQUINOL,11154,CHEMBL3869,Matrix metalloproteinase-14,5.92,5.92,1200.0,1,9
8193,CHEMBL497,CLIOQUINOL,12054,CHEMBL2903,Polyunsaturated fatty acid lipoxygenase ALOX15,5.9,5.9,1258.9,1,9
8193,CHEMBL497,CLIOQUINOL,103660,CHEMBL1293227,Ubiquitin carboxyl-terminal hydrolase 2,5.8,5.75,1584.9,2,9
8193,CHEMBL497,CLIOQUINOL,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.55,5.55,2790.0,1,8
8516,CHEMBL498,CHLORPROPAMIDE,103668,CHEMBL1293235,Prelamin-A/C,8.3,8.3,5.0,1,9
8516,CHEMBL498,CHLORPROPAMIDE,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,6.35,6.35,446.7,2,9
8516,CHEMBL498,CHLORPROPAMIDE,78,CHEMBL1963,Thyrotropin receptor,5.8,5.65,1584.9,4,9
8516,CHEMBL498,CHLORPROPAMIDE,103665,CHEMBL1293232,Survival motor neuron protein,5.8,5.8,1584.9,1,9
8516,CHEMBL498,CHLORPROPAMIDE,271,CHEMBL1947,Thyroid hormone receptor beta,5.7,5.7,1995.3,1,9
8531,CHEMBL499,TIMOLOL,43,CHEMBL210,Beta-2 adrenergic receptor,9.7,9.34,0.201,6,9
8531,CHEMBL499,TIMOLOL,50,CHEMBL213,Beta-1 adrenergic receptor,8.82,8.5,1.503,5,9
8531,CHEMBL499,TIMOLOL,226,CHEMBL246,Beta-3 adrenergic receptor,6.47,6.4,339.0,2,8
8531,CHEMBL499,TIMOLOL,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.41,6.41,391.2,1,9
147,CHEMBL5,NALIDIXIC ACID,103668,CHEMBL1293235,Prelamin-A/C,6.9,6.9,125.9,1,9
8543,CHEMBL500,PINDOLOL,43,CHEMBL210,Beta-2 adrenergic receptor,9.49,9.02,0.32,9,9
8543,CHEMBL500,PINDOLOL,50,CHEMBL213,Beta-1 adrenergic receptor,9.28,8.87,0.52,6,9
8543,CHEMBL500,PINDOLOL,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.65,7.21,22.4,10,9
8543,CHEMBL500,PINDOLOL,226,CHEMBL246,Beta-3 adrenergic receptor,7.18,7.01,66.0,3,9
8543,CHEMBL500,PINDOLOL,11638,CHEMBL4040,Mitogen-activated protein kinase 1,7.0,7.0,100.0,1,9
8543,CHEMBL500,PINDOLOL,103668,CHEMBL1293235,Prelamin-A/C,6.9,6.9,125.9,1,9
8543,CHEMBL500,PINDOLOL,17045,CHEMBL340,Cytochrome P450 3A4,6.5,6.5,316.2,2,9
8543,CHEMBL500,PINDOLOL,130,CHEMBL234,D(3) dopamine receptor,6.0,6.0,994.49,1,9
8543,CHEMBL500,PINDOLOL,90,CHEMBL219,D(4) dopamine receptor,5.78,5.78,1661.88,1,9
8543,CHEMBL500,PINDOLOL,106,CHEMBL1898,5-hydroxytryptamine receptor 1B,5.58,5.58,2600.0,1,8
8543,CHEMBL500,PINDOLOL,137,CHEMBL237,Kappa-type opioid receptor,5.5,5.5,3170.4,1,8
451744,CHEMBL501849,SIMEPREVIR,11534,CHEMBL2954,Cathepsin S,6.1,6.1,800.0,1,9
490427,CHEMBL501867,VINCRISTINE SULFATE,103668,CHEMBL1293235,Prelamin-A/C,7.55,7.55,28.2,1,9
490427,CHEMBL501867,VINCRISTINE SULFATE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,7.2,7.2,63.1,2,9
490427,CHEMBL501867,VINCRISTINE SULFATE,103727,CHEMBL1293294,Ras-related protein Rab-9A,7.05,7.05,89.1,1,9
490427,CHEMBL501867,VINCRISTINE SULFATE,103710,CHEMBL1293277,NPC intracellular cholesterol transporter 1,6.05,6.05,891.3,1,9
9372,CHEMBL502,DONEPEZIL,93,CHEMBL220,Acetylcholinesterase,8.7,7.73,2.0,162,9
9372,CHEMBL502,DONEPEZIL,3,CHEMBL1827,"cGMP-specific 3',5'-cyclic phosphodiesterase",7.96,7.96,11.0,1,9
9372,CHEMBL502,DONEPEZIL,10532,CHEMBL1914,Cholinesterase,7.85,5.88,14.0,28,9
9372,CHEMBL502,DONEPEZIL,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,7.84,7.84,14.6,2,9
9372,CHEMBL502,DONEPEZIL,12252,CHEMBL4822,Beta-secretase 1,7.75,6.51,18.0,8,9
9372,CHEMBL502,DONEPEZIL,10639,CHEMBL2484,Acetylcholine receptor subunit epsilon,7.49,7.49,32.36,1,9
9372,CHEMBL502,DONEPEZIL,10280,CHEMBL264,Histamine H3 receptor,6.46,6.03,350.0,2,8
9372,CHEMBL502,DONEPEZIL,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.19,5.85,640.0,3,9
9372,CHEMBL502,DONEPEZIL,90,CHEMBL219,D(4) dopamine receptor,6.08,6.08,824.4,1,8
9372,CHEMBL502,DONEPEZIL,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.95,5.76,1113.9,2,8
515206,CHEMBL502182,ELAGOLIX SODIUM,118,CHEMBL1855,Gonadotropin-releasing hormone receptor,9.05,8.82,0.9,4,9
515206,CHEMBL502182,ELAGOLIX SODIUM,137,CHEMBL237,Kappa-type opioid receptor,5.62,5.62,2383.41,1,9
522730,CHEMBL502835,NINTEDANIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,9.38,8.44,0.42,11,9
522730,CHEMBL502835,NINTEDANIB,197,CHEMBL1913,Platelet-derived growth factor receptor beta,8.74,8.04,1.8,14,9
522730,CHEMBL502835,NINTEDANIB,10371,CHEMBL4948,Dual specificity mitogen-activated protein kinase kinase 5,8.74,7.75,1.8,2,9
522730,CHEMBL502835,NINTEDANIB,12627,CHEMBL2007,Platelet-derived growth factor receptor alpha,8.72,7.93,1.9,11,9
522730,CHEMBL502835,NINTEDANIB,30042,CHEMBL4522,BMP-2-inducible protein kinase,8.66,7.12,2.2,2,9
522730,CHEMBL502835,NINTEDANIB,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,8.59,8.59,2.6,1,9
522730,CHEMBL502835,NINTEDANIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,8.57,7.75,2.7,8,8
522730,CHEMBL502835,NINTEDANIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,8.54,8.22,2.9,14,9
522730,CHEMBL502835,NINTEDANIB,11752,CHEMBL1955,Vascular endothelial growth factor receptor 3,8.52,7.94,3.0,7,9
522730,CHEMBL502835,NINTEDANIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,8.52,7.84,3.0,6,9
522730,CHEMBL502835,NINTEDANIB,101324,CHEMBL5776,Mitogen-activated protein kinase kinase kinase 7,8.39,8.39,4.1,1,8
522730,CHEMBL502835,NINTEDANIB,11902,CHEMBL2815,High affinity nerve growth factor receptor,8.35,7.04,4.5,3,9
522730,CHEMBL502835,NINTEDANIB,10919,CHEMBL2835,Tyrosine-protein kinase JAK1,8.32,6.96,4.8,2,8
522730,CHEMBL502835,NINTEDANIB,100854,CHEMBL4578,Maternal embryonic leucine zipper kinase,8.31,7.72,4.9,5,9
522730,CHEMBL502835,NINTEDANIB,102799,CHEMBL6191,Mitogen-activated protein kinase kinase kinase 19,8.28,8.28,5.2,1,8
522730,CHEMBL502835,NINTEDANIB,11926,CHEMBL2742,Fibroblast growth factor receptor 3,8.23,7.43,5.9,9,9
522730,CHEMBL502835,NINTEDANIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,8.21,7.74,6.2,4,9
522730,CHEMBL502835,NINTEDANIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,8.09,8.09,8.2,1,8
522730,CHEMBL502835,NINTEDANIB,104313,CHEMBL1908382,Serine/threonine-protein kinase PRP4 homolog,8.08,8.08,8.4,1,8
522730,CHEMBL502835,NINTEDANIB,100948,CHEMBL5331,Tyrosine-protein kinase Mer,8.07,8.07,8.5,1,8
522730,CHEMBL502835,NINTEDANIB,30013,CHEMBL4224,Dual specificity protein kinase CLK1,8.06,8.06,8.8,1,8
522730,CHEMBL502835,NINTEDANIB,30024,CHEMBL4598,Serine/threonine-protein kinase 4,8.05,7.41,9.0,2,9
522730,CHEMBL502835,NINTEDANIB,102711,CHEMBL5914,Mitogen-activated protein kinase kinase kinase 2,8.03,6.92,9.4,2,9
522730,CHEMBL502835,NINTEDANIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,8.0,6.93,10.0,15,9
522730,CHEMBL502835,NINTEDANIB,11409,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,8.0,8.0,10.0,1,8
522730,CHEMBL502835,NINTEDANIB,100410,CHEMBL4895,Tyrosine-protein kinase receptor UFO,7.92,7.92,12.0,1,8
522730,CHEMBL502835,NINTEDANIB,100917,CHEMBL5319,Epithelial discoidin domain-containing receptor 1,7.92,7.81,12.0,2,9
522730,CHEMBL502835,NINTEDANIB,100975,CHEMBL5415,SRSF protein kinase 3,7.92,7.92,12.0,1,8
522730,CHEMBL502835,NINTEDANIB,10979,CHEMBL1868,Vascular endothelial growth factor receptor 1,7.89,7.35,13.0,10,9
522730,CHEMBL502835,NINTEDANIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,7.85,7.42,14.0,2,9
522730,CHEMBL502835,NINTEDANIB,11019,CHEMBL4273,cGMP-dependent protein kinase 1,7.85,7.85,14.0,1,8
522730,CHEMBL502835,NINTEDANIB,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,7.8,6.92,16.0,4,9
522730,CHEMBL502835,NINTEDANIB,101079,CHEMBL5122,Discoidin domain-containing receptor 2,7.8,7.59,16.0,2,9
522730,CHEMBL502835,NINTEDANIB,101495,CHEMBL5667,Phosphatidylinositol 5-phosphate 4-kinase type-2 beta,7.77,7.77,17.0,1,8
522730,CHEMBL502835,NINTEDANIB,101584,CHEMBL5861,G protein-coupled receptor kinase 4,7.77,7.77,17.0,1,8
522730,CHEMBL502835,NINTEDANIB,30004,CHEMBL3938,Serine/threonine-protein kinase 16,7.75,7.75,18.0,1,8
522730,CHEMBL502835,NINTEDANIB,30036,CHEMBL4203,Dual specificity protein kinase CLK4,7.75,7.75,18.0,1,8
522730,CHEMBL502835,NINTEDANIB,101032,CHEMBL5606,Serine/threonine-protein kinase STK11,7.75,7.75,18.0,1,8
522730,CHEMBL502835,NINTEDANIB,100413,CHEMBL4898,BDNF/NT-3 growth factors receptor,7.72,7.72,19.0,1,8
522730,CHEMBL502835,NINTEDANIB,30022,CHEMBL4597,Cyclin-dependent kinase 16,7.68,7.68,21.0,1,8
522730,CHEMBL502835,NINTEDANIB,101211,CHEMBL5483,Insulin receptor-related protein,7.68,7.68,21.0,1,8
522730,CHEMBL502835,NINTEDANIB,101503,CHEMBL5698,NUAK family SNF1-like kinase 2,7.68,7.68,21.0,1,8
522730,CHEMBL502835,NINTEDANIB,30011,CHEMBL3983,Dual specificity protein kinase TTK,7.66,7.66,22.0,1,8
522730,CHEMBL502835,NINTEDANIB,101404,CHEMBL5975,Serine/threonine-protein kinase RIO1,7.64,7.64,23.0,1,8
522730,CHEMBL502835,NINTEDANIB,35,CHEMBL1981,Insulin receptor,7.62,7.62,24.0,1,8
522730,CHEMBL502835,NINTEDANIB,100417,CHEMBL4247,ALK tyrosine kinase receptor,7.51,7.51,31.0,1,8
522730,CHEMBL502835,NINTEDANIB,10266,CHEMBL3650,Fibroblast growth factor receptor 1,7.5,7.18,32.0,16,9
522730,CHEMBL502835,NINTEDANIB,101034,CHEMBL5608,NT-3 growth factor receptor,7.5,7.5,32.0,1,8
522730,CHEMBL502835,NINTEDANIB,101399,CHEMBL5970,Mitogen-activated protein kinase kinase kinase 3,7.47,7.47,34.0,1,8
522730,CHEMBL502835,NINTEDANIB,101312,CHEMBL5749,Mitogen-activated protein kinase kinase kinase kinase 1,7.46,7.46,35.0,1,8
522730,CHEMBL502835,NINTEDANIB,101278,CHEMBL5659,Serine/threonine-protein kinase RIO3,7.44,7.44,36.0,1,8
522730,CHEMBL502835,NINTEDANIB,101496,CHEMBL5668,SRSF protein kinase 2,7.44,7.44,36.0,1,8
522730,CHEMBL502835,NINTEDANIB,10264,CHEMBL4142,Fibroblast growth factor receptor 2,7.43,7.27,37.0,6,9
522730,CHEMBL502835,NINTEDANIB,12694,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,7.43,6.87,37.0,2,8
522730,CHEMBL502835,NINTEDANIB,100789,CHEMBL4375,SRSF protein kinase 1,7.43,7.43,37.0,1,8
522730,CHEMBL502835,NINTEDANIB,103154,CHEMBL1075104,Leucine-rich repeat serine/threonine-protein kinase 2,7.43,7.38,37.0,2,8
522730,CHEMBL502835,NINTEDANIB,10277,CHEMBL4708,Serine/threonine-protein kinase 3,7.42,6.77,38.0,2,9
522730,CHEMBL502835,NINTEDANIB,11046,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,7.38,7.38,42.0,1,8
522730,CHEMBL502835,NINTEDANIB,12840,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,7.32,7.32,48.0,1,8
522730,CHEMBL502835,NINTEDANIB,101398,CHEMBL5969,Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha,7.31,7.31,49.0,1,8
522730,CHEMBL502835,NINTEDANIB,101613,CHEMBL5941,Serine/threonine-protein kinase 26,7.31,6.44,49.0,2,9
522730,CHEMBL502835,NINTEDANIB,30035,CHEMBL4202,STE20-like serine/threonine-protein kinase,7.29,7.29,51.0,1,8
522730,CHEMBL502835,NINTEDANIB,30003,CHEMBL3788,Serine/threonine-protein kinase PLK4,7.28,7.28,53.0,1,8
522730,CHEMBL502835,NINTEDANIB,30047,CHEMBL4527,TRAF2 and NCK-interacting protein kinase,7.28,6.62,53.0,2,9
522730,CHEMBL502835,NINTEDANIB,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,7.26,6.68,55.0,4,9
522730,CHEMBL502835,NINTEDANIB,100993,CHEMBL5467,Bone morphogenetic protein receptor type-2,7.25,7.25,56.0,2,9
522730,CHEMBL502835,NINTEDANIB,11843,CHEMBL3906,Ribosomal protein S6 kinase alpha-2,7.24,7.24,58.0,1,8
522730,CHEMBL502835,NINTEDANIB,101048,CHEMBL5047,Serine/threonine-protein kinase ULK3,7.22,7.22,60.0,1,8
522730,CHEMBL502835,NINTEDANIB,234,CHEMBL1957,Insulin-like growth factor 1 receptor,7.21,7.21,62.0,1,8
522730,CHEMBL502835,NINTEDANIB,30000,CHEMBL3830,AP2-associated protein kinase 1,7.2,7.2,63.0,1,8
522730,CHEMBL502835,NINTEDANIB,12724,CHEMBL2345,Ribosomal protein S6 kinase alpha-3,7.19,7.19,65.0,1,8
522730,CHEMBL502835,NINTEDANIB,30007,CHEMBL3982,Tyrosine-protein kinase Fer,7.14,7.14,73.0,1,8
522730,CHEMBL502835,NINTEDANIB,18033,CHEMBL2073,Tyrosine-protein kinase Yes,7.1,6.55,80.0,2,9
522730,CHEMBL502835,NINTEDANIB,100995,CHEMBL5469,Protein-tyrosine kinase 2-beta,7.09,7.09,81.0,1,8
522730,CHEMBL502835,NINTEDANIB,101220,CHEMBL5518,Misshapen-like kinase 1,7.09,6.32,82.0,2,9
522730,CHEMBL502835,NINTEDANIB,10197,CHEMBL262,Glycogen synthase kinase-3 beta,7.08,7.08,83.0,1,8
522730,CHEMBL502835,NINTEDANIB,10659,CHEMBL2116,5'-AMP-activated protein kinase catalytic subunit alpha-2,7.08,7.08,84.0,1,8
522730,CHEMBL502835,NINTEDANIB,11364,CHEMBL4045,5'-AMP-activated protein kinase catalytic subunit alpha-1,7.06,6.34,87.0,2,9
522730,CHEMBL502835,NINTEDANIB,30006,CHEMBL3981,Serine/threonine-protein kinase 10,7.06,6.57,87.0,2,9
522730,CHEMBL502835,NINTEDANIB,101553,CHEMBL5790,Cyclin-dependent kinase 17,7.03,7.03,93.0,1,8
522730,CHEMBL502835,NINTEDANIB,12959,CHEMBL4627,Myosin light chain kinase,6.96,6.96,110.0,1,8
522730,CHEMBL502835,NINTEDANIB,30045,CHEMBL4525,Serine/threonine-protein kinase 17A,6.96,6.96,110.0,1,8
522730,CHEMBL502835,NINTEDANIB,101056,CHEMBL5082,Serine/threonine-protein kinase 24,6.96,6.96,110.0,1,8
522730,CHEMBL502835,NINTEDANIB,103458,CHEMBL1163129,Serine/threonine-protein kinase SBK1,6.96,6.96,110.0,1,8
522730,CHEMBL502835,NINTEDANIB,19623,CHEMBL3357,Interleukin-1 receptor-associated kinase 1,6.92,6.92,120.0,1,8
522730,CHEMBL502835,NINTEDANIB,101504,CHEMBL5699,Serine/threonine-protein kinase SIK2,6.91,6.73,122.0,2,9
522730,CHEMBL502835,NINTEDANIB,11361,CHEMBL4004,"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",6.85,6.85,140.0,1,8
522730,CHEMBL502835,NINTEDANIB,102676,CHEMBL5836,Ephrin type-B receptor 6,6.85,6.85,140.0,1,8
522730,CHEMBL502835,NINTEDANIB,103453,CHEMBL1163124,Mitogen-activated protein kinase kinase kinase 13,6.85,6.85,140.0,1,8
522730,CHEMBL502835,NINTEDANIB,104320,CHEMBL1908389,Mitogen-activated protein kinase kinase kinase 12,6.85,6.85,140.0,1,8
522730,CHEMBL502835,NINTEDANIB,12828,CHEMBL4442,Cyclin-dependent kinase 3,6.84,6.84,145.0,1,9
522730,CHEMBL502835,NINTEDANIB,100856,CHEMBL5408,Serine/threonine-protein kinase TBK1,6.82,6.82,150.0,1,8
522730,CHEMBL502835,NINTEDANIB,101464,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,6.82,6.34,150.0,2,9
522730,CHEMBL502835,NINTEDANIB,101484,CHEMBL5627,Leukocyte tyrosine kinase receptor,6.82,6.82,150.0,1,8
522730,CHEMBL502835,NINTEDANIB,12946,CHEMBL331,Cyclin-dependent kinase 4,6.8,6.47,160.0,2,8
522730,CHEMBL502835,NINTEDANIB,101332,CHEMBL5784,NUAK family SNF1-like kinase 1,6.8,6.8,160.0,1,8
522730,CHEMBL502835,NINTEDANIB,12915,CHEMBL3529,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,6.77,6.76,170.0,2,9
522730,CHEMBL502835,NINTEDANIB,10929,CHEMBL2553,Ribosomal protein S6 kinase alpha-1,6.75,6.22,180.0,2,9
522730,CHEMBL502835,NINTEDANIB,12944,CHEMBL4501,Ribosomal protein S6 kinase beta-1,6.72,6.72,190.0,1,8
522730,CHEMBL502835,NINTEDANIB,20171,CHEMBL3935,Aurora kinase C,6.72,6.72,190.0,1,8
522730,CHEMBL502835,NINTEDANIB,10850,CHEMBL4237,Ribosomal protein S6 kinase alpha-5,6.7,6.7,200.0,1,8
522730,CHEMBL502835,NINTEDANIB,11451,CHEMBL3717,Hepatocyte growth factor receptor,6.7,6.5,200.0,3,8
522730,CHEMBL502835,NINTEDANIB,10918,CHEMBL2959,Tyrosine-protein kinase ITK/TSK,6.68,6.68,210.0,1,8
522730,CHEMBL502835,NINTEDANIB,11242,CHEMBL2695,Focal adhesion kinase 1,6.68,6.68,210.0,1,8
522730,CHEMBL502835,NINTEDANIB,11908,CHEMBL2999,Serine/threonine-protein kinase PAK 3,6.68,6.68,210.0,1,8
522730,CHEMBL502835,NINTEDANIB,100951,CHEMBL5334,Non-receptor tyrosine-protein kinase TNK1,6.68,6.68,210.0,1,8
522730,CHEMBL502835,NINTEDANIB,12038,CHEMBL2872,Mitogen-activated protein kinase kinase kinase 9,6.66,6.66,220.0,1,8
522730,CHEMBL502835,NINTEDANIB,10939,CHEMBL4924,Ribosomal protein S6 kinase alpha-6,6.64,6.64,230.0,1,8
522730,CHEMBL502835,NINTEDANIB,10967,CHEMBL4937,Casein kinase I isoform epsilon,6.64,6.64,230.0,1,8
522730,CHEMBL502835,NINTEDANIB,100990,CHEMBL5464,Receptor-interacting serine/threonine-protein kinase 1,6.62,6.62,240.0,1,8
522730,CHEMBL502835,NINTEDANIB,12735,CHEMBL2349,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",6.58,6.58,260.0,1,8
522730,CHEMBL502835,NINTEDANIB,30031,CHEMBL5258,Calcium/calmodulin-dependent protein kinase type 1G,6.58,6.58,260.0,1,8
522730,CHEMBL502835,NINTEDANIB,11408,CHEMBL2637,Mitogen-activated protein kinase 10,6.57,6.57,270.0,1,8
522730,CHEMBL502835,NINTEDANIB,11398,CHEMBL4302,ATP-dependent translocase ABCB1,6.56,6.56,276.0,1,9
522730,CHEMBL502835,NINTEDANIB,10250,CHEMBL2428,"Myosin light chain kinase, smooth muscle",6.54,6.54,290.0,1,8
522730,CHEMBL502835,NINTEDANIB,12967,CHEMBL4630,Serine/threonine-protein kinase Chk1,6.54,6.54,290.0,1,8
522730,CHEMBL502835,NINTEDANIB,100947,CHEMBL5330,Mitogen-activated protein kinase kinase kinase kinase 2,6.54,6.54,290.0,1,8
522730,CHEMBL502835,NINTEDANIB,101188,CHEMBL5432,Mitogen-activated protein kinase kinase kinase kinase 3,6.54,6.54,290.0,1,8
522730,CHEMBL502835,NINTEDANIB,12829,CHEMBL3055,Cyclin-dependent kinase 7,6.52,6.52,300.0,1,8
522730,CHEMBL502835,NINTEDANIB,100127,CHEMBL4454,Tyrosine-protein kinase Fgr,6.52,6.52,300.0,1,8
522730,CHEMBL502835,NINTEDANIB,100128,CHEMBL5146,Breakpoint cluster region protein,6.52,6.52,301.0,1,9
522730,CHEMBL502835,NINTEDANIB,100097,CHEMBL5251,Tyrosine-protein kinase BTK,6.51,6.51,310.0,1,8
522730,CHEMBL502835,NINTEDANIB,101411,CHEMBL6006,Serine/threonine-protein kinase ULK1,6.47,6.47,340.0,1,8
522730,CHEMBL502835,NINTEDANIB,11691,CHEMBL2250,Tyrosine-protein kinase Blk,6.42,6.42,380.0,1,8
522730,CHEMBL502835,NINTEDANIB,101191,CHEMBL5435,Serine/threonine-protein kinase ULK2,6.42,6.42,380.0,1,8
522730,CHEMBL502835,NINTEDANIB,101602,CHEMBL5907,Serine/threonine-protein kinase LATS2,6.42,6.42,380.0,1,8
522730,CHEMBL502835,NINTEDANIB,30049,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,6.41,6.41,390.0,1,8
522730,CHEMBL502835,NINTEDANIB,10781,CHEMBL2185,Aurora kinase B,6.38,6.2,420.0,2,9
522730,CHEMBL502835,NINTEDANIB,101465,CHEMBL6167,Serine/threonine-protein kinase LATS1,6.38,6.38,420.0,1,8
522730,CHEMBL502835,NINTEDANIB,11017,CHEMBL2850,Glycogen synthase kinase-3 alpha,6.37,6.37,430.0,1,8
522730,CHEMBL502835,NINTEDANIB,101182,CHEMBL5426,Myosin light chain kinase family member 4,6.36,6.36,440.0,1,8
522730,CHEMBL502835,NINTEDANIB,101434,CHEMBL6083,Receptor-interacting serine/threonine-protein kinase 4,6.36,6.36,440.0,1,8
522730,CHEMBL502835,NINTEDANIB,101460,CHEMBL6162,Cyclin-dependent kinase 14,6.33,6.33,470.0,1,8
522730,CHEMBL502835,NINTEDANIB,100914,CHEMBL5316,Cyclin-dependent kinase 18,6.29,6.29,510.0,1,8
522730,CHEMBL502835,NINTEDANIB,103437,CHEMBL1163108,STE20/SPS1-related proline-alanine-rich protein kinase,6.28,6.28,520.0,1,8
522730,CHEMBL502835,NINTEDANIB,101281,CHEMBL5683,Serine/threonine-protein kinase DCLK1,6.27,6.27,540.0,1,8
522730,CHEMBL502835,NINTEDANIB,30020,CHEMBL5072,Ephrin type-B receptor 1,6.26,6.26,550.0,1,8
522730,CHEMBL502835,NINTEDANIB,101282,CHEMBL5684,"Muscle, skeletal receptor tyrosine-protein kinase",6.23,6.23,590.0,1,8
522730,CHEMBL502835,NINTEDANIB,101598,CHEMBL5903,Activin receptor type-1,6.22,6.04,600.0,2,9
522730,CHEMBL502835,NINTEDANIB,10782,CHEMBL3125,Ribosomal protein S6 kinase alpha-4,6.21,6.21,620.0,1,8
522730,CHEMBL502835,NINTEDANIB,11925,CHEMBL3973,Fibroblast growth factor receptor 4,6.21,6.06,610.0,3,9
522730,CHEMBL502835,NINTEDANIB,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,6.2,5.99,630.0,2,9
522730,CHEMBL502835,NINTEDANIB,12261,CHEMBL2276,Mitogen-activated protein kinase 8,6.2,6.2,630.0,1,8
522730,CHEMBL502835,NINTEDANIB,30029,CHEMBL5256,Calcium/calmodulin-dependent protein kinase kinase 1,6.2,6.2,630.0,1,8
522730,CHEMBL502835,NINTEDANIB,10885,CHEMBL2595,Serine/threonine-protein kinase D3,6.19,6.19,640.0,1,8
522730,CHEMBL502835,NINTEDANIB,30005,CHEMBL3980,Serine/threonine-protein kinase 17B,6.17,6.17,670.0,1,8
522730,CHEMBL502835,NINTEDANIB,101433,CHEMBL6082,Serine/threonine-protein kinase SIK1,6.17,6.17,670.0,1,8
522730,CHEMBL502835,NINTEDANIB,11870,CHEMBL2708,Mitogen-activated protein kinase kinase kinase 11,6.16,6.16,700.0,2,9
522730,CHEMBL502835,NINTEDANIB,100415,CHEMBL4900,Serine/threonine-protein kinase D2,6.14,6.14,720.0,1,8
522730,CHEMBL502835,NINTEDANIB,11637,CHEMBL3384,Serine/threonine-protein kinase N1,6.13,6.13,740.0,1,8
522730,CHEMBL502835,NINTEDANIB,30014,CHEMBL4225,Dual specificity protein kinase CLK2,6.12,6.12,760.0,1,8
522730,CHEMBL502835,NINTEDANIB,100140,CHEMBL5600,MAP/microtubule affinity-regulating kinase 3,6.11,6.11,770.0,1,8
522730,CHEMBL502835,NINTEDANIB,101448,CHEMBL6123,Serine/threonine-protein kinase DCLK3,6.11,6.11,770.0,1,8
522730,CHEMBL502835,NINTEDANIB,100852,CHEMBL4576,Homeodomain-interacting protein kinase 2,6.1,6.1,790.0,1,8
522730,CHEMBL502835,NINTEDANIB,19639,CHEMBL3778,Interleukin-1 receptor-associated kinase 4,6.09,6.09,810.0,1,8
522730,CHEMBL502835,NINTEDANIB,101270,CHEMBL5651,Serine/threonine-protein kinase 35,6.09,6.09,810.0,1,8
522730,CHEMBL502835,NINTEDANIB,100424,CHEMBL4367,Tyrosine-protein kinase TXK,6.07,6.07,860.0,1,8
522730,CHEMBL502835,NINTEDANIB,100853,CHEMBL4577,Homeodomain-interacting protein kinase 3,6.07,6.07,850.0,1,8
522730,CHEMBL502835,NINTEDANIB,12780,CHEMBL4070,Casein kinase II subunit alpha',6.05,6.05,890.0,1,8
522730,CHEMBL502835,NINTEDANIB,30032,CHEMBL5284,Calcium/calmodulin-dependent protein kinase kinase 2,6.04,6.04,920.0,1,8
522730,CHEMBL502835,NINTEDANIB,30046,CHEMBL4526,Ephrin type-A receptor 6,6.03,6.03,940.0,1,8
522730,CHEMBL502835,NINTEDANIB,10903,CHEMBL3863,Serine/threonine-protein kinase D1,6.0,6.0,990.0,1,8
522730,CHEMBL502835,NINTEDANIB,101033,CHEMBL5607,Rhodopsin kinase GRK1,6.0,6.0,1000.0,1,8
522730,CHEMBL502835,NINTEDANIB,102465,CHEMBL6186,Serine/threonine-protein kinase Sgk3,6.0,6.0,1000.0,1,8
522730,CHEMBL502835,NINTEDANIB,100129,CHEMBL5147,Ephrin type-B receptor 4,5.96,5.96,1100.0,1,8
522730,CHEMBL502835,NINTEDANIB,101410,CHEMBL6005,Serine/threonine-protein kinase 33,5.96,5.96,1100.0,1,8
522730,CHEMBL502835,NINTEDANIB,100069,CHEMBL5455,Tyrosine-protein kinase Fes/Fps,5.92,5.92,1200.0,1,8
522730,CHEMBL502835,NINTEDANIB,101340,CHEMBL5810,Ephrin type-A receptor 1,5.92,5.92,1200.0,1,8
522730,CHEMBL502835,NINTEDANIB,103062,CHEMBL1075133,Rhodopsin kinase GRK7,5.92,5.92,1200.0,1,8
522730,CHEMBL502835,NINTEDANIB,103106,CHEMBL1075167,Homeodomain-interacting protein kinase 4,5.92,5.92,1200.0,1,8
522730,CHEMBL502835,NINTEDANIB,10368,CHEMBL2828,Casein kinase I isoform delta,5.89,5.89,1300.0,1,8
522730,CHEMBL502835,NINTEDANIB,30044,CHEMBL4524,Serine/threonine-protein kinase PAK 5,5.89,5.89,1300.0,1,8
522730,CHEMBL502835,NINTEDANIB,101183,CHEMBL5427,Homeodomain-interacting protein kinase 1,5.89,5.89,1300.0,1,8
522730,CHEMBL502835,NINTEDANIB,101309,CHEMBL5728,Cyclin-dependent kinase-like 2,5.89,5.89,1300.0,1,8
522730,CHEMBL502835,NINTEDANIB,103433,CHEMBL1163104,Serine/threonine-protein kinase OSR1,5.89,5.89,1300.0,1,8
522730,CHEMBL502835,NINTEDANIB,10842,CHEMBL3032,Serine/threonine-protein kinase N2,5.85,5.85,1400.0,1,8
522730,CHEMBL502835,NINTEDANIB,11678,CHEMBL301,Cyclin-dependent kinase 2,5.85,5.85,1400.0,1,8
522730,CHEMBL502835,NINTEDANIB,12913,CHEMBL4128,Angiopoietin-1 receptor,5.85,5.85,1400.0,1,8
522730,CHEMBL502835,NINTEDANIB,30001,CHEMBL3831,Serine/threonine-protein kinase MARK2,5.85,5.85,1400.0,1,8
522730,CHEMBL502835,NINTEDANIB,101612,CHEMBL5940,Serine/threonine-protein kinase MARK1,5.85,5.85,1400.0,1,8
522730,CHEMBL502835,NINTEDANIB,103456,CHEMBL1163127,Mitogen-activated protein kinase kinase kinase 15,5.85,5.85,1400.0,1,8
522730,CHEMBL502835,NINTEDANIB,11785,CHEMBL3234,Tyrosine-protein kinase HCK,5.82,5.82,1503.0,1,9
522730,CHEMBL502835,NINTEDANIB,30023,CHEMBL4599,Activated CDC42 kinase 1,5.8,5.8,1600.0,1,8
522730,CHEMBL502835,NINTEDANIB,101014,CHEMBL5543,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,5.8,5.8,1600.0,1,8
522730,CHEMBL502835,NINTEDANIB,103455,CHEMBL1163126,Serine/threonine-protein kinase ICK,5.77,5.77,1700.0,1,8
522730,CHEMBL502835,NINTEDANIB,13004,CHEMBL4439,TGF-beta receptor type-1,5.73,5.73,1866.0,1,9
522730,CHEMBL502835,NINTEDANIB,11209,CHEMBL4014,Tyrosine-protein kinase ABL2,5.7,5.7,2000.0,1,8
522730,CHEMBL502835,NINTEDANIB,100925,CHEMBL5358,eIF-2-alpha kinase GCN2,5.7,5.7,2000.0,1,8
522730,CHEMBL502835,NINTEDANIB,101073,CHEMBL5116,Uncharacterized serine/threonine-protein kinase SBK3,5.7,5.7,2000.0,1,8
522730,CHEMBL502835,NINTEDANIB,101317,CHEMBL5754,MAP/microtubule affinity-regulating kinase 4,5.7,5.7,2000.0,1,8
522730,CHEMBL502835,NINTEDANIB,103430,CHEMBL1163101,Serine/threonine-protein kinase/endoribonuclease IRE1,5.7,5.7,2000.0,1,8
522730,CHEMBL502835,NINTEDANIB,10051,CHEMBL2468,Death-associated protein kinase 3,5.68,5.68,2100.0,1,8
522730,CHEMBL502835,NINTEDANIB,10478,CHEMBL2109,Dual specificity mitogen-activated protein kinase kinase 3,5.68,5.68,2100.0,1,8
522730,CHEMBL502835,NINTEDANIB,30028,CHEMBL5073,Calcium/calmodulin-dependent protein kinase type 1D,5.66,5.66,2200.0,1,8
522730,CHEMBL502835,NINTEDANIB,100906,CHEMBL5274,Tyrosine-protein kinase receptor Tie-1,5.66,5.66,2200.0,1,8
522730,CHEMBL502835,NINTEDANIB,11873,CHEMBL2873,Mitogen-activated protein kinase kinase kinase 10,5.64,5.64,2300.0,1,8
522730,CHEMBL502835,NINTEDANIB,100949,CHEMBL5332,Mitogen-activated protein kinase 7,5.6,5.6,2500.0,1,8
522730,CHEMBL502835,NINTEDANIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,5.57,5.57,2700.0,1,8
522730,CHEMBL502835,NINTEDANIB,101273,CHEMBL5654,Myosin-IIIb,5.57,5.57,2700.0,1,8
522730,CHEMBL502835,NINTEDANIB,10612,CHEMBL2534,3-phosphoinositide-dependent protein kinase 1,5.55,5.55,2800.0,1,8
522730,CHEMBL502835,NINTEDANIB,30008,CHEMBL2068,Ephrin type-A receptor 2,5.54,5.54,2900.0,1,8
522730,CHEMBL502835,NINTEDANIB,100098,CHEMBL5491,Wee1-like protein kinase,5.54,5.54,2900.0,1,8
522730,CHEMBL502835,NINTEDANIB,100080,CHEMBL4482,Serine/threonine-protein kinase PAK 4,5.52,5.52,3000.0,1,8
522730,CHEMBL502835,NINTEDANIB,10778,CHEMBL3123,Death-associated protein kinase 2,5.5,5.5,3200.0,1,8
9495,CHEMBL503,LOVASTATIN,24,CHEMBL402,3-hydroxy-3-methylglutaryl-coenzyme A reductase,9.22,7.83,0.6,12,9
10358,CHEMBL505,CHLORPHENIRAMINE,127,CHEMBL231,Histamine H1 receptor,9.04,7.91,0.92,6,9
10358,CHEMBL505,CHLORPHENIRAMINE,102,CHEMBL1941,Histamine H2 receptor,6.38,6.38,412.3,1,8
10358,CHEMBL505,CHLORPHENIRAMINE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.96,5.96,1100.0,1,8
10358,CHEMBL505,CHLORPHENIRAMINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.96,5.96,1100.0,1,8
10358,CHEMBL505,CHLORPHENIRAMINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.93,5.93,1185.7,1,8
10358,CHEMBL505,CHLORPHENIRAMINE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.84,5.84,1460.0,1,8
77129,CHEMBL50588,EMETINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.85,7.06,14.0,4,8
77129,CHEMBL50588,EMETINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.58,6.99,26.0,3,8
77129,CHEMBL50588,EMETINE,11173,CHEMBL2535,"Solute carrier family 2, facilitated glucose transporter member 1",6.97,6.97,108.0,1,8
77129,CHEMBL50588,EMETINE,103700,CHEMBL1293267,G-protein coupled receptor 35,6.45,6.45,352.52,1,9
77129,CHEMBL50588,EMETINE,11400,CHEMBL2842,Serine/threonine-protein kinase mTOR,5.73,5.73,1849.3,1,9
77129,CHEMBL50588,EMETINE,11398,CHEMBL4302,ATP-dependent translocase ABCB1,5.62,5.62,2400.0,1,8
77129,CHEMBL50588,EMETINE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.6,5.6,2510.0,1,8
10389,CHEMBL506,PRIMAQUINE,121,CHEMBL228,Sodium-dependent serotonin transporter,8.07,7.48,8.405,4,8
10389,CHEMBL506,PRIMAQUINE,12594,CHEMBL3356,Cytochrome P450 1A2,6.74,6.74,182.4,1,8
10389,CHEMBL506,PRIMAQUINE,117992,CHEMBL4295747,"Serine hydroxymethyltransferase, mitochondrial",6.36,6.36,436.52,1,9
10389,CHEMBL506,PRIMAQUINE,96,CHEMBL221,Prostaglandin G/H synthase 1,5.57,5.57,2702.0,1,8
10389,CHEMBL506,PRIMAQUINE,170,CHEMBL241,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",5.54,5.54,2900.0,1,8
10389,CHEMBL506,PRIMAQUINE,118080,CHEMBL4295835,Thiosulfate sulfurtransferase,5.54,5.54,2900.0,1,9
464846,CHEMBL506247,TANNIC ACID,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,7.66,7.66,22.0,1,8
464846,CHEMBL506247,TANNIC ACID,10140,CHEMBL258,Tyrosine-protein kinase Lck,7.1,7.1,79.0,1,8
464846,CHEMBL506247,TANNIC ACID,103624,CHEMBL1287622,Lethal(3)malignant brain tumor-like protein 1,7.0,7.0,100.0,1,9
464846,CHEMBL506247,TANNIC ACID,11638,CHEMBL4040,Mitogen-activated protein kinase 1,6.73,6.73,185.0,1,8
464846,CHEMBL506247,TANNIC ACID,248,CHEMBL1835,Thromboxane-A synthase,6.49,6.49,325.0,1,9
464846,CHEMBL506247,TANNIC ACID,10188,CHEMBL260,Mitogen-activated protein kinase 14,6.43,6.43,375.0,1,8
464846,CHEMBL506247,TANNIC ACID,12594,CHEMBL3356,Cytochrome P450 1A2,6.04,6.04,919.0,1,8
464846,CHEMBL506247,TANNIC ACID,103947,CHEMBL1697668,Solute carrier organic anion transporter family member 1B1,5.84,5.71,1460.0,2,8
464846,CHEMBL506247,TANNIC ACID,104220,CHEMBL1795140,Transmembrane protease serine 2,5.64,5.64,2310.0,1,9
464846,CHEMBL506247,TANNIC ACID,24,CHEMBL402,3-hydroxy-3-methylglutaryl-coenzyme A reductase,5.5,5.5,3127.0,1,8
508755,CHEMBL507674,CEFOPERAZONE,103829,CHEMBL1641347,Solute carrier family 22 member 6,6.68,6.68,210.0,1,8
508755,CHEMBL507674,CEFOPERAZONE,103830,CHEMBL1641348,Organic anion transporter 3,5.72,5.72,1890.0,1,8
508755,CHEMBL507674,CEFOPERAZONE,104618,CHEMBL2073677,Solute carrier family 22 member 11,5.55,5.55,2800.0,1,8
10531,CHEMBL509,MECLOFENAMIC ACID,126,CHEMBL230,Prostaglandin G/H synthase 2,7.96,7.17,11.0,3,9
10531,CHEMBL509,MECLOFENAMIC ACID,96,CHEMBL221,Prostaglandin G/H synthase 1,7.85,7.24,14.2,4,9
10531,CHEMBL509,MECLOFENAMIC ACID,12704,CHEMBL3194,Transthyretin,6.32,6.31,480.0,2,9
10531,CHEMBL509,MECLOFENAMIC ACID,100481,CHEMBL4681,Aldo-keto reductase family 1 member C3,6.29,6.28,512.0,3,9
10531,CHEMBL509,MECLOFENAMIC ACID,101600,CHEMBL5905,Aldo-keto reductase family 1 member C1,6.13,5.71,740.0,3,9
10531,CHEMBL509,MECLOFENAMIC ACID,11638,CHEMBL4040,Mitogen-activated protein kinase 1,5.5,5.5,3144.0,1,8
10661,CHEMBL511,PYRILAMINE,127,CHEMBL231,Histamine H1 receptor,10.85,8.63,0.014,29,9
10661,CHEMBL511,PYRILAMINE,103668,CHEMBL1293235,Prelamin-A/C,8.96,8.03,1.1,2,9
10661,CHEMBL511,PYRILAMINE,121,CHEMBL228,Sodium-dependent serotonin transporter,7.6,7.22,25.0,3,8
10661,CHEMBL511,PYRILAMINE,11365,CHEMBL289,Cytochrome P450 2D6,7.0,6.7,100.0,7,9
10661,CHEMBL511,PYRILAMINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.54,6.27,285.0,2,8
10661,CHEMBL511,PYRILAMINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.23,6.09,592.0,2,8
10661,CHEMBL511,PYRILAMINE,17045,CHEMBL340,Cytochrome P450 3A4,6.2,6.2,630.96,3,9
10661,CHEMBL511,PYRILAMINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.18,5.99,655.0,2,8
10661,CHEMBL511,PYRILAMINE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.16,5.95,699.0,3,8
10661,CHEMBL511,PYRILAMINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.96,5.96,1100.0,1,8
10661,CHEMBL511,PYRILAMINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.95,5.74,1116.0,2,8
10661,CHEMBL511,PYRILAMINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.75,5.65,1774.0,2,8
446784,CHEMBL511142,BUPRENORPHINE,137,CHEMBL237,Kappa-type opioid receptor,10.4,9.35,0.04,16,9
446784,CHEMBL511142,BUPRENORPHINE,129,CHEMBL233,Mu-type opioid receptor,10.05,9.11,0.09,30,9
446784,CHEMBL511142,BUPRENORPHINE,136,CHEMBL236,Delta-type opioid receptor,9.07,8.56,0.85,8,9
446784,CHEMBL511142,BUPRENORPHINE,138,CHEMBL2014,Nociceptin receptor,7.27,6.8,53.43,7,9
459679,CHEMBL512351,BETRIXABAN,194,CHEMBL244,Coagulation factor X,9.93,9.07,0.117,5,9
459679,CHEMBL512351,BETRIXABAN,11,CHEMBL204,Prothrombin,7.75,7.75,18.0,1,9
459679,CHEMBL512351,BETRIXABAN,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.75,5.75,1800.0,1,9
10840,CHEMBL513,CARMUSTINE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,7.85,7.85,14.1,2,9
10840,CHEMBL513,CARMUSTINE,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,5.5,5.5,3162.3,1,9
458773,CHEMBL514800,APREMILAST,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",8.57,7.34,2.7,9,9
458773,CHEMBL514800,APREMILAST,10599,CHEMBL275,"3',5'-cyclic-AMP phosphodiesterase 4B",7.78,7.52,16.5,5,9
11002,CHEMBL515,CHLORAMBUCIL,78,CHEMBL1963,Thyrotropin receptor,6.2,6.2,631.0,2,9
11002,CHEMBL515,CHLORAMBUCIL,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,5.72,5.72,1887.0,1,9
460014,CHEMBL515387,GOSOGLIPTIN,11140,CHEMBL284,Dipeptidyl peptidase 4,7.95,7.91,11.3,3,9
519284,CHEMBL515408,MARIBAVIR,11307,CHEMBL1865,Histone deacetylase 6,6.17,6.17,669.0,1,9
453649,CHEMBL515914,AZARIBINE,103668,CHEMBL1293235,Prelamin-A/C,6.25,6.25,562.3,1,9
453649,CHEMBL515914,AZARIBINE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,5.6,5.6,2511.9,2,9
11005,CHEMBL516,CYPROHEPTADINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,9.56,9.05,0.278,5,8
11005,CHEMBL516,CYPROHEPTADINE,127,CHEMBL231,Histamine H1 receptor,9.37,8.9,0.43,2,8
11005,CHEMBL516,CYPROHEPTADINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,8.89,8.49,1.278,3,8
11005,CHEMBL516,CYPROHEPTADINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,8.82,8.36,1.5,3,9
11005,CHEMBL516,CYPROHEPTADINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,8.66,8.23,2.186,2,8
11005,CHEMBL516,CYPROHEPTADINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,8.56,8.49,2.755,2,8
11005,CHEMBL516,CYPROHEPTADINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,8.4,7.98,3.943,3,8
11005,CHEMBL516,CYPROHEPTADINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,8.24,7.87,5.7,3,8
11005,CHEMBL516,CYPROHEPTADINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,8.02,7.68,9.655,2,8
11005,CHEMBL516,CYPROHEPTADINE,130,CHEMBL234,D(3) dopamine receptor,7.8,7.52,16.0,3,8
11005,CHEMBL516,CYPROHEPTADINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.77,7.59,17.0,2,8
11005,CHEMBL516,CYPROHEPTADINE,88,CHEMBL2056,D(1A) dopamine receptor,7.49,7.13,32.3,3,8
11005,CHEMBL516,CYPROHEPTADINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.34,7.34,45.3,1,8
11005,CHEMBL516,CYPROHEPTADINE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,7.3,7.1,50.12,2,9
11005,CHEMBL516,CYPROHEPTADINE,103,CHEMBL223,Alpha-1D adrenergic receptor,7.28,7.13,53.0,2,8
11005,CHEMBL516,CYPROHEPTADINE,72,CHEMBL217,D(2) dopamine receptor,7.26,7.0,55.0,3,8
11005,CHEMBL516,CYPROHEPTADINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.97,6.61,106.0,3,8
11005,CHEMBL516,CYPROHEPTADINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.89,6.72,130.0,2,8
11005,CHEMBL516,CYPROHEPTADINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.73,6.31,185.0,2,8
11005,CHEMBL516,CYPROHEPTADINE,102,CHEMBL1941,Histamine H2 receptor,6.71,6.71,195.0,2,8
11005,CHEMBL516,CYPROHEPTADINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.54,6.17,290.0,4,8
11005,CHEMBL516,CYPROHEPTADINE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.03,6.03,925.6,1,8
11005,CHEMBL516,CYPROHEPTADINE,78,CHEMBL1963,Thyrotropin receptor,6.0,6.0,1000.0,1,9
11005,CHEMBL516,CYPROHEPTADINE,100877,CHEMBL5523,Histone-lysine N-methyltransferase SETD7,6.0,6.0,1000.0,1,9
11005,CHEMBL516,CYPROHEPTADINE,11365,CHEMBL289,Cytochrome P450 2D6,5.6,5.6,2511.89,2,9
11143,CHEMBL517,DISOPYRAMIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,6.25,6.25,562.3,2,9
11143,CHEMBL517,DISOPYRAMIDE,104063,CHEMBL1743122,Solute carrier family 22 member 2,5.54,5.54,2900.0,1,9
11143,CHEMBL517,DISOPYRAMIDE,271,CHEMBL1947,Thyroid hormone receptor beta,5.5,5.5,3162.3,1,9
445395,CHEMBL517712,ATROPINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,9.98,9.14,0.104,7,9
445395,CHEMBL517712,ATROPINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,9.68,9.2,0.21,8,9
445395,CHEMBL517712,ATROPINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,9.6,8.93,0.25,13,9
445395,CHEMBL517712,ATROPINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,9.46,8.46,0.344,24,9
445395,CHEMBL517712,ATROPINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,9.36,8.97,0.439,7,9
445395,CHEMBL517712,ATROPINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.28,6.14,530.0,2,8
445395,CHEMBL517712,ATROPINE,103,CHEMBL223,Alpha-1D adrenergic receptor,6.18,6.03,666.0,2,8
508408,CHEMBL518924,MAVORIXAFOR,10473,CHEMBL2107,C-X-C chemokine receptor type 4,8.3,7.93,5.0,5,9
508408,CHEMBL518924,MAVORIXAFOR,11365,CHEMBL289,Cytochrome P450 2D6,5.8,5.79,1600.0,3,9
2760970,CHEMBL5189739,BEROTRALSTAT,23,CHEMBL2000,Plasma kallikrein,9.36,8.07,0.44,14,9
11674,CHEMBL521,IBUPROFEN,103668,CHEMBL1293235,Prelamin-A/C,8.25,8.25,5.6,1,9
11674,CHEMBL521,IBUPROFEN,126,CHEMBL230,Prostaglandin G/H synthase 2,7.0,5.98,100.0,16,9
11674,CHEMBL521,IBUPROFEN,96,CHEMBL221,Prostaglandin G/H synthase 1,6.67,5.87,212.0,8,9
11674,CHEMBL521,IBUPROFEN,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,6.65,6.65,223.9,2,9
461225,CHEMBL521606,NADOLOL,43,CHEMBL210,Beta-2 adrenergic receptor,8.89,7.93,1.3,3,9
461225,CHEMBL521606,NADOLOL,50,CHEMBL213,Beta-1 adrenergic receptor,6.99,6.99,102.0,1,8
461225,CHEMBL521606,NADOLOL,103669,CHEMBL1293236,ATP-dependent DNA helicase Q1,6.9,6.9,125.9,1,9
469866,CHEMBL521686,OLAPARIB,11663,CHEMBL3105,Poly [ADP-ribose] polymerase 1,10.0,8.37,0.1,111,9
469866,CHEMBL521686,OLAPARIB,100933,CHEMBL5366,Poly [ADP-ribose] polymerase 2,10.0,8.84,0.1,42,9
469866,CHEMBL521686,OLAPARIB,102783,CHEMBL6154,Poly [ADP-ribose] polymerase tankyrase-2,8.28,6.29,5.2,6,9
469866,CHEMBL521686,OLAPARIB,101057,CHEMBL5083,Protein mono-ADP-ribosyltransferase PARP3,8.24,7.26,5.8,8,9
469866,CHEMBL521686,OLAPARIB,101462,CHEMBL6164,Poly [ADP-ribose] polymerase tankyrase-1,7.98,6.06,10.4,10,9
469866,CHEMBL521686,OLAPARIB,102445,CHEMBL6142,Protein mono-ADP-ribosyltransferase PARP4,7.87,6.88,13.5,4,9
469866,CHEMBL521686,OLAPARIB,107589,CHEMBL2380187,Protein mono-ADP-ribosyltransferase PARP6,6.92,6.33,120.0,2,9
469866,CHEMBL521686,OLAPARIB,107973,CHEMBL3091262,Protein mono-ADP-ribosyltransferase PARP8,6.62,6.19,240.0,2,9
469866,CHEMBL521686,OLAPARIB,107664,CHEMBL2429708,Protein mono-ADP-ribosyltransferase PARP10,6.46,6.13,350.0,5,9
469866,CHEMBL521686,OLAPARIB,107590,CHEMBL2380188,Protein mono-ADP-ribosyltransferase TIPARP,6.2,6.2,631.0,1,9
469866,CHEMBL521686,OLAPARIB,107665,CHEMBL2429709,Protein mono-ADP-ribosyltransferase PARP12,6.16,6.04,690.0,2,9
469866,CHEMBL521686,OLAPARIB,105353,CHEMBL2176778,Protein mono-ADP-ribosyltransferase PARP15,5.58,5.58,2600.0,1,9
478003,CHEMBL522038,XIMELAGATRAN,11,CHEMBL204,Prothrombin,8.7,7.6,2.01,2,9
499120,CHEMBL523299,UMECLIDINIUM BROMIDE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,10.5,10.16,0.03162,2,9
499120,CHEMBL523299,UMECLIDINIUM BROMIDE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,10.5,10.07,0.03162,3,9
499120,CHEMBL523299,UMECLIDINIUM BROMIDE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,9.8,9.65,0.16,2,9
11775,CHEMBL524,METHOXAMINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.68,6.91,21.0,2,8
469580,CHEMBL524004,MEPENZOLATE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,8.35,8.35,4.5,1,8
77456,CHEMBL52440,DEXTROMETHORPHAN,121,CHEMBL228,Sodium-dependent serotonin transporter,8.84,8.1,1.44,3,8
77456,CHEMBL52440,DEXTROMETHORPHAN,78,CHEMBL1963,Thyrotropin receptor,8.2,8.2,6.3,2,9
77456,CHEMBL52440,DEXTROMETHORPHAN,11365,CHEMBL289,Cytochrome P450 2D6,7.39,6.63,40.8,8,9
77456,CHEMBL52440,DEXTROMETHORPHAN,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.46,6.46,348.0,1,8
77456,CHEMBL52440,DEXTROMETHORPHAN,129,CHEMBL233,Mu-type opioid receptor,5.57,5.57,2700.0,1,8
77456,CHEMBL52440,DEXTROMETHORPHAN,137,CHEMBL237,Kappa-type opioid receptor,5.53,5.53,2967.9,1,8
500007,CHEMBL525610,TERIPARATIDE,160,CHEMBL1793,Parathyroid hormone/parathyroid hormone-related peptide receptor,10.1,9.3,0.08,4,9
11819,CHEMBL526,PROPOFOL,10260,CHEMBL4794,Transient receptor potential cation channel subfamily V member 1,8.3,8.3,5.05,1,9
11819,CHEMBL526,PROPOFOL,103668,CHEMBL1293235,Prelamin-A/C,5.95,5.95,1122.0,1,9
11968,CHEMBL527,PIROXICAM,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.05,8.05,8.9,2,9
11968,CHEMBL527,PIROXICAM,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,8.0,8.0,10.0,2,9
11968,CHEMBL527,PIROXICAM,17045,CHEMBL340,Cytochrome P450 3A4,5.9,5.9,1258.9,2,9
11968,CHEMBL527,PIROXICAM,96,CHEMBL221,Prostaglandin G/H synthase 1,5.89,5.88,1300.0,2,9
12428,CHEMBL529,AZITHROMYCIN,103668,CHEMBL1293235,Prelamin-A/C,6.2,6.2,631.0,1,9
447955,CHEMBL529437,COCAINE HYDROCHLORIDE,155,CHEMBL238,Sodium-dependent dopamine transporter,7.33,6.91,46.3,4,9
447955,CHEMBL529437,COCAINE HYDROCHLORIDE,121,CHEMBL228,Sodium-dependent serotonin transporter,7.02,7.02,95.0,2,8
447955,CHEMBL529437,COCAINE HYDROCHLORIDE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.2,5.87,630.0,3,9
3854,CHEMBL53,APOMORPHINE,72,CHEMBL217,D(2) dopamine receptor,9.21,7.71,0.62,39,9
3854,CHEMBL53,APOMORPHINE,130,CHEMBL234,D(3) dopamine receptor,8.59,7.81,2.6,7,9
3854,CHEMBL53,APOMORPHINE,88,CHEMBL2056,D(1A) dopamine receptor,8.42,6.91,3.77,18,9
3854,CHEMBL53,APOMORPHINE,90,CHEMBL219,D(4) dopamine receptor,8.37,8.29,4.3,4,9
3854,CHEMBL53,APOMORPHINE,220,CHEMBL1850,D(1B) dopamine receptor,7.82,7.27,15.0,2,9
3854,CHEMBL53,APOMORPHINE,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,7.7,7.7,20.0,1,9
3854,CHEMBL53,APOMORPHINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.44,6.47,36.3,2,9
3854,CHEMBL53,APOMORPHINE,103,CHEMBL223,Alpha-1D adrenergic receptor,7.19,7.19,64.6,1,9
3854,CHEMBL53,APOMORPHINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.18,6.38,66.1,2,9
3854,CHEMBL53,APOMORPHINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.99,6.99,102.0,1,9
3854,CHEMBL53,APOMORPHINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.93,6.56,117.0,5,9
3854,CHEMBL53,APOMORPHINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.92,6.4,120.0,4,9
3854,CHEMBL53,APOMORPHINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.88,6.39,132.0,2,9
3854,CHEMBL53,APOMORPHINE,20131,CHEMBL5023,E3 ubiquitin-protein ligase Mdm2,6.71,6.69,195.0,2,9
3854,CHEMBL53,APOMORPHINE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.55,6.55,281.8,1,9
3854,CHEMBL53,APOMORPHINE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.5,6.5,320.0,1,8
3854,CHEMBL53,APOMORPHINE,280,CHEMBL256,Adenosine receptor A3,6.17,6.17,670.0,1,8
3854,CHEMBL53,APOMORPHINE,19,CHEMBL206,Estrogen receptor,5.83,5.83,1470.0,1,8
3854,CHEMBL53,APOMORPHINE,126,CHEMBL230,Prostaglandin G/H synthase 2,5.82,5.82,1500.0,1,8
3854,CHEMBL53,APOMORPHINE,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",5.66,5.66,2200.0,1,8
3854,CHEMBL53,APOMORPHINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.62,5.62,2371.2,1,8
3854,CHEMBL53,APOMORPHINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.62,5.62,2398.83,1,9
12494,CHEMBL531,PERGOLIDE,72,CHEMBL217,D(2) dopamine receptor,9.45,7.93,0.3548,10,9
12494,CHEMBL531,PERGOLIDE,130,CHEMBL234,D(3) dopamine receptor,9.07,8.46,0.8511,6,9
12494,CHEMBL531,PERGOLIDE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,8.74,7.86,1.8,5,9
12494,CHEMBL531,PERGOLIDE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.41,7.98,3.904,6,9
12494,CHEMBL531,PERGOLIDE,90,CHEMBL219,D(4) dopamine receptor,8.21,8.21,6.2,1,9
12494,CHEMBL531,PERGOLIDE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,8.08,7.6,8.4,5,8
12494,CHEMBL531,PERGOLIDE,88,CHEMBL2056,D(1A) dopamine receptor,7.95,6.37,11.3,6,9
12494,CHEMBL531,PERGOLIDE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,7.75,7.58,18.0,2,8
12494,CHEMBL531,PERGOLIDE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.54,7.12,29.0,3,8
12494,CHEMBL531,PERGOLIDE,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.33,6.6,47.0,5,9
12494,CHEMBL531,PERGOLIDE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.92,6.79,120.23,2,9
12494,CHEMBL531,PERGOLIDE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.7,6.59,199.0,3,9
12494,CHEMBL531,PERGOLIDE,11365,CHEMBL289,Cytochrome P450 2D6,6.7,6.7,200.0,1,8
12494,CHEMBL531,PERGOLIDE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.69,6.17,205.0,3,8
12494,CHEMBL531,PERGOLIDE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.48,6.09,330.0,3,9
12494,CHEMBL531,PERGOLIDE,103,CHEMBL223,Alpha-1D adrenergic receptor,6.13,5.97,744.0,2,8
12494,CHEMBL531,PERGOLIDE,102,CHEMBL1941,Histamine H2 receptor,6.02,6.02,950.0,1,8
2831992,CHEMBL5314341,GLUCAGON,25,CHEMBL2034,Glucocorticoid receptor,10.7,10.61,0.02,2,9
2831992,CHEMBL5314341,GLUCAGON,146,CHEMBL1985,Glucagon receptor,10.67,9.93,0.0212,7,9
2831992,CHEMBL5314341,GLUCAGON,11758,CHEMBL1784,Glucagon-like peptide 1 receptor,10.36,8.97,0.0439,8,9
2831997,CHEMBL5314346,VERTEPORFIN,119156,CHEMBL4523406,Protein odd-skipped-related 1,6.7,6.7,200.0,1,9
2831999,CHEMBL5314348,BIVALIRUDIN,11,CHEMBL204,Prothrombin,8.04,8.04,9.2,1,8
2832005,CHEMBL5314354,POLYMYXIN B,100444,CHEMBL5255,Toll-like receptor 4,5.91,5.91,1230.0,1,9
2832028,CHEMBL5314377,GANIRELIX ACETATE,118,CHEMBL1855,Gonadotropin-releasing hormone receptor,9.3,8.87,0.5012,2,8
12506,CHEMBL532,ERYTHROMYCIN,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,7.41,7.41,39.0,1,9
12506,CHEMBL532,ERYTHROMYCIN,11061,CHEMBL2203,Motilin receptor,7.36,6.71,43.65,8,9
12506,CHEMBL532,ERYTHROMYCIN,17045,CHEMBL340,Cytochrome P450 3A4,6.72,6.22,190.0,2,9
12506,CHEMBL532,ERYTHROMYCIN,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.5,5.5,3176.2,1,8
78364,CHEMBL53292,ISOXICAM,103668,CHEMBL1293235,Prelamin-A/C,6.05,6.05,891.3,1,9
12608,CHEMBL533,IBUTILIDE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,8.0,7.75,10.0,6,9
12608,CHEMBL533,IBUTILIDE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.8,5.8,1600.0,1,8
12608,CHEMBL533,IBUTILIDE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.5,5.5,3200.0,1,8
12957,CHEMBL534,KETOTIFEN,127,CHEMBL231,Histamine H1 receptor,9.86,8.14,0.138,6,9
12957,CHEMBL534,KETOTIFEN,103668,CHEMBL1293235,Prelamin-A/C,8.7,7.1,2.0,2,9
12957,CHEMBL534,KETOTIFEN,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.05,7.46,8.977,5,9
12957,CHEMBL534,KETOTIFEN,219,CHEMBL245,Muscarinic acetylcholine receptor M3,7.75,6.58,18.0,3,8
12957,CHEMBL534,KETOTIFEN,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.54,7.38,29.0,5,9
12957,CHEMBL534,KETOTIFEN,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.08,6.55,84.0,4,9
12957,CHEMBL534,KETOTIFEN,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.85,6.42,141.0,2,8
12957,CHEMBL534,KETOTIFEN,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.57,6.1,268.0,3,8
12957,CHEMBL534,KETOTIFEN,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.57,6.5,269.0,2,8
12957,CHEMBL534,KETOTIFEN,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.53,6.17,298.0,4,8
12957,CHEMBL534,KETOTIFEN,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.49,6.32,324.0,2,8
12957,CHEMBL534,KETOTIFEN,88,CHEMBL2056,D(1A) dopamine receptor,6.36,6.21,436.0,2,8
12957,CHEMBL534,KETOTIFEN,12912,CHEMBL3622,Cytochrome P450 2C19,6.3,6.3,501.2,1,9
12957,CHEMBL534,KETOTIFEN,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.28,6.11,530.0,2,8
12957,CHEMBL534,KETOTIFEN,130,CHEMBL234,D(3) dopamine receptor,6.18,5.8,667.0,3,8
12957,CHEMBL534,KETOTIFEN,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.09,5.88,820.0,2,8
12957,CHEMBL534,KETOTIFEN,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.82,5.82,1500.0,1,8
12957,CHEMBL534,KETOTIFEN,17045,CHEMBL340,Cytochrome P450 3A4,5.8,5.8,1584.9,2,9
12957,CHEMBL534,KETOTIFEN,103,CHEMBL223,Alpha-1D adrenergic receptor,5.74,5.74,1832.0,1,8
12957,CHEMBL534,KETOTIFEN,11365,CHEMBL289,Cytochrome P450 2D6,5.5,5.5,3162.28,2,9
82895,CHEMBL53418,DANTHRON,78,CHEMBL1963,Thyrotropin receptor,5.7,5.7,1995.3,2,9
82895,CHEMBL53418,DANTHRON,11638,CHEMBL4040,Mitogen-activated protein kinase 1,5.5,5.5,3162.3,1,9
78759,CHEMBL53463,DOXORUBICIN,63,CHEMBL1806,DNA topoisomerase 2-alpha,8.31,6.2,4.9,8,9
78759,CHEMBL53463,DOXORUBICIN,20014,CHEMBL4722,Aurora kinase A,7.4,7.4,40.0,1,8
78759,CHEMBL53463,DOXORUBICIN,11398,CHEMBL4302,ATP-dependent translocase ABCB1,6.3,6.3,504.0,1,9
78759,CHEMBL53463,DOXORUBICIN,19,CHEMBL206,Estrogen receptor,6.28,6.28,530.0,1,8
78759,CHEMBL53463,DOXORUBICIN,12026,CHEMBL3396,DNA topoisomerase 2-beta,6.14,6.14,727.0,1,9
78759,CHEMBL53463,DOXORUBICIN,13001,CHEMBL333,72 kDa type IV collagenase,5.96,5.96,1100.0,1,8
78759,CHEMBL53463,DOXORUBICIN,36,CHEMBL208,Progesterone receptor,5.77,5.77,1700.0,1,8
78759,CHEMBL53463,DOXORUBICIN,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.68,5.68,2087.3,1,8
78759,CHEMBL53463,DOXORUBICIN,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,5.61,5.61,2485.0,1,8
78759,CHEMBL53463,DOXORUBICIN,25,CHEMBL2034,Glucocorticoid receptor,5.59,5.59,2590.0,1,8
78759,CHEMBL53463,DOXORUBICIN,62,CHEMBL1781,DNA topoisomerase 1,5.5,5.5,3200.0,1,9
13048,CHEMBL535,SUNITINIB,197,CHEMBL1913,Platelet-derived growth factor receptor beta,10.12,8.6,0.075,16,9
13048,CHEMBL535,SUNITINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,9.7,7.67,0.2,64,9
13048,CHEMBL535,SUNITINIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,9.68,7.86,0.21,52,9
13048,CHEMBL535,SUNITINIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,9.66,8.05,0.22,61,9
13048,CHEMBL535,SUNITINIB,12627,CHEMBL2007,Platelet-derived growth factor receptor alpha,9.1,8.12,0.79,7,9
13048,CHEMBL535,SUNITINIB,10979,CHEMBL1868,Vascular endothelial growth factor receptor 1,9.0,8.4,1.0,7,9
13048,CHEMBL535,SUNITINIB,30045,CHEMBL4525,Serine/threonine-protein kinase 17A,9.0,8.47,1.0,5,9
13048,CHEMBL535,SUNITINIB,12840,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,8.7,7.05,2.0,14,9
13048,CHEMBL535,SUNITINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,8.3,7.14,5.0,22,9
13048,CHEMBL535,SUNITINIB,11361,CHEMBL4004,"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",8.26,7.82,5.5,5,9
13048,CHEMBL535,SUNITINIB,30042,CHEMBL4522,BMP-2-inducible protein kinase,8.26,7.78,5.5,6,9
13048,CHEMBL535,SUNITINIB,12735,CHEMBL2349,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",8.23,7.61,5.9,6,9
13048,CHEMBL535,SUNITINIB,101499,CHEMBL5671,Protein delta homolog 1,8.2,7.8,6.3,3,9
13048,CHEMBL535,SUNITINIB,10531,CHEMBL2527,Serine/threonine-protein kinase Chk2,8.15,7.97,7.1,3,8
13048,CHEMBL535,SUNITINIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,8.05,6.62,8.9,6,9
13048,CHEMBL535,SUNITINIB,10919,CHEMBL2835,Tyrosine-protein kinase JAK1,8.05,7.39,9.0,6,9
13048,CHEMBL535,SUNITINIB,11752,CHEMBL1955,Vascular endothelial growth factor receptor 3,8.05,7.53,8.9,8,9
13048,CHEMBL535,SUNITINIB,100410,CHEMBL4895,Tyrosine-protein kinase receptor UFO,8.05,8.05,9.0,5,9
13048,CHEMBL535,SUNITINIB,30000,CHEMBL3830,AP2-associated protein kinase 1,7.96,7.59,11.0,14,9
13048,CHEMBL535,SUNITINIB,10918,CHEMBL2959,Tyrosine-protein kinase ITK/TSK,7.89,7.89,13.0,3,9
13048,CHEMBL535,SUNITINIB,10967,CHEMBL4937,Casein kinase I isoform epsilon,7.89,7.43,13.0,4,9
13048,CHEMBL535,SUNITINIB,101191,CHEMBL5435,Serine/threonine-protein kinase ULK2,7.89,7.89,13.0,2,8
13048,CHEMBL535,SUNITINIB,19623,CHEMBL3357,Interleukin-1 receptor-associated kinase 1,7.85,7.85,14.0,2,8
13048,CHEMBL535,SUNITINIB,10368,CHEMBL2828,Casein kinase I isoform delta,7.82,7.38,15.0,4,9
13048,CHEMBL535,SUNITINIB,101182,CHEMBL5426,Myosin light chain kinase family member 4,7.82,7.82,15.0,3,9
13048,CHEMBL535,SUNITINIB,103154,CHEMBL1075104,Leucine-rich repeat serine/threonine-protein kinase 2,7.82,7.39,15.0,10,9
13048,CHEMBL535,SUNITINIB,11908,CHEMBL2999,Serine/threonine-protein kinase PAK 3,7.8,7.8,16.0,3,9
13048,CHEMBL535,SUNITINIB,101312,CHEMBL5749,Mitogen-activated protein kinase kinase kinase kinase 1,7.8,7.5,16.0,4,9
13048,CHEMBL535,SUNITINIB,10850,CHEMBL4237,Ribosomal protein S6 kinase alpha-5,7.77,6.69,17.0,8,9
13048,CHEMBL535,SUNITINIB,11843,CHEMBL3906,Ribosomal protein S6 kinase alpha-2,7.77,7.22,17.0,6,9
13048,CHEMBL535,SUNITINIB,101410,CHEMBL6005,Serine/threonine-protein kinase 33,7.77,7.77,17.0,3,9
13048,CHEMBL535,SUNITINIB,102799,CHEMBL6191,Mitogen-activated protein kinase kinase kinase 19,7.77,7.77,17.0,2,8
13048,CHEMBL535,SUNITINIB,11364,CHEMBL4045,5'-AMP-activated protein kinase catalytic subunit alpha-1,7.72,7.21,19.0,7,9
13048,CHEMBL535,SUNITINIB,30006,CHEMBL3981,Serine/threonine-protein kinase 10,7.72,7.34,19.0,4,9
13048,CHEMBL535,SUNITINIB,30024,CHEMBL4598,Serine/threonine-protein kinase 4,7.72,7.17,19.0,6,9
13048,CHEMBL535,SUNITINIB,20020,CHEMBL4355,Cyclin-G-associated kinase,7.7,7.22,20.0,7,9
13048,CHEMBL535,SUNITINIB,30014,CHEMBL4225,Dual specificity protein kinase CLK2,7.7,7.18,20.0,7,9
13048,CHEMBL535,SUNITINIB,10051,CHEMBL2468,Death-associated protein kinase 3,7.66,7.17,22.0,6,9
13048,CHEMBL535,SUNITINIB,30013,CHEMBL4224,Dual specificity protein kinase CLK1,7.66,7.29,22.0,7,9
13048,CHEMBL535,SUNITINIB,10250,CHEMBL2428,"Myosin light chain kinase, smooth muscle",7.64,6.82,23.0,4,9
13048,CHEMBL535,SUNITINIB,12959,CHEMBL4627,Myosin light chain kinase,7.64,7.64,23.0,1,8
13048,CHEMBL535,SUNITINIB,101411,CHEMBL6006,Serine/threonine-protein kinase ULK1,7.64,6.98,23.0,3,9
13048,CHEMBL535,SUNITINIB,30047,CHEMBL4527,TRAF2 and NCK-interacting protein kinase,7.6,7.43,25.0,7,9
13048,CHEMBL535,SUNITINIB,100948,CHEMBL5331,Tyrosine-protein kinase Mer,7.58,7.58,26.0,3,9
13048,CHEMBL535,SUNITINIB,30036,CHEMBL4203,Dual specificity protein kinase CLK4,7.54,7.39,29.0,6,9
13048,CHEMBL535,SUNITINIB,101220,CHEMBL5518,Misshapen-like kinase 1,7.54,7.54,29.0,2,8
13048,CHEMBL535,SUNITINIB,100852,CHEMBL4576,Homeodomain-interacting protein kinase 2,7.51,7.51,31.0,2,8
13048,CHEMBL535,SUNITINIB,9,CHEMBL203,Epidermal growth factor receptor,7.5,6.51,31.8,4,9
13048,CHEMBL535,SUNITINIB,100947,CHEMBL5330,Mitogen-activated protein kinase kinase kinase kinase 2,7.48,7.48,33.0,1,8
13048,CHEMBL535,SUNITINIB,101404,CHEMBL5975,Serine/threonine-protein kinase RIO1,7.46,7.46,35.0,3,9
13048,CHEMBL535,SUNITINIB,101032,CHEMBL5606,Serine/threonine-protein kinase STK11,7.42,7.42,38.0,3,9
13048,CHEMBL535,SUNITINIB,101495,CHEMBL5667,Phosphatidylinositol 5-phosphate 4-kinase type-2 beta,7.41,7.41,39.0,3,9
13048,CHEMBL535,SUNITINIB,30049,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,7.39,7.05,41.0,6,9
13048,CHEMBL535,SUNITINIB,100853,CHEMBL4577,Homeodomain-interacting protein kinase 3,7.39,7.39,41.0,2,8
13048,CHEMBL535,SUNITINIB,101048,CHEMBL5047,Serine/threonine-protein kinase ULK3,7.38,6.9,42.0,3,9
13048,CHEMBL535,SUNITINIB,10371,CHEMBL4948,Dual specificity mitogen-activated protein kinase kinase 5,7.34,7.34,46.0,1,8
13048,CHEMBL535,SUNITINIB,12944,CHEMBL4501,Ribosomal protein S6 kinase beta-1,7.32,7.01,48.0,2,8
13048,CHEMBL535,SUNITINIB,101332,CHEMBL5784,NUAK family SNF1-like kinase 1,7.32,7.32,48.0,4,9
13048,CHEMBL535,SUNITINIB,12037,CHEMBL2777,"Myosin light chain kinase 2, skeletal/cardiac muscle",7.31,7.28,49.0,5,9
13048,CHEMBL535,SUNITINIB,100912,CHEMBL5314,Tyrosine-protein kinase receptor TYRO3,7.31,7.31,49.0,3,9
13048,CHEMBL535,SUNITINIB,101405,CHEMBL6000,Serine/threonine-protein kinase RIO2,7.31,7.31,49.0,2,8
13048,CHEMBL535,SUNITINIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,7.26,6.33,55.0,38,9
13048,CHEMBL535,SUNITINIB,12724,CHEMBL2345,Ribosomal protein S6 kinase alpha-3,7.26,6.46,55.0,7,9
13048,CHEMBL535,SUNITINIB,100417,CHEMBL4247,ALK tyrosine kinase receptor,7.26,6.64,54.64,5,9
13048,CHEMBL535,SUNITINIB,101183,CHEMBL5427,Homeodomain-interacting protein kinase 1,7.26,7.26,55.0,1,8
13048,CHEMBL535,SUNITINIB,10277,CHEMBL4708,Serine/threonine-protein kinase 3,7.25,6.84,56.0,4,9
13048,CHEMBL535,SUNITINIB,30035,CHEMBL4202,STE20-like serine/threonine-protein kinase,7.25,6.91,56.0,6,9
13048,CHEMBL535,SUNITINIB,102711,CHEMBL5914,Mitogen-activated protein kinase kinase kinase 2,7.24,6.7,57.0,3,9
13048,CHEMBL535,SUNITINIB,100975,CHEMBL5415,SRSF protein kinase 3,7.23,7.23,59.0,2,8
13048,CHEMBL535,SUNITINIB,10659,CHEMBL2116,5'-AMP-activated protein kinase catalytic subunit alpha-2,7.21,7.09,61.7,4,9
13048,CHEMBL535,SUNITINIB,30011,CHEMBL3983,Dual specificity protein kinase TTK,7.2,6.98,63.0,5,9
13048,CHEMBL535,SUNITINIB,101056,CHEMBL5082,Serine/threonine-protein kinase 24,7.2,7.2,63.0,3,9
13048,CHEMBL535,SUNITINIB,11691,CHEMBL2250,Tyrosine-protein kinase Blk,7.19,7.19,65.0,3,9
13048,CHEMBL535,SUNITINIB,19639,CHEMBL3778,Interleukin-1 receptor-associated kinase 4,7.18,6.38,66.0,2,9
13048,CHEMBL535,SUNITINIB,12967,CHEMBL4630,Serine/threonine-protein kinase Chk1,7.11,6.67,77.27,4,9
13048,CHEMBL535,SUNITINIB,12415,CHEMBL4147,Calcium/calmodulin-dependent protein kinase type II subunit alpha,7.1,6.83,80.0,5,9
13048,CHEMBL535,SUNITINIB,10044,CHEMBL3629,Casein kinase II subunit alpha,7.09,6.74,81.0,3,9
13048,CHEMBL535,SUNITINIB,100995,CHEMBL5469,Protein-tyrosine kinase 2-beta,7.09,7.09,82.0,3,9
13048,CHEMBL535,SUNITINIB,101324,CHEMBL5776,Mitogen-activated protein kinase kinase kinase 7,7.03,7.03,93.0,2,8
13048,CHEMBL535,SUNITINIB,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.02,7.02,95.9,1,8
13048,CHEMBL535,SUNITINIB,10782,CHEMBL3125,Ribosomal protein S6 kinase alpha-4,7.02,6.42,96.0,6,9
13048,CHEMBL535,SUNITINIB,10929,CHEMBL2553,Ribosomal protein S6 kinase alpha-1,7.02,6.57,96.0,6,9
13048,CHEMBL535,SUNITINIB,103453,CHEMBL1163124,Mitogen-activated protein kinase kinase kinase 13,7.02,7.02,95.0,2,8
13048,CHEMBL535,SUNITINIB,11720,CHEMBL2793,Casein kinase I isoform alpha,7.0,6.63,99.0,2,8
13048,CHEMBL535,SUNITINIB,11902,CHEMBL2815,High affinity nerve growth factor receptor,7.0,6.72,100.0,7,9
13048,CHEMBL535,SUNITINIB,104320,CHEMBL1908389,Mitogen-activated protein kinase kinase kinase 12,7.0,7.0,100.0,1,8
13048,CHEMBL535,SUNITINIB,90,CHEMBL219,D(4) dopamine receptor,6.96,6.96,108.5,1,8
13048,CHEMBL535,SUNITINIB,11046,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,6.96,6.67,110.0,4,9
13048,CHEMBL535,SUNITINIB,11629,CHEMBL2543,Casein kinase I isoform gamma-2,6.96,6.96,110.0,3,9
13048,CHEMBL535,SUNITINIB,30005,CHEMBL3980,Serine/threonine-protein kinase 17B,6.96,6.84,110.0,5,9
13048,CHEMBL535,SUNITINIB,101448,CHEMBL6123,Serine/threonine-protein kinase DCLK3,6.96,6.96,110.0,3,9
13048,CHEMBL535,SUNITINIB,11150,CHEMBL2558,Death-associated protein kinase 1,6.92,6.92,120.0,3,9
13048,CHEMBL535,SUNITINIB,18033,CHEMBL2073,Tyrosine-protein kinase Yes,6.92,6.7,120.0,5,9
13048,CHEMBL535,SUNITINIB,100856,CHEMBL5408,Serine/threonine-protein kinase TBK1,6.92,6.55,120.0,3,9
13048,CHEMBL535,SUNITINIB,11409,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,6.89,6.56,130.0,4,9
13048,CHEMBL535,SUNITINIB,30022,CHEMBL4597,Cyclin-dependent kinase 16,6.89,6.64,130.0,6,9
13048,CHEMBL535,SUNITINIB,11149,CHEMBL2973,Rho-associated protein kinase 2,6.85,6.85,140.0,2,8
13048,CHEMBL535,SUNITINIB,101464,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,6.85,6.78,140.0,4,9
13048,CHEMBL535,SUNITINIB,101584,CHEMBL5861,G protein-coupled receptor kinase 4,6.85,6.85,140.0,2,8
13048,CHEMBL535,SUNITINIB,103437,CHEMBL1163108,STE20/SPS1-related proline-alanine-rich protein kinase,6.85,6.85,140.0,2,8
13048,CHEMBL535,SUNITINIB,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,6.82,5.96,152.8,6,9
13048,CHEMBL535,SUNITINIB,10778,CHEMBL3123,Death-associated protein kinase 2,6.82,6.62,150.0,5,9
13048,CHEMBL535,SUNITINIB,101503,CHEMBL5698,NUAK family SNF1-like kinase 2,6.82,6.82,150.0,3,9
13048,CHEMBL535,SUNITINIB,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.8,6.8,158.2,1,8
13048,CHEMBL535,SUNITINIB,12780,CHEMBL4070,Casein kinase II subunit alpha',6.8,6.29,160.0,4,9
13048,CHEMBL535,SUNITINIB,103106,CHEMBL1075167,Homeodomain-interacting protein kinase 4,6.8,6.8,160.0,2,8
13048,CHEMBL535,SUNITINIB,10266,CHEMBL3650,Fibroblast growth factor receptor 1,6.77,6.12,170.0,7,9
13048,CHEMBL535,SUNITINIB,35,CHEMBL1981,Insulin receptor,6.75,6.32,180.0,6,9
13048,CHEMBL535,SUNITINIB,100925,CHEMBL5358,eIF-2-alpha kinase GCN2,6.75,6.75,180.0,3,9
13048,CHEMBL535,SUNITINIB,101188,CHEMBL5432,Mitogen-activated protein kinase kinase kinase kinase 3,6.75,6.63,180.0,4,9
13048,CHEMBL535,SUNITINIB,103062,CHEMBL1075133,Rhodopsin kinase GRK7,6.75,6.75,180.0,2,8
13048,CHEMBL535,SUNITINIB,125,CHEMBL229,Alpha-1A adrenergic receptor,6.73,6.38,185.3,3,8
13048,CHEMBL535,SUNITINIB,11785,CHEMBL3234,Tyrosine-protein kinase HCK,6.72,6.12,190.0,5,9
13048,CHEMBL535,SUNITINIB,30003,CHEMBL3788,Serine/threonine-protein kinase PLK4,6.72,6.6,190.0,5,9
13048,CHEMBL535,SUNITINIB,101496,CHEMBL5668,SRSF protein kinase 2,6.72,6.72,190.0,3,9
13048,CHEMBL535,SUNITINIB,12090,CHEMBL2292,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,6.7,6.7,200.0,2,8
13048,CHEMBL535,SUNITINIB,103457,CHEMBL1163128,Microtubule-associated serine/threonine-protein kinase 1,6.7,6.7,200.0,2,8
13048,CHEMBL535,SUNITINIB,103458,CHEMBL1163129,Serine/threonine-protein kinase SBK1,6.7,6.7,200.0,1,8
13048,CHEMBL535,SUNITINIB,101506,CHEMBL5701,Serine/threonine-protein kinase TAO3,6.68,6.68,210.0,2,8
13048,CHEMBL535,SUNITINIB,20171,CHEMBL3935,Aurora kinase C,6.66,6.6,220.0,5,9
13048,CHEMBL535,SUNITINIB,101399,CHEMBL5970,Mitogen-activated protein kinase kinase kinase 3,6.66,6.66,220.0,2,8
13048,CHEMBL535,SUNITINIB,102465,CHEMBL6186,Serine/threonine-protein kinase Sgk3,6.66,6.66,220.0,1,8
13048,CHEMBL535,SUNITINIB,101058,CHEMBL5084,Casein kinase I isoform gamma-3,6.62,6.35,240.0,4,9
13048,CHEMBL535,SUNITINIB,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.6,6.36,251.19,4,9
13048,CHEMBL535,SUNITINIB,30004,CHEMBL3938,Serine/threonine-protein kinase 16,6.6,6.54,250.0,5,9
13048,CHEMBL535,SUNITINIB,100789,CHEMBL4375,SRSF protein kinase 1,6.6,6.6,250.0,3,9
13048,CHEMBL535,SUNITINIB,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,6.57,6.35,270.0,6,9
13048,CHEMBL535,SUNITINIB,100127,CHEMBL4454,Tyrosine-protein kinase Fgr,6.57,6.43,270.0,6,9
13048,CHEMBL535,SUNITINIB,101460,CHEMBL6162,Cyclin-dependent kinase 14,6.57,6.57,270.0,3,9
13048,CHEMBL535,SUNITINIB,10885,CHEMBL2595,Serine/threonine-protein kinase D3,6.55,6.36,280.0,4,9
13048,CHEMBL535,SUNITINIB,11926,CHEMBL2742,Fibroblast growth factor receptor 3,6.54,6.24,290.0,7,9
13048,CHEMBL535,SUNITINIB,101033,CHEMBL5607,Rhodopsin kinase GRK1,6.54,6.54,290.0,2,8
13048,CHEMBL535,SUNITINIB,101231,CHEMBL5552,Serine/threonine-protein kinase 25,6.54,6.54,290.0,3,9
13048,CHEMBL535,SUNITINIB,10903,CHEMBL3863,Serine/threonine-protein kinase D1,6.51,6.51,310.0,3,9
13048,CHEMBL535,SUNITINIB,30001,CHEMBL3831,Serine/threonine-protein kinase MARK2,6.51,6.31,310.0,5,9
13048,CHEMBL535,SUNITINIB,101226,CHEMBL5547,Ankyrin repeat and protein kinase domain-containing protein 1,6.51,6.51,310.0,3,9
13048,CHEMBL535,SUNITINIB,12829,CHEMBL3055,Cyclin-dependent kinase 7,6.48,6.34,330.0,4,9
13048,CHEMBL535,SUNITINIB,101179,CHEMBL5404,Serine/threonine-protein kinase tousled-like 2,6.48,6.38,330.0,5,9
13048,CHEMBL535,SUNITINIB,101613,CHEMBL5941,Serine/threonine-protein kinase 26,6.47,6.26,340.0,4,9
13048,CHEMBL535,SUNITINIB,100854,CHEMBL4578,Maternal embryonic leucine zipper kinase,6.46,6.31,350.0,4,9
13048,CHEMBL535,SUNITINIB,12694,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,6.44,6.06,360.0,5,9
13048,CHEMBL535,SUNITINIB,100990,CHEMBL5464,Receptor-interacting serine/threonine-protein kinase 1,6.43,6.43,370.0,4,9
13048,CHEMBL535,SUNITINIB,101281,CHEMBL5683,Serine/threonine-protein kinase DCLK1,6.43,6.43,370.0,3,9
13048,CHEMBL535,SUNITINIB,10781,CHEMBL2185,Aurora kinase B,6.42,6.21,380.0,6,9
13048,CHEMBL535,SUNITINIB,100415,CHEMBL4900,Serine/threonine-protein kinase D2,6.42,6.3,380.0,4,9
13048,CHEMBL535,SUNITINIB,104313,CHEMBL1908382,Serine/threonine-protein kinase PRP4 homolog,6.41,6.41,390.0,2,8
13048,CHEMBL535,SUNITINIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,6.39,6.3,410.0,4,9
13048,CHEMBL535,SUNITINIB,100140,CHEMBL5600,MAP/microtubule affinity-regulating kinase 3,6.39,6.19,410.0,5,9
13048,CHEMBL535,SUNITINIB,103095,CHEMBL1075155,Serine/threonine-protein kinase 38,6.39,6.39,410.0,2,8
13048,CHEMBL535,SUNITINIB,11622,CHEMBL2801,Calcium/calmodulin-dependent protein kinase type II subunit delta,6.38,6.28,420.0,4,9
13048,CHEMBL535,SUNITINIB,30029,CHEMBL5256,Calcium/calmodulin-dependent protein kinase kinase 1,6.38,6.3,420.0,4,9
13048,CHEMBL535,SUNITINIB,101211,CHEMBL5483,Insulin receptor-related protein,6.37,6.37,430.0,3,9
13048,CHEMBL535,SUNITINIB,117538,CHEMBL4105933,Uncharacterized protein FLJ45252,6.37,6.37,431.0,1,9
13048,CHEMBL535,SUNITINIB,11242,CHEMBL2695,Focal adhesion kinase 1,6.36,6.22,440.0,6,9
13048,CHEMBL535,SUNITINIB,30002,CHEMBL3829,Calcium/calmodulin-dependent protein kinase type II subunit gamma,6.36,6.16,440.0,7,9
13048,CHEMBL535,SUNITINIB,30031,CHEMBL5258,Calcium/calmodulin-dependent protein kinase type 1G,6.36,6.24,440.0,3,9
13048,CHEMBL535,SUNITINIB,10811,CHEMBL3231,Rho-associated protein kinase 1,6.34,6.34,460.0,2,8
13048,CHEMBL535,SUNITINIB,101602,CHEMBL5907,Serine/threonine-protein kinase LATS2,6.34,6.34,460.0,3,9
13048,CHEMBL535,SUNITINIB,103455,CHEMBL1163126,Serine/threonine-protein kinase ICK,6.33,6.33,470.0,2,8
13048,CHEMBL535,SUNITINIB,30020,CHEMBL5072,Ephrin type-B receptor 1,6.32,6.2,480.0,5,9
13048,CHEMBL535,SUNITINIB,101282,CHEMBL5684,"Muscle, skeletal receptor tyrosine-protein kinase",6.31,6.31,490.0,3,9
13048,CHEMBL535,SUNITINIB,30017,CHEMBL3835,Serine/threonine-protein kinase Nek2,6.3,6.03,500.0,5,9
13048,CHEMBL535,SUNITINIB,30040,CHEMBL4311,Serine/threonine-protein kinase PAK 6,6.3,5.79,500.0,4,9
13048,CHEMBL535,SUNITINIB,30044,CHEMBL4524,Serine/threonine-protein kinase PAK 5,6.3,6.22,500.0,4,9
13048,CHEMBL535,SUNITINIB,100080,CHEMBL4482,Serine/threonine-protein kinase PAK 4,6.3,5.95,500.0,6,9
13048,CHEMBL535,SUNITINIB,104245,CHEMBL1795165,Hormonally up-regulated neu tumor-associated kinase,6.3,6.3,500.0,2,8
13048,CHEMBL535,SUNITINIB,121,CHEMBL228,Sodium-dependent serotonin transporter,6.29,6.29,510.0,1,8
13048,CHEMBL535,SUNITINIB,30028,CHEMBL5073,Calcium/calmodulin-dependent protein kinase type 1D,6.29,6.21,510.0,4,9
13048,CHEMBL535,SUNITINIB,10264,CHEMBL4142,Fibroblast growth factor receptor 2,6.28,6.26,530.0,5,9
13048,CHEMBL535,SUNITINIB,10751,CHEMBL3476,Inhibitor of nuclear factor kappa-B kinase subunit alpha,6.28,6.28,520.0,2,8
13048,CHEMBL535,SUNITINIB,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,6.28,6.28,520.0,3,9
13048,CHEMBL535,SUNITINIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,6.28,6.28,530.0,3,9
13048,CHEMBL535,SUNITINIB,103433,CHEMBL1163104,Serine/threonine-protein kinase OSR1,6.28,6.28,530.0,2,8
13048,CHEMBL535,SUNITINIB,101222,CHEMBL5520,Casein kinase I isoform alpha-like,6.26,6.26,550.0,2,9
13048,CHEMBL535,SUNITINIB,100993,CHEMBL5467,Bone morphogenetic protein receptor type-2,6.24,6.11,570.0,5,9
13048,CHEMBL535,SUNITINIB,101504,CHEMBL5699,Serine/threonine-protein kinase SIK2,6.24,6.24,580.0,3,9
13048,CHEMBL535,SUNITINIB,100413,CHEMBL4898,BDNF/NT-3 growth factors receptor,6.23,6.23,590.0,3,9
13048,CHEMBL535,SUNITINIB,103430,CHEMBL1163101,Serine/threonine-protein kinase/endoribonuclease IRE1,6.22,6.22,600.0,2,8
13048,CHEMBL535,SUNITINIB,12915,CHEMBL3529,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,6.21,6.1,620.0,4,9
13048,CHEMBL535,SUNITINIB,101465,CHEMBL6167,Serine/threonine-protein kinase LATS1,6.2,6.18,630.0,4,9
13048,CHEMBL535,SUNITINIB,104315,CHEMBL1908384,SNF-related serine/threonine-protein kinase,6.19,6.19,640.0,1,8
13048,CHEMBL535,SUNITINIB,100790,CHEMBL4376,Dual specificity tyrosine-phosphorylation-regulated kinase 2,6.17,6.17,680.0,2,8
13048,CHEMBL535,SUNITINIB,100951,CHEMBL5334,Non-receptor tyrosine-protein kinase TNK1,6.17,6.17,680.0,3,9
13048,CHEMBL535,SUNITINIB,101333,CHEMBL5785,"Interferon-induced, double-stranded RNA-activated protein kinase",6.17,6.17,670.0,3,9
13048,CHEMBL535,SUNITINIB,11047,CHEMBL2897,Dual specificity mitogen-activated protein kinase kinase 4,6.16,6.16,700.0,1,8
13048,CHEMBL535,SUNITINIB,11637,CHEMBL3384,Serine/threonine-protein kinase N1,6.15,6.15,710.0,3,9
13048,CHEMBL535,SUNITINIB,30027,CHEMBL4602,Ephrin type-A receptor 7,6.15,5.83,710.0,5,9
13048,CHEMBL535,SUNITINIB,100969,CHEMBL5388,Serine/threonine-protein kinase tousled-like 1,6.13,6.13,740.0,4,9
13048,CHEMBL535,SUNITINIB,102420,CHEMBL5678,G protein-coupled receptor kinase 5,6.08,6.08,830.0,1,9
13048,CHEMBL535,SUNITINIB,100824,CHEMBL3542,Serine/threonine-protein kinase NIM1,6.07,6.07,850.0,2,8
13048,CHEMBL535,SUNITINIB,102676,CHEMBL5836,Ephrin type-B receptor 6,6.07,6.04,850.0,2,8
13048,CHEMBL535,SUNITINIB,10280,CHEMBL264,Histamine H3 receptor,6.06,6.06,880.0,1,8
13048,CHEMBL535,SUNITINIB,10971,CHEMBL2494,Calcium/calmodulin-dependent protein kinase type IV,6.05,5.92,890.0,4,9
13048,CHEMBL535,SUNITINIB,101131,CHEMBL5261,Serine/threonine-protein kinase TAO1,6.05,6.05,890.0,2,8
13048,CHEMBL535,SUNITINIB,10262,CHEMBL2426,Casein kinase I isoform gamma-1,6.03,6.03,930.0,3,9
13048,CHEMBL535,SUNITINIB,101055,CHEMBL5081,Interleukin-1 receptor-associated kinase 3,6.03,6.03,940.0,3,9
13048,CHEMBL535,SUNITINIB,30046,CHEMBL4526,Ephrin type-A receptor 6,6.02,5.94,960.0,4,9
13048,CHEMBL535,SUNITINIB,100069,CHEMBL5455,Tyrosine-protein kinase Fes/Fps,6.02,6.02,960.0,3,9
13048,CHEMBL535,SUNITINIB,10970,CHEMBL2493,Calcium/calmodulin-dependent protein kinase type 1,6.01,5.93,970.0,4,9
13048,CHEMBL535,SUNITINIB,30048,CHEMBL4851,Serine/threonine-protein kinase 38-like,6.01,5.96,970.0,4,9
13048,CHEMBL535,SUNITINIB,11209,CHEMBL4014,Tyrosine-protein kinase ABL2,6.0,5.98,1000.0,4,9
13048,CHEMBL535,SUNITINIB,12828,CHEMBL4442,Cyclin-dependent kinase 3,5.99,5.99,1024.0,1,9
13048,CHEMBL535,SUNITINIB,30007,CHEMBL3982,Tyrosine-protein kinase Fer,5.96,5.89,1100.0,5,9
13048,CHEMBL535,SUNITINIB,100098,CHEMBL5491,Wee1-like protein kinase,5.96,5.96,1100.0,3,9
13048,CHEMBL535,SUNITINIB,100850,CHEMBL4574,Serine/threonine-protein kinase BRSK2,5.96,5.96,1100.0,3,9
13048,CHEMBL535,SUNITINIB,101309,CHEMBL5728,Cyclin-dependent kinase-like 2,5.96,5.96,1100.0,2,8
13048,CHEMBL535,SUNITINIB,72,CHEMBL217,D(2) dopamine receptor,5.94,5.94,1148.9,1,8
13048,CHEMBL535,SUNITINIB,10341,CHEMBL2393,5'-AMP-activated protein kinase subunit gamma-1,5.94,5.94,1140.0,1,9
13048,CHEMBL535,SUNITINIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,5.92,5.92,1200.0,3,9
13048,CHEMBL535,SUNITINIB,11451,CHEMBL3717,Hepatocyte growth factor receptor,5.92,5.85,1200.0,3,9
13048,CHEMBL535,SUNITINIB,30019,CHEMBL3987,Ephrin type-A receptor 5,5.92,5.92,1200.0,1,8
13048,CHEMBL535,SUNITINIB,101553,CHEMBL5790,Cyclin-dependent kinase 17,5.92,5.83,1200.0,4,9
13048,CHEMBL535,SUNITINIB,101612,CHEMBL5940,Serine/threonine-protein kinase MARK1,5.92,5.92,1200.0,3,9
13048,CHEMBL535,SUNITINIB,117348,CHEMBL4105743,General transcription and DNA repair factor IIH helicase subunit XPD,5.91,5.91,1225.0,1,9
13048,CHEMBL535,SUNITINIB,10842,CHEMBL3032,Serine/threonine-protein kinase N2,5.89,5.89,1300.0,3,9
13048,CHEMBL535,SUNITINIB,11870,CHEMBL2708,Mitogen-activated protein kinase kinase kinase 11,5.89,5.79,1300.0,4,9
13048,CHEMBL535,SUNITINIB,101270,CHEMBL5651,Serine/threonine-protein kinase 35,5.89,5.89,1300.0,2,8
13048,CHEMBL535,SUNITINIB,103456,CHEMBL1163127,Mitogen-activated protein kinase kinase kinase 15,5.89,5.89,1300.0,2,8
13048,CHEMBL535,SUNITINIB,104317,CHEMBL1908386,Dual serine/threonine and tyrosine protein kinase,5.89,5.89,1300.0,1,8
13048,CHEMBL535,SUNITINIB,10396,CHEMBL4121,Calcium/calmodulin-dependent protein kinase type II subunit beta,5.85,5.76,1400.0,4,9
13048,CHEMBL535,SUNITINIB,30032,CHEMBL5284,Calcium/calmodulin-dependent protein kinase kinase 2,5.82,5.82,1500.0,3,9
13048,CHEMBL535,SUNITINIB,219,CHEMBL245,Muscarinic acetylcholine receptor M3,5.79,5.79,1612.4,1,8
13048,CHEMBL535,SUNITINIB,102447,CHEMBL6144,G protein-coupled receptor kinase 6,5.79,5.79,1615.0,1,9
13048,CHEMBL535,SUNITINIB,36,CHEMBL208,Progesterone receptor,5.77,5.77,1700.0,1,8
13048,CHEMBL535,SUNITINIB,136,CHEMBL236,Delta-type opioid receptor,5.77,5.77,1700.0,1,8
13048,CHEMBL535,SUNITINIB,10478,CHEMBL2109,Dual specificity mitogen-activated protein kinase kinase 3,5.77,5.77,1700.0,1,8
13048,CHEMBL535,SUNITINIB,20014,CHEMBL4722,Aurora kinase A,5.77,5.76,1700.0,4,9
13048,CHEMBL535,SUNITINIB,100914,CHEMBL5316,Cyclin-dependent kinase 18,5.77,5.77,1700.0,3,9
13048,CHEMBL535,SUNITINIB,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.76,5.76,1755.0,1,8
13048,CHEMBL535,SUNITINIB,10662,CHEMBL2453,5'-AMP-activated protein kinase subunit gamma-2,5.76,5.76,1734.0,1,9
13048,CHEMBL535,SUNITINIB,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.75,5.75,1766.3,1,8
13048,CHEMBL535,SUNITINIB,101484,CHEMBL5627,Leukocyte tyrosine kinase receptor,5.75,5.75,1800.0,3,9
13048,CHEMBL535,SUNITINIB,101073,CHEMBL5116,Uncharacterized serine/threonine-protein kinase SBK3,5.72,5.72,1900.0,2,8
13048,CHEMBL535,SUNITINIB,130,CHEMBL234,D(3) dopamine receptor,5.71,5.71,1936.5,1,8
13048,CHEMBL535,SUNITINIB,12946,CHEMBL331,Cyclin-dependent kinase 4,5.7,5.7,2000.0,1,8
13048,CHEMBL535,SUNITINIB,100917,CHEMBL5319,Epithelial discoidin domain-containing receptor 1,5.7,5.7,2000.0,4,9
13048,CHEMBL535,SUNITINIB,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.69,5.69,2049.4,1,8
13048,CHEMBL535,SUNITINIB,11925,CHEMBL3973,Fibroblast growth factor receptor 4,5.68,5.68,2100.0,1,8
13048,CHEMBL535,SUNITINIB,30009,CHEMBL4954,Ephrin type-A receptor 3,5.68,5.68,2100.0,3,9
13048,CHEMBL535,SUNITINIB,100097,CHEMBL5251,Tyrosine-protein kinase BTK,5.68,5.68,2100.0,1,8
13048,CHEMBL535,SUNITINIB,101434,CHEMBL6083,Receptor-interacting serine/threonine-protein kinase 4,5.68,5.68,2100.0,2,8
13048,CHEMBL535,SUNITINIB,30023,CHEMBL4599,Activated CDC42 kinase 1,5.66,5.66,2200.0,1,9
13048,CHEMBL535,SUNITINIB,100129,CHEMBL5147,Ephrin type-B receptor 4,5.66,5.58,2200.0,2,9
13048,CHEMBL535,SUNITINIB,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.65,5.65,2245.0,1,8
13048,CHEMBL535,SUNITINIB,101014,CHEMBL5543,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,5.64,5.64,2300.0,3,9
13048,CHEMBL535,SUNITINIB,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,5.62,5.62,2391.6,1,8
13048,CHEMBL535,SUNITINIB,10939,CHEMBL4924,Ribosomal protein S6 kinase alpha-6,5.62,5.62,2400.0,3,9
13048,CHEMBL535,SUNITINIB,11407,CHEMBL4179,Mitogen-activated protein kinase 9,5.62,5.62,2400.0,1,8
13048,CHEMBL535,SUNITINIB,100855,CHEMBL5407,Serine/threonine-protein kinase pim-3,5.62,5.62,2400.0,3,9
13048,CHEMBL535,SUNITINIB,101204,CHEMBL5476,Bone morphogenetic protein receptor type-1B,5.62,5.62,2400.0,1,8
13048,CHEMBL535,SUNITINIB,10034,CHEMBL3157,B2 bradykinin receptor,5.6,5.6,2500.0,1,8
13048,CHEMBL535,SUNITINIB,234,CHEMBL1957,Insulin-like growth factor 1 receptor,5.58,5.58,2600.0,3,9
13048,CHEMBL535,SUNITINIB,10695,CHEMBL2431,RAC-beta serine/threonine-protein kinase,5.57,5.57,2700.0,3,9
13048,CHEMBL535,SUNITINIB,101221,CHEMBL5519,Serine/threonine-protein kinase DCLK2,5.57,5.57,2700.0,3,9
13048,CHEMBL535,SUNITINIB,101079,CHEMBL5122,Discoidin domain-containing receptor 2,5.54,5.54,2900.0,1,8
13048,CHEMBL535,SUNITINIB,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,5.52,5.52,3000.0,1,9
13048,CHEMBL535,SUNITINIB,101225,CHEMBL5546,Myosin-IIIa,5.51,5.51,3100.0,1,8
13048,CHEMBL535,SUNITINIB,101433,CHEMBL6082,Serine/threonine-protein kinase SIK1,5.5,5.5,3200.0,3,9
13329,CHEMBL537,HYDROQUINONE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.55,8.55,2.8,2,9
13329,CHEMBL537,HYDROQUINONE,15,CHEMBL205,Carbonic anhydrase 2,7.05,7.05,90.0,2,9
13329,CHEMBL537,HYDROQUINONE,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,6.4,6.07,398.1,3,9
13329,CHEMBL537,HYDROQUINONE,17045,CHEMBL340,Cytochrome P450 3A4,6.0,6.0,1000.0,2,9
13329,CHEMBL537,HYDROQUINONE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,5.7,5.7,1995.3,2,9
13329,CHEMBL537,HYDROQUINONE,103668,CHEMBL1293235,Prelamin-A/C,5.55,5.55,2818.4,1,9
13342,CHEMBL539,ACETIC ACID,10140,CHEMBL258,Tyrosine-protein kinase Lck,6.19,6.04,640.0,2,8
13342,CHEMBL539,ACETIC ACID,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,6.05,6.05,900.0,1,8
298316,CHEMBL539423,SPARSENTAN,115,CHEMBL227,Type-1 angiotensin II receptor,9.1,9.1,0.8,2,9
298316,CHEMBL539423,SPARSENTAN,249,CHEMBL252,Endothelin-1 receptor,8.03,8.03,9.3,2,9
561520,CHEMBL539697,DABIGATRAN ETEXILATE,11,CHEMBL204,Prothrombin,8.58,8.5,2.61,3,9
561520,CHEMBL539697,DABIGATRAN ETEXILATE,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,5.52,5.52,3000.0,1,8
3859,CHEMBL54,HALOPERIDOL,130,CHEMBL234,D(3) dopamine receptor,10.22,8.26,0.06,65,9
3859,CHEMBL54,HALOPERIDOL,72,CHEMBL217,D(2) dopamine receptor,9.92,8.74,0.12,114,9
3859,CHEMBL54,HALOPERIDOL,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,9.7,8.44,0.2,67,9
3859,CHEMBL54,HALOPERIDOL,90,CHEMBL219,D(4) dopamine receptor,9.13,8.25,0.74,52,9
3859,CHEMBL54,HALOPERIDOL,88,CHEMBL2056,D(1A) dopamine receptor,8.21,7.15,6.166,15,9
3859,CHEMBL54,HALOPERIDOL,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,8.0,7.12,10.0,19,9
3859,CHEMBL54,HALOPERIDOL,125,CHEMBL229,Alpha-1A adrenergic receptor,7.96,7.43,11.0,6,9
3859,CHEMBL54,HALOPERIDOL,117512,CHEMBL4105907,Sigma intracellular receptor 2,7.8,7.44,16.0,9,9
3859,CHEMBL54,HALOPERIDOL,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.68,6.94,21.0,23,9
3859,CHEMBL54,HALOPERIDOL,220,CHEMBL1850,D(1B) dopamine receptor,7.42,7.01,38.0,6,9
3859,CHEMBL54,HALOPERIDOL,103,CHEMBL223,Alpha-1D adrenergic receptor,7.39,7.23,41.0,2,8
3859,CHEMBL54,HALOPERIDOL,102,CHEMBL1941,Histamine H2 receptor,6.93,6.27,116.8,3,8
3859,CHEMBL54,HALOPERIDOL,11165,CHEMBL4931,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",6.72,6.72,190.0,1,9
3859,CHEMBL54,HALOPERIDOL,11398,CHEMBL4302,ATP-dependent translocase ABCB1,6.7,6.7,200.0,1,8
3859,CHEMBL54,HALOPERIDOL,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.57,6.19,268.0,3,9
3859,CHEMBL54,HALOPERIDOL,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,6.55,6.55,281.8,2,9
3859,CHEMBL54,HALOPERIDOL,129,CHEMBL233,Mu-type opioid receptor,6.54,5.89,287.9,5,9
3859,CHEMBL54,HALOPERIDOL,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,6.5,6.24,316.23,5,9
3859,CHEMBL54,HALOPERIDOL,127,CHEMBL231,Histamine H1 receptor,6.49,6.2,323.0,7,9
3859,CHEMBL54,HALOPERIDOL,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.32,6.13,480.0,3,9
3859,CHEMBL54,HALOPERIDOL,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.02,5.8,964.4,6,9
3859,CHEMBL54,HALOPERIDOL,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.97,5.85,1074.1,3,8
3859,CHEMBL54,HALOPERIDOL,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,5.96,5.96,1083.0,1,9
3859,CHEMBL54,HALOPERIDOL,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,5.82,5.82,1504.0,1,8
3859,CHEMBL54,HALOPERIDOL,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.8,5.71,1600.0,3,9
3859,CHEMBL54,HALOPERIDOL,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.76,5.68,1753.0,2,8
3859,CHEMBL54,HALOPERIDOL,121,CHEMBL228,Sodium-dependent serotonin transporter,5.75,5.75,1799.0,3,9
3859,CHEMBL54,HALOPERIDOL,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.74,5.72,1820.0,3,8
3859,CHEMBL54,HALOPERIDOL,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.73,5.73,1865.0,1,8
3859,CHEMBL54,HALOPERIDOL,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,5.55,5.55,2795.0,1,8
3859,CHEMBL54,HALOPERIDOL,12912,CHEMBL3622,Cytochrome P450 2C19,5.54,5.54,2870.0,1,9
3859,CHEMBL54,HALOPERIDOL,17045,CHEMBL340,Cytochrome P450 3A4,5.5,5.5,3162.3,2,9
2856578,CHEMBL5416410,DASATINIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,10.8,8.64,0.016,49,9
2856578,CHEMBL5416410,DASATINIB,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,10.8,9.4,0.016,25,9
2856578,CHEMBL5416410,DASATINIB,102676,CHEMBL5836,Ephrin type-B receptor 6,10.41,8.94,0.039,2,9
2856578,CHEMBL5416410,DASATINIB,30009,CHEMBL4954,Ephrin type-A receptor 3,10.03,10.03,0.093,2,9
2856578,CHEMBL5416410,DASATINIB,11209,CHEMBL4014,Tyrosine-protein kinase ABL2,9.77,8.4,0.17,4,9
2856578,CHEMBL5416410,DASATINIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,9.7,9.03,0.2,9,9
2856578,CHEMBL5416410,DASATINIB,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,9.7,8.97,0.2,7,9
2856578,CHEMBL5416410,DASATINIB,11691,CHEMBL2250,Tyrosine-protein kinase Blk,9.68,9.68,0.21,2,9
2856578,CHEMBL5416410,DASATINIB,30010,CHEMBL4134,Ephrin type-A receptor 8,9.62,9.62,0.24,2,9
2856578,CHEMBL5416410,DASATINIB,30019,CHEMBL3987,Ephrin type-A receptor 5,9.62,9.21,0.24,3,9
2856578,CHEMBL5416410,DASATINIB,18033,CHEMBL2073,Tyrosine-protein kinase Yes,9.52,9.22,0.3,6,9
2856578,CHEMBL5416410,DASATINIB,100424,CHEMBL4367,Tyrosine-protein kinase TXK,9.52,8.96,0.3,3,9
2856578,CHEMBL5416410,DASATINIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,9.51,9.21,0.31,4,9
2856578,CHEMBL5416410,DASATINIB,11785,CHEMBL3234,Tyrosine-protein kinase HCK,9.5,8.99,0.3162,4,9
2856578,CHEMBL5416410,DASATINIB,100129,CHEMBL5147,Ephrin type-B receptor 4,9.47,9.11,0.34,3,9
2856578,CHEMBL5416410,DASATINIB,11569,CHEMBL3290,Ephrin type-B receptor 2,9.41,8.89,0.39,4,9
2856578,CHEMBL5416410,DASATINIB,101079,CHEMBL5122,Discoidin domain-containing receptor 2,9.4,8.2,0.4,11,9
2856578,CHEMBL5416410,DASATINIB,30020,CHEMBL5072,Ephrin type-B receptor 1,9.35,9.35,0.45,2,9
2856578,CHEMBL5416410,DASATINIB,12627,CHEMBL2007,Platelet-derived growth factor receptor alpha,9.33,8.37,0.47,5,9
2856578,CHEMBL5416410,DASATINIB,30033,CHEMBL3984,Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase,9.3,7.23,0.5,8,9
2856578,CHEMBL5416410,DASATINIB,100127,CHEMBL4454,Tyrosine-protein kinase Fgr,9.3,8.97,0.5,3,9
2856578,CHEMBL5416410,DASATINIB,100917,CHEMBL5319,Epithelial discoidin domain-containing receptor 1,9.3,8.66,0.5,5,9
2856578,CHEMBL5416410,DASATINIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,9.24,8.48,0.57,25,9
2856578,CHEMBL5416410,DASATINIB,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,9.24,8.88,0.57,4,9
2856578,CHEMBL5416410,DASATINIB,12840,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,9.24,8.73,0.57,7,9
2856578,CHEMBL5416410,DASATINIB,197,CHEMBL1913,Platelet-derived growth factor receptor beta,9.2,8.28,0.63,5,9
2856578,CHEMBL5416410,DASATINIB,101508,CHEMBL5703,Tyrosine-protein kinase Srms,9.2,8.33,0.631,3,9
2856578,CHEMBL5416410,DASATINIB,101504,CHEMBL5699,Serine/threonine-protein kinase SIK2,9.1,8.32,0.7943,5,9
2856578,CHEMBL5416410,DASATINIB,30008,CHEMBL2068,Ephrin type-A receptor 2,9.07,8.32,0.85,5,9
2856578,CHEMBL5416410,DASATINIB,10844,CHEMBL2634,Tyrosine-protein kinase CSK,9.0,8.64,1.0,4,9
2856578,CHEMBL5416410,DASATINIB,30023,CHEMBL4599,Activated CDC42 kinase 1,9.0,8.29,1.0,8,9
2856578,CHEMBL5416410,DASATINIB,101433,CHEMBL6082,Serine/threonine-protein kinase SIK1,9.0,8.61,1.0,3,9
2856578,CHEMBL5416410,DASATINIB,30021,CHEMBL3988,Ephrin type-A receptor 4,8.92,8.66,1.2,3,9
2856578,CHEMBL5416410,DASATINIB,100097,CHEMBL5251,Tyrosine-protein kinase BTK,8.89,8.57,1.3,7,9
2856578,CHEMBL5416410,DASATINIB,30016,CHEMBL3834,Cytoplasmic tyrosine-protein kinase BMX,8.85,8.85,1.4,2,9
2856578,CHEMBL5416410,DASATINIB,20020,CHEMBL4355,Cyclin-G-associated kinase,8.59,8.23,2.6,5,9
2856578,CHEMBL5416410,DASATINIB,10371,CHEMBL4948,Dual specificity mitogen-activated protein kinase kinase 5,8.48,7.16,3.3,2,9
2856578,CHEMBL5416410,DASATINIB,101340,CHEMBL5810,Ephrin type-A receptor 1,8.39,8.2,4.1,3,9
2856578,CHEMBL5416410,DASATINIB,30026,CHEMBL4601,Protein-tyrosine kinase 6,8.3,8.01,5.012,6,9
2856578,CHEMBL5416410,DASATINIB,100128,CHEMBL5146,Breakpoint cluster region protein,8.3,8.3,5.0,1,9
2856578,CHEMBL5416410,DASATINIB,102770,CHEMBL6149,Serine/threonine-protein kinase SIK3,8.3,7.67,5.0,4,9
2856578,CHEMBL5416410,DASATINIB,100416,CHEMBL4901,Ephrin type-B receptor 3,8.16,7.95,6.9,3,9
2856578,CHEMBL5416410,DASATINIB,101130,CHEMBL5260,Serine/threonine-protein kinase TNNI3K,7.96,7.96,11.0,2,9
2856578,CHEMBL5416410,DASATINIB,100418,CHEMBL4246,Tyrosine-protein kinase Tec,7.89,7.42,13.0,4,9
2856578,CHEMBL5416410,DASATINIB,30049,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,7.8,7.13,15.85,4,9
2856578,CHEMBL5416410,DASATINIB,102678,CHEMBL5838,Receptor tyrosine-protein kinase erbB-3,7.75,7.75,18.0,1,8
2856578,CHEMBL5416410,DASATINIB,9,CHEMBL203,Epidermal growth factor receptor,7.7,6.7,20.0,29,9
2856578,CHEMBL5416410,DASATINIB,20025,CHEMBL5014,Receptor-interacting serine/threonine-protein kinase 2,7.7,7.42,20.0,4,9
2856578,CHEMBL5416410,DASATINIB,10188,CHEMBL260,Mitogen-activated protein kinase 14,7.57,6.9,27.0,8,9
2856578,CHEMBL5416410,DASATINIB,101030,CHEMBL5604,Dual specificity testis-specific protein kinase 1,7.48,7.38,33.0,3,9
2856578,CHEMBL5416410,DASATINIB,12699,CHEMBL3009,Receptor tyrosine-protein kinase erbB-4,7.4,7.33,39.81,2,8
2856578,CHEMBL5416410,DASATINIB,20007,CHEMBL3886,Mitogen-activated protein kinase kinase kinase 20,7.35,7.17,45.0,4,9
2856578,CHEMBL5416410,DASATINIB,101204,CHEMBL5476,Bone morphogenetic protein receptor type-1B,7.28,7.28,53.0,1,8
2856578,CHEMBL5416410,DASATINIB,30018,CHEMBL3836,LIM domain kinase 1,7.23,6.45,58.88,9,9
2856578,CHEMBL5416410,DASATINIB,105640,CHEMBL2331044,Myelin transcription factor 1,7.2,7.2,63.0,1,9
2856578,CHEMBL5416410,DASATINIB,10250,CHEMBL2428,"Myosin light chain kinase, smooth muscle",7.14,7.14,72.0,1,9
2856578,CHEMBL5416410,DASATINIB,101598,CHEMBL5903,Activin receptor type-1,7.1,6.51,79.43,3,9
2856578,CHEMBL5416410,DASATINIB,102799,CHEMBL6191,Mitogen-activated protein kinase kinase kinase 19,7.1,7.1,79.0,1,8
2856578,CHEMBL5416410,DASATINIB,101386,CHEMBL5932,LIM domain kinase 2,7.07,6.61,86.0,7,9
2856578,CHEMBL5416410,DASATINIB,12694,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,6.96,6.19,110.0,3,9
2856578,CHEMBL5416410,DASATINIB,102711,CHEMBL5914,Mitogen-activated protein kinase kinase kinase 2,6.85,6.26,140.0,2,9
2856578,CHEMBL5416410,DASATINIB,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,6.8,6.24,158.49,6,9
2856578,CHEMBL5416410,DASATINIB,10904,CHEMBL1906,RAF proto-oncogene serine/threonine-protein kinase,6.79,6.42,164.0,3,9
2856578,CHEMBL5416410,DASATINIB,101229,CHEMBL5550,"Atypical kinase COQ8A, mitochondrial",6.72,6.72,190.0,2,9
2856578,CHEMBL5416410,DASATINIB,10906,CHEMBL2599,Tyrosine-protein kinase SYK,6.7,5.85,199.53,4,9
2856578,CHEMBL5416410,DASATINIB,101069,CHEMBL5095,Wee1-like protein kinase 2,6.7,6.51,200.0,2,9
2856578,CHEMBL5416410,DASATINIB,30041,CHEMBL4312,Serine/threonine-protein kinase 36,6.68,6.68,210.0,2,9
2856578,CHEMBL5416410,DASATINIB,101220,CHEMBL5518,Misshapen-like kinase 1,6.68,6.38,209.0,3,9
2856578,CHEMBL5416410,DASATINIB,101473,CHEMBL5616,Activin receptor type-2A,6.68,6.68,210.0,2,9
2856578,CHEMBL5416410,DASATINIB,10918,CHEMBL2959,Tyrosine-protein kinase ITK/TSK,6.64,6.64,228.0,1,9
2856578,CHEMBL5416410,DASATINIB,13004,CHEMBL4439,TGF-beta receptor type-1,6.64,6.35,230.0,3,9
2856578,CHEMBL5416410,DASATINIB,100931,CHEMBL5364,Serine/threonine-protein kinase NLK,6.59,6.58,258.0,3,9
2856578,CHEMBL5416410,DASATINIB,101399,CHEMBL5970,Mitogen-activated protein kinase kinase kinase 3,6.55,6.55,280.0,1,8
2856578,CHEMBL5416410,DASATINIB,30050,CHEMBL4853,Mitogen-activated protein kinase kinase kinase 4,6.51,6.51,310.0,2,9
2856578,CHEMBL5416410,DASATINIB,100908,CHEMBL5310,Activin receptor type-1B,6.48,6.3,330.0,3,9
2856578,CHEMBL5416410,DASATINIB,11637,CHEMBL3384,Serine/threonine-protein kinase N1,6.45,6.45,359.0,1,9
2856578,CHEMBL5416410,DASATINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,6.41,6.08,390.0,8,9
2856578,CHEMBL5416410,DASATINIB,10120,CHEMBL3961,Mitogen-activated protein kinase 11,6.39,6.39,410.0,2,9
2856578,CHEMBL5416410,DASATINIB,100909,CHEMBL5311,Activin receptor type-1-like,6.34,6.34,460.0,2,9
2856578,CHEMBL5416410,DASATINIB,102473,CHEMBL5638,Serine/threonine-protein kinase Nek11,6.33,6.33,470.0,1,8
2856578,CHEMBL5416410,DASATINIB,100126,CHEMBL5145,Serine/threonine-protein kinase B-raf,6.3,6.27,500.0,4,9
2856578,CHEMBL5416410,DASATINIB,11082,CHEMBL2208,MAP kinase-activated protein kinase 2,6.27,6.27,538.0,1,9
2856578,CHEMBL5416410,DASATINIB,100992,CHEMBL5466,Activin receptor type-2B,6.24,6.03,570.0,3,9
2856578,CHEMBL5416410,DASATINIB,11409,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,6.2,6.07,630.96,3,9
2856578,CHEMBL5416410,DASATINIB,30035,CHEMBL4202,STE20-like serine/threonine-protein kinase,6.2,6.04,630.96,4,9
2856578,CHEMBL5416410,DASATINIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,6.19,6.19,640.0,1,8
2856578,CHEMBL5416410,DASATINIB,101188,CHEMBL5432,Mitogen-activated protein kinase kinase kinase kinase 3,6.19,6.02,640.0,3,9
2856578,CHEMBL5416410,DASATINIB,100951,CHEMBL5334,Non-receptor tyrosine-protein kinase TNK1,6.17,6.17,678.0,1,9
2856578,CHEMBL5416410,DASATINIB,12665,CHEMBL3920,Protein kinase C theta type,6.15,6.15,711.0,1,9
2856578,CHEMBL5416410,DASATINIB,100080,CHEMBL4482,Serine/threonine-protein kinase PAK 4,6.13,6.13,746.0,1,9
2856578,CHEMBL5416410,DASATINIB,101270,CHEMBL5651,Serine/threonine-protein kinase 35,6.11,6.11,770.0,1,8
2856578,CHEMBL5416410,DASATINIB,10266,CHEMBL3650,Fibroblast growth factor receptor 1,6.06,5.88,880.0,2,9
2856578,CHEMBL5416410,DASATINIB,101312,CHEMBL5749,Mitogen-activated protein kinase kinase kinase kinase 1,6.01,5.9,980.0,3,9
2856578,CHEMBL5416410,DASATINIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,6.0,5.97,1000.0,3,9
2856578,CHEMBL5416410,DASATINIB,101131,CHEMBL5261,Serine/threonine-protein kinase TAO1,6.0,6.0,1000.0,1,8
2856578,CHEMBL5416410,DASATINIB,10207,CHEMBL2918,cAMP-dependent protein kinase catalytic subunit beta,5.92,5.92,1215.0,1,9
2856578,CHEMBL5416410,DASATINIB,30006,CHEMBL3981,Serine/threonine-protein kinase 10,5.92,5.8,1200.0,3,9
2856578,CHEMBL5416410,DASATINIB,101041,CHEMBL5615,Serine/threonine-protein kinase MRCK gamma,5.92,5.92,1200.0,2,9
2856578,CHEMBL5416410,DASATINIB,103458,CHEMBL1163129,Serine/threonine-protein kinase SBK1,5.92,5.92,1200.0,1,8
2856578,CHEMBL5416410,DASATINIB,10781,CHEMBL2185,Aurora kinase B,5.9,5.9,1258.93,1,8
2856578,CHEMBL5416410,DASATINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,5.9,5.71,1258.93,4,8
2856578,CHEMBL5416410,DASATINIB,11926,CHEMBL2742,Fibroblast growth factor receptor 3,5.9,5.9,1258.93,1,8
2856578,CHEMBL5416410,DASATINIB,12276,CHEMBL3956,Mitogen-activated protein kinase kinase kinase 1,5.9,5.9,1263.0,1,9
2856578,CHEMBL5416410,DASATINIB,30047,CHEMBL4527,TRAF2 and NCK-interacting protein kinase,5.9,5.77,1262.0,3,9
2856578,CHEMBL5416410,DASATINIB,100851,CHEMBL4575,Dual specificity tyrosine-phosphorylation-regulated kinase 3,5.9,5.9,1258.93,1,8
2856578,CHEMBL5416410,DASATINIB,100918,CHEMBL5320,Myotonin-protein kinase,5.89,5.89,1300.0,2,9
2856578,CHEMBL5416410,DASATINIB,100947,CHEMBL5330,Mitogen-activated protein kinase kinase kinase kinase 2,5.89,5.82,1300.0,2,9
2856578,CHEMBL5416410,DASATINIB,10264,CHEMBL4142,Fibroblast growth factor receptor 2,5.85,5.85,1400.0,2,9
2856578,CHEMBL5416410,DASATINIB,11046,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,5.85,5.83,1400.0,3,9
2856578,CHEMBL5416410,DASATINIB,10967,CHEMBL4937,Casein kinase I isoform epsilon,5.82,5.75,1500.0,3,9
2856578,CHEMBL5416410,DASATINIB,100925,CHEMBL5358,eIF-2-alpha kinase GCN2,5.8,5.8,1600.0,2,9
2856578,CHEMBL5416410,DASATINIB,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.77,5.77,1683.7,1,8
2856578,CHEMBL5416410,DASATINIB,101613,CHEMBL5941,Serine/threonine-protein kinase 26,5.72,5.72,1900.0,2,9
2856578,CHEMBL5416410,DASATINIB,30003,CHEMBL3788,Serine/threonine-protein kinase PLK4,5.7,5.7,1995.26,1,8
2856578,CHEMBL5416410,DASATINIB,100069,CHEMBL5455,Tyrosine-protein kinase Fes/Fps,5.7,5.7,1995.26,1,8
2856578,CHEMBL5416410,DASATINIB,100410,CHEMBL4895,Tyrosine-protein kinase receptor UFO,5.7,5.7,1995.26,1,8
2856578,CHEMBL5416410,DASATINIB,100845,CHEMBL4516,Serine/threonine-protein kinase MRCK alpha,5.7,5.7,2000.0,2,9
2856578,CHEMBL5416410,DASATINIB,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,5.7,5.7,2000.0,1,9
2856578,CHEMBL5416410,DASATINIB,30046,CHEMBL4526,Ephrin type-A receptor 6,5.68,5.68,2100.0,1,8
2856578,CHEMBL5416410,DASATINIB,101053,CHEMBL5052,Serine/threonine-protein kinase MRCK beta,5.68,5.68,2100.0,2,9
2856578,CHEMBL5416410,DASATINIB,101506,CHEMBL5701,Serine/threonine-protein kinase TAO3,5.64,5.64,2300.0,1,8
2856578,CHEMBL5416410,DASATINIB,11873,CHEMBL2873,Mitogen-activated protein kinase kinase kinase 10,5.6,5.6,2511.89,1,8
2856578,CHEMBL5416410,DASATINIB,20014,CHEMBL4722,Aurora kinase A,5.58,5.58,2633.0,1,8
2856578,CHEMBL5416410,DASATINIB,100075,CHEMBL4267,TGF-beta receptor type-2,5.54,5.53,2900.0,3,9
2856578,CHEMBL5416410,DASATINIB,12704,CHEMBL3194,Transthyretin,5.51,5.51,3100.0,1,9
2856578,CHEMBL5416410,DASATINIB,101464,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,5.51,5.51,3100.0,2,9
2856578,CHEMBL5416410,DASATINIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,5.5,5.5,3200.0,1,8
2856578,CHEMBL5416410,DASATINIB,103855,CHEMBL1649059,Serine/threonine-protein kinase VRK2,5.5,5.5,3200.0,1,8
83245,CHEMBL54349,ALPIDEM,101532,CHEMBL5742,Translocator protein,9.3,9.0,0.5,4,9
83245,CHEMBL54349,ALPIDEM,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,6.72,6.52,191.8,2,8
83245,CHEMBL54349,ALPIDEM,10697,CHEMBL3253,Albumin,5.7,5.7,2000.0,1,9
543306,CHEMBL544665,FINGOLIMOD HYDROCHLORIDE,11631,CHEMBL4333,Sphingosine 1-phosphate receptor 1,5.52,5.52,3000.0,1,9
13618,CHEMBL545,ALCOHOL,78,CHEMBL1963,Thyrotropin receptor,7.5,7.5,31.6,2,9
13756,CHEMBL546,OXPRENOLOL,43,CHEMBL210,Beta-2 adrenergic receptor,8.33,8.33,4.7,1,8
13756,CHEMBL546,OXPRENOLOL,50,CHEMBL213,Beta-1 adrenergic receptor,8.18,8.18,6.6,1,8
13756,CHEMBL546,OXPRENOLOL,103668,CHEMBL1293235,Prelamin-A/C,6.9,6.9,125.9,1,9
13756,CHEMBL546,OXPRENOLOL,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.15,6.15,710.4,1,8
13756,CHEMBL546,OXPRENOLOL,125,CHEMBL229,Alpha-1A adrenergic receptor,5.52,5.52,2997.9,1,8
2882612,CHEMBL5465559,NYSTATIN,96,CHEMBL221,Prostaglandin G/H synthase 1,5.79,5.79,1630.0,1,8
13928,CHEMBL547,ISOTRETINOIN,119204,CHEMBL4523454,Olfactory receptor 51E2,6.8,6.8,160.0,1,9
13928,CHEMBL547,ISOTRETINOIN,11638,CHEMBL4040,Mitogen-activated protein kinase 1,6.33,6.33,462.0,1,8
13928,CHEMBL547,ISOTRETINOIN,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.27,6.17,540.0,2,8
13928,CHEMBL547,ISOTRETINOIN,280,CHEMBL256,Adenosine receptor A3,5.63,5.63,2357.0,1,8
13928,CHEMBL547,ISOTRETINOIN,103731,CHEMBL1293298,Peripheral myelin protein 22,5.62,5.62,2393.4,1,9
13928,CHEMBL547,ISOTRETINOIN,10188,CHEMBL260,Mitogen-activated protein kinase 14,5.6,5.6,2529.0,1,8
13928,CHEMBL547,ISOTRETINOIN,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.52,5.52,3019.0,1,8
14125,CHEMBL548,DINOPROSTONE,262,CHEMBL1836,Prostaglandin E2 receptor EP4 subtype,10.7,9.07,0.02,22,9
14125,CHEMBL548,DINOPROSTONE,10329,CHEMBL3710,Prostaglandin E2 receptor EP3 subtype,9.48,8.92,0.33,6,9
14125,CHEMBL548,DINOPROSTONE,142,CHEMBL1881,Prostaglandin E2 receptor EP2 subtype,8.99,8.14,1.03,18,9
14125,CHEMBL548,DINOPROSTONE,261,CHEMBL1811,Prostaglandin E2 receptor EP1 subtype,8.96,8.24,1.1,5,9
14125,CHEMBL548,DINOPROSTONE,78,CHEMBL1963,Thyrotropin receptor,8.0,8.0,10.0,2,9
14125,CHEMBL548,DINOPROSTONE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,7.0,7.0,100.0,1,9
14125,CHEMBL548,DINOPROSTONE,140,CHEMBL1987,Prostaglandin F2-alpha receptor,6.6,6.6,250.0,1,9
14125,CHEMBL548,DINOPROSTONE,143,CHEMBL1995,Prostacyclin receptor,6.58,6.52,260.0,2,9
14125,CHEMBL548,DINOPROSTONE,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,6.14,6.11,720.0,2,8
14367,CHEMBL549,CITALOPRAM,121,CHEMBL228,Sodium-dependent serotonin transporter,9.32,8.15,0.479,20,9
14367,CHEMBL549,CITALOPRAM,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,8.0,6.78,10.0,2,9
14367,CHEMBL549,CITALOPRAM,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.81,6.67,156.0,2,8
14367,CHEMBL549,CITALOPRAM,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.78,6.59,167.0,2,8
14367,CHEMBL549,CITALOPRAM,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.56,6.18,273.1,5,8
14367,CHEMBL549,CITALOPRAM,102,CHEMBL1941,Histamine H2 receptor,6.46,6.46,349.6,1,8
14367,CHEMBL549,CITALOPRAM,127,CHEMBL231,Histamine H1 receptor,6.43,5.8,371.0,4,8
14367,CHEMBL549,CITALOPRAM,125,CHEMBL229,Alpha-1A adrenergic receptor,5.96,5.96,1102.4,1,8
14367,CHEMBL549,CITALOPRAM,103665,CHEMBL1293232,Survival motor neuron protein,5.95,5.95,1122.0,1,9
14367,CHEMBL549,CITALOPRAM,103,CHEMBL223,Alpha-1D adrenergic receptor,5.79,5.79,1617.0,1,8
14367,CHEMBL549,CITALOPRAM,130,CHEMBL234,D(3) dopamine receptor,5.72,5.72,1900.0,1,8
14367,CHEMBL549,CITALOPRAM,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.67,5.67,2154.9,1,8
14367,CHEMBL549,CITALOPRAM,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.66,5.66,2178.0,2,8
84633,CHEMBL54976,TRYPTOPHAN,10567,CHEMBL2439,Myeloperoxidase,5.65,5.65,2250.0,1,9
3965,CHEMBL55,PENTAMIDINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.66,6.23,220.0,2,8
3965,CHEMBL55,PENTAMIDINE,10664,CHEMBL2118,Diamine oxidase [copper-containing],6.54,6.54,290.0,1,9
3965,CHEMBL55,PENTAMIDINE,100485,CHEMBL4162,Protein tyrosine phosphatase type IVA 3,6.52,6.52,300.0,1,9
3965,CHEMBL55,PENTAMIDINE,103108,CHEMBL1075169,Protein tyrosine phosphatase type IVA 1,6.52,6.52,300.0,1,9
3965,CHEMBL55,PENTAMIDINE,103155,CHEMBL1075105,Protein tyrosine phosphatase type IVA 2,6.52,6.52,300.0,1,9
3965,CHEMBL55,PENTAMIDINE,104067,CHEMBL1743126,Multidrug and toxin extrusion protein 1,6.39,5.89,410.0,3,9
3965,CHEMBL55,PENTAMIDINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.33,6.06,468.0,2,8
3965,CHEMBL55,PENTAMIDINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.29,5.98,507.0,3,8
3965,CHEMBL55,PENTAMIDINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.29,6.08,516.0,2,8
3965,CHEMBL55,PENTAMIDINE,10280,CHEMBL264,Histamine H3 receptor,6.19,6.19,643.2,1,8
3965,CHEMBL55,PENTAMIDINE,86,CHEMBL1951,Amine oxidase [flavin-containing] A,6.1,5.92,793.0,2,8
3965,CHEMBL55,PENTAMIDINE,100282,CHEMBL4300,Protein S100-B,6.0,6.0,1000.0,1,9
3965,CHEMBL55,PENTAMIDINE,12725,CHEMBL3018,Suppressor of tumorigenicity 14 protein,5.94,5.94,1160.0,1,8
3965,CHEMBL55,PENTAMIDINE,104063,CHEMBL1743122,Solute carrier family 22 member 2,5.92,5.92,1200.0,1,9
3965,CHEMBL55,PENTAMIDINE,104220,CHEMBL1795140,Transmembrane protease serine 2,5.92,5.92,1200.0,1,9
3965,CHEMBL55,PENTAMIDINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.88,5.73,1325.8,3,8
3965,CHEMBL55,PENTAMIDINE,130,CHEMBL234,D(3) dopamine receptor,5.87,5.87,1358.0,1,8
3965,CHEMBL55,PENTAMIDINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.76,5.76,1717.0,1,8
3965,CHEMBL55,PENTAMIDINE,12678,CHEMBL4286,Diamine acetyltransferase 1,5.7,5.7,2000.0,1,9
3965,CHEMBL55,PENTAMIDINE,129,CHEMBL233,Mu-type opioid receptor,5.68,5.68,2102.6,1,8
3965,CHEMBL55,PENTAMIDINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,5.68,5.61,2073.0,2,8
3965,CHEMBL55,PENTAMIDINE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.62,5.57,2395.0,3,8
3965,CHEMBL55,PENTAMIDINE,104068,CHEMBL1743127,Multidrug and toxin extrusion protein 2,5.57,5.57,2700.0,1,9
14406,CHEMBL550,PILOCARPINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.76,6.33,17.5,7,9
14406,CHEMBL550,PILOCARPINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.2,6.2,630.96,1,9
14406,CHEMBL550,PILOCARPINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.0,6.0,1000.0,1,9
14406,CHEMBL550,PILOCARPINE,109702,CHEMBL3542436,Cytochrome P450 2A13,5.85,5.68,1400.0,2,9
14406,CHEMBL550,PILOCARPINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,5.84,5.84,1445.44,1,9
14406,CHEMBL550,PILOCARPINE,20073,CHEMBL5282,Cytochrome P450 2A6,5.52,5.52,3000.0,1,9
564990,CHEMBL550348,DEFERASIROX,100283,CHEMBL5019,Flavin reductase (NADPH),5.77,5.77,1698.24,2,9
563451,CHEMBL550495,METHYLENE BLUE,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,5.8,5.8,1584.9,1,9
563451,CHEMBL550495,METHYLENE BLUE,20053,CHEMBL4096,Cellular tumor antigen p53,5.5,5.5,3162.3,1,9
565417,CHEMBL550755,FORODESINE HYDROCHLORIDE,12690,CHEMBL4338,Purine nucleoside phosphorylase,9.32,9.32,0.48,1,9
562404,CHEMBL551466,ACLIDINIUM BROMIDE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,10.15,9.53,0.07,5,9
562404,CHEMBL551466,ACLIDINIUM BROMIDE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,10.1,9.65,0.08,5,9
562404,CHEMBL551466,ACLIDINIUM BROMIDE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,10.1,9.43,0.08,4,9
562404,CHEMBL551466,ACLIDINIUM BROMIDE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,9.8,9.8,0.1585,1,9
562404,CHEMBL551466,ACLIDINIUM BROMIDE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,9.7,9.7,0.1995,1,9
562404,CHEMBL551466,ACLIDINIUM BROMIDE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.37,6.37,430.0,1,8
562404,CHEMBL551466,ACLIDINIUM BROMIDE,250,CHEMBL249,Substance-P receptor,6.3,6.3,496.7,1,8
562404,CHEMBL551466,ACLIDINIUM BROMIDE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.64,5.64,2270.4,1,8
562404,CHEMBL551466,ACLIDINIUM BROMIDE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.6,5.6,2500.0,1,8
14785,CHEMBL553,ERLOTINIB,9,CHEMBL203,Epidermal growth factor receptor,10.54,7.92,0.029,210,9
14785,CHEMBL553,ERLOTINIB,20020,CHEMBL4355,Cyclin-G-associated kinase,8.51,7.96,3.1,16,9
14785,CHEMBL553,ERLOTINIB,102678,CHEMBL5838,Receptor tyrosine-protein kinase erbB-3,8.0,6.98,10.0,2,9
14785,CHEMBL553,ERLOTINIB,30006,CHEMBL3981,Serine/threonine-protein kinase 10,7.72,7.15,19.0,5,9
14785,CHEMBL553,ERLOTINIB,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,7.7,6.58,19.95,34,9
14785,CHEMBL553,ERLOTINIB,102799,CHEMBL6191,Mitogen-activated protein kinase kinase kinase 19,7.6,7.6,25.0,1,8
14785,CHEMBL553,ERLOTINIB,30035,CHEMBL4202,STE20-like serine/threonine-protein kinase,7.58,7.05,26.0,5,9
14785,CHEMBL553,ERLOTINIB,96,CHEMBL221,Prostaglandin G/H synthase 1,7.41,7.41,38.8,1,8
14785,CHEMBL553,ERLOTINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,7.3,6.73,50.12,5,9
14785,CHEMBL553,ERLOTINIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,7.24,6.55,58.0,31,9
14785,CHEMBL553,ERLOTINIB,100126,CHEMBL5145,Serine/threonine-protein kinase B-raf,7.22,7.22,60.0,2,9
14785,CHEMBL553,ERLOTINIB,10371,CHEMBL4948,Dual specificity mitogen-activated protein kinase kinase 5,7.02,7.02,96.0,1,8
14785,CHEMBL553,ERLOTINIB,104146,CHEMBL1772932,Mitotic checkpoint serine/threonine-protein kinase BUB1,6.95,6.95,113.0,1,9
14785,CHEMBL553,ERLOTINIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,6.89,6.33,130.0,10,9
14785,CHEMBL553,ERLOTINIB,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,6.89,6.83,130.0,2,9
14785,CHEMBL553,ERLOTINIB,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,6.8,6.45,158.49,3,9
14785,CHEMBL553,ERLOTINIB,11691,CHEMBL2250,Tyrosine-protein kinase Blk,6.72,6.48,190.0,3,9
14785,CHEMBL553,ERLOTINIB,11209,CHEMBL4014,Tyrosine-protein kinase ABL2,6.7,6.64,200.0,3,9
14785,CHEMBL553,ERLOTINIB,12699,CHEMBL3009,Receptor tyrosine-protein kinase erbB-4,6.64,6.04,230.0,5,9
14785,CHEMBL553,ERLOTINIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,6.6,6.44,250.0,4,9
14785,CHEMBL553,ERLOTINIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,6.5,5.97,316.23,3,9
14785,CHEMBL553,ERLOTINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,6.48,6.07,330.0,6,9
14785,CHEMBL553,ERLOTINIB,20025,CHEMBL5014,Receptor-interacting serine/threonine-protein kinase 2,6.39,6.24,410.0,3,9
14785,CHEMBL553,ERLOTINIB,100104,CHEMBL5247,Integrin-linked protein kinase,6.37,6.37,430.0,1,9
14785,CHEMBL553,ERLOTINIB,30046,CHEMBL4526,Ephrin type-A receptor 6,6.36,6.2,440.0,4,9
14785,CHEMBL553,ERLOTINIB,10967,CHEMBL4937,Casein kinase I isoform epsilon,6.3,6.3,500.0,1,8
14785,CHEMBL553,ERLOTINIB,104065,CHEMBL1743124,Solute carrier organic anion transporter family member 2B1,6.28,6.27,530.0,2,9
14785,CHEMBL553,ERLOTINIB,101130,CHEMBL5260,Serine/threonine-protein kinase TNNI3K,6.24,6.24,570.0,2,9
14785,CHEMBL553,ERLOTINIB,20171,CHEMBL3935,Aurora kinase C,6.22,6.22,600.0,2,9
14785,CHEMBL553,ERLOTINIB,100951,CHEMBL5334,Non-receptor tyrosine-protein kinase TNK1,6.2,6.2,630.0,2,9
14785,CHEMBL553,ERLOTINIB,101239,CHEMBL5579,Citron Rho-interacting kinase,6.17,6.17,680.0,2,9
14785,CHEMBL553,ERLOTINIB,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,6.16,6.01,700.0,3,9
14785,CHEMBL553,ERLOTINIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,6.16,6.1,700.0,2,9
14785,CHEMBL553,ERLOTINIB,100835,CHEMBL4718,MAP kinase-interacting serine/threonine-protein kinase 1,6.16,6.16,690.0,2,9
14785,CHEMBL553,ERLOTINIB,30019,CHEMBL3987,Ephrin type-A receptor 5,6.15,6.15,710.0,1,8
14785,CHEMBL553,ERLOTINIB,10781,CHEMBL2185,Aurora kinase B,6.1,5.93,794.33,3,9
14785,CHEMBL553,ERLOTINIB,11752,CHEMBL1955,Vascular endothelial growth factor receptor 3,6.1,5.82,794.33,3,9
14785,CHEMBL553,ERLOTINIB,100917,CHEMBL5319,Epithelial discoidin domain-containing receptor 1,6.1,6.1,790.0,2,9
14785,CHEMBL553,ERLOTINIB,100906,CHEMBL5274,Tyrosine-protein kinase receptor Tie-1,6.07,6.07,850.0,2,9
14785,CHEMBL553,ERLOTINIB,101484,CHEMBL5627,Leukocyte tyrosine kinase receptor,6.05,5.93,890.0,3,9
14785,CHEMBL553,ERLOTINIB,101048,CHEMBL5047,Serine/threonine-protein kinase ULK3,6.04,6.04,920.0,1,8
14785,CHEMBL553,ERLOTINIB,30010,CHEMBL4134,Ephrin type-A receptor 8,6.03,6.03,940.0,2,9
14785,CHEMBL553,ERLOTINIB,103106,CHEMBL1075167,Homeodomain-interacting protein kinase 4,6.02,6.02,960.0,1,8
14785,CHEMBL553,ERLOTINIB,12037,CHEMBL2777,"Myosin light chain kinase 2, skeletal/cardiac muscle",6.01,6.01,970.0,2,9
14785,CHEMBL553,ERLOTINIB,100948,CHEMBL5331,Tyrosine-protein kinase Mer,6.01,6.01,980.0,1,8
14785,CHEMBL553,ERLOTINIB,11451,CHEMBL3717,Hepatocyte growth factor receptor,6.0,5.84,1000.0,3,8
14785,CHEMBL553,ERLOTINIB,30037,CHEMBL4204,MAP kinase-interacting serine/threonine-protein kinase 2,6.0,5.9,1000.0,3,9
14785,CHEMBL553,ERLOTINIB,104126,CHEMBL1770034,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,6.0,6.0,1000.0,1,8
14785,CHEMBL553,ERLOTINIB,30020,CHEMBL5072,Ephrin type-B receptor 1,5.96,5.96,1100.0,1,8
14785,CHEMBL553,ERLOTINIB,100127,CHEMBL4454,Tyrosine-protein kinase Fgr,5.96,5.96,1100.0,2,9
14785,CHEMBL553,ERLOTINIB,11678,CHEMBL301,Cyclin-dependent kinase 2,5.94,5.94,1140.0,2,9
14785,CHEMBL553,ERLOTINIB,30000,CHEMBL3830,AP2-associated protein kinase 1,5.92,5.92,1200.0,5,9
14785,CHEMBL553,ERLOTINIB,30042,CHEMBL4522,BMP-2-inducible protein kinase,5.92,5.86,1200.0,3,9
14785,CHEMBL553,ERLOTINIB,100417,CHEMBL4247,ALK tyrosine kinase receptor,5.92,5.81,1200.0,3,9
14785,CHEMBL553,ERLOTINIB,103458,CHEMBL1163129,Serine/threonine-protein kinase SBK1,5.92,5.92,1200.0,1,8
14785,CHEMBL553,ERLOTINIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,5.89,5.75,1300.0,8,9
14785,CHEMBL553,ERLOTINIB,100790,CHEMBL4376,Dual specificity tyrosine-phosphorylation-regulated kinase 2,5.89,5.89,1300.0,1,8
14785,CHEMBL553,ERLOTINIB,101220,CHEMBL5518,Misshapen-like kinase 1,5.89,5.89,1300.0,1,8
14785,CHEMBL553,ERLOTINIB,101333,CHEMBL5785,"Interferon-induced, double-stranded RNA-activated protein kinase",5.89,5.89,1300.0,2,9
14785,CHEMBL553,ERLOTINIB,197,CHEMBL1913,Platelet-derived growth factor receptor beta,5.85,5.78,1400.0,3,9
14785,CHEMBL553,ERLOTINIB,30027,CHEMBL4602,Ephrin type-A receptor 7,5.85,5.85,1400.0,2,9
14785,CHEMBL553,ERLOTINIB,10906,CHEMBL2599,Tyrosine-protein kinase SYK,5.8,5.8,1584.89,1,8
14785,CHEMBL553,ERLOTINIB,10979,CHEMBL1868,Vascular endothelial growth factor receptor 1,5.8,5.8,1584.89,1,8
14785,CHEMBL553,ERLOTINIB,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.79,5.79,1639.9,1,8
14785,CHEMBL553,ERLOTINIB,102676,CHEMBL5836,Ephrin type-B receptor 6,5.77,5.77,1700.0,1,8
14785,CHEMBL553,ERLOTINIB,11785,CHEMBL3234,Tyrosine-protein kinase HCK,5.75,5.75,1800.0,2,9
14785,CHEMBL553,ERLOTINIB,12627,CHEMBL2007,Platelet-derived growth factor receptor alpha,5.75,5.75,1800.0,2,9
14785,CHEMBL553,ERLOTINIB,100128,CHEMBL5146,Breakpoint cluster region protein,5.74,5.74,1832.0,1,9
14785,CHEMBL553,ERLOTINIB,10264,CHEMBL4142,Fibroblast growth factor receptor 2,5.72,5.72,1900.0,1,9
14785,CHEMBL553,ERLOTINIB,30003,CHEMBL3788,Serine/threonine-protein kinase PLK4,5.72,5.72,1900.0,1,8
14785,CHEMBL553,ERLOTINIB,101229,CHEMBL5550,"Atypical kinase COQ8A, mitochondrial",5.72,5.72,1900.0,2,9
14785,CHEMBL553,ERLOTINIB,11407,CHEMBL4179,Mitogen-activated protein kinase 9,5.7,5.7,2000.0,1,8
14785,CHEMBL553,ERLOTINIB,18033,CHEMBL2073,Tyrosine-protein kinase Yes,5.66,5.66,2200.0,2,9
14785,CHEMBL553,ERLOTINIB,20014,CHEMBL4722,Aurora kinase A,5.66,5.66,2200.0,2,9
14785,CHEMBL553,ERLOTINIB,100129,CHEMBL5147,Ephrin type-B receptor 4,5.66,5.66,2200.0,1,8
14785,CHEMBL553,ERLOTINIB,12276,CHEMBL3956,Mitogen-activated protein kinase kinase kinase 1,5.65,5.65,2247.0,1,9
14785,CHEMBL553,ERLOTINIB,101399,CHEMBL5970,Mitogen-activated protein kinase kinase kinase 3,5.64,5.64,2300.0,1,8
14785,CHEMBL553,ERLOTINIB,12694,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,5.62,5.62,2400.0,1,8
14785,CHEMBL553,ERLOTINIB,30009,CHEMBL4954,Ephrin type-A receptor 3,5.62,5.62,2400.0,2,9
14785,CHEMBL553,ERLOTINIB,10842,CHEMBL3032,Serine/threonine-protein kinase N2,5.6,5.6,2511.89,1,8
14785,CHEMBL553,ERLOTINIB,100415,CHEMBL4900,Serine/threonine-protein kinase D2,5.6,5.6,2511.89,1,8
14785,CHEMBL553,ERLOTINIB,101316,CHEMBL5753,"Atypical kinase COQ8B, mitochondrial",5.6,5.6,2500.0,2,9
14785,CHEMBL553,ERLOTINIB,101538,CHEMBL5759,Mitogen-activated protein kinase 4,5.6,5.6,2500.0,2,9
14785,CHEMBL553,ERLOTINIB,102711,CHEMBL5914,Mitogen-activated protein kinase kinase kinase 2,5.6,5.6,2500.0,1,8
14785,CHEMBL553,ERLOTINIB,101504,CHEMBL5699,Serine/threonine-protein kinase SIK2,5.58,5.58,2600.0,1,8
14785,CHEMBL553,ERLOTINIB,100918,CHEMBL5320,Myotonin-protein kinase,5.54,5.54,2900.0,2,9
14785,CHEMBL553,ERLOTINIB,103154,CHEMBL1075104,Leucine-rich repeat serine/threonine-protein kinase 2,5.54,5.54,2900.0,1,8
14785,CHEMBL553,ERLOTINIB,280,CHEMBL256,Adenosine receptor A3,5.52,5.52,3009.7,1,8
14785,CHEMBL553,ERLOTINIB,100856,CHEMBL5408,Serine/threonine-protein kinase TBK1,5.51,5.51,3100.0,1,8
14785,CHEMBL553,ERLOTINIB,116735,CHEMBL3769292,dCTP pyrophosphatase 1,5.51,5.51,3054.0,1,9
560078,CHEMBL553025,VINORELBINE,10184,CHEMBL2327,Substance-K receptor,6.27,6.03,535.55,2,8
560078,CHEMBL553025,VINORELBINE,17045,CHEMBL340,Cytochrome P450 3A4,6.0,6.0,1000.0,1,8
14805,CHEMBL554,LAPATINIB,9,CHEMBL203,Epidermal growth factor receptor,10.22,7.98,0.06,126,9
14805,CHEMBL554,LAPATINIB,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,8.8,7.62,1.585,58,9
14805,CHEMBL554,LAPATINIB,12699,CHEMBL3009,Receptor tyrosine-protein kinase erbB-4,7.6,7.09,25.12,9,9
14805,CHEMBL554,LAPATINIB,101233,CHEMBL5554,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,6.17,6.17,670.0,2,9
14805,CHEMBL554,LAPATINIB,11941,CHEMBL3268,Phosphatidylinositol 4-kinase beta,6.03,6.03,940.0,2,9
14805,CHEMBL554,LAPATINIB,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.0,6.0,1000.0,1,8
14805,CHEMBL554,LAPATINIB,10371,CHEMBL4948,Dual specificity mitogen-activated protein kinase kinase 5,5.96,5.96,1100.0,2,9
14805,CHEMBL554,LAPATINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,5.9,5.9,1258.93,1,8
14805,CHEMBL554,LAPATINIB,17045,CHEMBL340,Cytochrome P450 3A4,5.77,5.77,1700.0,1,9
14805,CHEMBL554,LAPATINIB,10781,CHEMBL2185,Aurora kinase B,5.7,5.7,1995.26,1,8
14805,CHEMBL554,LAPATINIB,30006,CHEMBL3981,Serine/threonine-protein kinase 10,5.58,5.58,2600.0,1,9
14805,CHEMBL554,LAPATINIB,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,5.5,5.5,3200.0,2,9
87251,CHEMBL55643,COPPER,103516,CHEMBL1250402,Transient receptor potential cation channel subfamily M member 2,5.58,5.58,2600.0,1,9
563655,CHEMBL557555,CIPROFIBRATE,163,CHEMBL239,Peroxisome proliferator-activated receptor alpha,6.05,6.05,900.0,2,9
563655,CHEMBL557555,CIPROFIBRATE,103668,CHEMBL1293235,Prelamin-A/C,5.55,5.55,2818.4,1,9
15958,CHEMBL558,MEXILETINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.14,6.04,724.0,2,8
15958,CHEMBL558,MEXILETINE,18072,CHEMBL4187,Sodium channel protein type 2 subunit alpha,5.54,5.54,2900.0,1,9
15958,CHEMBL558,MEXILETINE,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,5.52,5.52,3000.0,1,9
15990,CHEMBL559,DEXTROTHYROXINE,271,CHEMBL1947,Thyroid hormone receptor beta,8.25,8.25,5.6,1,9
15990,CHEMBL559,DEXTROTHYROXINE,103668,CHEMBL1293235,Prelamin-A/C,7.05,7.05,89.1,1,9
15990,CHEMBL559,DEXTROTHYROXINE,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",6.58,6.58,260.0,1,8
16308,CHEMBL563,FLURBIPROFEN,96,CHEMBL221,Prostaglandin G/H synthase 1,8.52,7.54,3.0,5,9
16308,CHEMBL563,FLURBIPROFEN,126,CHEMBL230,Prostaglandin G/H synthase 2,8.0,6.68,10.0,6,9
16308,CHEMBL563,FLURBIPROFEN,130,CHEMBL234,D(3) dopamine receptor,7.07,7.07,86.0,1,8
16308,CHEMBL563,FLURBIPROFEN,100481,CHEMBL4681,Aldo-keto reductase family 1 member C3,6.34,6.07,460.0,2,9
16308,CHEMBL563,FLURBIPROFEN,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.27,6.27,540.0,1,8
16308,CHEMBL563,FLURBIPROFEN,101351,CHEMBL5847,Aldo-keto reductase family 1 member C2,6.26,6.26,550.0,1,9
16308,CHEMBL563,FLURBIPROFEN,103829,CHEMBL1641347,Solute carrier family 22 member 6,5.82,5.82,1500.0,1,8
16308,CHEMBL563,FLURBIPROFEN,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.72,5.72,1900.0,1,8
16308,CHEMBL563,FLURBIPROFEN,101600,CHEMBL5905,Aldo-keto reductase family 1 member C1,5.69,5.69,2050.0,1,9
16308,CHEMBL563,FLURBIPROFEN,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.58,5.58,2600.0,1,8
16308,CHEMBL563,FLURBIPROFEN,101251,CHEMBL4999,Aldo-keto reductase family 1 member C4,5.53,5.53,2980.0,1,9
88882,CHEMBL56337,EPALRESTAT,242,CHEMBL1900,Aldo-keto reductase family 1 member B1,8.0,7.08,10.0,12,9
88882,CHEMBL56337,EPALRESTAT,10197,CHEMBL262,Glycogen synthase kinase-3 beta,7.68,7.68,21.0,1,9
88882,CHEMBL56337,EPALRESTAT,102631,CHEMBL5983,Aldo-keto reductase family 1 member B10,7.45,6.96,35.2,4,9
88882,CHEMBL56337,EPALRESTAT,11308,CHEMBL2246,Aldo-keto reductase family 1 member A1,6.49,5.88,325.0,3,9
88882,CHEMBL56337,EPALRESTAT,115,CHEMBL227,Type-1 angiotensin II receptor,5.82,5.82,1500.0,1,8
88882,CHEMBL56337,EPALRESTAT,102394,CHEMBL6020,Bile salt export pump,5.8,5.8,1600.0,1,8
85553,CHEMBL56367,NIMESULIDE,126,CHEMBL230,Prostaglandin G/H synthase 2,7.82,6.29,15.0,12,9
85553,CHEMBL56367,NIMESULIDE,96,CHEMBL221,Prostaglandin G/H synthase 1,7.29,6.6,50.7,2,9
85553,CHEMBL56367,NIMESULIDE,78,CHEMBL1963,Thyrotropin receptor,7.0,7.0,100.0,1,9
85553,CHEMBL56367,NIMESULIDE,103668,CHEMBL1293235,Prelamin-A/C,6.9,6.9,125.9,1,9
85553,CHEMBL56367,NIMESULIDE,10567,CHEMBL2439,Myeloperoxidase,5.68,5.68,2100.0,1,9
85553,CHEMBL56367,NIMESULIDE,12911,CHEMBL3397,Cytochrome P450 2C9,5.5,5.5,3162.28,2,9
85553,CHEMBL56367,NIMESULIDE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,5.5,5.5,3162.3,2,9
16391,CHEMBL564,PROMAZINE,127,CHEMBL231,Histamine H1 receptor,9.4,8.0,0.399,4,9
16391,CHEMBL564,PROMAZINE,103,CHEMBL223,Alpha-1D adrenergic receptor,8.21,8.05,6.18,2,8
16391,CHEMBL564,PROMAZINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.17,7.19,6.695,4,8
16391,CHEMBL564,PROMAZINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,8.07,7.61,8.418,3,8
16391,CHEMBL564,PROMAZINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,7.89,7.61,13.0,3,8
16391,CHEMBL564,PROMAZINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.86,7.49,13.8,3,8
16391,CHEMBL564,PROMAZINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.43,6.71,37.0,3,8
16391,CHEMBL564,PROMAZINE,78,CHEMBL1963,Thyrotropin receptor,7.4,7.4,39.8,1,9
16391,CHEMBL564,PROMAZINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,7.38,6.58,42.0,3,8
16391,CHEMBL564,PROMAZINE,121,CHEMBL228,Sodium-dependent serotonin transporter,7.34,7.21,46.0,2,8
16391,CHEMBL564,PROMAZINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,7.34,6.92,46.0,3,8
16391,CHEMBL564,PROMAZINE,11365,CHEMBL289,Cytochrome P450 2D6,7.3,6.86,50.1,5,9
16391,CHEMBL564,PROMAZINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.28,7.03,52.0,3,8
16391,CHEMBL564,PROMAZINE,130,CHEMBL234,D(3) dopamine receptor,7.16,6.99,69.0,3,8
16391,CHEMBL564,PROMAZINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,7.06,6.45,88.0,3,8
16391,CHEMBL564,PROMAZINE,102,CHEMBL1941,Histamine H2 receptor,6.96,6.02,110.8,3,8
16391,CHEMBL564,PROMAZINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.94,6.76,114.0,2,8
16391,CHEMBL564,PROMAZINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.93,6.39,117.0,3,8
16391,CHEMBL564,PROMAZINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.9,6.69,126.0,2,8
16391,CHEMBL564,PROMAZINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.9,6.69,127.0,3,8
16391,CHEMBL564,PROMAZINE,72,CHEMBL217,D(2) dopamine receptor,6.78,6.49,168.0,3,8
16391,CHEMBL564,PROMAZINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.72,6.61,192.4,3,8
16391,CHEMBL564,PROMAZINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.41,6.12,387.0,3,8
16391,CHEMBL564,PROMAZINE,90,CHEMBL219,D(4) dopamine receptor,6.26,6.26,551.3,1,8
16391,CHEMBL564,PROMAZINE,10624,CHEMBL3426,5-hydroxytryptamine receptor 5A,6.08,6.08,822.5,1,8
16391,CHEMBL564,PROMAZINE,88,CHEMBL2056,D(1A) dopamine receptor,5.97,5.83,1077.2,3,8
16391,CHEMBL564,PROMAZINE,12594,CHEMBL3356,Cytochrome P450 1A2,5.9,5.9,1258.93,1,8
16391,CHEMBL564,PROMAZINE,137,CHEMBL237,Kappa-type opioid receptor,5.7,5.7,1989.6,1,8
16391,CHEMBL564,PROMAZINE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,5.67,5.67,2155.6,1,8
16391,CHEMBL564,PROMAZINE,129,CHEMBL233,Mu-type opioid receptor,5.54,5.54,2900.0,1,8
16415,CHEMBL565,CLOFIBRATE,78,CHEMBL1963,Thyrotropin receptor,5.6,5.6,2511.9,1,9
574221,CHEMBL566315,OBETICHOLIC ACID,11180,CHEMBL2047,Bile acid receptor,8.0,6.78,10.0,34,9
574221,CHEMBL566315,OBETICHOLIC ACID,100857,CHEMBL5409,G-protein coupled bile acid receptor 1,7.62,6.5,23.7,6,9
573926,CHEMBL566534,ARTEMETHER,103668,CHEMBL1293235,Prelamin-A/C,6.25,6.25,562.3,1,9
574519,CHEMBL566752,FLORBETABEN F18,10656,CHEMBL2487,Amyloid-beta precursor protein,8.66,8.65,2.2,4,9
16505,CHEMBL567,PERPHENAZINE,72,CHEMBL217,D(2) dopamine receptor,9.52,8.64,0.3,2,9
16505,CHEMBL567,PERPHENAZINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.68,6.96,20.7,2,8
16505,CHEMBL567,PERPHENAZINE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,7.64,7.64,23.0,1,9
16505,CHEMBL567,PERPHENAZINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.59,7.59,25.8,1,8
16505,CHEMBL567,PERPHENAZINE,11365,CHEMBL289,Cytochrome P450 2D6,7.5,7.16,31.6,4,9
16505,CHEMBL567,PERPHENAZINE,12056,CHEMBL3257,Aldehyde oxidase,7.48,7.48,33.0,1,9
16505,CHEMBL567,PERPHENAZINE,130,CHEMBL234,D(3) dopamine receptor,7.41,7.41,39.0,1,8
16505,CHEMBL567,PERPHENAZINE,127,CHEMBL231,Histamine H1 receptor,7.38,7.38,42.0,1,8
16505,CHEMBL567,PERPHENAZINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.85,6.85,140.0,1,8
16505,CHEMBL567,PERPHENAZINE,12594,CHEMBL3356,Cytochrome P450 1A2,6.5,6.5,316.23,1,8
16505,CHEMBL567,PERPHENAZINE,103665,CHEMBL1293232,Survival motor neuron protein,6.4,5.97,398.1,2,9
16505,CHEMBL567,PERPHENAZINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.34,6.34,460.0,1,8
16505,CHEMBL567,PERPHENAZINE,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,6.28,6.28,524.21,1,9
16505,CHEMBL567,PERPHENAZINE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.15,6.15,707.9,1,9
16505,CHEMBL567,PERPHENAZINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.11,6.11,770.0,1,8
16505,CHEMBL567,PERPHENAZINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.05,6.05,900.0,1,8
16505,CHEMBL567,PERPHENAZINE,137,CHEMBL237,Kappa-type opioid receptor,5.98,5.98,1045.1,1,8
16505,CHEMBL567,PERPHENAZINE,17045,CHEMBL340,Cytochrome P450 3A4,5.6,5.6,2511.9,2,9
16505,CHEMBL567,PERPHENAZINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.57,5.57,2700.0,1,8
16505,CHEMBL567,PERPHENAZINE,43,CHEMBL210,Beta-2 adrenergic receptor,5.56,5.56,2777.1,1,9
16505,CHEMBL567,PERPHENAZINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.56,5.56,2774.51,1,9
16505,CHEMBL567,PERPHENAZINE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.54,5.54,2900.0,1,8
16505,CHEMBL567,PERPHENAZINE,100138,CHEMBL4843,CX3C chemokine receptor 1,5.53,5.53,2949.1,1,9
16505,CHEMBL567,PERPHENAZINE,12912,CHEMBL3622,Cytochrome P450 2C19,5.5,5.5,3162.3,1,9
16506,CHEMBL568,OXAZEPAM,103668,CHEMBL1293235,Prelamin-A/C,6.35,6.35,446.7,1,9
579689,CHEMBL569713,SCOPOLAMINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,9.15,8.25,0.7,11,9
579689,CHEMBL569713,SCOPOLAMINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,8.89,8.29,1.288,4,9
579689,CHEMBL569713,SCOPOLAMINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,8.89,8.32,1.288,2,9
579689,CHEMBL569713,SCOPOLAMINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,8.82,8.5,1.5,10,9
579689,CHEMBL569713,SCOPOLAMINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,8.72,8.34,1.9,3,9
4345,CHEMBL57,NEVIRAPINE,103668,CHEMBL1293235,Prelamin-A/C,7.45,7.45,35.5,1,9
4345,CHEMBL57,NEVIRAPINE,280,CHEMBL256,Adenosine receptor A3,5.99,5.99,1020.0,1,8
16584,CHEMBL570,TRIFLUPROMAZINE,130,CHEMBL234,D(3) dopamine receptor,8.52,8.52,3.0,1,8
16584,CHEMBL570,TRIFLUPROMAZINE,125,CHEMBL229,Alpha-1A adrenergic receptor,8.48,8.48,3.3,1,8
16584,CHEMBL570,TRIFLUPROMAZINE,88,CHEMBL2056,D(1A) dopamine receptor,7.77,7.77,17.1,1,8
16584,CHEMBL570,TRIFLUPROMAZINE,121,CHEMBL228,Sodium-dependent serotonin transporter,7.08,7.08,82.9,1,8
16584,CHEMBL570,TRIFLUPROMAZINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.97,6.97,108.0,1,8
16584,CHEMBL570,TRIFLUPROMAZINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.72,6.72,192.2,1,8
16584,CHEMBL570,TRIFLUPROMAZINE,11365,CHEMBL289,Cytochrome P450 2D6,6.4,6.25,398.1,4,9
16584,CHEMBL570,TRIFLUPROMAZINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.23,6.23,591.0,1,8
16584,CHEMBL570,TRIFLUPROMAZINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.18,6.18,654.3,1,8
16584,CHEMBL570,TRIFLUPROMAZINE,12594,CHEMBL3356,Cytochrome P450 1A2,6.1,5.95,794.33,2,8
16584,CHEMBL570,TRIFLUPROMAZINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.04,6.04,922.7,1,8
16584,CHEMBL570,TRIFLUPROMAZINE,129,CHEMBL233,Mu-type opioid receptor,5.71,5.71,1949.8,1,8
16591,CHEMBL571,KETOPROFEN,96,CHEMBL221,Prostaglandin G/H synthase 1,8.7,7.93,2.0,4,9
16591,CHEMBL571,KETOPROFEN,126,CHEMBL230,Prostaglandin G/H synthase 2,7.58,6.91,26.0,6,9
16591,CHEMBL571,KETOPROFEN,103665,CHEMBL1293232,Survival motor neuron protein,7.3,7.3,50.1,1,9
16591,CHEMBL571,KETOPROFEN,103668,CHEMBL1293235,Prelamin-A/C,6.5,6.5,316.2,1,9
16591,CHEMBL571,KETOPROFEN,103829,CHEMBL1641347,Solute carrier family 22 member 6,5.89,5.87,1300.0,2,8
579824,CHEMBL571546,TIRBANIBULIN,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,8.19,7.93,6.5,3,9
579824,CHEMBL571546,TIRBANIBULIN,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,7.0,7.0,100.0,1,9
16592,CHEMBL572,NITROFURANTOIN,104248,CHEMBL1795168,CDGSH iron-sulfur domain-containing protein 1,6.09,6.09,816.0,1,9
16592,CHEMBL572,NITROFURANTOIN,103668,CHEMBL1293235,Prelamin-A/C,6.0,6.0,1000.0,1,9
16656,CHEMBL573,NIACIN,100579,CHEMBL3785,Hydroxycarboxylic acid receptor 2,8.06,6.75,8.71,45,9
16716,CHEMBL575,METHICILLIN,170,CHEMBL241,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",5.55,5.55,2807.5,1,8
581798,CHEMBL576127,FENSPIRIDE,103668,CHEMBL1293235,Prelamin-A/C,8.46,8.46,3.5,1,9
573133,CHEMBL576982,QUIZARTINIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,9.7,8.01,0.2,118,9
573133,CHEMBL576982,QUIZARTINIB,197,CHEMBL1913,Platelet-derived growth factor receptor beta,8.8,8.05,1.6,10,9
573133,CHEMBL576982,QUIZARTINIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,8.8,7.93,1.6,26,9
573133,CHEMBL576982,QUIZARTINIB,12627,CHEMBL2007,Platelet-derived growth factor receptor alpha,8.8,7.9,1.6,10,9
573133,CHEMBL576982,QUIZARTINIB,12840,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,8.8,7.97,1.6,8,9
573133,CHEMBL576982,QUIZARTINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,8.8,8.06,1.6,20,9
573133,CHEMBL576982,QUIZARTINIB,19639,CHEMBL3778,Interleukin-1 receptor-associated kinase 4,8.69,8.69,2.06,2,9
573133,CHEMBL576982,QUIZARTINIB,11691,CHEMBL2250,Tyrosine-protein kinase Blk,7.68,7.68,20.7,2,9
573133,CHEMBL576982,QUIZARTINIB,11752,CHEMBL1955,Vascular endothelial growth factor receptor 3,7.42,7.39,38.0,6,9
573133,CHEMBL576982,QUIZARTINIB,10979,CHEMBL1868,Vascular endothelial growth factor receptor 1,7.39,7.32,41.0,6,9
573133,CHEMBL576982,QUIZARTINIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,7.24,6.42,57.8,4,9
573133,CHEMBL576982,QUIZARTINIB,100917,CHEMBL5319,Epithelial discoidin domain-containing receptor 1,7.09,7.07,81.0,6,9
573133,CHEMBL576982,QUIZARTINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,7.06,6.86,87.0,7,9
573133,CHEMBL576982,QUIZARTINIB,100413,CHEMBL4898,BDNF/NT-3 growth factors receptor,6.96,6.4,110.0,4,9
573133,CHEMBL576982,QUIZARTINIB,19623,CHEMBL3357,Interleukin-1 receptor-associated kinase 1,6.94,6.94,116.0,2,8
573133,CHEMBL576982,QUIZARTINIB,101079,CHEMBL5122,Discoidin domain-containing receptor 2,6.75,6.24,180.0,5,9
573133,CHEMBL576982,QUIZARTINIB,101034,CHEMBL5608,NT-3 growth factor receptor,6.7,6.37,200.0,4,9
573133,CHEMBL576982,QUIZARTINIB,30037,CHEMBL4204,MAP kinase-interacting serine/threonine-protein kinase 2,6.66,5.85,220.0,4,9
573133,CHEMBL576982,QUIZARTINIB,100833,CHEMBL5198,Mitogen-activated protein kinase 15,6.57,6.49,270.0,4,9
573133,CHEMBL576982,QUIZARTINIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,6.5,6.19,320.0,3,9
573133,CHEMBL576982,QUIZARTINIB,10781,CHEMBL2185,Aurora kinase B,6.5,6.5,320.0,1,9
573133,CHEMBL576982,QUIZARTINIB,103106,CHEMBL1075167,Homeodomain-interacting protein kinase 4,6.5,6.45,320.0,4,9
573133,CHEMBL576982,QUIZARTINIB,11902,CHEMBL2815,High affinity nerve growth factor receptor,6.41,5.83,390.0,4,9
573133,CHEMBL576982,QUIZARTINIB,101282,CHEMBL5684,"Muscle, skeletal receptor tyrosine-protein kinase",6.41,6.1,390.0,4,9
573133,CHEMBL576982,QUIZARTINIB,10250,CHEMBL2428,"Myosin light chain kinase, smooth muscle",6.39,6.39,410.0,2,9
573133,CHEMBL576982,QUIZARTINIB,12959,CHEMBL4627,Myosin light chain kinase,6.39,6.39,410.0,1,8
573133,CHEMBL576982,QUIZARTINIB,30049,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,6.36,6.28,440.0,4,9
573133,CHEMBL576982,QUIZARTINIB,102799,CHEMBL6191,Mitogen-activated protein kinase kinase kinase 19,6.35,5.86,450.0,4,9
573133,CHEMBL576982,QUIZARTINIB,100990,CHEMBL5464,Receptor-interacting serine/threonine-protein kinase 1,6.21,6.1,618.4,3,9
573133,CHEMBL576982,QUIZARTINIB,104279,CHEMBL1795199,Receptor-interacting serine/threonine-protein kinase 3,6.21,6.21,618.4,1,9
573133,CHEMBL576982,QUIZARTINIB,30006,CHEMBL3981,Serine/threonine-protein kinase 10,6.17,5.92,680.0,2,9
573133,CHEMBL576982,QUIZARTINIB,117351,CHEMBL4105746,Myosin-10,6.12,6.12,758.0,1,9
573133,CHEMBL576982,QUIZARTINIB,30047,CHEMBL4527,TRAF2 and NCK-interacting protein kinase,6.02,5.79,950.0,2,9
573133,CHEMBL576982,QUIZARTINIB,30035,CHEMBL4202,STE20-like serine/threonine-protein kinase,5.96,5.96,1100.0,1,9
573133,CHEMBL576982,QUIZARTINIB,102676,CHEMBL5836,Ephrin type-B receptor 6,5.92,5.91,1200.0,4,9
573133,CHEMBL576982,QUIZARTINIB,101220,CHEMBL5518,Misshapen-like kinase 1,5.8,5.8,1600.0,1,9
573133,CHEMBL576982,QUIZARTINIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,5.75,5.69,1800.0,4,9
573133,CHEMBL576982,QUIZARTINIB,101204,CHEMBL5476,Bone morphogenetic protein receptor type-1B,5.64,5.64,2302.0,1,9
573133,CHEMBL576982,QUIZARTINIB,101464,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,5.6,5.6,2500.0,3,9
573133,CHEMBL576982,QUIZARTINIB,20025,CHEMBL5014,Receptor-interacting serine/threonine-protein kinase 2,5.57,5.57,2700.0,1,8
573133,CHEMBL576982,QUIZARTINIB,30027,CHEMBL4602,Ephrin type-A receptor 7,5.52,5.52,3000.0,1,9
573133,CHEMBL576982,QUIZARTINIB,100906,CHEMBL5274,Tyrosine-protein kinase receptor Tie-1,5.5,5.5,3200.0,3,9
16759,CHEMBL577,ENALAPRILAT ANHYDROUS,69,CHEMBL1808,Angiotensin-converting enzyme,8.92,8.48,1.2,12,9
16847,CHEMBL578,ENALAPRIL,69,CHEMBL1808,Angiotensin-converting enzyme,8.35,6.87,4.5,8,8
16847,CHEMBL578,ENALAPRIL,103668,CHEMBL1293235,Prelamin-A/C,7.65,6.58,22.4,2,9
574539,CHEMBL578767,FLUMEXADOL,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.6,6.6,251.19,1,8
577065,CHEMBL579205,FLUTEMETAMOL,10656,CHEMBL2487,Amyloid-beta precursor protein,9.13,8.38,0.74,2,9
4504,CHEMBL58,MITOXANTRONE,12030,CHEMBL3004,Multidrug resistance-associated protein 1,8.82,8.48,1.5,4,9
4504,CHEMBL58,MITOXANTRONE,103689,CHEMBL1293256,Thrombopoietin,7.6,7.6,25.1,2,9
4504,CHEMBL58,MITOXANTRONE,103668,CHEMBL1293235,Prelamin-A/C,7.15,7.15,70.8,1,9
4504,CHEMBL58,MITOXANTRONE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.11,6.88,77.9,2,8
4504,CHEMBL58,MITOXANTRONE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,7.05,6.62,89.8,2,8
4504,CHEMBL58,MITOXANTRONE,11400,CHEMBL2842,Serine/threonine-protein kinase mTOR,6.83,6.83,146.9,1,9
4504,CHEMBL58,MITOXANTRONE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.74,6.44,180.3,2,8
4504,CHEMBL58,MITOXANTRONE,104067,CHEMBL1743126,Multidrug and toxin extrusion protein 1,6.72,6.47,190.0,3,9
4504,CHEMBL58,MITOXANTRONE,104068,CHEMBL1743127,Multidrug and toxin extrusion protein 2,6.28,6.18,530.0,2,9
4504,CHEMBL58,MITOXANTRONE,103665,CHEMBL1293232,Survival motor neuron protein,6.1,6.1,794.3,1,9
4504,CHEMBL58,MITOXANTRONE,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,6.04,6.04,903.8,1,9
4504,CHEMBL58,MITOXANTRONE,10475,CHEMBL4777,Neuropeptide Y receptor type 1,6.0,6.0,1000.0,1,8
4504,CHEMBL58,MITOXANTRONE,100097,CHEMBL5251,Tyrosine-protein kinase BTK,6.0,6.0,1000.0,1,9
4504,CHEMBL58,MITOXANTRONE,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,5.9,5.9,1257.9,1,8
4504,CHEMBL58,MITOXANTRONE,126,CHEMBL230,Prostaglandin G/H synthase 2,5.89,5.89,1300.0,1,8
4504,CHEMBL58,MITOXANTRONE,11398,CHEMBL4302,ATP-dependent translocase ABCB1,5.82,5.82,1501.0,1,9
4504,CHEMBL58,MITOXANTRONE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.73,5.73,1865.7,1,8
4504,CHEMBL58,MITOXANTRONE,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,5.7,5.7,1995.3,2,9
4504,CHEMBL58,MITOXANTRONE,20053,CHEMBL4096,Cellular tumor antigen p53,5.7,5.7,1995.3,1,9
4504,CHEMBL58,MITOXANTRONE,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,5.69,5.69,2035.2,1,8
4504,CHEMBL58,MITOXANTRONE,108005,CHEMBL3108645,Histone-lysine N-methyltransferase NSD2,5.63,5.63,2340.0,1,8
4504,CHEMBL58,MITOXANTRONE,137,CHEMBL237,Kappa-type opioid receptor,5.57,5.57,2700.4,1,8
4504,CHEMBL58,MITOXANTRONE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.53,5.53,2937.0,1,8
4504,CHEMBL58,MITOXANTRONE,101019,CHEMBL5568,Proto-oncogene tyrosine-protein kinase ROS,5.52,5.52,2998.7,1,9
4504,CHEMBL58,MITOXANTRONE,104062,CHEMBL1743121,Solute carrier organic anion transporter family member 1B3,5.51,5.51,3100.0,1,9
4504,CHEMBL58,MITOXANTRONE,12054,CHEMBL2903,Polyunsaturated fatty acid lipoxygenase ALOX15,5.5,5.5,3162.3,1,9
17025,CHEMBL582,ISOPROPYL ALCOHOL,103668,CHEMBL1293235,Prelamin-A/C,5.95,5.95,1122.0,1,9
88739,CHEMBL58323,LACOSAMIDE,18061,CHEMBL4296,Sodium channel protein type 9 subunit alpha,6.74,6.74,182.0,1,9
88739,CHEMBL58323,LACOSAMIDE,15,CHEMBL205,Carbonic anhydrase 2,6.48,6.48,331.0,1,9
88739,CHEMBL58323,LACOSAMIDE,11016,CHEMBL3969,"Carbonic anhydrase 5B, mitochondrial",6.47,6.47,341.0,1,9
88739,CHEMBL58323,LACOSAMIDE,12952,CHEMBL3594,Carbonic anhydrase 9,6.45,6.45,353.0,1,9
88739,CHEMBL58323,LACOSAMIDE,10193,CHEMBL261,Carbonic anhydrase 1,6.44,6.44,362.0,1,9
88739,CHEMBL58323,LACOSAMIDE,10139,CHEMBL2885,Carbonic anhydrase 3,6.43,6.43,374.0,1,9
88739,CHEMBL58323,LACOSAMIDE,10186,CHEMBL3025,Carbonic anhydrase 6,6.38,6.38,412.0,1,9
88739,CHEMBL58323,LACOSAMIDE,11063,CHEMBL3510,Carbonic anhydrase 14,6.33,6.33,473.0,1,9
88739,CHEMBL58323,LACOSAMIDE,12896,CHEMBL3729,Carbonic anhydrase 4,6.28,6.28,525.0,1,9
88739,CHEMBL58323,LACOSAMIDE,12923,CHEMBL3912,Carbonic anhydrase 13,5.92,5.92,1210.0,1,9
17224,CHEMBL584,NELFINAVIR,11398,CHEMBL4302,ATP-dependent translocase ABCB1,6.46,5.95,350.0,4,9
17224,CHEMBL584,NELFINAVIR,17045,CHEMBL340,Cytochrome P450 3A4,6.32,6.07,480.0,4,9
17224,CHEMBL584,NELFINAVIR,12739,CHEMBL3019,Cytochrome P450 3A5,6.24,6.24,570.0,1,9
17224,CHEMBL584,NELFINAVIR,280,CHEMBL256,Adenosine receptor A3,5.55,5.55,2842.0,1,8
17411,CHEMBL585,TRIAMTERENE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,7.6,7.6,25.1,1,9
17411,CHEMBL585,TRIAMTERENE,103668,CHEMBL1293235,Prelamin-A/C,7.35,7.35,44.7,1,9
17411,CHEMBL585,TRIAMTERENE,78,CHEMBL1963,Thyrotropin receptor,6.9,6.9,125.9,1,9
17411,CHEMBL585,TRIAMTERENE,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,6.65,6.65,223.9,2,9
17411,CHEMBL585,TRIAMTERENE,103688,CHEMBL1293255,15-hydroxyprostaglandin dehydrogenase [NAD(+)],6.15,5.88,707.9,2,9
17411,CHEMBL585,TRIAMTERENE,103659,CHEMBL1293226,Lysine-specific demethylase 4E,5.95,5.95,1122.0,1,9
17411,CHEMBL585,TRIAMTERENE,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,5.9,5.58,1258.9,5,9
17411,CHEMBL585,TRIAMTERENE,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,5.5,5.5,3162.3,2,9
19278,CHEMBL588,FENOLDOPAM,88,CHEMBL2056,D(1A) dopamine receptor,9.7,7.9,0.2,7,9
19278,CHEMBL588,FENOLDOPAM,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.88,6.88,130.3,1,8
19278,CHEMBL588,FENOLDOPAM,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.61,6.61,245.8,1,8
19278,CHEMBL588,FENOLDOPAM,121,CHEMBL228,Sodium-dependent serotonin transporter,6.48,6.48,334.1,1,8
19278,CHEMBL588,FENOLDOPAM,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.36,6.36,437.9,1,8
19278,CHEMBL588,FENOLDOPAM,130,CHEMBL234,D(3) dopamine receptor,6.18,6.03,660.0,2,8
19278,CHEMBL588,FENOLDOPAM,72,CHEMBL217,D(2) dopamine receptor,6.09,6.09,810.0,1,8
19278,CHEMBL588,FENOLDOPAM,102439,CHEMBL6136,Lysine-specific histone demethylase 1A,6.05,6.05,890.0,1,9
19278,CHEMBL588,FENOLDOPAM,103659,CHEMBL1293226,Lysine-specific demethylase 4E,5.72,5.62,1920.0,2,9
19316,CHEMBL589,ROPINIROLE,130,CHEMBL234,D(3) dopamine receptor,8.54,7.75,2.9,9,9
19316,CHEMBL589,ROPINIROLE,72,CHEMBL217,D(2) dopamine receptor,8.43,7.01,3.7,15,9
19316,CHEMBL589,ROPINIROLE,90,CHEMBL219,D(4) dopamine receptor,8.11,8.11,7.8,1,9
19316,CHEMBL589,ROPINIROLE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.85,6.85,141.25,1,9
19316,CHEMBL589,ROPINIROLE,17045,CHEMBL340,Cytochrome P450 3A4,6.5,6.5,316.2,2,9
19316,CHEMBL589,ROPINIROLE,137,CHEMBL237,Kappa-type opioid receptor,6.46,6.46,349.2,1,8
19316,CHEMBL589,ROPINIROLE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.77,5.77,1706.0,1,9
19316,CHEMBL589,ROPINIROLE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.56,5.56,2764.2,1,8
19316,CHEMBL589,ROPINIROLE,11365,CHEMBL289,Cytochrome P450 2D6,5.5,5.5,3162.28,2,9
598560,CHEMBL589586,MONOMETHYL FUMARATE,100579,CHEMBL3785,Hydroxycarboxylic acid receptor 2,9.02,7.88,0.96,2,9
4584,CHEMBL59,DOPAMINE,130,CHEMBL234,D(3) dopamine receptor,9.96,8.03,0.11,53,9
4584,CHEMBL59,DOPAMINE,72,CHEMBL217,D(2) dopamine receptor,9.17,7.22,0.67,74,9
4584,CHEMBL59,DOPAMINE,90,CHEMBL219,D(4) dopamine receptor,8.92,7.78,1.2,20,9
4584,CHEMBL59,DOPAMINE,220,CHEMBL1850,D(1B) dopamine receptor,8.7,6.98,2.0,3,9
4584,CHEMBL59,DOPAMINE,88,CHEMBL2056,D(1A) dopamine receptor,8.59,6.84,2.6,16,9
4584,CHEMBL59,DOPAMINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,8.18,8.18,6.63,1,9
4584,CHEMBL59,DOPAMINE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.49,6.49,325.0,1,8
4584,CHEMBL59,DOPAMINE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.35,6.13,446.7,2,9
4584,CHEMBL59,DOPAMINE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.34,6.06,460.0,3,9
4584,CHEMBL59,DOPAMINE,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,6.3,6.3,501.2,1,9
4584,CHEMBL59,DOPAMINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.28,6.28,521.1,1,8
4584,CHEMBL59,DOPAMINE,102780,CHEMBL6152,Alpha-synuclein,6.28,6.28,530.0,1,9
4584,CHEMBL59,DOPAMINE,96,CHEMBL221,Prostaglandin G/H synthase 1,6.14,6.14,726.5,1,8
4584,CHEMBL59,DOPAMINE,103657,CHEMBL1293224,Microtubule-associated protein tau,5.8,5.8,1584.9,1,9
4584,CHEMBL59,DOPAMINE,101361,CHEMBL5857,Trace amine-associated receptor 1,5.77,5.77,1710.0,1,9
4584,CHEMBL59,DOPAMINE,103669,CHEMBL1293236,ATP-dependent DNA helicase Q1,5.75,5.75,1778.3,1,9
4584,CHEMBL59,DOPAMINE,103659,CHEMBL1293226,Lysine-specific demethylase 4E,5.52,5.52,3000.0,1,9
4584,CHEMBL59,DOPAMINE,103689,CHEMBL1293256,Thrombopoietin,5.5,5.5,3162.3,2,9
19344,CHEMBL590,MENADIONE,12594,CHEMBL3356,Cytochrome P450 1A2,6.8,6.8,158.49,1,8
19344,CHEMBL590,MENADIONE,12056,CHEMBL3257,Aldehyde oxidase,6.7,6.28,200.0,3,9
19344,CHEMBL590,MENADIONE,100643,CHEMBL4685,"Indoleamine 2,3-dioxygenase 1",6.43,6.13,370.0,3,9
19344,CHEMBL590,MENADIONE,104,CHEMBL2039,Amine oxidase [flavin-containing] B,6.4,6.4,400.0,1,9
19344,CHEMBL590,MENADIONE,118080,CHEMBL4295835,Thiosulfate sulfurtransferase,6.0,6.0,1000.0,1,9
19344,CHEMBL590,MENADIONE,103665,CHEMBL1293232,Survival motor neuron protein,5.8,5.8,1584.9,1,9
19344,CHEMBL590,MENADIONE,11565,CHEMBL4804,M-phase inducer phosphatase 2,5.66,5.66,2200.0,1,8
19344,CHEMBL590,MENADIONE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,5.6,5.6,2511.9,1,9
19344,CHEMBL590,MENADIONE,12912,CHEMBL3622,Cytochrome P450 2C19,5.6,5.6,2511.89,2,9
19572,CHEMBL592,LEVORPHANOL,129,CHEMBL233,Mu-type opioid receptor,9.89,9.71,0.13,8,9
19572,CHEMBL592,LEVORPHANOL,137,CHEMBL237,Kappa-type opioid receptor,8.64,8.61,2.3,8,9
19572,CHEMBL592,LEVORPHANOL,136,CHEMBL236,Delta-type opioid receptor,8.54,8.39,2.9,11,9
19572,CHEMBL592,LEVORPHANOL,121,CHEMBL228,Sodium-dependent serotonin transporter,6.76,6.76,173.0,1,8
19737,CHEMBL595,PIOGLITAZONE,133,CHEMBL235,Peroxisome proliferator-activated receptor gamma,7.21,6.32,62.0,60,9
19737,CHEMBL595,PIOGLITAZONE,102394,CHEMBL6020,Bile salt export pump,7.0,6.55,100.0,7,9
19737,CHEMBL595,PIOGLITAZONE,15,CHEMBL205,Carbonic anhydrase 2,6.94,6.94,114.0,1,9
19737,CHEMBL595,PIOGLITAZONE,104,CHEMBL2039,Amine oxidase [flavin-containing] B,6.7,6.53,199.4,5,9
19737,CHEMBL595,PIOGLITAZONE,104248,CHEMBL1795168,CDGSH iron-sulfur domain-containing protein 1,6.43,6.43,370.0,1,9
19915,CHEMBL596,FENTANYL,129,CHEMBL233,Mu-type opioid receptor,10.29,8.46,0.051,23,9
19915,CHEMBL596,FENTANYL,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,9.41,7.93,0.39,2,9
19915,CHEMBL596,FENTANYL,136,CHEMBL236,Delta-type opioid receptor,6.82,6.36,150.03,8,9
19915,CHEMBL596,FENTANYL,137,CHEMBL237,Kappa-type opioid receptor,6.71,6.17,196.5,3,9
19915,CHEMBL596,FENTANYL,90,CHEMBL219,D(4) dopamine receptor,6.26,6.26,554.0,1,9
19915,CHEMBL596,FENTANYL,128,CHEMBL232,Alpha-1B adrenergic receptor,5.96,5.96,1100.0,1,9
19915,CHEMBL596,FENTANYL,125,CHEMBL229,Alpha-1A adrenergic receptor,5.85,5.85,1407.0,1,9
19915,CHEMBL596,FENTANYL,219,CHEMBL245,Muscarinic acetylcholine receptor M3,5.77,5.77,1700.0,1,8
19915,CHEMBL596,FENTANYL,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.74,5.74,1819.7,1,8
20131,CHEMBL597,PHENTOLAMINE,125,CHEMBL229,Alpha-1A adrenergic receptor,9.22,7.96,0.6,9,9
20131,CHEMBL597,PHENTOLAMINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,8.77,7.62,1.7,8,9
20131,CHEMBL597,PHENTOLAMINE,128,CHEMBL232,Alpha-1B adrenergic receptor,8.32,7.87,4.8,3,9
20131,CHEMBL597,PHENTOLAMINE,103,CHEMBL223,Alpha-1D adrenergic receptor,8.12,7.87,7.6,5,9
20131,CHEMBL597,PHENTOLAMINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,8.12,7.66,7.6,5,9
20131,CHEMBL597,PHENTOLAMINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,8.08,7.2,8.4,5,9
20131,CHEMBL597,PHENTOLAMINE,11684,CHEMBL3923,Nischarin,7.94,7.94,11.4,2,9
20131,CHEMBL597,PHENTOLAMINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.99,6.41,103.0,3,8
20131,CHEMBL597,PHENTOLAMINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.68,6.54,207.0,2,8
20131,CHEMBL597,PHENTOLAMINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.26,6.26,549.54,1,8
20131,CHEMBL597,PHENTOLAMINE,11365,CHEMBL289,Cytochrome P450 2D6,6.1,6.05,794.3,3,9
20131,CHEMBL597,PHENTOLAMINE,137,CHEMBL237,Kappa-type opioid receptor,5.72,5.72,1890.2,1,8
20131,CHEMBL597,PHENTOLAMINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.62,5.62,2422.0,1,8
20496,CHEMBL599,MELOXICAM,126,CHEMBL230,Prostaglandin G/H synthase 2,6.8,6.25,160.0,8,9
20496,CHEMBL599,MELOXICAM,96,CHEMBL221,Prostaglandin G/H synthase 1,5.88,5.8,1319.0,3,9
173,CHEMBL6,INDOMETHACIN,56,CHEMBL1871,Androgen receptor,9.85,9.85,0.14,1,9
173,CHEMBL6,INDOMETHACIN,96,CHEMBL221,Prostaglandin G/H synthase 1,9.85,7.13,0.14,75,9
173,CHEMBL6,INDOMETHACIN,126,CHEMBL230,Prostaglandin G/H synthase 2,9.85,6.5,0.14,100,9
173,CHEMBL6,INDOMETHACIN,119104,CHEMBL4523354,Nicotinate phosphoribosyltransferase,9.82,9.82,0.15,1,9
173,CHEMBL6,INDOMETHACIN,10040,CHEMBL2157,Interleukin-8,7.3,7.3,50.0,1,9
173,CHEMBL6,INDOMETHACIN,20174,CHEMBL5071,Prostaglandin D2 receptor 2,7.3,6.86,50.0,2,9
173,CHEMBL6,INDOMETHACIN,101472,CHEMBL6174,Cytochrome c oxidase subunit 2,7.16,6.69,70.0,2,9
173,CHEMBL6,INDOMETHACIN,248,CHEMBL1835,Thromboxane-A synthase,7.0,7.0,100.0,1,8
173,CHEMBL6,INDOMETHACIN,100481,CHEMBL4681,Aldo-keto reductase family 1 member C3,7.0,6.1,100.0,4,9
173,CHEMBL6,INDOMETHACIN,10697,CHEMBL3253,Albumin,6.16,6.16,700.0,1,9
173,CHEMBL6,INDOMETHACIN,101097,CHEMBL5162,Neuropeptide S receptor,5.8,5.8,1584.9,1,9
173,CHEMBL6,INDOMETHACIN,280,CHEMBL256,Adenosine receptor A3,5.76,5.76,1747.2,1,8
173,CHEMBL6,INDOMETHACIN,103829,CHEMBL1641347,Solute carrier family 22 member 6,5.52,5.52,3000.0,1,8
20881,CHEMBL600,ACETYLCYSTEINE,12054,CHEMBL2903,Polyunsaturated fatty acid lipoxygenase ALOX15,7.6,7.6,25.1,1,9
20881,CHEMBL600,ACETYLCYSTEINE,271,CHEMBL1947,Thyroid hormone receptor beta,6.25,6.25,562.3,1,9
20881,CHEMBL600,ACETYLCYSTEINE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,6.0,6.0,1000.0,2,9
20881,CHEMBL600,ACETYLCYSTEINE,103669,CHEMBL1293236,ATP-dependent DNA helicase Q1,5.85,5.85,1412.5,1,9
20881,CHEMBL600,ACETYLCYSTEINE,103665,CHEMBL1293232,Survival motor neuron protein,5.8,5.8,1584.9,1,9
20881,CHEMBL600,ACETYLCYSTEINE,126,CHEMBL230,Prostaglandin G/H synthase 2,5.62,5.62,2400.0,1,8
602271,CHEMBL601719,CRIZOTINIB,11451,CHEMBL3717,Hepatocyte growth factor receptor,9.7,8.3,0.2,61,9
602271,CHEMBL601719,CRIZOTINIB,100417,CHEMBL4247,ALK tyrosine kinase receptor,9.33,7.35,0.47,119,9
602271,CHEMBL601719,CRIZOTINIB,101019,CHEMBL5568,Proto-oncogene tyrosine-protein kinase ROS,9.22,8.11,0.6,20,9
602271,CHEMBL601719,CRIZOTINIB,101484,CHEMBL5627,Leukocyte tyrosine kinase receptor,8.74,8.33,1.8,2,9
602271,CHEMBL601719,CRIZOTINIB,100413,CHEMBL4898,BDNF/NT-3 growth factors receptor,8.7,7.72,2.0,4,9
602271,CHEMBL601719,CRIZOTINIB,11902,CHEMBL2815,High affinity nerve growth factor receptor,8.49,7.56,3.2,5,9
602271,CHEMBL601719,CRIZOTINIB,100410,CHEMBL4895,Tyrosine-protein kinase receptor UFO,8.48,7.23,3.3,5,9
602271,CHEMBL601719,CRIZOTINIB,100948,CHEMBL5331,Tyrosine-protein kinase Mer,8.47,8.46,3.4,2,9
602271,CHEMBL601719,CRIZOTINIB,101034,CHEMBL5608,NT-3 growth factor receptor,8.36,7.72,4.4,2,9
602271,CHEMBL601719,CRIZOTINIB,12913,CHEMBL4128,Angiopoietin-1 receptor,8.3,7.07,5.0,3,8
602271,CHEMBL601719,CRIZOTINIB,11379,CHEMBL2689,Macrophage-stimulating protein receptor,8.26,7.29,5.5,6,9
602271,CHEMBL601719,CRIZOTINIB,102676,CHEMBL5836,Ephrin type-B receptor 6,8.22,7.24,6.0,2,9
602271,CHEMBL601719,CRIZOTINIB,101282,CHEMBL5684,"Muscle, skeletal receptor tyrosine-protein kinase",8.04,7.34,9.1,2,9
602271,CHEMBL601719,CRIZOTINIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,8.0,6.81,10.0,18,9
602271,CHEMBL601719,CRIZOTINIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,7.96,6.49,11.0,5,9
602271,CHEMBL601719,CRIZOTINIB,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,7.96,7.51,10.99,4,9
602271,CHEMBL601719,CRIZOTINIB,11362,CHEMBL4005,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",7.96,7.96,11.0,1,9
602271,CHEMBL601719,CRIZOTINIB,30035,CHEMBL4202,STE20-like serine/threonine-protein kinase,7.75,6.84,18.0,2,9
602271,CHEMBL601719,CRIZOTINIB,100912,CHEMBL5314,Tyrosine-protein kinase receptor TYRO3,7.7,6.9,20.0,2,9
602271,CHEMBL601719,CRIZOTINIB,101055,CHEMBL5081,Interleukin-1 receptor-associated kinase 3,7.51,6.86,31.0,2,9
602271,CHEMBL601719,CRIZOTINIB,101312,CHEMBL5749,Mitogen-activated protein kinase kinase kinase kinase 1,7.41,6.56,39.0,2,9
602271,CHEMBL601719,CRIZOTINIB,30006,CHEMBL3981,Serine/threonine-protein kinase 10,7.36,6.46,44.0,2,9
602271,CHEMBL601719,CRIZOTINIB,19623,CHEMBL3357,Interleukin-1 receptor-associated kinase 1,7.31,7.31,49.0,1,8
602271,CHEMBL601719,CRIZOTINIB,101188,CHEMBL5432,Mitogen-activated protein kinase kinase kinase kinase 3,7.31,6.58,49.0,5,9
602271,CHEMBL601719,CRIZOTINIB,30008,CHEMBL2068,Ephrin type-A receptor 2,7.27,6.72,54.0,3,9
602271,CHEMBL601719,CRIZOTINIB,30046,CHEMBL4526,Ephrin type-A receptor 6,7.27,7.23,54.0,2,9
602271,CHEMBL601719,CRIZOTINIB,30003,CHEMBL3788,Serine/threonine-protein kinase PLK4,7.22,7.22,60.0,1,8
602271,CHEMBL601719,CRIZOTINIB,100129,CHEMBL5147,Ephrin type-B receptor 4,7.17,6.71,68.0,2,9
602271,CHEMBL601719,CRIZOTINIB,102711,CHEMBL5914,Mitogen-activated protein kinase kinase kinase 2,7.14,7.14,72.0,1,8
602271,CHEMBL601719,CRIZOTINIB,10781,CHEMBL2185,Aurora kinase B,7.12,6.52,76.0,2,9
602271,CHEMBL601719,CRIZOTINIB,30049,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,7.1,6.53,79.0,2,9
602271,CHEMBL601719,CRIZOTINIB,100947,CHEMBL5330,Mitogen-activated protein kinase kinase kinase kinase 2,7.1,6.92,80.0,2,9
602271,CHEMBL601719,CRIZOTINIB,20014,CHEMBL4722,Aurora kinase A,7.05,6.64,89.24,3,9
602271,CHEMBL601719,CRIZOTINIB,35,CHEMBL1981,Insulin receptor,6.99,6.28,102.0,6,9
602271,CHEMBL601719,CRIZOTINIB,11691,CHEMBL2250,Tyrosine-protein kinase Blk,6.96,6.96,110.0,1,8
602271,CHEMBL601719,CRIZOTINIB,100906,CHEMBL5274,Tyrosine-protein kinase receptor Tie-1,6.96,6.96,110.0,1,8
602271,CHEMBL601719,CRIZOTINIB,101130,CHEMBL5260,Serine/threonine-protein kinase TNNI3K,6.96,6.96,110.0,1,8
602271,CHEMBL601719,CRIZOTINIB,101399,CHEMBL5970,Mitogen-activated protein kinase kinase kinase 3,6.96,6.96,110.0,1,8
602271,CHEMBL601719,CRIZOTINIB,30020,CHEMBL5072,Ephrin type-B receptor 1,6.92,6.92,120.0,1,8
602271,CHEMBL601719,CRIZOTINIB,101503,CHEMBL5698,NUAK family SNF1-like kinase 2,6.92,6.92,120.0,1,8
602271,CHEMBL601719,CRIZOTINIB,101340,CHEMBL5810,Ephrin type-A receptor 1,6.85,6.85,140.0,1,8
602271,CHEMBL601719,CRIZOTINIB,104312,CHEMBL1908381,Peripheral plasma membrane protein CASK,6.85,6.85,140.0,1,8
602271,CHEMBL601719,CRIZOTINIB,234,CHEMBL1957,Insulin-like growth factor 1 receptor,6.84,6.47,143.0,2,9
602271,CHEMBL601719,CRIZOTINIB,101499,CHEMBL5671,Protein delta homolog 1,6.77,6.77,170.0,1,9
602271,CHEMBL601719,CRIZOTINIB,104320,CHEMBL1908389,Mitogen-activated protein kinase kinase kinase 12,6.77,6.77,170.0,1,8
602271,CHEMBL601719,CRIZOTINIB,100995,CHEMBL5469,Protein-tyrosine kinase 2-beta,6.72,6.72,190.0,1,8
602271,CHEMBL601719,CRIZOTINIB,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,6.7,6.29,200.0,2,9
602271,CHEMBL601719,CRIZOTINIB,101504,CHEMBL5699,Serine/threonine-protein kinase SIK2,6.7,6.7,200.0,1,8
602271,CHEMBL601719,CRIZOTINIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,6.68,6.12,210.0,7,8
602271,CHEMBL601719,CRIZOTINIB,12694,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,6.68,6.09,210.0,3,9
602271,CHEMBL601719,CRIZOTINIB,12840,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,6.68,6.68,210.0,1,8
602271,CHEMBL601719,CRIZOTINIB,104428,CHEMBL1938217,Mixed lineage kinase domain-like protein,6.66,6.66,217.0,3,9
602271,CHEMBL601719,CRIZOTINIB,101204,CHEMBL5476,Bone morphogenetic protein receptor type-1B,6.64,6.64,230.0,1,8
602271,CHEMBL601719,CRIZOTINIB,103453,CHEMBL1163124,Mitogen-activated protein kinase kinase kinase 13,6.64,6.64,230.0,1,8
602271,CHEMBL601719,CRIZOTINIB,101073,CHEMBL5116,Uncharacterized serine/threonine-protein kinase SBK3,6.62,6.62,240.0,1,8
602271,CHEMBL601719,CRIZOTINIB,30007,CHEMBL3982,Tyrosine-protein kinase Fer,6.57,6.57,270.0,1,8
602271,CHEMBL601719,CRIZOTINIB,30010,CHEMBL4134,Ephrin type-A receptor 8,6.55,6.55,280.0,1,8
602271,CHEMBL601719,CRIZOTINIB,11242,CHEMBL2695,Focal adhesion kinase 1,6.51,6.37,310.0,2,9
602271,CHEMBL601719,CRIZOTINIB,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.5,6.04,316.1,2,8
602271,CHEMBL601719,CRIZOTINIB,100951,CHEMBL5334,Non-receptor tyrosine-protein kinase TNK1,6.5,6.5,320.0,1,8
602271,CHEMBL601719,CRIZOTINIB,10919,CHEMBL2835,Tyrosine-protein kinase JAK1,6.48,6.37,330.0,2,9
602271,CHEMBL601719,CRIZOTINIB,12829,CHEMBL3055,Cyclin-dependent kinase 7,6.48,6.48,330.0,1,8
602271,CHEMBL601719,CRIZOTINIB,101281,CHEMBL5683,Serine/threonine-protein kinase DCLK1,6.48,6.48,330.0,1,8
602271,CHEMBL601719,CRIZOTINIB,30021,CHEMBL3988,Ephrin type-A receptor 4,6.44,6.44,360.0,1,8
602271,CHEMBL601719,CRIZOTINIB,101221,CHEMBL5519,Serine/threonine-protein kinase DCLK2,6.43,6.43,370.0,1,8
602271,CHEMBL601719,CRIZOTINIB,101030,CHEMBL5604,Dual specificity testis-specific protein kinase 1,6.42,6.42,380.0,1,8
602271,CHEMBL601719,CRIZOTINIB,100976,CHEMBL5416,Cyclin-dependent kinase 11A,6.38,6.38,420.0,1,8
602271,CHEMBL601719,CRIZOTINIB,11209,CHEMBL4014,Tyrosine-protein kinase ABL2,6.37,6.36,427.0,2,9
602271,CHEMBL601719,CRIZOTINIB,101598,CHEMBL5903,Activin receptor type-1,6.36,6.36,440.0,1,8
602271,CHEMBL601719,CRIZOTINIB,100069,CHEMBL5455,Tyrosine-protein kinase Fes/Fps,6.35,6.35,450.0,1,8
602271,CHEMBL601719,CRIZOTINIB,104317,CHEMBL1908386,Dual serine/threonine and tyrosine protein kinase,6.35,6.35,450.0,1,8
602271,CHEMBL601719,CRIZOTINIB,30027,CHEMBL4602,Ephrin type-A receptor 7,6.33,6.33,470.0,1,8
602271,CHEMBL601719,CRIZOTINIB,101506,CHEMBL5701,Serine/threonine-protein kinase TAO3,6.31,6.31,490.0,1,8
602271,CHEMBL601719,CRIZOTINIB,10885,CHEMBL2595,Serine/threonine-protein kinase D3,6.29,6.17,510.0,2,9
602271,CHEMBL601719,CRIZOTINIB,100917,CHEMBL5319,Epithelial discoidin domain-containing receptor 1,6.29,6.29,510.0,1,8
602271,CHEMBL601719,CRIZOTINIB,100949,CHEMBL5332,Mitogen-activated protein kinase 7,6.29,6.29,510.0,1,8
602271,CHEMBL601719,CRIZOTINIB,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,6.25,6.25,560.0,1,8
602271,CHEMBL601719,CRIZOTINIB,30024,CHEMBL4598,Serine/threonine-protein kinase 4,6.24,6.24,580.0,1,8
602271,CHEMBL601719,CRIZOTINIB,101211,CHEMBL5483,Insulin receptor-related protein,6.22,6.22,600.0,1,8
602271,CHEMBL601719,CRIZOTINIB,101270,CHEMBL5651,Serine/threonine-protein kinase 35,6.21,6.21,610.0,1,8
602271,CHEMBL601719,CRIZOTINIB,12944,CHEMBL4501,Ribosomal protein S6 kinase beta-1,6.19,6.19,640.0,1,8
602271,CHEMBL601719,CRIZOTINIB,9,CHEMBL203,Epidermal growth factor receptor,6.17,5.77,681.0,3,9
602271,CHEMBL601719,CRIZOTINIB,100127,CHEMBL4454,Tyrosine-protein kinase Fgr,6.17,6.17,670.0,1,8
602271,CHEMBL601719,CRIZOTINIB,30009,CHEMBL4954,Ephrin type-A receptor 3,6.16,6.16,700.0,1,8
602271,CHEMBL601719,CRIZOTINIB,100856,CHEMBL5408,Serine/threonine-protein kinase TBK1,6.16,6.16,690.0,1,8
602271,CHEMBL601719,CRIZOTINIB,101386,CHEMBL5932,LIM domain kinase 2,6.16,6.16,690.0,1,8
602271,CHEMBL601719,CRIZOTINIB,12915,CHEMBL3529,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,6.15,5.86,710.0,2,9
602271,CHEMBL601719,CRIZOTINIB,125,CHEMBL229,Alpha-1A adrenergic receptor,6.13,6.04,745.2,2,8
602271,CHEMBL601719,CRIZOTINIB,30042,CHEMBL4522,BMP-2-inducible protein kinase,6.13,6.13,740.0,1,8
602271,CHEMBL601719,CRIZOTINIB,30023,CHEMBL4599,Activated CDC42 kinase 1,6.12,6.12,760.0,1,8
602271,CHEMBL601719,CRIZOTINIB,101338,CHEMBL5808,Cyclin-dependent kinase 11B,6.12,6.12,760.0,1,8
602271,CHEMBL601719,CRIZOTINIB,18033,CHEMBL2073,Tyrosine-protein kinase Yes,6.11,6.11,770.0,1,8
602271,CHEMBL601719,CRIZOTINIB,101226,CHEMBL5547,Ankyrin repeat and protein kinase domain-containing protein 1,6.11,6.11,780.0,1,8
602271,CHEMBL601719,CRIZOTINIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,6.1,6.1,800.0,1,8
602271,CHEMBL601719,CRIZOTINIB,30030,CHEMBL5257,Serine/threonine-protein kinase Nek9,6.1,6.1,790.0,1,8
602271,CHEMBL601719,CRIZOTINIB,30018,CHEMBL3836,LIM domain kinase 1,6.08,5.9,830.0,2,9
602271,CHEMBL601719,CRIZOTINIB,100424,CHEMBL4367,Tyrosine-protein kinase TXK,6.07,6.07,850.0,1,8
602271,CHEMBL601719,CRIZOTINIB,100908,CHEMBL5310,Activin receptor type-1B,6.07,6.07,860.0,1,8
602271,CHEMBL601719,CRIZOTINIB,20025,CHEMBL5014,Receptor-interacting serine/threonine-protein kinase 2,6.05,6.05,900.0,1,8
602271,CHEMBL601719,CRIZOTINIB,103140,CHEMBL1075195,Serine/threonine-protein kinase TAO2,6.05,6.05,900.0,1,8
602271,CHEMBL601719,CRIZOTINIB,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,6.03,6.03,940.0,1,8
602271,CHEMBL601719,CRIZOTINIB,102799,CHEMBL6191,Mitogen-activated protein kinase kinase kinase 19,6.01,6.01,980.0,1,8
602271,CHEMBL601719,CRIZOTINIB,10277,CHEMBL4708,Serine/threonine-protein kinase 3,6.0,6.0,990.0,1,8
602271,CHEMBL601719,CRIZOTINIB,10903,CHEMBL3863,Serine/threonine-protein kinase D1,6.0,6.0,990.0,1,8
602271,CHEMBL601719,CRIZOTINIB,13004,CHEMBL4439,TGF-beta receptor type-1,6.0,6.0,1000.0,1,8
602271,CHEMBL601719,CRIZOTINIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,6.0,5.77,1000.0,2,9
602271,CHEMBL601719,CRIZOTINIB,30019,CHEMBL3987,Ephrin type-A receptor 5,6.0,6.0,1000.0,1,8
602271,CHEMBL601719,CRIZOTINIB,100990,CHEMBL5464,Receptor-interacting serine/threonine-protein kinase 1,6.0,5.85,1000.0,5,9
602271,CHEMBL601719,CRIZOTINIB,101411,CHEMBL6006,Serine/threonine-protein kinase ULK1,6.0,6.0,1000.0,1,8
602271,CHEMBL601719,CRIZOTINIB,12276,CHEMBL3956,Mitogen-activated protein kinase kinase kinase 1,5.96,5.85,1100.0,2,9
602271,CHEMBL601719,CRIZOTINIB,101316,CHEMBL5753,"Atypical kinase COQ8B, mitochondrial",5.96,5.96,1100.0,1,8
602271,CHEMBL601719,CRIZOTINIB,101333,CHEMBL5785,"Interferon-induced, double-stranded RNA-activated protein kinase",5.96,5.96,1100.0,1,8
602271,CHEMBL601719,CRIZOTINIB,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.92,5.92,1195.8,1,8
602271,CHEMBL601719,CRIZOTINIB,101131,CHEMBL5261,Serine/threonine-protein kinase TAO1,5.92,5.92,1200.0,1,8
602271,CHEMBL601719,CRIZOTINIB,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,5.89,5.89,1300.0,1,8
602271,CHEMBL601719,CRIZOTINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,5.89,5.79,1300.0,2,8
602271,CHEMBL601719,CRIZOTINIB,103458,CHEMBL1163129,Serine/threonine-protein kinase SBK1,5.89,5.89,1300.0,1,8
602271,CHEMBL601719,CRIZOTINIB,100918,CHEMBL5320,Myotonin-protein kinase,5.85,5.85,1400.0,1,8
602271,CHEMBL601719,CRIZOTINIB,30032,CHEMBL5284,Calcium/calmodulin-dependent protein kinase kinase 2,5.82,5.82,1500.0,1,8
602271,CHEMBL601719,CRIZOTINIB,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.8,5.8,1584.9,1,8
602271,CHEMBL601719,CRIZOTINIB,101191,CHEMBL5435,Serine/threonine-protein kinase ULK2,5.8,5.8,1600.0,1,8
602271,CHEMBL601719,CRIZOTINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,5.79,5.79,1630.9,1,8
602271,CHEMBL601719,CRIZOTINIB,100789,CHEMBL4375,SRSF protein kinase 1,5.75,5.75,1800.0,1,8
602271,CHEMBL601719,CRIZOTINIB,101324,CHEMBL5776,Mitogen-activated protein kinase kinase kinase 7,5.75,5.75,1800.0,1,8
602271,CHEMBL601719,CRIZOTINIB,117312,CHEMBL4105707,Acyl-CoA dehydrogenase family member 11,5.72,5.72,1916.0,1,9
602271,CHEMBL601719,CRIZOTINIB,10918,CHEMBL2959,Tyrosine-protein kinase ITK/TSK,5.7,5.7,2000.0,1,8
602271,CHEMBL601719,CRIZOTINIB,101309,CHEMBL5728,Cyclin-dependent kinase-like 2,5.68,5.68,2100.0,1,8
602271,CHEMBL601719,CRIZOTINIB,101434,CHEMBL6083,Receptor-interacting serine/threonine-protein kinase 4,5.68,5.68,2100.0,1,8
602271,CHEMBL601719,CRIZOTINIB,104279,CHEMBL1795199,Receptor-interacting serine/threonine-protein kinase 3,5.67,5.67,2120.0,1,9
602271,CHEMBL601719,CRIZOTINIB,10979,CHEMBL1868,Vascular endothelial growth factor receptor 1,5.64,5.64,2300.0,1,8
602271,CHEMBL601719,CRIZOTINIB,30000,CHEMBL3830,AP2-associated protein kinase 1,5.64,5.64,2300.0,1,8
602271,CHEMBL601719,CRIZOTINIB,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.63,5.63,2352.3,1,8
602271,CHEMBL601719,CRIZOTINIB,11364,CHEMBL4045,5'-AMP-activated protein kinase catalytic subunit alpha-1,5.62,5.62,2400.0,1,8
602271,CHEMBL601719,CRIZOTINIB,100128,CHEMBL5146,Breakpoint cluster region protein,5.61,5.61,2485.0,1,9
602271,CHEMBL601719,CRIZOTINIB,10906,CHEMBL2599,Tyrosine-protein kinase SYK,5.6,5.6,2500.0,1,8
602271,CHEMBL601719,CRIZOTINIB,11926,CHEMBL2742,Fibroblast growth factor receptor 3,5.57,5.57,2700.0,1,8
602271,CHEMBL601719,CRIZOTINIB,101613,CHEMBL5941,Serine/threonine-protein kinase 26,5.55,5.55,2800.0,1,8
602271,CHEMBL601719,CRIZOTINIB,103456,CHEMBL1163127,Mitogen-activated protein kinase kinase kinase 15,5.55,5.55,2800.0,1,8
602271,CHEMBL601719,CRIZOTINIB,101398,CHEMBL5969,Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha,5.5,5.5,3200.0,1,8
21036,CHEMBL602,CYSTEAMINE,17045,CHEMBL340,Cytochrome P450 3A4,6.0,6.0,1000.0,2,9
21523,CHEMBL603,ZAFIRLUKAST,179,CHEMBL1798,Cysteinyl leukotriene receptor 1,9.59,8.79,0.26,6,9
21523,CHEMBL603,ZAFIRLUKAST,10188,CHEMBL260,Mitogen-activated protein kinase 14,6.45,6.45,353.0,1,8
21523,CHEMBL603,ZAFIRLUKAST,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,6.38,6.27,420.6,2,9
21523,CHEMBL603,ZAFIRLUKAST,11638,CHEMBL4040,Mitogen-activated protein kinase 1,6.27,6.27,538.0,1,8
21523,CHEMBL603,ZAFIRLUKAST,280,CHEMBL256,Adenosine receptor A3,6.11,5.99,770.0,2,8
21523,CHEMBL603,ZAFIRLUKAST,104067,CHEMBL1743126,Multidrug and toxin extrusion protein 1,5.89,5.89,1300.0,1,9
21523,CHEMBL603,ZAFIRLUKAST,11727,CHEMBL2409,Bifunctional epoxide hydrolase 2,5.7,5.7,2000.0,2,9
21523,CHEMBL603,ZAFIRLUKAST,12911,CHEMBL3397,Cytochrome P450 2C9,5.65,5.63,2257.5,2,8
21523,CHEMBL603,ZAFIRLUKAST,11180,CHEMBL2047,Bile acid receptor,5.64,5.64,2300.0,1,8
21523,CHEMBL603,ZAFIRLUKAST,102394,CHEMBL6020,Bile salt export pump,5.64,5.64,2276.8,1,8
21523,CHEMBL603,ZAFIRLUKAST,133,CHEMBL235,Peroxisome proliferator-activated receptor gamma,5.61,5.61,2440.0,1,9
21845,CHEMBL605,PROCAINAMIDE HYDROCHLORIDE,103668,CHEMBL1293235,Prelamin-A/C,8.4,8.4,4.0,1,9
21845,CHEMBL605,PROCAINAMIDE HYDROCHLORIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,7.3,7.3,50.1,2,9
603199,CHEMBL605846,OLODATEROL,43,CHEMBL210,Beta-2 adrenergic receptor,10.7,9.95,0.02,4,9
603199,CHEMBL605846,OLODATEROL,50,CHEMBL213,Beta-1 adrenergic receptor,7.47,6.87,33.88,3,9
603199,CHEMBL605846,OLODATEROL,125,CHEMBL229,Alpha-1A adrenergic receptor,7.26,7.26,55.0,1,8
603199,CHEMBL605846,OLODATEROL,121,CHEMBL228,Sodium-dependent serotonin transporter,7.22,7.22,60.8,1,8
22391,CHEMBL606,MISOPROSTOL,103668,CHEMBL1293235,Prelamin-A/C,6.1,6.1,794.3,1,9
3283072,CHEMBL6067481,COLISTIN,11003,CHEMBL4644,Melanocortin receptor 3,6.78,6.75,168.0,2,8
3283072,CHEMBL6067481,COLISTIN,11006,CHEMBL4608,Melanocortin receptor 5,6.6,6.59,249.0,2,8
3283072,CHEMBL6067481,COLISTIN,10142,CHEMBL259,Melanocortin receptor 4,6.09,6.08,809.0,2,8
3283072,CHEMBL6067481,COLISTIN,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,6.02,6.02,959.0,1,8
3283072,CHEMBL6067481,COLISTIN,9,CHEMBL203,Epidermal growth factor receptor,5.82,5.82,1500.0,1,8
3283072,CHEMBL6067481,COLISTIN,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,5.65,5.65,2227.0,1,8
3283078,CHEMBL6067487,IVERMECTIN,11398,CHEMBL4302,ATP-dependent translocase ABCB1,7.97,7.17,10.6,4,8
3283078,CHEMBL6067487,IVERMECTIN,11180,CHEMBL2047,Bile acid receptor,6.58,6.58,260.0,1,9
3283078,CHEMBL6067487,IVERMECTIN,280,CHEMBL256,Adenosine receptor A3,6.54,6.42,289.4,2,8
3283078,CHEMBL6067487,IVERMECTIN,12030,CHEMBL3004,Multidrug resistance-associated protein 1,6.3,6.3,500.0,1,8
3283078,CHEMBL6067487,IVERMECTIN,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.24,6.24,569.7,1,8
3283078,CHEMBL6067487,IVERMECTIN,130,CHEMBL234,D(3) dopamine receptor,6.12,5.89,750.3,2,8
3283078,CHEMBL6067487,IVERMECTIN,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.92,5.92,1190.7,1,8
3283078,CHEMBL6067487,IVERMECTIN,219,CHEMBL245,Muscarinic acetylcholine receptor M3,5.89,5.89,1285.0,1,8
3283078,CHEMBL6067487,IVERMECTIN,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.66,5.66,2189.9,1,8
3283078,CHEMBL6067487,IVERMECTIN,88,CHEMBL2056,D(1A) dopamine receptor,5.65,5.65,2257.4,1,8
3283078,CHEMBL6067487,IVERMECTIN,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,5.59,5.59,2592.2,1,8
3283083,CHEMBL6067492,BLEOMYCIN,120098,CHEMBL4680030,Aspartyl/asparaginyl beta-hydroxylase,5.83,5.77,1470.0,3,9
3283085,CHEMBL6067494,SECRETIN,147,CHEMBL1925,Secretin receptor,10.1,9.28,0.08,2,8
3283085,CHEMBL6067494,SECRETIN,11758,CHEMBL1784,Glucagon-like peptide 1 receptor,5.64,5.64,2300.0,1,9
3283141,CHEMBL6067650,PAROXETINE HYDROCHLORIDE,11365,CHEMBL289,Cytochrome P450 2D6,6.02,6.02,960.0,1,9
3283141,CHEMBL6067650,PAROXETINE HYDROCHLORIDE,10711,CHEMBL4079,Beta-adrenergic receptor kinase 1,5.6,5.6,2500.0,1,9
22528,CHEMBL607,MEPERIDINE,129,CHEMBL233,Mu-type opioid receptor,6.5,6.16,315.0,2,8
22528,CHEMBL607,MEPERIDINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.49,6.49,323.59,1,8
22528,CHEMBL607,MEPERIDINE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.72,5.72,1900.0,1,8
22528,CHEMBL607,MEPERIDINE,137,CHEMBL237,Kappa-type opioid receptor,5.62,5.62,2370.0,1,8
22528,CHEMBL607,MEPERIDINE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.59,5.59,2559.9,1,8
22641,CHEMBL608,PROBUCOL,104670,CHEMBL2079849,Serine protease hepsin,6.37,6.37,430.0,1,8
22641,CHEMBL608,PROBUCOL,105223,CHEMBL2163183,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",5.8,5.8,1600.0,1,9
608601,CHEMBL608533,MIDOSTAURIN,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,9.0,7.79,1.0,34,9
608601,CHEMBL608533,MIDOSTAURIN,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,8.11,7.02,7.7,23,9
608601,CHEMBL608533,MIDOSTAURIN,9,CHEMBL203,Epidermal growth factor receptor,8.06,6.09,8.8,24,9
608601,CHEMBL608533,MIDOSTAURIN,11637,CHEMBL3384,Serine/threonine-protein kinase N1,8.03,7.7,9.3,4,9
608601,CHEMBL608533,MIDOSTAURIN,100856,CHEMBL5408,Serine/threonine-protein kinase TBK1,8.03,7.6,9.3,3,9
608601,CHEMBL608533,MIDOSTAURIN,10849,CHEMBL2148,Tyrosine-protein kinase JAK3,7.92,7.92,12.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,10842,CHEMBL3032,Serine/threonine-protein kinase N2,7.82,7.82,15.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,12038,CHEMBL2872,Mitogen-activated protein kinase kinase kinase 9,7.82,7.82,15.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,102799,CHEMBL6191,Mitogen-activated protein kinase kinase kinase 19,7.82,7.82,15.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,11870,CHEMBL2708,Mitogen-activated protein kinase kinase kinase 11,7.77,7.1,17.0,5,9
608601,CHEMBL608533,MIDOSTAURIN,30024,CHEMBL4598,Serine/threonine-protein kinase 4,7.77,7.52,17.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,20014,CHEMBL4722,Aurora kinase A,7.71,6.98,19.29,6,9
608601,CHEMBL608533,MIDOSTAURIN,12415,CHEMBL4147,Calcium/calmodulin-dependent protein kinase type II subunit alpha,7.7,7.7,20.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,7.7,7.06,20.0,10,9
608601,CHEMBL608533,MIDOSTAURIN,100140,CHEMBL5600,MAP/microtubule affinity-regulating kinase 3,7.68,7.25,21.0,4,9
608601,CHEMBL608533,MIDOSTAURIN,11622,CHEMBL2801,Calcium/calmodulin-dependent protein kinase type II subunit delta,7.44,7.14,36.0,4,9
608601,CHEMBL608533,MIDOSTAURIN,100925,CHEMBL5358,eIF-2-alpha kinase GCN2,7.41,7.41,39.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,10277,CHEMBL4708,Serine/threonine-protein kinase 3,7.4,6.91,40.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101332,CHEMBL5784,NUAK family SNF1-like kinase 1,7.39,7.39,41.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,100789,CHEMBL4375,SRSF protein kinase 1,7.38,7.38,42.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,30000,CHEMBL3830,AP2-associated protein kinase 1,7.32,7.06,48.0,6,9
608601,CHEMBL608533,MIDOSTAURIN,103062,CHEMBL1075133,Rhodopsin kinase GRK7,7.32,7.32,48.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,104313,CHEMBL1908382,Serine/threonine-protein kinase PRP4 homolog,7.26,7.26,55.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,10781,CHEMBL2185,Aurora kinase B,7.21,6.81,62.0,4,9
608601,CHEMBL608533,MIDOSTAURIN,101503,CHEMBL5698,NUAK family SNF1-like kinase 2,7.2,7.2,63.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,30003,CHEMBL3788,Serine/threonine-protein kinase PLK4,7.18,7.05,66.0,4,9
608601,CHEMBL608533,MIDOSTAURIN,11398,CHEMBL4302,ATP-dependent translocase ABCB1,7.17,7.17,68.0,1,9
608601,CHEMBL608533,MIDOSTAURIN,30032,CHEMBL5284,Calcium/calmodulin-dependent protein kinase kinase 2,7.14,7.14,73.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,11018,CHEMBL2896,cGMP-dependent protein kinase 2,7.13,7.13,74.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,100975,CHEMBL5415,SRSF protein kinase 3,7.1,7.1,80.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,100951,CHEMBL5334,Non-receptor tyrosine-protein kinase TNK1,7.08,6.83,83.0,4,9
608601,CHEMBL608533,MIDOSTAURIN,101033,CHEMBL5607,Rhodopsin kinase GRK1,7.07,7.07,85.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,10906,CHEMBL2599,Tyrosine-protein kinase SYK,7.06,7.06,88.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,100912,CHEMBL5314,Tyrosine-protein kinase receptor TYRO3,7.06,7.06,88.0,1,9
608601,CHEMBL608533,MIDOSTAURIN,10938,CHEMBL2971,Tyrosine-protein kinase JAK2,7.03,7.03,94.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101405,CHEMBL6000,Serine/threonine-protein kinase RIO2,7.01,7.01,97.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,102770,CHEMBL6149,Serine/threonine-protein kinase SIK3,7.01,7.01,98.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,12090,CHEMBL2292,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,7.0,6.68,100.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,30001,CHEMBL3831,Serine/threonine-protein kinase MARK2,7.0,6.78,100.0,4,9
608601,CHEMBL608533,MIDOSTAURIN,197,CHEMBL1913,Platelet-derived growth factor receptor beta,6.96,6.78,110.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,10612,CHEMBL2534,3-phosphoinositide-dependent protein kinase 1,6.96,6.8,110.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101584,CHEMBL5861,G protein-coupled receptor kinase 4,6.96,6.96,110.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,30023,CHEMBL4599,Activated CDC42 kinase 1,6.92,6.79,120.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101188,CHEMBL5432,Mitogen-activated protein kinase kinase kinase kinase 3,6.92,6.92,120.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,102783,CHEMBL6154,Poly [ADP-ribose] polymerase tankyrase-2,6.92,6.92,120.0,1,8
608601,CHEMBL608533,MIDOSTAURIN,30029,CHEMBL5256,Calcium/calmodulin-dependent protein kinase kinase 1,6.89,6.89,130.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101324,CHEMBL5776,Mitogen-activated protein kinase kinase kinase 7,6.89,6.89,130.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,12840,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,6.85,6.57,142.0,4,9
608601,CHEMBL608533,MIDOSTAURIN,30002,CHEMBL3829,Calcium/calmodulin-dependent protein kinase type II subunit gamma,6.85,6.54,140.0,5,9
608601,CHEMBL608533,MIDOSTAURIN,102711,CHEMBL5914,Mitogen-activated protein kinase kinase kinase 2,6.85,6.85,140.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,12915,CHEMBL3529,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,6.8,6.69,160.0,4,9
608601,CHEMBL608533,MIDOSTAURIN,101433,CHEMBL6082,Serine/threonine-protein kinase SIK1,6.8,6.8,160.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,20171,CHEMBL3935,Aurora kinase C,6.77,6.77,170.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101220,CHEMBL5518,Misshapen-like kinase 1,6.77,6.77,170.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,101612,CHEMBL5940,Serine/threonine-protein kinase MARK1,6.77,6.77,170.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,11364,CHEMBL4045,5'-AMP-activated protein kinase catalytic subunit alpha-1,6.75,6.75,180.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,11908,CHEMBL2999,Serine/threonine-protein kinase PAK 3,6.75,6.75,180.0,2,9
608601,CHEMBL608533,MIDOSTAURIN,12627,CHEMBL2007,Platelet-derived growth factor receptor alpha,6.75,6.53,180.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101055,CHEMBL5081,Interleukin-1 receptor-associated kinase 3,6.75,6.75,180.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,103154,CHEMBL1075104,Leucine-rich repeat serine/threonine-protein kinase 2,6.75,6.5,180.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,11361,CHEMBL4004,"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",6.72,6.27,190.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101410,CHEMBL6005,Serine/threonine-protein kinase 33,6.72,6.72,190.0,1,8
608601,CHEMBL608533,MIDOSTAURIN,103457,CHEMBL1163128,Microtubule-associated serine/threonine-protein kinase 1,6.72,6.72,190.0,1,8
608601,CHEMBL608533,MIDOSTAURIN,10396,CHEMBL4121,Calcium/calmodulin-dependent protein kinase type II subunit beta,6.68,6.68,210.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101399,CHEMBL5970,Mitogen-activated protein kinase kinase kinase 3,6.68,6.68,210.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,10250,CHEMBL2428,"Myosin light chain kinase, smooth muscle",6.66,6.02,220.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,30035,CHEMBL4202,STE20-like serine/threonine-protein kinase,6.66,6.66,220.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,30042,CHEMBL4522,BMP-2-inducible protein kinase,6.66,6.57,220.0,4,9
608601,CHEMBL608533,MIDOSTAURIN,10207,CHEMBL2918,cAMP-dependent protein kinase catalytic subunit beta,6.62,6.62,240.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,10850,CHEMBL4237,Ribosomal protein S6 kinase alpha-5,6.62,6.46,240.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,11843,CHEMBL3906,Ribosomal protein S6 kinase alpha-2,6.62,6.3,240.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,104245,CHEMBL1795165,Hormonally up-regulated neu tumor-associated kinase,6.62,6.62,240.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,10044,CHEMBL3629,Casein kinase II subunit alpha,6.6,6.6,250.0,2,9
608601,CHEMBL608533,MIDOSTAURIN,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,6.6,5.78,250.0,4,9
608601,CHEMBL608533,MIDOSTAURIN,11019,CHEMBL4273,cGMP-dependent protein kinase 1,6.6,6.6,250.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,12694,CHEMBL3553,Non-receptor tyrosine-protein kinase TYK2,6.6,6.6,250.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,10782,CHEMBL3125,Ribosomal protein S6 kinase alpha-4,6.58,6.44,260.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,10929,CHEMBL2553,Ribosomal protein S6 kinase alpha-1,6.58,6.26,260.0,4,9
608601,CHEMBL608533,MIDOSTAURIN,100417,CHEMBL4247,ALK tyrosine kinase receptor,6.57,6.57,270.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101495,CHEMBL5667,Phosphatidylinositol 5-phosphate 4-kinase type-2 beta,6.57,6.57,270.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,10140,CHEMBL258,Tyrosine-protein kinase Lck,6.55,6.55,280.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,30004,CHEMBL3938,Serine/threonine-protein kinase 16,6.55,6.55,280.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,100854,CHEMBL4578,Maternal embryonic leucine zipper kinase,6.55,6.55,280.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,11617,CHEMBL3616,Protein kinase C eta type,6.54,6.54,290.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,117538,CHEMBL4105933,Uncharacterized protein FLJ45252,6.53,6.53,293.0,1,9
608601,CHEMBL608533,MIDOSTAURIN,100413,CHEMBL4898,BDNF/NT-3 growth factors receptor,6.51,6.51,310.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101398,CHEMBL5969,Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha,6.51,6.51,310.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,12247,CHEMBL2996,Protein kinase C delta type,6.5,6.5,320.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101014,CHEMBL5543,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,6.48,6.28,330.0,4,9
608601,CHEMBL608533,MIDOSTAURIN,101496,CHEMBL5668,SRSF protein kinase 2,6.48,6.48,330.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,30011,CHEMBL3983,Dual specificity protein kinase TTK,6.46,6.46,350.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,30013,CHEMBL4224,Dual specificity protein kinase CLK1,6.46,6.31,350.0,4,9
608601,CHEMBL608533,MIDOSTAURIN,101032,CHEMBL5606,Serine/threonine-protein kinase STK11,6.46,6.46,350.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101317,CHEMBL5754,MAP/microtubule affinity-regulating kinase 4,6.43,6.43,370.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,11902,CHEMBL2815,High affinity nerve growth factor receptor,6.42,6.42,380.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,20020,CHEMBL4355,Cyclin-G-associated kinase,6.42,6.42,380.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101278,CHEMBL5659,Serine/threonine-protein kinase RIO3,6.4,6.38,398.11,5,9
608601,CHEMBL608533,MIDOSTAURIN,30036,CHEMBL4203,Dual specificity protein kinase CLK4,6.39,6.24,410.0,4,9
608601,CHEMBL608533,MIDOSTAURIN,10939,CHEMBL4924,Ribosomal protein S6 kinase alpha-6,6.38,5.96,419.0,4,9
608601,CHEMBL608533,MIDOSTAURIN,101019,CHEMBL5568,Proto-oncogene tyrosine-protein kinase ROS,6.37,6.37,430.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,10979,CHEMBL1868,Vascular endothelial growth factor receptor 1,6.35,6.35,450.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,10659,CHEMBL2116,5'-AMP-activated protein kinase catalytic subunit alpha-2,6.34,6.34,460.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,11691,CHEMBL2250,Tyrosine-protein kinase Blk,6.3,6.3,500.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,10878,CHEMBL3582,Protein kinase C epsilon type,6.27,6.27,540.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,10839,CHEMBL2147,Serine/threonine-protein kinase pim-1,6.25,6.25,560.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,11451,CHEMBL3717,Hepatocyte growth factor receptor,6.25,6.05,560.0,7,9
608601,CHEMBL608533,MIDOSTAURIN,100855,CHEMBL5407,Serine/threonine-protein kinase pim-3,6.25,6.25,560.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101504,CHEMBL5699,Serine/threonine-protein kinase SIK2,6.25,6.17,560.0,4,9
608601,CHEMBL608533,MIDOSTAURIN,103449,CHEMBL1163120,Phosphatidylinositol 3-kinase C2 domain-containing subunit gamma,6.24,6.24,570.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,30006,CHEMBL3981,Serine/threonine-protein kinase 10,6.23,6.23,590.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,100410,CHEMBL4895,Tyrosine-protein kinase receptor UFO,6.21,6.21,620.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,100850,CHEMBL4574,Serine/threonine-protein kinase BRSK2,6.19,6.19,650.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101182,CHEMBL5426,Myosin light chain kinase family member 4,6.19,6.19,640.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101464,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,6.19,6.19,650.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,100995,CHEMBL5469,Protein-tyrosine kinase 2-beta,6.18,6.18,660.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,10919,CHEMBL2835,Tyrosine-protein kinase JAK1,6.17,6.17,670.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,11752,CHEMBL1955,Vascular endothelial growth factor receptor 3,6.17,6.17,670.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,30028,CHEMBL5073,Calcium/calmodulin-dependent protein kinase type 1D,6.17,6.17,670.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,11635,CHEMBL299,Protein kinase C alpha type,6.14,6.14,720.0,1,8
608601,CHEMBL608533,MIDOSTAURIN,11785,CHEMBL3234,Tyrosine-protein kinase HCK,6.14,6.14,720.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,11969,CHEMBL4101,cAMP-dependent protein kinase catalytic subunit alpha,6.14,6.14,720.0,2,9
608601,CHEMBL608533,MIDOSTAURIN,100127,CHEMBL4454,Tyrosine-protein kinase Fgr,6.14,6.14,730.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,12724,CHEMBL2345,Ribosomal protein S6 kinase alpha-3,6.13,6.13,740.0,2,9
608601,CHEMBL608533,MIDOSTAURIN,10695,CHEMBL2431,RAC-beta serine/threonine-protein kinase,6.11,6.11,780.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,8,CHEMBL1862,Tyrosine-protein kinase ABL1,6.1,5.65,790.0,4,9
608601,CHEMBL608533,MIDOSTAURIN,11873,CHEMBL2873,Mitogen-activated protein kinase kinase kinase 10,6.1,6.1,790.0,2,9
608601,CHEMBL608533,MIDOSTAURIN,30014,CHEMBL4225,Dual specificity protein kinase CLK2,6.07,5.94,860.0,4,9
608601,CHEMBL608533,MIDOSTAURIN,10778,CHEMBL3123,Death-associated protein kinase 2,6.05,6.05,890.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,12735,CHEMBL2349,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",6.05,5.92,900.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,12665,CHEMBL3920,Protein kinase C theta type,6.04,6.04,920.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,12666,CHEMBL4282,RAC-alpha serine/threonine-protein kinase,6.02,6.02,950.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,18033,CHEMBL2073,Tyrosine-protein kinase Yes,6.02,6.02,950.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,30037,CHEMBL4204,MAP kinase-interacting serine/threonine-protein kinase 2,6.02,6.02,950.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101348,CHEMBL5818,cAMP-dependent protein kinase catalytic subunit PRKX,6.02,6.02,960.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,103106,CHEMBL1075167,Homeodomain-interacting protein kinase 4,6.02,6.02,950.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,11362,CHEMBL4005,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",5.96,5.96,1100.0,2,9
608601,CHEMBL608533,MIDOSTAURIN,30049,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,5.96,5.96,1100.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101465,CHEMBL6167,Serine/threonine-protein kinase LATS1,5.96,5.96,1100.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,10341,CHEMBL2393,5'-AMP-activated protein kinase subunit gamma-1,5.93,5.93,1168.0,1,9
608601,CHEMBL608533,MIDOSTAURIN,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,5.92,5.92,1200.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,30007,CHEMBL3982,Tyrosine-protein kinase Fer,5.92,5.82,1200.0,4,9
608601,CHEMBL608533,MIDOSTAURIN,101269,CHEMBL5650,Serine/threonine-protein kinase BRSK1,5.92,5.92,1200.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101404,CHEMBL5975,Serine/threonine-protein kinase RIO1,5.92,5.92,1200.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,12944,CHEMBL4501,Ribosomal protein S6 kinase beta-1,5.89,5.89,1300.0,1,8
608601,CHEMBL608533,MIDOSTAURIN,12967,CHEMBL4630,Serine/threonine-protein kinase Chk1,5.89,5.89,1300.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101048,CHEMBL5047,Serine/threonine-protein kinase ULK3,5.89,5.89,1300.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,100906,CHEMBL5274,Tyrosine-protein kinase receptor Tie-1,5.85,5.85,1400.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101233,CHEMBL5554,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,5.85,5.85,1400.0,1,8
608601,CHEMBL608533,MIDOSTAURIN,102465,CHEMBL6186,Serine/threonine-protein kinase Sgk3,5.85,5.85,1400.0,1,8
608601,CHEMBL608533,MIDOSTAURIN,10266,CHEMBL3650,Fibroblast growth factor receptor 1,5.8,5.8,1600.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,30047,CHEMBL4527,TRAF2 and NCK-interacting protein kinase,5.8,5.8,1600.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,11926,CHEMBL2742,Fibroblast growth factor receptor 3,5.77,5.77,1700.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101034,CHEMBL5608,NT-3 growth factor receptor,5.77,5.77,1700.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,10051,CHEMBL2468,Death-associated protein kinase 3,5.75,5.75,1800.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,10197,CHEMBL262,Glycogen synthase kinase-3 beta,5.75,5.75,1800.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,30031,CHEMBL5258,Calcium/calmodulin-dependent protein kinase type 1G,5.75,5.75,1800.0,2,9
608601,CHEMBL608533,MIDOSTAURIN,101231,CHEMBL5552,Serine/threonine-protein kinase 25,5.75,5.75,1800.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,12913,CHEMBL4128,Angiopoietin-1 receptor,5.72,5.72,1900.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,30045,CHEMBL4525,Serine/threonine-protein kinase 17A,5.72,5.72,1900.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,10970,CHEMBL2493,Calcium/calmodulin-dependent protein kinase type 1,5.7,5.7,2000.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,30025,CHEMBL4600,Serine/threonine-protein kinase PAK 1,5.7,5.69,2000.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,102667,CHEMBL6029,Eukaryotic translation initiation factor 2-alpha kinase 1,5.69,5.69,2047.0,1,9
608601,CHEMBL608533,MIDOSTAURIN,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,5.68,5.68,2100.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,100071,CHEMBL4487,Serine/threonine-protein kinase PAK 2,5.68,5.68,2100.0,1,8
608601,CHEMBL608533,MIDOSTAURIN,101312,CHEMBL5749,Mitogen-activated protein kinase kinase kinase kinase 1,5.68,5.68,2100.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101602,CHEMBL5907,Serine/threonine-protein kinase LATS2,5.66,5.66,2200.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,11149,CHEMBL2973,Rho-associated protein kinase 2,5.64,5.64,2300.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,12959,CHEMBL4627,Myosin light chain kinase,5.64,5.64,2300.0,1,8
608601,CHEMBL608533,MIDOSTAURIN,100853,CHEMBL4577,Homeodomain-interacting protein kinase 3,5.64,5.64,2300.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,103430,CHEMBL1163101,Serine/threonine-protein kinase/endoribonuclease IRE1,5.64,5.64,2300.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,10264,CHEMBL4142,Fibroblast growth factor receptor 2,5.62,5.62,2400.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,30012,CHEMBL4223,Tyrosine-protein kinase FRK,5.62,5.62,2400.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,102774,CHEMBL6150,Serine/threonine-protein kinase 32A,5.62,5.62,2400.0,1,8
608601,CHEMBL608533,MIDOSTAURIN,11017,CHEMBL2850,Glycogen synthase kinase-3 alpha,5.6,5.6,2500.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,100947,CHEMBL5330,Mitogen-activated protein kinase kinase kinase kinase 2,5.6,5.6,2500.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,12214,CHEMBL2803,Tyrosine-protein kinase ZAP-70,5.58,5.58,2600.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,103453,CHEMBL1163124,Mitogen-activated protein kinase kinase kinase 13,5.55,5.55,2800.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,100948,CHEMBL5331,Tyrosine-protein kinase Mer,5.54,5.54,2900.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,101484,CHEMBL5627,Leukocyte tyrosine kinase receptor,5.52,5.52,3000.0,3,9
608601,CHEMBL608533,MIDOSTAURIN,12699,CHEMBL3009,Receptor tyrosine-protein kinase erbB-4,5.51,5.51,3100.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,30043,CHEMBL4523,Serine/threonine-protein kinase pim-2,5.51,5.51,3100.0,1,8
608601,CHEMBL608533,MIDOSTAURIN,100852,CHEMBL4576,Homeodomain-interacting protein kinase 2,5.51,5.51,3100.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,102676,CHEMBL5836,Ephrin type-B receptor 6,5.51,5.51,3100.0,2,8
608601,CHEMBL608533,MIDOSTAURIN,10885,CHEMBL2595,Serine/threonine-protein kinase D3,5.5,5.5,3200.0,3,9
22956,CHEMBL609,TRIENTINE,103668,CHEMBL1293235,Prelamin-A/C,6.3,6.3,501.2,1,9
4775,CHEMBL61,PODOFILOX,25,CHEMBL2034,Glucocorticoid receptor,7.85,7.85,14.0,1,9
4775,CHEMBL61,PODOFILOX,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,7.8,7.8,15.8,2,9
4775,CHEMBL61,PODOFILOX,103668,CHEMBL1293235,Prelamin-A/C,7.55,7.53,28.2,2,9
4775,CHEMBL61,PODOFILOX,103727,CHEMBL1293294,Ras-related protein Rab-9A,6.95,6.95,112.2,1,9
4775,CHEMBL61,PODOFILOX,103665,CHEMBL1293232,Survival motor neuron protein,6.35,6.35,446.7,1,9
4775,CHEMBL61,PODOFILOX,103710,CHEMBL1293277,NPC intracellular cholesterol transporter 1,6.3,6.3,501.2,1,9
4775,CHEMBL61,PODOFILOX,17045,CHEMBL340,Cytochrome P450 3A4,6.22,5.87,600.0,3,9
4775,CHEMBL61,PODOFILOX,104176,CHEMBL1795094,Nuclear receptor subfamily 0 group B member 1,5.67,5.67,2145.0,1,8
94091,CHEMBL61006,PHENYLPROPANOLAMINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.56,6.56,275.42,1,8
23093,CHEMBL611,TERAZOSIN,128,CHEMBL232,Alpha-1B adrenergic receptor,9.3,8.67,0.5,12,9
23093,CHEMBL611,TERAZOSIN,103,CHEMBL223,Alpha-1D adrenergic receptor,9.07,8.45,0.85,11,9
23093,CHEMBL611,TERAZOSIN,125,CHEMBL229,Alpha-1A adrenergic receptor,8.7,7.9,2.0,23,9
23093,CHEMBL611,TERAZOSIN,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.58,6.83,26.0,6,9
23093,CHEMBL611,TERAZOSIN,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.11,6.62,78.0,6,8
23093,CHEMBL611,TERAZOSIN,103668,CHEMBL1293235,Prelamin-A/C,6.95,6.95,112.2,1,9
23093,CHEMBL611,TERAZOSIN,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.26,6.11,549.54,3,8
23093,CHEMBL611,TERAZOSIN,103659,CHEMBL1293226,Lysine-specific demethylase 4E,6.2,6.2,631.0,1,9
23093,CHEMBL611,TERAZOSIN,137,CHEMBL237,Kappa-type opioid receptor,5.63,5.63,2362.9,1,8
23093,CHEMBL611,TERAZOSIN,129,CHEMBL233,Mu-type opioid receptor,5.52,5.52,3000.0,1,8
23199,CHEMBL612,DEXTROAMPHETAMINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,8.15,7.12,7.1,3,9
23199,CHEMBL612,DEXTROAMPHETAMINE,155,CHEMBL238,Sodium-dependent dopamine transporter,7.61,7.04,24.8,3,9
23199,CHEMBL612,DEXTROAMPHETAMINE,101361,CHEMBL5857,Trace amine-associated receptor 1,6.85,6.28,140.0,4,9
23199,CHEMBL612,DEXTROAMPHETAMINE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.75,5.75,1770.0,1,9
23522,CHEMBL614,PYRAZINAMIDE,78,CHEMBL1963,Thyrotropin receptor,7.7,7.7,20.0,2,9
92458,CHEMBL61593,CYCLOTHIAZIDE,271,CHEMBL1947,Thyroid hormone receptor beta,6.85,6.85,141.3,1,9
92458,CHEMBL61593,CYCLOTHIAZIDE,11114,CHEMBL2009,Glutamate receptor 1,6.0,5.85,1000.0,2,8
92458,CHEMBL61593,CYCLOTHIAZIDE,11221,CHEMBL4016,Glutamate receptor 2,5.65,5.65,2240.0,1,9
24991,CHEMBL617,CEPHALOTHIN,103830,CHEMBL1641348,Organic anion transporter 3,7.4,7.4,40.0,1,8
24991,CHEMBL617,CEPHALOTHIN,104618,CHEMBL2073677,Solute carrier family 22 member 11,6.7,6.7,200.0,1,8
24991,CHEMBL617,CEPHALOTHIN,103829,CHEMBL1641347,Solute carrier family 22 member 6,6.66,6.66,220.0,1,8
24991,CHEMBL617,CEPHALOTHIN,104180,CHEMBL1795098,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1,5.55,5.55,2786.0,1,8
26351,CHEMBL620,CLIDINIUM,219,CHEMBL245,Muscarinic acetylcholine receptor M3,8.72,8.72,1.9,1,8
26351,CHEMBL620,CLIDINIUM,61,CHEMBL216,Muscarinic acetylcholine receptor M1,8.51,8.51,3.1,1,8
26351,CHEMBL620,CLIDINIUM,47,CHEMBL211,Muscarinic acetylcholine receptor M2,8.49,8.49,3.2,1,8
26351,CHEMBL620,CLIDINIUM,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,8.33,8.33,4.7,1,8
26351,CHEMBL620,CLIDINIUM,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,8.17,8.17,6.8,1,8
26351,CHEMBL620,CLIDINIUM,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.89,5.89,1300.0,1,8
26401,CHEMBL621,TRAZODONE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.25,7.26,5.602,5,9
26401,CHEMBL621,TRAZODONE,127,CHEMBL231,Histamine H1 receptor,7.38,6.5,42.0,4,8
26401,CHEMBL621,TRAZODONE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.33,6.74,47.0,3,8
26401,CHEMBL621,TRAZODONE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.17,6.99,68.0,5,9
26401,CHEMBL621,TRAZODONE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.99,6.67,102.0,3,8
26401,CHEMBL621,TRAZODONE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.93,6.24,118.0,4,9
26401,CHEMBL621,TRAZODONE,103,CHEMBL223,Alpha-1D adrenergic receptor,6.89,6.73,130.0,2,8
26401,CHEMBL621,TRAZODONE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.75,6.58,178.0,2,8
26401,CHEMBL621,TRAZODONE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.74,6.25,182.6,2,8
26401,CHEMBL621,TRAZODONE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.55,6.24,282.0,3,8
26401,CHEMBL621,TRAZODONE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.47,6.19,341.0,3,8
26401,CHEMBL621,TRAZODONE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.03,5.85,926.0,2,8
26401,CHEMBL621,TRAZODONE,90,CHEMBL219,D(4) dopamine receptor,5.91,5.91,1228.3,1,8
26401,CHEMBL621,TRAZODONE,130,CHEMBL234,D(3) dopamine receptor,5.9,5.86,1271.0,2,8
26401,CHEMBL621,TRAZODONE,72,CHEMBL217,D(2) dopamine receptor,5.52,5.52,3000.0,1,8
93930,CHEMBL62193,SULFADIMETHOXINE,103668,CHEMBL1293235,Prelamin-A/C,8.74,8.74,1.8,1,9
93930,CHEMBL62193,SULFADIMETHOXINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.21,6.04,622.0,2,8
26431,CHEMBL622,ETODOLAC,96,CHEMBL221,Prostaglandin G/H synthase 1,8.03,6.8,9.4,2,9
26431,CHEMBL622,ETODOLAC,126,CHEMBL230,Prostaglandin G/H synthase 2,8.03,6.66,9.4,3,9
26431,CHEMBL622,ETODOLAC,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,6.65,6.65,223.9,2,9
26431,CHEMBL622,ETODOLAC,17045,CHEMBL340,Cytochrome P450 3A4,5.5,5.5,3162.3,2,9
26465,CHEMBL623,NEFAZODONE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.24,7.27,5.8,3,8
26465,CHEMBL623,NEFAZODONE,17045,CHEMBL340,Cytochrome P450 3A4,7.82,6.55,15.0,3,9
26465,CHEMBL623,NEFAZODONE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.08,6.52,84.0,2,8
26465,CHEMBL623,NEFAZODONE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.89,6.89,130.0,1,8
26465,CHEMBL623,NEFAZODONE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.88,6.21,130.5,3,8
26465,CHEMBL623,NEFAZODONE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.8,6.36,158.49,3,8
26465,CHEMBL623,NEFAZODONE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.7,6.62,200.0,2,8
26465,CHEMBL623,NEFAZODONE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,6.62,6.62,237.2,1,8
26465,CHEMBL623,NEFAZODONE,72,CHEMBL217,D(2) dopamine receptor,6.57,6.57,270.0,1,8
26465,CHEMBL623,NEFAZODONE,90,CHEMBL219,D(4) dopamine receptor,6.57,6.57,271.0,1,8
26465,CHEMBL623,NEFAZODONE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.47,6.47,340.0,1,8
26465,CHEMBL623,NEFAZODONE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.44,6.17,360.0,2,8
26465,CHEMBL623,NEFAZODONE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.44,6.26,360.0,2,8
26465,CHEMBL623,NEFAZODONE,127,CHEMBL231,Histamine H1 receptor,6.39,6.39,410.0,1,8
26465,CHEMBL623,NEFAZODONE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.2,6.2,630.0,1,8
26465,CHEMBL623,NEFAZODONE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.09,6.09,808.0,1,8
26465,CHEMBL623,NEFAZODONE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.05,6.05,890.0,1,8
26465,CHEMBL623,NEFAZODONE,93,CHEMBL220,Acetylcholinesterase,5.98,5.98,1037.0,1,9
26465,CHEMBL623,NEFAZODONE,130,CHEMBL234,D(3) dopamine receptor,5.92,5.92,1200.0,1,8
26465,CHEMBL623,NEFAZODONE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.85,5.85,1418.7,1,8
26465,CHEMBL623,NEFAZODONE,102,CHEMBL1941,Histamine H2 receptor,5.84,5.84,1430.9,1,8
26465,CHEMBL623,NEFAZODONE,88,CHEMBL2056,D(1A) dopamine receptor,5.8,5.8,1597.6,1,8
26465,CHEMBL623,NEFAZODONE,250,CHEMBL249,Substance-P receptor,5.61,5.61,2454.2,1,8
26590,CHEMBL625,THIABENDAZOLE,12594,CHEMBL3356,Cytochrome P450 1A2,6.9,6.5,125.89,2,8
26590,CHEMBL625,THIABENDAZOLE,11307,CHEMBL1865,Histone deacetylase 6,6.44,6.44,362.9,1,9
26590,CHEMBL625,THIABENDAZOLE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,5.6,5.6,2511.9,2,9
26590,CHEMBL625,THIABENDAZOLE,103727,CHEMBL1293294,Ras-related protein Rab-9A,5.6,5.6,2511.9,1,9
26722,CHEMBL626,NAFTIFINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.06,6.06,880.0,1,8
26722,CHEMBL626,NAFTIFINE,11165,CHEMBL4931,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",5.82,5.82,1500.0,1,9
26722,CHEMBL626,NAFTIFINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.69,5.69,2021.0,1,8
26722,CHEMBL626,NAFTIFINE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.67,5.67,2149.4,1,8
26722,CHEMBL626,NAFTIFINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.62,5.62,2395.0,1,8
27072,CHEMBL629,AMITRIPTYLINE,127,CHEMBL231,Histamine H1 receptor,9.26,8.61,0.555,4,9
27072,CHEMBL629,AMITRIPTYLINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,9.13,8.71,0.739,2,8
27072,CHEMBL629,AMITRIPTYLINE,121,CHEMBL228,Sodium-dependent serotonin transporter,9.05,7.98,0.882,10,9
27072,CHEMBL629,AMITRIPTYLINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,8.56,7.51,2.724,4,8
27072,CHEMBL629,AMITRIPTYLINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,8.5,7.85,3.168,3,8
27072,CHEMBL629,AMITRIPTYLINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,8.43,7.69,3.687,3,8
27072,CHEMBL629,AMITRIPTYLINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.36,7.44,4.374,4,8
27072,CHEMBL629,AMITRIPTYLINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,8.27,7.48,5.436,3,8
27072,CHEMBL629,AMITRIPTYLINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,8.24,8.17,5.762,2,8
27072,CHEMBL629,AMITRIPTYLINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,8.07,7.28,8.599,3,8
27072,CHEMBL629,AMITRIPTYLINE,102,CHEMBL1941,Histamine H2 receptor,7.67,6.65,21.3,3,8
27072,CHEMBL629,AMITRIPTYLINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,7.66,6.88,22.0,6,9
27072,CHEMBL629,AMITRIPTYLINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.58,7.34,26.0,3,8
27072,CHEMBL629,AMITRIPTYLINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.54,6.96,29.0,6,8
27072,CHEMBL629,AMITRIPTYLINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.35,6.89,45.0,4,8
27072,CHEMBL629,AMITRIPTYLINE,103,CHEMBL223,Alpha-1D adrenergic receptor,7.28,7.13,52.0,2,8
27072,CHEMBL629,AMITRIPTYLINE,130,CHEMBL234,D(3) dopamine receptor,7.21,6.77,62.0,5,9
27072,CHEMBL629,AMITRIPTYLINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,7.19,7.02,65.0,2,8
27072,CHEMBL629,AMITRIPTYLINE,88,CHEMBL2056,D(1A) dopamine receptor,7.05,6.73,89.0,5,9
27072,CHEMBL629,AMITRIPTYLINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.88,6.2,132.0,4,8
27072,CHEMBL629,AMITRIPTYLINE,220,CHEMBL1850,D(1B) dopamine receptor,6.77,6.77,170.0,1,9
27072,CHEMBL629,AMITRIPTYLINE,72,CHEMBL217,D(2) dopamine receptor,6.71,6.36,196.0,4,9
27072,CHEMBL629,AMITRIPTYLINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.47,6.47,337.0,1,8
27072,CHEMBL629,AMITRIPTYLINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.36,6.18,433.0,2,8
27072,CHEMBL629,AMITRIPTYLINE,90,CHEMBL219,D(4) dopamine receptor,6.09,6.09,818.7,1,8
27072,CHEMBL629,AMITRIPTYLINE,18061,CHEMBL4296,Sodium channel protein type 9 subunit alpha,6.0,5.82,1000.0,2,9
27072,CHEMBL629,AMITRIPTYLINE,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,6.0,6.0,1000.0,1,9
27072,CHEMBL629,AMITRIPTYLINE,137,CHEMBL237,Kappa-type opioid receptor,5.96,5.96,1101.6,1,8
27072,CHEMBL629,AMITRIPTYLINE,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,5.92,5.82,1200.0,3,9
27072,CHEMBL629,AMITRIPTYLINE,115,CHEMBL227,Type-1 angiotensin II receptor,5.85,5.85,1400.0,1,8
27072,CHEMBL629,AMITRIPTYLINE,11663,CHEMBL3105,Poly [ADP-ribose] polymerase 1,5.78,5.78,1650.0,1,9
27072,CHEMBL629,AMITRIPTYLINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.74,5.59,1810.0,3,9
27072,CHEMBL629,AMITRIPTYLINE,18072,CHEMBL4187,Sodium channel protein type 2 subunit alpha,5.51,5.51,3100.0,1,9
27112,CHEMBL631,PROPAFENONE,43,CHEMBL210,Beta-2 adrenergic receptor,7.44,7.36,36.0,2,8
27112,CHEMBL631,PROPAFENONE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.24,7.14,58.0,2,8
27112,CHEMBL631,PROPAFENONE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.73,6.46,187.0,2,8
27112,CHEMBL631,PROPAFENONE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.7,6.56,201.0,2,8
27112,CHEMBL631,PROPAFENONE,50,CHEMBL213,Beta-1 adrenergic receptor,6.69,6.52,205.0,3,8
27112,CHEMBL631,PROPAFENONE,226,CHEMBL246,Beta-3 adrenergic receptor,6.5,6.44,318.0,2,8
27112,CHEMBL631,PROPAFENONE,11398,CHEMBL4302,ATP-dependent translocase ABCB1,6.5,6.49,320.0,4,9
27112,CHEMBL631,PROPAFENONE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.36,6.04,440.0,4,9
27112,CHEMBL631,PROPAFENONE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.06,5.89,865.0,2,8
27112,CHEMBL631,PROPAFENONE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,5.96,5.77,1097.0,2,8
27112,CHEMBL631,PROPAFENONE,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,5.92,5.71,1190.0,2,9
27112,CHEMBL631,PROPAFENONE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.83,5.78,1484.0,2,8
27112,CHEMBL631,PROPAFENONE,103665,CHEMBL1293232,Survival motor neuron protein,5.65,5.65,2238.7,1,9
27112,CHEMBL631,PROPAFENONE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.52,5.52,2991.0,2,8
27152,CHEMBL632,BETAMETHASONE,25,CHEMBL2034,Glucocorticoid receptor,8.45,8.28,3.516,2,8
27185,CHEMBL633,AMIODARONE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,9.0,7.8,1.0,3,8
27185,CHEMBL633,AMIODARONE,12911,CHEMBL3397,Cytochrome P450 2C9,8.1,7.65,7.9,4,9
27185,CHEMBL633,AMIODARONE,11165,CHEMBL4931,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",7.6,7.6,25.0,1,9
27185,CHEMBL633,AMIODARONE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,7.52,6.6,30.0,3,9
27185,CHEMBL633,AMIODARONE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.93,6.72,117.0,2,8
27185,CHEMBL633,AMIODARONE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.77,6.77,168.9,1,8
27185,CHEMBL633,AMIODARONE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.67,6.53,212.0,2,8
27185,CHEMBL633,AMIODARONE,130,CHEMBL234,D(3) dopamine receptor,6.39,6.04,410.0,3,8
27185,CHEMBL633,AMIODARONE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.3,6.3,506.0,1,8
27185,CHEMBL633,AMIODARONE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.23,6.0,587.0,3,8
27185,CHEMBL633,AMIODARONE,271,CHEMBL1947,Thyroid hormone receptor beta,6.22,6.22,600.0,1,8
27185,CHEMBL633,AMIODARONE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.2,5.89,629.0,2,8
27185,CHEMBL633,AMIODARONE,59,CHEMBL1860,Thyroid hormone receptor alpha,6.19,6.19,650.0,1,8
27185,CHEMBL633,AMIODARONE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.17,5.83,679.0,2,8
27185,CHEMBL633,AMIODARONE,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,6.09,6.09,817.0,1,8
27185,CHEMBL633,AMIODARONE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.99,5.94,1026.0,2,8
27185,CHEMBL633,AMIODARONE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,5.97,5.89,1077.0,2,8
27185,CHEMBL633,AMIODARONE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.91,5.78,1224.0,2,8
27185,CHEMBL633,AMIODARONE,10163,CHEMBL3721,Cytochrome P450 2C8,5.82,5.82,1500.0,1,9
27185,CHEMBL633,AMIODARONE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.74,5.74,1806.0,1,8
27185,CHEMBL633,AMIODARONE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.7,5.65,1990.0,2,8
27185,CHEMBL633,AMIODARONE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.65,5.64,2252.0,2,8
27185,CHEMBL633,AMIODARONE,127,CHEMBL231,Histamine H1 receptor,5.62,5.62,2391.6,1,8
27185,CHEMBL633,AMIODARONE,10280,CHEMBL264,Histamine H3 receptor,5.62,5.62,2391.6,1,8
27185,CHEMBL633,AMIODARONE,102,CHEMBL1941,Histamine H2 receptor,5.55,5.55,2822.2,1,8
27185,CHEMBL633,AMIODARONE,136,CHEMBL236,Delta-type opioid receptor,5.55,5.55,2825.0,1,8
27185,CHEMBL633,AMIODARONE,50,CHEMBL213,Beta-1 adrenergic receptor,5.54,5.54,2900.0,1,8
27185,CHEMBL633,AMIODARONE,72,CHEMBL217,D(2) dopamine receptor,5.5,5.5,3146.4,1,8
27185,CHEMBL633,AMIODARONE,11398,CHEMBL4302,ATP-dependent translocase ABCB1,5.5,5.5,3200.0,1,8
27185,CHEMBL633,AMIODARONE,12594,CHEMBL3356,Cytochrome P450 1A2,5.5,5.5,3162.28,1,8
27229,CHEMBL635,PREDNISONE,25,CHEMBL2034,Glucocorticoid receptor,7.54,6.58,29.0,4,9
27251,CHEMBL636,RIVASTIGMINE,10532,CHEMBL1914,Cholinesterase,7.84,6.63,14.3,39,9
27251,CHEMBL636,RIVASTIGMINE,93,CHEMBL220,Acetylcholinesterase,7.43,6.01,37.0,31,9
27278,CHEMBL637,VENLAFAXINE,103668,CHEMBL1293235,Prelamin-A/C,8.7,8.7,2.0,1,9
27278,CHEMBL637,VENLAFAXINE,121,CHEMBL228,Sodium-dependent serotonin transporter,8.42,7.6,3.814,14,9
27278,CHEMBL637,VENLAFAXINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.83,6.22,149.0,12,9
27278,CHEMBL637,VENLAFAXINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.28,6.28,523.0,1,8
27278,CHEMBL637,VENLAFAXINE,127,CHEMBL231,Histamine H1 receptor,5.96,5.96,1100.0,1,8
27308,CHEMBL638,VORICONAZOLE,119260,CHEMBL4523510,Cholesterol 24-hydroxylase,7.96,7.56,11.0,4,9
27308,CHEMBL638,VORICONAZOLE,20085,CHEMBL4729,Cytochrome P450 2B6,6.47,6.06,340.0,6,9
27308,CHEMBL638,VORICONAZOLE,12911,CHEMBL3397,Cytochrome P450 2C9,5.55,5.55,2800.0,1,9
104250,CHEMBL63857,PHENOLPHTHALEIN,103668,CHEMBL1293235,Prelamin-A/C,7.6,7.6,25.1,1,9
104250,CHEMBL63857,PHENOLPHTHALEIN,103665,CHEMBL1293232,Survival motor neuron protein,6.45,6.45,354.8,1,9
104250,CHEMBL63857,PHENOLPHTHALEIN,28,CHEMBL1952,Thymidylate synthase,5.92,5.92,1200.0,1,9
27309,CHEMBL639,AZELASTINE,127,CHEMBL231,Histamine H1 receptor,9.7,9.18,0.1995,10,9
27309,CHEMBL639,AZELASTINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.7,7.7,19.95,1,9
27309,CHEMBL639,AZELASTINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.3,7.03,50.12,5,9
27309,CHEMBL639,AZELASTINE,128,CHEMBL232,Alpha-1B adrenergic receptor,7.3,7.3,50.12,4,9
27309,CHEMBL639,AZELASTINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,7.0,6.87,100.0,7,9
27309,CHEMBL639,AZELASTINE,10280,CHEMBL264,Histamine H3 receptor,6.83,6.82,147.91,3,9
27309,CHEMBL639,AZELASTINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.3,6.3,501.19,1,9
27309,CHEMBL639,AZELASTINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.07,6.07,860.0,1,8
27309,CHEMBL639,AZELASTINE,11365,CHEMBL289,Cytochrome P450 2D6,6.0,6.0,1000.0,1,8
27309,CHEMBL639,AZELASTINE,144,CHEMBL1899,5-hydroxytryptamine receptor 3A,5.62,5.62,2400.0,1,8
27309,CHEMBL639,AZELASTINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.62,5.62,2400.0,1,8
27341,CHEMBL640,PROCAINAMIDE,103668,CHEMBL1293235,Prelamin-A/C,8.0,8.0,10.0,1,9
27341,CHEMBL640,PROCAINAMIDE,93,CHEMBL220,Acetylcholinesterase,6.0,6.0,1000.0,4,9
27342,CHEMBL641,ATOMOXETINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,8.69,8.39,2.03,14,9
27342,CHEMBL641,ATOMOXETINE,121,CHEMBL228,Sodium-dependent serotonin transporter,8.05,7.08,8.9,12,9
27342,CHEMBL641,ATOMOXETINE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.97,5.57,1080.0,8,9
27342,CHEMBL641,ATOMOXETINE,137,CHEMBL237,Kappa-type opioid receptor,5.75,5.75,1800.0,1,8
27342,CHEMBL641,ATOMOXETINE,11365,CHEMBL289,Cytochrome P450 2D6,5.7,5.7,2000.0,2,8
27342,CHEMBL641,ATOMOXETINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.68,5.68,2100.0,1,9
27347,CHEMBL642,ACEBUTOLOL,50,CHEMBL213,Beta-1 adrenergic receptor,6.38,6.17,422.0,3,8
27368,CHEMBL643,PROMETHAZINE,127,CHEMBL231,Histamine H1 receptor,9.48,8.61,0.334,4,9
27368,CHEMBL643,PROMETHAZINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,8.98,8.55,1.057,2,8
27368,CHEMBL643,PROMETHAZINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,8.48,7.63,3.321,4,8
27368,CHEMBL643,PROMETHAZINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,8.48,8.41,3.307,2,8
27368,CHEMBL643,PROMETHAZINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,8.38,7.53,4.149,3,8
27368,CHEMBL643,PROMETHAZINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,8.19,7.47,6.477,3,8
27368,CHEMBL643,PROMETHAZINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.92,7.24,12.0,5,8
27368,CHEMBL643,PROMETHAZINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.72,7.16,19.0,5,9
27368,CHEMBL643,PROMETHAZINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.62,6.94,24.0,3,8
27368,CHEMBL643,PROMETHAZINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.52,6.77,30.0,4,8
27368,CHEMBL643,PROMETHAZINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.37,6.89,43.0,4,8
27368,CHEMBL643,PROMETHAZINE,102,CHEMBL1941,Histamine H2 receptor,7.27,6.38,53.6,3,8
27368,CHEMBL643,PROMETHAZINE,103668,CHEMBL1293235,Prelamin-A/C,7.25,7.25,56.2,1,9
27368,CHEMBL643,PROMETHAZINE,103,CHEMBL223,Alpha-1D adrenergic receptor,7.05,6.89,90.0,2,8
27368,CHEMBL643,PROMETHAZINE,72,CHEMBL217,D(2) dopamine receptor,7.0,6.42,100.0,4,9
27368,CHEMBL643,PROMETHAZINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.92,6.73,120.0,2,8
27368,CHEMBL643,PROMETHAZINE,130,CHEMBL234,D(3) dopamine receptor,6.72,6.46,190.0,4,8
27368,CHEMBL643,PROMETHAZINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.59,6.1,256.0,3,8
27368,CHEMBL643,PROMETHAZINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.45,5.86,353.0,3,8
27368,CHEMBL643,PROMETHAZINE,137,CHEMBL237,Kappa-type opioid receptor,6.21,6.21,618.8,1,8
27368,CHEMBL643,PROMETHAZINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.16,6.16,700.0,1,8
27368,CHEMBL643,PROMETHAZINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.09,6.09,810.0,1,8
27368,CHEMBL643,PROMETHAZINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.04,6.04,922.0,1,8
27368,CHEMBL643,PROMETHAZINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,5.95,5.79,1128.0,2,8
27368,CHEMBL643,PROMETHAZINE,88,CHEMBL2056,D(1A) dopamine receptor,5.86,5.73,1372.0,3,8
27368,CHEMBL643,PROMETHAZINE,129,CHEMBL233,Mu-type opioid receptor,5.84,5.7,1460.0,2,8
27368,CHEMBL643,PROMETHAZINE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.67,5.67,2130.0,1,8
27368,CHEMBL643,PROMETHAZINE,90,CHEMBL219,D(4) dopamine receptor,5.56,5.56,2745.5,1,8
573,CHEMBL6437,MIANSERIN,127,CHEMBL231,Histamine H1 receptor,9.76,8.91,0.175,5,9
573,CHEMBL6437,MIANSERIN,107,CHEMBL224,5-hydroxytryptamine receptor 2A,9.3,8.31,0.504,18,9
573,CHEMBL6437,MIANSERIN,108,CHEMBL225,5-hydroxytryptamine receptor 2C,9.22,8.49,0.606,11,9
573,CHEMBL6437,MIANSERIN,218,CHEMBL1916,Alpha-2C adrenergic receptor,8.42,7.46,3.8,6,9
573,CHEMBL6437,MIANSERIN,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,8.33,8.03,4.642,5,9
573,CHEMBL6437,MIANSERIN,52,CHEMBL1867,Alpha-2A adrenergic receptor,8.32,7.23,4.8,8,9
573,CHEMBL6437,MIANSERIN,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.62,7.22,24.0,3,8
573,CHEMBL6437,MIANSERIN,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,7.4,7.26,40.0,5,9
573,CHEMBL6437,MIANSERIN,103,CHEMBL223,Alpha-1D adrenergic receptor,7.39,7.23,41.0,2,8
573,CHEMBL6437,MIANSERIN,125,CHEMBL229,Alpha-1A adrenergic receptor,7.32,6.53,47.8,7,8
573,CHEMBL6437,MIANSERIN,102,CHEMBL1941,Histamine H2 receptor,7.27,6.42,53.8,3,8
573,CHEMBL6437,MIANSERIN,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,7.25,6.96,56.0,4,9
573,CHEMBL6437,MIANSERIN,88,CHEMBL2056,D(1A) dopamine receptor,6.8,6.49,156.8,4,8
573,CHEMBL6437,MIANSERIN,103668,CHEMBL1293235,Prelamin-A/C,6.8,6.8,158.5,1,9
573,CHEMBL6437,MIANSERIN,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.79,6.69,161.0,4,8
573,CHEMBL6437,MIANSERIN,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.64,6.57,230.0,2,8
573,CHEMBL6437,MIANSERIN,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.54,6.39,290.5,5,8
573,CHEMBL6437,MIANSERIN,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.54,6.11,288.0,2,8
573,CHEMBL6437,MIANSERIN,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.53,6.03,298.0,3,8
573,CHEMBL6437,MIANSERIN,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.46,6.15,343.0,2,8
573,CHEMBL6437,MIANSERIN,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.42,6.13,383.0,3,8
573,CHEMBL6437,MIANSERIN,105,CHEMBL1983,5-hydroxytryptamine receptor 1D,6.42,6.42,380.19,2,8
573,CHEMBL6437,MIANSERIN,137,CHEMBL237,Kappa-type opioid receptor,6.38,6.38,413.3,1,8
573,CHEMBL6437,MIANSERIN,121,CHEMBL228,Sodium-dependent serotonin transporter,5.96,5.82,1098.0,2,8
573,CHEMBL6437,MIANSERIN,144,CHEMBL1899,5-hydroxytryptamine receptor 3A,5.68,5.68,2100.0,1,8
573,CHEMBL6437,MIANSERIN,90,CHEMBL219,D(4) dopamine receptor,5.67,5.67,2142.4,1,8
573,CHEMBL6437,MIANSERIN,72,CHEMBL217,D(2) dopamine receptor,5.66,5.58,2197.0,2,9
573,CHEMBL6437,MIANSERIN,130,CHEMBL234,D(3) dopamine receptor,5.55,5.55,2841.0,1,9
97867,CHEMBL64391,ITRACONAZOLE,11398,CHEMBL4302,ATP-dependent translocase ABCB1,7.52,6.05,30.0,5,8
97867,CHEMBL64391,ITRACONAZOLE,17045,CHEMBL340,Cytochrome P450 3A4,7.49,7.01,32.6,7,9
97867,CHEMBL64391,ITRACONAZOLE,11574,CHEMBL4029,C-X-C chemokine receptor type 1,7.0,6.9,100.0,2,9
97867,CHEMBL64391,ITRACONAZOLE,10579,CHEMBL2414,C-C chemokine receptor type 4,6.7,6.43,200.0,3,9
97867,CHEMBL64391,ITRACONAZOLE,102394,CHEMBL6020,Bile salt export pump,6.18,6.18,660.0,1,8
97867,CHEMBL64391,ITRACONAZOLE,112,CHEMBL1790,Vasopressin V2 receptor,6.1,6.1,794.33,2,9
97867,CHEMBL64391,ITRACONAZOLE,103657,CHEMBL1293224,Microtubule-associated protein tau,5.85,5.66,1412.5,4,9
97867,CHEMBL64391,ITRACONAZOLE,250,CHEMBL249,Substance-P receptor,5.81,5.81,1543.2,1,8
97867,CHEMBL64391,ITRACONAZOLE,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,5.7,5.7,2000.0,1,9
97867,CHEMBL64391,ITRACONAZOLE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,5.6,5.6,2511.9,2,9
27385,CHEMBL644,TRIMIPRAMINE,130,CHEMBL234,D(3) dopamine receptor,7.75,7.75,17.8,1,8
27385,CHEMBL644,TRIMIPRAMINE,88,CHEMBL2056,D(1A) dopamine receptor,6.83,6.83,148.5,1,8
27385,CHEMBL644,TRIMIPRAMINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.8,6.8,158.1,1,8
27385,CHEMBL644,TRIMIPRAMINE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.79,6.79,163.6,1,8
27385,CHEMBL644,TRIMIPRAMINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.51,6.51,310.8,1,8
27385,CHEMBL644,TRIMIPRAMINE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.24,6.24,578.7,1,8
27385,CHEMBL644,TRIMIPRAMINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.9,5.9,1269.9,1,8
27417,CHEMBL645,BISOPROLOL,50,CHEMBL213,Beta-1 adrenergic receptor,7.0,7.0,99.0,1,8
27417,CHEMBL645,BISOPROLOL,43,CHEMBL210,Beta-2 adrenergic receptor,6.82,6.39,150.0,3,9
27419,CHEMBL646,TRIAZOLAM,74,CHEMBL1962,Gamma-aminobutyric acid receptor subunit alpha-1,9.0,9.0,1.0,1,8
27419,CHEMBL646,TRIAZOLAM,11440,CHEMBL5112,Gamma-aminobutyric acid receptor subunit alpha-5,8.4,8.4,4.0,1,8
27419,CHEMBL646,TRIAZOLAM,137,CHEMBL237,Kappa-type opioid receptor,5.76,5.76,1716.4,1,8
27419,CHEMBL646,TRIAZOLAM,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.5,5.5,3195.0,1,8
1256,CHEMBL6466,COUMARIN,11063,CHEMBL3510,Carbonic anhydrase 14,7.32,7.32,48.0,1,9
1256,CHEMBL6466,COUMARIN,109783,CHEMBL3580487,Sclerostin,6.64,6.6,230.8,2,9
1256,CHEMBL6466,COUMARIN,103668,CHEMBL1293235,Prelamin-A/C,6.1,6.1,794.3,1,9
1256,CHEMBL6466,COUMARIN,10186,CHEMBL3025,Carbonic anhydrase 6,5.7,5.7,2000.0,1,9
1256,CHEMBL6466,COUMARIN,10193,CHEMBL261,Carbonic anhydrase 1,5.51,5.51,3100.0,9,9
27495,CHEMBL647,APRACLONIDINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,8.54,8.54,2.9,1,8
27495,CHEMBL647,APRACLONIDINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.52,7.52,30.0,1,8
27495,CHEMBL647,APRACLONIDINE,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,5.9,5.9,1258.9,1,9
27546,CHEMBL648,CYCLIZINE,127,CHEMBL231,Histamine H1 receptor,8.35,7.88,4.443,2,8
27546,CHEMBL648,CYCLIZINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.19,6.92,64.0,2,8
27546,CHEMBL648,CYCLIZINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.92,6.5,119.0,2,8
27546,CHEMBL648,CYCLIZINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.8,6.46,159.0,2,8
27546,CHEMBL648,CYCLIZINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.79,6.19,163.0,3,8
27546,CHEMBL648,CYCLIZINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.62,6.53,238.0,2,8
27546,CHEMBL648,CYCLIZINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.48,6.27,334.2,3,8
27546,CHEMBL648,CYCLIZINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.34,6.27,455.0,2,8
27546,CHEMBL648,CYCLIZINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.27,6.13,535.0,2,8
27546,CHEMBL648,CYCLIZINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.24,6.03,582.0,2,8
27546,CHEMBL648,CYCLIZINE,103,CHEMBL223,Alpha-1D adrenergic receptor,6.22,6.07,597.0,2,8
27546,CHEMBL648,CYCLIZINE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.22,6.01,606.0,3,8
27546,CHEMBL648,CYCLIZINE,130,CHEMBL234,D(3) dopamine receptor,5.99,5.72,1016.0,3,8
98346,CHEMBL64894,GENTIAN VIOLET,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.85,6.42,140.0,2,8
98346,CHEMBL64894,GENTIAN VIOLET,10656,CHEMBL2487,Amyloid-beta precursor protein,6.82,6.82,150.0,1,9
98346,CHEMBL64894,GENTIAN VIOLET,102780,CHEMBL6152,Alpha-synuclein,6.82,6.82,151.46,1,9
98346,CHEMBL64894,GENTIAN VIOLET,103657,CHEMBL1293224,Microtubule-associated protein tau,6.75,6.75,180.0,1,9
98346,CHEMBL64894,GENTIAN VIOLET,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.7,6.27,201.0,3,8
98346,CHEMBL64894,GENTIAN VIOLET,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.58,6.19,264.0,3,8
98346,CHEMBL64894,GENTIAN VIOLET,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.56,6.14,274.0,2,8
98346,CHEMBL64894,GENTIAN VIOLET,130,CHEMBL234,D(3) dopamine receptor,6.55,6.18,282.0,3,8
98346,CHEMBL64894,GENTIAN VIOLET,109543,CHEMBL3351219,Deoxyribonuclease-1,6.46,6.46,350.0,1,9
98346,CHEMBL64894,GENTIAN VIOLET,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.42,6.34,384.0,2,8
98346,CHEMBL64894,GENTIAN VIOLET,9,CHEMBL203,Epidermal growth factor receptor,6.33,6.33,473.0,1,8
98346,CHEMBL64894,GENTIAN VIOLET,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.32,6.15,477.5,3,8
98346,CHEMBL64894,GENTIAN VIOLET,10184,CHEMBL2327,Substance-K receptor,6.25,6.02,560.0,2,8
98346,CHEMBL64894,GENTIAN VIOLET,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.24,6.07,574.0,2,8
98346,CHEMBL64894,GENTIAN VIOLET,137,CHEMBL237,Kappa-type opioid receptor,6.21,6.01,616.0,2,8
98346,CHEMBL64894,GENTIAN VIOLET,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.12,5.85,751.0,2,8
98346,CHEMBL64894,GENTIAN VIOLET,11365,CHEMBL289,Cytochrome P450 2D6,6.08,6.08,824.4,1,8
98346,CHEMBL64894,GENTIAN VIOLET,125,CHEMBL229,Alpha-1A adrenergic receptor,6.07,6.07,844.9,1,8
98346,CHEMBL64894,GENTIAN VIOLET,129,CHEMBL233,Mu-type opioid receptor,6.06,5.87,871.0,2,8
98346,CHEMBL64894,GENTIAN VIOLET,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.04,6.04,918.0,1,8
98346,CHEMBL64894,GENTIAN VIOLET,11307,CHEMBL1865,Histone deacetylase 6,6.02,6.02,953.2,1,9
98346,CHEMBL64894,GENTIAN VIOLET,103,CHEMBL223,Alpha-1D adrenergic receptor,6.01,5.86,973.0,2,8
98346,CHEMBL64894,GENTIAN VIOLET,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.0,6.0,1000.0,1,8
98346,CHEMBL64894,GENTIAN VIOLET,72,CHEMBL217,D(2) dopamine receptor,5.97,5.73,1059.0,2,8
98346,CHEMBL64894,GENTIAN VIOLET,102,CHEMBL1941,Histamine H2 receptor,5.95,5.95,1136.0,2,8
98346,CHEMBL64894,GENTIAN VIOLET,280,CHEMBL256,Adenosine receptor A3,5.91,5.77,1226.1,2,8
98346,CHEMBL64894,GENTIAN VIOLET,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,5.9,5.83,1258.9,2,9
98346,CHEMBL64894,GENTIAN VIOLET,88,CHEMBL2056,D(1A) dopamine receptor,5.81,5.65,1551.0,3,8
98346,CHEMBL64894,GENTIAN VIOLET,36,CHEMBL208,Progesterone receptor,5.78,5.78,1671.7,1,8
98346,CHEMBL64894,GENTIAN VIOLET,252,CHEMBL251,Adenosine receptor A2a,5.72,5.72,1889.0,1,8
98346,CHEMBL64894,GENTIAN VIOLET,11638,CHEMBL4040,Mitogen-activated protein kinase 1,5.7,5.7,1995.3,1,9
98346,CHEMBL64894,GENTIAN VIOLET,246,CHEMBL2069,Thromboxane A2 receptor,5.69,5.69,2029.4,1,8
98346,CHEMBL64894,GENTIAN VIOLET,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,5.67,5.67,2148.0,1,8
98346,CHEMBL64894,GENTIAN VIOLET,103665,CHEMBL1293232,Survival motor neuron protein,5.65,5.65,2238.7,1,9
98346,CHEMBL64894,GENTIAN VIOLET,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,5.53,5.53,2971.1,1,8
98346,CHEMBL64894,GENTIAN VIOLET,20053,CHEMBL4096,Cellular tumor antigen p53,5.5,5.5,3162.3,1,9
27575,CHEMBL650,METHYLPREDNISOLONE,25,CHEMBL2034,Glucocorticoid receptor,8.3,8.1,5.033,3,8
27575,CHEMBL650,METHYLPREDNISOLONE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,7.3,7.3,50.1,2,9
27575,CHEMBL650,METHYLPREDNISOLONE,36,CHEMBL208,Progesterone receptor,5.89,5.89,1300.0,1,8
27576,CHEMBL651,METHADONE,129,CHEMBL233,Mu-type opioid receptor,8.39,8.14,4.1,2,9
27576,CHEMBL651,METHADONE,137,CHEMBL237,Kappa-type opioid receptor,6.29,6.29,512.0,1,8
27576,CHEMBL651,METHADONE,136,CHEMBL236,Delta-type opioid receptor,5.96,5.96,1090.0,1,8
27576,CHEMBL651,METHADONE,130,CHEMBL234,D(3) dopamine receptor,5.68,5.68,2110.0,1,9
27588,CHEMBL652,FLECAINIDE,103668,CHEMBL1293235,Prelamin-A/C,5.9,5.9,1258.9,1,9
27588,CHEMBL652,FLECAINIDE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.52,5.52,3000.0,1,8
27588,CHEMBL652,FLECAINIDE,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,5.52,5.52,3000.0,1,8
102584,CHEMBL65375,TIPIRACIL HYDROCHLORIDE,11723,CHEMBL3106,Thymidine phosphorylase,7.77,7.57,17.0,12,9
27610,CHEMBL654,MIRTAZAPINE,127,CHEMBL231,Histamine H1 receptor,8.8,8.5,1.6,2,9
27610,CHEMBL654,MIRTAZAPINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.09,7.24,8.2,3,9
27610,CHEMBL654,MIRTAZAPINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.75,7.75,18.0,1,9
27610,CHEMBL654,MIRTAZAPINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.75,6.9,18.0,3,9
27610,CHEMBL654,MIRTAZAPINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.7,6.75,20.0,4,9
27610,CHEMBL654,MIRTAZAPINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.41,7.41,39.0,1,9
27610,CHEMBL654,MIRTAZAPINE,12911,CHEMBL3397,Cytochrome P450 2C9,7.3,7.3,50.1,2,9
27610,CHEMBL654,MIRTAZAPINE,12912,CHEMBL3622,Cytochrome P450 2C19,7.3,7.3,50.1,2,9
27610,CHEMBL654,MIRTAZAPINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.65,6.25,223.87,2,8
27610,CHEMBL654,MIRTAZAPINE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,6.58,6.58,265.0,1,9
27610,CHEMBL654,MIRTAZAPINE,11365,CHEMBL289,Cytochrome P450 2D6,6.3,6.3,501.19,2,9
27610,CHEMBL654,MIRTAZAPINE,144,CHEMBL1899,5-hydroxytryptamine receptor 3A,5.54,5.54,2900.0,1,9
27610,CHEMBL654,MIRTAZAPINE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.5,5.5,3162.28,1,8
27611,CHEMBL655,MIDAZOLAM,17045,CHEMBL340,Cytochrome P450 3A4,7.33,6.93,47.0,6,9
27611,CHEMBL655,MIDAZOLAM,137,CHEMBL237,Kappa-type opioid receptor,5.92,5.92,1192.5,1,8
27624,CHEMBL656,OXYCODONE,129,CHEMBL233,Mu-type opioid receptor,7.92,7.32,12.0,10,9
27624,CHEMBL656,OXYCODONE,137,CHEMBL237,Kappa-type opioid receptor,5.7,5.7,2000.0,1,8
27629,CHEMBL657,DIPHENHYDRAMINE,127,CHEMBL231,Histamine H1 receptor,7.83,7.45,14.79,4,9
27629,CHEMBL657,DIPHENHYDRAMINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,7.28,6.41,52.0,3,8
27629,CHEMBL657,DIPHENHYDRAMINE,103689,CHEMBL1293256,Thrombopoietin,7.2,7.2,63.1,2,9
27629,CHEMBL657,DIPHENHYDRAMINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.08,6.49,83.0,3,8
27629,CHEMBL657,DIPHENHYDRAMINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.94,6.65,116.0,3,8
27629,CHEMBL657,DIPHENHYDRAMINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.86,6.27,137.0,3,8
27629,CHEMBL657,DIPHENHYDRAMINE,102,CHEMBL1941,Histamine H2 receptor,6.6,6.6,252.2,1,8
27629,CHEMBL657,DIPHENHYDRAMINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.43,6.06,373.0,4,8
27629,CHEMBL657,DIPHENHYDRAMINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.43,6.13,370.0,3,8
27629,CHEMBL657,DIPHENHYDRAMINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.29,6.13,513.0,3,8
27629,CHEMBL657,DIPHENHYDRAMINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.18,6.09,667.4,3,8
27629,CHEMBL657,DIPHENHYDRAMINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.59,5.59,2570.4,1,9
27629,CHEMBL657,DIPHENHYDRAMINE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.54,5.54,2920.0,1,8
27629,CHEMBL657,DIPHENHYDRAMINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.53,5.53,2969.8,1,8
27638,CHEMBL658,SUFENTANIL,129,CHEMBL233,Mu-type opioid receptor,8.89,8.86,1.3,2,9
27639,CHEMBL659,GALANTAMINE,10532,CHEMBL1914,Cholinesterase,7.29,6.38,51.0,8,9
27639,CHEMBL659,GALANTAMINE,93,CHEMBL220,Acetylcholinesterase,7.21,6.04,61.9,80,9
27647,CHEMBL660,AMANTADINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,7.69,7.69,20.25,1,8
27647,CHEMBL660,AMANTADINE,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,5.55,5.55,2818.4,2,9
27648,CHEMBL661,ALPRAZOLAM,11440,CHEMBL5112,Gamma-aminobutyric acid receptor subunit alpha-5,8.0,8.0,10.0,1,8
27648,CHEMBL661,ALPRAZOLAM,12770,CHEMBL4956,Gamma-aminobutyric acid receptor subunit alpha-2,7.92,7.92,12.0,1,8
27648,CHEMBL661,ALPRAZOLAM,103668,CHEMBL1293235,Prelamin-A/C,7.9,7.9,12.6,1,9
27648,CHEMBL661,ALPRAZOLAM,74,CHEMBL1962,Gamma-aminobutyric acid receptor subunit alpha-1,7.43,7.43,37.0,1,8
27648,CHEMBL661,ALPRAZOLAM,12757,CHEMBL3026,Gamma-aminobutyric acid receptor subunit alpha-3,7.16,7.16,69.0,1,8
27648,CHEMBL661,ALPRAZOLAM,103454,CHEMBL1163125,Bromodomain-containing protein 4,5.61,5.61,2460.0,1,8
27812,CHEMBL667,ACETYLCHOLINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,8.96,7.37,1.1,11,9
27812,CHEMBL667,ACETYLCHOLINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,8.92,7.72,1.2,5,9
27812,CHEMBL667,ACETYLCHOLINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,8.49,7.31,3.2,8,9
27812,CHEMBL667,ACETYLCHOLINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,8.15,6.84,7.0,19,9
27812,CHEMBL667,ACETYLCHOLINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,8.0,7.46,10.0,6,9
27812,CHEMBL667,ACETYLCHOLINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.82,6.82,150.0,1,8
27812,CHEMBL667,ACETYLCHOLINE,246,CHEMBL2069,Thromboxane A2 receptor,6.47,6.47,340.0,1,8
27812,CHEMBL667,ACETYLCHOLINE,10635,CHEMBL2492,Neuronal acetylcholine receptor subunit alpha-7,6.3,6.3,501.19,1,9
28112,CHEMBL668,PROTRIPTYLINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,8.96,8.54,1.1,18,9
28112,CHEMBL668,PROTRIPTYLINE,103668,CHEMBL1293235,Prelamin-A/C,8.15,8.15,7.1,1,9
28112,CHEMBL668,PROTRIPTYLINE,127,CHEMBL231,Histamine H1 receptor,7.3,7.3,50.0,1,8
28112,CHEMBL668,PROTRIPTYLINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.62,6.62,240.0,1,8
28112,CHEMBL668,PROTRIPTYLINE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.34,6.34,460.7,1,8
28112,CHEMBL668,PROTRIPTYLINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.24,6.24,570.0,1,8
28112,CHEMBL668,PROTRIPTYLINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.18,5.96,653.5,2,8
28112,CHEMBL668,PROTRIPTYLINE,130,CHEMBL234,D(3) dopamine receptor,6.07,6.07,850.0,1,8
28112,CHEMBL668,PROTRIPTYLINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.0,6.0,1004.0,1,8
28112,CHEMBL668,PROTRIPTYLINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.75,5.75,1800.0,1,8
28112,CHEMBL668,PROTRIPTYLINE,137,CHEMBL237,Kappa-type opioid receptor,5.67,5.67,2124.9,1,8
28119,CHEMBL669,CYCLOBENZAPRINE,121,CHEMBL228,Sodium-dependent serotonin transporter,8.15,8.15,7.0,1,8
28119,CHEMBL669,CYCLOBENZAPRINE,127,CHEMBL231,Histamine H1 receptor,7.68,7.68,21.0,1,8
28119,CHEMBL669,CYCLOBENZAPRINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.36,6.69,44.1,2,8
28119,CHEMBL669,CYCLOBENZAPRINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.75,6.75,180.0,1,8
28119,CHEMBL669,CYCLOBENZAPRINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.64,6.09,230.3,2,8
28119,CHEMBL669,CYCLOBENZAPRINE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.58,6.46,261.5,2,8
28119,CHEMBL669,CYCLOBENZAPRINE,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,6.52,6.52,300.0,1,9
28119,CHEMBL669,CYCLOBENZAPRINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.46,6.46,350.0,1,8
28119,CHEMBL669,CYCLOBENZAPRINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.46,6.46,350.0,1,8
28119,CHEMBL669,CYCLOBENZAPRINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.42,6.42,377.7,1,8
28119,CHEMBL669,CYCLOBENZAPRINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.06,6.06,880.0,1,8
28119,CHEMBL669,CYCLOBENZAPRINE,130,CHEMBL234,D(3) dopamine receptor,5.96,5.96,1100.0,1,8
28119,CHEMBL669,CYCLOBENZAPRINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.9,5.9,1246.6,1,8
28119,CHEMBL669,CYCLOBENZAPRINE,137,CHEMBL237,Kappa-type opioid receptor,5.57,5.57,2665.8,1,8
28310,CHEMBL671,THIOTEPA,121,CHEMBL228,Sodium-dependent serotonin transporter,8.15,8.15,7.1,1,8
28310,CHEMBL671,THIOTEPA,100,CHEMBL222,Sodium-dependent noradrenaline transporter,7.75,7.75,18.0,1,8
28310,CHEMBL671,THIOTEPA,125,CHEMBL229,Alpha-1A adrenergic receptor,7.36,7.36,44.0,1,8
28310,CHEMBL671,THIOTEPA,127,CHEMBL231,Histamine H1 receptor,7.2,7.2,63.0,1,8
28310,CHEMBL671,THIOTEPA,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.41,6.41,390.0,1,8
28310,CHEMBL671,THIOTEPA,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.24,6.24,570.0,1,8
28310,CHEMBL671,THIOTEPA,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.8,5.8,1600.0,1,8
28310,CHEMBL671,THIOTEPA,20085,CHEMBL4729,Cytochrome P450 2B6,5.66,5.66,2200.0,1,9
28310,CHEMBL671,THIOTEPA,11544,CHEMBL4331,Hemoglobin subunit beta,5.6,5.6,2511.9,1,9
28331,CHEMBL672,FENOFIBRATE,133,CHEMBL235,Peroxisome proliferator-activated receptor gamma,6.24,6.24,570.0,1,8
28331,CHEMBL672,FENOFIBRATE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.22,5.95,605.0,2,8
28331,CHEMBL672,FENOFIBRATE,163,CHEMBL239,Peroxisome proliferator-activated receptor alpha,6.0,5.85,1000.0,2,9
28331,CHEMBL672,FENOFIBRATE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.91,5.77,1242.0,2,8
28331,CHEMBL672,FENOFIBRATE,87,CHEMBL218,Cannabinoid receptor 1,5.53,5.53,2928.7,1,8
28477,CHEMBL673,PARGYLINE,104,CHEMBL2039,Amine oxidase [flavin-containing] B,8.09,6.78,8.2,37,9
28477,CHEMBL673,PARGYLINE,86,CHEMBL1951,Amine oxidase [flavin-containing] A,7.94,6.32,11.52,4,9
28477,CHEMBL673,PARGYLINE,78,CHEMBL1963,Thyrotropin receptor,6.9,6.9,125.9,1,9
28477,CHEMBL673,PARGYLINE,17045,CHEMBL340,Cytochrome P450 3A4,6.2,6.2,631.0,2,9
28699,CHEMBL675,ALENDRONATE SODIUM,71,CHEMBL1782,Farnesyl pyrophosphate synthase,6.34,6.34,460.0,1,9
28939,CHEMBL677,LEVONORDEFRIN,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,7.0,6.17,100.0,3,9
28939,CHEMBL677,LEVONORDEFRIN,103668,CHEMBL1293235,Prelamin-A/C,6.6,6.6,251.2,1,9
28939,CHEMBL677,LEVONORDEFRIN,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.45,6.45,354.8,1,9
28939,CHEMBL677,LEVONORDEFRIN,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,6.3,5.9,501.2,4,9
28939,CHEMBL677,LEVONORDEFRIN,103669,CHEMBL1293236,ATP-dependent DNA helicase Q1,5.75,5.75,1778.3,1,9
28939,CHEMBL677,LEVONORDEFRIN,12054,CHEMBL2903,Polyunsaturated fatty acid lipoxygenase ALOX15,5.5,5.5,3162.3,1,9
28976,CHEMBL679,EPINEPHRINE,125,CHEMBL229,Alpha-1A adrenergic receptor,8.59,7.41,2.6,5,8
28976,CHEMBL679,EPINEPHRINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,8.25,7.19,5.626,7,9
28976,CHEMBL679,EPINEPHRINE,43,CHEMBL210,Beta-2 adrenergic receptor,7.66,6.57,22.0,7,9
28976,CHEMBL679,EPINEPHRINE,226,CHEMBL246,Beta-3 adrenergic receptor,7.51,7.41,31.0,2,9
28976,CHEMBL679,EPINEPHRINE,88,CHEMBL2056,D(1A) dopamine receptor,7.5,7.5,32.0,1,8
28976,CHEMBL679,EPINEPHRINE,128,CHEMBL232,Alpha-1B adrenergic receptor,7.12,7.12,75.0,1,9
28976,CHEMBL679,EPINEPHRINE,103,CHEMBL223,Alpha-1D adrenergic receptor,6.66,6.5,221.0,2,8
28976,CHEMBL679,EPINEPHRINE,50,CHEMBL213,Beta-1 adrenergic receptor,6.54,6.28,290.0,2,9
28976,CHEMBL679,EPINEPHRINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.45,5.89,356.0,4,9
28976,CHEMBL679,EPINEPHRINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.4,6.07,397.0,3,9
28976,CHEMBL679,EPINEPHRINE,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,6.1,6.1,794.3,1,9
28976,CHEMBL679,EPINEPHRINE,72,CHEMBL217,D(2) dopamine receptor,6.04,6.04,910.0,1,9
28976,CHEMBL679,EPINEPHRINE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,5.8,5.8,1584.9,2,9
28976,CHEMBL679,EPINEPHRINE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,5.5,5.5,3162.3,1,9
29090,CHEMBL681,ETOMIDATE,11541,CHEMBL2722,"Cytochrome P450 11B2, mitochondrial",10.0,9.38,0.1,4,9
29090,CHEMBL681,ETOMIDATE,76,CHEMBL1908,"Cytochrome P450 11B1, mitochondrial",9.3,9.3,0.5,4,9
29097,CHEMBL682,AMODIAQUINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.19,6.19,650.0,1,8
29097,CHEMBL682,AMODIAQUINE,11365,CHEMBL289,Cytochrome P450 2D6,6.19,6.19,640.0,1,9
29097,CHEMBL682,AMODIAQUINE,100611,CHEMBL3491,Cytochrome P450 2J2,6.0,6.0,990.0,1,9
29097,CHEMBL682,AMODIAQUINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.82,5.82,1500.0,1,8
29637,CHEMBL685,MEBENDAZOLE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,6.1,5.8,794.3,4,9
29637,CHEMBL685,MEBENDAZOLE,103668,CHEMBL1293235,Prelamin-A/C,6.05,6.05,891.3,1,9
29637,CHEMBL685,MEBENDAZOLE,12911,CHEMBL3397,Cytochrome P450 2C9,5.8,5.8,1584.9,1,9
29989,CHEMBL686,MEFENAMIC ACID,119104,CHEMBL4523354,Nicotinate phosphoribosyltransferase,10.3,10.3,0.05,1,9
29989,CHEMBL686,MEFENAMIC ACID,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,7.95,7.95,11.2,1,9
29989,CHEMBL686,MEFENAMIC ACID,96,CHEMBL221,Prostaglandin G/H synthase 1,7.94,7.45,11.5,3,9
29989,CHEMBL686,MEFENAMIC ACID,101351,CHEMBL5847,Aldo-keto reductase family 1 member C2,6.66,6.66,220.0,1,9
29989,CHEMBL686,MEFENAMIC ACID,100481,CHEMBL4681,Aldo-keto reductase family 1 member C3,6.52,6.38,300.0,2,9
29989,CHEMBL686,MEFENAMIC ACID,126,CHEMBL230,Prostaglandin G/H synthase 2,6.22,5.88,602.0,2,9
29989,CHEMBL686,MEFENAMIC ACID,101600,CHEMBL5905,Aldo-keto reductase family 1 member C1,6.09,6.09,810.0,1,9
29989,CHEMBL686,MEFENAMIC ACID,10567,CHEMBL2439,Myeloperoxidase,6.01,5.83,980.0,2,9
29989,CHEMBL686,MEFENAMIC ACID,102631,CHEMBL5983,Aldo-keto reductase family 1 member B10,5.8,5.8,1600.0,1,9
30602,CHEMBL690,PRAVASTATIN SODIUM,24,CHEMBL402,3-hydroxy-3-methylglutaryl-coenzyme A reductase,7.52,6.69,30.0,2,8
31241,CHEMBL691,ETHINYL ESTRADIOL,19,CHEMBL206,Estrogen receptor,9.89,8.86,0.128,7,9
31241,CHEMBL691,ETHINYL ESTRADIOL,174,CHEMBL242,Estrogen receptor beta,9.8,8.77,0.16,4,9
31241,CHEMBL691,ETHINYL ESTRADIOL,104076,CHEMBL1743291,Sulfotransferase 1A1,8.37,7.66,4.3,6,9
31241,CHEMBL691,ETHINYL ESTRADIOL,12056,CHEMBL3257,Aldehyde oxidase,8.3,6.97,5.0,3,9
31241,CHEMBL691,ETHINYL ESTRADIOL,36,CHEMBL208,Progesterone receptor,7.7,7.7,20.0,1,8
31241,CHEMBL691,ETHINYL ESTRADIOL,121,CHEMBL228,Sodium-dependent serotonin transporter,7.54,6.86,29.0,4,8
31241,CHEMBL691,ETHINYL ESTRADIOL,56,CHEMBL1871,Androgen receptor,7.05,7.05,90.0,1,8
31241,CHEMBL691,ETHINYL ESTRADIOL,25,CHEMBL2034,Glucocorticoid receptor,6.92,6.27,120.0,3,8
31241,CHEMBL691,ETHINYL ESTRADIOL,12643,CHEMBL3305,Sex hormone-binding globulin,6.81,6.81,154.88,1,9
31241,CHEMBL691,ETHINYL ESTRADIOL,155,CHEMBL238,Sodium-dependent dopamine transporter,6.35,6.06,444.0,4,8
31241,CHEMBL691,ETHINYL ESTRADIOL,20085,CHEMBL4729,Cytochrome P450 2B6,6.1,6.07,800.0,2,9
31241,CHEMBL691,ETHINYL ESTRADIOL,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.02,5.9,951.0,4,8
31241,CHEMBL691,ETHINYL ESTRADIOL,104063,CHEMBL1743122,Solute carrier family 22 member 2,5.66,5.66,2200.0,1,9
31241,CHEMBL691,ETHINYL ESTRADIOL,100997,CHEMBL5503,Nuclear receptor subfamily 1 group I member 3,5.6,5.56,2500.0,2,9
31422,CHEMBL692,GLYCERIN,103668,CHEMBL1293235,Prelamin-A/C,6.45,6.45,354.8,1,9
1219,CHEMBL6966,VERAPAMIL,11398,CHEMBL4302,ATP-dependent translocase ABCB1,8.53,6.68,2.97,67,9
1219,CHEMBL6966,VERAPAMIL,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,8.0,6.58,10.0,21,9
1219,CHEMBL6966,VERAPAMIL,17045,CHEMBL340,Cytochrome P450 3A4,7.96,7.96,11.0,1,9
1219,CHEMBL6966,VERAPAMIL,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.3,6.75,50.2,4,8
1219,CHEMBL6966,VERAPAMIL,130,CHEMBL234,D(3) dopamine receptor,7.2,6.76,63.0,4,8
1219,CHEMBL6966,VERAPAMIL,12030,CHEMBL3004,Multidrug resistance-associated protein 1,7.1,6.41,79.0,2,9
1219,CHEMBL6966,VERAPAMIL,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.9,6.58,126.0,3,8
1219,CHEMBL6966,VERAPAMIL,121,CHEMBL228,Sodium-dependent serotonin transporter,6.9,6.46,127.0,4,8
1219,CHEMBL6966,VERAPAMIL,169,CHEMBL1940,Voltage-dependent L-type calcium channel subunit alpha-1C,6.82,6.82,150.0,1,8
1219,CHEMBL6966,VERAPAMIL,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.81,6.41,155.0,3,8
1219,CHEMBL6966,VERAPAMIL,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.66,6.04,217.0,4,8
1219,CHEMBL6966,VERAPAMIL,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.33,6.33,473.1,1,8
1219,CHEMBL6966,VERAPAMIL,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,6.05,5.98,900.0,2,9
1219,CHEMBL6966,VERAPAMIL,125,CHEMBL229,Alpha-1A adrenergic receptor,5.88,5.88,1334.7,1,8
1219,CHEMBL6966,VERAPAMIL,102,CHEMBL1941,Histamine H2 receptor,5.59,5.59,2547.0,2,8
1219,CHEMBL6966,VERAPAMIL,101283,CHEMBL5685,Solute carrier family 22 member 1,5.54,5.54,2900.0,1,8
32027,CHEMBL698,TETRACAINE,87,CHEMBL218,Cannabinoid receptor 1,9.22,9.22,0.6,1,8
32027,CHEMBL698,TETRACAINE,18056,CHEMBL3585,Sodium channel protein type 7 subunit alpha,7.25,7.25,56.0,1,9
32027,CHEMBL698,TETRACAINE,18061,CHEMBL4296,Sodium channel protein type 9 subunit alpha,7.25,6.65,56.0,6,9
32027,CHEMBL698,TETRACAINE,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,6.7,6.34,200.0,4,9
32027,CHEMBL698,TETRACAINE,86,CHEMBL1951,Amine oxidase [flavin-containing] A,6.5,6.12,317.0,3,8
32027,CHEMBL698,TETRACAINE,18072,CHEMBL4187,Sodium channel protein type 2 subunit alpha,6.31,6.13,490.0,2,9
32027,CHEMBL698,TETRACAINE,18079,CHEMBL5202,Sodium channel protein type 8 subunit alpha,6.28,6.28,520.0,1,9
32027,CHEMBL698,TETRACAINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.15,5.96,703.0,2,8
32027,CHEMBL698,TETRACAINE,18075,CHEMBL5163,Sodium channel protein type 3 subunit alpha,6.13,6.13,740.0,1,9
32027,CHEMBL698,TETRACAINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.01,6.01,976.0,1,8
32027,CHEMBL698,TETRACAINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.85,5.85,1418.2,1,8
32027,CHEMBL698,TETRACAINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.77,5.77,1712.0,1,8
1380,CHEMBL6995,PRACTOLOL,137,CHEMBL237,Kappa-type opioid receptor,5.55,5.55,2806.2,1,8
6005,CHEMBL70,MORPHINE,129,CHEMBL233,Mu-type opioid receptor,9.85,7.99,0.14,80,9
6005,CHEMBL70,MORPHINE,137,CHEMBL237,Kappa-type opioid receptor,8.16,6.9,6.9,37,9
6005,CHEMBL70,MORPHINE,136,CHEMBL236,Delta-type opioid receptor,7.81,6.63,15.6,45,9
6005,CHEMBL70,MORPHINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.85,6.85,141.0,1,9
32869,CHEMBL701,BACLOFEN,17045,CHEMBL340,Cytochrome P450 3A4,7.5,7.5,31.6,2,9
32869,CHEMBL701,BACLOFEN,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,6.7,6.7,199.5,2,9
32869,CHEMBL701,BACLOFEN,10227,CHEMBL2064,Gamma-aminobutyric acid type B receptor subunit 1,5.62,5.62,2384.2,1,8
33060,CHEMBL703,SUXAMETHONIUM,125,CHEMBL229,Alpha-1A adrenergic receptor,6.18,6.18,667.4,1,8
33202,CHEMBL704,MESALAMINE,118080,CHEMBL4295835,Thiosulfate sulfurtransferase,6.55,6.55,280.0,1,9
33202,CHEMBL704,MESALAMINE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.0,5.8,1000.0,2,9
33216,CHEMBL705,ALITRETINOIN,270,CHEMBL2008,Retinoic acid receptor beta,9.3,7.96,0.5,21,9
33216,CHEMBL705,ALITRETINOIN,240,CHEMBL2003,Retinoic acid receptor gamma,9.1,7.75,0.8,20,9
33216,CHEMBL705,ALITRETINOIN,57,CHEMBL2055,Retinoic acid receptor alpha,9.0,7.29,1.0,21,9
33216,CHEMBL705,ALITRETINOIN,275,CHEMBL2061,Retinoic acid receptor RXR-alpha,8.82,7.52,1.5,38,9
33216,CHEMBL705,ALITRETINOIN,277,CHEMBL1870,Retinoic acid receptor RXR-beta,8.59,7.57,2.6,15,9
33216,CHEMBL705,ALITRETINOIN,266,CHEMBL2004,Retinoic acid receptor RXR-gamma,8.4,7.59,4.0,16,9
33216,CHEMBL705,ALITRETINOIN,103662,CHEMBL1293229,Nuclear receptor subfamily 4immunitygroup A member 1,6.09,6.09,810.0,1,8
33216,CHEMBL705,ALITRETINOIN,11269,CHEMBL2808,Oxysterols receptor LXR-alpha,5.96,5.96,1090.0,1,9
33216,CHEMBL705,ALITRETINOIN,20113,CHEMBL4093,Oxysterols receptor LXR-beta,5.76,5.76,1730.0,1,9
33254,CHEMBL706,CETYL ALCOHOL,103668,CHEMBL1293235,Prelamin-A/C,6.45,6.45,354.8,1,9
33373,CHEMBL707,DOXAZOSIN,103,CHEMBL223,Alpha-1D adrenergic receptor,9.49,8.89,0.3236,7,9
33373,CHEMBL707,DOXAZOSIN,125,CHEMBL229,Alpha-1A adrenergic receptor,9.27,8.25,0.537,10,9
33373,CHEMBL707,DOXAZOSIN,128,CHEMBL232,Alpha-1B adrenergic receptor,9.2,9.1,0.631,5,9
33373,CHEMBL707,DOXAZOSIN,155,CHEMBL238,Sodium-dependent dopamine transporter,7.08,6.63,83.7,4,8
33373,CHEMBL707,DOXAZOSIN,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.63,6.47,234.0,3,8
33373,CHEMBL707,DOXAZOSIN,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.55,6.51,280.0,2,9
33373,CHEMBL707,DOXAZOSIN,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.54,6.28,285.0,3,8
33373,CHEMBL707,DOXAZOSIN,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.23,5.93,588.84,4,9
33373,CHEMBL707,DOXAZOSIN,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.14,5.82,729.0,3,9
33373,CHEMBL707,DOXAZOSIN,121,CHEMBL228,Sodium-dependent serotonin transporter,5.84,5.71,1428.0,2,8
33373,CHEMBL707,DOXAZOSIN,43,CHEMBL210,Beta-2 adrenergic receptor,5.72,5.64,1889.0,2,8
33373,CHEMBL707,DOXAZOSIN,102,CHEMBL1941,Histamine H2 receptor,5.63,5.63,2353.0,1,8
33373,CHEMBL707,DOXAZOSIN,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.58,5.58,2623.9,1,8
33373,CHEMBL707,DOXAZOSIN,129,CHEMBL233,Mu-type opioid receptor,5.58,5.58,2600.0,1,8
33664,CHEMBL708,ZIPRASIDONE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,10.1,9.25,0.08,12,9
33664,CHEMBL708,ZIPRASIDONE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,9.26,8.45,0.55,8,9
33664,CHEMBL708,ZIPRASIDONE,72,CHEMBL217,D(2) dopamine receptor,9.1,8.47,0.8,16,9
33664,CHEMBL708,ZIPRASIDONE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,8.8,8.07,1.585,8,9
33664,CHEMBL708,ZIPRASIDONE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,8.8,7.77,1.585,3,9
33664,CHEMBL708,ZIPRASIDONE,88,CHEMBL2056,D(1A) dopamine receptor,8.52,7.38,3.0,7,9
33664,CHEMBL708,ZIPRASIDONE,130,CHEMBL234,D(3) dopamine receptor,8.52,8.11,3.0,7,9
33664,CHEMBL708,ZIPRASIDONE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,8.3,8.27,5.0,3,9
33664,CHEMBL708,ZIPRASIDONE,127,CHEMBL231,Histamine H1 receptor,8.28,7.27,5.3,6,9
33664,CHEMBL708,ZIPRASIDONE,125,CHEMBL229,Alpha-1A adrenergic receptor,8.22,7.44,6.0,5,9
33664,CHEMBL708,ZIPRASIDONE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,7.7,7.29,20.0,5,9
33664,CHEMBL708,ZIPRASIDONE,90,CHEMBL219,D(4) dopamine receptor,7.5,7.25,32.0,5,9
33664,CHEMBL708,ZIPRASIDONE,121,CHEMBL228,Sodium-dependent serotonin transporter,7.28,6.78,53.0,5,9
33664,CHEMBL708,ZIPRASIDONE,155,CHEMBL238,Sodium-dependent dopamine transporter,7.06,7.06,87.5,1,8
33664,CHEMBL708,ZIPRASIDONE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.92,6.77,120.23,9,9
33664,CHEMBL708,ZIPRASIDONE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.48,6.48,330.0,1,8
33664,CHEMBL708,ZIPRASIDONE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.29,6.17,506.7,2,8
33664,CHEMBL708,ZIPRASIDONE,102,CHEMBL1941,Histamine H2 receptor,6.22,6.22,596.2,1,8
33664,CHEMBL708,ZIPRASIDONE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.05,5.87,895.1,3,8
33664,CHEMBL708,ZIPRASIDONE,137,CHEMBL237,Kappa-type opioid receptor,5.82,5.82,1502.5,1,8
33667,CHEMBL709,ALFUZOSIN,128,CHEMBL232,Alpha-1B adrenergic receptor,8.55,8.16,2.8,3,9
33667,CHEMBL709,ALFUZOSIN,103,CHEMBL223,Alpha-1D adrenergic receptor,8.5,8.47,3.162,2,9
33667,CHEMBL709,ALFUZOSIN,125,CHEMBL229,Alpha-1A adrenergic receptor,8.09,7.45,8.2,5,9
33667,CHEMBL709,ALFUZOSIN,93,CHEMBL220,Acetylcholinesterase,7.75,7.75,18.0,1,9
33667,CHEMBL709,ALFUZOSIN,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.09,6.09,810.0,1,8
112090,CHEMBL70927,DEFERIPRONE,12911,CHEMBL3397,Cytochrome P450 2C9,5.6,5.6,2511.9,1,9
112090,CHEMBL70927,DEFERIPRONE,12912,CHEMBL3622,Cytochrome P450 2C19,5.5,5.5,3162.3,1,9
111798,CHEMBL70972,SERATRODAST,246,CHEMBL2069,Thromboxane A2 receptor,8.13,6.86,7.4,2,8
111798,CHEMBL70972,SERATRODAST,126,CHEMBL230,Prostaglandin G/H synthase 2,5.89,5.89,1300.0,1,8
6216,CHEMBL71,CHLORPROMAZINE,72,CHEMBL217,D(2) dopamine receptor,9.0,8.3,1.0,15,9
6216,CHEMBL71,CHLORPROMAZINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.96,8.1,1.1,9,9
6216,CHEMBL71,CHLORPROMAZINE,130,CHEMBL234,D(3) dopamine receptor,8.8,8.16,1.585,13,9
6216,CHEMBL71,CHLORPROMAZINE,103,CHEMBL223,Alpha-1D adrenergic receptor,8.71,8.55,1.962,2,8
6216,CHEMBL71,CHLORPROMAZINE,127,CHEMBL231,Histamine H1 receptor,8.71,8.08,1.957,5,9
6216,CHEMBL71,CHLORPROMAZINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,8.56,7.65,2.742,7,9
6216,CHEMBL71,CHLORPROMAZINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,8.4,7.54,4.0,7,9
6216,CHEMBL71,CHLORPROMAZINE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,7.97,7.28,10.72,7,9
6216,CHEMBL71,CHLORPROMAZINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.92,7.31,12.0,3,8
6216,CHEMBL71,CHLORPROMAZINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,7.75,7.67,18.0,2,8
6216,CHEMBL71,CHLORPROMAZINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,7.72,7.44,19.0,3,8
6216,CHEMBL71,CHLORPROMAZINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.71,7.2,19.4,2,8
6216,CHEMBL71,CHLORPROMAZINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.7,6.86,20.0,4,9
6216,CHEMBL71,CHLORPROMAZINE,121,CHEMBL228,Sodium-dependent serotonin transporter,7.68,7.33,21.0,5,9
6216,CHEMBL71,CHLORPROMAZINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,7.68,7.1,21.0,3,9
6216,CHEMBL71,CHLORPROMAZINE,90,CHEMBL219,D(4) dopamine receptor,7.6,6.96,25.12,5,9
6216,CHEMBL71,CHLORPROMAZINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.4,6.9,39.81,6,9
6216,CHEMBL71,CHLORPROMAZINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,7.36,6.62,44.0,3,8
6216,CHEMBL71,CHLORPROMAZINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.27,6.41,54.0,3,8
6216,CHEMBL71,CHLORPROMAZINE,88,CHEMBL2056,D(1A) dopamine receptor,7.02,6.72,96.0,4,9
6216,CHEMBL71,CHLORPROMAZINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.88,6.28,132.0,3,8
6216,CHEMBL71,CHLORPROMAZINE,11365,CHEMBL289,Cytochrome P450 2D6,6.8,6.45,158.49,5,9
6216,CHEMBL71,CHLORPROMAZINE,102,CHEMBL1941,Histamine H2 receptor,6.77,5.98,171.2,3,8
6216,CHEMBL71,CHLORPROMAZINE,220,CHEMBL1850,D(1B) dopamine receptor,6.76,6.76,172.0,1,9
6216,CHEMBL71,CHLORPROMAZINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.72,6.54,189.0,2,8
6216,CHEMBL71,CHLORPROMAZINE,103668,CHEMBL1293235,Prelamin-A/C,6.65,6.65,223.9,1,9
6216,CHEMBL71,CHLORPROMAZINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.63,5.99,232.0,4,8
6216,CHEMBL71,CHLORPROMAZINE,10624,CHEMBL3426,5-hydroxytryptamine receptor 5A,6.42,6.42,380.0,1,8
6216,CHEMBL71,CHLORPROMAZINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.27,5.88,539.6,9,9
6216,CHEMBL71,CHLORPROMAZINE,12056,CHEMBL3257,Aldehyde oxidase,6.24,6.03,570.0,3,9
6216,CHEMBL71,CHLORPROMAZINE,11398,CHEMBL4302,ATP-dependent translocase ABCB1,6.22,6.22,600.0,1,8
6216,CHEMBL71,CHLORPROMAZINE,137,CHEMBL237,Kappa-type opioid receptor,6.2,6.2,629.2,1,8
6216,CHEMBL71,CHLORPROMAZINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.17,6.17,673.0,1,8
6216,CHEMBL71,CHLORPROMAZINE,12594,CHEMBL3356,Cytochrome P450 1A2,6.0,6.0,1000.0,1,8
6216,CHEMBL71,CHLORPROMAZINE,17045,CHEMBL340,Cytochrome P450 3A4,6.0,6.0,1000.0,3,9
6216,CHEMBL71,CHLORPROMAZINE,101444,CHEMBL6093,Calmodulin-1,5.91,5.91,1240.0,1,9
6216,CHEMBL71,CHLORPROMAZINE,10887,CHEMBL4869,Major prion protein,5.7,5.7,2000.0,1,8
6216,CHEMBL71,CHLORPROMAZINE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.68,5.63,2100.0,2,8
6216,CHEMBL71,CHLORPROMAZINE,105604,CHEMBL2321615,Potassium channel subfamily K member 2,5.57,5.57,2700.0,1,9
33679,CHEMBL710,FINASTERIDE,120,CHEMBL1856,3-oxo-5-alpha-steroid 4-dehydrogenase 2,9.74,8.36,0.18,28,9
33679,CHEMBL710,FINASTERIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.55,8.55,2.8,2,9
33679,CHEMBL710,FINASTERIDE,79,CHEMBL1787,3-oxo-5-alpha-steroid 4-dehydrogenase 1,7.58,6.78,26.3,24,9
33679,CHEMBL710,FINASTERIDE,12912,CHEMBL3622,Cytochrome P450 2C19,6.0,6.0,1000.0,1,8
33679,CHEMBL710,FINASTERIDE,12911,CHEMBL3397,Cytochrome P450 2C9,5.7,5.7,2000.0,1,8
33679,CHEMBL710,FINASTERIDE,17045,CHEMBL340,Cytochrome P450 3A4,5.7,5.7,1995.3,2,9
34094,CHEMBL714,ALBUTEROL,43,CHEMBL210,Beta-2 adrenergic receptor,9.96,6.66,0.11,14,9
34094,CHEMBL714,ALBUTEROL,50,CHEMBL213,Beta-1 adrenergic receptor,8.81,7.37,1.53,2,9
34197,CHEMBL715,OLANZAPINE,127,CHEMBL231,Histamine H1 receptor,10.06,8.52,0.087,13,9
34197,CHEMBL715,OLANZAPINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,9.38,8.35,0.42,31,9
34197,CHEMBL715,OLANZAPINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,8.68,7.75,2.1,6,9
34197,CHEMBL715,OLANZAPINE,72,CHEMBL217,D(2) dopamine receptor,8.68,7.69,2.1,33,9
34197,CHEMBL715,OLANZAPINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,8.55,7.99,2.8,15,9
34197,CHEMBL715,OLANZAPINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,8.3,8.09,5.0,23,9
34197,CHEMBL715,OLANZAPINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,8.2,7.62,6.31,6,9
34197,CHEMBL715,OLANZAPINE,88,CHEMBL2056,D(1A) dopamine receptor,8.0,7.12,10.0,13,9
34197,CHEMBL715,OLANZAPINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,8.0,7.46,10.0,4,9
34197,CHEMBL715,OLANZAPINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,7.9,6.98,12.59,5,9
34197,CHEMBL715,OLANZAPINE,90,CHEMBL219,D(4) dopamine receptor,7.72,7.39,19.0,10,9
34197,CHEMBL715,OLANZAPINE,130,CHEMBL234,D(3) dopamine receptor,7.7,7.3,19.95,14,9
34197,CHEMBL715,OLANZAPINE,103,CHEMBL223,Alpha-1D adrenergic receptor,7.35,7.2,45.0,2,8
34197,CHEMBL715,OLANZAPINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.31,6.82,49.4,6,9
34197,CHEMBL715,OLANZAPINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.11,6.75,77.0,5,9
34197,CHEMBL715,OLANZAPINE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,7.1,6.53,79.43,6,9
34197,CHEMBL715,OLANZAPINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,7.08,6.73,83.0,4,9
34197,CHEMBL715,OLANZAPINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.07,6.83,84.4,4,9
34197,CHEMBL715,OLANZAPINE,220,CHEMBL1850,D(1B) dopamine receptor,7.05,6.82,90.0,3,9
34197,CHEMBL715,OLANZAPINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.0,6.51,100.0,4,9
34197,CHEMBL715,OLANZAPINE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,7.0,7.0,100.0,1,9
34197,CHEMBL715,OLANZAPINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.74,6.7,181.0,8,9
34197,CHEMBL715,OLANZAPINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.72,6.26,192.0,5,9
34197,CHEMBL715,OLANZAPINE,103985,CHEMBL1741189,FAD-linked sulfhydryl oxidase ALR,6.43,6.43,369.0,1,8
34197,CHEMBL715,OLANZAPINE,102,CHEMBL1941,Histamine H2 receptor,6.37,6.37,430.1,1,8
34197,CHEMBL715,OLANZAPINE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.26,6.13,549.0,2,8
34197,CHEMBL715,OLANZAPINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.21,5.81,610.0,5,9
34197,CHEMBL715,OLANZAPINE,106,CHEMBL1898,5-hydroxytryptamine receptor 1B,6.0,6.0,1000.0,1,9
34197,CHEMBL715,OLANZAPINE,128,CHEMBL232,Alpha-1B adrenergic receptor,6.0,6.0,1000.0,1,9
34197,CHEMBL715,OLANZAPINE,144,CHEMBL1899,5-hydroxytryptamine receptor 3A,6.0,5.91,1000.0,2,9
34197,CHEMBL715,OLANZAPINE,10624,CHEMBL3426,5-hydroxytryptamine receptor 5A,5.64,5.64,2283.2,1,8
34197,CHEMBL715,OLANZAPINE,43,CHEMBL210,Beta-2 adrenergic receptor,5.59,5.59,2551.5,1,8
34234,CHEMBL716,QUETIAPINE,127,CHEMBL231,Histamine H1 receptor,8.34,7.86,4.599,9,9
34234,CHEMBL716,QUETIAPINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.7,7.03,20.0,6,9
34234,CHEMBL716,QUETIAPINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.51,6.82,31.0,15,9
34234,CHEMBL716,QUETIAPINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.34,6.67,45.8,4,9
34234,CHEMBL716,QUETIAPINE,103,CHEMBL223,Alpha-1D adrenergic receptor,7.32,7.17,47.5,2,8
34234,CHEMBL716,QUETIAPINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.25,6.21,56.0,8,9
34234,CHEMBL716,QUETIAPINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.21,6.65,61.1,4,9
34234,CHEMBL716,QUETIAPINE,72,CHEMBL217,D(2) dopamine receptor,7.2,6.52,63.1,11,9
34234,CHEMBL716,QUETIAPINE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,7.2,6.29,63.1,3,9
34234,CHEMBL716,QUETIAPINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.1,6.48,79.43,10,9
34234,CHEMBL716,QUETIAPINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.07,6.75,86.0,5,9
34234,CHEMBL716,QUETIAPINE,128,CHEMBL232,Alpha-1B adrenergic receptor,7.0,7.0,100.0,1,9
34234,CHEMBL716,QUETIAPINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.9,6.34,125.89,4,9
34234,CHEMBL716,QUETIAPINE,88,CHEMBL2056,D(1A) dopamine receptor,6.67,6.2,214.6,8,9
34234,CHEMBL716,QUETIAPINE,130,CHEMBL234,D(3) dopamine receptor,6.6,6.23,251.19,9,9
34234,CHEMBL716,QUETIAPINE,102,CHEMBL1941,Histamine H2 receptor,6.39,6.39,410.2,1,8
34234,CHEMBL716,QUETIAPINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.06,5.91,876.4,3,8
34234,CHEMBL716,QUETIAPINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.03,5.81,934.3,2,8
34234,CHEMBL716,QUETIAPINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.02,5.83,963.9,2,8
34234,CHEMBL716,QUETIAPINE,129,CHEMBL233,Mu-type opioid receptor,5.86,5.8,1397.5,2,8
34234,CHEMBL716,QUETIAPINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.85,5.73,1400.0,5,9
34234,CHEMBL716,QUETIAPINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,5.85,5.85,1400.0,1,9
34234,CHEMBL716,QUETIAPINE,90,CHEMBL219,D(4) dopamine receptor,5.8,5.76,1596.2,4,9
34234,CHEMBL716,QUETIAPINE,137,CHEMBL237,Kappa-type opioid receptor,5.8,5.8,1583.9,1,8
34234,CHEMBL716,QUETIAPINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,5.67,5.59,2155.9,2,8
34608,CHEMBL717,MEDROXYPROGESTERONE ACETATE,36,CHEMBL208,Progesterone receptor,10.0,9.3,0.1,28,9
34608,CHEMBL717,MEDROXYPROGESTERONE ACETATE,56,CHEMBL1871,Androgen receptor,9.0,8.47,1.0,10,9
34608,CHEMBL717,MEDROXYPROGESTERONE ACETATE,25,CHEMBL2034,Glucocorticoid receptor,8.06,7.92,8.637,13,9
34608,CHEMBL717,MEDROXYPROGESTERONE ACETATE,100481,CHEMBL4681,Aldo-keto reductase family 1 member C3,6.55,6.22,280.0,3,9
34608,CHEMBL717,MEDROXYPROGESTERONE ACETATE,12643,CHEMBL3305,Sex hormone-binding globulin,6.2,6.2,630.96,1,9
34608,CHEMBL717,MEDROXYPROGESTERONE ACETATE,101600,CHEMBL5905,Aldo-keto reductase family 1 member C1,6.16,5.96,700.0,2,9
34608,CHEMBL717,MEDROXYPROGESTERONE ACETATE,48,CHEMBL1994,Mineralocorticoid receptor,5.92,5.92,1197.0,3,9
34608,CHEMBL717,MEDROXYPROGESTERONE ACETATE,101351,CHEMBL5847,Aldo-keto reductase family 1 member C2,5.8,5.8,1600.0,1,8
34608,CHEMBL717,MEDROXYPROGESTERONE ACETATE,101097,CHEMBL5162,Neuropeptide S receptor,5.6,5.6,2511.9,1,9
35271,CHEMBL719,MUPIROCIN,11787,CHEMBL3235,"Isoleucine--tRNA ligase, cytoplasmic",9.1,9.1,0.8,1,8
6243,CHEMBL72,DESIPRAMINE,155,CHEMBL238,Sodium-dependent dopamine transporter,9.31,7.42,0.49,2,8
6243,CHEMBL72,DESIPRAMINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,9.22,8.56,0.6,33,9
6243,CHEMBL72,DESIPRAMINE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,8.1,8.1,7.9,1,9
6243,CHEMBL72,DESIPRAMINE,121,CHEMBL228,Sodium-dependent serotonin transporter,7.72,7.15,19.1,7,9
6243,CHEMBL72,DESIPRAMINE,127,CHEMBL231,Histamine H1 receptor,6.85,6.85,140.0,1,8
6243,CHEMBL72,DESIPRAMINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.8,6.8,160.0,1,8
6243,CHEMBL72,DESIPRAMINE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.24,6.24,570.0,1,8
6243,CHEMBL72,DESIPRAMINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.86,5.84,1380.38,8,9
6243,CHEMBL72,DESIPRAMINE,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,5.82,5.76,1520.0,2,9
6243,CHEMBL72,DESIPRAMINE,130,CHEMBL234,D(3) dopamine receptor,5.77,5.77,1700.0,1,8
6243,CHEMBL72,DESIPRAMINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.66,5.66,2200.0,1,8
6243,CHEMBL72,DESIPRAMINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,5.54,5.54,2900.0,1,8
6243,CHEMBL72,DESIPRAMINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.5,5.5,3200.0,1,8
35486,CHEMBL720,BENZYL ALCOHOL,78,CHEMBL1963,Thyrotropin receptor,7.7,7.7,20.0,2,9
36662,CHEMBL723,CARVEDILOL,50,CHEMBL213,Beta-1 adrenergic receptor,9.99,9.4,0.103,3,8
36662,CHEMBL723,CARVEDILOL,43,CHEMBL210,Beta-2 adrenergic receptor,9.78,9.45,0.166,5,9
36662,CHEMBL723,CARVEDILOL,103,CHEMBL223,Alpha-1D adrenergic receptor,9.05,8.9,0.883,2,8
36662,CHEMBL723,CARVEDILOL,226,CHEMBL246,Beta-3 adrenergic receptor,8.51,8.27,3.116,3,8
36662,CHEMBL723,CARVEDILOL,125,CHEMBL229,Alpha-1A adrenergic receptor,8.0,7.41,9.9,3,8
36662,CHEMBL723,CARVEDILOL,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,8.0,7.43,10.1,4,8
36662,CHEMBL723,CARVEDILOL,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.89,7.38,13.0,3,8
36662,CHEMBL723,CARVEDILOL,90,CHEMBL219,D(4) dopamine receptor,7.76,7.76,17.2,1,8
36662,CHEMBL723,CARVEDILOL,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.7,7.55,20.0,2,8
36662,CHEMBL723,CARVEDILOL,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.4,6.65,40.0,4,8
36662,CHEMBL723,CARVEDILOL,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.37,7.05,43.0,3,8
36662,CHEMBL723,CARVEDILOL,72,CHEMBL217,D(2) dopamine receptor,7.31,7.01,49.0,3,8
36662,CHEMBL723,CARVEDILOL,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.22,6.71,60.0,3,8
36662,CHEMBL723,CARVEDILOL,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.95,6.76,111.7,3,8
36662,CHEMBL723,CARVEDILOL,121,CHEMBL228,Sodium-dependent serotonin transporter,6.93,6.48,118.0,3,8
36662,CHEMBL723,CARVEDILOL,130,CHEMBL234,D(3) dopamine receptor,6.71,6.43,196.0,3,8
36662,CHEMBL723,CARVEDILOL,115,CHEMBL227,Type-1 angiotensin II receptor,6.59,6.59,254.6,1,8
36662,CHEMBL723,CARVEDILOL,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.46,6.03,350.0,2,8
36662,CHEMBL723,CARVEDILOL,250,CHEMBL249,Substance-P receptor,6.32,6.32,481.4,1,8
36662,CHEMBL723,CARVEDILOL,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.27,6.27,533.0,2,8
36662,CHEMBL723,CARVEDILOL,155,CHEMBL238,Sodium-dependent dopamine transporter,6.17,6.12,671.0,2,8
36662,CHEMBL723,CARVEDILOL,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.15,5.96,705.0,3,8
36662,CHEMBL723,CARVEDILOL,88,CHEMBL2056,D(1A) dopamine receptor,6.13,5.86,749.0,3,8
36662,CHEMBL723,CARVEDILOL,10147,CHEMBL4878,Cytochrome P450 1B1,5.96,5.96,1100.0,1,9
36662,CHEMBL723,CARVEDILOL,102,CHEMBL1941,Histamine H2 receptor,5.81,5.81,1558.3,1,8
36662,CHEMBL723,CARVEDILOL,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,5.8,5.8,1581.6,1,8
36662,CHEMBL723,CARVEDILOL,105604,CHEMBL2321615,Potassium channel subfamily K member 2,5.8,5.8,1600.0,1,9
36662,CHEMBL723,CARVEDILOL,129,CHEMBL233,Mu-type opioid receptor,5.77,5.77,1700.0,1,8
36662,CHEMBL723,CARVEDILOL,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,5.75,5.75,1800.0,1,8
36842,CHEMBL726,FLUPHENAZINE,130,CHEMBL234,D(3) dopamine receptor,9.7,8.81,0.202,5,9
36842,CHEMBL726,FLUPHENAZINE,72,CHEMBL217,D(2) dopamine receptor,9.27,8.83,0.539,5,9
36842,CHEMBL726,FLUPHENAZINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.84,7.79,1.458,5,9
36842,CHEMBL726,FLUPHENAZINE,127,CHEMBL231,Histamine H1 receptor,8.33,7.67,4.662,5,9
36842,CHEMBL726,FLUPHENAZINE,125,CHEMBL229,Alpha-1A adrenergic receptor,8.19,8.07,6.5,2,9
36842,CHEMBL726,FLUPHENAZINE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,8.1,8.1,8.0,1,9
36842,CHEMBL726,FLUPHENAZINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,8.07,7.88,8.575,2,8
36842,CHEMBL726,FLUPHENAZINE,88,CHEMBL2056,D(1A) dopamine receptor,7.96,7.29,11.0,5,9
36842,CHEMBL726,FLUPHENAZINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.89,7.24,13.0,4,9
36842,CHEMBL726,FLUPHENAZINE,103,CHEMBL223,Alpha-1D adrenergic receptor,7.8,7.64,16.0,2,8
36842,CHEMBL726,FLUPHENAZINE,220,CHEMBL1850,D(1B) dopamine receptor,7.68,7.68,21.0,2,9
36842,CHEMBL726,FLUPHENAZINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.66,7.08,22.0,4,9
36842,CHEMBL726,FLUPHENAZINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,7.62,7.44,24.0,3,9
36842,CHEMBL726,FLUPHENAZINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.6,7.09,25.0,4,8
36842,CHEMBL726,FLUPHENAZINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.46,6.85,35.0,3,8
36842,CHEMBL726,FLUPHENAZINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.1,6.5,80.0,4,9
36842,CHEMBL726,FLUPHENAZINE,90,CHEMBL219,D(4) dopamine receptor,6.89,6.29,130.0,2,9
36842,CHEMBL726,FLUPHENAZINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.84,6.37,145.7,2,9
36842,CHEMBL726,FLUPHENAZINE,102,CHEMBL1941,Histamine H2 receptor,6.59,6.14,259.7,3,8
36842,CHEMBL726,FLUPHENAZINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.32,6.32,484.0,1,8
36842,CHEMBL726,FLUPHENAZINE,11365,CHEMBL289,Cytochrome P450 2D6,6.2,6.05,630.96,4,9
36842,CHEMBL726,FLUPHENAZINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.19,5.88,646.0,2,8
36842,CHEMBL726,FLUPHENAZINE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.1,5.95,793.0,3,8
36842,CHEMBL726,FLUPHENAZINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.0,6.0,1002.0,1,8
36842,CHEMBL726,FLUPHENAZINE,12594,CHEMBL3356,Cytochrome P450 1A2,6.0,5.8,1000.0,2,8
36842,CHEMBL726,FLUPHENAZINE,137,CHEMBL237,Kappa-type opioid receptor,5.85,5.85,1410.0,1,8
36842,CHEMBL726,FLUPHENAZINE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.79,5.74,1631.0,2,8
36842,CHEMBL726,FLUPHENAZINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.74,5.74,1842.6,1,8
36842,CHEMBL726,FLUPHENAZINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.71,5.71,1946.0,2,8
36842,CHEMBL726,FLUPHENAZINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.58,5.58,2660.0,1,8
36864,CHEMBL727,THIOGUANINE,96,CHEMBL221,Prostaglandin G/H synthase 1,6.22,6.06,601.0,3,9
36864,CHEMBL727,THIOGUANINE,11544,CHEMBL4331,Hemoglobin subunit beta,5.95,5.95,1122.02,1,9
36864,CHEMBL727,THIOGUANINE,105692,CHEMBL2362980,Paired box protein Pax-8,5.93,5.93,1180.0,1,8
37266,CHEMBL728,PROCHLORPERAZINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.7,8.15,2.018,3,8
37266,CHEMBL728,PROCHLORPERAZINE,127,CHEMBL231,Histamine H1 receptor,8.55,7.25,2.794,4,8
37266,CHEMBL728,PROCHLORPERAZINE,72,CHEMBL217,D(2) dopamine receptor,8.44,7.92,3.608,3,8
37266,CHEMBL728,PROCHLORPERAZINE,130,CHEMBL234,D(3) dopamine receptor,8.35,7.84,4.454,3,8
37266,CHEMBL728,PROCHLORPERAZINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,8.32,7.49,4.741,3,8
37266,CHEMBL728,PROCHLORPERAZINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,7.92,6.95,12.0,3,8
37266,CHEMBL728,PROCHLORPERAZINE,103,CHEMBL223,Alpha-1D adrenergic receptor,7.8,7.63,16.0,2,8
37266,CHEMBL728,PROCHLORPERAZINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,7.64,7.46,23.0,2,8
37266,CHEMBL728,PROCHLORPERAZINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.39,6.8,41.0,3,8
37266,CHEMBL728,PROCHLORPERAZINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.2,6.98,63.0,2,8
37266,CHEMBL728,PROCHLORPERAZINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.19,6.58,65.0,3,8
37266,CHEMBL728,PROCHLORPERAZINE,88,CHEMBL2056,D(1A) dopamine receptor,7.11,6.96,78.0,2,8
37266,CHEMBL728,PROCHLORPERAZINE,103668,CHEMBL1293235,Prelamin-A/C,7.05,7.05,89.1,1,9
37266,CHEMBL728,PROCHLORPERAZINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.91,6.74,124.0,2,8
37266,CHEMBL728,PROCHLORPERAZINE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.9,6.43,125.2,2,8
37266,CHEMBL728,PROCHLORPERAZINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.8,6.73,158.0,2,8
37266,CHEMBL728,PROCHLORPERAZINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.72,6.29,190.0,2,8
37266,CHEMBL728,PROCHLORPERAZINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.61,6.3,244.0,2,8
37266,CHEMBL728,PROCHLORPERAZINE,11365,CHEMBL289,Cytochrome P450 2D6,6.52,6.3,300.0,5,9
37266,CHEMBL728,PROCHLORPERAZINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.49,6.16,321.0,2,8
37266,CHEMBL728,PROCHLORPERAZINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.4,6.4,396.0,2,8
37266,CHEMBL728,PROCHLORPERAZINE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.21,6.07,621.0,2,8
37266,CHEMBL728,PROCHLORPERAZINE,137,CHEMBL237,Kappa-type opioid receptor,6.16,6.16,686.8,1,8
37266,CHEMBL728,PROCHLORPERAZINE,90,CHEMBL219,D(4) dopamine receptor,6.09,5.87,810.0,2,8
37266,CHEMBL728,PROCHLORPERAZINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.0,5.85,994.0,3,8
37266,CHEMBL728,PROCHLORPERAZINE,12594,CHEMBL3356,Cytochrome P450 1A2,6.0,5.77,1000.0,3,8
37266,CHEMBL728,PROCHLORPERAZINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.96,5.73,1107.0,2,8
37266,CHEMBL728,PROCHLORPERAZINE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.86,5.81,1379.0,2,8
37266,CHEMBL728,PROCHLORPERAZINE,12912,CHEMBL3622,Cytochrome P450 2C19,5.7,5.7,1995.26,2,9
37266,CHEMBL728,PROCHLORPERAZINE,103665,CHEMBL1293232,Survival motor neuron protein,5.7,5.7,1995.3,1,9
37266,CHEMBL728,PROCHLORPERAZINE,78,CHEMBL1963,Thyrotropin receptor,5.5,5.5,3162.3,2,9
37316,CHEMBL729,LOPINAVIR,17045,CHEMBL340,Cytochrome P450 3A4,6.39,6.13,410.0,3,9
37316,CHEMBL729,LOPINAVIR,11398,CHEMBL4302,ATP-dependent translocase ABCB1,5.77,5.77,1700.0,1,8
117805,CHEMBL73234,CARBETAPENTANE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,9.0,9.0,1.0,1,9
117805,CHEMBL73234,CARBETAPENTANE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,7.71,7.3,19.5,2,9
117805,CHEMBL73234,CARBETAPENTANE,10331,CHEMBL2335,Lysosomal Pro-X carboxypeptidase,7.5,7.5,32.0,1,8
117805,CHEMBL73234,CARBETAPENTANE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.12,7.12,76.0,2,9
117805,CHEMBL73234,CARBETAPENTANE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.78,6.78,167.0,1,8
117805,CHEMBL73234,CARBETAPENTANE,78,CHEMBL1963,Thyrotropin receptor,6.5,6.5,316.2,2,9
117805,CHEMBL73234,CARBETAPENTANE,101283,CHEMBL5685,Solute carrier family 22 member 1,5.81,5.81,1550.0,1,9
117805,CHEMBL73234,CARBETAPENTANE,117512,CHEMBL4105907,Sigma intracellular receptor 2,5.71,5.71,1953.0,1,9
6480,CHEMBL74,CROMOLYN SODIUM,103700,CHEMBL1293267,G-protein coupled receptor 35,5.9,5.9,1260.0,1,9
38727,CHEMBL741,LAMOTRIGINE,170,CHEMBL241,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",5.68,5.68,2100.0,1,8
38833,CHEMBL742,KETAMINE,169,CHEMBL1940,Voltage-dependent L-type calcium channel subunit alpha-1C,5.75,5.75,1800.0,1,9
38898,CHEMBL744,RILUZOLE,12594,CHEMBL3356,Cytochrome P450 1A2,6.5,6.35,316.23,2,8
38898,CHEMBL744,RILUZOLE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.76,5.7,1718.0,3,8
38898,CHEMBL744,RILUZOLE,18072,CHEMBL4187,Sodium channel protein type 2 subunit alpha,5.66,5.66,2200.0,1,8
39857,CHEMBL750,ZONISAMIDE,11060,CHEMBL2326,Carbonic anhydrase 7,9.05,7.2,0.9,8,9
39857,CHEMBL750,ZONISAMIDE,12209,CHEMBL3242,Carbonic anhydrase 12,8.42,8.42,3.8,1,9
39857,CHEMBL750,ZONISAMIDE,12952,CHEMBL3594,Carbonic anhydrase 9,8.3,8.29,5.0,9,9
39857,CHEMBL750,ZONISAMIDE,15,CHEMBL205,Carbonic anhydrase 2,7.99,7.4,10.3,56,9
39857,CHEMBL750,ZONISAMIDE,11042,CHEMBL4789,"Carbonic anhydrase 5A, mitochondrial",7.7,7.7,20.0,5,9
39857,CHEMBL750,ZONISAMIDE,10193,CHEMBL261,Carbonic anhydrase 1,7.46,7.24,35.0,45,9
39857,CHEMBL750,ZONISAMIDE,10186,CHEMBL3025,Carbonic anhydrase 6,7.05,6.33,89.0,4,9
39857,CHEMBL750,ZONISAMIDE,12923,CHEMBL3912,Carbonic anhydrase 13,6.37,6.37,430.0,1,9
39857,CHEMBL750,ZONISAMIDE,103668,CHEMBL1293235,Prelamin-A/C,6.05,6.05,891.3,1,9
39857,CHEMBL750,ZONISAMIDE,104,CHEMBL2039,Amine oxidase [flavin-containing] B,5.51,5.51,3100.0,2,9
40940,CHEMBL752,ADENOSINE PHOSPHATE,11907,CHEMBL4398,P2Y purinoceptor 2,7.07,7.07,85.0,1,8
40940,CHEMBL752,ADENOSINE PHOSPHATE,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,7.0,7.0,100.0,1,8
40940,CHEMBL752,ADENOSINE PHOSPHATE,11415,CHEMBL3975,"Fructose-1,6-bisphosphatase 1",6.85,5.92,140.0,11,9
40940,CHEMBL752,ADENOSINE PHOSPHATE,114,CHEMBL226,Adenosine receptor A1,6.3,6.3,500.0,1,9
40940,CHEMBL752,ADENOSINE PHOSPHATE,10544,CHEMBL4315,P2Y purinoceptor 1,5.82,5.82,1500.0,1,8
41434,CHEMBL753,PHENOXYBENZAMINE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.47,6.47,340.0,1,8
41434,CHEMBL753,PHENOXYBENZAMINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.77,5.77,1700.0,1,8
41434,CHEMBL753,PHENOXYBENZAMINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.68,5.68,2100.0,1,8
41434,CHEMBL753,PHENOXYBENZAMINE,88,CHEMBL2056,D(1A) dopamine receptor,5.66,5.66,2200.0,1,8
41434,CHEMBL753,PHENOXYBENZAMINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.64,5.64,2300.0,1,8
41434,CHEMBL753,PHENOXYBENZAMINE,101283,CHEMBL5685,Solute carrier family 22 member 1,5.57,5.57,2720.0,1,8
41434,CHEMBL753,PHENOXYBENZAMINE,127,CHEMBL231,Histamine H1 receptor,5.52,5.52,3000.0,1,8
41434,CHEMBL753,PHENOXYBENZAMINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.5,5.5,3200.0,1,8
41644,CHEMBL754,FOSCARNET SODIUM,103668,CHEMBL1293235,Prelamin-A/C,6.45,6.45,354.8,1,9
117758,CHEMBL75435,DEXKETOPROFEN,96,CHEMBL221,Prostaglandin G/H synthase 1,8.72,8.27,1.9,4,9
117758,CHEMBL75435,DEXKETOPROFEN,126,CHEMBL230,Prostaglandin G/H synthase 2,7.57,7.11,27.0,2,8
2355,CHEMBL7568,QUINACRINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.58,6.24,266.0,2,8
2355,CHEMBL7568,QUINACRINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.56,6.13,277.0,2,8
2355,CHEMBL7568,QUINACRINE,10887,CHEMBL4869,Major prion protein,6.52,6.52,300.0,1,8
2355,CHEMBL7568,QUINACRINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.46,6.2,343.0,3,8
2355,CHEMBL7568,QUINACRINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.45,6.14,359.0,2,8
2355,CHEMBL7568,QUINACRINE,130,CHEMBL234,D(3) dopamine receptor,6.35,6.12,448.0,2,8
2355,CHEMBL7568,QUINACRINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.25,6.25,560.0,1,8
2355,CHEMBL7568,QUINACRINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.16,6.16,700.0,1,8
2355,CHEMBL7568,QUINACRINE,10280,CHEMBL264,Histamine H3 receptor,6.16,6.16,692.8,1,8
2355,CHEMBL7568,QUINACRINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.12,5.85,761.0,2,8
2355,CHEMBL7568,QUINACRINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.08,5.91,833.0,2,8
2355,CHEMBL7568,QUINACRINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.07,5.86,855.0,2,8
2355,CHEMBL7568,QUINACRINE,93,CHEMBL220,Acetylcholinesterase,6.03,5.8,928.2,2,8
2355,CHEMBL7568,QUINACRINE,103,CHEMBL223,Alpha-1D adrenergic receptor,5.99,5.83,1015.0,2,8
2355,CHEMBL7568,QUINACRINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.65,5.65,2261.0,1,8
2355,CHEMBL7568,QUINACRINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,5.57,5.57,2684.0,1,8
2355,CHEMBL7568,QUINACRINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.54,5.54,2872.0,2,8
119288,CHEMBL75880,PERHEXILINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.3,6.3,500.9,1,8
119288,CHEMBL75880,PERHEXILINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.18,5.88,652.8,2,8
119288,CHEMBL75880,PERHEXILINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.18,5.84,661.0,2,8
119288,CHEMBL75880,PERHEXILINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.11,6.04,785.4,2,8
119288,CHEMBL75880,PERHEXILINE,11365,CHEMBL289,Cytochrome P450 2D6,6.03,6.03,940.8,1,8
119288,CHEMBL75880,PERHEXILINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,5.96,5.77,1092.4,2,8
119288,CHEMBL75880,PERHEXILINE,9,CHEMBL203,Epidermal growth factor receptor,5.83,5.83,1485.2,1,8
6579,CHEMBL76,CHLOROQUINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,7.1,7.1,79.43,1,9
6579,CHEMBL76,CHLOROQUINE,11400,CHEMBL2842,Serine/threonine-protein kinase mTOR,6.57,6.57,270.0,2,9
6579,CHEMBL76,CHLOROQUINE,117512,CHEMBL4105907,Sigma intracellular receptor 2,6.3,6.3,501.19,1,9
6579,CHEMBL76,CHLOROQUINE,11848,CHEMBL3736,Angiotensin-converting enzyme 2,5.95,5.95,1130.0,1,9
6579,CHEMBL76,CHLOROQUINE,10170,CHEMBL3959,Ribosyldihydronicotinamide dehydrogenase [quinone],5.82,5.82,1500.0,1,9
6579,CHEMBL76,CHLOROQUINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.6,5.58,2500.0,5,9
42290,CHEMBL760,ANAGRELIDE,170,CHEMBL241,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",7.31,7.31,48.9,1,8
42290,CHEMBL760,ANAGRELIDE,176,CHEMBL2001,P2Y purinoceptor 12,5.98,5.98,1050.0,1,8
42468,CHEMBL761,NAPHAZOLINE,125,CHEMBL229,Alpha-1A adrenergic receptor,9.22,8.12,0.6,4,8
42468,CHEMBL761,NAPHAZOLINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,8.64,7.46,2.291,3,9
42468,CHEMBL761,NAPHAZOLINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,8.06,7.49,8.7,4,8
42468,CHEMBL761,NAPHAZOLINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.95,6.95,113.6,1,8
42468,CHEMBL761,NAPHAZOLINE,11684,CHEMBL3923,Nischarin,6.92,6.92,121.6,2,9
42468,CHEMBL761,NAPHAZOLINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.72,6.72,190.0,1,8
42468,CHEMBL761,NAPHAZOLINE,103657,CHEMBL1293224,Microtubule-associated protein tau,6.1,6.1,794.3,1,9
42468,CHEMBL761,NAPHAZOLINE,103668,CHEMBL1293235,Prelamin-A/C,5.7,5.7,1995.3,1,9
42520,CHEMBL762,OXYMETAZOLINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,9.54,8.31,0.29,7,9
42520,CHEMBL762,OXYMETAZOLINE,106,CHEMBL1898,5-hydroxytryptamine receptor 1B,9.52,9.52,0.3,1,8
42520,CHEMBL762,OXYMETAZOLINE,105,CHEMBL1983,5-hydroxytryptamine receptor 1D,9.4,8.13,0.4,2,8
42520,CHEMBL762,OXYMETAZOLINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,9.0,7.06,1.0,6,9
42520,CHEMBL762,OXYMETAZOLINE,125,CHEMBL229,Alpha-1A adrenergic receptor,8.72,7.68,1.9,6,8
42520,CHEMBL762,OXYMETAZOLINE,11684,CHEMBL3923,Nischarin,8.21,8.21,6.194,2,9
42520,CHEMBL762,OXYMETAZOLINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,8.03,8.03,9.4,1,8
42520,CHEMBL762,OXYMETAZOLINE,11365,CHEMBL289,Cytochrome P450 2D6,7.4,7.17,39.8,3,9
42520,CHEMBL762,OXYMETAZOLINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.01,6.44,98.7,3,8
42520,CHEMBL762,OXYMETAZOLINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.57,5.93,266.4,3,8
42520,CHEMBL762,OXYMETAZOLINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.52,6.38,303.0,2,8
42520,CHEMBL762,OXYMETAZOLINE,103668,CHEMBL1293235,Prelamin-A/C,6.4,6.4,398.1,1,9
42520,CHEMBL762,OXYMETAZOLINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.34,6.34,455.0,1,8
42520,CHEMBL762,OXYMETAZOLINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.24,6.06,581.0,2,8
42520,CHEMBL762,OXYMETAZOLINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.11,5.95,775.0,2,8
42520,CHEMBL762,OXYMETAZOLINE,128,CHEMBL232,Alpha-1B adrenergic receptor,6.08,6.08,831.76,1,8
42520,CHEMBL762,OXYMETAZOLINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.02,5.95,957.0,2,8
42520,CHEMBL762,OXYMETAZOLINE,103,CHEMBL223,Alpha-1D adrenergic receptor,5.87,5.76,1348.96,3,8
122247,CHEMBL76370,TEGASEROD,168,CHEMBL1875,5-hydroxytryptamine receptor 4,9.0,8.38,1.0,10,9
122247,CHEMBL76370,TEGASEROD,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.69,7.08,20.6,2,8
122247,CHEMBL76370,TEGASEROD,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.4,6.74,40.0,3,8
122247,CHEMBL76370,TEGASEROD,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.76,6.29,174.3,2,8
122247,CHEMBL76370,TEGASEROD,10624,CHEMBL3426,5-hydroxytryptamine receptor 5A,6.72,6.72,190.0,1,8
122247,CHEMBL76370,TEGASEROD,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.7,6.7,197.6,1,8
122247,CHEMBL76370,TEGASEROD,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.58,6.44,260.0,2,8
122247,CHEMBL76370,TEGASEROD,125,CHEMBL229,Alpha-1A adrenergic receptor,6.57,5.97,266.9,4,8
122247,CHEMBL76370,TEGASEROD,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.51,6.28,310.1,2,8
122247,CHEMBL76370,TEGASEROD,88,CHEMBL2056,D(1A) dopamine receptor,6.47,6.21,340.0,3,8
122247,CHEMBL76370,TEGASEROD,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.26,6.26,543.4,1,8
122247,CHEMBL76370,TEGASEROD,90,CHEMBL219,D(4) dopamine receptor,6.18,6.18,656.5,1,8
122247,CHEMBL76370,TEGASEROD,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.11,6.11,771.1,1,8
122247,CHEMBL76370,TEGASEROD,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,6.1,6.1,802.3,1,8
122247,CHEMBL76370,TEGASEROD,115,CHEMBL227,Type-1 angiotensin II receptor,5.75,5.75,1800.0,1,8
122247,CHEMBL76370,TEGASEROD,155,CHEMBL238,Sodium-dependent dopamine transporter,5.73,5.73,1850.0,1,8
122247,CHEMBL76370,TEGASEROD,129,CHEMBL233,Mu-type opioid receptor,5.63,5.59,2320.0,2,8
122247,CHEMBL76370,TEGASEROD,144,CHEMBL1899,5-hydroxytryptamine receptor 3A,5.6,5.6,2511.89,1,9
122247,CHEMBL76370,TEGASEROD,121,CHEMBL228,Sodium-dependent serotonin transporter,5.59,5.59,2570.0,1,8
122247,CHEMBL76370,TEGASEROD,96,CHEMBL221,Prostaglandin G/H synthase 1,5.58,5.58,2650.0,1,8
122247,CHEMBL76370,TEGASEROD,72,CHEMBL217,D(2) dopamine receptor,5.51,5.51,3100.0,1,8
43086,CHEMBL765,GUANETHIDINE,103668,CHEMBL1293235,Prelamin-A/C,5.85,5.85,1412.5,1,9
43354,CHEMBL768,ESMOLOL,50,CHEMBL213,Beta-1 adrenergic receptor,6.94,6.57,113.7,3,8
43448,CHEMBL770,TOLAZOLINE,103668,CHEMBL1293235,Prelamin-A/C,6.75,6.75,177.8,1,9
43448,CHEMBL770,TOLAZOLINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.08,6.08,840.0,1,8
43448,CHEMBL770,TOLAZOLINE,101361,CHEMBL5857,Trace amine-associated receptor 1,5.79,5.79,1640.0,1,9
43448,CHEMBL770,TOLAZOLINE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.72,5.72,1900.0,1,8
43740,CHEMBL771,CYCLOSERINE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.96,8.96,1.1,2,9
43740,CHEMBL771,CYCLOSERINE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,5.8,5.8,1584.9,2,9
43952,CHEMBL772,RESERPINE,162,CHEMBL1893,Synaptic vesicular amine transporter,8.28,7.44,5.26,6,9
43952,CHEMBL772,RESERPINE,267,CHEMBL1838,Chromaffin granule amine transporter,7.3,7.3,50.0,1,9
43952,CHEMBL772,RESERPINE,11398,CHEMBL4302,ATP-dependent translocase ABCB1,7.0,5.93,100.0,8,9
43952,CHEMBL772,RESERPINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.83,5.83,1462.4,1,8
43952,CHEMBL772,RESERPINE,93,CHEMBL220,Acetylcholinesterase,5.77,5.77,1700.0,1,9
43952,CHEMBL772,RESERPINE,129,CHEMBL233,Mu-type opioid receptor,5.77,5.77,1686.0,1,8
43952,CHEMBL772,RESERPINE,10532,CHEMBL1914,Cholinesterase,5.55,5.55,2800.0,1,9
44010,CHEMBL773,GLYCINE,119204,CHEMBL4523454,Olfactory receptor 51E2,7.24,7.24,58.0,1,9
44647,CHEMBL776,METAPROTERENOL,43,CHEMBL210,Beta-2 adrenergic receptor,6.3,6.3,501.19,1,9
44647,CHEMBL776,METAPROTERENOL,125,CHEMBL229,Alpha-1A adrenergic receptor,5.51,5.51,3106.1,1,8
44905,CHEMBL778,DEXMEDETOMIDINE,103,CHEMBL223,Alpha-1D adrenergic receptor,10.82,8.37,0.015,2,9
44905,CHEMBL778,DEXMEDETOMIDINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,9.32,8.16,0.48,4,9
44905,CHEMBL778,DEXMEDETOMIDINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,9.1,8.72,0.8,6,9
44905,CHEMBL778,DEXMEDETOMIDINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,8.72,8.6,1.91,2,9
44905,CHEMBL778,DEXMEDETOMIDINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.88,6.88,13.03,2,9
44905,CHEMBL778,DEXMEDETOMIDINE,12594,CHEMBL3356,Cytochrome P450 1A2,6.8,6.8,158.49,1,8
44905,CHEMBL778,DEXMEDETOMIDINE,17045,CHEMBL340,Cytochrome P450 3A4,6.8,6.8,158.49,3,9
44905,CHEMBL778,DEXMEDETOMIDINE,12911,CHEMBL3397,Cytochrome P450 2C9,6.7,6.7,199.5,2,9
44920,CHEMBL779,TADALAFIL,3,CHEMBL1827,"cGMP-specific 3',5'-cyclic phosphodiesterase",8.92,8.44,1.2,22,9
44920,CHEMBL779,TADALAFIL,12448,CHEMBL2717,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",8.0,7.23,10.0,11,9
44920,CHEMBL779,TADALAFIL,11360,CHEMBL3977,"Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'",6.4,6.4,402.0,1,9
44920,CHEMBL779,TADALAFIL,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.99,5.99,1030.0,1,8
46073,CHEMBL780,PENTETIC ACID,12912,CHEMBL3622,Cytochrome P450 2C19,8.6,8.6,2.5,2,9
46073,CHEMBL780,PENTETIC ACID,121,CHEMBL228,Sodium-dependent serotonin transporter,7.37,7.37,42.9,1,8
46073,CHEMBL780,PENTETIC ACID,103668,CHEMBL1293235,Prelamin-A/C,6.9,6.9,125.9,1,9
46073,CHEMBL780,PENTETIC ACID,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.7,6.28,199.5,3,9
46073,CHEMBL780,PENTETIC ACID,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,6.35,6.35,446.7,2,9
46073,CHEMBL780,PENTETIC ACID,12054,CHEMBL2903,Polyunsaturated fatty acid lipoxygenase ALOX15,6.1,6.1,794.3,1,9
46073,CHEMBL780,PENTETIC ACID,125,CHEMBL229,Alpha-1A adrenergic receptor,5.89,5.89,1281.5,1,8
46073,CHEMBL780,PENTETIC ACID,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.88,5.88,1318.9,1,8
46073,CHEMBL780,PENTETIC ACID,130,CHEMBL234,D(3) dopamine receptor,5.64,5.64,2264.7,1,8
46385,CHEMBL781,MAZINDOL,100,CHEMBL222,Sodium-dependent noradrenaline transporter,9.04,8.03,0.92,7,9
46385,CHEMBL781,MAZINDOL,155,CHEMBL238,Sodium-dependent dopamine transporter,7.89,7.48,13.0,15,9
46385,CHEMBL781,MAZINDOL,121,CHEMBL228,Sodium-dependent serotonin transporter,7.35,7.11,45.0,7,9
46385,CHEMBL781,MAZINDOL,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.63,6.63,234.42,1,8
46726,CHEMBL782,TOLBUTAMIDE,103668,CHEMBL1293235,Prelamin-A/C,6.65,6.65,223.9,1,9
46726,CHEMBL782,TOLBUTAMIDE,12911,CHEMBL3397,Cytochrome P450 2C9,6.42,6.4,380.0,4,9
47340,CHEMBL786,TAMOXIFEN CITRATE,174,CHEMBL242,Estrogen receptor beta,8.3,8.3,5.0,1,9
47340,CHEMBL786,TAMOXIFEN CITRATE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,6.5,6.5,316.2,2,9
47340,CHEMBL786,TAMOXIFEN CITRATE,19,CHEMBL206,Estrogen receptor,5.77,5.77,1700.0,1,9
47340,CHEMBL786,TAMOXIFEN CITRATE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,5.6,5.6,2511.9,1,9
47447,CHEMBL787,MONTELUKAST,179,CHEMBL1798,Cysteinyl leukotriene receptor 1,9.3,8.63,0.5,6,9
47447,CHEMBL787,MONTELUKAST,10163,CHEMBL3721,Cytochrome P450 2C8,6.89,6.26,130.0,3,9
47447,CHEMBL787,MONTELUKAST,280,CHEMBL256,Adenosine receptor A3,6.61,6.16,245.0,3,8
47447,CHEMBL787,MONTELUKAST,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.12,6.12,767.0,1,8
47447,CHEMBL787,MONTELUKAST,10188,CHEMBL260,Mitogen-activated protein kinase 14,6.07,6.07,856.0,1,8
47447,CHEMBL787,MONTELUKAST,10184,CHEMBL2327,Substance-K receptor,5.89,5.89,1274.0,1,8
47447,CHEMBL787,MONTELUKAST,102394,CHEMBL6020,Bile salt export pump,5.89,5.89,1300.0,1,8
47447,CHEMBL787,MONTELUKAST,219,CHEMBL245,Muscarinic acetylcholine receptor M3,5.85,5.85,1404.0,1,8
47447,CHEMBL787,MONTELUKAST,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.83,5.83,1470.0,1,8
47447,CHEMBL787,MONTELUKAST,248,CHEMBL1835,Thromboxane-A synthase,5.82,5.82,1525.0,1,9
47447,CHEMBL787,MONTELUKAST,136,CHEMBL236,Delta-type opioid receptor,5.77,5.77,1690.0,1,8
47447,CHEMBL787,MONTELUKAST,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.71,5.71,1938.0,1,8
47447,CHEMBL787,MONTELUKAST,133,CHEMBL235,Peroxisome proliferator-activated receptor gamma,5.68,5.68,2100.0,1,8
47447,CHEMBL787,MONTELUKAST,155,CHEMBL238,Sodium-dependent dopamine transporter,5.68,5.63,2067.0,2,8
47447,CHEMBL787,MONTELUKAST,43,CHEMBL210,Beta-2 adrenergic receptor,5.62,5.62,2398.0,1,8
47447,CHEMBL787,MONTELUKAST,130,CHEMBL234,D(3) dopamine receptor,5.58,5.58,2631.0,1,8
47447,CHEMBL787,MONTELUKAST,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.57,5.57,2667.0,2,8
47447,CHEMBL787,MONTELUKAST,25,CHEMBL2034,Glucocorticoid receptor,5.55,5.55,2800.0,1,8
47447,CHEMBL787,MONTELUKAST,9,CHEMBL203,Epidermal growth factor receptor,5.5,5.5,3197.0,1,8
47447,CHEMBL787,MONTELUKAST,226,CHEMBL246,Beta-3 adrenergic receptor,5.5,5.5,3200.0,1,8
47447,CHEMBL787,MONTELUKAST,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",5.5,5.5,3200.0,1,8
47675,CHEMBL788,IDOXURIDINE,10125,CHEMBL2883,"Thymidine kinase, cytosolic",7.05,7.05,90.0,1,8
6723,CHEMBL79,LIDOCAINE,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,6.05,6.05,891.3,1,9
6723,CHEMBL79,LIDOCAINE,17045,CHEMBL340,Cytochrome P450 3A4,5.7,5.7,1995.3,2,9
6723,CHEMBL79,LIDOCAINE,18043,CHEMBL2072,Sodium channel protein type 4 subunit alpha,5.7,5.7,2000.0,1,9
48849,CHEMBL790,CHLORHEXIDINE,20053,CHEMBL4096,Cellular tumor antigen p53,8.1,8.1,7.9,1,9
48849,CHEMBL790,CHLORHEXIDINE,103668,CHEMBL1293235,Prelamin-A/C,7.45,6.6,35.5,2,9
48849,CHEMBL790,CHLORHEXIDINE,101283,CHEMBL5685,Solute carrier family 22 member 1,6.68,6.68,210.0,1,9
48849,CHEMBL790,CHLORHEXIDINE,10142,CHEMBL259,Melanocortin receptor 4,6.57,6.13,271.0,2,8
48849,CHEMBL790,CHLORHEXIDINE,104063,CHEMBL1743122,Solute carrier family 22 member 2,6.4,6.4,400.0,1,9
48849,CHEMBL790,CHLORHEXIDINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.39,6.39,409.0,1,8
48849,CHEMBL790,CHLORHEXIDINE,104614,CHEMBL2073673,Solute carrier family 22 member 3,6.39,6.39,410.0,1,9
48849,CHEMBL790,CHLORHEXIDINE,11003,CHEMBL4644,Melanocortin receptor 3,6.31,6.31,490.0,1,8
48849,CHEMBL790,CHLORHEXIDINE,104068,CHEMBL1743127,Multidrug and toxin extrusion protein 2,6.3,6.3,500.0,1,9
48849,CHEMBL790,CHLORHEXIDINE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.22,6.22,600.0,2,8
48849,CHEMBL790,CHLORHEXIDINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.17,6.04,683.2,2,8
48849,CHEMBL790,CHLORHEXIDINE,104067,CHEMBL1743126,Multidrug and toxin extrusion protein 1,6.16,6.16,700.0,1,9
48849,CHEMBL790,CHLORHEXIDINE,11061,CHEMBL2203,Motilin receptor,6.11,6.11,784.0,1,8
48849,CHEMBL790,CHLORHEXIDINE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.0,6.0,1000.0,1,8
48849,CHEMBL790,CHLORHEXIDINE,11536,CHEMBL4616,Growth hormone secretagogue receptor type 1,6.0,6.0,1000.0,1,8
48849,CHEMBL790,CHLORHEXIDINE,50,CHEMBL213,Beta-1 adrenergic receptor,5.85,5.85,1400.0,1,8
48849,CHEMBL790,CHLORHEXIDINE,105690,CHEMBL2362978,DNA repair protein RAD52 homolog,5.77,5.77,1700.0,1,8
48849,CHEMBL790,CHLORHEXIDINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.75,5.75,1800.0,1,8
48849,CHEMBL790,CHLORHEXIDINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.74,5.74,1833.0,1,8
48849,CHEMBL790,CHLORHEXIDINE,10475,CHEMBL4777,Neuropeptide Y receptor type 1,5.66,5.66,2200.0,1,8
48849,CHEMBL790,CHLORHEXIDINE,101440,CHEMBL6089,Ubiquitin-conjugating enzyme E2 N,5.66,5.59,2197.0,2,9
48849,CHEMBL790,CHLORHEXIDINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.62,5.62,2400.0,1,8
48849,CHEMBL790,CHLORHEXIDINE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.52,5.52,3000.0,1,8
48849,CHEMBL790,CHLORHEXIDINE,87,CHEMBL218,Cannabinoid receptor 1,5.51,5.51,3073.5,1,8
48849,CHEMBL790,CHLORHEXIDINE,130,CHEMBL234,D(3) dopamine receptor,5.5,5.5,3200.0,1,8
49842,CHEMBL796,METHYLPHENIDATE,155,CHEMBL238,Sodium-dependent dopamine transporter,7.77,7.32,17.0,4,9
49842,CHEMBL796,METHYLPHENIDATE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,7.21,6.62,61.0,3,9
50440,CHEMBL799,CILOSTAZOL,170,CHEMBL241,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",8.41,7.45,3.89,3,9
50440,CHEMBL799,CILOSTAZOL,11395,CHEMBL290,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B",7.3,7.3,50.0,1,9
50440,CHEMBL799,CILOSTAZOL,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,7.0,7.0,100.0,2,9
50440,CHEMBL799,CILOSTAZOL,103665,CHEMBL1293232,Survival motor neuron protein,6.05,6.05,891.3,1,9
50440,CHEMBL799,CILOSTAZOL,137,CHEMBL237,Kappa-type opioid receptor,5.51,5.51,3056.2,1,8
6902,CHEMBL80,NALOXONE,129,CHEMBL233,Mu-type opioid receptor,9.66,8.22,0.2188,44,9
6902,CHEMBL80,NALOXONE,137,CHEMBL237,Kappa-type opioid receptor,9.6,7.98,0.25,23,9
6902,CHEMBL80,NALOXONE,136,CHEMBL236,Delta-type opioid receptor,7.8,7.09,15.85,34,9
6902,CHEMBL80,NALOXONE,103629,CHEMBL1287627,Cytochrome b-245 heavy chain,5.71,5.71,1960.0,1,9
6902,CHEMBL80,NALOXONE,11365,CHEMBL289,Cytochrome P450 2D6,5.7,5.7,2000.0,1,8
51182,CHEMBL803,CYTARABINE,20131,CHEMBL5023,E3 ubiquitin-protein ligase Mdm2,7.7,7.7,20.0,1,9
51182,CHEMBL803,CYTARABINE,103668,CHEMBL1293235,Prelamin-A/C,7.4,7.4,39.8,1,9
51182,CHEMBL803,CYTARABINE,11400,CHEMBL2842,Serine/threonine-protein kinase mTOR,7.13,6.35,73.6,3,9
52087,CHEMBL806,FLUTAMIDE,56,CHEMBL1871,Androgen receptor,7.26,6.31,55.0,8,9
52087,CHEMBL806,FLUTAMIDE,103668,CHEMBL1293235,Prelamin-A/C,7.1,7.1,79.4,1,9
52087,CHEMBL806,FLUTAMIDE,12594,CHEMBL3356,Cytochrome P450 1A2,6.5,6.5,316.23,1,8
52087,CHEMBL806,FLUTAMIDE,109673,CHEMBL3509584,Arylacetamide deacetylase,6.22,6.22,600.0,1,9
52087,CHEMBL806,FLUTAMIDE,11507,CHEMBL3180,Cocaine esterase,5.64,5.64,2300.0,1,9
52087,CHEMBL806,FLUTAMIDE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.6,5.6,2528.0,1,8
52523,CHEMBL807,MEMANTINE,93,CHEMBL220,Acetylcholinesterase,8.31,7.21,4.9,2,9
52523,CHEMBL807,MEMANTINE,19,CHEMBL206,Estrogen receptor,5.8,5.8,1600.0,1,8
52874,CHEMBL808,ECONAZOLE,248,CHEMBL1835,Thromboxane-A synthase,7.54,7.54,29.0,1,9
52874,CHEMBL808,ECONAZOLE,12912,CHEMBL3622,Cytochrome P450 2C19,7.4,7.4,40.0,1,8
52874,CHEMBL808,ECONAZOLE,11188,CHEMBL3849,Lanosterol 14-alpha demethylase,7.3,7.3,50.0,1,9
52874,CHEMBL808,ECONAZOLE,17045,CHEMBL340,Cytochrome P450 3A4,7.3,6.68,50.0,3,9
52874,CHEMBL808,ECONAZOLE,12911,CHEMBL3397,Cytochrome P450 2C9,6.7,6.7,200.0,1,8
52874,CHEMBL808,ECONAZOLE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.65,6.22,225.0,3,8
52874,CHEMBL808,ECONAZOLE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.53,6.1,296.0,2,8
52874,CHEMBL808,ECONAZOLE,12594,CHEMBL3356,Cytochrome P450 1A2,6.52,6.52,300.0,1,8
52874,CHEMBL808,ECONAZOLE,119244,CHEMBL4523494,7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase,6.51,6.51,310.0,1,9
52874,CHEMBL808,ECONAZOLE,12949,CHEMBL3522,"Steroid 17-alpha-hydroxylase/17,20 lyase",6.49,6.49,325.0,1,9
52874,CHEMBL808,ECONAZOLE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.42,6.08,379.0,2,8
52874,CHEMBL808,ECONAZOLE,11365,CHEMBL289,Cytochrome P450 2D6,6.4,6.4,400.0,1,8
52874,CHEMBL808,ECONAZOLE,103167,CHEMBL1075319,Transient receptor potential cation channel subfamily M member 8,6.38,6.38,420.0,1,9
52874,CHEMBL808,ECONAZOLE,136,CHEMBL236,Delta-type opioid receptor,6.29,6.06,508.0,2,8
52874,CHEMBL808,ECONAZOLE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.2,5.89,636.0,2,8
52874,CHEMBL808,ECONAZOLE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.18,6.13,663.0,2,8
52874,CHEMBL808,ECONAZOLE,100643,CHEMBL4685,"Indoleamine 2,3-dioxygenase 1",5.96,5.96,1100.0,1,9
52874,CHEMBL808,ECONAZOLE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.94,5.94,1158.0,1,8
52874,CHEMBL808,ECONAZOLE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.94,5.94,1152.0,1,8
52874,CHEMBL808,ECONAZOLE,102,CHEMBL1941,Histamine H2 receptor,5.8,5.8,1565.0,2,8
52874,CHEMBL808,ECONAZOLE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.79,5.79,1622.0,1,8
52874,CHEMBL808,ECONAZOLE,130,CHEMBL234,D(3) dopamine receptor,5.79,5.79,1615.0,1,8
52874,CHEMBL808,ECONAZOLE,280,CHEMBL256,Adenosine receptor A3,5.74,5.74,1836.0,1,8
52874,CHEMBL808,ECONAZOLE,10184,CHEMBL2327,Substance-K receptor,5.7,5.7,2011.0,1,8
52874,CHEMBL808,ECONAZOLE,129,CHEMBL233,Mu-type opioid receptor,5.64,5.64,2311.0,1,8
52874,CHEMBL808,ECONAZOLE,137,CHEMBL237,Kappa-type opioid receptor,5.63,5.63,2334.3,1,8
52874,CHEMBL808,ECONAZOLE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.62,5.62,2415.0,2,8
52874,CHEMBL808,ECONAZOLE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.57,5.57,2700.0,1,8
52874,CHEMBL808,ECONAZOLE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.57,5.57,2677.0,1,8
52874,CHEMBL808,ECONAZOLE,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.57,5.57,2700.0,1,8
52874,CHEMBL808,ECONAZOLE,103516,CHEMBL1250402,Transient receptor potential cation channel subfamily M member 2,5.52,5.52,3000.0,1,9
53616,CHEMBL809,SERTRALINE,121,CHEMBL228,Sodium-dependent serotonin transporter,10.12,9.28,0.075,7,9
53616,CHEMBL809,SERTRALINE,155,CHEMBL238,Sodium-dependent dopamine transporter,7.6,7.06,25.0,6,9
53616,CHEMBL809,SERTRALINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,7.53,7.31,29.3,3,8
53616,CHEMBL809,SERTRALINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.08,6.45,82.8,3,8
53616,CHEMBL809,SERTRALINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.96,6.75,108.3,2,8
53616,CHEMBL809,SERTRALINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.51,6.2,310.2,2,8
53616,CHEMBL809,SERTRALINE,12912,CHEMBL3622,Cytochrome P450 2C19,6.51,6.25,310.0,2,8
53616,CHEMBL809,SERTRALINE,137,CHEMBL237,Kappa-type opioid receptor,6.46,6.46,346.4,1,8
53616,CHEMBL809,SERTRALINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.44,6.37,364.5,2,8
53616,CHEMBL809,SERTRALINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.43,6.0,366.9,2,8
53616,CHEMBL809,SERTRALINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.38,6.11,420.0,5,9
53616,CHEMBL809,SERTRALINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.25,6.11,567.3,2,8
53616,CHEMBL809,SERTRALINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.19,6.19,650.5,1,8
53616,CHEMBL809,SERTRALINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.11,5.83,783.1,2,8
53616,CHEMBL809,SERTRALINE,17045,CHEMBL340,Cytochrome P450 3A4,6.1,6.1,800.0,1,8
53616,CHEMBL809,SERTRALINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.01,5.79,984.0,2,8
53616,CHEMBL809,SERTRALINE,11365,CHEMBL289,Cytochrome P450 2D6,5.85,5.7,1400.0,2,9
53616,CHEMBL809,SERTRALINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.71,5.71,1929.8,1,8
53616,CHEMBL809,SERTRALINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.67,5.67,2159.5,1,8
6914,CHEMBL81,RALOXIFENE,19,CHEMBL206,Estrogen receptor,10.52,8.66,0.03,45,9
6914,CHEMBL81,RALOXIFENE,174,CHEMBL242,Estrogen receptor beta,9.1,7.7,0.8,31,9
6914,CHEMBL81,RALOXIFENE,12056,CHEMBL3257,Aldehyde oxidase,9.06,8.61,0.87,10,9
6914,CHEMBL81,RALOXIFENE,11165,CHEMBL4931,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",9.0,9.0,1.0,1,9
6914,CHEMBL81,RALOXIFENE,12911,CHEMBL3397,Cytochrome P450 2C9,7.8,6.75,15.8,2,9
6914,CHEMBL81,RALOXIFENE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,7.42,6.71,38.0,3,8
6914,CHEMBL81,RALOXIFENE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.16,6.76,69.0,4,9
6914,CHEMBL81,RALOXIFENE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.97,6.47,107.0,3,8
6914,CHEMBL81,RALOXIFENE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.55,6.48,280.0,3,8
6914,CHEMBL81,RALOXIFENE,103668,CHEMBL1293235,Prelamin-A/C,6.45,6.45,354.8,1,9
6914,CHEMBL81,RALOXIFENE,72,CHEMBL217,D(2) dopamine receptor,6.41,6.12,391.0,3,8
6914,CHEMBL81,RALOXIFENE,93,CHEMBL220,Acetylcholinesterase,6.4,6.4,400.0,1,8
6914,CHEMBL81,RALOXIFENE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.38,6.13,414.0,3,8
6914,CHEMBL81,RALOXIFENE,103,CHEMBL223,Alpha-1D adrenergic receptor,6.32,6.17,478.0,2,8
6914,CHEMBL81,RALOXIFENE,129,CHEMBL233,Mu-type opioid receptor,6.32,6.13,477.0,2,8
6914,CHEMBL81,RALOXIFENE,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,6.3,5.95,501.2,2,9
6914,CHEMBL81,RALOXIFENE,130,CHEMBL234,D(3) dopamine receptor,6.28,6.04,531.0,2,8
6914,CHEMBL81,RALOXIFENE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.21,6.0,624.0,2,8
6914,CHEMBL81,RALOXIFENE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.21,6.07,617.0,2,8
6914,CHEMBL81,RALOXIFENE,137,CHEMBL237,Kappa-type opioid receptor,6.19,5.9,641.0,3,8
6914,CHEMBL81,RALOXIFENE,106142,CHEMBL2364163,Complement C5,6.15,6.15,710.0,1,9
6914,CHEMBL81,RALOXIFENE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.12,6.12,750.0,1,9
6914,CHEMBL81,RALOXIFENE,252,CHEMBL251,Adenosine receptor A2a,5.93,5.8,1185.0,2,8
6914,CHEMBL81,RALOXIFENE,17045,CHEMBL340,Cytochrome P450 3A4,5.9,5.75,1258.9,6,9
6914,CHEMBL81,RALOXIFENE,10184,CHEMBL2327,Substance-K receptor,5.88,5.88,1330.0,1,8
6914,CHEMBL81,RALOXIFENE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.83,5.78,1485.0,2,8
6914,CHEMBL81,RALOXIFENE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.77,5.77,1688.0,1,8
6914,CHEMBL81,RALOXIFENE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.72,5.64,1900.0,2,8
6914,CHEMBL81,RALOXIFENE,88,CHEMBL2056,D(1A) dopamine receptor,5.71,5.71,1932.0,1,8
6914,CHEMBL81,RALOXIFENE,102439,CHEMBL6136,Lysine-specific histone demethylase 1A,5.68,5.68,2080.0,2,9
6914,CHEMBL81,RALOXIFENE,136,CHEMBL236,Delta-type opioid receptor,5.63,5.63,2342.0,1,8
6914,CHEMBL81,RALOXIFENE,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,5.6,5.6,2511.9,1,9
6914,CHEMBL81,RALOXIFENE,36,CHEMBL208,Progesterone receptor,5.57,5.57,2720.0,1,8
54051,CHEMBL811,BROMPHENIRAMINE,121,CHEMBL228,Sodium-dependent serotonin transporter,7.82,7.64,15.0,2,8
54051,CHEMBL811,BROMPHENIRAMINE,127,CHEMBL231,Histamine H1 receptor,7.28,7.28,52.0,1,8
54051,CHEMBL811,BROMPHENIRAMINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.05,6.05,891.25,1,9
54051,CHEMBL811,BROMPHENIRAMINE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.76,5.72,1732.2,2,8
54149,CHEMBL812,PYRIDOSTIGMINE BROMIDE,93,CHEMBL220,Acetylcholinesterase,6.46,6.46,350.0,4,9
54149,CHEMBL812,PYRIDOSTIGMINE BROMIDE,10532,CHEMBL1914,Cholinesterase,6.05,6.01,900.0,4,9
54149,CHEMBL812,PYRIDOSTIGMINE BROMIDE,103668,CHEMBL1293235,Prelamin-A/C,6.05,6.05,891.3,1,9
54211,CHEMBL813,EPROSARTAN,115,CHEMBL227,Type-1 angiotensin II receptor,8.72,8.42,1.9,6,8
54722,CHEMBL814,FLUVOXAMINE,155,CHEMBL238,Sodium-dependent dopamine transporter,8.84,8.84,1.46,1,8
54722,CHEMBL814,FLUVOXAMINE,121,CHEMBL228,Sodium-dependent serotonin transporter,8.51,7.92,3.08,4,9
54722,CHEMBL814,FLUVOXAMINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,7.44,7.44,36.0,1,8
54722,CHEMBL814,FLUVOXAMINE,12912,CHEMBL3622,Cytochrome P450 2C19,7.0,7.0,100.0,2,9
54722,CHEMBL814,FLUVOXAMINE,12594,CHEMBL3356,Cytochrome P450 1A2,6.8,6.8,158.49,1,8
54722,CHEMBL814,FLUVOXAMINE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.59,5.59,2547.1,1,8
54722,CHEMBL814,FLUVOXAMINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.51,5.51,3100.0,1,8
55033,CHEMBL815,DINOPROST,140,CHEMBL1987,Prostaglandin F2-alpha receptor,8.6,7.75,2.5,7,9
55033,CHEMBL815,DINOPROST,104644,CHEMBL2073703,Solute carrier organic anion transporter family member 2A1,7.64,7.64,23.0,1,8
55033,CHEMBL815,DINOPROST,10329,CHEMBL3710,Prostaglandin E2 receptor EP3 subtype,6.96,6.36,110.0,3,9
55033,CHEMBL815,DINOPROST,261,CHEMBL1811,Prostaglandin E2 receptor EP1 subtype,6.66,6.43,220.0,3,9
55033,CHEMBL815,DINOPROST,246,CHEMBL2069,Thromboxane A2 receptor,5.85,5.71,1400.0,2,8
56131,CHEMBL817,TOLAZAMIDE,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,6.55,6.55,281.8,1,9
56402,CHEMBL818,IOBENGUANE,103689,CHEMBL1293256,Thrombopoietin,5.8,5.8,1584.9,2,9
56644,CHEMBL820,BUSULFAN,103668,CHEMBL1293235,Prelamin-A/C,6.1,6.1,794.3,1,9
56831,CHEMBL822,TERBINAFINE,103668,CHEMBL1293235,Prelamin-A/C,7.8,7.8,15.8,1,9
56831,CHEMBL822,TERBINAFINE,11230,CHEMBL3592,Squalene monooxygenase,7.52,7.52,30.0,1,8
56831,CHEMBL822,TERBINAFINE,11365,CHEMBL289,Cytochrome P450 2D6,6.7,6.7,200.0,1,8
56831,CHEMBL822,TERBINAFINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.63,6.44,235.4,2,8
56831,CHEMBL822,TERBINAFINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.67,5.67,2138.6,1,8
57175,CHEMBL826,ENOXACIN,10363,CHEMBL2098,RISC-loading complex subunit TARBP2,7.03,7.03,94.0,1,9
57175,CHEMBL826,ENOXACIN,103668,CHEMBL1293235,Prelamin-A/C,5.9,5.9,1258.9,1,9
57397,CHEMBL827,DEXMETHYLPHENIDATE,155,CHEMBL238,Sodium-dependent dopamine transporter,7.8,7.32,16.0,4,9
57833,CHEMBL829,METHYLPROMAZINE,130,CHEMBL234,D(3) dopamine receptor,7.54,7.54,28.8,1,8
57833,CHEMBL829,METHYLPROMAZINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.53,7.53,29.6,1,8
57833,CHEMBL829,METHYLPROMAZINE,88,CHEMBL2056,D(1A) dopamine receptor,6.87,6.87,136.3,1,8
57833,CHEMBL829,METHYLPROMAZINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.51,6.51,307.0,1,8
57833,CHEMBL829,METHYLPROMAZINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.47,6.47,334.6,1,8
57833,CHEMBL829,METHYLPROMAZINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.04,6.04,909.3,1,8
57833,CHEMBL829,METHYLPROMAZINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.77,5.77,1706.4,1,8
57833,CHEMBL829,METHYLPROMAZINE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.63,5.63,2352.9,1,8
57833,CHEMBL829,METHYLPROMAZINE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,5.6,5.6,2514.3,1,8
6968,CHEMBL83,TAMOXIFEN,174,CHEMBL242,Estrogen receptor beta,9.29,6.67,0.51,15,9
6968,CHEMBL83,TAMOXIFEN,19,CHEMBL206,Estrogen receptor,8.82,6.78,1.5,35,9
6968,CHEMBL83,TAMOXIFEN,105591,CHEMBL2311238,Emopamil-binding protein-like,8.55,8.55,2.8,1,9
6968,CHEMBL83,TAMOXIFEN,11165,CHEMBL4931,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",8.3,8.3,5.0,1,9
6968,CHEMBL83,TAMOXIFEN,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,8.06,7.73,8.714,3,8
6968,CHEMBL83,TAMOXIFEN,11255,CHEMBL4245,Estrogen-related receptor gamma,7.21,7.21,62.2,1,9
6968,CHEMBL83,TAMOXIFEN,11398,CHEMBL4302,ATP-dependent translocase ABCB1,7.0,7.0,100.0,1,8
6968,CHEMBL83,TAMOXIFEN,36,CHEMBL208,Progesterone receptor,6.89,6.89,128.82,1,9
6968,CHEMBL83,TAMOXIFEN,10133,CHEMBL3429,Steroid hormone receptor ERR1,6.7,6.7,200.0,1,9
6968,CHEMBL83,TAMOXIFEN,17045,CHEMBL340,Cytochrome P450 3A4,6.7,6.7,200.0,1,9
6968,CHEMBL83,TAMOXIFEN,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.62,6.48,241.0,2,8
6968,CHEMBL83,TAMOXIFEN,130,CHEMBL234,D(3) dopamine receptor,6.44,5.98,364.0,3,8
6968,CHEMBL83,TAMOXIFEN,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.2,5.87,630.0,2,8
6968,CHEMBL83,TAMOXIFEN,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.17,5.86,681.0,2,8
6968,CHEMBL83,TAMOXIFEN,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.17,6.17,672.0,1,8
6968,CHEMBL83,TAMOXIFEN,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.14,5.92,726.0,2,8
6968,CHEMBL83,TAMOXIFEN,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.1,5.96,792.2,4,9
6968,CHEMBL83,TAMOXIFEN,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.05,5.87,896.2,3,8
6968,CHEMBL83,TAMOXIFEN,20085,CHEMBL4729,Cytochrome P450 2B6,6.05,6.05,900.0,1,9
6968,CHEMBL83,TAMOXIFEN,248,CHEMBL1835,Thromboxane-A synthase,6.04,6.04,916.0,1,9
6968,CHEMBL83,TAMOXIFEN,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,5.98,5.82,1041.0,3,9
6968,CHEMBL83,TAMOXIFEN,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,5.92,5.92,1195.0,1,8
6968,CHEMBL83,TAMOXIFEN,121,CHEMBL228,Sodium-dependent serotonin transporter,5.91,5.77,1240.0,2,8
6968,CHEMBL83,TAMOXIFEN,10184,CHEMBL2327,Substance-K receptor,5.91,5.91,1223.0,1,8
6968,CHEMBL83,TAMOXIFEN,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.86,5.68,1372.0,2,8
6968,CHEMBL83,TAMOXIFEN,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.84,5.83,1459.0,2,8
6968,CHEMBL83,TAMOXIFEN,155,CHEMBL238,Sodium-dependent dopamine transporter,5.83,5.79,1462.0,2,8
6968,CHEMBL83,TAMOXIFEN,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.79,5.79,1606.0,1,8
6968,CHEMBL83,TAMOXIFEN,102,CHEMBL1941,Histamine H2 receptor,5.76,5.76,1745.8,1,8
6968,CHEMBL83,TAMOXIFEN,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,5.73,5.66,1857.0,2,8
6968,CHEMBL83,TAMOXIFEN,280,CHEMBL256,Adenosine receptor A3,5.68,5.68,2092.0,1,8
6968,CHEMBL83,TAMOXIFEN,103,CHEMBL223,Alpha-1D adrenergic receptor,5.61,5.61,2449.0,1,8
6968,CHEMBL83,TAMOXIFEN,10733,CHEMBL2179,Lysosomal acid glucosylceramidase,5.6,5.6,2500.0,1,9
6968,CHEMBL83,TAMOXIFEN,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.56,5.56,2771.0,1,8
6968,CHEMBL83,TAMOXIFEN,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,5.53,5.53,2949.0,1,8
6968,CHEMBL83,TAMOXIFEN,72,CHEMBL217,D(2) dopamine receptor,5.5,5.5,3200.0,1,8
138594,CHEMBL83063,RITODRINE,12886,CHEMBL2731,Galanin receptor type 3,6.03,6.03,932.0,1,8
138594,CHEMBL83063,RITODRINE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.81,5.75,1537.2,2,8
59519,CHEMBL831,LOXAPINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,8.62,8.02,2.42,3,9
59519,CHEMBL831,LOXAPINE,90,CHEMBL219,D(4) dopamine receptor,8.31,8.07,4.9,5,9
59519,CHEMBL831,LOXAPINE,127,CHEMBL231,Histamine H1 receptor,7.92,7.92,12.0,1,8
59519,CHEMBL831,LOXAPINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,7.82,7.53,15.0,2,8
59519,CHEMBL831,LOXAPINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.75,7.33,17.8,2,8
59519,CHEMBL831,LOXAPINE,130,CHEMBL234,D(3) dopamine receptor,7.72,7.63,19.0,3,8
59519,CHEMBL831,LOXAPINE,72,CHEMBL217,D(2) dopamine receptor,7.68,7.46,21.0,4,8
59519,CHEMBL831,LOXAPINE,88,CHEMBL2056,D(1A) dopamine receptor,7.61,7.3,24.5,2,8
59519,CHEMBL831,LOXAPINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,7.54,7.54,29.0,1,8
59519,CHEMBL831,LOXAPINE,125,CHEMBL229,Alpha-1A adrenergic receptor,7.28,6.88,52.0,4,8
59519,CHEMBL831,LOXAPINE,102,CHEMBL1941,Histamine H2 receptor,6.85,6.85,139.9,1,8
59519,CHEMBL831,LOXAPINE,11290,CHEMBL3759,Histamine H4 receptor,6.66,6.66,218.78,1,9
59519,CHEMBL831,LOXAPINE,220,CHEMBL1850,D(1B) dopamine receptor,6.61,6.61,248.0,1,8
59519,CHEMBL831,LOXAPINE,144,CHEMBL1899,5-hydroxytryptamine receptor 3A,6.42,6.42,380.0,1,8
59519,CHEMBL831,LOXAPINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.32,6.07,482.1,2,8
59519,CHEMBL831,LOXAPINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.17,6.17,670.8,1,8
59519,CHEMBL831,LOXAPINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.13,6.04,732.7,2,8
59519,CHEMBL831,LOXAPINE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,6.13,6.13,732.0,1,8
59519,CHEMBL831,LOXAPINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.1,5.97,793.8,2,8
59519,CHEMBL831,LOXAPINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.05,5.95,899.5,2,8
59519,CHEMBL831,LOXAPINE,10624,CHEMBL3426,5-hydroxytryptamine receptor 5A,5.98,5.98,1040.6,1,8
59519,CHEMBL831,LOXAPINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.93,5.93,1186.4,1,8
59519,CHEMBL831,LOXAPINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.85,5.85,1406.3,1,8
59519,CHEMBL831,LOXAPINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,5.85,5.85,1400.0,1,8
60232,CHEMBL832,SULFINPYRAZONE,119104,CHEMBL4523354,Nicotinate phosphoribosyltransferase,9.3,9.3,0.5,1,9
60232,CHEMBL832,SULFINPYRAZONE,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,6.1,6.1,794.3,1,9
60232,CHEMBL832,SULFINPYRAZONE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,5.95,5.95,1122.0,1,9
60319,CHEMBL833,TICLOPIDINE,12912,CHEMBL3622,Cytochrome P450 2C19,7.4,6.71,39.8,4,9
60319,CHEMBL833,TICLOPIDINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.86,6.45,139.0,3,8
60319,CHEMBL833,TICLOPIDINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.84,6.25,143.0,4,8
60319,CHEMBL833,TICLOPIDINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.77,6.22,171.0,3,8
60319,CHEMBL833,TICLOPIDINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.75,6.56,179.0,2,8
60319,CHEMBL833,TICLOPIDINE,20085,CHEMBL4729,Cytochrome P450 2B6,6.7,6.42,200.0,4,9
60319,CHEMBL833,TICLOPIDINE,11365,CHEMBL289,Cytochrome P450 2D6,6.4,6.4,398.1,2,9
60319,CHEMBL833,TICLOPIDINE,12594,CHEMBL3356,Cytochrome P450 1A2,6.3,6.3,501.19,1,8
60401,CHEMBL834,PAMIDRONIC ACID,71,CHEMBL1782,Farnesyl pyrophosphate synthase,7.25,6.38,55.9,10,9
60401,CHEMBL834,PAMIDRONIC ACID,170,CHEMBL241,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",5.72,5.72,1894.0,1,8
61181,CHEMBL836,TAMSULOSIN,125,CHEMBL229,Alpha-1A adrenergic receptor,10.54,9.61,0.029,17,9
61181,CHEMBL836,TAMSULOSIN,103,CHEMBL223,Alpha-1D adrenergic receptor,10.24,9.6,0.058,12,9
61181,CHEMBL836,TAMSULOSIN,128,CHEMBL232,Alpha-1B adrenergic receptor,9.89,8.72,0.13,12,9
61181,CHEMBL836,TAMSULOSIN,130,CHEMBL234,D(3) dopamine receptor,9.55,9.02,0.28,2,8
61181,CHEMBL836,TAMSULOSIN,51,CHEMBL214,5-hydroxytryptamine receptor 1A,9.1,8.4,0.79,2,8
61181,CHEMBL836,TAMSULOSIN,218,CHEMBL1916,Alpha-2C adrenergic receptor,8.1,7.31,7.9,2,8
61181,CHEMBL836,TAMSULOSIN,72,CHEMBL217,D(2) dopamine receptor,7.89,7.33,13.0,3,8
61181,CHEMBL836,TAMSULOSIN,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.87,7.06,13.4,3,8
61181,CHEMBL836,TAMSULOSIN,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,7.08,7.08,84.0,1,8
61181,CHEMBL836,TAMSULOSIN,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.72,5.72,1900.0,1,8
61181,CHEMBL836,TAMSULOSIN,43,CHEMBL210,Beta-2 adrenergic receptor,5.66,5.66,2200.0,1,8
61181,CHEMBL836,TAMSULOSIN,50,CHEMBL213,Beta-1 adrenergic receptor,5.6,5.6,2500.0,1,8
61706,CHEMBL838,BENAZEPRIL,69,CHEMBL1808,Angiotensin-converting enzyme,8.77,8.77,1.7,1,8
62182,CHEMBL839,CARTEOLOL,50,CHEMBL213,Beta-1 adrenergic receptor,9.0,8.86,1.0,2,8
62182,CHEMBL839,CARTEOLOL,43,CHEMBL210,Beta-2 adrenergic receptor,8.22,8.22,6.0,1,8
7501,CHEMBL84,TOPOTECAN,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,7.92,7.57,12.0,2,9
7501,CHEMBL84,TOPOTECAN,62,CHEMBL1781,DNA topoisomerase 1,7.68,6.63,21.0,12,9
7501,CHEMBL84,TOPOTECAN,104067,CHEMBL1743126,Multidrug and toxin extrusion protein 1,5.89,5.89,1300.0,1,9
7501,CHEMBL84,TOPOTECAN,17045,CHEMBL340,Cytochrome P450 3A4,5.82,5.82,1521.1,1,8
62259,CHEMBL841,LOPERAMIDE,129,CHEMBL233,Mu-type opioid receptor,9.57,9.09,0.268,5,9
62259,CHEMBL841,LOPERAMIDE,11365,CHEMBL289,Cytochrome P450 2D6,7.8,7.1,15.8,3,9
62259,CHEMBL841,LOPERAMIDE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,7.48,6.82,33.0,2,9
62259,CHEMBL841,LOPERAMIDE,136,CHEMBL236,Delta-type opioid receptor,6.81,6.45,156.0,3,8
62259,CHEMBL841,LOPERAMIDE,11480,CHEMBL1980,Sodium channel protein type 5 subunit alpha,6.62,6.62,239.0,1,9
62259,CHEMBL841,LOPERAMIDE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.58,6.39,264.0,2,8
62259,CHEMBL841,LOPERAMIDE,130,CHEMBL234,D(3) dopamine receptor,6.34,5.97,454.0,3,9
62259,CHEMBL841,LOPERAMIDE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.93,5.79,1170.0,2,8
62259,CHEMBL841,LOPERAMIDE,78,CHEMBL1963,Thyrotropin receptor,5.9,5.9,1258.9,2,9
62259,CHEMBL841,LOPERAMIDE,137,CHEMBL237,Kappa-type opioid receptor,5.9,5.7,1250.0,2,8
62259,CHEMBL841,LOPERAMIDE,11507,CHEMBL3180,Cocaine esterase,5.82,5.82,1500.0,1,9
62259,CHEMBL841,LOPERAMIDE,90,CHEMBL219,D(4) dopamine receptor,5.73,5.73,1850.0,1,9
62259,CHEMBL841,LOPERAMIDE,43,CHEMBL210,Beta-2 adrenergic receptor,5.68,5.6,2066.0,2,8
62259,CHEMBL841,LOPERAMIDE,11398,CHEMBL4302,ATP-dependent translocase ABCB1,5.6,5.6,2500.0,1,8
62259,CHEMBL841,LOPERAMIDE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.58,5.58,2613.0,1,8
62259,CHEMBL841,LOPERAMIDE,102,CHEMBL1941,Histamine H2 receptor,5.52,5.51,3030.0,2,8
62615,CHEMBL842,CHLOROTHIAZIDE,10193,CHEMBL261,Carbonic anhydrase 1,6.34,6.34,460.0,1,9
62615,CHEMBL842,CHLOROTHIAZIDE,103668,CHEMBL1293235,Prelamin-A/C,6.05,6.05,891.3,1,9
62701,CHEMBL843,ROSIGLITAZONE MALEATE,133,CHEMBL235,Peroxisome proliferator-activated receptor gamma,7.85,6.95,14.0,3,8
62817,CHEMBL844,BRIMONIDINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,9.21,8.19,0.6166,8,9
62817,CHEMBL844,BRIMONIDINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,8.47,7.45,3.4,6,9
62817,CHEMBL844,BRIMONIDINE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.25,8.25,5.6,2,9
62817,CHEMBL844,BRIMONIDINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.46,6.58,34.67,4,9
62817,CHEMBL844,BRIMONIDINE,17045,CHEMBL340,Cytochrome P450 3A4,6.4,6.4,398.1,3,9
62817,CHEMBL844,BRIMONIDINE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.19,5.87,644.8,2,9
62817,CHEMBL844,BRIMONIDINE,103,CHEMBL223,Alpha-1D adrenergic receptor,6.07,5.95,846.0,3,9
62817,CHEMBL844,BRIMONIDINE,103668,CHEMBL1293235,Prelamin-A/C,5.6,5.6,2511.9,1,9
63252,CHEMBL846,CALCITRIOL,64,CHEMBL1977,Vitamin D3 receptor,10.97,8.87,0.0106,59,9
63252,CHEMBL846,CALCITRIOL,100474,CHEMBL4521,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",8.52,8.52,3.02,1,9
63252,CHEMBL846,CALCITRIOL,11572,CHEMBL2259,Vitamin D-binding protein,7.62,7.62,24.0,1,9
63252,CHEMBL846,CALCITRIOL,126,CHEMBL230,Prostaglandin G/H synthase 2,5.51,5.51,3100.0,1,8
63649,CHEMBL848,LENALIDOMIDE,120172,CHEMBL4739707,Zinc finger protein Aiolos,7.16,7.16,70.0,1,9
63649,CHEMBL848,LENALIDOMIDE,116734,CHEMBL3763008,Protein cereblon,7.05,6.26,88.99,7,9
63649,CHEMBL848,LENALIDOMIDE,185,CHEMBL1825,Tumor necrosis factor,6.66,6.66,220.0,1,9
63649,CHEMBL848,LENALIDOMIDE,104335,CHEMBL1909490,Interleukin-1 beta,6.41,6.41,390.0,1,9
64200,CHEMBL849,TRICLOSAN,103668,CHEMBL1293235,Prelamin-A/C,7.5,7.5,31.6,1,9
64200,CHEMBL849,TRICLOSAN,101246,CHEMBL5586,Carbonyl reductase [NADPH] 1,7.22,6.81,60.0,2,9
64200,CHEMBL849,TRICLOSAN,103657,CHEMBL1293224,Microtubule-associated protein tau,6.7,6.7,199.5,1,9
64200,CHEMBL849,TRICLOSAN,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.16,6.16,700.0,1,8
7714,CHEMBL85,RISPERIDONE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,10.0,9.29,0.099,28,9
7714,CHEMBL85,RISPERIDONE,10209,CHEMBL3155,5-hydroxytryptamine receptor 7,9.4,8.46,0.4,5,9
7714,CHEMBL85,RISPERIDONE,72,CHEMBL217,D(2) dopamine receptor,9.36,8.32,0.44,28,9
7714,CHEMBL85,RISPERIDONE,218,CHEMBL1916,Alpha-2C adrenergic receptor,8.86,8.13,1.389,5,9
7714,CHEMBL85,RISPERIDONE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,8.74,7.83,1.81,26,9
7714,CHEMBL85,RISPERIDONE,125,CHEMBL229,Alpha-1A adrenergic receptor,8.64,8.07,2.3,13,9
7714,CHEMBL85,RISPERIDONE,127,CHEMBL231,Histamine H1 receptor,8.59,7.2,2.6,17,9
7714,CHEMBL85,RISPERIDONE,52,CHEMBL1867,Alpha-2A adrenergic receptor,8.44,7.24,3.628,9,9
7714,CHEMBL85,RISPERIDONE,90,CHEMBL219,D(4) dopamine receptor,8.41,7.93,3.9,8,9
7714,CHEMBL85,RISPERIDONE,103,CHEMBL223,Alpha-1D adrenergic receptor,8.31,8.16,4.913,2,8
7714,CHEMBL85,RISPERIDONE,130,CHEMBL234,D(3) dopamine receptor,8.17,7.79,6.7,16,9
7714,CHEMBL85,RISPERIDONE,106,CHEMBL1898,5-hydroxytryptamine receptor 1B,8.0,8.0,10.0,1,9
7714,CHEMBL85,RISPERIDONE,128,CHEMBL232,Alpha-1B adrenergic receptor,8.0,8.0,10.0,1,9
7714,CHEMBL85,RISPERIDONE,216,CHEMBL1942,Alpha-2B adrenergic receptor,7.92,7.1,12.0,4,9
7714,CHEMBL85,RISPERIDONE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,7.82,7.37,15.0,6,9
7714,CHEMBL85,RISPERIDONE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,7.68,6.48,21.0,13,9
7714,CHEMBL85,RISPERIDONE,88,CHEMBL2056,D(1A) dopamine receptor,7.68,6.6,21.0,11,9
7714,CHEMBL85,RISPERIDONE,102,CHEMBL1941,Histamine H2 receptor,7.34,6.34,45.4,3,8
7714,CHEMBL85,RISPERIDONE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.83,6.48,147.91,21,9
7714,CHEMBL85,RISPERIDONE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.65,5.97,224.0,8,9
7714,CHEMBL85,RISPERIDONE,102688,CHEMBL5845,Glycine receptor subunit alpha-1,6.5,6.5,320.0,1,9
7714,CHEMBL85,RISPERIDONE,105,CHEMBL1983,5-hydroxytryptamine receptor 1D,6.0,6.0,1000.0,1,9
7714,CHEMBL85,RISPERIDONE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.0,5.92,1000.0,2,9
7714,CHEMBL85,RISPERIDONE,220,CHEMBL1850,D(1B) dopamine receptor,6.0,6.0,1000.0,1,9
7714,CHEMBL85,RISPERIDONE,10624,CHEMBL3426,5-hydroxytryptamine receptor 5A,6.0,6.0,1000.0,1,9
7714,CHEMBL85,RISPERIDONE,10280,CHEMBL264,Histamine H3 receptor,5.96,5.96,1105.5,1,9
7714,CHEMBL85,RISPERIDONE,103665,CHEMBL1293232,Survival motor neuron protein,5.9,5.9,1258.9,1,9
7714,CHEMBL85,RISPERIDONE,12912,CHEMBL3622,Cytochrome P450 2C19,5.8,5.8,1584.89,2,9
7714,CHEMBL85,RISPERIDONE,104067,CHEMBL1743126,Multidrug and toxin extrusion protein 1,5.8,5.8,1600.0,1,9
7714,CHEMBL85,RISPERIDONE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.55,5.55,2800.0,1,9
7714,CHEMBL85,RISPERIDONE,11365,CHEMBL289,Cytochrome P450 2D6,5.5,5.5,3162.28,2,9
65415,CHEMBL852,MELPHALAN,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,5.55,5.55,2818.4,1,9
65415,CHEMBL852,MELPHALAN,17045,CHEMBL340,Cytochrome P450 3A4,5.5,5.5,3162.3,2,9
65494,CHEMBL853,ZALCITABINE,10473,CHEMBL2107,C-X-C chemokine receptor type 4,7.06,7.06,88.0,1,8
65494,CHEMBL853,ZALCITABINE,103668,CHEMBL1293235,Prelamin-A/C,7.0,7.0,100.0,1,9
65494,CHEMBL853,ZALCITABINE,103657,CHEMBL1293224,Microtubule-associated protein tau,6.9,6.9,125.9,1,9
65494,CHEMBL853,ZALCITABINE,11531,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,6.1,6.1,794.3,2,9
65539,CHEMBL855,TRIPROLIDINE,127,CHEMBL231,Histamine H1 receptor,8.8,8.28,1.6,2,8
65539,CHEMBL855,TRIPROLIDINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,5.75,5.75,1800.0,1,8
65539,CHEMBL855,TRIPROLIDINE,137,CHEMBL237,Kappa-type opioid receptor,5.75,5.75,1792.2,1,8
65539,CHEMBL855,TRIPROLIDINE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.6,5.6,2528.3,1,8
65539,CHEMBL855,TRIPROLIDINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.57,5.57,2700.0,1,8
65798,CHEMBL857,BIOTIN,103668,CHEMBL1293235,Prelamin-A/C,8.0,8.0,10.0,1,9
65798,CHEMBL857,BIOTIN,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,7.9,7.03,12.6,3,9
65798,CHEMBL857,BIOTIN,103624,CHEMBL1287622,Lethal(3)malignant brain tumor-like protein 1,6.45,6.45,354.8,1,9
65798,CHEMBL857,BIOTIN,103720,CHEMBL1293287,Insulin-degrading enzyme,5.62,5.61,2373.0,2,8
65798,CHEMBL857,BIOTIN,11638,CHEMBL4040,Mitogen-activated protein kinase 1,5.6,5.6,2511.9,1,9
7736,CHEMBL86,METOCLOPRAMIDE,103668,CHEMBL1293235,Prelamin-A/C,8.15,8.15,7.1,1,9
7736,CHEMBL86,METOCLOPRAMIDE,130,CHEMBL234,D(3) dopamine receptor,7.8,7.36,16.0,6,9
7736,CHEMBL86,METOCLOPRAMIDE,72,CHEMBL217,D(2) dopamine receptor,7.38,7.11,42.0,4,8
7736,CHEMBL86,METOCLOPRAMIDE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.5,6.37,314.0,3,8
7736,CHEMBL86,METOCLOPRAMIDE,10567,CHEMBL2439,Myeloperoxidase,6.46,6.46,350.0,1,9
7736,CHEMBL86,METOCLOPRAMIDE,168,CHEMBL1875,5-hydroxytryptamine receptor 4,6.1,6.1,794.33,1,8
7736,CHEMBL86,METOCLOPRAMIDE,11365,CHEMBL289,Cytochrome P450 2D6,6.1,6.06,800.0,2,9
7736,CHEMBL86,METOCLOPRAMIDE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.99,5.78,1020.0,2,8
7736,CHEMBL86,METOCLOPRAMIDE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.98,5.79,1050.0,2,8
7736,CHEMBL86,METOCLOPRAMIDE,90,CHEMBL219,D(4) dopamine receptor,5.93,5.93,1163.9,1,8
7736,CHEMBL86,METOCLOPRAMIDE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.9,5.76,1248.0,2,8
7736,CHEMBL86,METOCLOPRAMIDE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.56,5.56,2772.0,1,8
7736,CHEMBL86,METOCLOPRAMIDE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.52,5.52,3000.0,1,8
66016,CHEMBL861,MEPHENYTOIN,12912,CHEMBL3622,Cytochrome P450 2C19,5.96,5.84,1110.0,5,9
66029,CHEMBL862,GUANFACINE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,8.4,8.4,4.0,1,9
66029,CHEMBL862,GUANFACINE,125,CHEMBL229,Alpha-1A adrenergic receptor,8.03,7.82,9.3,2,8
66029,CHEMBL862,GUANFACINE,11684,CHEMBL3923,Nischarin,7.72,7.72,19.01,1,9
66029,CHEMBL862,GUANFACINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,7.3,6.92,50.0,6,9
66029,CHEMBL862,GUANFACINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.94,6.44,114.0,4,9
66029,CHEMBL862,GUANFACINE,11365,CHEMBL289,Cytochrome P450 2D6,6.9,6.9,125.89,2,9
66029,CHEMBL862,GUANFACINE,12912,CHEMBL3622,Cytochrome P450 2C19,6.6,6.6,251.19,2,9
66029,CHEMBL862,GUANFACINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.45,5.97,358.0,5,8
66029,CHEMBL862,GUANFACINE,103668,CHEMBL1293235,Prelamin-A/C,6.45,6.45,354.8,1,9
66029,CHEMBL862,GUANFACINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.22,5.95,602.56,3,9
66029,CHEMBL862,GUANFACINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.21,5.9,610.0,4,8
66029,CHEMBL862,GUANFACINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.12,5.98,761.0,2,8
139099,CHEMBL86304,MOCLOBEMIDE,86,CHEMBL1951,Amine oxidase [flavin-containing] A,9.3,7.64,0.5,8,9
139099,CHEMBL86304,MOCLOBEMIDE,104,CHEMBL2039,Amine oxidase [flavin-containing] B,5.97,5.87,1080.0,4,9
66273,CHEMBL864,CARBINOXAMINE,127,CHEMBL231,Histamine H1 receptor,6.96,6.96,110.0,1,8
66273,CHEMBL864,CARBINOXAMINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.89,5.89,1300.0,1,8
66273,CHEMBL864,CARBINOXAMINE,121,CHEMBL228,Sodium-dependent serotonin transporter,5.52,5.52,3000.0,1,8
67010,CHEMBL865,VALDECOXIB,126,CHEMBL230,Prostaglandin G/H synthase 2,8.3,7.5,5.0,15,9
67010,CHEMBL865,VALDECOXIB,12209,CHEMBL3242,Carbonic anhydrase 12,7.89,7.89,13.0,5,9
67010,CHEMBL865,VALDECOXIB,96,CHEMBL221,Prostaglandin G/H synthase 1,7.77,7.77,17.1,1,8
67010,CHEMBL865,VALDECOXIB,12952,CHEMBL3594,Carbonic anhydrase 9,7.57,7.57,27.0,8,9
67010,CHEMBL865,VALDECOXIB,15,CHEMBL205,Carbonic anhydrase 2,7.37,7.37,43.0,41,9
67010,CHEMBL865,VALDECOXIB,11016,CHEMBL3969,"Carbonic anhydrase 5B, mitochondrial",7.06,7.06,88.0,1,9
67010,CHEMBL865,VALDECOXIB,11063,CHEMBL3510,Carbonic anhydrase 14,6.97,6.97,107.0,1,9
67010,CHEMBL865,VALDECOXIB,12896,CHEMBL3729,Carbonic anhydrase 4,6.47,6.07,340.0,3,9
67010,CHEMBL865,VALDECOXIB,12923,CHEMBL3912,Carbonic anhydrase 13,6.37,6.37,425.0,1,9
67010,CHEMBL865,VALDECOXIB,10186,CHEMBL3025,Carbonic anhydrase 6,6.24,6.24,572.0,2,9
67010,CHEMBL865,VALDECOXIB,11042,CHEMBL4789,"Carbonic anhydrase 5A, mitochondrial",6.04,6.04,912.0,1,9
67010,CHEMBL865,VALDECOXIB,101472,CHEMBL6174,Cytochrome c oxidase subunit 2,5.96,5.96,1100.0,1,9
67010,CHEMBL865,VALDECOXIB,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.64,5.57,2308.1,3,8
68396,CHEMBL866,MYCOPHENOLIC ACID,68,CHEMBL2002,Inosine-5'-monophosphate dehydrogenase 2,8.22,7.65,6.0,24,9
68396,CHEMBL866,MYCOPHENOLIC ACID,84,CHEMBL1822,Inosine-5'-monophosphate dehydrogenase 1,7.72,7.4,19.0,12,9
68396,CHEMBL866,MYCOPHENOLIC ACID,103665,CHEMBL1293232,Survival motor neuron protein,7.2,6.62,63.1,7,9
68396,CHEMBL866,MYCOPHENOLIC ACID,103668,CHEMBL1293235,Prelamin-A/C,6.85,6.53,141.3,2,9
68396,CHEMBL866,MYCOPHENOLIC ACID,100637,CHEMBL4370,UDP-glucuronosyltransferase 2B7,5.82,5.76,1500.0,8,9
139241,CHEMBL86715,PROCYCLIDINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.51,7.17,31.0,2,8
139241,CHEMBL86715,PROCYCLIDINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.96,6.42,110.0,3,8
139241,CHEMBL86715,PROCYCLIDINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.89,6.89,130.0,1,8
70239,CHEMBL869,NITROFURAZONE,103668,CHEMBL1293235,Prelamin-A/C,7.95,7.95,11.2,1,9
70674,CHEMBL870,ALENDRONIC ACID,71,CHEMBL1782,Farnesyl pyrophosphate synthase,7.36,6.6,44.2,10,9
70674,CHEMBL870,ALENDRONIC ACID,170,CHEMBL241,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",5.96,5.96,1090.9,1,8
70675,CHEMBL871,ETIDRONIC ACID,103668,CHEMBL1293235,Prelamin-A/C,5.9,5.9,1258.9,1,9
139434,CHEMBL87493,FENFLURAMINE,103657,CHEMBL1293224,Microtubule-associated protein tau,6.9,6.9,125.9,1,9
73547,CHEMBL877,TRANEXAMIC ACID,12,CHEMBL1801,Plasminogen,5.96,5.72,1100.0,5,9
73548,CHEMBL878,METOLAZONE,11060,CHEMBL2326,Carbonic anhydrase 7,8.68,8.68,2.1,1,9
73548,CHEMBL878,METOLAZONE,15,CHEMBL205,Carbonic anhydrase 2,5.7,5.63,2000.0,2,9
75752,CHEMBL887,RASAGILINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,8.85,8.85,1.4,1,9
75752,CHEMBL887,RASAGILINE,104,CHEMBL2039,Amine oxidase [flavin-containing] B,8.4,7.43,4.0,67,9
75752,CHEMBL887,RASAGILINE,93,CHEMBL220,Acetylcholinesterase,7.72,7.72,19.0,1,9
75752,CHEMBL887,RASAGILINE,86,CHEMBL1951,Amine oxidase [flavin-containing] A,7.5,6.08,32.0,33,9
75901,CHEMBL888,GEMCITABINE,175,CHEMBL1997,Equilibrative nucleoside transporter 1,6.72,6.72,190.0,1,9
77128,CHEMBL894,BUPROPION,155,CHEMBL238,Sodium-dependent dopamine transporter,6.76,6.09,173.0,18,9
77128,CHEMBL894,BUPROPION,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.35,5.86,443.0,6,9
77128,CHEMBL894,BUPROPION,12912,CHEMBL3622,Cytochrome P450 2C19,5.7,5.7,1998.3,1,8
77207,CHEMBL895,NALBUPHINE,129,CHEMBL233,Mu-type opioid receptor,9.05,7.84,0.89,23,9
77207,CHEMBL895,NALBUPHINE,137,CHEMBL237,Kappa-type opioid receptor,8.66,7.49,2.2,12,9
77207,CHEMBL895,NALBUPHINE,136,CHEMBL236,Delta-type opioid receptor,6.62,6.32,240.0,7,9
77459,CHEMBL896,HYDROXYZINE,127,CHEMBL231,Histamine H1 receptor,8.7,7.49,2.0,3,9
77459,CHEMBL896,HYDROXYZINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,7.3,7.06,50.0,2,9
77459,CHEMBL896,HYDROXYZINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.8,6.23,156.7,2,8
77459,CHEMBL896,HYDROXYZINE,102,CHEMBL1941,Histamine H2 receptor,6.72,6.72,188.4,1,8
77459,CHEMBL896,HYDROXYZINE,10624,CHEMBL3426,5-hydroxytryptamine receptor 5A,6.55,6.55,280.0,1,8
77459,CHEMBL896,HYDROXYZINE,130,CHEMBL234,D(3) dopamine receptor,6.54,6.54,290.0,1,8
77459,CHEMBL896,HYDROXYZINE,72,CHEMBL217,D(2) dopamine receptor,6.42,6.02,378.0,2,9
77459,CHEMBL896,HYDROXYZINE,125,CHEMBL229,Alpha-1A adrenergic receptor,6.26,6.02,545.8,2,8
77459,CHEMBL896,HYDROXYZINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.13,6.13,748.0,1,8
77459,CHEMBL896,HYDROXYZINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,5.66,5.66,2200.0,1,8
77459,CHEMBL896,HYDROXYZINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.64,5.64,2300.0,1,8
77474,CHEMBL897,PROBENECID,12952,CHEMBL3594,Carbonic anhydrase 9,6.44,6.44,360.0,3,9
77474,CHEMBL897,PROBENECID,15,CHEMBL205,Carbonic anhydrase 2,6.37,6.37,431.0,3,9
77474,CHEMBL897,PROBENECID,12209,CHEMBL3242,Carbonic anhydrase 12,5.91,5.91,1245.0,3,9
77474,CHEMBL897,PROBENECID,103665,CHEMBL1293232,Survival motor neuron protein,5.9,5.9,1258.9,1,9
77652,CHEMBL898,DIFLUNISAL,12704,CHEMBL3194,Transthyretin,7.12,6.11,75.0,7,9
77652,CHEMBL898,DIFLUNISAL,103829,CHEMBL1641347,Solute carrier family 22 member 6,6.07,6.07,850.0,1,8
77652,CHEMBL898,DIFLUNISAL,10697,CHEMBL3253,Albumin,5.91,5.71,1230.27,2,9
77652,CHEMBL898,DIFLUNISAL,103668,CHEMBL1293235,Prelamin-A/C,5.65,5.65,2238.7,1,9
77652,CHEMBL898,DIFLUNISAL,117546,CHEMBL4105941,2-amino-3-carboxymuconate-6-semialdehyde decarboxylase,5.59,5.59,2560.0,1,9
77652,CHEMBL898,DIFLUNISAL,15,CHEMBL205,Carbonic anhydrase 2,5.57,5.57,2700.0,1,9
246,CHEMBL9,NORFLOXACIN,103454,CHEMBL1163125,Bromodomain-containing protein 4,6.01,6.01,980.0,1,9
246,CHEMBL9,NORFLOXACIN,103659,CHEMBL1293226,Lysine-specific demethylase 4E,5.9,5.9,1258.9,1,9
246,CHEMBL9,NORFLOXACIN,100611,CHEMBL3491,Cytochrome P450 2J2,5.59,5.59,2560.0,1,9
246,CHEMBL9,NORFLOXACIN,103688,CHEMBL1293255,15-hydroxyprostaglandin dehydrogenase [NAD(+)],5.55,5.55,2818.4,1,9
8910,CHEMBL90,HISTAMINE,11290,CHEMBL3759,Histamine H4 receptor,9.0,7.82,1.0,43,9
8910,CHEMBL90,HISTAMINE,10280,CHEMBL264,Histamine H3 receptor,8.6,7.65,2.512,41,9
8910,CHEMBL90,HISTAMINE,127,CHEMBL231,Histamine H1 receptor,8.35,6.82,4.5,13,9
8910,CHEMBL90,HISTAMINE,102,CHEMBL1941,Histamine H2 receptor,7.91,6.32,12.2,18,9
8910,CHEMBL90,HISTAMINE,103668,CHEMBL1293235,Prelamin-A/C,6.05,6.05,891.3,1,9
77779,CHEMBL900,ORPHENADRINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,7.77,7.33,17.0,2,8
77779,CHEMBL900,ORPHENADRINE,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,7.7,7.63,20.0,2,8
77779,CHEMBL900,ORPHENADRINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.44,6.76,36.0,3,8
77779,CHEMBL900,ORPHENADRINE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,7.43,7.09,37.0,2,8
77779,CHEMBL900,ORPHENADRINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.9,6.63,125.0,2,8
77779,CHEMBL900,ORPHENADRINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.87,6.58,134.0,3,8
77779,CHEMBL900,ORPHENADRINE,127,CHEMBL231,Histamine H1 receptor,6.84,6.38,144.0,2,8
77779,CHEMBL900,ORPHENADRINE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.61,6.2,243.0,3,8
77779,CHEMBL900,ORPHENADRINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,6.55,6.41,280.0,2,8
77779,CHEMBL900,ORPHENADRINE,11365,CHEMBL289,Cytochrome P450 2D6,6.4,6.4,400.0,1,8
77779,CHEMBL900,ORPHENADRINE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,6.28,6.12,521.0,2,8
77779,CHEMBL900,ORPHENADRINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.09,5.88,809.0,2,8
77779,CHEMBL900,ORPHENADRINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.07,6.07,851.14,1,9
77779,CHEMBL900,ORPHENADRINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.06,5.89,865.0,2,8
77779,CHEMBL900,ORPHENADRINE,130,CHEMBL234,D(3) dopamine receptor,5.67,5.67,2116.0,1,8
77779,CHEMBL900,ORPHENADRINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.67,5.67,2158.0,1,8
77779,CHEMBL900,ORPHENADRINE,104063,CHEMBL1743122,Solute carrier family 22 member 2,5.6,5.6,2500.0,1,9
77779,CHEMBL900,ORPHENADRINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.58,5.58,2643.0,2,8
78303,CHEMBL902,FAMOTIDINE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.8,8.8,1.6,2,9
78303,CHEMBL902,FAMOTIDINE,11060,CHEMBL2326,Carbonic anhydrase 7,8.52,8.52,3.0,1,9
78303,CHEMBL902,FAMOTIDINE,102,CHEMBL1941,Histamine H2 receptor,8.2,7.66,6.3,3,8
78303,CHEMBL902,FAMOTIDINE,103668,CHEMBL1293235,Prelamin-A/C,7.55,7.05,28.2,2,9
78303,CHEMBL902,FAMOTIDINE,12209,CHEMBL3242,Carbonic anhydrase 12,7.34,7.34,45.3,1,9
78303,CHEMBL902,FAMOTIDINE,15,CHEMBL205,Carbonic anhydrase 2,7.24,7.24,57.9,1,9
78303,CHEMBL902,FAMOTIDINE,10186,CHEMBL3025,Carbonic anhydrase 6,7.01,7.01,98.2,1,9
78303,CHEMBL902,FAMOTIDINE,12952,CHEMBL3594,Carbonic anhydrase 9,6.9,6.9,126.3,1,9
78303,CHEMBL902,FAMOTIDINE,12923,CHEMBL3912,Carbonic anhydrase 13,6.77,6.77,171.5,1,9
78303,CHEMBL902,FAMOTIDINE,11063,CHEMBL3510,Carbonic anhydrase 14,6.17,6.17,677.2,1,9
78303,CHEMBL902,FAMOTIDINE,104067,CHEMBL1743126,Multidrug and toxin extrusion protein 1,6.12,6.12,760.0,1,9
78303,CHEMBL902,FAMOTIDINE,10193,CHEMBL261,Carbonic anhydrase 1,6.04,6.04,922.4,1,9
78303,CHEMBL902,FAMOTIDINE,12896,CHEMBL3729,Carbonic anhydrase 4,6.03,6.03,938.8,1,9
78303,CHEMBL902,FAMOTIDINE,11042,CHEMBL4789,"Carbonic anhydrase 5A, mitochondrial",5.84,5.84,1429.5,1,9
79047,CHEMBL905,RIZATRIPTAN,105,CHEMBL1983,5-hydroxytryptamine receptor 1D,8.52,7.98,3.0,8,9
79047,CHEMBL905,RIZATRIPTAN,106,CHEMBL1898,5-hydroxytryptamine receptor 1B,8.52,7.97,3.0,3,9
79047,CHEMBL905,RIZATRIPTAN,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.85,6.25,140.0,6,9
142808,CHEMBL90555,VINCRISTINE,103668,CHEMBL1293235,Prelamin-A/C,8.96,8.96,1.1,1,9
142808,CHEMBL90555,VINCRISTINE,101216,CHEMBL5514,Huntingtin,7.75,7.75,17.8,1,9
149457,CHEMBL90593,PRASTERONE,12643,CHEMBL3305,Sex hormone-binding globulin,7.84,7.84,14.45,1,9
80209,CHEMBL908,CHLORPROTHIXENE,127,CHEMBL231,Histamine H1 receptor,9.0,7.83,1.0,3,9
80209,CHEMBL908,CHLORPROTHIXENE,72,CHEMBL217,D(2) dopamine receptor,8.53,8.53,2.96,1,9
80209,CHEMBL908,CHLORPROTHIXENE,88,CHEMBL2056,D(1A) dopamine receptor,8.52,8.13,3.0,2,9
80209,CHEMBL908,CHLORPROTHIXENE,130,CHEMBL234,D(3) dopamine receptor,8.52,8.43,3.0,2,9
80209,CHEMBL908,CHLORPROTHIXENE,10627,CHEMBL3371,5-hydroxytryptamine receptor 6,8.52,8.52,3.0,1,8
80209,CHEMBL908,CHLORPROTHIXENE,125,CHEMBL229,Alpha-1A adrenergic receptor,8.46,8.46,3.5,1,8
80209,CHEMBL908,CHLORPROTHIXENE,220,CHEMBL1850,D(1B) dopamine receptor,8.05,8.05,9.0,1,9
80209,CHEMBL908,CHLORPROTHIXENE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,8.0,7.31,10.0,2,8
80209,CHEMBL908,CHLORPROTHIXENE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.22,7.22,60.0,1,8
80209,CHEMBL908,CHLORPROTHIXENE,51,CHEMBL214,5-hydroxytryptamine receptor 1A,6.96,6.96,110.0,1,8
80209,CHEMBL908,CHLORPROTHIXENE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.92,6.92,120.0,1,8
80209,CHEMBL908,CHLORPROTHIXENE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.77,6.67,170.0,2,8
80209,CHEMBL908,CHLORPROTHIXENE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.42,6.42,380.0,1,8
80209,CHEMBL908,CHLORPROTHIXENE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.28,6.28,520.0,1,8
8917,CHEMBL91,MICONAZOLE,12912,CHEMBL3622,Cytochrome P450 2C19,10.7,8.18,0.02,5,9
8917,CHEMBL91,MICONAZOLE,17045,CHEMBL340,Cytochrome P450 3A4,9.0,6.84,1.0,10,9
8917,CHEMBL91,MICONAZOLE,103668,CHEMBL1293235,Prelamin-A/C,8.05,8.05,8.9,1,9
8917,CHEMBL91,MICONAZOLE,12911,CHEMBL3397,Cytochrome P450 2C9,6.94,6.66,115.0,4,9
8917,CHEMBL91,MICONAZOLE,11188,CHEMBL3849,Lanosterol 14-alpha demethylase,6.7,6.7,200.0,1,9
8917,CHEMBL91,MICONAZOLE,12949,CHEMBL3522,"Steroid 17-alpha-hydroxylase/17,20 lyase",6.61,6.61,243.0,1,9
8917,CHEMBL91,MICONAZOLE,248,CHEMBL1835,Thromboxane-A synthase,6.58,6.58,263.0,1,9
8917,CHEMBL91,MICONAZOLE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.38,6.25,414.0,2,8
8917,CHEMBL91,MICONAZOLE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.35,5.92,446.0,2,8
8917,CHEMBL91,MICONAZOLE,100611,CHEMBL3491,Cytochrome P450 2J2,6.24,6.21,580.0,2,9
8917,CHEMBL91,MICONAZOLE,65,CHEMBL1978,Aromatase,6.22,6.22,600.0,1,9
8917,CHEMBL91,MICONAZOLE,219,CHEMBL245,Muscarinic acetylcholine receptor M3,6.17,5.83,668.0,2,8
8917,CHEMBL91,MICONAZOLE,11365,CHEMBL289,Cytochrome P450 2D6,6.06,5.97,875.0,5,9
8917,CHEMBL91,MICONAZOLE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.02,6.02,956.0,1,8
8917,CHEMBL91,MICONAZOLE,130,CHEMBL234,D(3) dopamine receptor,5.96,5.73,1086.0,2,8
8917,CHEMBL91,MICONAZOLE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,5.95,5.95,1116.0,1,8
8917,CHEMBL91,MICONAZOLE,136,CHEMBL236,Delta-type opioid receptor,5.92,5.92,1194.0,1,8
8917,CHEMBL91,MICONAZOLE,12594,CHEMBL3356,Cytochrome P450 1A2,5.9,5.74,1258.93,2,9
8917,CHEMBL91,MICONAZOLE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.87,5.82,1352.0,2,8
8917,CHEMBL91,MICONAZOLE,100643,CHEMBL4685,"Indoleamine 2,3-dioxygenase 1",5.85,5.7,1400.0,2,9
8917,CHEMBL91,MICONAZOLE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.83,5.83,1487.0,1,8
8917,CHEMBL91,MICONAZOLE,103,CHEMBL223,Alpha-1D adrenergic receptor,5.83,5.67,1497.0,2,8
8917,CHEMBL91,MICONAZOLE,119244,CHEMBL4523494,7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase,5.82,5.82,1500.0,1,9
8917,CHEMBL91,MICONAZOLE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.81,5.81,1542.0,1,8
8917,CHEMBL91,MICONAZOLE,280,CHEMBL256,Adenosine receptor A3,5.8,5.67,1589.0,2,8
8917,CHEMBL91,MICONAZOLE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.79,5.79,1642.0,1,8
8917,CHEMBL91,MICONAZOLE,10184,CHEMBL2327,Substance-K receptor,5.79,5.79,1613.0,1,8
8917,CHEMBL91,MICONAZOLE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.74,5.74,1830.0,1,8
8917,CHEMBL91,MICONAZOLE,11398,CHEMBL4302,ATP-dependent translocase ABCB1,5.7,5.7,2000.0,1,8
8917,CHEMBL91,MICONAZOLE,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.7,5.7,2000.0,1,8
8917,CHEMBL91,MICONAZOLE,129,CHEMBL233,Mu-type opioid receptor,5.61,5.61,2460.0,1,8
8917,CHEMBL91,MICONAZOLE,137,CHEMBL237,Kappa-type opioid receptor,5.58,5.58,2637.0,1,8
8917,CHEMBL91,MICONAZOLE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.55,5.55,2784.0,1,8
8917,CHEMBL91,MICONAZOLE,25,CHEMBL2034,Glucocorticoid receptor,5.54,5.54,2900.0,1,8
8917,CHEMBL91,MICONAZOLE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,5.54,5.54,2915.0,2,8
8917,CHEMBL91,MICONAZOLE,88,CHEMBL2056,D(1A) dopamine receptor,5.5,5.5,3124.0,1,8
80965,CHEMBL911,ZOLPIDEM,74,CHEMBL1962,Gamma-aminobutyric acid receptor subunit alpha-1,7.85,7.18,14.0,6,9
80965,CHEMBL911,ZOLPIDEM,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.68,6.68,210.0,1,8
80965,CHEMBL911,ZOLPIDEM,12757,CHEMBL3026,Gamma-aminobutyric acid receptor subunit alpha-3,6.4,6.4,400.0,1,9
80965,CHEMBL911,ZOLPIDEM,12770,CHEMBL4956,Gamma-aminobutyric acid receptor subunit alpha-2,6.13,6.13,737.0,1,8
147769,CHEMBL91397,RUPATADINE,127,CHEMBL231,Histamine H1 receptor,8.41,8.41,3.9,2,9
81683,CHEMBL914,FEXOFENADINE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.05,8.05,8.9,2,9
81683,CHEMBL914,FEXOFENADINE,127,CHEMBL231,Histamine H1 receptor,7.82,7.27,15.0,6,9
81683,CHEMBL914,FEXOFENADINE,103668,CHEMBL1293235,Prelamin-A/C,6.8,6.8,158.5,1,9
82983,CHEMBL917,FLOXURIDINE,103668,CHEMBL1293235,Prelamin-A/C,8.4,7.73,4.0,3,9
82983,CHEMBL917,FLOXURIDINE,103665,CHEMBL1293232,Survival motor neuron protein,6.75,6.33,177.8,2,9
83515,CHEMBL922,ADEFOVIR DIPIVOXIL,13074,CHEMBL2732,DNA polymerase subunit gamma-1,6.01,6.01,970.0,1,9
83515,CHEMBL922,ADEFOVIR DIPIVOXIL,54,CHEMBL1828,DNA polymerase alpha catalytic subunit,5.93,5.93,1180.0,1,9
5622,CHEMBL9225,HEXESTROL,19,CHEMBL206,Estrogen receptor,7.6,7.6,25.2,1,8
5622,CHEMBL9225,HEXESTROL,103668,CHEMBL1293235,Prelamin-A/C,6.5,6.5,316.2,1,9
5622,CHEMBL9225,HEXESTROL,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.3,6.3,501.2,1,9
5622,CHEMBL9225,HEXESTROL,36,CHEMBL208,Progesterone receptor,5.73,5.73,1848.2,1,8
5622,CHEMBL9225,HEXESTROL,12912,CHEMBL3622,Cytochrome P450 2C19,5.5,5.5,3162.28,2,9
83772,CHEMBL923,RISEDRONIC ACID,71,CHEMBL1782,Farnesyl pyrophosphate synthase,9.44,7.75,0.36,24,9
83772,CHEMBL923,RISEDRONIC ACID,117363,CHEMBL4105758,Butyrophilin subfamily 3 member A1,7.1,7.1,80.0,1,9
83838,CHEMBL924,ZOLEDRONIC ACID ANHYDROUS,71,CHEMBL1782,Farnesyl pyrophosphate synthase,6.26,6.26,550.0,1,9
84505,CHEMBL926,DOBUTAMINE,125,CHEMBL229,Alpha-1A adrenergic receptor,8.27,7.34,5.4,3,8
84505,CHEMBL926,DOBUTAMINE,103,CHEMBL223,Alpha-1D adrenergic receptor,7.25,7.1,56.0,2,8
84505,CHEMBL926,DOBUTAMINE,155,CHEMBL238,Sodium-dependent dopamine transporter,6.91,6.59,123.0,3,8
84505,CHEMBL926,DOBUTAMINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.42,6.2,380.0,3,8
84505,CHEMBL926,DOBUTAMINE,15,CHEMBL205,Carbonic anhydrase 2,6.32,6.32,480.0,1,9
84505,CHEMBL926,DOBUTAMINE,130,CHEMBL234,D(3) dopamine receptor,6.14,5.96,728.0,2,8
84505,CHEMBL926,DOBUTAMINE,11042,CHEMBL4789,"Carbonic anhydrase 5A, mitochondrial",6.14,6.14,730.0,1,9
84505,CHEMBL926,DOBUTAMINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,6.1,6.1,798.1,1,8
84505,CHEMBL926,DOBUTAMINE,11016,CHEMBL3969,"Carbonic anhydrase 5B, mitochondrial",6.05,6.05,890.0,1,9
84505,CHEMBL926,DOBUTAMINE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.0,5.86,1006.0,2,8
84505,CHEMBL926,DOBUTAMINE,43,CHEMBL210,Beta-2 adrenergic receptor,5.98,5.9,1043.0,2,8
84505,CHEMBL926,DOBUTAMINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,5.98,5.79,1058.0,2,8
84505,CHEMBL926,DOBUTAMINE,50,CHEMBL213,Beta-1 adrenergic receptor,5.95,5.83,1123.0,2,8
84505,CHEMBL926,DOBUTAMINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.87,5.7,1354.0,2,8
84505,CHEMBL926,DOBUTAMINE,129,CHEMBL233,Mu-type opioid receptor,5.77,5.77,1700.0,1,8
84505,CHEMBL926,DOBUTAMINE,10193,CHEMBL261,Carbonic anhydrase 1,5.72,5.72,1920.0,1,9
84505,CHEMBL926,DOBUTAMINE,126,CHEMBL230,Prostaglandin G/H synthase 2,5.63,5.63,2323.8,1,8
84505,CHEMBL926,DOBUTAMINE,90,CHEMBL219,D(4) dopamine receptor,5.62,5.62,2417.0,1,8
9217,CHEMBL93,ZILEUTON,55,CHEMBL215,Polyunsaturated fatty acid 5-lipoxygenase,6.82,6.08,150.0,81,9
9217,CHEMBL93,ZILEUTON,103668,CHEMBL1293235,Prelamin-A/C,6.65,6.65,223.9,1,9
9217,CHEMBL93,ZILEUTON,12054,CHEMBL2903,Polyunsaturated fatty acid lipoxygenase ALOX15,6.4,6.4,400.0,1,9
9217,CHEMBL93,ZILEUTON,10542,CHEMBL3911,Leukotriene B4 receptor 1,6.38,6.38,420.0,1,9
9217,CHEMBL93,ZILEUTON,10102,CHEMBL4550,Arachidonate 5-lipoxygenase-activating protein,6.24,5.95,580.0,2,9
9217,CHEMBL93,ZILEUTON,11727,CHEMBL2409,Bifunctional epoxide hydrolase 2,6.23,6.23,591.0,1,9
9217,CHEMBL93,ZILEUTON,101277,CHEMBL5658,Prostaglandin E synthase,6.22,6.22,600.0,1,9
9217,CHEMBL93,ZILEUTON,237,CHEMBL4618,Leukotriene A-4 hydrolase,6.07,6.07,850.0,1,8
85305,CHEMBL930,GLUTAMINE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.55,8.55,2.8,2,9
86042,CHEMBL932,DIPYRIDAMOLE,103668,CHEMBL1293235,Prelamin-A/C,8.4,7.03,4.0,2,9
86042,CHEMBL932,DIPYRIDAMOLE,175,CHEMBL1997,Equilibrative nucleoside transporter 1,8.09,7.77,8.1,5,9
86042,CHEMBL932,DIPYRIDAMOLE,103069,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,6.5,6.5,316.2,1,9
86042,CHEMBL932,DIPYRIDAMOLE,12448,CHEMBL2717,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",6.4,6.4,400.0,1,9
86042,CHEMBL932,DIPYRIDAMOLE,3,CHEMBL1827,"cGMP-specific 3',5'-cyclic phosphodiesterase",6.28,6.02,520.0,3,9
86042,CHEMBL932,DIPYRIDAMOLE,104671,CHEMBL2079850,Exopolyphosphatase PRUNE1,6.11,6.11,780.0,1,9
86042,CHEMBL932,DIPYRIDAMOLE,103665,CHEMBL1293232,Survival motor neuron protein,6.05,6.05,891.3,1,9
86042,CHEMBL932,DIPYRIDAMOLE,100010,CHEMBL4409,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",6.0,6.0,1000.0,1,9
86042,CHEMBL932,DIPYRIDAMOLE,12912,CHEMBL3622,Cytochrome P450 2C19,5.9,5.9,1258.9,2,9
86042,CHEMBL932,DIPYRIDAMOLE,103657,CHEMBL1293224,Microtubule-associated protein tau,5.85,5.72,1412.5,2,9
86042,CHEMBL932,DIPYRIDAMOLE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,5.7,5.7,2000.0,1,8
86042,CHEMBL932,DIPYRIDAMOLE,104069,CHEMBL1743128,ATP-binding cassette sub-family C member 4,5.7,5.7,2000.0,1,8
86042,CHEMBL932,DIPYRIDAMOLE,104063,CHEMBL1743122,Solute carrier family 22 member 2,5.58,5.58,2600.0,1,9
86042,CHEMBL932,DIPYRIDAMOLE,11359,CHEMBL288,"3',5'-cyclic-AMP phosphodiesterase 4D",5.55,5.55,2800.0,1,9
86284,CHEMBL934,METYRAPONE,76,CHEMBL1908,"Cytochrome P450 11B1, mitochondrial",7.84,7.78,14.6,12,9
86284,CHEMBL934,METYRAPONE,11541,CHEMBL2722,"Cytochrome P450 11B2, mitochondrial",7.38,7.12,42.0,12,9
86284,CHEMBL934,METYRAPONE,17045,CHEMBL340,Cytochrome P450 3A4,6.1,5.81,800.0,6,9
86466,CHEMBL936,DIPHENIDOL,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,7.42,7.0,38.0,2,8
86466,CHEMBL936,DIPHENIDOL,219,CHEMBL245,Muscarinic acetylcholine receptor M3,7.28,6.95,52.0,2,8
86466,CHEMBL936,DIPHENIDOL,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.11,6.63,78.0,3,8
86466,CHEMBL936,DIPHENIDOL,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,6.97,6.78,108.0,2,8
86466,CHEMBL936,DIPHENIDOL,11365,CHEMBL289,Cytochrome P450 2D6,6.9,6.76,125.89,3,9
86466,CHEMBL936,DIPHENIDOL,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.56,6.28,274.0,4,8
86466,CHEMBL936,DIPHENIDOL,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.13,5.86,739.0,2,8
86466,CHEMBL936,DIPHENIDOL,130,CHEMBL234,D(3) dopamine receptor,6.11,5.81,785.0,3,8
86466,CHEMBL936,DIPHENIDOL,215,CHEMBL2035,Muscarinic acetylcholine receptor M5,6.07,6.0,855.0,2,8
86466,CHEMBL936,DIPHENIDOL,72,CHEMBL217,D(2) dopamine receptor,5.96,5.96,1097.0,1,8
87771,CHEMBL938,SARALASIN,10692,CHEMBL4607,Type-2 angiotensin II receptor,9.82,9.36,0.15,6,9
87771,CHEMBL938,SARALASIN,115,CHEMBL227,Type-1 angiotensin II receptor,9.77,9.29,0.17,13,9
88232,CHEMBL939,GEFITINIB,9,CHEMBL203,Epidermal growth factor receptor,10.0,7.9,0.1,265,9
88232,CHEMBL939,GEFITINIB,20025,CHEMBL5014,Receptor-interacting serine/threonine-protein kinase 2,8.42,6.82,3.8,7,9
88232,CHEMBL939,GEFITINIB,20020,CHEMBL4355,Cyclin-G-associated kinase,8.15,7.58,7.0,10,9
88232,CHEMBL939,GEFITINIB,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,7.62,6.51,24.0,26,9
88232,CHEMBL939,GEFITINIB,10980,CHEMBL279,Vascular endothelial growth factor receptor 2,7.48,6.53,33.0,4,9
88232,CHEMBL939,GEFITINIB,100168,CHEMBL5533,Transcription factor p65,7.26,7.26,55.0,1,9
88232,CHEMBL939,GEFITINIB,19623,CHEMBL3357,Interleukin-1 receptor-associated kinase 1,7.16,6.72,69.0,3,8
88232,CHEMBL939,GEFITINIB,11785,CHEMBL3234,Tyrosine-protein kinase HCK,6.96,6.05,110.0,3,8
88232,CHEMBL939,GEFITINIB,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,6.8,6.4,158.49,4,9
88232,CHEMBL939,GEFITINIB,12699,CHEMBL3009,Receptor tyrosine-protein kinase erbB-4,6.8,6.53,158.49,5,9
88232,CHEMBL939,GEFITINIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,6.64,6.15,230.0,12,8
88232,CHEMBL939,GEFITINIB,102799,CHEMBL6191,Mitogen-activated protein kinase kinase kinase 19,6.62,6.62,240.0,1,8
88232,CHEMBL939,GEFITINIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,6.6,6.15,251.19,4,9
88232,CHEMBL939,GEFITINIB,100835,CHEMBL4718,MAP kinase-interacting serine/threonine-protein kinase 1,6.54,6.54,290.0,2,9
88232,CHEMBL939,GEFITINIB,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,6.52,6.1,300.0,6,9
88232,CHEMBL939,GEFITINIB,103106,CHEMBL1075167,Homeodomain-interacting protein kinase 4,6.51,6.1,310.0,3,8
88232,CHEMBL939,GEFITINIB,101504,CHEMBL5699,Serine/threonine-protein kinase SIK2,6.5,6.09,316.23,4,9
88232,CHEMBL939,GEFITINIB,30037,CHEMBL4204,MAP kinase-interacting serine/threonine-protein kinase 2,6.44,6.22,360.0,5,9
88232,CHEMBL939,GEFITINIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,6.4,6.23,398.11,5,9
88232,CHEMBL939,GEFITINIB,30035,CHEMBL4202,STE20-like serine/threonine-protein kinase,6.4,6.17,398.11,5,9
88232,CHEMBL939,GEFITINIB,10967,CHEMBL4937,Casein kinase I isoform epsilon,6.37,6.15,430.0,3,9
88232,CHEMBL939,GEFITINIB,30006,CHEMBL3981,Serine/threonine-protein kinase 10,6.33,6.24,470.0,3,9
88232,CHEMBL939,GEFITINIB,10188,CHEMBL260,Mitogen-activated protein kinase 14,6.3,6.3,501.19,2,8
88232,CHEMBL939,GEFITINIB,19639,CHEMBL3778,Interleukin-1 receptor-associated kinase 4,6.27,6.09,540.0,3,8
88232,CHEMBL939,GEFITINIB,103458,CHEMBL1163129,Serine/threonine-protein kinase SBK1,6.25,6.25,560.0,1,8
88232,CHEMBL939,GEFITINIB,30046,CHEMBL4526,Ephrin type-A receptor 6,6.23,6.1,590.0,3,9
88232,CHEMBL939,GEFITINIB,10371,CHEMBL4948,Dual specificity mitogen-activated protein kinase kinase 5,6.22,6.22,600.0,1,8
88232,CHEMBL939,GEFITINIB,12829,CHEMBL3055,Cyclin-dependent kinase 7,6.21,6.21,610.0,1,8
88232,CHEMBL939,GEFITINIB,10531,CHEMBL2527,Serine/threonine-protein kinase Chk2,6.2,6.17,630.96,3,8
88232,CHEMBL939,GEFITINIB,11408,CHEMBL2637,Mitogen-activated protein kinase 10,6.1,5.77,794.33,5,9
88232,CHEMBL939,GEFITINIB,102678,CHEMBL5838,Receptor tyrosine-protein kinase erbB-3,6.1,6.1,790.0,1,8
88232,CHEMBL939,GEFITINIB,30026,CHEMBL4601,Protein-tyrosine kinase 6,6.01,6.01,980.0,1,8
88232,CHEMBL939,GEFITINIB,11691,CHEMBL2250,Tyrosine-protein kinase Blk,6.0,5.96,1000.0,4,9
88232,CHEMBL939,GEFITINIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,6.0,5.75,1000.0,8,9
88232,CHEMBL939,GEFITINIB,100129,CHEMBL5147,Ephrin type-B receptor 4,6.0,5.8,1000.0,2,8
88232,CHEMBL939,GEFITINIB,101464,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,6.0,6.0,1000.0,2,8
88232,CHEMBL939,GEFITINIB,10434,CHEMBL267,Proto-oncogene tyrosine-protein kinase Src,5.96,5.96,1100.0,1,8
88232,CHEMBL939,GEFITINIB,10782,CHEMBL3125,Ribosomal protein S6 kinase alpha-4,5.92,5.92,1200.0,1,8
88232,CHEMBL939,GEFITINIB,10885,CHEMBL2595,Serine/threonine-protein kinase D3,5.9,5.9,1258.93,2,8
88232,CHEMBL939,GEFITINIB,100855,CHEMBL5407,Serine/threonine-protein kinase pim-3,5.9,5.9,1258.93,2,8
88232,CHEMBL939,GEFITINIB,30020,CHEMBL5072,Ephrin type-B receptor 1,5.89,5.89,1300.0,1,8
88232,CHEMBL939,GEFITINIB,101239,CHEMBL5579,Citron Rho-interacting kinase,5.89,5.89,1300.0,2,9
88232,CHEMBL939,GEFITINIB,11407,CHEMBL4179,Mitogen-activated protein kinase 9,5.85,5.71,1400.0,4,9
88232,CHEMBL939,GEFITINIB,30019,CHEMBL3987,Ephrin type-A receptor 5,5.82,5.82,1500.0,1,8
88232,CHEMBL939,GEFITINIB,101055,CHEMBL5081,Interleukin-1 receptor-associated kinase 3,5.82,5.82,1500.0,2,9
88232,CHEMBL939,GEFITINIB,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.8,5.74,1600.0,2,9
88232,CHEMBL939,GEFITINIB,11209,CHEMBL4014,Tyrosine-protein kinase ABL2,5.8,5.8,1600.0,1,8
88232,CHEMBL939,GEFITINIB,30049,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,5.8,5.8,1584.89,2,8
88232,CHEMBL939,GEFITINIB,100410,CHEMBL4895,Tyrosine-protein kinase receptor UFO,5.8,5.78,1584.89,3,8
88232,CHEMBL939,GEFITINIB,101078,CHEMBL5121,Mitogen-activated protein kinase 6,5.8,5.8,1600.0,2,9
88232,CHEMBL939,GEFITINIB,100079,CHEMBL2041,Proto-oncogene tyrosine-protein kinase receptor Ret,5.77,5.77,1700.0,1,8
88232,CHEMBL939,GEFITINIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,5.75,5.75,1800.0,1,8
88232,CHEMBL939,GEFITINIB,30010,CHEMBL4134,Ephrin type-A receptor 8,5.75,5.75,1800.0,2,9
88232,CHEMBL939,GEFITINIB,101220,CHEMBL5518,Misshapen-like kinase 1,5.75,5.75,1800.0,1,8
88232,CHEMBL939,GEFITINIB,12037,CHEMBL2777,"Myosin light chain kinase 2, skeletal/cardiac muscle",5.72,5.72,1900.0,2,9
88232,CHEMBL939,GEFITINIB,10839,CHEMBL2147,Serine/threonine-protein kinase pim-1,5.7,5.7,1995.26,2,8
88232,CHEMBL939,GEFITINIB,30045,CHEMBL4525,Serine/threonine-protein kinase 17A,5.7,5.65,2000.0,3,9
88232,CHEMBL939,GEFITINIB,100126,CHEMBL5145,Serine/threonine-protein kinase B-raf,5.7,5.7,2000.0,1,9
88232,CHEMBL939,GEFITINIB,101399,CHEMBL5970,Mitogen-activated protein kinase kinase kinase 3,5.68,5.68,2100.0,1,8
88232,CHEMBL939,GEFITINIB,30023,CHEMBL4599,Activated CDC42 kinase 1,5.64,5.64,2300.0,1,8
88232,CHEMBL939,GEFITINIB,11622,CHEMBL2801,Calcium/calmodulin-dependent protein kinase type II subunit delta,5.6,5.6,2511.89,2,8
88232,CHEMBL939,GEFITINIB,100415,CHEMBL4900,Serine/threonine-protein kinase D2,5.6,5.6,2511.89,2,8
88232,CHEMBL939,GEFITINIB,100127,CHEMBL4454,Tyrosine-protein kinase Fgr,5.58,5.58,2600.0,1,8
88232,CHEMBL939,GEFITINIB,12735,CHEMBL2349,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",5.57,5.52,2700.0,3,8
88232,CHEMBL939,GEFITINIB,104279,CHEMBL1795199,Receptor-interacting serine/threonine-protein kinase 3,5.57,5.57,2664.0,1,9
88232,CHEMBL939,GEFITINIB,101448,CHEMBL6123,Serine/threonine-protein kinase DCLK3,5.54,5.54,2900.0,1,8
88232,CHEMBL939,GEFITINIB,101538,CHEMBL5759,Mitogen-activated protein kinase 4,5.51,5.51,3100.0,2,9
88232,CHEMBL939,GEFITINIB,10368,CHEMBL2828,Casein kinase I isoform delta,5.5,5.5,3200.0,1,8
88232,CHEMBL939,GEFITINIB,30002,CHEMBL3829,Calcium/calmodulin-dependent protein kinase type II subunit gamma,5.5,5.5,3162.28,2,8
88232,CHEMBL939,GEFITINIB,101269,CHEMBL5650,Serine/threonine-protein kinase BRSK1,5.5,5.5,3162.28,2,8
88232,CHEMBL939,GEFITINIB,102676,CHEMBL5836,Ephrin type-B receptor 6,5.5,5.5,3200.0,1,8
88316,CHEMBL940,GABAPENTIN,150,CHEMBL1919,Voltage-dependent calcium channel subunit alpha-2/delta-1,7.57,7.57,27.0,1,9
88316,CHEMBL940,GABAPENTIN,103665,CHEMBL1293232,Survival motor neuron protein,5.85,5.85,1412.5,1,9
88797,CHEMBL941,IMATINIB,188,CHEMBL1824,Receptor tyrosine-protein kinase erbB-2,10.22,10.22,0.06,1,9
88797,CHEMBL941,IMATINIB,9,CHEMBL203,Epidermal growth factor receptor,9.96,9.96,0.11,1,9
88797,CHEMBL941,IMATINIB,100917,CHEMBL5319,Epithelial discoidin domain-containing receptor 1,9.15,7.99,0.7,7,9
88797,CHEMBL941,IMATINIB,8,CHEMBL1862,Tyrosine-protein kinase ABL1,9.0,6.84,1.0,98,9
88797,CHEMBL941,IMATINIB,12627,CHEMBL2007,Platelet-derived growth factor receptor alpha,8.7,7.24,1.995,13,9
88797,CHEMBL941,IMATINIB,11209,CHEMBL4014,Tyrosine-protein kinase ABL2,8.22,7.42,6.0,10,9
88797,CHEMBL941,IMATINIB,100128,CHEMBL5146,Breakpoint cluster region protein,8.15,8.15,7.0,1,9
88797,CHEMBL941,IMATINIB,12840,CHEMBL1844,Macrophage colony-stimulating factor 1 receptor,8.0,7.08,10.0,8,9
88797,CHEMBL941,IMATINIB,238,CHEMBL1936,Mast/stem cell growth factor receptor Kit,7.9,6.94,12.59,46,9
88797,CHEMBL941,IMATINIB,197,CHEMBL1913,Platelet-derived growth factor receptor beta,7.85,7.0,14.0,10,9
88797,CHEMBL941,IMATINIB,101079,CHEMBL5122,Discoidin domain-containing receptor 2,7.82,7.08,15.0,5,9
88797,CHEMBL941,IMATINIB,15,CHEMBL205,Carbonic anhydrase 2,7.52,7.52,30.2,1,9
88797,CHEMBL941,IMATINIB,10193,CHEMBL261,Carbonic anhydrase 1,7.5,7.5,31.9,1,9
88797,CHEMBL941,IMATINIB,10170,CHEMBL3959,Ribosyldihydronicotinamide dehydrogenase [quinone],7.41,7.13,39.0,5,9
88797,CHEMBL941,IMATINIB,10140,CHEMBL258,Tyrosine-protein kinase Lck,7.4,6.96,39.81,8,9
88797,CHEMBL941,IMATINIB,104067,CHEMBL1743126,Multidrug and toxin extrusion protein 1,7.4,7.05,40.0,3,9
88797,CHEMBL941,IMATINIB,12952,CHEMBL3594,Carbonic anhydrase 9,7.12,7.12,75.7,1,9
88797,CHEMBL941,IMATINIB,11060,CHEMBL2326,Carbonic anhydrase 7,6.96,6.96,109.0,1,9
88797,CHEMBL941,IMATINIB,12670,CHEMBL1974,Receptor-type tyrosine-protein kinase FLT3,6.88,6.88,131.0,1,9
88797,CHEMBL941,IMATINIB,248,CHEMBL1835,Thromboxane-A synthase,6.7,6.7,198.0,1,9
88797,CHEMBL941,IMATINIB,11842,CHEMBL3905,Tyrosine-protein kinase Lyn,6.7,6.47,199.53,3,9
88797,CHEMBL941,IMATINIB,30012,CHEMBL4223,Tyrosine-protein kinase FRK,6.5,6.05,316.23,3,9
88797,CHEMBL941,IMATINIB,104068,CHEMBL1743127,Multidrug and toxin extrusion protein 2,6.46,6.0,350.0,2,9
88797,CHEMBL941,IMATINIB,104126,CHEMBL1770034,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,6.42,6.42,380.0,1,8
88797,CHEMBL941,IMATINIB,10186,CHEMBL3025,Carbonic anhydrase 6,6.41,6.41,392.0,1,9
88797,CHEMBL941,IMATINIB,101232,CHEMBL5553,ATP-dependent RNA helicase DDX3X,6.36,6.36,435.0,1,9
88797,CHEMBL941,IMATINIB,11063,CHEMBL3510,Carbonic anhydrase 14,6.33,6.33,468.0,1,9
88797,CHEMBL941,IMATINIB,100974,CHEMBL5393,Broad substrate specificity ATP-binding cassette transporter ABCG2,6.3,6.17,500.0,2,8
88797,CHEMBL941,IMATINIB,10139,CHEMBL2885,Carbonic anhydrase 3,6.28,6.28,528.0,1,9
88797,CHEMBL941,IMATINIB,11691,CHEMBL2250,Tyrosine-protein kinase Blk,6.28,6.28,520.0,2,9
88797,CHEMBL941,IMATINIB,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.27,5.99,540.0,2,8
88797,CHEMBL941,IMATINIB,11398,CHEMBL4302,ATP-dependent translocase ABCB1,6.24,6.24,580.0,1,9
88797,CHEMBL941,IMATINIB,121,CHEMBL228,Sodium-dependent serotonin transporter,6.13,5.99,745.0,2,8
88797,CHEMBL941,IMATINIB,103106,CHEMBL1075167,Homeodomain-interacting protein kinase 4,6.02,6.02,960.0,1,8
88797,CHEMBL941,IMATINIB,12209,CHEMBL3242,Carbonic anhydrase 12,6.01,6.01,980.0,1,9
88797,CHEMBL941,IMATINIB,11408,CHEMBL2637,Mitogen-activated protein kinase 10,6.0,5.67,1000.0,3,9
88797,CHEMBL941,IMATINIB,20020,CHEMBL4355,Cyclin-G-associated kinase,6.0,6.0,1000.0,2,9
88797,CHEMBL941,IMATINIB,19623,CHEMBL3357,Interleukin-1 receptor-associated kinase 1,5.92,5.92,1200.0,1,8
88797,CHEMBL941,IMATINIB,30036,CHEMBL4203,Dual specificity protein kinase CLK4,5.9,5.73,1258.93,4,9
88797,CHEMBL941,IMATINIB,30010,CHEMBL4134,Ephrin type-A receptor 8,5.85,5.79,1400.0,3,9
88797,CHEMBL941,IMATINIB,10904,CHEMBL1906,RAF proto-oncogene serine/threonine-protein kinase,5.77,5.77,1700.0,2,9
88797,CHEMBL941,IMATINIB,100854,CHEMBL4578,Maternal embryonic leucine zipper kinase,5.72,5.72,1900.0,2,9
88797,CHEMBL941,IMATINIB,102,CHEMBL1941,Histamine H2 receptor,5.71,5.71,1930.0,2,8
88797,CHEMBL941,IMATINIB,100127,CHEMBL4454,Tyrosine-protein kinase Fgr,5.62,5.62,2400.0,2,9
88797,CHEMBL941,IMATINIB,20007,CHEMBL3886,Mitogen-activated protein kinase kinase kinase 20,5.58,5.58,2600.0,2,9
88797,CHEMBL941,IMATINIB,30045,CHEMBL4525,Serine/threonine-protein kinase 17A,5.55,5.55,2800.0,1,9
88797,CHEMBL941,IMATINIB,11755,CHEMBL1841,Tyrosine-protein kinase Fyn,5.51,5.51,3100.0,2,9
88797,CHEMBL941,IMATINIB,10188,CHEMBL260,Mitogen-activated protein kinase 14,5.5,5.5,3162.28,1,9
88797,CHEMBL941,IMATINIB,12261,CHEMBL2276,Mitogen-activated protein kinase 8,5.5,5.5,3200.0,1,9
88797,CHEMBL941,IMATINIB,101026,CHEMBL5575,Lysine--tRNA ligase,5.5,5.5,3162.28,1,9
88841,CHEMBL942,BISACODYL,101176,CHEMBL5401,Signal transducer and activator of transcription 6,6.4,6.4,398.1,2,9
88841,CHEMBL942,BISACODYL,155,CHEMBL238,Sodium-dependent dopamine transporter,6.35,5.92,450.0,3,8
88841,CHEMBL942,BISACODYL,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,6.3,6.2,501.2,4,9
88841,CHEMBL942,BISACODYL,103170,CHEMBL1075322,G-protein coupled receptor 55,6.04,6.04,908.43,1,9
88841,CHEMBL942,BISACODYL,137,CHEMBL237,Kappa-type opioid receptor,6.01,5.81,975.0,2,8
88841,CHEMBL942,BISACODYL,78,CHEMBL1963,Thyrotropin receptor,5.9,5.75,1258.9,4,9
88841,CHEMBL942,BISACODYL,103668,CHEMBL1293235,Prelamin-A/C,5.85,5.85,1412.5,1,9
153408,CHEMBL94394,BUFEXAMAC,276,CHEMBL254,"3',5'-cyclic-AMP phosphodiesterase 4A",6.28,6.28,529.8,1,8
153408,CHEMBL94394,BUFEXAMAC,103665,CHEMBL1293232,Survival motor neuron protein,5.85,5.85,1412.5,1,9
153408,CHEMBL94394,BUFEXAMAC,12594,CHEMBL3356,Cytochrome P450 1A2,5.8,5.8,1584.89,1,8
152819,CHEMBL94454,MIZOLASTINE,127,CHEMBL231,Histamine H1 receptor,8.57,8.57,2.7,1,9
152819,CHEMBL94454,MIZOLASTINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.96,7.96,11.0,1,8
152819,CHEMBL94454,MIZOLASTINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.46,6.4,350.0,8,9
89526,CHEMBL945,AMILORIDE,103668,CHEMBL1293235,Prelamin-A/C,6.15,6.15,707.9,1,9
89526,CHEMBL945,AMILORIDE,132,CHEMBL1791,Amiloride-sensitive sodium channel subunit alpha,6.11,6.11,776.0,1,8
89526,CHEMBL945,AMILORIDE,11942,CHEMBL3286,Urokinase-type plasminogen activator,5.62,5.61,2400.0,4,9
89526,CHEMBL945,AMILORIDE,125,CHEMBL229,Alpha-1A adrenergic receptor,5.57,5.57,2693.3,1,8
89672,CHEMBL946,AZATADINE,127,CHEMBL231,Histamine H1 receptor,8.18,7.68,6.6,2,8
89672,CHEMBL946,AZATADINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.19,7.14,64.0,2,8
89672,CHEMBL946,AZATADINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,6.96,6.96,110.0,1,8
89672,CHEMBL946,AZATADINE,107,CHEMBL224,5-hydroxytryptamine receptor 2A,6.84,6.65,143.8,2,8
89672,CHEMBL946,AZATADINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,5.8,5.8,1600.0,1,8
89672,CHEMBL946,AZATADINE,108,CHEMBL225,5-hydroxytryptamine receptor 2C,5.51,5.51,3100.0,1,8
9333,CHEMBL95,TACRINE,10532,CHEMBL1914,Cholinesterase,10.57,7.54,0.0267,139,9
9333,CHEMBL95,TACRINE,93,CHEMBL220,Acetylcholinesterase,8.5,6.74,3.16,198,9
9333,CHEMBL95,TACRINE,10656,CHEMBL2487,Amyloid-beta precursor protein,7.91,7.91,12.21,1,9
9333,CHEMBL95,TACRINE,10639,CHEMBL2484,Acetylcholine receptor subunit epsilon,7.36,7.09,44.0,2,9
9333,CHEMBL95,TACRINE,11365,CHEMBL289,Cytochrome P450 2D6,6.52,6.52,300.0,1,8
9333,CHEMBL95,TACRINE,12594,CHEMBL3356,Cytochrome P450 1A2,6.3,5.83,501.19,4,9
9333,CHEMBL95,TACRINE,100,CHEMBL222,Sodium-dependent noradrenaline transporter,6.29,6.22,513.0,3,8
9333,CHEMBL95,TACRINE,104063,CHEMBL1743122,Solute carrier family 22 member 2,6.17,6.17,680.0,1,9
9333,CHEMBL95,TACRINE,104067,CHEMBL1743126,Multidrug and toxin extrusion protein 1,5.96,5.96,1100.0,1,9
9333,CHEMBL95,TACRINE,105661,CHEMBL2331065,Alpha-ketoglutarate-dependent dioxygenase FTO,5.77,5.77,1710.0,1,9
92412,CHEMBL953,ENTACAPONE,103668,CHEMBL1293235,Prelamin-A/C,7.35,7.35,44.7,1,9
92412,CHEMBL953,ENTACAPONE,91,CHEMBL2023,Catechol O-methyltransferase,7.22,6.81,60.0,2,9
92412,CHEMBL953,ENTACAPONE,105661,CHEMBL2331065,Alpha-ketoglutarate-dependent dioxygenase FTO,5.52,5.52,3000.0,1,9
93117,CHEMBL956,SUPROFEN,96,CHEMBL221,Prostaglandin G/H synthase 1,6.25,6.25,560.0,1,9
93117,CHEMBL956,SUPROFEN,126,CHEMBL230,Prostaglandin G/H synthase 2,5.56,5.56,2750.0,1,9
93617,CHEMBL957,BOSENTAN,249,CHEMBL252,Endothelin-1 receptor,8.44,7.66,3.67,18,9
93617,CHEMBL957,BOSENTAN,247,CHEMBL1785,Endothelin receptor type B,7.1,6.64,80.0,13,9
93617,CHEMBL957,BOSENTAN,100997,CHEMBL5503,Nuclear receptor subfamily 1 group I member 3,5.68,5.68,2100.0,1,8
160056,CHEMBL95889,BETAINE,78,CHEMBL1963,Thyrotropin receptor,8.4,8.4,4.0,2,9
93895,CHEMBL960,LEFLUNOMIDE,103668,CHEMBL1293235,Prelamin-A/C,8.49,8.49,3.2,1,9
93895,CHEMBL960,LEFLUNOMIDE,12594,CHEMBL3356,Cytochrome P450 1A2,7.2,6.75,63.1,2,8
93895,CHEMBL960,LEFLUNOMIDE,101097,CHEMBL5162,Neuropeptide S receptor,7.1,7.1,79.4,1,9
93895,CHEMBL960,LEFLUNOMIDE,101216,CHEMBL5514,Huntingtin,6.5,6.5,316.2,1,9
93895,CHEMBL960,LEFLUNOMIDE,103710,CHEMBL1293277,NPC intracellular cholesterol transporter 1,6.25,6.0,562.3,2,9
93895,CHEMBL960,LEFLUNOMIDE,17045,CHEMBL340,Cytochrome P450 3A4,6.2,6.2,631.0,2,9
93895,CHEMBL960,LEFLUNOMIDE,103727,CHEMBL1293294,Ras-related protein Rab-9A,6.14,5.99,730.8,2,9
93895,CHEMBL960,LEFLUNOMIDE,157,CHEMBL1966,"Dihydroorotate dehydrogenase (quinone), mitochondrial",6.1,6.1,800.0,1,9
93895,CHEMBL960,LEFLUNOMIDE,155,CHEMBL238,Sodium-dependent dopamine transporter,5.64,5.59,2291.0,2,8
93895,CHEMBL960,LEFLUNOMIDE,103711,CHEMBL1293278,Geminin,5.5,5.5,3162.3,1,9
94484,CHEMBL963,OXYMORPHONE,129,CHEMBL233,Mu-type opioid receptor,8.75,8.43,1.79,2,9
94484,CHEMBL963,OXYMORPHONE,137,CHEMBL237,Kappa-type opioid receptor,7.6,7.6,25.3,1,9
94484,CHEMBL963,OXYMORPHONE,136,CHEMBL236,Delta-type opioid receptor,7.35,7.16,45.0,4,9
94571,CHEMBL964,DISULFIRAM,103657,CHEMBL1293224,Microtubule-associated protein tau,7.6,6.28,25.1,3,9
94571,CHEMBL964,DISULFIRAM,118171,CHEMBL4295926,Lysyl oxidase homolog 4,7.23,7.23,59.0,1,9
94571,CHEMBL964,DISULFIRAM,12054,CHEMBL2903,Polyunsaturated fatty acid lipoxygenase ALOX15,7.2,6.63,63.1,3,9
94571,CHEMBL964,DISULFIRAM,11400,CHEMBL2842,Serine/threonine-protein kinase mTOR,7.18,6.48,65.6,3,9
94571,CHEMBL964,DISULFIRAM,11130,CHEMBL3577,Aldehyde dehydrogenase 1A1,7.05,6.82,89.1,6,9
94571,CHEMBL964,DISULFIRAM,103668,CHEMBL1293235,Prelamin-A/C,7.05,6.53,89.1,4,9
94571,CHEMBL964,DISULFIRAM,117594,CHEMBL4105989,Lysyl oxidase homolog 3,7.03,7.03,93.0,1,9
94571,CHEMBL964,DISULFIRAM,115990,CHEMBL3714029,Lysyl oxidase homolog 2,6.82,6.82,150.0,1,9
94571,CHEMBL964,DISULFIRAM,100782,CHEMBL4159,3-hydroxyacyl-CoA dehydrogenase type-2,6.8,6.8,158.5,2,9
94571,CHEMBL964,DISULFIRAM,280,CHEMBL256,Adenosine receptor A3,6.7,6.33,201.0,3,8
94571,CHEMBL964,DISULFIRAM,10978,CHEMBL2249,Protein-lysine 6-oxidase,6.5,6.5,320.0,1,9
94571,CHEMBL964,DISULFIRAM,100193,CHEMBL4191,Monoglyceride lipase,6.44,6.17,360.0,2,9
94571,CHEMBL964,DISULFIRAM,130,CHEMBL234,D(3) dopamine receptor,6.43,6.01,368.0,3,8
94571,CHEMBL964,DISULFIRAM,12911,CHEMBL3397,Cytochrome P450 2C9,6.4,6.0,398.1,4,9
94571,CHEMBL964,DISULFIRAM,103689,CHEMBL1293256,Thrombopoietin,6.4,6.4,398.1,2,9
94571,CHEMBL964,DISULFIRAM,118997,CHEMBL4523247,Gasdermin-D,6.4,6.4,400.0,1,9
94571,CHEMBL964,DISULFIRAM,105596,CHEMBL2311243,D-3-phosphoglycerate dehydrogenase,6.23,6.23,590.0,1,9
94571,CHEMBL964,DISULFIRAM,11415,CHEMBL3975,"Fructose-1,6-bisphosphatase 1",6.22,5.88,600.0,9,9
94571,CHEMBL964,DISULFIRAM,102672,CHEMBL6032,Histone-lysine N-methyltransferase EHMT2,6.22,6.22,600.0,1,9
94571,CHEMBL964,DISULFIRAM,12912,CHEMBL3622,Cytochrome P450 2C19,6.1,6.1,794.3,2,9
94571,CHEMBL964,DISULFIRAM,101216,CHEMBL5514,Huntingtin,6.1,6.1,794.3,1,9
94571,CHEMBL964,DISULFIRAM,11575,CHEMBL4015,C-C chemokine receptor type 2,6.02,5.81,954.0,2,8
94571,CHEMBL964,DISULFIRAM,88,CHEMBL2056,D(1A) dopamine receptor,5.97,5.82,1079.0,2,8
94571,CHEMBL964,DISULFIRAM,90,CHEMBL219,D(4) dopamine receptor,5.96,5.73,1105.0,2,8
94571,CHEMBL964,DISULFIRAM,129,CHEMBL233,Mu-type opioid receptor,5.85,5.85,1425.0,1,8
94571,CHEMBL964,DISULFIRAM,216,CHEMBL1942,Alpha-2B adrenergic receptor,5.83,5.83,1469.0,1,8
94571,CHEMBL964,DISULFIRAM,11639,CHEMBL3385,Mitogen-activated protein kinase 3,5.82,5.82,1510.0,1,8
94571,CHEMBL964,DISULFIRAM,12594,CHEMBL3356,Cytochrome P450 1A2,5.8,5.8,1584.89,1,8
94571,CHEMBL964,DISULFIRAM,102671,CHEMBL6031,Histone-lysine N-methyltransferase EHMT1,5.8,5.8,1600.0,1,9
94571,CHEMBL964,DISULFIRAM,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.74,5.74,1839.0,1,8
94571,CHEMBL964,DISULFIRAM,11134,CHEMBL3687,Polyunsaturated fatty acid lipoxygenase ALOX12,5.7,5.6,1995.3,2,9
94571,CHEMBL964,DISULFIRAM,137,CHEMBL237,Kappa-type opioid receptor,5.61,5.61,2441.0,1,8
94571,CHEMBL964,DISULFIRAM,103688,CHEMBL1293255,15-hydroxyprostaglandin dehydrogenase [NAD(+)],5.6,5.54,2511.9,4,9
94571,CHEMBL964,DISULFIRAM,101412,CHEMBL6007,Transient receptor potential cation channel subfamily A member 1,5.52,5.52,3000.0,1,9
94790,CHEMBL965,CARBAMOYLCHOLINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,7.39,6.46,41.0,3,9
94790,CHEMBL965,CARBAMOYLCHOLINE,12912,CHEMBL3622,Cytochrome P450 2C19,7.0,7.0,100.0,1,9
94790,CHEMBL965,CARBAMOYLCHOLINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,6.81,6.22,154.88,2,9
94790,CHEMBL965,CARBAMOYLCHOLINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,6.45,6.45,356.1,1,8
95909,CHEMBL967,TEMAZEPAM,103668,CHEMBL1293235,Prelamin-A/C,6.55,6.55,281.8,1,9
95909,CHEMBL967,TEMAZEPAM,170,CHEMBL241,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",5.52,5.52,3000.0,1,8
95929,CHEMBL968,FLURAZEPAM,137,CHEMBL237,Kappa-type opioid receptor,6.68,6.68,209.6,1,8
95929,CHEMBL968,FLURAZEPAM,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.05,6.05,896.0,1,8
95970,CHEMBL970,HALAZEPAM,129,CHEMBL233,Mu-type opioid receptor,5.92,5.92,1200.0,1,8
96021,CHEMBL972,SELEGILINE,104,CHEMBL2039,Amine oxidase [flavin-containing] B,10.77,7.52,0.017,106,9
96021,CHEMBL972,SELEGILINE,86,CHEMBL1951,Amine oxidase [flavin-containing] A,7.17,6.04,67.25,10,9
96021,CHEMBL972,SELEGILINE,216,CHEMBL1942,Alpha-2B adrenergic receptor,6.76,6.59,172.0,2,8
96021,CHEMBL972,SELEGILINE,102780,CHEMBL6152,Alpha-synuclein,6.57,6.57,270.0,1,9
96021,CHEMBL972,SELEGILINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,6.17,5.96,674.0,2,8
96021,CHEMBL972,SELEGILINE,218,CHEMBL1916,Alpha-2C adrenergic receptor,5.54,5.54,2900.0,1,8
96107,CHEMBL973,TERIFLUNOMIDE,157,CHEMBL1966,"Dihydroorotate dehydrogenase (quinone), mitochondrial",7.52,6.52,30.0,22,9
96107,CHEMBL973,TERIFLUNOMIDE,6,CHEMBL202,Dihydrofolate reductase,6.41,6.41,388.0,1,9
99024,CHEMBL976,PRAZIQUANTEL,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,8.49,8.49,3.2,2,9
99024,CHEMBL976,PRAZIQUANTEL,20053,CHEMBL4096,Cellular tumor antigen p53,6.9,6.9,125.9,1,9
99024,CHEMBL976,PRAZIQUANTEL,103665,CHEMBL1293232,Survival motor neuron protein,5.85,5.85,1412.5,1,9
99284,CHEMBL977,HYDROCORTISONE HEMISUCCINATE ANHYDROUS,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,6.1,6.1,794.3,2,9
99284,CHEMBL977,HYDROCORTISONE HEMISUCCINATE ANHYDROUS,103665,CHEMBL1293232,Survival motor neuron protein,5.9,5.9,1258.9,1,9
99320,CHEMBL978,METHACHOLINE,61,CHEMBL216,Muscarinic acetylcholine receptor M1,8.1,8.1,7.9,1,8
99320,CHEMBL978,METHACHOLINE,47,CHEMBL211,Muscarinic acetylcholine receptor M2,7.23,6.44,59.0,3,9
99320,CHEMBL978,METHACHOLINE,246,CHEMBL2069,Thromboxane A2 receptor,6.08,6.08,824.4,1,8
99320,CHEMBL978,METHACHOLINE,214,CHEMBL1821,Muscarinic acetylcholine receptor M4,5.8,5.8,1600.0,1,9
99389,CHEMBL979,MEPROBAMATE,103668,CHEMBL1293235,Prelamin-A/C,6.35,6.35,446.7,1,9
11305,CHEMBL98,VORINOSTAT,12697,CHEMBL325,Histone deacetylase 1,9.64,7.33,0.23,404,9
11305,CHEMBL98,VORINOSTAT,11232,CHEMBL3524,Histone deacetylase 4,9.0,6.74,1.0,31,9
11305,CHEMBL98,VORINOSTAT,11307,CHEMBL1865,Histone deacetylase 6,9.0,7.46,1.0,339,9
11305,CHEMBL98,VORINOSTAT,11797,CHEMBL4145,Histone deacetylase 9,9.0,6.83,1.0,17,9
11305,CHEMBL98,VORINOSTAT,12283,CHEMBL2563,Histone deacetylase 5,9.0,6.48,1.0,22,9
11305,CHEMBL98,VORINOSTAT,11208,CHEMBL1829,Histone deacetylase 3,8.85,7.33,1.4,172,9
11305,CHEMBL98,VORINOSTAT,11206,CHEMBL1937,Histone deacetylase 2,8.8,7.05,1.6,232,9
11305,CHEMBL98,VORINOSTAT,12443,CHEMBL2716,Histone deacetylase 7,8.7,6.83,2.0,17,9
11305,CHEMBL98,VORINOSTAT,12021,CHEMBL3310,Histone deacetylase 11,8.4,6.89,4.0,34,9
11305,CHEMBL98,VORINOSTAT,10869,CHEMBL3192,Histone deacetylase 8,8.26,6.28,5.5,183,9
11305,CHEMBL98,VORINOSTAT,103454,CHEMBL1163125,Bromodomain-containing protein 4,8.0,7.17,10.0,3,9
11305,CHEMBL98,VORINOSTAT,9,CHEMBL203,Epidermal growth factor receptor,7.92,6.98,12.0,2,9
11305,CHEMBL98,VORINOSTAT,10945,CHEMBL5103,Polyamine deacetylase HDAC10,7.57,6.84,27.0,64,9
11305,CHEMBL98,VORINOSTAT,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.49,6.49,322.0,1,9
11305,CHEMBL98,VORINOSTAT,104176,CHEMBL1795094,Nuclear receptor subfamily 0 group B member 1,6.13,6.13,747.17,1,8
11305,CHEMBL98,VORINOSTAT,10907,CHEMBL3024,Serine/threonine-protein kinase PLK1,5.8,5.8,1596.78,1,9
11305,CHEMBL98,VORINOSTAT,237,CHEMBL4618,Leukotriene A-4 hydrolase,5.78,5.78,1670.0,1,9
100310,CHEMBL981,FENOFIBRIC ACID,10148,CHEMBL4879,"Fatty acid-binding protein, intestinal",6.0,6.0,1000.0,1,8
100310,CHEMBL981,FENOFIBRIC ACID,163,CHEMBL239,Peroxisome proliferator-activated receptor alpha,5.58,5.58,2646.0,1,9
100696,CHEMBL982,NALMEFENE,137,CHEMBL237,Kappa-type opioid receptor,10.08,8.64,0.083,6,9
100696,CHEMBL982,NALMEFENE,129,CHEMBL233,Mu-type opioid receptor,9.62,9.35,0.24,6,9
100696,CHEMBL982,NALMEFENE,136,CHEMBL236,Delta-type opioid receptor,9.04,7.95,0.912,6,9
101810,CHEMBL983,SUCCINYLCHOLINE CHLORIDE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,7.8,7.8,15.8,2,9
102073,CHEMBL985,UREA,119204,CHEMBL4523454,Olfactory receptor 51E2,7.64,7.64,23.0,1,9
102073,CHEMBL985,UREA,103668,CHEMBL1293235,Prelamin-A/C,6.1,6.1,794.3,1,9
104574,CHEMBL986,RETINOL,17041,CHEMBL3100,Retinol-binding protein 4,8.08,7.41,8.3,2,9
104574,CHEMBL986,RETINOL,11638,CHEMBL4040,Mitogen-activated protein kinase 1,7.5,7.5,31.6,1,9
104574,CHEMBL986,RETINOL,10656,CHEMBL2487,Amyloid-beta precursor protein,6.75,6.75,180.0,1,9
104574,CHEMBL986,RETINOL,102780,CHEMBL6152,Alpha-synuclein,6.72,6.72,190.0,1,9
105252,CHEMBL989,FLUOCINOLONE ACETONIDE,100325,CHEMBL4261,Hypoxia-inducible factor 1-alpha,8.89,8.89,1.3,2,9
105252,CHEMBL989,FLUOCINOLONE ACETONIDE,25,CHEMBL2034,Glucocorticoid receptor,8.85,8.68,1.423,2,8
105252,CHEMBL989,FLUOCINOLONE ACETONIDE,36,CHEMBL208,Progesterone receptor,7.97,7.97,10.7,1,8
105252,CHEMBL989,FLUOCINOLONE ACETONIDE,11638,CHEMBL4040,Mitogen-activated protein kinase 1,5.5,5.5,3162.3,1,9
105442,CHEMBL990,BUTENAFINE,11365,CHEMBL289,Cytochrome P450 2D6,6.52,6.52,300.0,1,8
105442,CHEMBL990,BUTENAFINE,121,CHEMBL228,Sodium-dependent serotonin transporter,6.12,5.98,750.0,2,8
105442,CHEMBL990,BUTENAFINE,52,CHEMBL1867,Alpha-2A adrenergic receptor,5.86,5.86,1366.6,1,8
105442,CHEMBL990,BUTENAFINE,11272,CHEMBL287,Sigma non-opioid intracellular receptor 1,5.78,5.78,1661.5,1,8
105442,CHEMBL990,BUTENAFINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,5.55,5.55,2800.0,1,8
107119,CHEMBL991,STAVUDINE,103670,CHEMBL1293237,RecQ-like DNA helicase BLM,6.1,6.1,794.3,2,9
109797,CHEMBL995,LOSARTAN POTASSIUM,115,CHEMBL227,Type-1 angiotensin II receptor,8.26,8.26,5.5,1,8
109807,CHEMBL996,CEFOXITIN,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.62,5.62,2400.0,1,8
110435,CHEMBL997,IBANDRONIC ACID,71,CHEMBL1782,Farnesyl pyrophosphate synthase,8.44,7.12,3.6,9,9
110435,CHEMBL997,IBANDRONIC ACID,170,CHEMBL241,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",5.72,5.72,1900.0,1,8
110803,CHEMBL998,LORATADINE,12912,CHEMBL3622,Cytochrome P450 2C19,7.8,6.58,16.0,3,9
110803,CHEMBL998,LORATADINE,127,CHEMBL231,Histamine H1 receptor,7.7,6.72,20.0,8,9
110803,CHEMBL998,LORATADINE,12911,CHEMBL3397,Cytochrome P450 2C9,7.4,7.4,39.8,1,9
110803,CHEMBL998,LORATADINE,227,CHEMBL1833,5-hydroxytryptamine receptor 2B,6.81,6.44,156.0,3,8
110803,CHEMBL998,LORATADINE,165,CHEMBL240,Voltage-gated inwardly rectifying potassium channel KCNH2,6.77,6.76,169.82,6,9
110803,CHEMBL998,LORATADINE,102,CHEMBL1941,Histamine H2 receptor,6.16,6.16,696.4,1,8
110803,CHEMBL998,LORATADINE,137,CHEMBL237,Kappa-type opioid receptor,6.02,6.02,963.9,1,8
110803,CHEMBL998,LORATADINE,10163,CHEMBL3721,Cytochrome P450 2C8,5.53,5.53,2950.0,1,9
110803,CHEMBL998,LORATADINE,11912,CHEMBL3401,Nuclear receptor subfamily 1 group I member 2,5.52,5.52,3000.0,1,9
110803,CHEMBL998,LORATADINE,11180,CHEMBL2047,Bile acid receptor,5.51,5.51,3070.0,1,9
164035,CHEMBL99946,LEVOMILNACIPRAN,100,CHEMBL222,Sodium-dependent noradrenaline transporter,7.98,7.59,10.5,3,9
164035,CHEMBL99946,LEVOMILNACIPRAN,121,CHEMBL228,Sodium-dependent serotonin transporter,6.5,6.5,320.0,2,9
164035,CHEMBL99946,LEVOMILNACIPRAN,155,CHEMBL238,Sodium-dependent dopamine transporter,5.5,5.5,3200.0,3,9
